FN Clarivate Analytics Web of Science
VR 1.0
PT J
AU de Jesus, JG
   Graf, T
   Giovanetti, M
   Mares-Guia, MA
   Xavier, J
   Maia, ML
   Fonseca, V
   Fabri, A
   dos Santos, RF
   Pereira, FM
   Santos, LFO
   da Silva, LRD
   Maia, ZPG
   Cerqueira, JXG
   Theze, J
   Abade, L
   Cordeiro, MDS
   Torquato, SSC
   Santana, EB
   Silva, NSD
   Dourado, RSO
   Alves, AB
   Guedes, AD
   da Silva, PM
   Faria, NR
   de Albuquerque, CFC
   de Abreu, AL
   Romano, APM
   Croda, J
   Said, RFD
   Cunha, GM
   Cerqueira, JMD
   de Mello, ALES
   de Filippis, AMB
   Alcantara, LC
AF de Jesus, Jaqueline Goes
   Graf, Tiago
   Giovanetti, Marta
   Mares-Guia, Maria Angelica
   Xavier, Joilson
   Maia, Maricelia Lima
   Fonseca, Vagner
   Fabri, Allison
   dos Santos, Roberto Fonseca
   Pereira, Felicidade Mota
   Oliveira Santos, Leandro Ferraz
   de Oliveira da Silva, Luciana Reboredo
   Gusmao Maia, Zuinara Pereira
   Gomes Cerqueira, Jananci Xavier
   Theze, Julien
   Abade, Leandro
   Santana Cordeiro, Mirza de Carvalho
   Cerqueira Torquato, Sintia Sacramento
   Santana, Eloisa Bahia
   de Jesus Silva, Neuza Santos
   Oiticica Dourado, Rosemary Sarmento
   Alves, Ademilson Bras
   Guedes, Adeilde do Socorro
   da Silva Filho, Pedro Macedo
   Faria, Nuno Rodrigues
   Campelo de Albuquerque, Carlos F.
   de Abreu, Andre Luiz
   Martins Romano, Alessandro Pecego
   Croda, Julio
   do Carmo Said, Rodrigo Fabiano
   Cunha, Gabriel Muricy
   da Fonseca Cerqueira, Jeane Magnavita
   de Mello, Arabela Leal e Silva
   Bispo de Filippis, Ana Maria
   Alcantara, Luiz Carlos Junior
TI Yellow fever transmission in non-human primates, Bahia, Northeastern
   Brazil
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID EPIDEMIOLOGY; MODEL
AB Author summary Between 2016 and 2018, Brazil witnessed the largest YFV outbreak since years, with 2.154 cases and 745 deaths. Here we report the introduction of the virus in the state of Bahia suggesting two independent introductions from Minas Gerais and Espirito Santo. We also highlight the actions taken by epidemiological surveillance division that may have prevent human infections.
   Yellow fever virus (YFV) causes a clinical syndrome of acute hemorrhagic hepatitis. YFV transmission involves non-human primates (NHP), mosquitoes and humans. By late 2016, Brazil experienced the largest YFV outbreak of the last 100 years, with 2050 human confirmed cases, with 681 cases ending in death and 764 confirmed epizootic cases in NHP. Among affected areas, Bahia state in Northeastern was the only region with no autochthonous human cases. By using next generation sequence approach, we investigated the molecular epidemiology of YFV in NHP in Bahia and discuss what factors might have prevented human cases. We investigated 47 YFV positive tissue samples from NHP cases to generate 8 novel YFV genomes. ML phylogenetic tree reconstructions and automated subtyping tools placed the newly generated genomes within the South American genotype I (SA I). Our analysis revealed that the YFV genomes from Bahia formed two distinct well-supported phylogenetic clusters that emerged most likely of an introduction from Minas Gerais and Espirito Santo states. Vegetation coverage analysis performed shows predominantly low to medium vegetation coverage in Bahia state. Together, our findings support the hypothesis of two independent YFV SA-I introductions. We also highlighted the effectiveness of the actions taken by epidemiological surveillance team of the state to prevented human cases.
C1 [de Jesus, Jaqueline Goes; Graf, Tiago] Fundacao Oswaldo Cruz, Lab Patol Expt, Inst Goncalo Moniz, Salvador, BA, Brazil.
   [de Jesus, Jaqueline Goes] Univ Sao Paulo, Inst Med Trop Sao Paulo, Lab Parasitol Med, Sao Paulo, SP, Brazil.
   [Giovanetti, Marta; Mares-Guia, Maria Angelica; Fabri, Allison; Bispo de Filippis, Ana Maria; Alcantara, Luiz Carlos Junior] Fundacao Oswaldo Cruz, Lab Flavivirus, Rio De Janeiro, Brazil.
   [Giovanetti, Marta; Xavier, Joilson; Fonseca, Vagner; Alcantara, Luiz Carlos Junior] Univ Fed Minas Gerais, Lab Genet Celular & Mol, ICB, Belo Horizonte, MG, Brazil.
   [Maia, Maricelia Lima] Univ Estadual Feira de Santana, Feira De Santana, BA, Brazil.
   [Maia, Maricelia Lima; Santana Cordeiro, Mirza de Carvalho; Cerqueira Torquato, Sintia Sacramento; Santana, Eloisa Bahia; de Jesus Silva, Neuza Santos; Oiticica Dourado, Rosemary Sarmento] Minist Saude, Secretaria Saude Feira de Santana, Feira De Santana, BA, Brazil.
   [Fonseca, Vagner] Univ KwaZulu Natal, Coll Hlth Sci, KwaZulu Natal Res Innovat & Sequencing Platform K, ZA-4001 Durban, South Africa.
   [dos Santos, Roberto Fonseca; Pereira, Felicidade Mota; Oliveira Santos, Leandro Ferraz; de Oliveira da Silva, Luciana Reboredo; de Mello, Arabela Leal e Silva] Lab Cent Saude Publ Bahia Prof Goncalo Moniz LACE, Salvador, BA, Brazil.
   [Gusmao Maia, Zuinara Pereira] Fac Maria Milza FAMAM, Mangabeira, BA, Brazil.
   [Gomes Cerqueira, Jananci Xavier; Alves, Ademilson Bras; Guedes, Adeilde do Socorro; da Silva Filho, Pedro Macedo; Cunha, Gabriel Muricy; da Fonseca Cerqueira, Jeane Magnavita] Secretaria Saude Estado Bahia, Vigilancia Epidemiol Estado Bahia, Salvador, BA, Brazil.
   [Theze, Julien; Faria, Nuno Rodrigues] Univ Oxford, Dept Zool, Oxford, England.
   [Abade, Leandro] Univ Oxford, Nuffield Dept Med, Global Hlth Network, Oxford, England.
   [Campelo de Albuquerque, Carlos F.] Org Panamer Saude, Org Mundial Saude, Brasilia, DF, Brazil.
   [de Abreu, Andre Luiz] Minist Saude, CGLAB SVS MS Brasilia, Coordenacao Geral Lab Saude Publ, Secretaria Vigilancia Saude, Brasilia, DF, Brazil.
   [Martins Romano, Alessandro Pecego; do Carmo Said, Rodrigo Fabiano] Coordenacao Geral Vigilancia Arboviroses CGARB, Brasilia, DF, Brazil.
   [Croda, Julio] Minist Saude DEVIT SVS MS, Secretaria Vigilancia Saude, Dept Vigilancia Doencas Transmissiveis, Campo Grande, MS, Brazil.
RP Alcantara, LC (corresponding author), Fundacao Oswaldo Cruz, Lab Flavivirus, Rio De Janeiro, Brazil.; Alcantara, LC (corresponding author), Univ Fed Minas Gerais, Lab Genet Celular & Mol, ICB, Belo Horizonte, MG, Brazil.
EM luiz.alcantara@ioc.fiocruz.br
RI Faria, Nuno R/I-2975-2012; Maia, Zuinara/M-7713-2019; Graf,
   Tiago/S-8535-2019
OI Faria, Nuno R/0000-0001-8839-2798; Graf, Tiago/0000-0003-4921-7975;
   Theze, Julien/0000-0001-8188-9494; Fonseca, Vagner/0000-0001-5521-6448;
   Xavier, Joilson/0000-0003-3916-2018
FU CNPq/MCTI [440685/2016-8]; DECIT/SCTIE/MoH [440685/2016-8]; CAPESCAPES
   [88887.130716/2016-00]
FX This work was supported by CNPq/MCTI and DECIT/SCTIE/MoH
   (440685/2016-8), CAPES (88887.130716/2016-00). The funders had no role
   in study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Almeida MAB, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002741
   Barrett ADT, 2018, SCIENCE, V361, P847, DOI 10.1126/science.aau8225
   Brasil Ministerio da Saude Secretaria de Vigilancia em Saude, 2019, B EP MON FEBR AM BRA
   BRASIL Ministerio da Saude Secretaria de Vigilancia em Saude, 2017, B EP EM EP FEBR AM B, V48
   Brasil Ministerio da Saude Secretaria de Vigilancia em Saude, 2019, B EP MON CAS ARB URB, V50
   Brasil Ministerio da Saude Secretaria de Vigilancia em Saude, 2016, B EP MON CAS DENG FE, V47, P7
   BRASIL Ministerio da Saude Secretaria de Vigilancia em Saude, 2017, B EP MON PER SAZ FEB
   Brasil Ministerio da Saude Secretaria de Vigilancia em Saude. Diretoria de Vigilancia Epidemiologica. Superintendencia de Vigilancia em Saude, 2019, B EP FEBR AM
   Camara FP, 2011, REV SOC BRAS MED TRO, V44, P297, DOI [10.1590/S0037-86822011005000024, 10.1590/s0037-86822011005000024]
   Cardoso JD, 2010, EMERG INFECT DIS, V16, P1918, DOI 10.3201/eid1612.100608
   Chen C, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006738
   Domingo C, 2012, J CLIN MICROBIOL, V50, P4054, DOI 10.1128/JCM.01799-12
   Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088
   Faria NR, 2018, SCIENCE, V361, P894, DOI 10.1126/science.aat7115
   Gill MS, 2013, MOL BIOL EVOL, V30, P713, DOI 10.1093/molbev/mss265
   Huang YJS, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-60
   Kalyaanamoorthy S, 2017, NAT METHODS, V14, P587, DOI [10.1038/NMETH.4285, 10.1038/nmeth.4285]
   Katoh K, 2019, BRIEF BIOINFORM, V20, P1160, DOI 10.1093/bib/bbx108
   Nguyen LT, 2015, MOL BIOL EVOL, V32, P268, DOI 10.1093/molbev/msu300
   Larsson A, 2014, BIOINFORMATICS, V30, P3276, DOI 10.1093/bioinformatics/btu531
   Mares-Guia MAMD, 2020, PARASITE VECTOR, V13, DOI 10.1186/s13071-020-3966-x
   Mondet B, 1996, B SOC PATHOL EXOT, V89, P155
   Mondet B, 2001, B SOC PATHOL EXOT, V94, P260
   Possas C, 2019, INTELLECTUAL PROPERT
   Possas C, 2018, MEM I OSWALDO CRUZ, V113, DOI 10.1590/0074-02760180278
   Possas C, 2018, MEM I OSWALDO CRUZ, V113, P1, DOI 10.1590/0074-02760170361
   Quick J, 2017, NAT PROTOC, V12, P1261, DOI 10.1038/nprot.2017.066
   Rambaut A, 2018, SYST BIOL, V67, P901, DOI 10.1093/sysbio/syy032
   Rambaut A, 2016, VIRUS EVOL, V2, DOI 10.1093/ve/vew007
   Sanna A, 2018, EURO SURVEILLANCE B, V23
   Shapiro B, 2006, MOL BIOL EVOL, V23, P7, DOI 10.1093/molbev/msj021
   Simon LV, 2019, STATPEARLS
   Suchard MA, 2018, VIRUS EVOL, V4, DOI 10.1093/ve/vey016
   WHO, 2017, GLOB STRAT EL YELL F
   World Health Organization, 2019, EM PREP RESP YELL FE
NR 35
TC 0
Z9 0
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD AUG
PY 2020
VL 14
IS 8
AR e0008405
DI 10.1371/journal.pntd.0008405
PG 13
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA NC9JH
UT WOS:000561526200001
PM 32780745
OA DOAJ Gold, Green Published
DA 2020-10-22
ER

PT J
AU Hill, SC
   de Souza, R
   Theze, J
   Claro, I
   Aguiar, RS
   Abade, L
   Santos, FCP
   Cunha, MS
   Nogueira, JS
   Salles, FCS
   Rocco, IM
   Maeda, AY
   Vasami, FGS
   du Plessis, L
   Silveira, PP
   de Jesus, JG
   Quick, J
   Fernandes, NCCA
   Guerra, JM
   Ressio, RA
   Giovanetti, M
   Alcantara, LCJ
   Cirqueira, CS
   Diaz-Delgado, J
   Macedo, FLL
   Timenetsky, MDST
   de Paula, R
   Spinola, R
   de Deus, JT
   Mucci, LF
   Tubaki, RM
   de Menezes, RMT
   Ramos, PL
   de Abreu, AL
   Cruz, LN
   Loman, N
   Dellicour, S
   Pybus, OG
   Sabino, EC
   Faria, NR
AF Hill, Sarah C.
   de Souza, Renato
   Theze, Julien
   Claro, Ingra
   Aguiar, Renato S.
   Abade, Leandro
   Santos, Fabiana C. P.
   Cunha, Mariana S.
   Nogueira, Juliana S.
   Salles, Flavia C. S.
   Rocco, Iray M.
   Maeda, Adriana Y.
   Vasami, Fernanda G. S.
   du Plessis, Louis
   Silveira, Paola P.
   de Jesus, Jaqueline G.
   Quick, Joshua
   Fernandes, Natalia C. C. A.
   Guerra, Juliana M.
   Ressio, Rodrigo A.
   Giovanetti, Marta
   Alcantara, Luiz C. J.
   Cirqueira, Cinthya S.
   Diaz-Delgado, Josue
   Macedo, Fernando L. L.
   Timenetsky, Maria do Carmo S. T.
   de Paula, Regiane
   Spinola, Roberta
   de Deus, Juliana Telles
   Mucci, Luis F.
   Tubaki, Rosa Maria
   de Menezes, Regiane M. T.
   Ramos, Patricia L.
   de Abreu, Andre L.
   Cruz, Laura N.
   Loman, Nick
   Dellicour, Simon
   Pybus, Oliver G.
   Sabino, Ester C.
   Faria, Nuno R.
TI Genomic Surveillance of Yellow Fever Virus Epizootic in Sao Paulo,
   Brazil, 2016-2018
SO PLOS PATHOGENS
LA English
DT Article
ID REAL-TIME; STATE; PERFORMANCE; ALIGNMENT; DYNAMICS; EBOLA
AB Sao Paulo, a densely inhabited state in southeast Brazil that contains the fourth most populated city in the world, recently experienced its largest yellow fever virus (YFV) outbreak in decades. YFV does not normally circulate extensively in Sao Paulo, so most people were unvaccinated when the outbreak began. Surveillance in non-human primates (NHPs) is important for determining the magnitude and geographic extent of an epizootic, thereby helping to evaluate the risk of YFV spill over to humans. Data from infected NHPs can give more accurate insights into YFV spread than when using data from human cases alone. To contextualise human cases, identify epizootic foci and uncover the rate and direction of YFV spread in Sao Paulo, we generated and analysed virus genomic data and epizootic case data from NHP in Sao Paulo. We report the occurrence of three spatiotemporally distinct phases of the outbreak in Sao Paulo prior to February 2018. We generated 51 new virus genomes from YFV positive cases identified in 23 different municipalities in Sao Paulo, mostly sampled from NHPs between October 2016 and January 2018. Although we observe substantial heterogeneity in lineage dispersal velocities between phylogenetic branches, continuous phylogeographic analyses of generated YFV genomes suggest that YFV lineages spread in Sao Paulo at a mean rate of approximately 1km per day during all phases of the outbreak. Viral lineages from the first epizootic phase in northern Sao Paulo subsequently dispersed towards the south of the state to cause the second and third epizootic phases there. This alters our understanding of how YFV was introduced into the densely populated south of Sao Paulo state. Our results shed light on the sylvatic transmission of YFV in highly fragmented forested regions in Sao Paulo state and highlight the importance of continued surveillance of zoonotic pathogens in sentinel species.
C1 [Hill, Sarah C.; Theze, Julien; Abade, Leandro; du Plessis, Louis; Pybus, Oliver G.; Faria, Nuno R.] Univ Oxford, Dept Zool, Oxford, England.
   [Hill, Sarah C.; Pybus, Oliver G.] Royal Vet Coll, Dept Pathobiol & Populat Sci, Hawkshead, England.
   [de Souza, Renato; Santos, Fabiana C. P.; Cunha, Mariana S.; Nogueira, Juliana S.; Rocco, Iray M.; Maeda, Adriana Y.; Vasami, Fernanda G. S.; Fernandes, Natalia C. C. A.; Guerra, Juliana M.; Ressio, Rodrigo A.; Cirqueira, Cinthya S.; Diaz-Delgado, Josue; Macedo, Fernando L. L.; Timenetsky, Maria do Carmo S. T.; Cruz, Laura N.] Adolfo Lutz Inst, Sao Paulo, Brazil.
   [Theze, Julien] Univ Clermont Auvergne, INRAE, VetAgro Sup, UMR EPIA, St Genes Champanelle, France.
   [Claro, Ingra; Salles, Flavia C. S.; de Jesus, Jaqueline G.; Sabino, Ester C.] Inst Med Trop, Fac Med, Dept Molestias Infecciosas & Parasitarias, Sao Paulo, Brazil.
   [Claro, Ingra; Salles, Flavia C. S.; de Jesus, Jaqueline G.; Sabino, Ester C.] Univ Sao Paulo, Sao Paulo, Brazil.
   [Aguiar, Renato S.; Silveira, Paola P.] Inst Biol, Dept Genet, Lab Virol Mol, Rio De Janeiro, Brazil.
   [Quick, Joshua; Loman, Nick] Univ Birmingham, Inst Microbiol & Infect, Birmingham, W Midlands, England.
   [Giovanetti, Marta; Alcantara, Luiz C. J.] Fiocruz MS, Inst Oswaldo Cruz, Lab Flavivirus, Rio De Janeiro, Brazil.
   [de Paula, Regiane; Spinola, Roberta] Ctr Vigilancia Epidemiol Prof Alexandre Vranjac, Sao Paulo, Brazil.
   [de Deus, Juliana Telles; Mucci, Luis F.; Tubaki, Rosa Maria; de Menezes, Regiane M. T.] Superintendencia Controle Endemias Estado Sao Paul, Sao Paulo, Brazil.
   [Ramos, Patricia L.] Fundacao Parque Zool Sao Paulo, Sao Paulo, Brazil.
   [de Abreu, Andre L.] Minist Saude SVS MS, Secretaria Vigilancia Saude, Brasilia, DF, Brazil.
   [Dellicour, Simon] Univ Libre Bruxelles, Spatial Epidemiol Lab SpELL, CP160-12 50, Brussels, Belgium.
   [Dellicour, Simon] Katholieke Univ Leuven, Rega Inst, Dept Microbiol Immunol & Transplantat, Leuven, Belgium.
RP Hill, SC; Faria, NR (corresponding author), Univ Oxford, Dept Zool, Oxford, England.; Hill, SC (corresponding author), Royal Vet Coll, Dept Pathobiol & Populat Sci, Hawkshead, England.; Sabino, EC (corresponding author), Inst Med Trop, Fac Med, Dept Molestias Infecciosas & Parasitarias, Sao Paulo, Brazil.; Sabino, EC (corresponding author), Univ Sao Paulo, Sao Paulo, Brazil.
EM sarah.hill@zoo.ox.ac.uk; sabinoec@gmail.com; nuno.faria@zoo.ox.ac.uk
RI Dellicour, Simon/AAE-9054-2020; Guerra, Juliana Mariotti/H-5310-2012;
   Faria, Nuno R/I-2975-2012; Fernandes, Natalia/H-4537-2012
OI Dellicour, Simon/0000-0001-9558-1052; Guerra, Juliana
   Mariotti/0000-0002-0326-7187; Faria, Nuno R/0000-0001-8839-2798;
   Fernandes, Natalia/0000-0003-4754-4200; Theze,
   Julien/0000-0001-8188-9494; da Silva Sales, Flavia
   Cristina/0000-0002-9048-0030
FU Sao Paulo Research Foundation (FAPESP)Fundacao de Amparo a Pesquisa do
   Estado de Sao Paulo (FAPESP); Medical Research Council CADDE partnership
   award [MR/S0195/1, FAPESP 18/14389-0]; Wellcome TrustWellcome Trust;
   Royal Society Sir Henry Dale Fellowship [204311/Z/16/Z]; internal HEFCE
   GCRF grant [005073]; John Fell Research Fund [005166]; CNPqNational
   Council for Scientific and Technological Development (CNPq)
   [400354/2016-0]; FAPESPFundacao de Amparo a Pesquisa do Estado de Sao
   Paulo (FAPESP) [2016/01735-2]; Oxford Martin School; Fonds National de
   la Recherche Scientifique (FNRS, Belgium)Fonds de la Recherche
   Scientifique - FNRS; Fonds Wetenschappelijk Onderzoek (FWO, Belgium)FWO;
   CNPq/MCTI Decit/SCTIE/MoH [440685/2016-8]; CAPESCAPES
   [88887.130716/2016-00]; Fundacao de Amparo a Pesquisa do Estado do Rio
   de Janeiro - FAPERJCarlos Chagas Filho Foundation for Research Support
   of the State of Rio de Janeiro (FAPERJ)
FX NRF, ECS, OGP, SCH, NL and RdS were supported through a Sao Paulo
   Research Foundation (FAPESP) and Medical Research Council CADDE
   partnership award (MR/S0195/1 and FAPESP 18/14389-0)
   (http://caddecentre.org/).NRF and SCH were supported by a Wellcome Trust
   and Royal Society Sir Henry Dale Fellowship awarded to NRF (grant
   204311/Z/16/Z). The research was supported by an internal HEFCE GCRF
   grant 005073 and John Fell Research Fund Grant 005166, awarded to NRF.
   ECS was supported by grants CNPq #400354/2016-0 and FAPESP#2016/01735-2.
   OGP, NRF and LdP were supported by the Oxford Martin School. SD is
   supported by the Fonds National de la Recherche Scientifique (FNRS,
   Belgium) and was previously funded by the Fonds Wetenschappelijk
   Onderzoek (FWO, Belgium). LCJA was supported by CNPq/MCTI
   Decit/SCTIE/MoH (440685/2016-8) and CAPES (88887.130716/2016-00). MG was
   supported by Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro -
   FAPERJ. The funders had no role in study design, data collection and
   analysis, decision to publish, or preparation of the manuscript.
CR [Anonymous], 2008, BEPA, V5, P12
   Arruda DM, 2017, SCI NAT-HEIDELBERG, V104, DOI 10.1007/s00114-017-1456-6
   Ayres DL, 2012, SYST BIOL, V61, P170, DOI 10.1093/sysbio/syr100
   Centro de Vigilancia Epidemiologica, 2019, B EP FEBR AM 18 11 2
   Centro de Vigilancia Epidemiologica, 2019, B EP FEBR AM 21 01 2
   Centro de Vigilancia Epidemiologica, 2019, B EP FEBR AM 02 01 2
   Culot L, 2019, ECOLOGY, V100, DOI 10.1002/ecy.2525
   Cunha MS, 2019, SCI REP, V9, P1, DOI DOI 10.1038/s41598-018-37186-2
   Vasconcelos PFD, 2010, REV SAUDE PUBL, V44, P1144, DOI 10.1590/S0034-89102010005000046
   Darriba D, 2020, MOL BIOL EVOL, V37, P291, DOI 10.1093/molbev/msz189
   DELATORRE C, 2018, FRONT MICROBIOL, V10, P42744, DOI DOI 10.3389/FMICB.2019.00010
   Dellicour S, 2017, MOL BIOL EVOL, V34, P2563, DOI 10.1093/molbev/msx176
   Dellicour S, 2016, BIOINFORMATICS, V32, P3204, DOI 10.1093/bioinformatics/btw384
   do Nascimento Rafaela Almeida, 2013, Neotropical Biology and Conservation, V8, P79, DOI 10.4013/nbc.2013.82.03
   Domingo C, 2012, J CLIN MICROBIOL, V50, P4054, DOI 10.1128/JCM.01799-12
   Drosten C, 2002, J CLIN MICROBIOL, V40, P2323, DOI 10.1128/JCM.40.7.2323-2330.2002
   Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088
   Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075
   Faria NR, 2018, SCIENCE, V361, P894, DOI 10.1126/science.aat7115
   Faria NR, 2012, INFECT GENET EVOL, V12, P453, DOI 10.1016/j.meegid.2011.04.028
   Gill MS, 2013, MOL BIOL EVOL, V30, P713, DOI 10.1093/molbev/mss265
   GUBLER DJ, 1984, AM J TROP MED HYG, V33, P158, DOI 10.4269/ajtmh.1984.33.158
   Instituto Brasileiro de Geografia e Estatistica, 2019, MUN NETW
   Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010
   Lemey P, 2010, MOL BIOL EVOL, V27, P1877, DOI 10.1093/molbev/msq067
   Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324
   Loman NJ, 2015, NAT METHODS, V12, P733, DOI [10.1038/nmeth.3444, 10.1038/NMETH.3444]
   Monath TP, 2015, J CLIN VIROL, V64, P160, DOI 10.1016/j.jcv.2014.08.030
   Moreira-Soto A, 2018, CLIN MICROBIOL INFEC, V24, DOI 10.1016/j.cmi.2018.01.026
   Silva NIO, 2020, VIROL J, V17, DOI 10.1186/s12985-019-1277-7
   Pybus OG, 2012, P NATL ACAD SCI USA, V109, P15066, DOI 10.1073/pnas.1206598109
   QGIS Development Team, 2018, QGIS GEOGR INF SYST
   Quick J, 2017, NAT PROTOC, V12, P1261, DOI 10.1038/nprot.2017.066
   Quick J, 2016, NATURE, V530, P228, DOI 10.1038/nature16996
   Saad LD, 2016, EPIDEMIOL SERV SAUDE, V25, P531, DOI [10.5123/s1679-49742016000300009, 10.5123/S1679-49742016000300009]
   de Abreu FVS, 2019, EMERG MICROBES INFEC, V8, P218, DOI 10.1080/22221751.2019.1568180
   Shearer FM, 2017, LANCET INFECT DIS, V17, P1209, DOI 10.1016/S1473-3099(17)30419-X
   Souza Renato Pereira de, 2011, Rev. Inst. Med. trop. S. Paulo, V53, P133, DOI 10.1590/S0036-46652011000300004
   Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033
   Vainio J., 1998, YELLOW FEVER
   Vasconcelos Pedro Fernando da Costa, 2003, Rev. Soc. Bras. Med. Trop., V36, P275, DOI 10.1590/S0037-86822003000200012
   Vasconcelos PFC, 2003, T ROY SOC TROP MED H, V97, P60, DOI 10.1016/S0035-9203(03)90023-X
   WHO, YELL FEV BRAZ
NR 43
TC 0
Z9 0
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1553-7366
EI 1553-7374
J9 PLOS PATHOG
JI PLoS Pathog.
PD AUG
PY 2020
VL 16
IS 8
AR e1008699
DI 10.1371/journal.ppat.1008699
PG 18
WC Microbiology; Parasitology; Virology
SC Microbiology; Parasitology; Virology
GA NB9AT
UT WOS:000560808000002
PM 32764827
OA DOAJ Gold, Green Published
DA 2020-10-22
ER

PT J
AU Ribeiro, SP
   Silva, ACE
   Dattilo, W
   Reis, AB
   Goes-Neto, A
   Alcantara, LCJ
   Giovanetti, M
   Coura-Vital, W
   Fernandes, GW
   Azevedo, VAC
AF Ribeiro, Servio Pontes
   Castro e Silva, Alcides
   Dattilo, Wesley
   Reis, Alexandre Barbosa
   Goes-Neto, Aristoteles
   Junior Alcantara, Luiz Carlos
   Giovanetti, Marta
   Coura-Vital, Wendel
   Fernandes, Geraldo Wilson
   Azevedo, Vasco Ariston C.
TI Severe airport sanitarian control could slow down the spreading of
   COVID-19 pandemics in Brazil
SO PEERJ
LA English
DT Article
DE SIR model; Metapopulation dynamics; Amazonia; Indigenous people;
   One-Ecohealth; SARS-CoV-2 pandemic
AB Background: We investigated a likely scenario of COVID-19 spreading in Brazil through the complex airport network of the country, for the 90 days after the first national occurrence of the disease. After the confirmation of the first imported cases, the lack of a proper airport entrance control resulted in the infection spreading in a manner directly proportional to the amount of flights reaching each city, following the first occurrence of the virus coming from abroad.
   Methodology: We developed a Susceptible-Infected-Recovered model divided in a metapopulation structure, where cities with airports were demes connected by the number of flights. Subsequently, we further explored the role of the Manaus airport for a rapid entrance of the pandemic into indigenous territories situated in remote places of the Amazon region.
   Results: The expansion of the SARS-CoV-2 virus between cities was fast, directly proportional to the city closeness centrality within the Brazilian air transportation network. There was a clear pattern in the expansion of the pandemic, with a stiff exponential expansion of cases for all the cities. The more a city showed closeness centrality, the greater was its vulnerability to SARS-CoV-2.
   Conclusions: We discussed the weak pandemic control performance of Brazil in comparison with other tropical, developing countries, namely India and Nigeria. Finally, we proposed measures for containing virus spreading taking into consideration the scenario of high poverty.
C1 [Ribeiro, Servio Pontes; Reis, Alexandre Barbosa; Coura-Vital, Wendel] Univ Fed Ouro Preto, Nucleo Pesquisas Ciencias Biol, Ouro Preto, MG, Brazil.
   [Ribeiro, Servio Pontes] Univ Fed Ouro Preto, Lab Ecohlth Ecol Insetos Dossel & Sucessao Nat IC, Ouro Preto, MG, Brazil.
   [Ribeiro, Servio Pontes] Univ Fed Minas Gerais, Lab Fisiol Insetos Hematofagos DEPAR, Belo Horizonte, MG, Brazil.
   [Castro e Silva, Alcides] Univ Fed Ouro Preto, Lab Ciencia Complexidade, Dept Fis, Ouro Preto, MG, Brazil.
   [Dattilo, Wesley] Inst Ecol AC, Red Ecoetol, Xalapa, Veracruz, Mexico.
   [Reis, Alexandre Barbosa] Univ Fed Ouro Preto, Lab Imunopatol, Dept Anal Clin, Escola Farm, Ouro Preto, MG, Brazil.
   [Goes-Neto, Aristoteles] Univ Fed Minas Gerais, Lab Biol Mol & Computac Fungos, Dept Microbiol, ICB, Belo Horizonte, MG, Brazil.
   [Junior Alcantara, Luiz Carlos; Giovanetti, Marta] Fundacao Oswaldo Cruz, Lab Flavivirus, Inst Oswaldo Cruz, Rio De Janeiro, RJ, Brazil.
   [Junior Alcantara, Luiz Carlos; Azevedo, Vasco Ariston C.] Univ Fed Minas Gerais, Lab Genet Celular & Mol, Dept Genet Ecol & Evolucao, ICB, Belo Horizonte, MG, Brazil.
   [Coura-Vital, Wendel] Univ Fed Ouro Preto, Lab Epidemiol & Citol, Dept Anal Clin, Escola Farm, Ouro Preto, MG, Brazil.
   [Fernandes, Geraldo Wilson] Univ Fed Minas Gerais, Dept Genet Ecol & Evolucao, ICB, Belo Horizonte, MG, Brazil.
RP Ribeiro, SP (corresponding author), Univ Fed Ouro Preto, Nucleo Pesquisas Ciencias Biol, Ouro Preto, MG, Brazil.; Ribeiro, SP (corresponding author), Univ Fed Ouro Preto, Lab Ecohlth Ecol Insetos Dossel & Sucessao Nat IC, Ouro Preto, MG, Brazil.; Ribeiro, SP (corresponding author), Univ Fed Minas Gerais, Lab Fisiol Insetos Hematofagos DEPAR, Belo Horizonte, MG, Brazil.; Dattilo, W (corresponding author), Inst Ecol AC, Red Ecoetol, Xalapa, Veracruz, Mexico.
EM spribeiro@ufop.edu.br; wesley.dattilo@inecol.mx
RI Azevedo, Vasco A/B-1556-2019; Goes-Neto, Aristoteles/A-6955-2013;
   Dattilo, Wesley/A-6371-2012
OI Azevedo, Vasco A/0000-0002-4775-2280; Alcantara,
   Luiz/0000-0002-6769-9931; Castro e Silva, Alcides/0000-0003-2863-8076;
   Goes-Neto, Aristoteles/0000-0002-7692-6243; Reis,
   AlessanRSS/0000-0001-8486-7469; Dattilo, Wesley/0000-0002-4758-4379
FU CNPqNational Council for Scientific and Technological Development (CNPq)
FX The CNPq agency guaranteed research grant scholarships for Servio Pontes
   Ribeiro, Alexandre Barbosa Reis, Aristoteles Goes-Neto, Luiz Carlos
   Junior Alcantara, Geraldo Wilson Fernandes and Vasco Ariston C Azevedo.
   The funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Agencia Nacional de Aviacao Civil (ANAC), 2020, HIST VOOS
   Airports Authority of India, 2020, AIRP AUTH IND FLIGHT
   ANDERSON RM, 1991, B MATH BIOL, V53, P3, DOI 10.1016/S0092-8240(05)80039-4
   Balcan D, 2010, J COMPUT SCI-NETH, V1, P132, DOI 10.1016/j.jocs.2010.07.002
   Bedford J, 2020, LANCET, V395, P1015, DOI 10.1016/S0140-6736(20)30673-5
   Brazilian Ministry of Tourism, 2020, MIN TUR PAG IN
   Brockmann D, 2013, SCIENCE, V342, P1337, DOI 10.1126/science.1245200
   Coelho FC, 2020, ASSESSING POTENTIAL, DOI [10.1101/2020.03.19.20039131, DOI 10.1101/2020.03.19.20039131]
   Colizza V, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.148701
   Fathizadeh Hadis, 2020, Infez Med, V28, P185
   Federal Airports Authority of Nigeria, 2020, FED AIRP AUTH NIG
   Ferguson NM, 2003, NATURE, V422, P428, DOI 10.1038/nature01509
   Hanski I, 1998, NATURE, V396, P41, DOI 10.1038/23876
   Hellewell J, 2020, LANCET GLOB HEALTH, V8, pE488, DOI 10.1016/S2214-109X(20)30074-7
   Hethcote H. W., 1989, APPL MATH ECOLOGY BI, V18, P119, DOI DOI 10.1007/978-3-642-61317-3{\_}5
   Hubbell Stephen P., 2001, V32, pi
   Lai AL, 2020, J MED VIROL, V92, P675, DOI 10.1002/jmv.25723
   Lai CC, 2020, INT J ANTIMICROB AG, V55, DOI 10.1016/j.ijantimicag.2020.105924
   Lau MSY, 2017, P NATL ACAD SCI USA, V114, P2337, DOI 10.1073/pnas.1614595114
   Li G, 2020, J MED VIROL, V92, P424, DOI 10.1002/jmv.25685
   MAY RM, 1976, NATURE, V261, P459, DOI 10.1038/261459a0
   Morse SS, 2012, LANCET, V380, P1956, DOI 10.1016/S0140-6736(12)61684-5
   Nicolaides C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040961
   Nigeria Centre for Disease Control, 2020, NCDC COR COVID 19 IN
   Pianka E. R., 2000, EVOLUTIONARY ECOLOGY
   Rothe C, 2020, NEW ENGL J MED, V382, P970, DOI 10.1056/NEJMc2001468
   United Nations, 2019, STESASERA427 UN
   Vaughan A, 2020, WE DONT KNOW WHY SO
   WHO, 2020, COR DIS COVID 19
   World Health Organization, 2020, COVID 19 SIT UPD WHO
   World Health Organization, 2020, COR DIS 2019 COVID 1
   World Health Orgnization, 2020, NOV COR 2019 NCOV
   Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017
NR 33
TC 1
Z9 1
U1 2
U2 2
PU PEERJ INC
PI LONDON
PA 341-345 OLD ST, THIRD FLR, LONDON, EC1V 9LL, ENGLAND
SN 2167-8359
J9 PEERJ
JI PeerJ
PD JUN 25
PY 2020
VL 8
AR e9446
DI 10.7717/peerj.9446
PG 16
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA MB9LZ
UT WOS:000542919000004
PM 32617196
OA DOAJ Gold, Green Published
DA 2020-10-22
ER

PT J
AU Cleemput, S
   Dumon, W
   Fonseca, V
   Karim, WA
   Giovanetti, M
   Alcantara, LC
   Deforche, K
   de Oliveira, T
AF Cleemput, Sara
   Dumon, Wim
   Fonseca, Vagner
   Karim, Wasim Abdool
   Giovanetti, Marta
   Alcantara, Luiz Carlos
   Deforche, Koen
   de Oliveira, Tulio
TI Genome Detective Coronavirus Typing Tool for rapid identification and
   characterization of novel coronavirus genomes
SO BIOINFORMATICS
LA English
DT Article
ID MULTIPLE SEQUENCE ALIGNMENT; ALGORITHM
AB Genome detective is a web-based, user-friendly software application to quickly and accurately assemble all known virus genomes from next-generation sequencing datasets. This application allows the identification of phylogenetic clusters and genotypes from assembled genomes in FASTA format. Since its release in 2019, we have produced a number of typing tools for emergent viruses that have caused large outbreaks, such as Zika and Yellow Fever Virus in Brazil. Here, we present the Genome Detective Coronavirus Typing Tool that can accurately identify the novel severe acute respiratory syndrome (SARS)-related coronavirus (SARS-CoV-2) sequences isolated in China and around the world. The tool can accept up to 2000 sequences per submission and the analysis of a new whole-genome sequence will take approximately 1 min. The tool has been tested and validated with hundreds of whole genomes from 10 coronavirus species, and correctly classified all of the SARS-related coronavirus (SARSr-CoV) and all of the available public data for SARS-CoV-2. The tool also allows tracking of new viral mutations as the outbreak expands globally, which may help to accelerate the development of novel diagnostics, drugs and vaccines to stop the COVID-19 disease.
C1 [Cleemput, Sara; Dumon, Wim; Deforche, Koen] Emweb Bv, Herent, Belgium.
   [Fonseca, Vagner; Karim, Wasim Abdool; de Oliveira, Tulio] Univ KwaZulu Natal, KwaZulu Natal Res Innovat & Sequencing Platform K, Sch Lab Med & Med Sci, Coll Hlth Sci, Durban, South Africa.
   [Fonseca, Vagner; Alcantara, Luiz Carlos] Univ Fed Minas Gerais, Inst Ciencias Biol, Lab Genet Celular & Mol, Belo Horizonte, MG, Brazil.
   [Fonseca, Vagner] Minist Saude, Coordenacao Geral Lab Saude Publ, Secretaria Vigilancia Saude, CGLAB,SVS,MS, Brasilia, DF, Brazil.
   [Giovanetti, Marta; Alcantara, Luiz Carlos] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Flavivirus, Rio De Janeiro, RJ, Brazil.
   [de Oliveira, Tulio] Ctr AIDS Programme Res South Africa CAPRISA, Durban, South Africa.
   [de Oliveira, Tulio] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA.
RP Deforche, K (corresponding author), Emweb Bv, Herent, Belgium.; de Oliveira, T (corresponding author), Univ KwaZulu Natal, KwaZulu Natal Res Innovat & Sequencing Platform K, Sch Lab Med & Med Sci, Coll Hlth Sci, Durban, South Africa.; de Oliveira, T (corresponding author), Ctr AIDS Programme Res South Africa CAPRISA, Durban, South Africa.; de Oliveira, T (corresponding author), Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA.
EM koen@emweb.be; deoliveira@ukzn.ac.za
OI Fonseca, Vagner/0000-0001-5521-6448; Alcantara, Luiz/0000-0002-6769-9931
FU South African Medical Research Council [MRC-RFA-UFSP01-2013/UKZN
   HIVEPI]; VIROGENESIS project - European Union [634650]; National Human
   Genome Research Institute of the National Institutes of HealthUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)
   [U24HG006941]
FX Research reported in this publication was supported by a research
   Flagship grant from the South African Medical Research Council
   (MRC-RFA-UFSP01-2013/UKZN HIVEPI), the VIROGENESIS project, which
   received funding from the European Union's Horizon 2020 Research and
   Innovation Programme (under Grant Agreement no. 634650) and the National
   Human Genome Research Institute of the National Institutes of Health
   under Award Number U24HG006941. H3ABioNet is an initiative of the Human
   Health and Heredity in Africa Consortium (H3Africa). The content is
   solely the responsibility of the authors and does not necessarily
   represent the official views of the National Institutes of Health.
CR Deforche K., 2017, BIORXIV, DOI [10.1101/200394, DOI 10.1101/200394]
   Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340
   Fonseca V, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007231
   GOTOH O, 1982, J MOL BIOL, V162, P705, DOI 10.1016/0022-2836(82)90398-9
   Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520
   Iberoamerica C, 2020, LANCET, V395, P497
   Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010
   Lemoine F, 2018, NATURE, V556, P452, DOI 10.1038/s41586-018-0043-0
   Lu RJ, 2020, LANCET, V395, P565, DOI 10.1016/S0140-6736(20)30251-8
   Rambaut A., 2018, FIGTREE V1 4 4 I EVO
   Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180
   SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5
   SWOFFORD D, 2003, PAUP 4 0 PHYLOGENETI
   Vilsker M, 2019, BIOINFORMATICS, V35, P871, DOI 10.1093/bioinformatics/bty695
   World Health Organization, 2020, NOV COR COVID 19 SIT
   Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017
NR 16
TC 8
Z9 8
U1 9
U2 9
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 1367-4803
EI 1460-2059
J9 BIOINFORMATICS
JI Bioinformatics
PD JUN
PY 2020
VL 36
IS 11
BP 3552
EP 3555
DI 10.1093/bioinformatics/btaa145
PG 4
WC Biochemical Research Methods; Biotechnology & Applied Microbiology;
   Computer Science, Interdisciplinary Applications; Mathematical &
   Computational Biology; Statistics & Probability
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Computer Science; Mathematical & Computational Biology; Mathematics
GA MM4GO
UT WOS:000550117300035
PM 32108862
OA Green Published, Other Gold
DA 2020-10-22
ER

PT J
AU Giovanetti, M
   de Mendonca, MCL
   Fonseca, V
   Mares-Guia, MA
   Fabri, A
   Xavier, J
   de Jesus, JG
   Graf, T
   Rodrigues, CDD
   dos Santos, CC
   Sampaio, SA
   Chalhoub, FLL
   Nogueira, FD
   Theze, J
   Romano, APM
   Ramos, DG
   de Abreu, AL
   Oliveira, WK
   Said, RFD
   de Alburque, CFC
   de Oliveira, T
   Fernandes, CA
   Aguiar, SF
   Chieppe, A
   Sequeira, PC
   Faria, NR
   Cunha, RV
   Alcantara, LC
   de Filippis, AMB
AF Giovanetti, Marta
   Lima de Mendonca, Marcos Cesar
   Fonseca, Vagner
   Mares-Guia, Maria Angelica
   Fabri, Allison
   Xavier, Joilson
   de Jesus, Jaqueline Goes
   Graf, Tiago
   Rodrigues, Cintia Damasceno dos Santos
   dos Santos, Carolina Cardoso
   Sampaio, Simone Alves
   Levy Chalhoub, Flavia Lowen
   Nogueira, Fernanda de Bruycker
   Theze, Julien
   Martins Romano, Alessandro Pecego
   Ramos, Daniel Garkauskas
   de Abreu, Andre Luiz
   Oliveira, Wanderson Kleber
   do Carmo Said, Rodrigo Fabiano
   Campelo de Alburque, Carlos F.
   de Oliveira, Tulio
   Fernandes, Carlos Augusto
   Aguiar, Shirlei Ferreira
   Chieppe, Alexandre
   Sequeira, Patricia Carvalho
   Faria, Nuno Rodrigues
   Cunha, Rivaldo Venancio
   Junior Alcantara, Luiz Carlos
   Bispo de Filippis, Ana Maria
TI Yellow Fever Virus Reemergence and Spread in Southeast Brazil, 2016-2019
   (vol 94, e01623-19, 2020)
SO JOURNAL OF VIROLOGY
LA English
DT Correction
C1 [Giovanetti, Marta; Lima de Mendonca, Marcos Cesar; Mares-Guia, Maria Angelica; Fabri, Allison; Rodrigues, Cintia Damasceno dos Santos; dos Santos, Carolina Cardoso; Sampaio, Simone Alves; Levy Chalhoub, Flavia Lowen; Nogueira, Fernanda de Bruycker; Sequeira, Patricia Carvalho; Junior Alcantara, Luiz Carlos; Bispo de Filippis, Ana Maria] Inst Oswaldo Cruz Fiocruz, Lab Flavivirus, Rio De Janeiro, Brazil.
   [Giovanetti, Marta; Fonseca, Vagner; Xavier, Joilson; Junior Alcantara, Luiz Carlos] Univ Fed Minas Gerais, ICB, Lab Genet Celular & Mol, Belo Horizonte, MG, Brazil.
   [Fonseca, Vagner; de Oliveira, Tulio] Univ KwaZulu Natal, Coll Hlth Sci, KwaZulu Natal Res Innovat & Sequencing Platform K, Durban, South Africa.
   [de Jesus, Jaqueline Goes; Graf, Tiago] Minist Saude, Fundacao Oswaldo Cruz, Inst Goncalo Moniz, Salvador, BA, Brazil.
   [Theze, Julien; Faria, Nuno Rodrigues] Univ Oxford, Dept Zool, Oxford, England.
   [Martins Romano, Alessandro Pecego; Ramos, Daniel Garkauskas; do Carmo Said, Rodrigo Fabiano] Minist Saude CGLAB SVS MS, Coordenacao Geral Vigilancia Arboviroses CGARB, Brasilia, DF, Brazil.
   [de Abreu, Andre Luiz] Minist Saude CGLAB SVS MS, Coordenacao Geral Labs Saude Publ, Secretaria Vigilancia Saude, Brasilia, DF, Brazil.
   [Oliveira, Wanderson Kleber] Minist Saude SVS MS, Secretaria Vigilancia Saude, Brasilia, DF, Brazil.
   [Campelo de Alburque, Carlos F.] Org Mundial Saude, Org Panamer Saude, Brasilia, DF, Brazil.
   [Fernandes, Carlos Augusto; Aguiar, Shirlei Ferreira] Lab Cent Saude Publ Noel Nutels LACEN RJ, Rio De Janeiro, Brazil.
   [Chieppe, Alexandre] Superintendencia Vigilancia Estado, Rio De Janeiro, Brazil.
   [Cunha, Rivaldo Venancio] Fundacao Oswaldo Cruz, Biomanguinhos, Rio De Janeiro, Brazil.
   [Cunha, Rivaldo Venancio] Univ Fed Mato Grosso do Sul, Fac Med, Campo Grande, MS, Brazil.
RP Giovanetti, M (corresponding author), Inst Oswaldo Cruz Fiocruz, Lab Flavivirus, Rio De Janeiro, Brazil.; Giovanetti, M (corresponding author), Univ Fed Minas Gerais, ICB, Lab Genet Celular & Mol, Belo Horizonte, MG, Brazil.
EM giovanetti.marta@gmail.com
OI Fonseca, Vagner/0000-0001-5521-6448
CR Giovanetti M, 2020, J VIROL, V94, DOI 10.1128/JVI.01623-19
NR 1
TC 0
Z9 0
U1 1
U2 1
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0022-538X
EI 1098-5514
J9 J VIROL
JI J. Virol.
PD JUN
PY 2020
VL 94
IS 11
AR e02008-19
DI 10.1128/JVI.02008-19
PG 1
WC Virology
SC Virology
GA LP8YJ
UT WOS:000534602800022
PM 32423967
OA Green Published, Bronze
DA 2020-10-22
ER

PT J
AU Araujo, THA
   Barreto, FK
   Menezes, ADL
   de Lima, CPS
   de Oliveira, RS
   Lemos, PD
   Galvao-Castro, B
   Kashima, S
   Farre, L
   Bittencourte, AL
   de Carvalho, EM
   Santos, LA
   Rego, FFD
   Mota-Miranda, ACA
   Nunes, MRT
   Alcantara, LCJ
AF Almeida Araujo, Thessika Hialla
   Barreto, Fernanda Khouri
   Luz Menezes, Aline Dorea
   Silva de Lima, Clayton Pereira
   de Oliveira, Rodrigo Santos
   Lemos, Poliana da Silva
   Galvao-Castro, Bernardo
   Kashima, Simone
   Farre, Lourdes
   Bittencourte, Achilea Lisboa
   de Carvalho, Edgar Marcelino
   Santos, Luciane Amorim
   de Almeida Rego, Filipe Ferreira
   Andrade Mota-Miranda, Aline Cristina
   Teixeira Nunes, Marcio Roberto
   Junior Alcantara, Luiz Carlos
TI Complete genome sequence of human T-cell lymphotropic type 1 from
   patients with different clinical profiles, including infective
   dermatitis
SO INFECTION GENETICS AND EVOLUTION
LA English
DT Article
DE HTLV-1; Complete genome; Nucleotide variations
ID VIRUS TYPE-I; HTLV-I; NUCLEOTIDE-SEQUENCE; TAX ONCOPROTEIN; PROVIRAL
   LOAD; LEUKEMIA; UBIQUITINATION; SUMOYLATION; RETROVIRUS; EVOLUTION
AB The HTLV-1 is the first human retrovirus and is associated with several clinical syndromes, however, the pathogenesis of these clinical manifestations is still not fully understood. Furthermore, there are few complete genomes publicly available, about 0.12 complete genomes per 10,000 infected individuals and the databases have a major deficiency of sequences information. This study generated and characterized 31 HTLV-1 complete genomes sequences derived from individuals with Tropical Spastic Paraparesis/HTLV-1-Associated Myelopathy (TSP/HAM), Adult T-cell leukemia/lymphoma (ATL), infective dermatitis associated to HTLV-1 (IDH) and asymptomatic patients. These sequences are associated to clinical and epidemiological information about the patients. The sequencing data generated on Ion Torrent PGM platform were assembled and mapped against the reference HTLV-1 genome. These sequences were genotyped as Cosmopolitan subtype, Transcontinental subgroup. We identified the variants in the coding regions of the genome of the different clinical profiles, however, no statistical relation was detected. This study contributed to increase of HTLV-1 complete genomes in the world. Furthermore, to better investigate the contribution of HTLV-1 mutations for the disease outcome it is necessary to evaluate the interaction of the viral genome and characteristics of the human host.
C1 [Almeida Araujo, Thessika Hialla; Barreto, Fernanda Khouri; Luz Menezes, Aline Dorea; Farre, Lourdes; de Carvalho, Edgar Marcelino; Santos, Luciane Amorim; Junior Alcantara, Luiz Carlos] Fundacao Oswaldo Cruz, Rio De Janeiro, Brazil.
   [Silva de Lima, Clayton Pereira; de Oliveira, Rodrigo Santos; Lemos, Poliana da Silva; Teixeira Nunes, Marcio Roberto] Inst Evandro Chagas, Belem, Para, Brazil.
   [Almeida Araujo, Thessika Hialla; Galvao-Castro, Bernardo; Santos, Luciane Amorim] Escola Bahiana Med & Saude Publ Salvador, Salvador, BA, Brazil.
   [Kashima, Simone] Fundacao Hemoctr Ribeirao Preto, Ribeirao Preto, Brazil.
   [Barreto, Fernanda Khouri; Bittencourte, Achilea Lisboa; de Carvalho, Edgar Marcelino; Andrade Mota-Miranda, Aline Cristina] Univ Fed Bahia, Salvador, BA, Brazil.
   [de Almeida Rego, Filipe Ferreira] Univ Catolica Salvador, Salvador, BA, Brazil.
   [Farre, Lourdes] Bellvitge Biomed Res Inst, Catalan Inst Oncol, Barcelona, Spain.
RP Alcantara, LCJ (corresponding author), Fundacao Oswaldo Cruz, Rio De Janeiro, Brazil.
EM luiz.alcantara@ioc.fiocruz.br
OI Alcantara, Luiz/0000-0002-6769-9931
FU Fundacao de Amparo a Pesquisa do Estado da Bahia (FAPESB)
   [BOL0653/2012]; Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico (CNPq)National Council for Scientific and Technological
   Development (CNPq) [400900/2013-0]
FX We would like to thank the Fundacao de Amparo a Pesquisa do Estado da
   Bahia (FAPESB) Grant numbers: BOL0653/2012 and Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq) Grant numbers:
   400900/2013-0 financial support.
CR Andonov A, 2012, INFECT GENET EVOL, V12, P1822, DOI 10.1016/j.meegid.2012.07.015
   Barreto FK, 2016, INFECT GENET EVOL, V45, P420, DOI 10.1016/j.meegid.2016.08.020
   Cao F, 2000, AIDS RES HUM RETROV, V16, P921, DOI 10.1089/08892220050042855
   Capobianchi MR, 2013, CLIN MICROBIOL INFEC, V19, P15, DOI 10.1111/1469-0691.12056
   Carneiro-Proietti ABF, 2012, AIDS RES HUM RETROV, V28, P1265, DOI 10.1089/aid.2011.0143
   Cassar O, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002418
   CHOU KS, 1995, INT J CANCER, V60, P701
   Deforche K, 2006, BIOINFORMATICS, V22, P2975, DOI 10.1093/bioinformatics/btl508
   Dourado I, 2003, JAIDS-J ACQ IMM DEF, V34, P527, DOI 10.1097/00126334-200312150-00013
   Durkin SS, 2006, J BIOL CHEM, V281, P31705, DOI 10.1074/jbc.M607011200
   Ellerbrok H, 1998, AIDS RES HUM RETROV, V14, P1199, DOI 10.1089/aid.1998.14.1199
   Exarchos KP, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-113
   Forni D, 2013, IMMUNITY, V38, P1129, DOI 10.1016/j.immuni.2013.04.008
   Friedman N, 2013, ARXIV13016695 CS STA, P196
   GESSAIN A, 1985, LANCET, V2, P407
   Gessain A, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00388
   Iwanaga M, 2010, BLOOD, V116, P1211, DOI 10.1182/blood-2009-12-257410
   Jeang KT, 2001, CYTOKINE GROWTH F R, V12, P207, DOI 10.1016/S1359-6101(00)00028-9
   Alcantara LCJ, 2009, NUCLEIC ACIDS RES, V37, pW634, DOI 10.1093/nar/gkp455
   Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199
   Kfoury Y, 2008, ONCOGENE, V27, P1665, DOI 10.1038/sj.onc.1210804
   Kfoury Y, 2012, ADV CANCER RES, V113, P85, DOI 10.1016/B978-0-12-394280-7.00003-8
   Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]
   Kuramitsu M, 2015, J CLIN MICROBIOL, V53, P587, DOI 10.1128/JCM.02254-14
   La Grenade L, 1998, ARCH DERMATOL, V134, P439, DOI 10.1001/archderm.134.4.439
   Lamsoul I, 2005, MOL CELL BIOL, V25, P10391, DOI 10.1128/MCB.25.23.10391-10406.2005
   Lodewick J, 2011, VIRUSES-BASEL, V3, P829, DOI 10.3390/v3060829
   Lodewick J, 2009, VIROLOGY, V386, P68, DOI 10.1016/j.virol.2008.12.043
   Ma YY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066795
   MALIK KTA, 1988, J GEN VIROL, V69, P1695, DOI 10.1099/0022-1317-69-7-1695
   Martin F, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-86
   Mota-Miranda ACA, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-75
   Nagai M, 1998, J NEUROVIROL, V4, P586, DOI 10.3109/13550289809114225
   Nasr R, 2006, BLOOD, V107, P4021, DOI 10.1182/blood-2005-09-3572
   Neto WK, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-535
   Nicholas K. B., 1997, EMBNET NEWS, V4, P1
   Ohsugi T, 2004, ANAL BIOCHEM, V329, P281, DOI 10.1016/j.ab.2004.02.036
   Okayama A, 2004, INT J CANCER, V110, P621, DOI 10.1002/ijc.20144
   Peloponese JM, 2004, J VIROL, V78, P11686, DOI 10.1128/JVI.78.21.11686-11695.2004
   POIESZ BJ, 1980, P NATL ACAD SCI-BIOL, V77, P7415, DOI 10.1073/pnas.77.12.7415
   Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083
   Radford AD, 2012, J GEN VIROL, V93, P1853, DOI 10.1099/vir.0.043182-0
   Sigrist CJA, 2005, BIOINFORMATICS, V21, P4060, DOI 10.1093/bioinformatics/bti614
   Suchard MA, 2018, VIRUS EVOL, V4, DOI 10.1093/ve/vey016
   Vallinoto ACR, 2012, VIRUS RES, V163, P178, DOI 10.1016/j.virusres.2011.09.015
   Yakova M, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-4
   YOSHIDA M, 1982, P NATL ACAD SCI-BIOL, V79, P2031, DOI 10.1073/pnas.79.6.2031
   Zanella L, 2012, J VIROL, V86, P12451, DOI 10.1128/JVI.02258-12
NR 48
TC 0
Z9 0
U1 2
U2 8
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1567-1348
EI 1567-7257
J9 INFECT GENET EVOL
JI Infect. Genet. Evol.
PD APR
PY 2020
VL 79
AR 104166
DI 10.1016/j.meegid.2019.104166
PG 7
WC Infectious Diseases
SC Infectious Diseases
GA KH7YP
UT WOS:000510866400012
PM 31883457
DA 2020-10-22
ER

PT J
AU Duarte, AO
   Oliveira, JV
   Carvalho, TCX
   Pessoa, LD
   Magalhaes, C
   Lima, JGS
   Carvalho, DA
   dos Santos, DC
   Santos, CS
   Pessoa, R
   Souza, GB
   Calcagno, JI
   Santana, EM
   de Oliveira, AS
   Francisco, MVLD
   Costa, BGG
   Gomes, LN
   Romero, F
   Khouri, R
   Alcantara, LC
   Lima, FWD
   de Siqueira, IC
AF Duarte, Alan Oliveira
   Oliveira, Joao Vitor
   Xavier Carvalho, Tereza Cristina
   Pessoa, Lorena de Brito
   Magalhaes Filho, Claudio
   Souza Lima, Jessica Graziele
   Carvalho, Daniel Augusto
   dos Santos, Daiana Carlos
   Santos, Cleiton Silva
   Pessoa, Rosana
   Souza, Gloryane Bessa
   Calcagno, Juan Ignacio
   Santana, Edilene Mota
   de Oliveira, Aline Sousa
   de Oliveira Francisco, Marcos Vinicius Lima
   Gouvea Costa, Bernardo Gratival
   Gomes, Lillian Nunes
   Romero, Fernando
   Khouri, Ricardo
   Alcantara, Luiz Carlos, Jr.
   de Mendonca Lima, Fernanda Washington
   de Siqueira, Isadora Cristina
TI Maternal and congenital infections arising from Zika, dengue and
   Chikungunya arboviruses in Salvador, Brazil
SO TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
DE Chikungunya; congenital infection; microcephaly; seroprevalence; Zika
AB Background: Salvador was one of the Brazilian cities most affected during the 2015 Zika virus (ZIKV) outbreak.
   Methods: A cross-sectional study was performed with enrolment of parturients and their newborns.
   Results: Positive IgM antibodies for ZIKV, dengue (DENV) and Chikungunya (CHIKV) were present in 6.9, 11.9 and 22.8% of the parturients, and IgG antibodies were detected in 72.3, 92.3 and 38.6%, respectively. No cases of DENV congenital infection were identified. ZIKV and CHIKV congenital infections were observed in 16.5 and 13% of newborns, respectively.
   Conclusions: High exposure rates to the three arboviruses and the identification of newborns with ZIKV and CHIKV congenital infections reinforces the necessity of ZIKV and CHIKV prenatal and neonatal screening in endemic regions.
C1 [Duarte, Alan Oliveira; Santana, Edilene Mota; de Mendonca Lima, Fernanda Washington] Univ Fed Bahia, Fac Farm, Lab Imunol Doencas Infecciosas, BR-40170115 Salvador, BA, Brazil.
   [Oliveira, Joao Vitor; Pessoa, Lorena de Brito; Magalhaes Filho, Claudio; Souza Lima, Jessica Graziele; Carvalho, Daniel Augusto; dos Santos, Daiana Carlos; Santos, Cleiton Silva; de Oliveira, Aline Sousa; de Oliveira Francisco, Marcos Vinicius Lima; Gouvea Costa, Bernardo Gratival; Gomes, Lillian Nunes; Khouri, Ricardo; Alcantara, Luiz Carlos, Jr.; de Siqueira, Isadora Cristina] Minist Saude, Fundacao Oswaldo Cruz, Inst Goncalo Moniz, BR-40296710 Salvador, BA, Brazil.
   [Xavier Carvalho, Tereza Cristina; Pessoa, Rosana; Souza, Gloryane Bessa; Calcagno, Juan Ignacio; Romero, Fernando] Maternidade Referencia Prof Jose Maria Magalhaes, BR-40320350 Salvador, BA, Brazil.
   [Khouri, Ricardo] Univ Fed Bahia, Fac Med, Dept Patol & Med Legal, BR-40110100 Salvador, BA, Brazil.
RP de Siqueira, IC (corresponding author), Minist Saude, Fundacao Oswaldo Cruz, Inst Goncalo Moniz, BR-40296710 Salvador, BA, Brazil.
EM isadora.siqueira@fiocruz.br
RI de Siqueira, Isadora Cristina/R-9953-2016
OI de Siqueira, Isadora Cristina/0000-0002-2520-4099
FU National Council for Scientific and Technological DevelopmentNational
   Council for Scientific and Technological Development (CNPq)
   [425380/2016]; WHO's HRP/TDR/PAHO Joint Small Grants Program for
   research on the ZIKV outbreak in the Americas [770084-0/2017];
   Foundation of Support to Research of the State of Bahia
   [19.573.201.5418]
FX This work was supported by the National Council for Scientific and
   Technological Development [425380/2016], WHO's HRP/TDR/PAHO Joint Small
   Grants Program for research on the ZIKV outbreak in the Americas
   [770084-0/2017] and Foundation of Support to Research of the State of
   Bahia [19.573.201.5418].
CR Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Villar J, 2014, LANCET, V384, P857, DOI 10.1016/S0140-6736(14)60932-6
NR 3
TC 0
Z9 0
U1 0
U2 0
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0035-9203
EI 1878-3503
J9 T ROY SOC TROP MED H
JI Trans. Roy. Soc. Trop. Med. Hyg.
PD MAR
PY 2020
VL 114
IS 3
BP 222
EP 224
DI 10.1093/trstmh/trz098
PG 3
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA LS6DO
UT WOS:000536472500009
PM 32142153
DA 2020-10-22
ER

PT J
AU Giovanetti, M
   Faria, NR
   Lourenco, J
   de Jesus, JG
   Xavier, J
   Claro, IM
   Kraemer, MUG
   Fonseca, V
   Dellicour, S
   Theze, J
   Salles, FD
   Graf, T
   Silveira, PP
   do Nascimento, VA
   de Souza, VC
   Iani, FCD
   Castilho-Martins, EA
   Cruz, LN
   Wallau, G
   Fabri, A
   Levy, F
   Quick, J
   de Azevedo, V
   Aguiar, RS
   de Oliveira, T
   de Menezes, CB
   Castilho, MD
   Terra, TM
   da Silva, MS
   de Filippis, AMB
   de Abreu, AL
   Oliveira, WK
   Croda, J
   de Albuquerque, CFC
   Nunes, MRT
   Sabino, EC
   Loman, N
   Naveca, FG
   Pybus, OG
   Alcantara, LC
AF Giovanetti, Marta
   Faria, Nuno Rodrigues
   Lourenco, Jose
   de Jesus, Jaqueline Goes
   Xavier, Joilson
   Claro, Ingra Morales
   Kraemer, Moritz U. G.
   Fonseca, Vagner
   Dellicour, Simon
   Theze, Julien
   Salles, Flavia da Silva
   Graf, Tiago
   Silveira, Paola Paz
   do Nascimento, Valdinete Alves
   de Souza, Victor Costa
   de Melo Iani, Felipe Campos
   Castilho-Martins, Emerson Augusto
   Cruz, Laura Nogueira
   Wallau, Gabriel
   Fabri, Allison
   Levy, Flavia
   Quick, Joshua
   de Azevedo, Vasco
   Aguiar, Renato Santana
   de Oliveira, Tulio
   de Menezes, Camila Botto
   Castilho, Marcia da Costa
   Terra, Tirza Matos
   da Silva, Marineide Souza
   Bispo de Filippis, Ana Maria
   de Abreu, Andre Luiz
   Oliveira, Wanderson Kleber
   Croda, Julio
   Campelo de Albuquerque, Carlos F.
   Nunes, Marcio R. T.
   Sabino, Ester Cerdeira
   Loman, Nicholas
   Naveca, Felipe Gomes
   Pybus, Oliver G.
   Alcantara, Luiz Carlos
TI Genomic and Epidemiological Surveillance of Zika Virus in the Amazon
   Region
SO CELL REPORTS
LA English
DT Article
ID PHYLOGENETIC ANALYSIS; TRANSMISSION; OUTBREAK; SPREAD; BRAZIL;
   OROPOUCHE; REVEALS; MODELS; ANGOLA; FEVER
AB Zika virus (ZIKV) has caused an explosive epidemic linked to severe clinical outcomes in the Americas. As of June 2018, 4,929 ZIKV suspected infections and 46 congenital syndrome cases had been reported in Manaus, Amazonas, Brazil. Although Manaus is a key demographic hub in the Amazon region, little is known about the ZIKV epidemic there, in terms of both transmission and viral genetic diversity. Using portable virus genome sequencing, we generated 59 ZIKV genomes in Manaus. Phylogenetic analyses indicated multiple introductions of ZIKV from northeastern Brazil to Manaus. Spatial genomic analysis of virus movement among six areas in Manaus suggested that populous northern neighborhoods acted as sources of virus transmission to other neighborhoods. Our study revealed how the ZIKV epidemic was ignited and maintained within the largest urban metropolis in the Amazon. These results might contribute to improving the public health response to outbreaks in Brazil.
C1 [Giovanetti, Marta; de Jesus, Jaqueline Goes; Fabri, Allison; Levy, Flavia; Bispo de Filippis, Ana Maria; Alcantara, Luiz Carlos] Inst Oswaldo Cruz Fiocruz, Lab Flavivirus, Rio De Janeiro, Brazil.
   [Giovanetti, Marta; Faria, Nuno Rodrigues; Xavier, Joilson; Fonseca, Vagner; de Melo Iani, Felipe Campos; de Azevedo, Vasco; Alcantara, Luiz Carlos] Univ Fed Minas Gerais, Lab Genet Celular & Mol, ICB, Belo Horizonte, MG, Brazil.
   [Faria, Nuno Rodrigues; Lourenco, Jose; Kraemer, Moritz U. G.; Theze, Julien; Pybus, Oliver G.] Univ Oxford, Dept Zool, Oxford OX1 3PS, England.
   [Claro, Ingra Morales; Salles, Flavia da Silva; Sabino, Ester Cerdeira] Univ Sao Paulo, Inst Med Trop, Sao Paulo, Brazil.
   [Fonseca, Vagner; de Oliveira, Tulio] Univ KwaZulu Natal, Coll Hlth Sci, KwaZulu Natal Res Innovat & Sequencing Platform K, ZA-4001 Durban, South Africa.
   [Dellicour, Simon] Univ Libre Bruxelles, Spatial Epidemiol Lab, Brussels, Belgium.
   [Dellicour, Simon] Katholieke Univ Leuven, Dept Microbiol & Immunol, Rega Inst, Lab Clin & Epidemiol Virol, Leuven, Belgium.
   [Graf, Tiago; Silveira, Paola Paz; Aguiar, Renato Santana] Fundacao Oswaldo Cruz, Inst Goncalo Moniz, Salvador, BA, Brazil.
   [do Nascimento, Valdinete Alves; de Souza, Victor Costa; Naveca, Felipe Gomes] Fiocruz MS, Inst Leonidas & Maria Deane, Lab Ecol Doencas Transmissiveis Amazonia, Manaus, Amazonas, Brazil.
   [de Melo Iani, Felipe Campos] Fundacao Ezequiel Dias, Lab Cent Saude Publ, Belo Horizonte, MG, Brazil.
   [Castilho-Martins, Emerson Augusto] Univ Fed Amapa, Fac Med, Macapa, Brazil.
   [Cruz, Laura Nogueira; de Abreu, Andre Luiz] Minist Saude CGLAB SVS MS, Secretaria Vigilancia Saude, Coordenacao Geral Lab Saude Publ, Brasilia, DF, Brazil.
   [Wallau, Gabriel] Fundacao Oswaldo Cruz, Inst Aggeu Magalhaes, Recife, PE, Brazil.
   [Quick, Joshua; Loman, Nicholas] Univ Birmingham, Inst Microbiol & Infect, Birmingham, W Midlands, England.
   [de Menezes, Camila Botto] Univ Estado Amazonas, Manaus, Amazonas, Brazil.
   [Castilho, Marcia da Costa] Fundacao Med Trop Doutor Heitor Vieira Dourado, Dept Virol, Manaus, Amazonas, Brazil.
   [Terra, Tirza Matos; da Silva, Marineide Souza] Lab Cent Saude Publ Amazonas, Manaus, Amazonas, Brazil.
   [Oliveira, Wanderson Kleber] MS, SVS, Brasilia, DF, Brazil.
   [Croda, Julio] Minist Saude DEVIT SVS MS, Secretaria Vigilancia Saude, Dept Vigilancia Doencas Transmissiveis, Brasilia, DF, Brazil.
   [Campelo de Albuquerque, Carlos F.] OMS, OPAS, Brasilia, DF, Brazil.
   [Nunes, Marcio R. T.] Minist Hlth, Evandro Chagas Inst, Ctr Technol Innovat, Ananindeua, Para, Brazil.
RP Alcantara, LC (corresponding author), Inst Oswaldo Cruz Fiocruz, Lab Flavivirus, Rio De Janeiro, Brazil.; Faria, NR; Alcantara, LC (corresponding author), Univ Fed Minas Gerais, Lab Genet Celular & Mol, ICB, Belo Horizonte, MG, Brazil.; Faria, NR; Pybus, OG (corresponding author), Univ Oxford, Dept Zool, Oxford OX1 3PS, England.
EM nuno.faria@zoo.ox.ac.uk; oliver.pybus@zoo.ox.ac.uk;
   luiz.alcantara@ioc.fiocruz.br
RI Dellicour, Simon/AAE-9054-2020; Fonseca, Vagner/R-5813-2019; Pybus,
   Oliver G/B-2640-2012; Wallau, Gabriel Luz/B-5911-2008; Nascimento,
   Valdinete Alves do/AAV-1879-2020; Faria, Nuno R/I-2975-2012; Graf,
   Tiago/S-8535-2019; Castilho-Martins, Emerson Augusto/I-2094-2014;
   Oliveira, Wanderson/D-7140-2016
OI Dellicour, Simon/0000-0001-9558-1052; Fonseca,
   Vagner/0000-0001-5521-6448; Pybus, Oliver G/0000-0002-8797-2667; Wallau,
   Gabriel Luz/0000-0002-1419-5713; Nascimento, Valdinete Alves
   do/0000-0002-7786-4718; Faria, Nuno R/0000-0001-8839-2798; Graf,
   Tiago/0000-0003-4921-7975; Xavier, Joilson/0000-0003-3916-2018; Theze,
   Julien/0000-0001-8188-9494; Castilho-Martins, Emerson
   Augusto/0000-0003-0542-4294; Alcantara, Luiz/0000-0002-6769-9931;
   /0000-0002-8529-4022; da Silva Sales, Flavia
   Cristina/0000-0002-9048-0030; Oliveira, Wanderson/0000-0002-9662-1930
FU Decit/SCTIE/MoH; CNPqNational Council for Scientific and Technological
   Development (CNPq) [440685/2016-8, 440856/2016-7]; CAPESCAPES
   [88887.130716/2016-00, 88881.130825/2016-00, 88887.130823/201600];
   European Union (EU) Horizon 2020 Programme through ZIKAllianceEuropean
   Union (EU) [PRES-005-FEX-17-4-2-33]; Oxford Martin School; Branco Weiss
   Fellowship - Society in Science; Google Faculty Award; Training Grant
   from the National Institute of Child Health and Human Development
   [T32HD040128]; Fonds National de la Recherche Scientifique (FNRS;
   Belgium)Fonds de la Recherche Scientifique - FNRS; FaperjCarlos Chagas
   Filho Foundation for Research Support of the State of Rio de Janeiro
   (FAPERJ) [E-26/2002.930/2016]; International Development Research Centre
   (IDRC) Canada [108411-001]; EU Horizon 2020 Programme through ZikaPlan
   and ZikAction [734584, 734857]; Fundacao de Amparo a Pesquisa do Estado
   do Rio de Janeiro (FAPERJ)Carlos Chagas Filho Foundation for Research
   Support of the State of Rio de Janeiro (FAPERJ)
FX We thank Oxford Nanopore Technologies for technical support and QIAGEN
   for support of the ZIBRA-2 (Zika in Brazil Real Time Analyses-Second
   Round) project with reagents and equipment. This work was supported by
   Decit/SCTIE/MoH and CNPq (440685/2016-8 and 440856/2016-7); by CAPES
   (88887.130716/2016-00, 88881.130825/2016-00, and 88887.130823/201600);
   by the European Union (EU) Horizon 2020 Programme through ZIKAlliance
   (PRES-005-FEX-17-4-2-33); and by the Oxford Martin School. M.U.G.K. is
   supported by The Branco Weiss Fellowship - Society in Science,
   administered by ETH Zurich, and acknowledges funding from a Google
   Faculty Award and a Training Grant from the National Institute of Child
   Health and Human Development (T32HD040128). S.D. is supported by Fonds
   National de la Recherche Scientifique (FNRS; Belgium). The activities of
   the A.M.B.F. laboratory were supported by the Faperj under the grant no.
   E-26/2002.930/2016, by the International Development Research Centre
   (IDRC) Canada under the grant 108411-001) and the EU Horizon 2020
   Programme through ZikaPlan and ZikAction (grants 734584 and 734857).
   M.G. is supported by Fundacao de Amparo a Pesquisa do Estado do Rio de
   Janeiro (FAPERJ).
CR Azevedo RSS, 2009, EMERG INFECT DIS, V15, P1830, DOI 10.3201/eid1511.090461
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Caminade C, 2017, P NATL ACAD SCI USA, V114, P119, DOI 10.1073/pnas.1614303114
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Chaves BA, 2019, J MED ENTOMOL, V56, P1739, DOI 10.1093/jme/tjz110
   da Costa CF, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006594
   Azevedo RDD, 2007, EMERG INFECT DIS, V13, P912
   Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109
   de Oliveira WK, 2017, LANCET, V390, P861, DOI 10.1016/S0140-6736(17)31368-5
   Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088
   Faria NR, 2018, SCIENCE, V361, P894, DOI 10.1126/science.aat7115
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Faria NR, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15152-8
   Faria NR, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0356-2
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Ferguson NM, 2016, SCIENCE, V353, P1033, DOI 10.1126/science.aaf9590
   Ferreira MAR, 2008, CAN J STAT, V36, P355, DOI 10.1002/cjs.5550360302
   Fonseca V., 2019, PLOS NEGLECT TROP D, V213, P72
   Gill MS, 2013, MOL BIOL EVOL, V30, P713, DOI 10.1093/molbev/mss265
   Grubaugh ND, 2019, CELL, V178, P1057, DOI 10.1016/j.cell.2019.07.018
   Grubaugh ND, 2017, NATURE, V546, P401, DOI 10.1038/nature22400
   Hagan JE, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004275
   HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694
   Hill SC, 2019, LANCET INFECT DIS, V19, P1138, DOI 10.1016/S1473-3099(19)30293-2
   Izquierdo-Suzan M, 2019, EMERG INFECT DIS, V25, P1477, DOI 10.3201/eid2508.181533
   Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010
   Kraemer MUG, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-41192-3
   Kraemer MUG, 2019, EPIDEMIOL INFECT, V147, DOI 10.1017/S0950268818002881
   Kraemer MUG, 2019, NAT MICROBIOL, V4, P854, DOI 10.1038/s41564-019-0376-y
   Kraemer MUG, 2017, LANCET INFECT DIS, V17, P330, DOI [10.1016/s1473-3099(16)30513-8, 10.1016/S1473-3099(16)30513-8]
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lemey P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000520
   Lindoso JAL, 2009, REV INST MED TROP SP, V51, P247, DOI 10.1590/S0036-46652009000500003
   Loman NJ, 2014, BIOINFORMATICS, V30, P3399, DOI 10.1093/bioinformatics/btu555
   Lourenco J., 2017, ELIFE, V6, P290
   Messina JP, 2016, ELIFE, V5, DOI 10.7554/eLife.15272
   Naveca FG, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007065
   Naveca FG, 2017, MEM I OSWALDO CRUZ, V112, P510, DOI 10.1590/0074-02760160062
   Nunes MRT, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002769
   Oboist U, 2019, METHODS ECOL EVOL, V10, P1357, DOI 10.1111/2041-210X.13205
   Perez-Guzman P.N., 2018, PLOS CURR, V10, P16
   Perkins TA, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.126, 10.1038/nmicrobiol.2016.126]
   Petersen LR, 2016, NEW ENGL J MED, V375, P294, DOI 10.1056/NEJMc1606769
   Quick J, 2017, NAT PROTOC, V12, P1261, DOI 10.1038/nprot.2017.066
   Rambaut A, 2018, SYST BIOL, V67, P901, DOI 10.1093/sysbio/syy032
   Rambaut A, 2016, VIRUS EVOL, V2, DOI 10.1093/ve/vew007
   Secretaria de Vigilancia em Saude Ministerio da Saude, 2018, B EPIDEMIOLOGICO, V49
   Secretaria de Vigilancia em Saude/Ministerio da Saude, 2018, B EPIDEMIOLOGICO, V49
   Secretaria de Vigilancia em Saude Ministerio da Saude, 2019, B EPIDEMIOLOGICO
   Shapiro B, 2006, MOL BIOL EVOL, V23, P7, DOI 10.1093/molbev/msj021
   Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033
   Suchard MA, 2018, VIRUS EVOL, V4, DOI 10.1093/ve/vey016
   Sun JF, 2017, J INFECTION, V75, P356, DOI 10.1016/j.jinf.2017.07.001
   Nunes MRT, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0348-x
   Nunes MRT, 2012, EMERG INFECT DIS, V18, P1858, DOI 10.3201/eid1811.120217
   Theze J, 2018, CELL HOST MICROBE, V23, P855, DOI [10.101, 10.1016/j.chom.2018.04.017]
   Vasconcelos L., 2001, P 1 WORLD PLANN C AC, V32, P11
   Vasconcelos PFC, 1992, CIENC CULT-SAO PAULO, V43, P117
   Wickham H, 2016, ELEGANT GRAPHICS DAT
   Wilder-Smith Annelies, 2017, Lancet Infect Dis, V17, pe101, DOI 10.1016/S1473-3099(16)30518-7
   Yu GC, 2018, MOL BIOL EVOL, V35, P3041, DOI 10.1093/molbev/msy194
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zhang Q, 2017, P NATL ACAD SCI USA, V114, pE4334, DOI 10.1073/pnas.1620161114
NR 64
TC 1
Z9 1
U1 1
U2 1
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 2211-1247
J9 CELL REP
JI Cell Reports
PD FEB 18
PY 2020
VL 30
IS 7
BP 2275
EP 2283
DI 10.1016/j.celrep.2020.01.085
PG 9
WC Cell Biology
SC Cell Biology
GA KN4QZ
UT WOS:000514824500019
PM 32075736
OA DOAJ Gold, Green Published
DA 2020-10-22
ER

PT J
AU Benvenuto, D
   Giovanetti, M
   Salemi, M
   Prosperi, M
   De Flora, C
   Alcantara, LC
   Angeletti, S
   Ciccozzi, M
AF Benvenuto, Domenico
   Giovanetti, Marta
   Salemi, Marco
   Prosperi, Mattia
   De Flora, Cecilia
   Junior Alcantara, Luiz Carlos
   Angeletti, Silvia
   Ciccozzi, Massimo
TI The global spread of 2019-nCoV: a molecular evolutionary analysis
SO PATHOGENS AND GLOBAL HEALTH
LA English
DT Article
DE 2019-nCoV; molecular Epidemiology; phylogeny; SARS
ID CORONAVIRUS
AB The global spread of the 2019-nCoV is continuing and is fast moving, as indicated by the WHO raising the risk assessment to high. In this article, we provide a preliminary phylodynamic and phylogeographic analysis of this new virus. A Maximum Clade Credibility tree has been built using the 29 available whole genome sequences of 2019-nCoV and two whole genome sequences that are highly similar sequences from Bat SARS-like Coronavirus available in GeneBank. We are able to clarify the mechanism of transmission among the countries which have provided the 2019-nCoV sequence isolates from their patients. The Bayesian phylogeographic reconstruction shows that the 2019-2020 nCoV most probably originated from the Bat SARS-like Coronavirus circulating in the Rhinolophus bat family. In agreement with epidemiological observations, the most likely geographic origin of the new outbreak was the city of Wuhan, China, where 2019-nCoV time of the most recent common ancestor emerged, according to molecular clock analysis, around November 25(th), 2019. These results, together with previously recorded epidemics, suggest a recurring pattern of periodical epizootic outbreaks due to Betacoronavirus. Moreover, our study describes the same population genetic dynamic underlying the SARS 2003 epidemic, and suggests the urgent need for the development of effective molecular surveillance strategies of Betacoronavirus among animals and Rhinolophus of the bat family.
C1 [Benvenuto, Domenico; De Flora, Cecilia] Univ Campus Biomed Rome, Unit Med Stat & Mol Epidemiol, Rome, Italy.
   [Giovanetti, Marta; Junior Alcantara, Luiz Carlos; Ciccozzi, Massimo] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Flavivirus, Rio De Janeiro, Brazil.
   [Salemi, Marco; Prosperi, Mattia] Univ Florida, Dept Epidemiol, Gainesville, FL USA.
   [Salemi, Marco; Prosperi, Mattia] Univ Florida, Emerging Pathogens Inst, Gainesville, FL USA.
   [Angeletti, Silvia] Univ Campus Biomed Rome, Unit Clin Lab Sci, Rome, Italy.
RP Angeletti, S (corresponding author), Univ Campus Biomed Rome, Unit Clin Lab Sci, Rome, Italy.
EM s.angeletti@unicampus.it
RI Benvenuto, Domenico/AAO-5576-2020; Ribeiro, Nuno/AAH-2299-2020;
   Giovanetti, Marta/AAK-7408-2020
OI Benvenuto, Domenico/0000-0003-3833-2927; Alcantara,
   Luiz/0000-0002-6769-9931
CR [Anonymous], 2020, LANCET, V395, P311, DOI 10.1016/S0140-6736(20)30186-0
   Baele G, 2013, MOL BIOL EVOL, V30, P239, DOI 10.1093/molbev/mss243
   Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109
   Drosten C, 2003, NEW ENGL J MED, V348, P1967, DOI 10.1056/NEJMoa030747
   Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088
   Ji W, 2020, J MED VIROL, V92, P433, DOI 10.1002/jmv.25682
   Katoh K, 2019, BRIEF BIOINFORM, V20, P1160, DOI 10.1093/bib/bbx108
   Nguyen LT, 2015, MOL BIOL EVOL, V32, P268, DOI 10.1093/molbev/msu300
   Lau SKP, 2010, J VIROL, V84, P2808, DOI 10.1128/JVI.02219-09
   Lu HZ, 2020, J MED VIROL, V92, P401, DOI [10.1002/jmv.25678, 10.1002/jmv.2567]
   Rambaut A, 2018, SYST BIOL, V67, P901, DOI 10.1093/sysbio/syy032
   Rambaut A, 2016, VIRUS EVOL, V2, DOI 10.1093/ve/vew007
   Salemi M, 2004, J VIROL, V78, P1602, DOI 10.1128/JVI.78.3.1602-1603.2004
   Suchard MA, 2018, VIRUS EVOL, V4, DOI 10.1093/ve/vey016
   Weiss SR, 2011, ADV VIRUS RES, V81, P85, DOI 10.1016/B978-0-12-385885-6.00009-2
   Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017
NR 16
TC 26
Z9 28
U1 6
U2 39
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 2047-7724
EI 2047-7732
J9 PATHOG GLOB HEALTH
JI Pathog. Glob. Health
PD FEB 17
PY 2020
VL 114
IS 2
BP 64
EP 67
DI 10.1080/20477724.2020.1725339
EA FEB 2020
PG 4
WC Public, Environmental & Occupational Health; Parasitology; Tropical
   Medicine
SC Public, Environmental & Occupational Health; Parasitology; Tropical
   Medicine
GA KY8MH
UT WOS:000513613400001
PM 32048560
OA Bronze, Green Published
DA 2020-10-22
ER

PT J
AU de Jesus, JG
   Wallau, GD
   Maia, ML
   Xavier, J
   Lima, MAO
   Fonseca, V
   de Abreu, AS
   Tosta, SFD
   do Amaral, HR
   Lima, IAB
   Silva, PV
   dos Santos, DC
   de Oliveira, AS
   de Souza, SC
   Falcao, MB
   Cerqueira, E
   Machado, LC
   Sobral, MC
   Rezende, TMT
   Pereira, MR
   Pereira, FM
   Maia, ZPG
   Franca, RFD
   de Abreu, AL
   Melo, CFCDE
   Faria, NR
   da Cunha, RV
   Giovanetti, M
   Alcantara, LCJ
AF de Jesus, Jaqueline Goes
   Wallau, Gabriel da Luz
   Maia, Maricelia Lima
   Xavier, Joilson
   Oliveira Lima, Maria Aparecida
   Fonseca, Vagner
   de Abreu, Alvaro Salgado
   de Oliveira Tosta, Stephane Fraga
   do Amaral, Helineide Ramos
   Barbosa Lima, Italo Andrade
   Silva, Paloma Viana
   dos Santos, Daiana Carlos
   de Oliveira, Aline Sousa
   de Souza, Siane Campos
   Falcao, Melissa Barreto
   Cerqueira, Erenilde
   Machado, Lais Ceschini
   Sobral, Mariana Carolina
   Teodoro Rezende, Tatiana Maria
   Pereira, Mylena Ribeiro
   Pereira, Felicidade Mota
   Gusmao Maia, Zuinara Pereira
   de Oliveira Franca, Rafael Freitas
   de Abreu, Andre Luiz
   de Albuquerque e Melo, Carlos Frederico Campelo
   Faria, Nuno Rodrigues
   da Cunha, Rivaldo Venancio
   Giovanetti, Marta
   Junior Alcantara, Luiz Carlos
TI Persistence of chikungunya ECSA genotype and local outbreak in an upper
   medium class neighborhood in Northeast Brazil
SO PLOS ONE
LA English
DT Article
ID INDIAN-OCEAN; VIRUS; REEMERGENCE; POPULATION; GENOME; ZIKA
AB The chikungunya East/Central/South/Africa virus lineage (CHIKV-ECSA) was first detected in Brazil in the municipality of Feira de Santana (FS) by mid 2014. Following that, a large number of CHIKV cases have been notified in FS, which is the second-most populous city in Bahia state, northeastern Brazil, and plays an important role on the spread to other Brazilian states due to climate conditions and the abundance of competent vectors. To better understand CHIKV dynamics in Bahia state, we generated 5 complete genome sequences from a local outbreak raised in Serraria Brasil, a neighbourhood in FS, by next-generation sequencing using Illumina approach. Phylogenetic reconstructions revealed that the new FS genomes belongs to the ECSA genotype and falls within a single strongly supported monophyletic clade that includes other older CHIKV sequences from the same location, suggesting the persistence of the virus during distinct epidemic seasons. We also performed minor variants analysis and found a small number of SNPs per sample (b_29L and e_45SR = 16 SNPs, c_29SR = 29 and d_45PL and f_45FL = 21 SNPs). Out of the 93 SNPs found, 71 are synonymous, 21 are non-synonymous and one generated a stop codon. Although those mutations are not related to the increase of virus replication and/or infectivity, some SNPs were found in non-structural proteins which may have an effect on viral evasion from the mammal immunological system. These findings reinforce the needing of further studies on those variants and of continued genomic surveillance strategies to track viral adaptations and to monitor CHIKV epidemics for improved public health control.
C1 [de Jesus, Jaqueline Goes; Barbosa Lima, Italo Andrade; Silva, Paloma Viana; dos Santos, Daiana Carlos; de Oliveira, Aline Sousa; de Souza, Siane Campos] Fundacao Oswaldo Cruz, Inst Goncalo Moniz, Lab Patol Expt, Salvador, BA, Brazil.
   [Wallau, Gabriel da Luz; Machado, Lais Ceschini; Sobral, Mariana Carolina; Teodoro Rezende, Tatiana Maria] Fundacao Oswaldo Cruz, Inst Aggeu Magalhaes, Dept Entomol, Recife, PE, Brazil.
   [Maia, Maricelia Lima; Oliveira Lima, Maria Aparecida; do Amaral, Helineide Ramos; Cerqueira, Erenilde] Univ Estadual Feira De Santana, Feira De Santana, BA, Brazil.
   [Maia, Maricelia Lima; Falcao, Melissa Barreto] Minist Saude, Secretaria Sande Feira De Santana, Feira De Santana, BA, Brazil.
   [Xavier, Joilson; Fonseca, Vagner; de Abreu, Alvaro Salgado; de Oliveira Tosta, Stephane Fraga; Giovanetti, Marta; Junior Alcantara, Luiz Carlos] Univ Fed Minas Gerais, Lab Genet Celular Mol, ICB, Belo Horizonte, MG, Brazil.
   [Fonseca, Vagner] Univ KwaZulu Natal, Coll Hlth Sci, KwaZulu Natal Res Innovat & Sequencing Platform K, Durban, South Africa.
   [Pereira, Mylena Ribeiro; de Oliveira Franca, Rafael Freitas] Fundacao Oswaldo Cruz, Inst Aggeu Magalhaes, Dept Virol, Recife, PE, Brazil.
   [Pereira, Felicidade Mota; Gusmao Maia, Zuinara Pereira] Lab Cent Saude Publ Bahia, Salvador, BA, Brazil.
   [de Abreu, Andre Luiz] Minist Saude, Coordenacao Geral Labs Saude Publ, Secretaria Vigilancia Saude, Brasilia, DF, Brazil.
   [de Albuquerque e Melo, Carlos Frederico Campelo] Org Mundial Sande OPAS OMS, Org Pan Amer Saude, Brasilia, DF, Brazil.
   [Faria, Nuno Rodrigues] Univ Oxford, Dept Zool, Oxford, England.
   [da Cunha, Rivaldo Venancio] Univ Fed Mato Grosso do Sul, Dept Clin Medica, Fac Med, Campo Grande, MS, Brazil.
   [da Cunha, Rivaldo Venancio] Fundacao Oswaldo Cruz, Rio De Janeiro, Brazil.
   [Giovanetti, Marta; Junior Alcantara, Luiz Carlos] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Flavivirus, Rio De Janeiro, Brazil.
RP Giovanetti, M; Alcantara, LCJ (corresponding author), Univ Fed Minas Gerais, Lab Genet Celular Mol, ICB, Belo Horizonte, MG, Brazil.; Giovanetti, M; Alcantara, LCJ (corresponding author), Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Flavivirus, Rio De Janeiro, Brazil.
EM giovanetti.marta@gmail.com; luiz.alcantara@ioc.fiocruz.br
RI Fonseca, Vagner/R-5813-2019; Faria, Nuno R/I-2975-2012; Wallau, Gabriel
   Luz/B-5911-2008; Maia, Zuinara/M-7713-2019
OI Fonseca, Vagner/0000-0001-5521-6448; Faria, Nuno R/0000-0001-8839-2798;
   Wallau, Gabriel Luz/0000-0002-1419-5713; Xavier,
   Joilson/0000-0003-3916-2018; Andrade Barbosa Lima,
   Italo/0000-0002-7113-7579
FU CNPqNational Council for Scientific and Technological Development (CNPq)
   [440685/2016-8]; CAPESCAPES [88887.130716/2016-00]; Horizon 2020
   [PRES-005-FEX-17-4-2-33]
FX This research was funded by CNPq grant number (440685/2016-8); CAPES
   grant number (88887.130716/2016-00), and by Horizon 2020
   (PRES-005-FEX-17-4-2-33) to LCJA. The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Akhrymuk I, 2012, J VIROL, V86, P7180, DOI 10.1128/JVI.00541-12
   [Anonymous], 2016, B EP MON CAS DENG FE, V47, P7
   [Anonymous], 2019, B EP ARB BAH 2019
   [Anonymous], 2017, IBGE CID FEIR SANT
   Brasil. Ministerio da Saude. OPAS, 2015, OPAS DIV DAD LEV
   Brasil. Ministerio da Saude. Secretaria de Vigilacia em Saude, 2017, SECR VIG SAUD SECR A
   Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695
   Cunha MD, 2017, J CLIN VIROL, V97, P44, DOI 10.1016/j.jcv.2017.10.015
   Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109
   Dias JP, 2018, EMERG INFECT DIS, V24, P617, DOI 10.3201/eid2404.171370
   European Centre for Disease Prevention and Control, 2014, GUID SURV NAT MOSQ E, DOI [10.2900/37227, DOI 10.2900/37227]
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Faria NR, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15152-8
   Fonseca V, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007231
   Fros JJ, 2013, J VIROL, V87, P10394, DOI 10.1128/JVI.00884-13
   Fu JYL, 2019, J GEN VIROL, V100, P1541, DOI 10.1099/jgv.0.001338
   Ganesan VK, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9120368
   Gill MS, 2013, MOL BIOL EVOL, V30, P713, DOI 10.1093/molbev/mss265
   Huits R, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196630
   Johnson BW, 2016, AM J TROP MED HYG, V95, P182, DOI 10.4269/ajtmh.16-0013
   Jones PH, 2013, VIROLOGY, V438, P37, DOI 10.1016/j.virol.2013.01.010
   Katoh K, 2019, BRIEF BIOINFORM, V20, P1160, DOI 10.1093/bib/bbx108
   Kozlov AM, 2015, BIOINFORMATICS, V31, P2577, DOI 10.1093/bioinformatics/btv184
   Lanciotti RS, 2007, EMERG INFECT DIS, V13, P764, DOI 10.3201/eid1305.070015
   Larsson A, 2014, BIOINFORMATICS, V30, P3276, DOI 10.1093/bioinformatics/btu531
   Lima MM, 2018, ORG YVANNA CARLA SOU, V2
   Ministerio da Saude, 2017, B EP MON CAS DENG FE, V48, P4
   Morrison CR, 2016, MICROBIOL SPECTR, V4, DOI 10.1128/microbiolspec.EI10-0017-2016
   Morrison TE, 2014, J VIROL, V88, P11644, DOI 10.1128/JVI.01432-14
   Musso D, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0556-9
   Naveca FG, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007065
   Njenga MK, 2008, J GEN VIROL, V89, P2754, DOI 10.1099/vir.0.2008/005413-0
   Pathak H, 2019, CLIN MED, V19, P381, DOI 10.7861/clinmed.2019-0035
   Peres RC, 2013, J VECTOR ECOL, V38, P190, DOI 10.1111/j.1948-7134.2013.12027.x
   Pialoux G, 2007, LANCET INFECT DIS, V7, P319, DOI 10.1016/S1473-3099(07)70107-X
   Powers AM, 2000, J GEN VIROL, V81, P471, DOI 10.1099/0022-1317-81-2-471
   Powers AM, 2011, EXP BIOL MED, V236, P909, DOI 10.1258/ebm.2011.011078
   Quick J, 2017, NAT PROTOC, V12, P1261, DOI 10.1038/nprot.2017.066
   Rambaut A, 2018, SYST BIOL, V67, P901, DOI 10.1093/sysbio/syy032
   Rambaut A, 2016, VIRUS EVOL, V2, DOI 10.1093/ve/vew007
   Rezza G, 2007, LANCET, V370, P1840, DOI 10.1016/S0140-6736(07)61779-6
   Rodas JD, 2016, AM J TROP MED HYG, V95, P639, DOI 10.4269/ajtmh.16-0091
   Rodrigues Faria Nuno, 2016, PLoS Curr, V8, DOI 10.1371/currents.outbreaks.c97507e3e48efb946401755d468c28b2
   Schuffenecker I, 2006, PLOS MED, V3, P1058, DOI 10.1371/journal.pmed.0030263
   Suchard MA, 2018, VIRUS EVOL, V4, DOI 10.1093/ve/vey016
   Nunes MRT, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0348-x
   Tsetsarkin KA, 2011, P NATL ACAD SCI USA, V108, P7872, DOI 10.1073/pnas.1018344108
   Xavier J, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0217871
   Yactayo S, 2016, J INFECT DIS, V214, pS441, DOI 10.1093/infdis/jiw390
NR 49
TC 0
Z9 0
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JAN 8
PY 2020
VL 15
IS 1
AR e0226098
DI 10.1371/journal.pone.0226098
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA LP5DK
UT WOS:000534337700012
PM 31914137
OA DOAJ Gold, Green Published
DA 2020-10-22
ER

PT J
AU Tosta, SFD
   Passos, MS
   Kato, R
   Salgado, A
   Xavier, J
   Jaiswal, AK
   Soares, SC
   Azevedo, V
   Giovanetti, M
   Tiwari, S
   Alcantara, LC
AF de Oliveira Tosta, Stephane Fraga
   Passos, Mariana Santana
   Kato, Rodrigo
   Salgado, Alvaro
   Xavier, Joilson
   Jaiswal, Arun Kumar
   Soares, Siomar C.
   Azevedo, Vasco
   Giovanetti, Marta
   Tiwari, Sandeep
   Junior Alcantara, Luiz Carlos, Jr.
TI Multi-epitope based vaccine against yellow fever virus applying
   immunoinformatics approaches
SO JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
LA English
DT Article; Early Access
DE Immunoinformatics; flavivirus; multi-epitope vaccine; vaccine; Yellow
   fever virus
ID PEPTIDE VACCINE; NUCLEOTIDE-SEQUENCE; PROTEIN; DESIGN; PREDICTION;
   RESPONSES; STRATEGY; GENOME; ALPHA; IMMUNOGENICITY
AB Yellow fever disease is considered a re-emerging major health issue which has caused recent outbreaks with a high number of deaths. Tropical countries, mainly African and South American, are the most affected by Yellow fever outbreaks. Despite the availability of an attenuated vaccine, its use is limited for some groups such as pregnant and nursing women, immunocompromised and immunosuppressed patients, elderly people >65 years, infants <6 months and patients with biological disorders like thymus disorders. In order to achieve new preventive measures, we applied immunoinformatics approaches to develop a multi-epitope-based subunit vaccine for Yellow fever virus. Different epitopes, related to humoral and cell-mediated immunity, were predicted for complete polyproteins of two Yellow fever strains (Asibi and 17 D vaccine). Those epitopes common for both strains were mapped into a set of 137 sequences of Yellow fever virus, including 77 sequences from a recent outbreak at the state of Minas Gerais, southeast Brazil. Therefore, the present work uses robust bioinformatics approaches for the identification of a multi-epitope vaccine against the Yellow fever virus. Our results indicate that the identified multi-epitope vaccine might stimulate humoral and cellular immune responses and could be a potential vaccine candidate against Yellow fever virus infection. Hence, it should be subjected to further experimental validations. Communicated by Ramaswamy H. Sarma
C1 [de Oliveira Tosta, Stephane Fraga; Kato, Rodrigo; Salgado, Alvaro; Jaiswal, Arun Kumar; Azevedo, Vasco; Tiwari, Sandeep] Fed Univ Minas Gerais UFMG, Inst Biol Sci, Postgrad Program Bioinformat, BR-31270901 Belo Horizonte, MG, Brazil.
   [Passos, Mariana Santana; Xavier, Joilson; Giovanetti, Marta; Junior Alcantara, Luiz Carlos, Jr.] Fed Univ Minas Gerais UFMG, Inst Biol Sci, Dept Genet, Belo Horizonte, MG, Brazil.
   [Jaiswal, Arun Kumar; Soares, Siomar C.] Fed Univ Triangulo Mineiro UFTM, Inst Biol & Nat Sci, Dept Immunol Microbiol & Parasitol, Uberaba, MG, Brazil.
   [Giovanetti, Marta; Junior Alcantara, Luiz Carlos, Jr.] Fiocruz MS, Inst Oswaldo Cruz, Lab Flavivirus, Manguinho, RJ, Brazil.
RP Tiwari, S (corresponding author), Fed Univ Minas Gerais UFMG, Inst Biol Sci, Postgrad Program Bioinformat, BR-31270901 Belo Horizonte, MG, Brazil.; Giovanetti, M; Alcantara, LC (corresponding author), Fiocruz MS, Inst Oswaldo Cruz, Lab Flavivirus, Manguinho, RJ, Brazil.
EM giovanetti.marta@gmail.com; sandip_sbtbi@yahoo.com;
   luiz.alcantara@ioc.fiocruz.br
RI Azevedo, Vasco A/B-1556-2019; Giovanetti, Marta/AAK-7408-2020
OI Azevedo, Vasco A/0000-0002-4775-2280; Alcantara,
   Luiz/0000-0002-6769-9931; jaiswal, A run kumar/0000-0002-0558-483X;
   Xavier, Joilson/0000-0003-3916-2018; Kato, Rodrigo/0000-0002-9046-1702
FU CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior,
   Brasil)CAPES; CNPq (Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico)National Council for Scientific and Technological
   Development (CNPq)
FX We acknowledge the collaboration and assistance of all team members and
   the Brazilian funding agencies CAPES (Coordenacao de Aperfeicoamento de
   Pessoal de Nivel Superior, Brasil) and CNPq (Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico).
CR Ali M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09199-w
   ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999
   [Anonymous], 2013, Wkly Epidemiol Rec, V88, P269
   Backert L, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0245-0
   Barh D, 2010, BIOINFORMATION, V5, P77, DOI 10.6026/97320630005077
   Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989
   Benelli G, 2015, PARASITOL RES, V114, P1613, DOI 10.1007/s00436-015-4351-0
   Biscayart C, 2014, VACCINE, V32, P1266, DOI 10.1016/j.vaccine.2014.01.015
   Breugelmans JG, 2013, VACCINE, V31, P1819, DOI 10.1016/j.vaccine.2013.01.054
   Campi-Azevedo AC, 2016, HUM VACC IMMUNOTHER, V12, P491, DOI 10.1080/21645515.2015.1082693
   Chauhan V, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39299-8
   Chen HY, 2017, J MOL MICROB BIOTECH, V27, P64, DOI 10.1159/000454813
   Chen S, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9100291
   Chen XY, 2013, ADV DRUG DELIVER REV, V65, P1357, DOI 10.1016/j.addr.2012.09.039
   Cole GT, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003768
   Couto A. Mallmann, 2010, Morbidity and Mortality Weekly Report, V59, P130
   DALGARNO L, 1986, J MOL BIOL, V187, P309, DOI 10.1016/0022-2836(86)90435-3
   Dar HA, 2019, VACCINES-BASEL, V7, DOI 10.3390/vaccines7030088
   de Melo AB, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0001938
   Dhanda SK, 2013, BIOL DIRECT, V8, DOI 10.1186/1745-6150-8-30
   Dorosti H, 2019, J BIOMOL STRUCT DYN, V37, P3524, DOI 10.1080/07391102.2018.1519460
   Doytchinova IA, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-4
   El-Manzalawy Y, 2008, J MOL RECOGNIT, V21, P243, DOI 10.1002/jmr.893
   Faria NR, 2018, SCIENCE, V361, P894, DOI 10.1126/science.aat7115
   Finn RD, 2017, NUCLEIC ACIDS RES, V45, pD190, DOI 10.1093/nar/gkw1107
   Funderburg N, 2007, P NATL ACAD SCI USA, V104, P18631, DOI 10.1073/PNAS.0702130104
   Garske T, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001638
   Gasteiger E., 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571., DOI 10.1385/1-59259-890-0:571, 10.1385/1-59259-890-0:571]
   Giovanetti M, 2020, J VIROL, V94, DOI 10.1128/JVI.01623-19
   Greenbaum J, 2011, IMMUNOGENETICS, V63, P325, DOI 10.1007/s00251-011-0513-0
   Grote A, 2005, NUCLEIC ACIDS RES, V33, pW526, DOI 10.1093/nar/gki376
   Gu Y, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01475
   GURUPRASAD K, 1990, PROTEIN ENG, V4, P155, DOI 10.1093/protein/4.2.155
   HAHN CS, 1987, P NATL ACAD SCI USA, V84, P2019, DOI 10.1073/pnas.84.7.2019
   Hajighahramani N, 2017, INFECT GENET EVOL, V48, P83, DOI 10.1016/j.meegid.2016.12.010
   Hall T., 2013, BIOEDIT VERSION 7 2, DOI [10.1016/j.ifset.2004.06.001, DOI 10.1016/J.IFSET.2004.06.001]
   Heo L, 2013, NUCLEIC ACIDS RES, V41, pW384, DOI 10.1093/nar/gkt458
   Jenik M, 2012, NUCLEIC ACIDS RES, V40, pW348, DOI 10.1093/nar/gks447
   JENNINGS AD, 1994, J INFECT DIS, V169, P512, DOI 10.1093/infdis/169.3.512
   Jin MS, 2007, CELL, V130, P1071, DOI 10.1016/j.cell.2007.09.008
   Johansson MA, 2010, AM J TROP MED HYG, V83, P183, DOI 10.4269/ajtmh.2010.09-0782
   Karplus M, 2002, NAT STRUCT BIOL, V9, P646, DOI 10.1038/nsb0902-646
   Khan M, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-49354-z
   Khromava AY, 2005, VACCINE, V23, P3256, DOI 10.1016/j.vaccine.2005.01.089
   Kwok SC, 2002, PROTEIN SCI, V11, P1519, DOI 10.1110/ps.4170102
   Lang J, 1999, AM J TROP MED HYG, V60, P1045, DOI 10.4269/ajtmh.1999.60.1045
   Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404
   Larsen MV, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-424
   Lawrence GL, 2005, COMMUN DIS INTELL, V29, P248
   Li XY, 2015, INTERVIROLOGY, V58, P403, DOI 10.1159/000445059
   LIN C, 1993, J VIROL, V67, P2327, DOI 10.1128/JVI.67.4.2327-2335.1993
   Livingston B, 2002, J IMMUNOL, V168, P5499, DOI 10.4049/jimmunol.168.11.5499
   Lohia N, 2014, VIRAL IMMUNOL, V27, P225, DOI 10.1089/vim.2013.0135
   Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286
   Maciel M, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003693
   Magnan CN, 2010, BIOINFORMATICS, V26, P2936, DOI 10.1093/bioinformatics/btq551
   Marfin AA, 2005, INFECT DIS CLIN N AM, V19, P151, DOI 10.1016/j.idc.2004.11.004
   Minor PD, 2015, VIROLOGY, V479, P379, DOI 10.1016/j.virol.2015.03.032
   Mohan T, 2013, VACCINE, V31, P1707, DOI 10.1016/j.vaccine.2013.01.041
   Monath TP, 2007, NEW ENGL J MED, V357, P2222, DOI 10.1056/NEJMp0707161
   Monath TP, 2015, J CLIN VIROL, V64, P160, DOI 10.1016/j.jcv.2014.08.030
   Monath TP, 2010, VACCINE, V28, P3827, DOI 10.1016/j.vaccine.2010.03.023
   Murphy D, 2019, CHEM BIOL DRUG DES, V93, P21, DOI 10.1111/cbdd.13357
   Mutebi JP, 2001, J VIROL, V75, P6999, DOI 10.1128/JVI.75.15.6999-7008.2001
   Narula A, 2018, INFECT GENET EVOL, V61, P4, DOI 10.1016/j.meegid.2018.03.007
   Naz K, 2019, BMC BIOINFORMATICS, V20, DOI 10.1186/s12859-019-2713-9
   Nezafat N, 2016, COMPUT BIOL CHEM, V62, P82, DOI 10.1016/j.compbiolchem.2016.04.006
   Nezafat N, 2014, J THEOR BIOL, V349, P121, DOI 10.1016/j.jtbi.2014.01.018
   Nishioka SD, 1998, TROP MED INT HEALTH, V3, P29, DOI 10.1046/j.1365-3156.1998.00164.x
   Ode H, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00258
   Paho, 2018, EP UPD YELL FEV SIT
   Pandey RK, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19456-1
   Paules CI, 2017, NEW ENGL J MED, V376, P1397, DOI 10.1056/NEJMp1702172
   Ponomarenko J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-514
   Porudominsky R, 2018, REV PANAM SALUD PUBL, V42, DOI [10.26633/rpsp.2018.75, 10.26633/RPSP.2018.75]
   Pritam M, 2019, BMC BIOINFORMATICS, V19, DOI 10.1186/s12859-018-2482-x
   Pulendran B, 2008, J INFECT DIS, V198, P500, DOI 10.1086/590187
   Pulendran B, 2009, NAT REV IMMUNOL, V9, P741, DOI 10.1038/nri2629
   Rana A, 2018, FRONT GENET, V9, DOI 10.3389/fgene.2018.00572
   Rana A, 2016, IMMUNOBIOLOGY, V221, P544, DOI 10.1016/j.imbio.2015.12.004
   Rappuoli R, 2001, VACCINE, V19, P2688, DOI 10.1016/S0264-410X(00)00554-5
   RICE CM, 1985, SCIENCE, V229, P726, DOI 10.1126/science.4023707
   RUIZLINARES A, 1989, J VIROL, V63, P4199, DOI 10.1128/JVI.63.10.4199-4209.1989
   Rutkowski K, 2013, INT ARCH ALLERGY IMM, V161, P274, DOI 10.1159/000346350
   Saadi M, 2017, INFECT GENET EVOL, V51, P227, DOI 10.1016/j.meegid.2017.04.009
   Sabetian S, 2019, J BIOMOL STRUCT DYN, V37, P2546, DOI 10.1080/07391102.2018.1491890
   Saha S, 2006, NUCLEIC ACIDS RES, V34, pW202, DOI 10.1093/nar/gkl343
   Shearer FM, 2018, LANCET GLOB HEALTH, V6, pE270, DOI 10.1016/S2214-109X(18)30024-X
   Shearer FM, 2017, LANCET INFECT DIS, V17, P1209, DOI 10.1016/S1473-3099(17)30419-X
   Shey RA, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-40833-x
   Simmonds P, 2017, J GEN VIROL, V98, P2, DOI 10.1099/jgv.0.000672
   Smith H. H., 1938, AM J TROP MED HYG, Vs1-18, P437, DOI [10.4269/ajtmh.1938.s1-18.437, DOI 10.4269/AJTMH.1938.S1-18.437]
   Staples J. E., 2018, 63 YELLOW FEVER VACC, DOI [10.1016/B978-0-323-35761-6.00063-8, DOI 10.1016/B978-0-323-35761-6.00063-8]
   TAKAHASHI H, 1989, J IMMUNOL, V142, P2221
   Theiler M, 1937, J EXP MED, V65, P787, DOI 10.1084/jem.65.6.787
   Tinto H, 2015, LANCET, V386, P31, DOI 10.1016/S0140-6736(15)60721-8
   Torchala M, 2013, BIOINFORMATICS, V29, P807, DOI 10.1093/bioinformatics/btt038
   Traiber C, 2011, J PEDIAT-BRAZIL, V87, P269, DOI [10.1590/S0021-75572011000300015, 10.2223/JPED.2067]
   TSAI TF, 1993, J INFECT DIS, V168, P1520, DOI 10.1093/infdis/168.6.1520
   Ul-Rahman A, 2020, J BIOMOL STRUCT DYN, V38, P3110, DOI 10.1080/07391102.2019.1651673
   Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291
   Velders MP, 2001, J IMMUNOL, V166, P5366, DOI 10.4049/jimmunol.166.9.5366
   Vita R, 2019, NUCLEIC ACIDS RES, V47, pD339, DOI 10.1093/nar/gky1006
   von Lindern JJ, 2006, J GEN VIROL, V87, P895, DOI 10.1099/vir.0.81236-0
   Wang E, 1996, VIROLOGY, V225, P274, DOI 10.1006/viro.1996.0601
   Wang LF, 2016, J INFECTION, V73, P377, DOI 10.1016/j.jinf.2016.07.003
   Wang S, 2016, NUCLEIC ACIDS RES, V44, pW430, DOI 10.1093/nar/gkw306
   Ward JJ, 2003, BIOINFORMATICS, V19, P1650, DOI 10.1093/bioinformatics/btg223
   Weiskopf D, 2013, P NATL ACAD SCI USA, V110, pE2046, DOI 10.1073/pnas.1305227110
   WHO, 2014, LIST COUNTR TERR AR
   Wilder-Smith A, 2017, LANCET INFECT DIS, V17, P248, DOI 10.1016/S1473-3099(16)30588-6
   Yano A, 2005, VACCINE, V23, P2322, DOI 10.1016/j.vaccine.2005.01.031
   Zhang LF, 2018, CELL MOL IMMUNOL, V15, P182, DOI 10.1038/cmi.2017.92
NR 113
TC 5
Z9 5
U1 3
U2 7
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 0739-1102
EI 1538-0254
J9 J BIOMOL STRUCT DYN
JI J. Biomol. Struct. Dyn.
DI 10.1080/07391102.2019.1707120
EA JAN 2020
PG 17
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA KA6EL
UT WOS:000505890000001
PM 31854239
DA 2020-10-22
ER

PT J
AU Xavier, J
   Giovanetti, M
   Adelino, T
   Fonseca, V
   da Costa, AVB
   Ribeiro, AA
   Felicio, KN
   Duarte, CG
   Silva, MVF
   Salgado, A
   Lima, MT
   de Jesus, R
   Fabri, A
   Zoboli, CFS
   Santos, TGS
   Iani, F
   Ciccozzi, M
   de Filippis, AMB
   de Siqueira, MAMT
   de Abreu, AL
   de Azevedo, V
   Ramalho, DB
   de Albuquerque, CCF
   de Oliveira, T
   Holmes, EC
   Lourenco, J
   Alcantara, LCJ
   Oliveira, MAA
AF Xavier, Joilson
   Giovanetti, Marta
   Adelino, Talita
   Fonseca, Vagner
   Barbosa da Costa, Alana Vitor
   Ribeiro, Adriana Aparecida
   Felicio, Katlin Nascimento
   Duarte, Clara Guerra
   Ferreira Silva, Marcos Vinicius
   Salgado, Alvaro
   Lima, Mauricio Teixeira
   de Jesus, Ronaldo
   Fabri, Allison
   Soares Zoboli, Cristiane Franco
   Souza Santos, Thales Gutemberg
   Iani, Felipe
   Ciccozzi, Massimo
   Bispo de Filippis, Ana Maria
   Teixeira de Siqueira, Marilda Agudo Mendonca
   de Abreu, Andre Luiz
   de Azevedo, Vasco
   Ramalho, Dario Brock
   Campelo de Albuquerque, Carlos F.
   de Oliveira, Tulio
   Holmes, Edward C.
   Lourenco, Jose
   Junior Alcantara, Luiz Carlos
   Assuncao Oliveira, Marluce Aparecida
TI The ongoing COVID-19 epidemic in Minas Gerais, Brazil: insights from
   epidemiological data and SARS-CoV-2 whole genome sequencing
SO EMERGING MICROBES & INFECTIONS
LA English
DT Article
DE SARS-CoV-2; genomic surveillance; Minas Gerais; southeast Brazil;
   pandemic; sequencing; genomic epidemiology
ID CORONAVIRUS
AB The recent emergence of a coronavirus (SARS-CoV-2), first identified in the Chinese city of Wuhan in December 2019, has had major public health and economic consequences. Although 61,888 confirmed cases were reported in Brazil by 28 April 2020, little is known about the SARS-CoV-2 epidemic in this country. To better understand the recent epidemic in the second most populous state in southeast Brazil - Minas Gerais (MG) - we sequenced 40 complete SARS-CoV-2 genomes from MG cases and examined epidemiological data from three Brazilian states. Both the genome analyses and the geographical distribution of reported cases indicate for multiple independent introductions into MG. Epidemiological estimates of the reproductive number (R) using different data sources and theoretical assumptions suggest the potential for sustained virus transmission despite a reduction in R from the first reported case to the end of April 2020. The estimated date of SARS-CoV-2 introduction into Brazil was consistent with epidemiological data from the first case of a returned traveller from Lombardy, Italy. These findings highlight the nature of the COVID-19 epidemic in MG and reinforce the need for real-time and continued genomic surveillance strategies to better understand and prepare for the epidemic spread of emerging viral pathogens..
C1 [Xavier, Joilson; Giovanetti, Marta; Adelino, Talita; Fonseca, Vagner; Salgado, Alvaro; Lima, Mauricio Teixeira; de Jesus, Ronaldo; Iani, Felipe; de Azevedo, Vasco; Junior Alcantara, Luiz Carlos] Univ Fed Minas Gerais, Lab Genet Celular & Mol, Belo Horizonte, MG, Brazil.
   [Giovanetti, Marta; Fabri, Allison; Bispo de Filippis, Ana Maria; Junior Alcantara, Luiz Carlos] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Flavivirus, Rio De Janeiro, Brazil.
   [Adelino, Talita; Barbosa da Costa, Alana Vitor; Ribeiro, Adriana Aparecida; Felicio, Katlin Nascimento; Duarte, Clara Guerra; Ferreira Silva, Marcos Vinicius; Soares Zoboli, Cristiane Franco; Souza Santos, Thales Gutemberg; Iani, Felipe; Assuncao Oliveira, Marluce Aparecida] Fundacao Ezequiel Dias, Lab Cent Saude Publ, Belo Horizonte, MG, Brazil.
   [Fonseca, Vagner; de Oliveira, Tulio] Univ KwaZulu Natal, DKwaZulu Natal Res Innovat & Sequencing Platform, Coll Hlth Sci, ZA-4001 Durban, South Africa.
   [Teixeira de Siqueira, Marilda Agudo Mendonca] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Virus Resp & Sarampo, Rio De Janeiro, Brazil.
   [de Abreu, Andre Luiz] Minist Saude, Secretaria Vigilancia Saude, Coordenacao Geral Labs Saude Publ, Brasilia, DF, Brazil.
   [Ramalho, Dario Brock] Secretaria Estado Saude Minas Gerais, Belo Horizonte, MG, Brazil.
   [Campelo de Albuquerque, Carlos F.] Org Mundial Saude, Org Pan Amer Saude, Brasilia, DF, Brazil.
   [Holmes, Edward C.] Univ Sydney, Marie Bashir Inst Infect Dis & Biosecur, Sch Life & Environm Sci, Sydney, NSW, Australia.
   [Holmes, Edward C.] Univ Sydney, Sch Med Sci, Sydney, NSW, Australia.
   [Lourenco, Jose] Univ Oxford, Dept Zool, Oxford OX1 3PS, England.
   [Ciccozzi, Massimo] Univ Campus Biomed Rome, Rome, Italy.
RP Alcantara, LCJ (corresponding author), Univ Oxford, Dept Zool, Oxford OX1 3PS, England.
EM luiz.alcantara@ioc.fiocruz.br
RI ; Guerra-Duarte, Clara/H-1409-2012
OI Reis, AlessanRSS/0000-0001-8486-7469; Guerra-Duarte,
   Clara/0000-0002-7698-3811; Fonseca, Vagner/0000-0001-5521-6448; Xavier,
   Joilson/0000-0003-3916-2018
FU Pan American World Health Organization [VPGDI-003-FIO-19-2-2-30];
   Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)Carlos
   Chagas Filho Foundation for Research Support of the State of Rio de
   Janeiro (FAPERJ); South African Medical Research Council
   [MRC-RFA-UFSP-01-2013/UKZN HIVEPI]; NIH H3AbioNet network, an initiative
   of the Human Health and Heredity in Africa Consortium (H3Africa);
   Australian Research Council Australian Laureate FellowshipAustralian
   Research Council [FL170100022]; Department of Zoology, University of
   Oxford; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior -
   Brasil (CAPES)CAPES [001]; Fundacao de Amparo a Pesquisa do Estado de
   Minas Gerais (FAPEMIG)Minas Gerais State Research Foundation (FAPEMIG);
   ZIKA - Announcement MCTIC/FNDCT-CNPq/MEC-CAPES/MS-Decit [14/2016];
   Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPQ)National Council for Scientific and Technological Development
   (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior
   (CAPES)CAPES [88887.506611/202-00]
FX This work was supported by the Pan American World Health Organization
   (VPGDI-003-FIO-19-2-2-30). M.G. is supported by Fundacao de Amparo a
   Pesquisa do Estado do Rio de Janeiro (FAPERJ). V.F. and T.d.O. are
   supported by the South African Medical Research Council
   (MRC-RFA-UFSP-01-2013/UKZN HIVEPI) and the NIH H3AbioNet network, which
   is an initiative of the Human Health and Heredity in Africa Consortium
   (H3Africa). E. C.H. is supported by an Australian Research Council
   Australian Laureate Fellowship (FL170100022). J.L. is supported by a
   lectureship from the Department of Zoology, University of Oxford. J.X.
   and F.I. are supported by the Coordenacao de Aperfeicoamento de Pessoal
   de Nivel Superior -Brasil (CAPES) - Finance Code 001. F.I. is also
   supported by Fundacao de Amparo a Pesquisa do Estado de Minas Gerais
   (FAPEMIG). A.S. has a scholarship from ZIKA - Announcement
   MCTIC/FNDCT-CNPq/MEC-CAPES/MS-Decit/No. 14/2016 -Prevention and Fight
   against Zika Virus. M.T.L. is supported by Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPQ). V.A. has a grant from
   the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior
   (CAPES)(#88887.506611/202-00). The funders had no role in study design,
   data collection and analysis, writing and/or decision to publish the
   manuscript.
CR Andersen KG, 2020, NAT MED, DOI 10.1038/s41591-020-0820-9
   [Anonymous], 2020, 165 WHO
   Cleemput S, 2020, BIOINFORMATICS, V36, P3552, DOI 10.1093/bioinformatics/btaa145
   Costa E, 2020, NOUV REV FR, P19
   de Jesus JG, 2020, REV INST MED TROP SP, V62, DOI [10.1590/S1678-9946202062030, 10.1590/s1678-9946202062030]
   Flaxman S, 2020, IMP COLL LONDON
   Gardy JL, 2018, NAT REV GENET, V19, P9, DOI 10.1038/nrg.2017.88
   Gonzalez-Reiche AS, 2020, INTRO EARLY SPREAD S
   Gorbalenya AE, 2020, NAT MICROBIOL, V5, P536, DOI 10.1038/s41564-020-0695-z
   GRIFFITHS RC, 1994, PHILOS T ROY SOC B, V344, P403, DOI 10.1098/rstb.1994.0079
   Instituto Brasileiro de Geografia e Estatistica-IBGE, 2020, CID EST BEL HOR
   Instituto Brasileiro de Geografia e Estatistica-IBGE, 2020, CID EST MIN GER
   Jaqueline Goes de J, 2020, VIROL GENOME REPORTS, P1
   Katoh K, 2019, BRIEF BIOINFORM, V20, P1160, DOI 10.1093/bib/bbx108
   Kucharski AJ, 2020, LANCET INFECT DIS, V20, P553, DOI 10.1016/S1473-3099(20)30144-4
   Nguyen LT, 2015, MOL BIOL EVOL, V32, P268, DOI 10.1093/molbev/msu300
   Larsson A, 2014, BIOINFORMATICS, V30, P3276, DOI 10.1093/bioinformatics/btu531
   Lu J, 2020, CELL
   Lu RJ, 2020, LANCET, V395, P565, DOI 10.1016/S0140-6736(20)30251-8
   Mavian C, 2020, JMIR PUBLIC HEAL SUR
   Mavian C, 2020, REGAINING PERSPECTIV
   McCrone JT, 2020, PHYLOGENETIC ASSIGNM
   Mellan TA, 2020, REPORT 21 ESTIMATING
   Moorthy V, 2020, B WORLD HEALTH ORGAN, P4
   Munnink BBO, 2020, BIORXIV
   Quick J., 2020, NCOV 2019 SEQUENCING
   Quick J, 2017, NAT PROTOC, V12, P1261, DOI 10.1038/nprot.2017.066
   Rambaut A., 2020, PHYLODYNAMIC ANAL 17
   Rambaut A, 2020, BIORXIV
   Rambaut A, 2018, SYST BIOL, V67, P901, DOI 10.1093/sysbio/syy032
   Rambaut A, 2016, VIRUS EVOL, V2, DOI 10.1093/ve/vew007
   Russell TW, 2020, EUROSURVEILLANCE, V25, P1
   Secretaria de Estado de Saude de Minas Gerais, 2020, B EP COVID 19 DOENC
   Spychalski P, 2020, LANCET INFECT DIS, V20, P774, DOI [10.1016/S1473-3099(20)30246-2, 10.1016/S1473-3099(20)30245-0]
   Suchard MA, 2018, VIRUS EVOL, V4, DOI 10.1093/ve/vey016
   Verity R, 2020, LANCET INFECT DIS, V20, P669, DOI 10.1016/S1473-3099(20)30243-7
   Vilsker M, 2019, BIOINFORMATICS, V35, P871, DOI 10.1093/bioinformatics/bty695
   Wallinga J, 2007, P ROY SOC B-BIOL SCI, V274, P599, DOI 10.1098/rspb.2006.3754
   WHO, 2020, 51 WHO
   World Health Organization, 2020, 103 WHO
   World Health Organization, 2020, 1 WHO
   Wu F, 2020, NATURE, DOI 10.1038/s41586-020-2008-3
   Wu JT, 2020, NAT MED, DOI 10.1038/s41591-020-0822-7
   Zhang T, 2020, BIORXIV, V1, P1
   Zhou P, 2020, NATURE, V579, P270, DOI 10.1038/s41586-020-2012-7
   Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017
NR 46
TC 1
Z9 1
U1 1
U2 1
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
EI 2222-1751
J9 EMERG MICROBES INFEC
JI Emerg. Microbes Infect.
PD JAN 1
PY 2020
VL 9
IS 1
BP 1824
EP 1834
DI 10.1080/22221751.2020.1803146
PG 11
WC Immunology; Microbiology
SC Immunology; Microbiology
GA NC9HM
UT WOS:000561521500001
PM 32726185
OA DOAJ Gold, Green Published
DA 2020-10-22
ER

PT J
AU Oliveira, JV
   Carvalho, TCX
   Giovanetti, M
   de Jesus, JG
   Santos, CS
   Pessoa, LB
   Magalhaes, CFQ
   Lima, JGS
   Carvalho, DAX
   Figueiredo, EM
   Biron, AC
   dos Santos, DC
   Viana, P
   Duarte, AO
   Pessoa, R
   Souza, GB
   Calcagno, JI
   Lima, FWM
   Alcantara, LCJ
   de Siqueira, IC
AF Oliveira, Joao, V
   Carvalho, Tereza C. X.
   Giovanetti, Marta
   de Jesus, Jaqueline G.
   Santos, Cleiton S.
   Pessoa, Lorena B.
   Magalhaes Filho, Claudio F. Q.
   Lima, Jessica G. S.
   Carvalho, Daniel A. X.
   Figueiredo, Eduardo M.
   Biron, Ana Carolina
   dos Santos, Daiana C.
   Viana, Paloma
   Duarte, Alan O.
   Pessoa, Rosana
   Souza, Gloryane B.
   Calcagno, Juan, I
   Lima, Fernanda W. M.
   Alcantara, Luiz C. J.
   de Siqueira, Isadora C.
TI Neonatal surveillance for congenital Zika infection during the 2016
   microcephaly outbreak in Salvador, Brazil: Zika virus detection in
   asymptomatic newborns
SO INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS
LA English
DT Article
DE Brazil; Congenital infection; Microcephaly; Neonatal surveillance; Zika
   virus
AB Objective To identify newborns with congenital Zika infection (CZI) at a maternity hospital in Salvador, Brazil, during the 2016 microcephaly outbreak. Methods A prospective study enrolled microcephalic and normocephalic newborns with suspected CZI between January and December 2016. Serology (immunoglobulins IgM and IgG) and quantitative reverse transcriptase polymerase chain reaction (RT-qPCR) for the Zika virus were performed. Demographic and clinical characteristics of newborns with and without microcephaly were compared. Results Of the 151 newborns enrolled, 32 (21.2%) were classified as microcephalic. The majority of these cases were born between January and May 2016. IgM and IgG Zika virus antibodies were detected in 5 (23.8%) and 17 (80.9%) microcephalic newborn blood samples, respectively. Six (24%) microcephalic newborns tested positive for Zika virus by RT-qPCR in urine or placenta samples. Thirteen (11.8%) normocephalic newborns also tested positive for Zika virus by PCR in urine, plasma, or placenta samples, while IgM antibodies against Zika were detected in 4 (4.2%) others. Conclusions Identification of 17 normocephalic CZI cases, confirmed by IgM serology or RT-qPCR for Zika virus, provides evidence that CZI can present asymptomatically at birth. This finding highlights the need for prenatal and neonatal screening for Zika virus in endemic regions.
C1 [Oliveira, Joao, V; de Jesus, Jaqueline G.; Santos, Cleiton S.; Pessoa, Lorena B.; Magalhaes Filho, Claudio F. Q.; Lima, Jessica G. S.; Carvalho, Daniel A. X.; dos Santos, Daiana C.; Viana, Paloma; de Siqueira, Isadora C.] Fundacao Oswaldo Cruz, Goncalo Moniz Inst, Minist Hlth, Salvador, BA, Brazil.
   [Carvalho, Tereza C. X.; Figueiredo, Eduardo M.; Biron, Ana Carolina; Pessoa, Rosana; Souza, Gloryane B.; Calcagno, Juan, I] Jose Maria de Magalhaes Netto Matern Hosp, Salvador, BA, Brazil.
   [Giovanetti, Marta; Alcantara, Luiz C. J.] Fiocruz MS, Flavivirus Lab, Oswald Cruz Inst, Rio De Janeiro, RJ, Brazil.
   [Giovanetti, Marta; Alcantara, Luiz C. J.] Univ Fed Minas Gerais, ICB, Cell & Mol Genet Lab, Belo Horizonte, MG, Brazil.
   [Duarte, Alan O.; Lima, Fernanda W. M.] Univ Fed Bahia, Fac Pharm, Immunol Infect Dis Lab, Salvador, BA, Brazil.
RP de Siqueira, IC (corresponding author), Fundacao Oswaldo Cruz, Inst Goncalo Moniz, Salvador, BA, Brazil.
EM isadora.siqueira@fiocruz.br
RI de Siqueira, Isadora Cristina/R-9953-2016; Giovanetti,
   Marta/AAK-7408-2020
OI de Siqueira, Isadora Cristina/0000-0002-2520-4099; Alcantara,
   Luiz/0000-0002-6769-9931
FU HRP Alliance, part of the UNDP/UNFPA/UNICEF/WHO/World Bank Special
   Programme of Research, Development and Research Training in Human
   Reproduction (HRP); UNICEF/UNDP/World Bank/WHO Special Programme for
   Research and Training in Tropical Diseases (TDR)World Health
   Organization; National Council for Scientific and Technological
   Development (CNPq)National Council for Scientific and Technological
   Development (CNPq) [425380/2016, 440685/2016-8, 443875/2018];
   Coordination for the Improvement of Higher Education Personnel
   (CAPES)CAPES [88887.130716/2016-00, 88881.130825/2016-00]
FX This work was funded by the HRP Alliance, part of the
   UNDP/UNFPA/UNICEF/WHO/World Bank Special Programme of Research,
   Development and Research Training in Human Reproduction (HRP) and the
   UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training
   in Tropical Diseases (TDR), both cosponsored programs hosted by the
   World Health Organization (WHO). The Pan American Health Organization
   (PAHO) provided technical support throughout project implementation.
   Financial support was also provided by the National Council for
   Scientific and Technological Development (CNPq) (425380/2016,
   440685/2016-8, and 443875/2018) and by Coordination for the Improvement
   of Higher Education Personnel (CAPES) (88887.130716/2016-00 and
   88881.130825/2016-00). The authors are grateful to the physicians and
   nurses charged with the patients' clinical care and would also like to
   thank the Arboviral Diseases Branch Diagnostic and Reference Team
   (Vector-Borne Diseases Division of the Centers for Disease Control and
   Prevention) for kindly providing the reagents necessary for MAC-ELISA
   serological testing. Andris K. Walter provided English language revision
   and manuscript copyediting assistance.
CR Bingham AM, 2016, MMWR-MORBID MORTAL W, V65, P475, DOI 10.15585/mmwr.mm6518e2
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Carvalho AL, 2019, CLIN MICROBIOL INFEC, V25, P524, DOI 10.1016/j.cmi.2018.12.021
   Centers for Disease Control and Prevention C, 2018, ZIK MAC ELISA INSTR, P101
   Cordeiro MT, 2016, LANCET, V387, P1811, DOI 10.1016/S0140-6736(16)30253-7
   de Araujo TVB, 2016, LANCET INFECT DIS, V16, P1356, DOI 10.1016/S1473-3099(16)30318-8
   de Onis M, 1996, ZIK MAC ELISA INSTR, V64, P650
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Moreira MEL, 2018, NEW ENGL J MED, V379, P2377, DOI 10.1056/NEJMc1800098
   European Centre for Disease Prevention and Control, 2015, RAP RISK ASS MICR BR
   Giovanetti M, 2018, CLIN MICROBIOL INFEC, V24, P1111, DOI 10.1016/j.cmi.2018.06.008
   Heang V, 2012, EMERG INFECT DIS, V18, P349, DOI 10.3201/eid1802.111224
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Ministry of Health, 2015, SURV RESP PROT OCC M
   Ministry of Health, 2016, EP B MON MICR CAS BR, V47
   Ministry of Health, 2018, EP B INT MON GROWTH, V49
   Ministry of Health, 2017, INT SURV HLTH CAR GU, P158
   Ministry of Health, 2015, PROT VIG RESP OC MIC, P55
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Pan American Health Organization (PAHO)/World Health Organization (WHO), 2015, EP AL INCR MICR NE B
   Paploski IAD, 2016, EMERG INFECT DIS, V22, P1438, DOI 10.3201/eid2208.160496
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
   van der Linden V, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i3899
   Villar J, 2014, LANCET, V384, P857, DOI 10.1016/S0140-6736(14)60932-6
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 26
TC 1
Z9 1
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0020-7292
EI 1879-3479
J9 INT J GYNECOL OBSTET
JI Int. J. Gynecol. Obstet.
PD JAN
PY 2020
VL 148
SU 2
SI SI
BP 9
EP 14
DI 10.1002/ijgo.13042
PG 6
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA KE9VY
UT WOS:000508899700003
PM 31975394
OA Green Published, Other Gold
DA 2020-10-22
ER

PT J
AU Maia, ZPG
   Pereira, FM
   Said, RFD
   Fonseca, V
   Graf, T
   Nogueira, FD
   Nardy, VB
   Xavier, J
   Maia, ML
   Abreu, AL
   de Albuquerque, CFC
   Oliveira, WK
   Croda, J
   de Filippis, AMB
   Cunha, RV
   Lourenco, J
   de Oliveira, T
   Faria, NR
   Alcantara, LCJ
   Giovanetti, M
AF Pereira Gusmao Maia, Zuinara
   Mota Pereira, Felicidade
   do Carmo Said, Rodrigo Fabiano
   Fonseca, Vagner
   Graef, Tiago
   de Bruycker Nogueira, Fernanda
   Brandao Nardy, Vanessa
   Xavier, Joilson
   Lima Maia, Maricelia
   Abreu, Andre L.
   Campelo de Albuquerque, Carlos F.
   Kleber Oliveira, Wanderson
   Croda, Julio
   de Filippis, Ana Maria Bispo
   Venancio Cunha, Rivaldo
   Lourenco, Jose
   de Oliveira, Tulio
   Faria, Nuno Rodrigues
   Junior Alcantara, Luiz Carlos
   Giovanetti, Marta
TI Return of the founder Chikungunya virus to its place of introduction
   into Brazil is revealed by genomic characterization of exanthematic
   disease cases
SO EMERGING MICROBES & INFECTIONS
LA English
DT Article
DE Chikungunya; East-Central-South-African genotype; Northeast Brazil;
   surveillance; portable genome sequencing
ID ZIKA
AB Between June 2017 and August 2018, several municipalities located in Bahia state (Brazil) reported a large increase in the number of patients presenting with febrile illness similar to that of arboviral infections. Using a combination of portable whole genome sequencing, molecular clock and epidemiological analyses, we revealed the return of the CHIKV-ECSA genotype into Bahia. Our results show local persistence of lineages in some municipalities and the re-introduction of new epidemiological strains from different Brazilian regions, highlighting a complex dynamic of transmission between epidemic seasons and sampled locations. Estimated climate-driven transmission potential of CHIKV remained at similar levels throughout the years, such that large reductions in the total number of confirmed cases suggests a slow, but gradual accumulation of herd-immunity over the 4 years of the epidemic in Bahia after its introduction in 2014. Bahia remains a reservoir of the genetic diversity of CHIKV in the Americas, and genomic surveillance strategies are essential to assist in monitoring and understanding arboviral transmission and persistence both locally and over large distances.
C1 [Pereira Gusmao Maia, Zuinara; Mota Pereira, Felicidade; Brandao Nardy, Vanessa] Dept Virol, Lab Cent Saude Publ, Salvador, BH, Brazil.
   [do Carmo Said, Rodrigo Fabiano; Giovanetti, Marta] Univ Fed Minas Gerais, Inst Ciencias Biol, Coordenacao Geral Vigilancia Arboviroses CGARB, Belo Horizonte, MG, Brazil.
   [Fonseca, Vagner; Xavier, Joilson; Junior Alcantara, Luiz Carlos] Univ Fed Minas Gerais, Inst Ciencias Biol, Lab Genet Celular & Mol, Belo Horizonte, MG, Brazil.
   [Fonseca, Vagner; de Oliveira, Tulio] Univ KwaZulu Natal, Coll Hlth Sci, KwaZulu Natal Res Innovat & Sequencing Platform K, Durban, South Africa.
   [Graef, Tiago] Fiocruz MS, Lab Patol Expt, Inst Goncalo Moniz, Salvador, BH, Brazil.
   [de Bruycker Nogueira, Fernanda; de Filippis, Ana Maria Bispo; Junior Alcantara, Luiz Carlos; Giovanetti, Marta] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Flavivirus, Rio De Janeiro, RJ, Brazil.
   [Lima Maia, Maricelia] Univ Estadual Feira de Santana, Feira De Santana, BA, Brazil.
   [Lima Maia, Maricelia] Secretaria Saude Feira de Santana, Feira De Santana, BA, Brazil.
   [Abreu, Andre L.] Minist Saude, Secretaria Vigilancia Saude, Coordenacao Geral Lab Saude Publ, CGLAB SVS MS, Brasilia, DF, Brazil.
   [Campelo de Albuquerque, Carlos F.] Org Mundial Saude, Org Panamer Saude, Brasilia, DF, Brazil.
   [Kleber Oliveira, Wanderson] Minist Saude SVS MS, Secretaria Vigilancia Saude, Brasilia, DF, Brazil.
   [Croda, Julio] Minist Saude DEVIT SVS MS, Secretaria Vigilancia Saude, Dept Vigilancia Doencas Transmissiveis, Brasilia, DF, Brazil.
   [Venancio Cunha, Rivaldo] Univ Fed Mato Grosso do Sul, Campo Grande, MS, Brazil.
   [Venancio Cunha, Rivaldo] Fundacao Oswaldo Cruz, Coordinat Hlth Surveillance & Reference Labs, Rio De Janeiro, RJ, Brazil.
   [Lourenco, Jose; Faria, Nuno Rodrigues] Univ Oxford, Dept Zool, Oxford, England.
RP Giovanetti, M (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Coordenacao Geral Vigilancia Arboviroses CGARB, Belo Horizonte, MG, Brazil.; Alcantara, LCJ (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Lab Genet Celular & Mol, Belo Horizonte, MG, Brazil.; Alcantara, LCJ; Giovanetti, M (corresponding author), Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Flavivirus, Rio De Janeiro, RJ, Brazil.
EM luiz.alcantara@ioc.fiocruz.br; giovanetti.marta@gmail.com
RI Maia, Zuinara/M-7713-2019; Graf, Tiago/S-8535-2019; Fonseca,
   Vagner/R-5813-2019; Giovanetti, Marta/AAK-7408-2020; Maia, Zuinara
   Pereira Gusmao/AAA-6737-2020; Faria, Nuno R/I-2975-2012
OI Graf, Tiago/0000-0003-4921-7975; Fonseca, Vagner/0000-0001-5521-6448;
   Maia, Zuinara Pereira Gusmao/0000-0003-0224-4335; Faria, Nuno
   R/0000-0001-8839-2798; Xavier, Joilson/0000-0003-3916-2018; Alcantara,
   Luiz/0000-0002-6769-9931
FU ZiBRA2 project - Brazilian Ministry of Health (SVS-MS); Pan American
   Organization (OPAS); CNPqNational Council for Scientific and
   Technological Development (CNPq) [440685/2016-8, 440856/2016-7];
   CAPESCAPES [88887.130716/2016-00, 88881.130825/2016-00,
   88887.130823/2016-00]; Horizon 2020 Framework Programme
   [PRES-005-FEX-17-4-2-33]; Faperj (Fundacao Carlos Chagas Filho de Amparo
   a Pesquisa do Estado do Rio de Janeiro)Carlos Chagas Filho Foundation
   for Research Support of the State of Rio de Janeiro (FAPERJ)
   [E-26/2002.930/2016]; International Development Research Centre (IDRC)
   Canada [108411-001]; EU's Horizon 2020 Framework Programme through
   ZikaPlan [734584, 734857]; EU's Horizon 2020 Framework Programme through
   ZikAction [734584, 734857]; Department of Zoology, University of Oxford;
   Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro - FAPERJCarlos
   Chagas Filho Foundation for Research Support of the State of Rio de
   Janeiro (FAPERJ); Conselho Nacional de Desenvolvimento Cientifico e
   TecnologicoNational Council for Scientific and Technological Development
   (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel SuperiorCAPES
FX This work was supported by the ZiBRA2 project, supported by the
   Brazilian Ministry of Health (SVS-MS) and the Pan American Organization
   (OPAS) and founded by CNPq [grant number 440685/2016-8 and
   440856/2016-7]; by CAPES [grant number 88887.130716/2016-00,
   88881.130825/2016-00 and 88887.130823/2016-00]; by Horizon 2020
   Framework Programme [grant number PRES-005-FEX-17-4-2-33]. The
   Flavivirus Laboratory activities were also supported by Faperj (Fundacao
   Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro)
   under the [grant number E-26/2002.930/2016], by the International
   Development Research Centre (IDRC) Canada over the [grant number
   108411-001] and EU's Horizon 2020 Framework Programme through ZikaPlan
   and ZikAction under the [grant number 734584 and 734857]. JL was
   supported by a lectureship from the Department of Zoology, University of
   Oxford. MG is supported by Fundacao de Amparo a Pesquisa do Estado do
   Rio de Janeiro - FAPERJ; Conselho Nacional de Desenvolvimento Cientifico
   e Tecnologico; Coordenacao de Aperfeicoamento de Pessoal de Nivel
   Superior.
CR Brasil, 2019, B EPIDEMIOLOGICO MON
   Fonseca V, 2019, PLOS NEGLECT TROP D, V8, P13
   Nguyen LT, 2015, MOL BIOL EVOL, V32, P268, DOI 10.1093/molbev/msu300
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanciotti RS, 2007, EMERG INFECT DIS, V13, P764, DOI 10.3201/eid1305.070015
   LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992
   Lourenco J, 2017, ELIFE, V9, P6
   Naveca FG, 2017, MEM I OSWALDO CRUZ, V112, P510, DOI 10.1590/0074-02760160062
   Naveca FG, 2019, PLOS NEGLECT TROP D, V7, P13
   Obolski U., 2019, METHODS ECOL EVOL, V1, P1
   Quick J, 2017, NAT PROTOC, V12, P1261, DOI 10.1038/nprot.2017.066
   Suchard MA, 2018, VIRUS EVOL, V4, DOI 10.1093/ve/vey016
   Nunes MRT, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0348-x
   Xavier J, 2019, PLOS ONE, V11, P14
NR 14
TC 0
Z9 1
U1 0
U2 6
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
EI 2222-1751
J9 EMERG MICROBES INFEC
JI Emerg. Microbes Infect.
PD JAN 1
PY 2020
VL 9
IS 1
BP 53
EP 57
DI 10.1080/22221751.2019.1701954
PG 5
WC Immunology; Microbiology
SC Immunology; Microbiology
GA JZ6DG
UT WOS:000505191100001
PM 31880218
OA DOAJ Gold, Green Published
DA 2020-10-22
ER

PT J
AU Giovanetti, M
   de Mendonca, MCL
   Fonseca, V
   Mares-Guia, MA
   Fabri, A
   Xavier, J
   de Jesus, JG
   Graf, T
   Rodrigues, CDD
   dos Santos, CC
   Sampaio, SA
   Chalhoub, FLL
   Nogueira, FD
   Theze, J
   Romano, APM
   Ramos, DG
   de Abreu, AL
   Oliveira, WK
   Said, RFD
   de Alburque, CFC
   de Oliveira, T
   Fernandes, CA
   Aguiar, SF
   Chieppe, A
   Sequeira, PC
   Faria, NR
   Cunha, RV
   Alcantara, LCJ
   de Filippis, AMB
AF Giovanetti, Marta
   Lima de Mendonca, Marcos Cesar
   Fonseca, Vagner
   Mares-Guia, Maria Angelica
   Fabri, Allison
   Xavier, Joilson
   de Jesus, Jaqueline Goes
   Graf, Tiago
   dos Santos Rodrigues, Cintia Damasceno
   dos Santos, Carolina Cardoso
   Sampaio, Simone Alves
   Levy Chalhoub, Flavia Lowen
   Nogueira, Fernanda de Bruycker
   Theze, Julien
   Martins Romano, Alessandro Pecego
   Ramos, Daniel Garkauskas
   de Abreu, Andre Luiz
   Oliveira, Wanderson Kleber
   do Carmo Said, Rodrigo Fabiano
   Campelo de Alburque, Carlos F.
   de Oliveira, Tulio
   Fernandes, Carlos Augusto
   Aguiar, Shirlei Ferreira
   Chieppe, Alexandre
   Sequeira, Patricia Carvalho
   Faria, Nuno Rodrigues
   Cunha, Rivaldo Venancio
   Junior Alcantara, Luiz Carlos
   Bispo de Filippis, Ana Maria
TI Yellow Fever Virus Reemergence and Spread in Southeast Brazil, 2016-2019
SO JOURNAL OF VIROLOGY
LA English
DT Article
DE yellow fever; outbreak; Southeast Brazil; genomic surveillance; outbreak
   response
ID PHYLOGENETIC ANALYSIS; DENGUE; ZIKA
AB The recent reemergence of yellow fever virus (YFV) in Brazil has raised serious concerns due to the rapid dissemination of the virus in the southeastern region. To better understand YFV genetic diversity and dynamics during the recent outbreak in southeastern Brazil, we generated 18 complete and nearly complete genomes from the peak of the epidemic curve from nonhuman primates (NHPs) and human infected cases across the Espirito Santo and Rio de Janeiro states. Genomic sequencing of 18 YFV genomes revealed the estimated timing, source, and likely routes of yellow fever virus transmission and dispersion during one of the largest outbreaks ever registered in Brazil. We showed that during the recent epidemic, YFV was reintroduced from Minas Gerais to the Espirito Santo and Rio de Janeiro states multiple times between 2016 and 2019. The analysis of data from portable sequencing could identify the corridor of spread of YFV. These findings reinforce the idea that continued genomic surveillance strategies can provide information on virus genetic diversity and transmission dynamics that might assist in understanding arbovirus epidemics.
   IMPORTANCE Arbovirus infections in Brazil, including yellow fever, dengue, zika, and chikungunya, result in considerable morbidity and mortality and are pressing public health concerns. However, our understanding of these outbreaks is hampered by the limited availability of genomic data. In this study, we investigated the genetic diversity and spatial distribution of YFV during the current outbreak by analyzing genomic data from areas in southeastern Brazil not covered by other previous studies. To gain insights into the routes of YFV introduction and dispersion, we tracked the virus by sequencing YFV genomes sampled from nonhuman primates and infected patients from the southeastern region. Our study provides an understanding of how YFV initiates transmission in new Brazilian regions and illustrates that genomics in the field can augment traditional approaches to infectious disease surveillance and control.
C1 [Giovanetti, Marta; Lima de Mendonca, Marcos Cesar; Mares-Guia, Maria Angelica; Fabri, Allison; dos Santos Rodrigues, Cintia Damasceno; dos Santos, Carolina Cardoso; Sampaio, Simone Alves; Levy Chalhoub, Flavia Lowen; Nogueira, Fernanda de Bruycker; Sequeira, Patricia Carvalho; Junior Alcantara, Luiz Carlos; Bispo de Filippis, Ana Maria] Inst Oswaldo Cruz Fiocruz, Lab Flavivirus, Rio De Janeiro, Brazil.
   [Giovanetti, Marta; Fonseca, Vagner; Xavier, Joilson; Junior Alcantara, Luiz Carlos] Univ Fed Minas Gerais, Lab Genet Celular Mol, ICB, Belo Horizonte, MG, Brazil.
   [Fonseca, Vagner] Univ KwaZulu Natal, Coll Hlth Sci, KwaZulu Natal Res Innovat & Sequencing Platform K, Durban, South Africa.
   [de Jesus, Jaqueline Goes; Graf, Tiago] Fundacao Oswaldo Cruz, Inst Goncalo Moniz, Minist Saude, Salvador, BA, Brazil.
   [Theze, Julien] Univ Oxford, Dept Zool, Oxford, England.
   [Martins Romano, Alessandro Pecego; Ramos, Daniel Garkauskas] Minist Saude, Coordenacao Geral Vigilancia Arboviroses CGARB, CGLAB SVS MS, Brasilia, DF, Brazil.
   [de Abreu, Andre Luiz] Minist Saude, Coordenacao Geral Lab Saude Publ, Secretaria Vigilancia Saude, Minist Saude,CGLAB SVS MS, Brasilia, DF, Brazil.
   [Oliveira, Wanderson Kleber] Minist Saude, SVS, Brasilia, DF, Brazil.
   [Campelo de Alburque, Carlos F.] Lab Cent Saude Publ Noel Nutels LACEN RJ, Rio De Janeiro, Brazil.
   [Fernandes, Carlos Augusto] Superintendencia Vigilancia Estado, Rio De Janeiro, Brazil.
   [Chieppe, Alexandre] Fundacao Oswaldo Cruz, Rio De Janeiro, Brazil.
   [Cunha, Rivaldo Venancio] Univ Fed Mato Grosso, Fac Med, Campo Grande, MS, Brazil.
RP Giovanetti, M (corresponding author), Inst Oswaldo Cruz Fiocruz, Lab Flavivirus, Rio De Janeiro, Brazil.; Giovanetti, M (corresponding author), Univ Fed Minas Gerais, Lab Genet Celular Mol, ICB, Belo Horizonte, MG, Brazil.
EM giovanetti.marta@gmail.com
RI Giovanetti, Marta/AAK-7408-2020; Faria, Nuno R/I-2975-2012; Graf,
   Tiago/S-8535-2019; Fonseca, Vagner/R-5813-2019
OI Faria, Nuno R/0000-0001-8839-2798; Graf, Tiago/0000-0003-4921-7975;
   Fonseca, Vagner/0000-0001-5521-6448; Theze, Julien/0000-0001-8188-9494;
   Alcantara, Luiz/0000-0002-6769-9931; Xavier, Joilson/0000-0003-3916-2018
FU ZiBRA2 project - Brazilian Ministry of Health (SVS-MS); Pan American
   Organization (OPAS); CNPqNational Council for Scientific and
   Technological Development (CNPq) [440685/2016-8, 440856/2016-7];
   CAPESCAPES [88887.130716/2016-00, 88881.130825/2016-00,
   88887.130823/2016-00]; EU's Horizon 2020 program through ZIKAlliance
   [PRES-005-FEX-17-4-2-33]; Faperj (Fundacao Carlos Chagas Filho de Amparo
   a Pesquisa do Estado do Rio de Janeiro)Carlos Chagas Filho Foundation
   for Research Support of the State of Rio de Janeiro (FAPERJ)
   [E-26/2002.930/2016]; International Development Research Centre (IDRC)
   Canada [108411-001]; Horizon 2020 through ZikaPlan [734584, 734857];
   Horizon 2020 through ZikAction [734584, 734857]; Fundacao de Amparo a
   Pesquisa do Estado do Rio de Janeiro (FAPERJ)Carlos Chagas Filho
   Foundation for Research Support of the State of Rio de Janeiro (FAPERJ)
FX We thank all personnel from Health Surveillance System in Rio de Janeiro
   that coordinated surveillance and helped with data collection and
   assembly. We also thank Ronaldo Lapa e Solange Regina Conceicao from the
   Instituto Oswaldo Cruz (Fiocruz, Rio de Janeiro) for their support.;
   This work was supported by the ZiBRA2 project supported by the Brazilian
   Ministry of Health (SVS-MS) and the Pan American Organization (OPAS) and
   founded by Decit/SCTIE/MoH and CNPq (440685/2016-8 and 440856/2016-7);
   by CAPES (88887.130716/2016-00, 88881.130825/2016-00, and
   88887.130823/2016-00); and by EU's Horizon 2020 program through
   ZIKAlliance (PRES-005-FEX-17-4-2-33). The Flavivirus Laboratory
   activities was also supported by Faperj (Fundacao Carlos Chagas Filho de
   Amparo a Pesquisa do Estado do Rio de Janeiro) under grant number
   E-26/2002.930/2016, by the International Development Research Centre
   (IDRC) Canada over the grant 108411-001 and Horizon 2020 through
   ZikaPlan and ZikAction under the grant's agreement numbers 734584 and
   734857. M.G. is supported by Fundacao de Amparo a Pesquisa do Estado do
   Rio de Janeiro (FAPERJ).
CR Ayres DL, 2012, SYST BIOL, V61, P170, DOI 10.1093/sysbio/syr100
   Barrett Alan D, 2003, Adv Virus Res, V61, P291, DOI 10.1016/S0065-3527(03)61007-9
   Brazilian Ministry of Health, 2017, EP UPD YELL FEV
   Brazilian Ministry of Health, 2018, EP UPD YELL FEV
   Bryant JE, 2007, PLOS PATHOG, V3, P668, DOI 10.1371/journal.ppat.0030075
   CHANG GJJ, 1995, J VIROL, V69, P5773, DOI 10.1128/JVI.69.9.5773-5780.1995
   Cunha MS, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-41950-3
   Degallier Nicolas, 1992, Ciencia e Cultura (Sao Paulo), V44, P143
   Delatorre E, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.01079
   deSouza RP, 2019, BIORXIV, DOI [10.1101/645341, DOI 10.1101/645341]
   Domingo C, 2012, J CLIN MICROBIOL, V50, P4054, DOI 10.1128/JCM.01799-12
   Drosten C, 2002, J CLIN MICROBIOL, V40, P2323, DOI 10.1128/JCM.40.7.2323-2330.2002
   Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088
   Faria NR, 2018, SCIENCE, V361, P894, DOI 10.1126/science.aat7115
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Ferreira MAR, 2008, CAN J STAT, V36, P355, DOI 10.1002/cjs.5550360302
   Gardy JL, 2018, NAT REV GENET, V19, P9, DOI 10.1038/nrg.2017.88
   Giovanetti M, 2019, BIORXIV, DOI [10.1101/711994, DOI 10.1101/711994]
   Lemey P, 2010, MOL BIOL EVOL, V27, P1877, DOI 10.1093/molbev/msq067
   Monath TP, 2015, J CLIN VIROL, V64, P160, DOI 10.1016/j.jcv.2014.08.030
   Mondet B, 1996, B SOC PATHOL EXOT, V89, P107
   Mutebi JP, 2001, J VIROL, V75, P6999, DOI 10.1128/JVI.75.15.6999-7008.2001
   Nunes MRT, 2012, J VIROL, V86, P13263, DOI 10.1128/JVI.00565-12
   Possas C, 2018, MEM I OSWALDO CRUZ, V113, DOI 10.1590/0074-02760180278
   Pybus OG, 2012, P NATL ACAD SCI USA, V109, P15066, DOI 10.1073/pnas.1206598109
   Quick J, 2017, NAT PROTOC, V12, P1261, DOI 10.1038/nprot.2017.066
   Rambaut A, 2018, SYST BIOL, V67, P901, DOI 10.1093/sysbio/syy032
   Rambaut A, 2016, VIRUS EVOL, V2, DOI 10.1093/ve/vew007
   Ribeiro AF, 2019, AM J TROP MED HYG, V101, P180, DOI 10.4269/ajtmh.18-0882
   de Abreu FVS, 2019, MEM I OSWALDO CRUZ, V114, DOI 10.1590/0074-02760190076
   Secretaria de Vigilancia em Saude, 2019, MON PER SAZ FEBR AM
   Shapiro B, 2006, MOL BIOL EVOL, V23, P7, DOI 10.1093/molbev/msj021
   Shearer FM, 2017, LANCET INFECT DIS, V17, P1209, DOI 10.1016/S1473-3099(17)30419-X
   Souza Renato Pereira de, 2011, Rev. Inst. Med. trop. S. Paulo, V53, P133, DOI 10.1590/S0036-46652011000300004
   Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033
   Suchard MA, 2018, VIRUS EVOL, V4, DOI 10.1093/ve/vey016
NR 36
TC 4
Z9 4
U1 3
U2 14
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0022-538X
EI 1098-5514
J9 J VIROL
JI J. Virol.
PD JAN
PY 2020
VL 94
IS 1
AR e01623-19
DI 10.1128/JVI.01623-19
PG 12
WC Virology
SC Virology
GA JX6LP
UT WOS:000503844300009
PM 31597773
OA Green Published, Bronze
DA 2020-10-22
ER

PT J
AU Hill, SC
   Vasconcelos, J
   Neto, Z
   Jandondo, D
   Ze-Ze, L
   Aguiar, RS
   Xavier, J
   Theze, J
   Mirandela, M
   Candido, ALM
   Vaz, F
   Sebastiao, CD
   Wu, CH
   Kraemer, MUG
   Melo, A
   Schamber-Reis, BLF
   de Azevedo, GS
   Tanuri, A
   Higa, LM
   Clemente, C
   da Silva, SP
   Candido, DD
   Claro, IM
   Quibuco, D
   Domingos, C
   Pocongo, B
   Watts, AG
   Khan, K
   Alcantara, LCJ
   Sabino, EC
   Lackritz, E
   Pybus, OG
   Alves, MJ
   Afonso, J
   Faria, NR
AF Hill, Sarah C.
   Vasconcelos, Jocelyne
   Neto, Zoraima
   Jandondo, Domingos
   Ze-Ze, Libia
   Aguiar, Renato Santana
   Xavier, Joilson
   Theze, Julien
   Mirandela, Marinela
   Micolo Candido, Ana Luisa
   Vaz, Filipa
   Sebastiao, Cruz dos Santos
   Wu, Chieh-Hsi
   Kraemer, Moritz U. G.
   Melo, Adriana
   Schamber-Reis, Bruno L. F.
   de Azevedo, Girlene S.
   Tanuri, Amilcar
   Higa, Luiza M.
   Clemente, Carina
   da Silva, Sara Pereira
   Candido, Darlan da Silva
   Claro, Ingra M.
   Quibuco, Domingos
   Domingos, Cristovao
   Pocongo, Barbara
   Watts, Alexander G.
   Khan, Kamran
   Junior Alcantara, Luiz Carlos
   Sabino, Ester C.
   Lackritz, Eve
   Pybus, Oliver G.
   Alves, Maria-Joao
   Afonso, Joana
   Faria, Nuno R.
TI Emergence of the Asian lineage of Zika virus in Angola: an outbreak
   investigation
SO LANCET INFECTIOUS DISEASES
LA English
DT Article
ID TRANSMISSION; AFRICA
AB Background Zika virus infections and suspected microcephaly cases have been reported in Angola since late 2016, but no data are available about the origins, epidemiology, and diversity of the virus. We aimed to investigate the emergence and circulation of Zika virus in Angola.
   Methods Diagnostic samples collected by the Angolan Ministry of Health as part of routine arboviral surveillance were tested by real-time reverse transcription PCR by the Instituto Nacional de Investigacao em Saude (Ministry of Health, Luanda, Angola). To identify further samples positive for Zika virus and appropriate for genomic sequencing, we also tested samples from a 2017 study of people with HIV in Luanda. Portable sequencing was used to generate Angolan Zika virus genome sequences from three people positive for Zika virus infection by real-time reverse transcription PCR, including one neonate with microcephaly. Genetic and mobility data were analysed to investigate the date of introduction and geographical origin of Zika virus in Angola. Brain CT and MRI, and serological assays were done on a child with microcephaly to confirm microcephaly and assess previous Zika virus infection.
   Findings Serum samples from 54 people with suspected acute Zika virus infection, 76 infants with suspected microcephaly, 24 mothers of infants with suspected microcephaly, 336 patients with suspected dengue virus or chikungunya virus infection, and 349 samples from the HIV study were tested by real-time reverse transcription PCR. Four cases identified between December, 2016, and June, 2017, tested positive for Zika virus. Analyses of viral genomic and human mobility data suggest that Zika virus was probably introduced to Angola from Brazil between July, 2015, and June, 2016. This introduction probably initiated local circulation of Zika virus in Angola that continued until at least June, 2017. The infant with microcephaly in whom CT and MRI were done had brain abnormalities consistent with congenital Zika syndrome and serological evidence for Zika virus infection.
   Interpretation Our analyses show that autochthonous transmission of the Asian lineage of Zika virus has taken place in Africa. Zika virus surveillance and surveillance of associated cases of microcephaly throughout the continent is crucial.
C1 [Hill, Sarah C.; Theze, Julien; Kraemer, Moritz U. G.; Candido, Darlan da Silva; Pybus, Oliver G.; Faria, Nuno R.] Univ Oxford, Dept Zool, Oxford OX1 3PS, England.
   [Wu, Chieh-Hsi] Univ Oxford, Dept Stat, Oxford, England.
   [Vasconcelos, Jocelyne; Neto, Zoraima; Jandondo, Domingos; Mirandela, Marinela; Micolo Candido, Ana Luisa; Vaz, Filipa; Sebastiao, Cruz dos Santos; Afonso, Joana] Minist Hlth, Inst Nacl Invest Saude, Luanda, Angola.
   [Ze-Ze, Libia; Alves, Maria-Joao] Inst Nacl Saude Doutor Ricardo Jorge, Aguas De Moura, Portugal.
   [Ze-Ze, Libia] Univ Lisbon, Fac Sci, BioISI Biosyst & Integrat Sci Inst, Lisbon, Portugal.
   [Aguiar, Renato Santana; Tanuri, Amilcar; Higa, Luiza M.] Univ Fed Rio de Janeiro, Inst Biol, Dept Genet, Rio De Janeiro, Brazil.
   [Aguiar, Renato Santana; Xavier, Joilson; Junior Alcantara, Luiz Carlos] Univ Fed Minas Gerais, Dept Genet Ecol & Evolucao, Inst Ciencias Biol, Belo Horizonte, MG, Brazil.
   [Sebastiao, Cruz dos Santos] Univ Agostinho Neto, Inst Super Ciencias Saude, Luanda, Angola.
   [Kraemer, Moritz U. G.] Boston Childrens Hosp, Computat Epidemiol Lab, Boston, MA USA.
   [Kraemer, Moritz U. G.] Harvard Med Sch, Boston, MA 02115 USA.
   [Melo, Adriana; de Azevedo, Girlene S.] Inst Pesquisa Prof Joaquim Amorim Neto, Campina Grande, Brazil.
   [Schamber-Reis, Bruno L. F.] Ctr Univ Unifacisa, Dept Human Genet, Campina Grande, Brazil.
   [Clemente, Carina; da Silva, Sara Pereira] Cligest Clin, Luanda, Angola.
   [Claro, Ingra M.; Sabino, Ester C.] Univ Sao Paulo, Inst Med Trop, Sao Paulo, Brazil.
   [Claro, Ingra M.; Sabino, Ester C.] Univ Sao Paulo, Fac Med, Sao Paulo, Brazil.
   [Quibuco, Domingos] Hosp Pediat David Bernardino, Luanda, Angola.
   [Domingos, Cristovao; Pocongo, Barbara] Inst Nacl Luta SIDA, Luanda, Angola.
   [Watts, Alexander G.; Khan, Kamran] St Michaels Hosp, Li Ka Shing Knowledge Inst, Toronto, ON, Canada.
   [Watts, Alexander G.; Khan, Kamran] BlueDot, Toronto, ON, Canada.
   [Khan, Kamran] Univ Toronto, Dept Med, Toronto, ON, Canada.
   [Junior Alcantara, Luiz Carlos] IOC Fundacao Oswaldo Cruz MS, Lab Flavivirus, Rio De Janeiro, Brazil.
   [Lackritz, Eve] WHO, Geneva, Switzerland.
RP Faria, NR (corresponding author), Univ Oxford, Dept Zool, Oxford OX1 3PS, England.; Afonso, J (corresponding author), Minist Hlth, Inst Nacl Invest Saude, Luanda, Angola.
EM jfm.morais9@gmail.com; nuno.faria@zoo.ox.ac.uk
RI Pybus, Oliver G/B-2640-2012; Higa, Luiza/W-2698-2019; Ze-Ze, Libia Maria
   Marques/U-5730-2017; Melo, Adriana S O/H-5650-2016; Faria, Nuno
   R/I-2975-2012; Sabino, Ester Cerdeira/F-7750-2010; Aguiar, Renato
   S/G-3542-2015
OI Pybus, Oliver G/0000-0002-8797-2667; Ze-Ze, Libia Maria
   Marques/0000-0001-7258-1439; Faria, Nuno R/0000-0001-8839-2798; Sabino,
   Ester Cerdeira/0000-0003-2623-5126; Aguiar, Renato
   S/0000-0001-5180-3717; da Silva Candido, Darlan/0000-0002-5080-3130;
   Theze, Julien/0000-0001-8188-9494; Sebastiao, Cruz/0000-0003-1232-0119;
   Alves, Maria Joao/0000-0003-0065-9000; Alcantara,
   Luiz/0000-0002-6769-9931; Hill, Sarah/0000-0002-2995-2596; Xavier,
   Joilson/0000-0003-3916-2018
FU Sir Henry Dale Fellowship [204311/Z/16/Z]; internal Higher Education
   Funding Council for England Global Challenges Research Fund [005073];
   Africa Oxford Initiative [AfiOx-48, AfiOx-60]; John Fell Research Fund
   [005166]; Medical Research CouncilMedical Research Council UK (MRC)
   [MR/S0195/1, 2018/14389-0]; O Conselho Nacional de Desenvolvimento
   Cientifico e TecnologicoNational Council for Scientific and
   Technological Development (CNPq) [440900/2016-6, 440685/2016-8];
   Fundacao Coordenacao de Aperfeicoamento de Pessoal de Nivel
   SuperiorCAPES [88881.130757/2016-01, 88887.130716/2016-00,
   88881.130728/2016-01]; European Research CouncilEuropean Research
   Council (ERC) [614725-PATHPHYLODYN]; Oxford Martin School; UK Medical
   Research CouncilMedical Research Council UK (MRC); Cancer Research
   UKCancer Research UK [ANR00310]
FX We thank the participants who participated in this study and the WHO
   Angolan country office for sharing information about suspected Zika and
   microcephaly cases. This research was supported by a Sir Henry Dale
   Fellowship (204311/Z/16/Z), internal Higher Education Funding Council
   for England Global Challenges Research Fund (005073), the Africa Oxford
   Initiative (AfiOx-48 and AfiOx-60), John Fell Research Fund (005166),
   and by the Medical Research Council (MR/S0195/1 and 2018/14389-0), O
   Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (440900/2016-6 and 440685/2016-8), Fundacao Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior (88881.130757/2016-01,
   88887.130716/2016-00, and 88881.130728/2016-01), the European Research
   Council (FP7 grant agreement 614725-PATHPHYLODYN), and the Oxford Martin
   School. C-HW is supported by the UK Medical Research Council and Cancer
   Research UK (ANR00310). We thank Patricia Alvarez Baptista and Antonio
   Gomes Pinto Ferreira (Fundacao Oswaldo Cruz, Instituto de Tecnologia em
   Imunobiologicos Bio-Manguinhos, Rio de Janeiro, Brazil) for donating
   Bio-Manguinhos reagents, and Jorge Munoz-Jordan and Gilberto Santiago
   (CDC) for donating real-time reverse transcription PCR reagents.
CR de Araujo TVB, 2018, LANCET INFECT DIS, V18, P328, DOI 10.1016/S1473-3099(17)30727-2
   Barzon L, 2018, CLIN INFECT DIS, V66, P1173, DOI 10.1093/cid/cix967
   Baud D, 2017, LANCET, V390, P2099, DOI [10.1016/S0140-6736(17)31450-2, 10.1016/s0140-6736(17)31450-2]
   Bogoch II, 2016, LANCET INFECT DIS, V16, P1237, DOI 10.1016/S1473-3099(16)30270-5
   Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Grubaugh ND, 2019, NAT MICROBIOL, V4, P10, DOI 10.1038/s41564-018-0296-2
   Grubaugh ND, 2018, CELL, V172, P1160, DOI 10.1016/j.cell.2018.02.027
   Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010
   Hill SC, 2019, EMERG INFECT DIS, V25, P784, DOI 10.3201/eid2504.180958
   Lourenco J, 2018, PLOS CURR OUTBREAKS
   Melo AS, 2016, JAMA NEUROL
   Niewiesk S, 2015, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00446
   Nutt C, 2017, LANCET, V389, P1595, DOI 10.1016/S0140-6736(17)31051-6
   Pan American Health Organization, 2018, DIG ZIK CAS INC RAT
   Pan American Health Organization WHO, 2018, ZIK CAS CONG SYNDR A
   Posen HJ, 2016, BMJ GLOB HEALTH, V1, DOI 10.1136/bmjgh-2016-000087
   Quick J, 2017, NAT PROTOC, V12, P1261, DOI 10.1038/nprot.2017.066
   Rabe IB, 2016, MMWR MORB MORTAL WKL, V65
   Santiago GA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03772-1
   Sassetti M, 2018, T ROY SOC TROP MED H, V112, P458, DOI 10.1093/trstmh/try074
   Sharp TM, 2013, MMWR-MORBID MORTAL W, V62, P504
   Suchard MA, 2018, VIRUS EVOL, V4, DOI 10.1093/ve/vey016
   Taiwan Centers for Disease Control, TRAV VIS RET ZIK AFF
   Nunes MRT, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0348-x
   Theze J, 2018, CELL HOST MICROBE, V23, P855, DOI [10.101, 10.1016/j.chom.2018.04.017]
   WHO, 2017, WEEK, V48
   World Health Organisation [WHO], 2007, WHO CHILD GROWTH STA
   World Health Organization, 2016, SCREEN ASS MAN NEON
   World Health Organization, 2017, SIT REP ZIK VIR MICR
NR 32
TC 11
Z9 11
U1 1
U2 9
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1473-3099
EI 1474-4457
J9 LANCET INFECT DIS
JI Lancet Infect. Dis.
PD OCT
PY 2019
VL 19
IS 10
BP 1138
EP 1147
DI 10.1016/S1473-3099(19)30293-2
PG 10
WC Infectious Diseases
SC Infectious Diseases
GA JA4ST
UT WOS:000487824300040
PM 31559967
OA Green Accepted, Other Gold, Green Published
DA 2020-10-22
ER

PT J
AU Rivera-Correa, J
   de Siqueira, IC
   Mota, S
   do Rosario, MS
   de Jesus, PAP
   Alcantara, LCJ
   Ernst, JD
   Rodriguez, A
AF Rivera-Correa, Juan
   de Siqueira, Isadora Cristina
   Mota, Sabrina
   do Rosario, Mateus Santana
   Pereira de Jesus, Pedro Antonio
   Junior Alcantara, Luiz Carlos
   Ernst, Joel D.
   Rodriguez, Ana
TI Anti-ganglioside antibodies in patients with Zika virus
   infection-associated Guillain-Barre Syndrome in Brazil
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID CHIKUNGUNYA-VIRUS; CAMPYLOBACTER-JEJUNI; AUTOIMMUNITY; AUTOANTIBODIES;
   OUTBREAK; AMERICA
AB Author summary Zika virus infection can trigger the development of Guillain Barre syndrome (GBS), a neurological autoimmune disorder mediated by antibodies recognizing gangliosides in nerve membranes. Mechanisms such as molecular mimicry have been identified as a cause for GBS development in certain infections, such as Campylobacter jejuni, but the broad self reactivity observed during GBS suggests a role for alternative mechanisms. Our finding that Zika patients with GBS present higher levels of anti-ganglioside antibodies compared to uncomplicated Zika patients in Brazil points to these auto-antibodies as a trigger for GBS in these patients. These findings further support infection-induced autoantibodies as a factor contributing to GBS development, adding novel mechanisms for GBS development beyond molecular mimicry.
   Zika virus infection is associated with the development of Guillain-Barre syndrome (GBS), a neurological autoimmune disorder caused by immune recognition of gangliosides and other components at nerve membranes. Using a high-throughput ELISA, we have analyzed the anti-glycolipid antibody profile, including gangliosides, of plasma samples from patients with Zika infections associated or not with GBS in Salvador, Brazil. We have observed that Zika patients that develop GBS present higher levels of anti-ganglioside antibodies when compared to Zika patients without GBS. We also observed that a broad repertoire of gangliosides was targeted by both IgM and IgG anti-self antibodies in these patients. Since Zika virus infects neurons, which contain membrane gangliosides, antigen presentation of these infected cells may trigger the observed autoimmune anti-ganglioside antibodies suggesting direct infection-induced autoantibodies as a cause leading to GBS development. Collectively, our results establish a link between anti-ganglioside antibodies and Zika-associated GBS in patients.
C1 [Rivera-Correa, Juan; Mota, Sabrina; Ernst, Joel D.; Rodriguez, Ana] NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA.
   [de Siqueira, Isadora Cristina] Minist Saude, Fundacao Oswaldo Cruz, Inst Goncalo Moniz, Salvador, BA, Brazil.
   [do Rosario, Mateus Santana] Hosp Santa Izabel, Salvador, BA, Brazil.
   [Pereira de Jesus, Pedro Antonio] Hosp Geral Roberto Santos, Secretaria Estadual Saude Bahia, Salvador, BA, Brazil.
   [Junior Alcantara, Luiz Carlos] Fundaco Oswaldo Cruz, Inst Oswaldo Cruz, Lab Flavivirus, Rio De Janeiro, Brazil.
   [Ernst, Joel D.] Univ Calif San Francisco, Div Expt Med, San Francisco, CA 94143 USA.
RP Rodriguez, A (corresponding author), NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA.
EM ana.rodriguez@nyumc.org
RI de Siqueira, Isadora Cristina/R-9953-2016
OI de Siqueira, Isadora Cristina/0000-0002-2520-4099; Rodriguez,
   Ana/0000-0002-0060-3405; Rivera-Correa, Juan/0000-0003-4822-0005; Ernst,
   Joel/0000-0001-9951-6207; do Rosario, Mateus/0000-0001-7404-6392;
   Alcantara, Luiz/0000-0002-6769-9931
FU New York University School of Medicine Internal Funds
FX AR and JRC received funding for this project from New York University
   School of Medicine Internal Funds. The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Anaya JM, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0601-y
   Arroyo-Avila M, 2017, AM J TROP MED HYG, V96, P916, DOI 10.4269/ajtmh.16-0890
   Azevedo RSS, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-17765-5
   Baskar D, 2018, NEUROL INDIA, V66, P1324, DOI 10.4103/0028-3886.241402
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Dirlikov E, 2018, EMERG INFECT DIS, V24, P114, DOI 10.3201/eid2401.171331
   do Rosario M, 2018, INT J INFECT DIS, V73, P49, DOI 10.1016/j.ijid.2018.04.3534
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Flodstrom-Tullberg M, 2003, MICROBES INFECT, V5, P911, DOI 10.1016/S1286-4579(03)00161-8
   Gabriel E, 2017, CELL STEM CELL, V20, P397, DOI 10.1016/j.stem.2016.12.005
   Godschalk PCR, 2007, INFECT IMMUN, V75, P1245, DOI 10.1128/IAI.00872-06
   Goodfellow JA, 2016, NAT REV NEUROL, V12, P723, DOI 10.1038/nrneurol.2016.172
   Hoen B, 2018, NEW ENGL J MED, V378, P985, DOI 10.1056/NEJMoa1709481
   Ikejezie J, 2017, MMWR-MORBID MORTAL W, V66, P329, DOI 10.15585/mmwr.mm6612a4
   Johnson BW, 2005, J CLIN MICROBIOL, V43, P4977, DOI 10.1128/JCM.43.10.4977-4983.2005
   Jurado KA, 2018, NAT MICROBIOL, V3, P141, DOI 10.1038/s41564-017-0060-z
   Koga M, 2015, J NEUROL, V262, P1954, DOI 10.1007/s00415-015-7806-4
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanciotti RS, 2007, EMERG INFECT DIS, V13, P764, DOI 10.3201/eid1305.070015
   Leuchten N, 2018, ARTHRIT CARE RES, V70, P428, DOI 10.1002/acr.23292
   Li C, 2016, CELL STEM CELL, V19, P672, DOI 10.1016/j.stem.2016.10.017
   Manimunda SP, 2010, T ROY SOC TROP MED H, V104, P392, DOI 10.1016/j.trstmh.2010.01.011
   Mehta R, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006212
   Monsalve DM, 2017, AUTOIMMUN REV, V16, P1237, DOI 10.1016/j.autrev.2017.10.008
   Nico D, 2018, FRONT MED-LAUSANNE, V5, DOI [10.3389/fmed.2018.00025, 10.3389/fmed2018.00025]
   Pinto-Diaz CA, 2017, AUTOIMMUN REV, V16, P327, DOI 10.1016/j.autrev.2017.02.002
   Ravindranath MH, 2005, ANN NY ACAD SCI, V1050, P229, DOI 10.1196/annals.1313.024
   Rinaldi S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082337
   Rodriguez-Barraquer I, 2019, SCIENCE, V363, P607, DOI 10.1126/science.aav6618
   Steiner I, 2005, EUR J NEUROL, V12, P331, DOI 10.1111/j.1468-1331.2005.01126.x
   Tanay A, 2017, CURR OPIN RHEUMATOL, V29, P389, DOI 10.1097/BOR.0000000000000396
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Sebastian UU, 2017, J CRIT CARE, V42, P275, DOI 10.1016/j.jcrc.2017.07.038
   Van Der Meche F. G. A., 1995, Annals of Neurology, V37, pS14
   Wakerley BR, 2014, NAT REV NEUROL, V10, P537, DOI 10.1038/nrneurol.2014.138
   Wan SW, 2013, J FORMOS MED ASSOC, V112, P3, DOI 10.1016/j.jfma.2012.11.006
NR 37
TC 3
Z9 3
U1 0
U2 2
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD SEP
PY 2019
VL 13
IS 9
AR e0007695
DI 10.1371/journal.pntd.0007695
PG 13
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA JE9CW
UT WOS:000490987100033
PM 31527907
OA DOAJ Gold, Green Published
DA 2020-10-22
ER

PT J
AU Giovanetti, M
   de Jesus, JG
   Joshua, Q
   Claro, IM
   Xavier, J
   Hill, SC
   Renato, S
   Paz, P
   Lourenco, J
   Dellicour, S
   Sabino, E
   Loman, NJ
   Naveca, F
   Pybus, OG
   Faria, NR
   Alcantara, LCJ
AF Giovanetti, Marta
   de Jesus, Jaqueline Goes
   Joshua, Quick
   Claro, Ingra Morales
   Xavier Junior, Joilson
   Hill, Sarah C.
   Renato, Souza
   Paz, Paola
   Lourenco, Jose
   Dellicour, Simon
   Sabino, Esther
   Loman, Nicholas J.
   Naveca, Felipe
   Pybus, Oliver G.
   Faria, Nuno Rodrigues
   Junior Alcantara, Luiz Carlos
TI Genomic surveillance of Zika virus transmission in the Amazonas State,
   Brazil
SO VIRUS EVOLUTION
LA English
DT Meeting Abstract
C1 [Giovanetti, Marta; de Jesus, Jaqueline Goes; Xavier Junior, Joilson; Junior Alcantara, Luiz Carlos] Inst Goncalo Moniz, Lab Patol Expt, Salvador, BA, Brazil.
   [Giovanetti, Marta; Junior Alcantara, Luiz Carlos] Fiocruz MS, Inst Oswaldo Cruz, Lab Flavivirus, Rio De Janeiro, Brazil.
   [Joshua, Quick; Loman, Nicholas J.] Univ Birmingham, Inst Microbiol & Infect, Birmingham, W Midlands, England.
   [Claro, Ingra Morales; Sabino, Esther] Univ Sao Paulo, Inst Med Trop, Sao Paulo, Brazil.
   [Hill, Sarah C.; Lourenco, Jose; Pybus, Oliver G.; Faria, Nuno Rodrigues] Univ Oxford, Dept Zool, Oxford OX1 3PS, England.
   [Renato, Souza; Paz, Paola] Univ Fed Rio de Janeiro, Inst Pasteur, Lab Clin & Epidemiol Virol, Rio De Janeiro, Brazil.
   [Dellicour, Simon] Univ Leuven, KU Leuven, Rega Inst, Dept Microbiol & Immunol, Leuven, Belgium.
   [Naveca, Felipe] Fiocruz MS, Fundacao Oswaldo Cruz, Manaus, Amazonas, Brazil.
RI Faria, Nuno R/I-2975-2012; Giovanetti, Marta/AAK-7408-2020; Pybus,
   Oliver G/B-2640-2012; Dellicour, Simon/AAE-9054-2020
OI Faria, Nuno R/0000-0001-8839-2798; Pybus, Oliver G/0000-0002-8797-2667;
   Dellicour, Simon/0000-0001-9558-1052
NR 0
TC 0
Z9 0
U1 0
U2 0
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
EI 2057-1577
J9 VIRUS EVOL
JI Virus Evol.
PD AUG
PY 2019
VL 5
SU 1
MA A32
BP S10
EP S10
DI 10.1093/ve/vez002.031
PG 1
WC Virology
SC Virology
GA JX6ZN
UT WOS:000503880600033
OA DOAJ Gold, Green Published
DA 2020-10-22
ER

PT J
AU Borba, MMN
   Farre, L
   Bittencourt, AL
   de Castro-Amarante, MF
   Galvao-Castro, B
   Santos, LA
   Araujo, THA
   Alcantara, LC
   Barreto, FK
AF Navarro Borba, Melina Mosquera
   Farre, Lourdes
   Bittencourt, Achilea Lisboa
   de Castro-Amarante, Maria Fernanda
   Galvao-Castro, Bernardo
   Santos, Luciane Amorim
   Almeida Araujo, Thessika Hialla
   Junior Alcantara, Luiz Carlos
   Barreto, Fernanda Khouri
TI Assessment of Genetic Diversity of HTLV-1 ORF-I Sequences Collected from
   Patients with Different Clinical Profiles
SO AIDS RESEARCH AND HUMAN RETROVIRUSES
LA English
DT Article
DE HTLV-1; ORF-I; mutations
ID VIRUS TYPE-I; T-CELL LEUKEMIA; RETROVIRUS; VACCINE
AB The human T cell lymphotropic virus type 1 (HTLV-1) infects 5 to 10 million individuals and remains without specific treatment. This retrovirus genome is composed of the genes gag, pol, env, and a region known as pX. This region contains four open reading frames (ORFs) that encode specific proteins. The ORF-I produces the protein p12 and its cleavage product, p8. In this study, we analyzed the genetic diversity of 32 ORF-I sequences from patients with different clinical profiles. Seven amino acid changes with frequency over 5% were identified: G29S, P34L, L55F, F61L, S63P, F78L, and S91P. The identification of regions where the posttranslational sites were identified showed a high identity among the sequences and the amino acid changes exclusive of specific clinical profile were found in less than 5% of the samples. We compare the findings with 2.406 sequences available in GenBank. The low overall genetic diversity found suggested that this region could be used in the HTLV-1 vaccine development.
C1 [Navarro Borba, Melina Mosquera; Farre, Lourdes; de Castro-Amarante, Maria Fernanda; Santos, Luciane Amorim; Almeida Araujo, Thessika Hialla] Fundacao Oswaldo Cruz, Salvador, BA, Brazil.
   [Farre, Lourdes] Catalan Inst Oncol, Bellvitge Biomed Res Inst, Barcelona, Spain.
   [Bittencourt, Achilea Lisboa] Univ Fed Bahia, Salvador, BA, Brazil.
   [Galvao-Castro, Bernardo; Santos, Luciane Amorim; Almeida Araujo, Thessika Hialla] Escola Bahiana Med & Saude Publ, Salvador, BA, Brazil.
   [Junior Alcantara, Luiz Carlos; Barreto, Fernanda Khouri] Fundacao Oswaldo Cruz, Rio De Janeiro, Brazil.
   [Barreto, Fernanda Khouri] Univ Fed Bahia, Inst Multidisciplinar Saude, Campus Anisio Teixeira,Rua Hormindo Barros 58, BR-45029094 Bairro Candeias, Vitoria Da Conq, Brazil.
RP Barreto, FK (corresponding author), Univ Fed Bahia, Inst Multidisciplinar Saude, Campus Anisio Teixeira,Rua Hormindo Barros 58, BR-45029094 Bairro Candeias, Vitoria Da Conq, Brazil.
EM fernanda.khouri@hotmail.com
OI Alcantara, Luiz/0000-0002-6769-9931
FU Conselho Nacional de Desenvolvimento Cientifico e TecnologicoNational
   Council for Scientific and Technological Development (CNPq) [CNPq
   400900/2013-0, CNPq 150892/2018-7]
FX The authors are grateful to all participating donors, the professionals
   of the centers of care and the sequencing platform of FIOCRUZ/IGM. This
   work was supported by Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico (CNPq 400900/2013-0, CNPq 150892/2018-7).
CR Barreto FK, 2016, INFECT GENET EVOL, V45, P420, DOI 10.1016/j.meegid.2016.08.020
   Bomford R, 1996, AIDS RES HUM RETROV, V12, P403, DOI 10.1089/aid.1996.12.403
   Combet C, 2000, TRENDS BIOCHEM SCI, V25, P147, DOI 10.1016/S0968-0004(99)01540-6
   DETHE G, 1993, AIDS RES HUM RETROV, V9, P381, DOI 10.1089/aid.1993.9.381
   GESSAIN A, 1985, LANCET, V2, P407
   Gessain A, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00388
   Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199
   La Grenade L, 1998, ARCH DERMATOL, V134, P439, DOI 10.1001/archderm.134.4.439
   Mahieux R, 2015, BLOOD, V126, P1052, DOI 10.1182/blood-2015-06-652040
   Pise-Masison CA, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004454
   POIESZ BJ, 1980, P NATL ACAD SCI-BIOL, V77, P7415, DOI 10.1073/pnas.77.12.7415
   Rodriguez SM, 2011, VIRUSES-BASEL, V3, P1210, DOI 10.3390/v3071210
   Sigrist CJA, 2013, NUCLEIC ACIDS RES, V41, pE344, DOI 10.1093/nar/gks1067
   Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/msr121, 10.1093/molbev/mst197]
   YOSHIDA M, 1982, P NATL ACAD SCI-BIOL, V79, P2031, DOI 10.1073/pnas.79.6.2031
NR 15
TC 0
Z9 0
U1 0
U2 0
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 0889-2229
EI 1931-8405
J9 AIDS RES HUM RETROV
JI Aids Res. Hum. Retrovir.
PD SEP 1
PY 2019
VL 35
IS 9
SI SI
BP 881
EP 884
DI 10.1089/aid.2019.0127
EA JUL 2019
PG 4
WC Immunology; Infectious Diseases; Virology
SC Immunology; Infectious Diseases; Virology
GA IW4NT
UT WOS:000474999200001
PM 31154802
DA 2020-10-22
ER

PT J
AU De Jesus, JG
   Giovanetti, M
   Faria, NR
   Alcantara, LC
AF De Jesus, Jaqueline Goes
   Giovanetti, Marta
   Faria, Nuno Rodrigues
   Alcantara, Luiz Carlos Junior
TI Acute Vector-Borne Viral Infection:Zika and MinION Surveillance
SO MICROBIOLOGY SPECTRUM
LA English
DT Article
ID ZIKA VIRUS-INFECTIONS; YELLOW-FEVER; ARBOVIRUS INFECTIONS;
   NUCLEOTIDE-SEQUENCE; EPIDEMIC; OUTBREAK; TRANSMISSION; CHIKUNGUNYA;
   ANTIBODIES; MOSQUITOS
AB The MinION sequencer was launched by the Oxford Nanopore Technologies start-up as a disruptive technology for genome sequencing based on single-molecule synthesis. Its characteristics as a portable device, low cost, and simple library preparation have made it a good candidate for field researchers. MinION has been used to sequence a number of microorganisms, such as bacteria, viruses, and fungi. Based on the experience that characterized the Ebola virus genetic diversity in Guinea during the 2014-2015 outbreak, the ZiBRA (Zika in Brazil Real-time Analysis) project aimed to sequence a large number of Zika virus genomes during a mobile laboratory trip in northeast Brazil to provide important epidemiological information about the spread of this disease in this country. In response to the positive and rapid results obtained by the ZiBRA project, the Brazilian Ministry of Health and many leading institutions, such as the Pan American Health Organization and WHO, have shown interest in expanding the strategy used in this project to other countries dealing with arbovirus infection.
C1 [De Jesus, Jaqueline Goes] Fundacao Oswaldo Cruz, Lab Expt Pathol, Goncalo Moniz Inst, BR-40296710 Salvador, BA, Brazil.
   [Giovanetti, Marta; Alcantara, Luiz Carlos Junior] Fundacao Oswaldo Cruz, Lab Flaviviruses, Oswaldo Cruz Inst, BR-21040900 Rio De Janeiro, RJ, Brazil.
   [Giovanetti, Marta; Alcantara, Luiz Carlos Junior] Univ Fed Minas Gerais, Lab Cellular & Mol Genet, ICB, BR-31270901 Belo Horizonte, MG, Brazil.
   [Faria, Nuno Rodrigues] Univ Oxford, Dept Zool, Oxford OX1 3SZ, England.
RP Alcantara, LC (corresponding author), Fundacao Oswaldo Cruz, Lab Flaviviruses, Oswaldo Cruz Inst, BR-21040900 Rio De Janeiro, RJ, Brazil.; Alcantara, LC (corresponding author), Univ Fed Minas Gerais, Lab Cellular & Mol Genet, ICB, BR-31270901 Belo Horizonte, MG, Brazil.
EM alcantaraluiz42@gmail.com
RI Faria, Nuno R/I-2975-2012; Giovanetti, Marta/AAK-7408-2020
OI Faria, Nuno R/0000-0001-8839-2798; Alcantara, Luiz/0000-0002-6769-9931
CR Althouse BM, 2015, AM J TROP MED HYG, V92, P88, DOI 10.4269/ajtmh.13-0617
   Ambardar S, 2016, INDIAN J MICROBIOL, V56, P394, DOI 10.1007/s12088-016-0606-4
   Antwerpen MH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123298
   Balasubramanian S, 2011, CHEM COMMUN, V47, P7281, DOI 10.1039/c1cc11078k
   BEARCROFT W. G. C., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P442, DOI 10.1016/0035-9203(56)90090-6
   BOWEN ETW, 1973, T ROY SOC TROP MED H, V67, P702, DOI 10.1016/0035-9203(73)90041-2
   BRASIL Ministerio da Saude Secretaria de Vigilancia em Saude, 2016, B EP MON CAS DENG FE, V21, P27
   BRASIL Ministerio da Saude Secretaria de Vigilancia em Saude, 2016, B EP MON CAS DENG FE, V6, P47
   Buathong R, 2015, AM J TROP MED HYG, V93, P380, DOI 10.4269/ajtmh.15-0022
   Buermans HPJ, 2014, BBA-MOL BASIS DIS, V1842, P1932, DOI 10.1016/j.bbadis.2014.06.015
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   DARWISH MA, 1983, T ROY SOC TROP MED H, V77, P442, DOI 10.1016/0035-9203(83)90106-2
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   DICK GWA, 1953, T ROY SOC TROP MED H, V47, P13, DOI 10.1016/0035-9203(53)90021-2
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   FAGBAMI A, 1977, TROP GEOGR MED, V29, P187
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213, DOI 10.1017/S0022172400025997
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Faria NR, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0356-2
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   FIERS W, 1976, NATURE, V260, P500, DOI 10.1038/260500a0
   Fonseca K, 2014, AM J TROP MED HYG, V91, P1035, DOI 10.4269/ajtmh.14-0151
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   HADDOW AJ, 1964, B WORLD HEALTH ORGAN, V31, P57
   Heather JM, 2016, GENOMICS, V107, P1, DOI 10.1016/j.ygeno.2015.11.003
   HOLLEY RW, 1965, SCIENCE, V147, P1462, DOI 10.1126/science.147.3664.1462
   KOKERNOT RH, 1965, T ROY SOC TROP MED H, V59, P553, DOI 10.1016/0035-9203(65)90158-6
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Kwong JC, 2013, AM J TROP MED HYG, V89, P516, DOI 10.4269/ajtmh.13-0029
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Laver T, 2015, Biomol Detect Quantif, V3, P1
   Lednicky J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004687
   LEE VH, 1972, B WORLD HEALTH ORGAN, V46, P669
   Lessler J, 2016, B WORLD HEALTH ORGAN, V94, P841, DOI 10.2471/BLT.16.174540
   Levene MJ, 2003, SCIENCE, V299, P682, DOI 10.1126/science.1079700
   Lu HY, 2016, GENOM PROTEOM BIOINF, V14, P265, DOI 10.1016/j.gpb.2016.05.004
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   MAXAM AM, 1977, P NATL ACAD SCI USA, V74, P560, DOI 10.1073/pnas.74.2.560
   MCCRAE AWR, 1982, T ROY SOC TROP MED H, V76, P552, DOI 10.1016/0035-9203(82)90161-4
   McINTOSH B. M., 1961, TRANS ROY SOC TROP MED AND HYG, V55, P192, DOI 10.1016/0035-9203(61)90025-6
   Meinel DM, 2016, CLIN MICROBIOL INFEC, V22, DOI 10.1016/j.cmi.2016.08.010
   Mellmann A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022751
   Mikheyev AS, 2014, MOL ECOL RESOUR, V14, P1097, DOI 10.1111/1755-0998.12324
   Min Jou W, 1972, Nature, V237, P82
   MONLUN E, 1993, B SOC PATHOL EXOT, V86, P21
   MOORE DL, 1975, ANN TROP MED PARASIT, V69, P49, DOI 10.1080/00034983.1975.11686983
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Nilakanta Haema, 2014, BMC Res Notes, V7, P830, DOI 10.1186/1756-0500-7-830
   OLSON JG, 1983, ANN TROP MED PARASIT, V77, P131, DOI 10.1080/00034983.1983.11811687
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Pettersson E, 2009, GENOMICS, V93, P105, DOI 10.1016/j.ygeno.2008.10.003
   Plesivkova D, 2019, WIRES FORENSIC SCI, V1, pe1323, DOI [10.1002/wfs2.1323, DOI 10.1002/wfs2.1323]
   POND WILLIAM L., 1963, TRANS ROY SOC TROP MED AND HYG, V57, P364, DOI 10.1016/0035-9203(63)90100-7
   Quick J, 2017, NAT PROTOC, V12, P1261, DOI 10.1038/nprot.2017.066
   Quick J, 2016, NATURE, V530, P228, DOI 10.1038/nature16996
   RODHAIN F, 1989, T ROY SOC TROP MED H, V83, P851, DOI 10.1016/0035-9203(89)90352-0
   Roth A, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.41.20929
   SANGER F, 1977, NATURE, V265, P687, DOI 10.1038/265687a0
   SANGER F., 1965, J MOL BIOL, V13, P373
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   SMITHBURN KC, 1954, J IMMUNOL, V72, P376
   SMITHBURN KC, 1952, J IMMUNOL, V69, P223
   SMITHBURN KC, 1952, J IMMUNOL, V68, P441
   Vogel G, 2016, SCIENCE, V352, P1152, DOI 10.1126/science.352.6290.1152
   Walter MC, 2017, J BIOTECHNOL, V250, P16, DOI 10.1016/j.jbiotec.2016.12.006
   WATSON JD, 1953, NATURE, V171, P737, DOI 10.1038/171737a0
   Webb JLA, 2016, LANCET, V388, P556, DOI 10.1016/S0140-6736(16)31225-9
   WEINBREN M. P., 1958, TRANS ROY SOC TROP MED AND HYG, V52, P263, DOI 10.1016/0035-9203(58)90085-3
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
   World Health Organization, 2016, WHO DIRECTOR GENERAL
   World Health Organization, 2016, ZIK VIR MICR GUILL B
   WU R, 1968, J MOL BIOL, V35, P523, DOI 10.1016/S0022-2836(68)80012-9
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 80
TC 2
Z9 2
U1 1
U2 1
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 2165-0497
J9 MICROBIOL SPECTR
JI Microbiol. Spectr.
PD JUL
PY 2019
VL 7
IS 4
AR AME-0008-2019
DI 10.1128/microbiolspec.AME-0008-2019
PG 11
WC Microbiology
SC Microbiology
GA IT2VO
UT WOS:000482711900003
PM 31400093
OA Bronze
DA 2020-10-22
ER

PT J
AU Xavier, J
   Giovanetti, M
   Fonseca, V
   Theze, J
   Graf, T
   Fabri, A
   de Jesus, JG
   de Mendonca, MCL
   Rodrigues, CDD
   Mares-Guia, MA
   dos Santos, CC
   Tosta, SFD
   Candido, D
   Nogueira, RMR
   de Abreu, AL
   Oliveira, WK
   de Albuquerque, CFC
   Chieppe, A
   de Oliveira, T
   Brasil, P
   Calvet, G
   Sequeira, PC
   Faria, NR
   de Filippis, AMB
   Alcantara, LCJ
AF Xavier, Joilson
   Giovanetti, Marta
   Fonseca, Vagner
   Theze, Julien
   Graf, Tiago
   Fabri, Allison
   de Jesus, Jaqueline Goes
   Lima de Mendonca, Marcos Cesar
   dos Santos Rodrigues, Cintia Damasceno
   Mares-Guia, Maria Angelica
   dos Santos, Carolina Cardoso
   de Oliveira Tosta, Stephane Fraga
   Candido, Darlan
   Ribeiro Nogueira, Rita Maria
   de Abreu, Andre Luiz
   Oliveira, Wanderson Kleber
   Campelo de Albuquerque, Carlos F.
   Chieppe, Alexandre
   de Oliveira, Tulio
   Brasil, Patricia
   Calvet, Guilherme
   Sequeira, Patricia Carvalho
   Faria, Nuno Rodrigues
   Bispo de Filippis, Ana Maria
   Junior Alcantara, Luiz Carlos
TI Circulation of chikungunya virus East/Central/South African lineage in
   Rio de Janeiro, Brazil
SO PLOS ONE
LA English
DT Article
ID TRANSMISSION; POPULATION; MODEL; ZIKA
AB The emergence of chikungunya virus (CHIKV) has raised serious concerns due to the virus' rapid dissemination into new geographic areas and the clinical features associated with infection. To better understand CHIKV dynamics in Rio de Janeiro, we generated 11 near-complete genomes by means of real-time portable nanopore sequencing of virus isolates obtained directly from clinical samples. To better understand CHIKV dynamics in Rio de Janeiro, we generated 11 near-complete genomes by means of real-time portable nanopore sequencing of virus isolates obtained directly from clinical samples. Our phylogenetic reconstructions indicated the circulation of the East-Central-South-African (ECSA) lineage in Rio de Janeiro. Time-measured phylogenetic analysis combined with CHIKV notified case numbers revealed the ECSA lineage was introduced in Rio de Janeiro around June 2015 (95% Bayesian credible interval: May to July 2015) indicating the virus was circulating unnoticed for 5 months before the first reports of CHIKV autochthonous transmissions in Rio de Janeiro, in November 2015. These findings reinforce that continued genomic surveillance strategies are needed to assist in the monitoring and understanding of arbovirus epidemics, which might help to attenuate public health impact of infectious diseases.
C1 [Xavier, Joilson; de Jesus, Jaqueline Goes] Fiocruz MS, Inst Goncalo Moniz, Lab Patol Expt, Salvador, BA, Brazil.
   [Xavier, Joilson; Giovanetti, Marta; Fabri, Allison; Lima de Mendonca, Marcos Cesar; dos Santos Rodrigues, Cintia Damasceno; Mares-Guia, Maria Angelica; dos Santos, Carolina Cardoso; Ribeiro Nogueira, Rita Maria; Sequeira, Patricia Carvalho; Bispo de Filippis, Ana Maria; Junior Alcantara, Luiz Carlos] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Flavivirus, Rio De Janeiro, Brazil.
   [Giovanetti, Marta; Fonseca, Vagner; de Oliveira Tosta, Stephane Fraga; Junior Alcantara, Luiz Carlos] Univ Fed Minas Gerais, Inst Ciencias Biol, Lab Genet Celular & Mol, Belo Horizonte, MG, Brazil.
   [Fonseca, Vagner; de Oliveira, Tulio] Univ KwaZulu Natal, Coll Hlth Sci, KwaZulu Natal Res Innovat & Sequencing Platform K, Durban, South Africa.
   [Theze, Julien; Candido, Darlan; Faria, Nuno Rodrigues] Univ Oxford, Dept Zool, Oxford, England.
   [Graf, Tiago; Fabri, Allison] Univ Fed Rio de Janeiro, Inst Biol, Dept Genet, Rio De Janeiro, Brazil.
   [de Abreu, Andre Luiz; Oliveira, Wanderson Kleber] Minist Saude, Secretaria Vigilancia Saude, Brasilia, DF, Brazil.
   [Campelo de Albuquerque, Carlos F.] Org Mundial Saude, Org Panamer Saude, Brasilia, DF, Brazil.
   [Chieppe, Alexandre] Superintendencia Vigilancia Estado, Rio De Janeiro, Brazil.
   [Brasil, Patricia; Calvet, Guilherme] Inst Nacl Infectol Evandro Chagas, Rio De Janeiro, Brazil.
RP de Filippis, AMB; Alcantara, LCJ (corresponding author), Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Flavivirus, Rio De Janeiro, Brazil.; Alcantara, LCJ (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Lab Genet Celular & Mol, Belo Horizonte, MG, Brazil.
EM abispo@ioc.fiocruz.br; luiz.alcantara@ioc.fiocruz.br
RI Faria, Nuno R/I-2975-2012; Oliveira, Wanderson/AAF-5182-2019; Graf,
   Tiago/S-8535-2019; Giovanetti, Marta/AAK-7408-2020; Fonseca,
   Vagner/R-5813-2019; Calvet, GA/G-6959-2013
OI Faria, Nuno R/0000-0001-8839-2798; Oliveira,
   Wanderson/0000-0002-9662-1930; Graf, Tiago/0000-0003-4921-7975; Fonseca,
   Vagner/0000-0001-5521-6448; Calvet, GA/0000-0002-3545-5238; Xavier,
   Joilson/0000-0003-3916-2018; De Jesus, Jaqueline/0000-0002-5404-272X;
   Theze, Julien/0000-0001-8188-9494; Alcantara, Luiz/0000-0002-6769-9931
FU CNPqNational Council for Scientific and Technological Development (CNPq)
   [440685/2016-8]; CAPESCAPES [88887.130716/2016-00]; Fundacao de Amparo a
   Pesquisa do Estado do Rio de Janeiro /FaperjCarlos Chagas Filho
   Foundation for Research Support of the State of Rio de Janeiro (FAPERJ)
   [E-26/202.930/2016]; Coordenacao de Vigilancia em Saude e Laboratorios
   de Referencia da Fundacao Oswaldo Cruz
FX This research was funded by CNPq grant number (440685/2016-8); CAPES
   grant number (88887.130716/2016-00). Fundacao de Amparo a Pesquisa do
   Estado do Rio de Janeiro /Faperj over the grant number E-26/202.930/2016
   and by the Coordenacao de Vigilancia em Saude e Laboratorios de
   Referencia da Fundacao Oswaldo Cruz.
CR Bastos MLA, 2018, BRAZ J INFECT DIS, V22, P248, DOI 10.1016/j.bjid.2018.05.002
   Baele G, 2013, MOL BIOL EVOL, V30, P239, DOI 10.1093/molbev/mss243
   Brasil, 2018, B EP MON CAS DENG FE
   Brasil, 2016, B EP ARB CEN EP DENG
   Brasil, 2019, B EP MON CAS DENG FE
   Brasil, 2015, B EP MON CAS DED FEB
   Brasil. Boletim Epidemiologico, 2017, B EP MON CAS DENG FE
   de Albuquerque IGC, 2012, REV SOC BRAS MED TRO, V45, P128, DOI 10.1590/S0037-86822012000100026
   Collado D, 2018, J VIROL
   Cunha MS, 2017, EMERG INFECT DIS, V23, P1737, DOI 10.3201/eid2310.161855
   Cunha MD, 2017, J CLIN VIROL, V97, P44, DOI 10.1016/j.jcv.2017.10.015
   da Costa AC, 2017, EMERG INFECT DIS, V23, P1742, DOI 10.3201/eid2310.170307
   Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109
   Tanabe ELD, 2018, REV INST MED TROP SP, V60, DOI [10.1590/S1678-9946201860019, 10.1590/s1678-9946201860019]
   Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088
   Faria NR, 2018, SCIENCE, V361, P894, DOI 10.1126/science.aat7115
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Faria NR, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15152-8
   Fuller TL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188002
   Gill MS, 2013, MOL BIOL EVOL, V30, P713, DOI 10.1093/molbev/mss265
   Katoh K, 2017, BRIEF BIOINFORM
   Nguyen LT, 2015, MOL BIOL EVOL, V32, P268, DOI 10.1093/molbev/msu300
   Lanciotti RS, 2007, EMERG INFECT DIS, V13, P764, DOI 10.3201/eid1305.070015
   Lessa-Aquino C, 2018, EPIDEMIOL INFECT, V146, P2056, DOI 10.1017/S0950268818002467
   Mascarenhas M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207554
   Naveca FG, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007065
   PAHO/WHO, 2017, NUM CAS REP CHIK PAI
   Pialoux G, 2007, LANCET INFECT DIS, V7, P319, DOI 10.1016/S1473-3099(07)70107-X
   Powers AM, 2000, J GEN VIROL, V81, P471, DOI 10.1099/0022-1317-81-2-471
   Powers AM, 2011, EXP BIOL MED, V236, P909, DOI 10.1258/ebm.2011.011078
   Quick J, 2017, NAT PROTOC, V12, P1261, DOI 10.1038/nprot.2017.066
   Rambaut A, 2018, SYST BIOL, V67, P901, DOI 10.1093/sysbio/syy032
   Rambaut A, 2016, VIRUS EVOL, V2, DOI 10.1093/ve/vew007
   ROSS R. W., 1956, JOUR HYG, V54, P177
   Schuffenecker I, 2006, PLOS MED, V3, P1058, DOI 10.1371/journal.pmed.0030263
   Shapiro B, 2011, MOL BIOL EVOL, V28, P879, DOI 10.1093/molbev/msq262
   Souza TML, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39406-9
   Souza TMA, 2017, PLOS CURR, V9
   STRAUSS JH, 1994, MICROBIOL REV, V58, P491, DOI 10.1128/MMBR.58.3.491-562.1994
   Suchard MA, 2018, VIRUS EVOL, V4, DOI 10.1093/ve/vey016
   Nunes MRT, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0348-x
   Theze J, 2018, CELL HOST MICROBE, V23, P855, DOI [10.101, 10.1016/j.chom.2018.04.017]
   Thiberville SD, 2013, ANTIVIR RES, V99, P345, DOI 10.1016/j.antiviral.2013.06.009
   Tsetsarkin KA, 2007, PLOS PATHOG, V3, P1895, DOI 10.1371/journal.ppat.0030201
   Vazeille M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001168
   Weaver SC, 2015, NEW ENGL J MED, V372, P1231, DOI 10.1056/NEJMra1406035
NR 46
TC 3
Z9 3
U1 0
U2 5
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUN 11
PY 2019
VL 14
IS 6
AR e0217871
DI 10.1371/journal.pone.0217871
PG 14
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA IC4XB
UT WOS:000470970000023
PM 31185030
OA DOAJ Gold, Green Published
DA 2020-10-22
ER

PT J
AU Fonseca, V
   Libin, PJK
   Theys, K
   Faria, NR
   Nunes, MRT
   Restovic, MI
   Freire, M
   Giovanetti, M
   Cuypers, L
   Nowe, A
   Abecasis, A
   Deforche, K
   Santiago, GA
   de Siqueira, IC
   San, EJ
   Machado, KCB
   Azevedo, V
   Bispo-de Filippis, AM
   da Cunha, RV
   Pybus, OG
   Vandamme, AM
   Alcantara, LCJ
   de Oliveira, T
AF Fonseca, Vagner
   Libin, Pieter J. K.
   Theys, Kristof
   Faria, Nuno R.
   Nunes, Marcio R. T.
   Restovic, Maria I.
   Freire, Murilo
   Giovanetti, Marta
   Cuypers, Lize
   Nowe, Ann
   Abecasis, Ana
   Deforche, Koen
   Santiago, Gilberto A.
   de Siqueira, Isadora C.
   San, Emmanuel J.
   Machado, Kaliane C. B.
   Azevedo, Vasco
   Bispo-de Filippis, Ana Maria
   da Cunha, Rivaldo Venancio
   Pybus, Oliver G.
   Vandamme, Anne-Mieke
   Alcantara, Luiz C. J.
   de Oliveira, Tulio
TI A computational method for the identification of Dengue, Zika and
   Chikungunya virus species and genotypes
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID MOLECULAR EPIDEMIOLOGY; LARGE PHYLOGENIES; PERFORMANCE; ACCURATE;
   BURDEN; SYSTEM; HIV-1
AB In recent years, an increasing number of outbreaks of Dengue, Chikungunya and Zika viruses have been reported in Asia and the Americas. Monitoring virus genotype diversity is crucial to understand the emergence and spread of outbreaks, both aspects that are vital to develop effective prevention and treatment strategies. Hence, we developed an efficient method to classify virus sequences with respect to their species and sub-species (i.e. serotype and/or genotype). This tool provides an easy-to-use software implementation of this new method and was validated on a large dataset assessing the classification performance with respect to whole-genome sequences and partial-genome sequences. Available online: http://krisp.org.za/tools.php.
   Author summary Dengue (DENV), Chikungunya (CHIKV) and Zika (ZIKV) are considered major public health challenges. In addition to the epidemic caused by DENV, which has been described in many tropical countries, the introduction of CHIKV and ZIKV in these countries is a major public health concern. These arboviruses are primarily transmitted by mosquitoes of the species Ae. Aegypti and its related diseases result in increased financial costs associated with diagnosis and treatment. To support the design of efficient diagnosis, prevention and treatment strategies, a bioinformatics tool has been developed for the genotyping of these viruses based on appropriate evolutionary models in an automatic, accurate and rapid manner. A set of virus reference sequences was obtained from GenBank and used for the development of the tools. This process involved the alignment of the reference sequences followed by phylogenetic tree reconstructions. To assign the genotypes uploaded by the user, the tool analyses the sequences one by one, genotypes through identification, alignment and phylogenetic reconstruction. This computational method allows the high-throughput classification of these virus species and genotypes in seconds. As shown experimentally, genotypes are classified most confidently using the envelope gene or complete genome sequences.
C1 [Fonseca, Vagner; Giovanetti, Marta; Bispo-de Filippis, Ana Maria; Alcantara, Luiz C. J.] Fundacao Oswaldo Cruz, IOC, Lab Flavivirus, Rio De Janeiro, Brazil.
   [Fonseca, Vagner; San, Emmanuel J.; de Oliveira, Tulio] Univ KwaZulu Natal, Coll Hlth Sci, KwaZulu Natal Res Innovat & Sequencing Platform K, Durban, South Africa.
   [Fonseca, Vagner; Azevedo, Vasco; Alcantara, Luiz C. J.] Univ Fed Minas Gerais, ICB, Lab Genet Celular & Mol, Belo Horizonte, MG, Brazil.
   [Libin, Pieter J. K.; Nowe, Ann] Vrije Univ Brussel, Dept Comp Sci, Artificial Intelligence Lab, Brussels, Belgium.
   [Libin, Pieter J. K.; Theys, Kristof; Cuypers, Lize; Vandamme, Anne-Mieke] Univ Leuven, KU Leuven, Dept Microbiol & Immunol, Rega Inst Med Res Clin & Epidemiol Virol, Leuven, Belgium.
   [Faria, Nuno R.; Pybus, Oliver G.] Univ Oxford, Dept Zool, Oxford, England.
   [Nunes, Marcio R. T.] Minist Hlth, Evandro Chagas Inst, Ananindeua, Brazil.
   [Restovic, Maria I.; Freire, Murilo; de Siqueira, Isadora C.; Machado, Kaliane C. B.] Fundacao Oswaldo Cruz, Lab Patol Expt, Salvador, BA, Brazil.
   [Abecasis, Ana; Vandamme, Anne-Mieke] Univ Nova Lisboa, Inst Higiene & Med Trop, Unidade Microbiol, Ctr Global Hlth & Trop Med, Lisbon, Portugal.
   [Deforche, Koen] EMWEB Private Co, Herent, Belgium.
   [Santiago, Gilberto A.] Ctr Dis Control & Prevent, Div Vector Borne Dis, San Juan, PR USA.
   [da Cunha, Rivaldo Venancio] Fundacao Oswaldo Cruz, Coordenacao Vigilancia Saude & Lab Referencias, Rio De Janeiro, Brazil.
RP Alcantara, LCJ (corresponding author), Fundacao Oswaldo Cruz, IOC, Lab Flavivirus, Rio De Janeiro, Brazil.; de Oliveira, T (corresponding author), Univ KwaZulu Natal, Coll Hlth Sci, KwaZulu Natal Res Innovat & Sequencing Platform K, Durban, South Africa.; Alcantara, LCJ (corresponding author), Univ Fed Minas Gerais, ICB, Lab Genet Celular & Mol, Belo Horizonte, MG, Brazil.
EM alcantaraluiz42@gmail.com; tuliodna@gmail.com
RI Faria, Nuno R/I-2975-2012; Azevedo, Vasco A/B-1556-2019; Fonseca,
   Vagner/R-5813-2019; Giovanetti, Marta/AAK-7408-2020; Pybus, Oliver
   G/B-2640-2012; de Siqueira, Isadora Cristina/R-9953-2016; Abecasis,
   Ana/B-6295-2009
OI Faria, Nuno R/0000-0001-8839-2798; Azevedo, Vasco A/0000-0002-4775-2280;
   Fonseca, Vagner/0000-0001-5521-6448; Pybus, Oliver
   G/0000-0002-8797-2667; de Siqueira, Isadora
   Cristina/0000-0002-2520-4099; Alcantara, Luiz/0000-0002-6769-9931; Nowe,
   Ann/0000-0001-6346-4564; Abecasis, Ana/0000-0002-3903-5265
FU South African Medical Re-search Council [MRC-RFA-UFSP-01-2013/UKZN
   HIVEPI]; Royal Society Newton Advanced Fellowship; VIROGENESIS project -
   European Union's Horizon 2020 Research and Innovation Programme
   [634650]; National Institutes of Health Common FundUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USA [U24HG006941]; FWO (Fonds Wetenschappelijk Onderzoek
   Vlaanderen)FWO; CNPqNational Council for Scientific and Technological
   Development (CNPq) [440685/2016-8, 440856/2016-7]; CAPESCAPES
   [88887.130716/201600, 88881.130825/2016-00, 88887.130823/2016-00]; EU's
   Horizon 2020 Programme through ZIKAlliance [PRES-005-FEX-17-4-2-33];
   Fundacao para a Ciencia e Tecnologia (FCT)Portuguese Foundation for
   Science and Technology [GHTM-UID/Multi/04413/2013]; Decit/SCTIE/MoH
FX Supported by a research Flagship grant from the South African Medical
   Re-search Council (MRC-RFA-UFSP-01-2013/UKZN HIVEPI), a Royal Society
   Newton Advanced Fellowship (TdO), the VIROGENESIS project receives
   funding from the European Union's Horizon 2020 Research and Innovation
   Programme (under Grant Agreement no. 634650) and the National Institutes
   of Health Common Fund, grant number U24HG006941. Pieter Libin was
   supported by a PhD grant of the FWO (Fonds Wetenschappelijk Onderzoek
   Vlaanderen). This work was supported by Decit/SCTIE/MoH and CNPq
   (440685/2016-8 and 440856/2016-7); by CAPES (88887.130716/201600,
   88881.130825/2016-00 and 88887.130823/2016-00); and by EU's Horizon 2020
   Programme through ZIKAlliance (PRES-005-FEX-17-4-2-33). Ana Abecasis was
   supported by Fundacao para a Ciencia e Tecnologia (FCT) through funds to
   GHTM-UID/Multi/04413/2013. The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Altschul SF, 1990, BASIC LOCAL ALIGNMEN
   [Anonymous], 2018, STROKE, V49, pe233
   Banoo S, 2006, NAT REV MICROBIOL, pS21, DOI [10.1038/nrmicro1523, 10.1038/nrmico1523]
   Benson DA, 2013, NUCLEIC ACIDS RES, V41, pD36, DOI [10.1093/nar/gks1195, 10.1093/nar/gkt1030, 10.1093/nar/gkr1202]
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Brasil P, 2016, LANCET, V387, P1482, DOI 10.1016/S0140-6736(16)30058-7
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   CHUNGUE E, 1993, J GEN VIROL, V74, P2765, DOI 10.1099/0022-1317-74-12-2765
   Cuypers L, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10100569
   de Oliveira T, 2005, BIOINFORMATICS, V21, P3797, DOI 10.1093/bioinformatics/bti607
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520
   Ha Schmidt, 2002, BIOINFORMATICS, V18, P502, DOI [10.1093/bioinformatics/18.3.502, DOI 10.1093/BIOINFORMATICS/18.3.502]
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754
   Alcantara LCJ, 2009, NUCLEIC ACIDS RES, V37, pW634, DOI 10.1093/nar/gkp455
   Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010
   Katzelnick LC, 2015, SCIENCE, V349, P1338, DOI 10.1126/science.aac5017
   Kindhauser MK, 2016, B WORLD HEALTH ORGAN, DOI DOI 10.2471/BLT.16.171082
   Klungthong C, 2004, VIROLOGY, V329, P168, DOI 10.1016/j.virol.2004.08.003
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404
   Libin P., 2018, BIOINFORMATICS OXFOR
   Libin P, 2017, BIOINFORMATICS, V33, P3993, DOI 10.1093/bioinformatics/btx535
   Libin P, 2013, BIOINFORMATICS, V29, P1477, DOI 10.1093/bioinformatics/btt162
   Manokaran G, 2015, SCIENCE, V350, P217, DOI 10.1126/science.aab3369
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Martin DP, 2010, BIOINFORMATICS, V26, P2462, DOI 10.1093/bioinformatics/btq467
   Morens DM, 2016, J INFECT DIS, V214, pS434, DOI 10.1093/infdis/jiw291
   Nylander JAA, 2008, BIOINFORMATICS, V24, P581, DOI 10.1093/bioinformatics/btm388
   Pineda-Pena AC, 2013, INFECT GENET EVOL, V19, P337, DOI 10.1016/j.meegid.2013.04.032
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   RICOHESSE R, 1990, VIROLOGY, V174, P479, DOI 10.1016/0042-6822(90)90102-W
   Roth A, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.41.20929
   Salemi M., 2003, PHYLOGENETIC HDB PRA
   Shepard DS, 2016, LANCET INFECT DIS, V16, P935, DOI 10.1016/S1473-3099(16)00146-8
   Strimmer K, 1997, P NATL ACAD SCI USA, V94, P6815, DOI 10.1073/pnas.94.13.6815
   Nunes MRT, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0348-x
   Theys K, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006528
   Twiddy SS, 2002, VIROLOGY, V298, P63, DOI 10.1006/viro.2002.1447
   Vilsker M, 2019, BIOINFORMATICS, V35, P871, DOI 10.1093/bioinformatics/bty695
   Volk SM, 2010, J VIROL, V84, P6497, DOI 10.1128/JVI.01603-09
   Weaver SC, 2015, NEW ENGL J MED, V372, P1231, DOI 10.1056/NEJMra1406035
NR 45
TC 6
Z9 6
U1 0
U2 4
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD MAY
PY 2019
VL 13
IS 5
AR e0007231
DI 10.1371/journal.pntd.0007231
PG 15
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA IB3ST
UT WOS:000470188100009
PM 31067235
OA DOAJ Gold, Green Published
DA 2020-10-22
ER

PT J
AU Queiroz, A
   Pinto, IFD
   Lima, M
   Giovanetti, M
   de Jesus, JG
   Xavier, J
   Barreto, FK
   Canuto, GAB
   do Amaral, HR
   de Filippis, AMB
   Mascarenhas, DL
   Falcao, MB
   Santos, NP
   Azevedo, VAD
   Yoshinaga, MY
   Miyamoto, S
   Alcantara, LC
AF Queiroz, Adriano
   Dantas Pinto, Isabella Fernanda
   Lima, Maricelia
   Giovanetti, Marta
   de Jesus, Jaqueline Goes
   Xavier, Joilson
   Barreto, Fernanda Khouri
   Baptista Canuto, Gisele Andre
   do Amaral, Helineide Ramos
   Bispo de Filippis, Ana Maria
   Mascarenhas, Denise Lima
   Falcao, Melissa Barreto
   Santos, Normeide Pedreira
   de Carvalho Azevedo, Vasco Ariston
   Yoshinaga, Marcos Yukio
   Miyamoto, Sayuri
   Alcantara, Luiz Carlos Junior
TI Lipidomic Analysis Reveals Serum Alteration of Plasmalogens in Patients
   Infected With ZIKA Virus
SO FRONTIERS IN MICROBIOLOGY
LA English
DT Article
DE Zika virus; serum lipidomics; plasmalogens; phosphatidylethanolamine;
   arbovirus
ID DENGUE VIRUS; REPLICATION; PHOSPHATIDYLSERINE; PEROXISOMES; MEMBRANES
AB Zika virus (ZIKV) is an arthropod-borne virus (arbovirus) in the Flavivirus genus of the Flaviviridae family. Since the large outbreaks in French Polynesia in 2013-2014 and in Brazil in 2015, ZIKV has been considered a new public health threat. Similar to other related flavivirus, ZIKV is associated with mild and self-limiting symptoms such as rash, pruritus, prostration, headache, arthralgia, myalgia, conjunctivitis, lower back pain and, when present, a short-term low grade fever. In addition, ZIKV has been implicated in neurological complications such as neonatal microcephaly and Guillain-Barre syndrome in adults. Herein, serum lipidomic analysis was used to identify possible alterations in lipid metabolism triggered by ZIKV infection. Patients who presented virus-like symptoms such as fever, arthralgia, headache, exanthema, myalgia and pruritus were selected as the control group. Our study reveals increased levels of several phosphatidylethanolamine (PE) lipid species in the serum of ZIKV patients, the majority of them plasmenyl-phosphatidylethanolamine (pPE) (or plasmalogens) linked to polyunsaturated fatty acids. Constituting up to 20% of total phospholipids in humans, plasmalogens linked to polyunsaturated fatty acids are particularly enriched in neural membranes of the brain. The biosynthesis of plasmalogens requires functional peroxisomes, which are important sites for viral replication, including ZIKV. Thus, increased levels of plasmalogens in serum of ZIKV infected subjects suggest a link between ZIKV life cycle and peroxisomes. Our data provide important insights into specific host cellular lipids that are likely associated with ZIKV replication and may serve as platform for antiviral strategy against ZIKV.
C1 [Queiroz, Adriano; Giovanetti, Marta; de Jesus, Jaqueline Goes; Xavier, Joilson; Alcantara, Luiz Carlos Junior] Inst Goncalo Moniz, Lab Patol Expt, Salvador, BA, Brazil.
   [Dantas Pinto, Isabella Fernanda; Yoshinaga, Marcos Yukio; Miyamoto, Sayuri] Univ Sao Paulo, Inst Quim, Dept Bioquim, Sao Paulo, Brazil.
   [Lima, Maricelia] Univ Estadual Feira de Santana, Dept Saude, Feira De Santana, Brazil.
   [Giovanetti, Marta; Bispo de Filippis, Ana Maria; Alcantara, Luiz Carlos Junior] Inst Oswaldo Cruz, Lab Flavivirus, Rio De Janeiro, Brazil.
   [Barreto, Fernanda Khouri] Univ Fed Bahia, Inst Multidisciplinar Saude, Vitoria Da Conquista, Brazil.
   [Baptista Canuto, Gisele Andre] Univ Fed Bahia, Dept Quim Analit, Inst Quim, Salvador, BA, Brazil.
   [do Amaral, Helineide Ramos] Univ Estadual Feira de Santana, Nucleo Pesquisa Vigilancia Saude, Feira De Santana, Brazil.
   [Mascarenhas, Denise Lima; Falcao, Melissa Barreto; Santos, Normeide Pedreira] Secretaria Municipal Saude Municipio Feira de San, Feira De Santana, Brazil.
   [de Carvalho Azevedo, Vasco Ariston] Univ Fed Minas Gerais, Inst Ciencias Biol, Belo Horizonte, MG, Brazil.
   [Alcantara, Luiz Carlos Junior] Univ Fed Minas Gerais, Inst Ciencias Biol, Lab Genet Celular & Mol, Belo Horizonte, Brazil.
RP Alcantara, LC (corresponding author), Inst Goncalo Moniz, Lab Patol Expt, Salvador, BA, Brazil.; Yoshinaga, MY (corresponding author), Univ Sao Paulo, Inst Quim, Dept Bioquim, Sao Paulo, Brazil.; Alcantara, LC (corresponding author), Inst Oswaldo Cruz, Lab Flavivirus, Rio De Janeiro, Brazil.; Alcantara, LC (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Lab Genet Celular & Mol, Belo Horizonte, Brazil.
EM marcosyukio@gmail.com; luiz.alcantara@ioc.fiocruz.br
RI Queiroz, Adriano/AAQ-1164-2020; Canuto, Gisele A B/N-7338-2015;
   Giovanetti, Marta/AAK-7408-2020; Azevedo, Vasco A/B-1556-2019; Miyamoto,
   Sayuri/A-2144-2008
OI Queiroz, Adriano/0000-0003-0080-6509; Canuto, Gisele A
   B/0000-0002-6616-3705; Azevedo, Vasco A/0000-0002-4775-2280; Miyamoto,
   Sayuri/0000-0002-5714-8984; Alcantara, Luiz/0000-0002-6769-9931; Xavier,
   Joilson/0000-0003-3916-2018
FU Conselho Nacional de Desenvolvimento Cientifico e TecnologicoNational
   Council for Scientific and Technological Development (CNPq) [CNPq
   440685/20168, CNPq 424094/2016-9]; CAPESCAPES [88887.130716/2016-00];
   Financiadora de Estudos e ProjetosCiencia Tecnologia e Inovacao (FINEP)
   [FINEP 04.16.0060.00]; EU's Horizon 2020 Program through ZIKAlliance
   [734548]; FAPESPFundacao de Amparo a Pesquisa do Estado de Sao Paulo
   (FAPESP) [13/07937-8]; International Development Research Centre (IDRC)
   over the Grant [108411-001]; European UnionEuropean Union (EU) [734857];
   CAPES (Brazilian Federal Agency for Support and Evaluation of Graduate
   Education within the Ministry of Education of Brazil); Fundacao de
   Amparo a Pesquisa do Estado de Sao PauloFundacao de Amparo a Pesquisa do
   Estado de Sao Paulo (FAPESP) [FAPESP 2014/11556-2]
FX This work was supported by Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico (CNPq 440685/20168, CNPq 424094/2016-9), CAPES
   (88887.130716/2016-00), Financiadora de Estudos e Projetos (FINEP
   04.16.0060.00) and EU's Horizon 2020 Program through ZIKAlliance (Grant
   734548). The activities ofMY, IP, and SMwere funded by FAPESP
   (CEPID-Redoxoma grant 13/07937-8). And the activities of AF was
   supported by the International Development Research Centre (IDRC) over
   the Grant 108411-001 and by the European Union's Horizon 2020 grant
   agreement ZikAction no. 734857. AQ, MG, FB, and MY were funded by a post
   doc fellowship from CAPES (Brazilian Federal Agency for Support and
   Evaluation of Graduate Education within the Ministry of Education of
   Brazil) and IP by a Ph.D fellowship from Fundacao de Amparo a Pesquisa
   do Estado de Sao Paulo (FAPESP 2014/11556-2).
CR Apte-Sengupta S, 2014, CURR OPIN VIROL, V9, P134, DOI 10.1016/j.coviro.2014.09.020
   Berger J, 2016, BBA-MOL CELL RES, V1863, P934, DOI 10.1016/j.bbamcr.2015.12.005
   Braverman NE, 2012, BBA-MOL BASIS DIS, V1822, P1442, DOI 10.1016/j.bbadis.2012.05.008
   Brugger B, 2006, P NATL ACAD SCI USA, V103, P2641, DOI 10.1073/pnas.0511136103
   Carnec X, 2016, J VIROL, V90, P92, DOI 10.1128/JVI.01849-15
   Chong J, 2018, NUCLEIC ACIDS RES, V46, pW486, DOI 10.1093/nar/gky310
   Coyaud E, 2018, MOL CELL PROTEOMICS, V17, P2242, DOI 10.1074/mcp.TIR118.000800
   Cui L, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002373
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   Dixit E, 2010, CELL, V141, P668, DOI 10.1016/j.cell.2010.04.018
   Fahy E, 2005, J LIPID RES, V46, P839, DOI 10.1194/jlr.E400004-JLR200
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Farooqui AA, 2001, NEUROSCIENTIST, V7, P232, DOI 10.1177/107385840100700308
   GLASER PE, 1995, BIOCHEMISTRY-US, V34, P12193, DOI 10.1021/bi00038a013
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Harak C, 2015, VIROLOGY, V479, P418, DOI 10.1016/j.virol.2015.02.029
   Jordan TX, 2016, CURR OPIN VIROL, V19, P7, DOI 10.1016/j.coviro.2016.05.007
   Kaufusi PH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084040
   Kuno G, 1998, J VIROL, V72, P73, DOI 10.1128/JVI.72.1.73-83.1998
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanciotti RS, 2007, EMERG INFECT DIS, V13, P764, DOI 10.3201/eid1305.070015
   Liu STH, 2011, P NATL ACAD SCI USA, V108, P12869, DOI 10.1073/pnas.1109796108
   Malone RW, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004530
   Martin-Acebes MA, 2016, PROG LIPID RES, V64, P123, DOI 10.1016/j.plipres.2016.09.005
   Martin-Acebes MA, 2014, J VIROL, V88, P12041, DOI 10.1128/JVI.02061-14
   Matyash V, 2008, J LIPID RES, V49, P1137, DOI 10.1194/jlr.D700041-JLR200
   Meertens L, 2012, CELL HOST MICROBE, V12, P544, DOI 10.1016/j.chom.2012.08.009
   Melo CFOR, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01954
   Miller S, 2007, J BIOL CHEM, V282, P8873, DOI 10.1074/jbc.M609919200
   Morita M, 2013, CELL, V153, P112, DOI 10.1016/j.cell.2013.02.027
   Nour AM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003585
   Odendall Charlotte, 2013, Subcell Biochem, V69, P67, DOI 10.1007/978-94-007-6889-5_4
   Melo CFOR, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30385-x
   Perera-Lecoin Manuel, 2013, Viruses, V6, P69, DOI 10.3390/v6010069
   Richard AS, 2015, P NATL ACAD SCI USA, V112, P14682, DOI 10.1073/pnas.1508095112
   Rog T, 2016, BBA-BIOMEMBRANES, V1858, P97, DOI 10.1016/j.bbamem.2015.10.023
   Roosendaal J, 2006, J VIROL, V80, P4623, DOI 10.1128/JVI.80.9.4623-4632.2006
   SATOH O, 1990, J LIPID RES, V31, P1293
   Schoeman JC, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0318-8
   Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002
   Tam VC, 2013, CELL, V154, P213, DOI 10.1016/j.cell.2013.05.052
   Tanner LB, 2014, J LIPID RES, V55, P1357, DOI 10.1194/jlr.M049148
   Wewer CR, 2018, SOFT MATTER, V14, P5615, DOI 10.1039/c8sm00223a
   White MK, 2016, ANN NEUROL, V80, P479, DOI 10.1002/ana.24748
   You J, 2015, J VIROL, V89, P12349, DOI 10.1128/JVI.01365-15
NR 45
TC 6
Z9 6
U1 0
U2 2
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-302X
J9 FRONT MICROBIOL
JI Front. Microbiol.
PD APR 12
PY 2019
VL 10
AR 753
DI 10.3389/fmicb.2019.00753
PG 10
WC Microbiology
SC Microbiology
GA HT1IR
UT WOS:000464317800001
PM 31031729
OA DOAJ Gold, Green Published
DA 2020-10-22
ER

PT J
AU Vilsker, M
   Moosa, Y
   Nooij, S
   Fonseca, V
   Ghysens, Y
   Dumon, K
   Pauwels, R
   Alcantara, LC
   Eynden, EV
   Vandamme, AM
   Deforche, K
   de Oliveira, T
AF Vilsker, Michael
   Moosa, Yumna
   Nooij, Sam
   Fonseca, Vagner
   Ghysens, Yoika
   Dumon, Korneel
   Pauwels, Raf
   Alcantara, Luiz Carlos
   Eynden, Ewout Vanden
   Vandamme, Anne-Mieke
   Deforche, Koen
   de Oliveira, Tulio
TI Genome Detective: an automated system for virus identification from
   high-throughput sequencing data
SO BIOINFORMATICS
LA English
DT Article
ID ALGORITHM; ALIGNMENT
AB Genome Detective is an easy to use web-based software application that assembles the genomes of viruses quickly and accurately. The application uses a novel alignment method that constructs genomes by reference-based linking of de novo contigs by combining amino-acids and nucleotide scores. The software was optimized using synthetic datasets to represent the great diversity of virus genomes. The application was then validated with next generation sequencing data of hundreds of viruses. User time is minimal and it is limited to the time required to upload the data.
C1 [Vilsker, Michael; Ghysens, Yoika; Dumon, Korneel; Pauwels, Raf; Deforche, Koen] Emweb Bvba, B-3020 Herent, Belgium.
   [Moosa, Yumna; Fonseca, Vagner; de Oliveira, Tulio] Univ KwaZulu Natal, KRISP, Sch Lab Med & Med Sci, Nelson R Mandela Sch Med,Coll Hlth Sci, ZA-4001 Durban, South Africa.
   [Nooij, Sam] Dutch Natl Inst Publ Hlth & Environm ( RIVM), Bilthoven, Netherlands.
   [Fonseca, Vagner; Alcantara, Luiz Carlos] Univ Fed Minas Gerais, Inst Ciencias Biol, Belo Horizonte, MG, Brazil.
   [Fonseca, Vagner; Alcantara, Luiz Carlos] Fiocruz MS, Lab Hematol Genet & Computat Biol, Goncalo Moniz Res Ctr, Oswaldo Cruz Fdn,LHGB,CPqGM, Salvador, BA, Brazil.
   [Alcantara, Luiz Carlos] Fundacao Oswaldo Cruz, Lab Flavivirus, IOC, Rio De Janeiro, Brazil.
   [Eynden, Ewout Vanden; Vandamme, Anne-Mieke] Katholieke Univ Leuven, Dept Microbiol & Immunol, Rega Inst Med Res Clin & Epidemiol Virol, Leuven, Belgium.
   [Vandamme, Anne-Mieke] Univ Nova Lisboa, Ctr Global Hlth & Trop Med, Unidade Microbiol, Inst Higiene & Med Trop, Lisbon, Portugal.
RP Deforche, K (corresponding author), Emweb Bvba, B-3020 Herent, Belgium.; de Oliveira, T (corresponding author), Univ KwaZulu Natal, KRISP, Sch Lab Med & Med Sci, Nelson R Mandela Sch Med,Coll Hlth Sci, ZA-4001 Durban, South Africa.
EM koen@emweb.be; deoliveira@ukzn.ac.za
RI Vandamme, Anne-Mieke/I-4127-2012; Fonseca, Vagner/R-5813-2019
OI Vandamme, Anne-Mieke/0000-0002-6594-2766; Fonseca,
   Vagner/0000-0001-5521-6448; Alcantara, Luiz/0000-0002-6769-9931; Nooij,
   Sam/0000-0001-5892-5637
FU South African Medical Research Council [MRC-RFA-UFSP-01-2013/UKZN
   HIVEPI]; Royal Society Newton Advanced Fellowship; European Union's
   Horizon 2020 Research and Innovation Program [634650]; National
   Institutes of Health Common FundUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USA [U24HG006941]
FX Supported by a research Flagship grant from the South African Medical
   Research Council (MRC-RFA-UFSP-01-2013/UKZN HIVEPI), a Royal Society
   Newton Advanced Fellowship (TdO), the VIROGENESIS project receives
   funding from the European Union's Horizon 2020 Research and Innovation
   Program (under Grant Agreement no. 634650) and the National Institutes
   of Health Common Fund, grant number U24HG006941. The content is solely
   the responsibility of the authors and does not necessarily represent the
   official views of the National Institutes of Health. We would like to
   acknowledge the contribution of Annelies Kroneman, Harry Vennema, Roel
   Standaert, Pieter Libin and Kristof Theys.
CR Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021
   Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170
   Brown J, 2017, BIOINFORMATICS, V33, P3137, DOI 10.1093/bioinformatics/btx373
   Buchfink B, 2015, NAT METHODS, V12, P59, DOI 10.1038/nmeth.3176
   Conceicao-Neto N, 2015, SCI REP-UK, V5, DOI 10.1038/srep16532
   de Oliveira T, 2005, BIOINFORMATICS, V21, P3797, DOI 10.1093/bioinformatics/bti607
   Deforche K., 2017, ALIGNMENT METHOD NUC, DOI [10.1101/200394, DOI 10.1101/200394]
   GOTOH O, 1982, J MOL BIOL, V162, P705, DOI 10.1016/0022-2836(82)90398-9
   Hunt M, 2015, BIOINFORMATICS, V31, P2374, DOI 10.1093/bioinformatics/btv120
   Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324
   Li Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep23774
   Lin HH, 2017, GIGASCIENCE, V6, DOI 10.1093/gigascience/gix003
   Naccache SN, 2014, GENOME RES, V24, P1180, DOI 10.1101/gr.171934.113
   Rose R, 2016, VIRUS EVOL, V2, DOI 10.1093/ve/vew022
   SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5
   Yamashita A, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00032
NR 16
TC 24
Z9 25
U1 0
U2 3
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 1367-4803
EI 1460-2059
J9 BIOINFORMATICS
JI Bioinformatics
PD MAR 1
PY 2019
VL 35
IS 5
BP 871
EP 873
DI 10.1093/bioinformatics/bty695
PG 3
WC Biochemical Research Methods; Biotechnology & Applied Microbiology;
   Computer Science, Interdisciplinary Applications; Mathematical &
   Computational Biology; Statistics & Probability
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Computer Science; Mathematical & Computational Biology; Mathematics
GA HX2MY
UT WOS:000467227300020
PM 30124794
OA Green Published, Other Gold
DA 2020-10-22
ER

PT J
AU Naveca, FG
   Claro, I
   Giovanetti, M
   de Jesus, JG
   Xavier, J
   Iani, FCD
   do Nascimento, VA
   de Souza, VC
   Silveira, PP
   Lourenco, J
   Santillana, M
   Kraemer, MUG
   Quick, J
   Hill, SC
   Theze, J
   Carvalho, RDD
   Azevedo, V
   Salles, FCD
   Nunes, MRT
   Lemos, PD
   Candido, DD
   Pereira, GD
   Oliveira, MAA
   Meneses, CAR
   Maito, RM
   Cunha, CRS
   Campos, DPD
   Castilho, MD
   Siqueira, TCD
   Terra, TM
   de Albuquerque, CFC
   da Cruz, LN
   de Abreu, AL
   Martins, DV
   Simoes, DSDV
   de Aguiar, RS
   Luz, SLB
   Loman, N
   Pybus, OG
   Sabino, EC
   Okumoto, O
   Alcantara, LCJ
   Faria, NR
AF Naveca, Felipe Gomes
   Claro, Ingra
   Giovanetti, Marta
   de Jesus, Jaqueline Goes
   Xavier, Joilson
   de Melo Iani, Felipe Campos
   do Nascimento, Valdinete Alves
   de Souza, Victor Costa
   Silveira, Paola Paz
   Lourenco, Jose
   Santillana, Mauricio
   Kraemer, Moritz U. G.
   Quick, Josh
   Hill, Sarah C.
   Theze, Julien
   de Oliveira Carvalho, Rodrigo Dias
   Azevedo, Vasco
   da Silva Salles, Flavia Cristina
   Teixeira Nunes, Marcio Roberto
   Lemos, Poliana da Silva
   Candido, Darlan da Silva
   Pereira, Glauco de Carvalho
   Assuncao Oliveira, Marluce Aparecida
   Ribeiro Meneses, Catia Alexandra
   Maito, Rodrigo Melo
   Santa Brigida Cunha, Claudeth Rocha
   de Sousa Campos, Daniela Palha
   Castilho, Marcia da Costa
   da Silva Siqueira, Thalita Caroline
   Terra, Tiza Matos
   Campelo de Albuquerque, Carlos F.
   da Cruz, Laura Nogueira
   de Abreu, Andre Luis
   Martins, Divino Valerio
   de Moraes Vanlume Simoes, Daniele Silva
   de Aguiar, Renato Santana
   Bessa Luz, Sergio Luiz
   Loman, Nicholas
   Pybus, Oliver G.
   Sabino, Ester C.
   Okumoto, Osnei
   Junior Alcantara, Luiz Carlos
   Faria, Nuno Rodrigues
TI Genomic, epidemiological and digital surveillance of Chikungunya virus
   in the Brazilian Amazon
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID MAYARO VIRUS; POPULATION-DYNAMICS; MATO-GROSSO; ZIKA VIRUS; OUTBREAK;
   INFERENCE; EMERGENCE; OROPOUCHE; DISEASE; ILLNESS
AB Background Since its first detection in the Caribbean in late 2013, chikungunya virus (CHIKV) has affected 51 countries in the Americas. The CHIKV epidemic in the Americas was caused by the CHIKV-Asian genotype. In August 2014, local transmission of the CHIKV-Asian genotype was detected in the Brazilian Amazon region. However, a distinct lineage, the CHIKV-East-Central-South-America (ECSA)-genotype, was detected nearly simultaneously in Feira de Santana, Bahia state, northeast Brazil. The genomic diversity and the dynamics of CHIKV in the Brazilian Amazon region remains poorly understood despite its importance to better understand the epidemiological spread and public health impact of CHIKV in the country.
   Methodology/Principal findings We report a large CHIKV outbreak (5,928 notified cases between August 2014 and August 2018) in Boa vista municipality, capital city of Roraima's state, located in the Brazilian Amazon region. We generated 20 novel CHIKV-ECSA genomes from the Brazilian Amazon region using MinION portable genome sequencing. Phylogenetic analyses revealed that despite an early introduction of the Asian genotype in 2015 in Roraima, the large CHIKV outbreak in 2017 in Boa Vista was caused by an ECSA-lineage most likely introduced from northeastern Brazil. Epidemiological analyses suggest a basic reproductive number of R-0 of 1.66, which translates in an estimated 39 (95% CI: 36 to 45) % of Roraima's population infected with CHIKV-ECSA. Finally, we find a strong association between Google search activity and the local laboratory-confirmed CHIKV cases in Roraima.
   Conclusions/Significance This study highlights the potential of combining traditional surveillance with portable genome sequencing technologies and digital epidemiology to inform public health surveillance in the Amazon region. Our data reveal a large CHIKV-ECSA outbreak in Boa Vista, limited potential for future CHIKV outbreaks, and indicate a replacement of the Asian genotype by the ECSA genotype in the Amazon region.
C1 [Naveca, Felipe Gomes; do Nascimento, Valdinete Alves; de Souza, Victor Costa; Bessa Luz, Sergio Luiz] Fiocruz MS, Inst Leonidas & Maria Deane, Lab Ecol Doencas Transmissiveis Amazonia, Manaus, Amazonas, Brazil.
   [Claro, Ingra; da Silva Salles, Flavia Cristina; Sabino, Ester C.] Univ Sao Paulo, Inst Med Trop, Sao Paulo, Brazil.
   [Claro, Ingra; da Silva Salles, Flavia Cristina; Sabino, Ester C.] Univ Sao Paulo, Fac Med, Sao Paulo, Brazil.
   [Giovanetti, Marta; de Jesus, Jaqueline Goes; Xavier, Joilson; Junior Alcantara, Luiz Carlos] Fiocruz MS, Inst Oswaldo Cruz, Lab Flavivirus, Rio De Janeiro, Brazil.
   [Giovanetti, Marta; de Melo Iani, Felipe Campos; de Oliveira Carvalho, Rodrigo Dias; Azevedo, Vasco; Pereira, Glauco de Carvalho; Assuncao Oliveira, Marluce Aparecida; Junior Alcantara, Luiz Carlos] Univ Fed Minas Gerais, Inst Ciencias Biol, Lab Genet Celular & Mol, Belo Horizonte, MG, Brazil.
   [de Jesus, Jaqueline Goes; Xavier, Joilson] Fundacao Oswaldo Cruz, Inst Goncalo Moniz, Lab Patol Expt, Salvador, BA, Brazil.
   [de Melo Iani, Felipe Campos] FUNED, Inst Octavio Magalhaes, Lab Cent Saude Publ, Belo Horizonte, MG, Brazil.
   [Silveira, Paola Paz; de Aguiar, Renato Santana] Univ Fed Rio de Janeiro, Inst Biol, Dept Genet, Lab Virol Mol, Rio De Janeiro, Brazil.
   [Lourenco, Jose; Kraemer, Moritz U. G.; Hill, Sarah C.; Theze, Julien; Candido, Darlan da Silva; Pybus, Oliver G.; Faria, Nuno Rodrigues] Univ Oxford, Dept Zool, South Parks Rd, Oxford, England.
   [Santillana, Mauricio] Harvard Med Sch, Dept Pediat, Boston, MA 02115 USA.
   [Santillana, Mauricio] Boston Childrens Hosp, Computat Hlth Informat Program, Boston, MA USA.
   [Kraemer, Moritz U. G.] Boston Childrens Hosp, Computat Epidemiol Lab, Boston, MA USA.
   [Quick, Josh; Loman, Nicholas] Univ Birmingham, Inst Microbiol & Infect, Birmingham, W Midlands, England.
   [Teixeira Nunes, Marcio Roberto; Lemos, Poliana da Silva] Brazilian Minist Hlth, Evandro Chagas Inst, Ananindeua, Brazil.
   [Ribeiro Meneses, Catia Alexandra; Maito, Rodrigo Melo; Santa Brigida Cunha, Claudeth Rocha] Lab Cent Saude Publ, Boa Vista, Roraima, Brazil.
   [de Sousa Campos, Daniela Palha; da Silva Siqueira, Thalita Caroline] Secretaria Municipal Saude Boa Vista, Superintendencia Vigilancia Saude, Roraima, Brazil.
   [Castilho, Marcia da Costa] Fundacao Med Trop Doutor Heitor Vieira Dourado, Dept Virol, Manaus, Amazonas, Brazil.
   [Terra, Tiza Matos] Lab Cent Saude Publ Amazonas, Manaus, Amazonas, Brazil.
   [Campelo de Albuquerque, Carlos F.] OMS, OPAS, Brasilia, DF, Brazil.
   [da Cruz, Laura Nogueira; de Abreu, Andre Luis; Martins, Divino Valerio; de Moraes Vanlume Simoes, Daniele Silva; Okumoto, Osnei] MS, SVS, Brasilia, DF, Brazil.
RP Alcantara, LCJ (corresponding author), Fiocruz MS, Inst Oswaldo Cruz, Lab Flavivirus, Rio De Janeiro, Brazil.; Alcantara, LCJ (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Lab Genet Celular & Mol, Belo Horizonte, MG, Brazil.; Faria, NR (corresponding author), Univ Oxford, Dept Zool, South Parks Rd, Oxford, England.
EM luiz.alcantara@ioc.fiocruz.br; nuno.faria@zoo.ox.ac.uk
RI Aguiar, Renato S/G-3542-2015; Giovanetti, Marta/AAK-7408-2020; Faria,
   Nuno R/I-2975-2012; Azevedo, Vasco A/B-1556-2019; Sabino, Ester
   Cerdeira/F-7750-2010; Pybus, Oliver G/B-2640-2012; Nascimento, Valdinete
   Alves do/AAV-1879-2020; Loman, Nicholas/Z-1573-2019
OI Aguiar, Renato S/0000-0001-5180-3717; Faria, Nuno R/0000-0001-8839-2798;
   Azevedo, Vasco A/0000-0002-4775-2280; Sabino, Ester
   Cerdeira/0000-0003-2623-5126; Pybus, Oliver G/0000-0002-8797-2667;
   Nascimento, Valdinete Alves do/0000-0002-7786-4718;
   /0000-0002-8529-4022; da Silva Candido, Darlan/0000-0002-5080-3130;
   Souza, Victor Costa de/0000-0002-3869-1519; Alcantara,
   Luiz/0000-0002-6769-9931; Iani, Felipe/0000-0002-3629-8529; Hill,
   Sarah/0000-0002-2995-2596; Xavier, Joilson/0000-0003-3916-2018;
   Lourenco, Jose/0000-0002-9318-2581; Luz, Sergio Luiz
   Bessa/0000-0001-5887-7372; Theze, Julien/0000-0001-8188-9494; Carvalho,
   Rodrigo/0000-0003-0216-7173; da Silva Sales, Flavia
   Cristina/0000-0002-9048-0030
FU Conselho Nacional de Desenvolvimento Cientifico e TecnologicoNational
   Council for Scientific and Technological Development (CNPq)
   [440685/2016-8, 440856/2016-7]; Coordenacao de Aperfeicoamento de
   Pessoal de Nivel SuperiorCAPES [88887.130716/2016-00,
   88881.130825/2016-00, 88887.130823/2016-00]; EU's Horizon 2020 Programme
   through ZIKAlliance [PRES-005-FEX-17-4-2-33]; Royal SocietyRoyal Society
   of London; Wellcome Trust Sir Henry Dale Fellowship [204311/Z/16/Z];
   John Fell Research Fund [005166]; ERCEuropean Research Council (ERC)
   [614725-PATHPHYLODYN]; National Institute of General Medical Sciences of
   the NIH (USA) [R01GM130668]; internal GCRF grant [005073]
FX The ZIBRA-2 project is funded by Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico (grant 440685/2016-8) and Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior (grant
   88887.130716/2016-00). FGN is funded by Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (http://www.cnpq.br, grant
   440856/2016-7) and Coordenacao de Aperfeicoamento de Pessoal de Nivel
   Superior (http://www.capes.gov.br, grants 88881.130825/2016-00 and
   88887.130823/2016-00). L.C.J.A. is supported by the EU's Horizon 2020
   Programme through ZIKAlliance (grant PRES-005-FEX-17-4-2-33). N.R.F. is
   funded by a Royal Society and Wellcome Trust Sir Henry Dale Fellowship
   (204311/Z/16/Z), internal GCRF grant 005073, and John Fell Research Fund
   grant 005166. This research received funding from the ERC (grant
   agreement 614725-PATHPHYLODYN). MS was partially supported by the
   National Institute of General Medical Sciences of the NIH (USA) under
   award number R01GM130668. The funders had no role in study design, data
   collection and analysis, decision to publish or preparation of the
   manuscript.
CR [Anonymous], 2015, PUBMED, V7, pe141
   [Anonymous], 2017, EMERGING INFECTIOUS, V23, ps6
   [Anonymous], 2015, PUBMED, V31, P43
   [Anonymous], 2016, PLOS CURRENTS OUTBRE, V39, pS1, DOI 10.2337/dc16-S001
   [Anonymous], 2015, PUBMED, V4, pA1
   [Anonymous], 2010, EURO SURVEILLANCE, V15, pe1936
   [Anonymous], 2016, PUBMED, V44, pD7
   [Anonymous], 2016, EVOLUTION, V2, pA49
   [Anonymous], 2016, PUBMED, V21, piii
   de Brito CAA, 2017, MEM I OSWALDO CRUZ, V112, P650, DOI 10.1590/0074-02760170124
   Aragao CF, 2018, ACTA TROP, V186, P1, DOI 10.1016/j.actatropica.2018.06.022
   Azevedo RSS, 2009, EMERG INFECT DIS, V15, P1830, DOI 10.3201/eid1511.090461
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Bruen TC, 2006, GENETICS, V172, P2665, DOI 10.1534/genetics.105.048975
   Brunini S, 2017, EMERG INFECT DIS, V23, P1025, DOI 10.3201/eid2306.160929
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Carrillo FB, 2019, J VIROL, V93, DOI 10.1128/JVI.01622-18
   CAUSEY OR, 1957, AM J TROP MED HYG, V6, P1017, DOI 10.4269/ajtmh.1957.6.1017
   Chan EH, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001206
   Cherian SS, 2009, INFECT GENET EVOL, V9, P16, DOI 10.1016/j.meegid.2008.09.004
   Cunha MD, 2017, J CLIN VIROL, V97, P44, DOI 10.1016/j.jcv.2017.10.015
   Cunha RV, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005319
   da Costa AC, 2017, EMERG INFECT DIS, V23, P1742, DOI 10.3201/eid2310.170307
   da Costa VG, 2017, INT J INFECT DIS, V62, P84, DOI 10.1016/j.ijid.2017.07.016
   da Silva NM, 2018, EPIDEMIOL SERV SAUDE, V27, DOI [10.5123/S1679-49742018000300003, 10.5123/s1679-49742018000300003]
   Vieira CJDP, 2015, ACTA TROP, V147, P12, DOI 10.1016/j.actatropica.2015.03.020
   Tanabe ELD, 2018, REV INST MED TROP SP, V60, DOI [10.1590/S1678-9946201860019, 10.1590/s1678-9946201860019]
   Del Valle SY, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3124-7
   Dias JP, 2018, EMERG INFECT DIS, V24, P617, DOI 10.3201/eid2404.171370
   Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI 10.1093/molbev/msi103
   Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088
   Faria NR, 2018, SCIENCE, V361, P894, DOI 10.1126/science.aat7115
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Faria NR, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15152-8
   Freitas Andre Ricardo Ribas, 2017, PLoS Curr, V9, DOI 10.1371/currents.outbreaks.14608e586cd321d8d5088652d7a0d884
   Gill MS, 2013, MOL BIOL EVOL, V30, P713, DOI 10.1093/molbev/mss265
   Mourao MPG, 2012, VECTOR-BORNE ZOONOT, V12, P42, DOI 10.1089/vbz.2011.0669
   Grubaugh ND, 2018, CELL, V172, P1160, DOI 10.1016/j.cell.2018.02.027
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Lanciotti RS, 2007, EMERG INFECT DIS, V13, P764, DOI 10.3201/eid1305.070015
   LEDUC JW, 1981, AM J TROP MED HYG, V30, P682, DOI 10.4269/ajtmh.1981.30.682
   Lourenco Jose, 2018, PLoS Curr, V10, DOI 10.1371/currents.outbreaks.19433b1e4d007451c691f138e1e67e8c
   Lourenco J, 2017, ELIFE, V6, DOI [10.7554/elife.29820, 10.7554/eLife.29820]
   Mavian C, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07152-5
   Minin VN, 2008, MOL BIOL EVOL, V25, P1459, DOI 10.1093/molbev/msn090
   Figueiredo LTM, 2017, REV SOC BRAS MED TRO, V50, P583, DOI 10.1590/0037-8682-0397-2017
   Naveca FG, 2017, MEM I OSWALDO CRUZ, V112, P510, DOI 10.1590/0074-02760160062
   Nunes MRT, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002769
   Obolski U, 2018, MVSE R PACKAGE ESTIM, DOI [10.1101/360701, DOI 10.1101/360701]
   Olival KJ, 2017, NATURE, V546, P646, DOI 10.1038/nature22975
   Organization PAWH, 2017, NUMB REP CAS CHIK FE
   Pauvolid-Correa A, 2015, MEM I OSWALDO CRUZ, V110, P125, DOI 10.1590/0074-02760140383
   Pessoa R, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003201
   Powers AM, 2001, J VIROL, V75, P10118, DOI 10.1128/JVI.75.21.10118-10131.2001
   Quick J, 2017, NAT PROTOC, V12, P1261, DOI 10.1038/nprot.2017.066
   Receveur M. C., 2010, EUROSURVEILLANCE, V15, P18
   Robinson M, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003120
   Sahadeo NSD, 2017, VIRUS EVOL, V3, DOI 10.1093/ve/vex010
   Salje H, 2016, P NATL ACAD SCI USA, V113, P13420, DOI 10.1073/pnas.1611391113
   Salje H, 2016, J INFECT DIS, V213, P604, DOI 10.1093/infdis/jiv470
   Sardi SI, 2016, J CLIN MICROBIOL, V54, P2348, DOI 10.1128/JCM.00877-16
   Serra OP, 2016, MEM I OSWALDO CRUZ, V111, P20, DOI 10.1590/0074-02760150270
   Silva MMO, 2016, EMERG INFECT DIS, V22, P336, DOI 10.3201/eid2202.150495
   Sissoko D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003066
   Souza TM, 2017, PLOS CURRENTS, V9, DOI [10.1371/currents.outbreaks.4200119978d62ccaa454599cd2735727, DOI 10.1371/CURRENTS.OUTBREAKS.4200119978D62CCAA454599CD27357]
   Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033
   Staples JE, 2009, CLIN INFECT DIS, V49, P942, DOI 10.1086/605496
   Suchard MA, 2018, VIRUS EVOL, V4, DOI 10.1093/ve/vey016
   Team RC, 2014, R LANG ENV COMP
   Nunes MRT, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0348-x
   Nunes MRT, 2012, EMERG INFECT DIS, V18, P1858, DOI 10.3201/eid1811.120217
   Teng Y, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0165085
   Tsetsarkin KA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006835
   Van Benthem BHB, 2005, AM J TROP MED HYG, V72, P201, DOI 10.4269/ajtmh.2005.72.201
   Vasconcelos PFC, 1992, CIENC CULT-SAO PAULO, V43, P117
   Volk SM, 2010, J VIROL, V84, P6497, DOI 10.1128/JVI.01603-09
   Weiss DJ, 2018, NATURE, V553, P333, DOI 10.1038/nature25181
   White SK, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196857
   Zuchi N, 2014, MEM I OSWALDO CRUZ, V109, P820, DOI 10.1590/0074-0276140108
NR 79
TC 13
Z9 13
U1 0
U2 3
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD MAR
PY 2019
VL 13
IS 3
AR e0007065
DI 10.1371/journal.pntd.0007065
PG 21
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA HS3YU
UT WOS:000463799300007
PM 30845267
OA DOAJ Gold, Green Published
DA 2020-10-22
ER

PT J
AU Colizzi, V
   Mezzana, D
   Ovseiko, PV
   Caiati, G
   Colonnello, C
   Declich, A
   Buchan, AM
   Edmunds, L
   Buzan, E
   Zerbini, L
   Djilianov, D
   Schmidt, EK
   Bielawski, KP
   Elster, D
   Solvato, M
   Alcantara, LC
   Minutolo, A
   Potesta, M
   Bachiddu, E
   Milano, MJ
   Henderson, LR
   Kiparoglou, V
   Friesen, P
   Sheehan, M
   Moyankova, D
   Rusanov, K
   Wium, M
   Raszczyk, I
   Konieczny, I
   Gwizdala, JP
   Sledzik, K
   Barendziak, T
   Birkholz, J
   Muller, N
   Warrelmann, J
   Meyer, U
   Filser, J
   Barreto, FK
   Montesano, C
AF Colizzi, Vittorio
   Mezzana, Daniele
   Ovseiko, Pavel, V
   Caiati, Giovanni
   Colonnello, Claudia
   Declich, Andrea
   Buchan, Alastair M.
   Edmunds, Laurel
   Buzan, Elena
   Zerbini, Luiz
   Djilianov, Dimitar
   Schmidt, Evanthia Kalpazidou
   Bielawski, Krzysztof P.
   Elster, Doris
   Solvato, Maria
   Alcantara, Luiz C., Jr.
   Minutolo, Antonella
   Potesta, Marina
   Bachiddu, Elena
   Milano, Maria J.
   Henderson, Lorna R.
   Kiparoglou, Vasiliki
   Friesen, Phoebe
   Sheehan, Mark
   Moyankova, Daniela
   Rusanov, Krasimir
   Wium, Martha
   Raszczyk, Izabela
   Konieczny, Igor
   Gwizdala, Jerzy P.
   Sledzik, Karol
   Barendziak, Tanja
   Birkholz, Julia
   Mueller, Nicklas
   Warrelmann, Juergen
   Meyer, Ute
   Filser, Juliane
   Barreto, Fernando Khouri
   Montesano, Carla
TI Structural Transformation to Attain Responsible BIOSciences (STARBIOS2):
   Protocol for a Horizon 2020 Funded European Multicenter Project to
   Promote Responsible Research and Innovation
SO JMIR RESEARCH PROTOCOLS
LA English
DT Article
DE action plans; ethics; gender; guidelines; Horizon 2020; institutional
   change; model for RRI in biosciences; open access; patient involvement;
   public engagement; responsible research and innovation; structural
   change; science education; science with and for Society
ID GENDER; SCIENCE; WOMEN
AB Background: Promoting Responsible Research and Innovation (RRI) is a major strategy of the "Science with and for Society" work program of the European Union's Horizon 2020 Framework Programme for Research and Innovation. RRI aims to achieve a better alignment of research and innovation with the values, needs, and expectations of society. The RRI strategy includes the "keys" of public engagement, open access, gender, ethics, and science education. The Structural Transformation to Attain Responsible BIOSciences (STARBIOS2) project promotes RRI in 6 European research institutions and universities from Bulgaria, Germany, Italy, Slovenia, Poland, and the United Kingdom, in partnership with a further 6 institutions from Brazil, Denmark, Italy, South Africa, Sweden, and the United States.
   Objective: The project aims to attain RRI structural change in 6 European institutions by implementing action plans (APs) and developing APs for 3 non-European institutions active in the field of biosciences; use the implementation of APs as a learning process with a view to developing a set of guidelines on the implementation of RRI; and develop a sustainable model for RRI in biosciences.
   Methods: The project comprises interrelated research and implementation designed to achieve the aforementioned specific objectives. The project is organized into 6 core work packages and 5 supporting work packages. The core work packages deal with the implementation of institutional APs in 6 European institutions based on the structural change activation model. The supporting work packages include technical assistance, learning process on RRI-oriented structural change, monitoring and assessment, communication and dissemination, and project management.
   Results: The project is funded by Horizon 2020 and will run for 4 years (May 2016-April 2020). As of June 2018, the initial phase has been completed. The participating institutions have developed and approved APs and commenced their implementation. An observation tool has been launched by the Technical Assistance Team to collect information from the implementation of APs; the Evaluation & Assessment team has started monitoring the advancement of the project. As part of the communication and dissemination strategy, a project website, a Facebook page, and a Twitter account have been launched and are updated periodically. The International Scientific Advisory Committee has been formed to advise on the reporting and dissemination of the project's results.
   Conclusions: In the short term, we anticipate that the project will have a considerable impact on the organizational processes and structures, improving the RRI uptake in the participating institutions. In the medium term, we expect to make RRI-oriented organizational change scalable across Europe by developing guidelines on RRI implementation and an RRI model in biosciences. In the long term, we expect that the project would help increase the ability of research institutions to make discoveries and innovations in better alignment with societal needs and values.
C1 [Colizzi, Vittorio; Mezzana, Daniele; Declich, Andrea; Minutolo, Antonella; Potesta, Marina; Montesano, Carla] Univ Roma Tor Vergata, Dept Biol, Via Ric Sci 1, I-00133 Rome, Italy.
   [Ovseiko, Pavel, V; Buchan, Alastair M.; Edmunds, Laurel; Milano, Maria J.] Univ Oxford, Radcliffe Dept Med, Oxford, England.
   [Caiati, Giovanni; Colonnello, Claudia] Lab Sci Cittadinanza, Rome, Italy.
   [Buzan, Elena] Univ Primorska, Dept Biodivers, Koper, Slovenia.
   [Zerbini, Luiz; Wium, Martha] Int Ctr Genet Engn & Biotechnol, Cape Town, South Africa.
   [Djilianov, Dimitar; Moyankova, Daniela; Rusanov, Krasimir] Agricultural Acad, Agrobioinst, Sofia, Bulgaria.
   [Schmidt, Evanthia Kalpazidou] Univ Aarhus, Danish Ctr Studies Res & Res Policy, Aarhus, Denmark.
   [Bielawski, Krzysztof P.; Raszczyk, Izabela; Konieczny, Igor] Univ Gdansk, Intercollegiate Fac Biotechnol, Gdansk, Poland.
   [Bielawski, Krzysztof P.; Raszczyk, Izabela; Konieczny, Igor] Med Univ Gdansk, Gdansk, Poland.
   [Elster, Doris; Barendziak, Tanja; Birkholz, Julia; Mueller, Nicklas; Warrelmann, Juergen; Meyer, Ute; Filser, Juliane] Univ Bremen, Fac Biol & Chem, Bremen, Germany.
   [Solvato, Maria] Univ Syst Maryland, Baltimore, MD USA.
   [Alcantara, Luiz C., Jr.; Barreto, Fernando Khouri] Fundacao Oswaldo Cruz, Rio De Janeiro, Brazil.
   [Bachiddu, Elena] Univ Roma Tor Vergata, Dept Hist Humanities & Soc, Rome, Italy.
   [Henderson, Lorna R.; Kiparoglou, Vasiliki] Oxford Univ Hosp Natl Hlth Serv Fdn Trust, Oxford, England.
   [Friesen, Phoebe; Sheehan, Mark] Univ Oxford, Nuffield Dept Populat Hlth, Oxford, England.
   [Gwizdala, Jerzy P.; Sledzik, Karol] Univ Gdansk, Fac Management, Gdansk, Poland.
RP Colizzi, V (corresponding author), Univ Roma Tor Vergata, Dept Biol, Via Ric Sci 1, I-00133 Rome, Italy.
EM colizzi@bio.uniroma2.it
RI Doris, Elster/AAU-5243-2020; Moyankova, Daniela P/K-8289-2013; Ovseiko,
   Pavel V/E-1824-2013; MINUTOLO, ANTONELLA/AAA-1788-2020; Zerbini,
   Luiz/B-7720-2015; Buchan, Alastair/B-9095-2009
OI Doris, Elster/0000-0003-2648-3832; Moyankova, Daniela
   P/0000-0003-4020-1918; Ovseiko, Pavel V/0000-0002-3504-2177; Zerbini,
   Luiz/0000-0003-0736-9508; Mezzana, Daniele/0000-0002-5409-8897;
   Alcantara, Luiz/0000-0002-6769-9931; Buchan,
   Alastair/0000-0002-2918-5200; Buzan, Elena/0000-0003-0714-5301;
   minutolo, antonella/0000-0003-4784-4297; Bielawski, Krzysztof
   Piotr/0000-0002-5812-6314; Wium, Martha/0000-0003-0527-1750
FU European UnionEuropean Union (EU) [709517]; National Institute for
   Health Oxford Biomedical Research Centre [BRC-1215-20008]; University of
   Oxford
FX This project has received funding from the European Union's Horizon 2020
   research and innovation program under grant agreement No. 709517.; PVO,
   LE, VK, LRH, MJM, PF, and MS are also supported by the National
   Institute for Health Oxford Biomedical Research Centre, grant
   BRC-1215-20008 to the Oxford University Hospitals NHS Foundation Trust
   and the University of Oxford. We gratefully acknowledge Josepine Fernow
   and Anna Holm (Uppsala University) for their expert assistance with
   graphic design.
CR Archer M, 1995, REALIST SOCIAL THEOR
   Berger P. L., 1966, SOCIAL CONSTRUCTION
   Bijker W. E., 2009, HDB SOCIALISATION SC
   Burget M, 2017, SCI ENG ETHICS, V23, P1, DOI 10.1007/s11948-016-9782-1
   Cacace M, 2018, ACCOMPANYING RES IMP
   DAndrea Luciano, 2005, J SCI COMMUNICATION, V4, P1
   Directorate-General for Research and Innovation (European Commission). Structural change in research institutions, 2012, STRUCT CHANG RES I E
   Douglas Conor M W, 2013, Syst Synth Biol, V7, P139, DOI 10.1007/s11693-013-9119-1
   Downs J.B., 2016, J COMMER BIOTECHNOL, V22, P19, DOI DOI 10.5912/JCB735
   European Commission, BRUSS RESP RES INN
   European Commission, 2014, RESP RES INN EUR AB
   European Commission, RESP RES INN
   European Commission. Luxembourg: Publications Office of the European Union, 2013, 25766 EUR EUR COMM
   Giddens Anthony, 1984, CONSTITUTION SOC OUT
   GREAT, 2013, ANN REP MAIN TRENDS
   Guston D. H., 2004, BUYING SELLING OUT C, P161
   Hasebrook J, 2017, JMIR RES PROTOC, V6, DOI 10.2196/resprot.7632
   Hellstrom T, 2003, TECHNOL SOC, V25, P369, DOI DOI 10.1016/S0160-791X(03)00041-1
   Kalpazidou Schmidt E., 2006, EVID POLICY, V2, P185, DOI [10.1332/174426406777068948, DOI 10.1332/174426406777068948]
   Kuhlmann E, 2017, HUM RESOUR HEALTH, V15, DOI 10.1186/s12960-016-0175-y
   Mezzana D., 2011, TECHNOLOGICAL RESPON
   Ovseiko PV, 2017, HEALTH RES POLICY SY, V15, DOI 10.1186/s12961-017-0177-9
   Ovseiko PV, 2016, HEALTH RES POLICY SY, V14, DOI 10.1186/s12961-016-0126-z
   Ovseiko PV, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-009022
   Owen R, 2009, ENVIRON SCI TECHNOL, V43, P6902, DOI 10.1021/es803332u
   Ribeiro BE, 2017, SCI ENG ETHICS, V23, P81, DOI 10.1007/s11948-016-9761-6
   Schmidt EK, 2019, SCI PUBL POLICY, V46, P321, DOI 10.1093/scipol/scy059
   Schmidt EK, 2017, RES EVALUAT, V26, P102, DOI 10.1093/reseval/rvx003
   Smart J. C., 2008, HIGHER ED HDB THEORY, V23, P73
   Stahl BC, 2014, TECHNOL FORECAST SOC, V84, P74, DOI 10.1016/j.techfore.2013.08.001
   STARBIOS2, 2018, PROJ TWITT ACC
   van den Brink M, 2012, ORGANIZATION, V19, P507, DOI 10.1177/1350508411414293
   von Schomberg R., 2011, RESPONSIBLE RES INNO, P7, DOI DOI 10.2777/58723
NR 33
TC 2
Z9 2
U1 1
U2 7
PU JMIR PUBLICATIONS, INC
PI TORONTO
PA 59 WINNERS CIRCLE, TORONTO, ON M4L 3Y7, CANADA
SN 1929-0748
J9 JMIR RES PROTOC
JI JMIR RES. Protoc.
PD MAR
PY 2019
VL 8
IS 3
AR e11745
DI 10.2196/11745
PG 11
WC Health Care Sciences & Services
SC Health Care Sciences & Services
GA HR1KE
UT WOS:000462890300021
PM 30843870
OA DOAJ Gold, Green Published
DA 2020-10-22
ER

PT J
AU de Almeida, BL
   Giovanetti, M
   Oliveira, JV
   Xavier, TC
   Figueiredo, EM
   Goes, JJ
   Alcantara, LC
   de Siqueira, IC
AF de Almeida, Breno L.
   Giovanetti, Marta
   Oliveira, Joao V.
   Xavier, Tereza C.
   Figueiredo, Eduardo M.
   Goes, Jaqueline J.
   Alcantara, Luiz C.
   de Siqueira, Isadora C.
TI DETECTION AND SEQUENCING OF ZIKA VIRUS IN NORMOCEPHALIC NEWBORNS WITH
   CONGENITAL ZIKA IN FECTION
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 68th Annual Meeting of the
   American-Society-for-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 20-24, 2019
CL National Harbor, MD
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Bavarian Nord, GSK, Takeda, Integrum Sci, Celgene, Vulcan, Plos Neglected Trop Dis, Elsevier
C1 [de Almeida, Breno L.; Giovanetti, Marta; Oliveira, Joao V.; Goes, Jaqueline J.; Alcantara, Luiz C.; de Siqueira, Isadora C.] Fundacao Oswaldo Cruz Fiocruz, Salvador, BA, Brazil.
   [Xavier, Tereza C.] Maternidade Referencia Prof Jose Maria de Maglhae, Salvador, BA, Brazil.
   [Figueiredo, Eduardo M.] Maternidade Referencia Prof Jose Maria de Magalha, Salvador, BA, Brazil.
RI de Siqueira, Isadora Cristina/R-9953-2016; Giovanetti,
   Marta/AAK-7408-2020
OI de Siqueira, Isadora Cristina/0000-0002-2520-4099; 
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2019
VL 101
SU 5
MA 209
BP 63
EP 63
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA KC7PF
UT WOS:000507364502209
DA 2020-10-22
ER

PT J
AU Cuypers, L
   Libin, PJK
   Simmonds, P
   Nowe, A
   Munoz-Jordan, J
   Alcantara, LCJ
   Vandamme, AM
   Santiago, GA
   Theys, K
AF Cuypers, Lize
   Libin, Pieter J. K.
   Simmonds, Peter
   Nowe, Ann
   Munoz-Jordan, Jorge
   Junior Alcantara, Luiz Carlos
   Vandamme, Anne-Mieke
   Santiago, Gilberto A.
   Theys, Kristof
TI Time to Harmonize Dengue Nomenclature and Classification
SO VIRUSES-BASEL
LA English
DT Article
DE dengue virus; classification; nomenclature; diversity
ID VIRUS EVOLUTION; VIRULENCE; TRANSMISSION; BURDEN; TYPE-1
AB Dengue virus (DENV) is estimated to cause 390 million infections per year worldwide. A quarter of these infections manifest clinically and are associated with a morbidity and mortality that put a significant burden on the affected regions. Reports of increased frequency, intensity, and extended geographical range of outbreaks highlight the virus's ongoing global spread. Persistent transmission in endemic areas and the emergence in territories formerly devoid of transmission have shaped DENV's current genetic diversity and divergence. This genetic layout is hierarchically organized in serotypes, genotypes, and sub-genotypic clades. While serotypes are well defined, the genotype nomenclature and classification system lack consistency, which complicates a broader analysis of their clinical and epidemiological characteristics. We identify five key challenges: (1) Currently, there is no formal definition of a DENV genotype; (2) Two different nomenclature systems are used in parallel, which causes significant confusion; (3) A standardized classification procedure is lacking so far; (4) No formal definition of sub-genotypic clades is in place; (5) There is no consensus on how to report antigenic diversity. Therefore, we believe that the time is right to re-evaluate DENV genetic diversity in an essential effort to provide harmonization across DENV studies.
C1 [Cuypers, Lize; Libin, Pieter J. K.; Vandamme, Anne-Mieke; Theys, Kristof] Katholieke Univ Leuven, Rega Inst Med Res Clin & Epidemiol Virol, Dept Microbiol & Immunol, B-3000 Louvain, Belgium.
   [Cuypers, Lize; Simmonds, Peter] Univ Oxford, Nuffield Dept Med, Oxford OX1 3SY, England.
   [Libin, Pieter J. K.; Nowe, Ann] Vrije Univ Brussel, Dept Comp Sci, Artificial Intelligence Lab, B-1050 Brussels, Belgium.
   [Munoz-Jordan, Jorge; Santiago, Gilberto A.] Ctr Dis Control & Prevent, Dengue Branch, Div Vector Borne Dis, San Juan, PR 00920 USA.
   [Junior Alcantara, Luiz Carlos] Fiocruz MS, Inst Oswaldo Cruz, Lab Flavivirus, BR-21040360 Rio De Janeiro, Brazil.
   [Vandamme, Anne-Mieke] Univ Nova Lisboa, Inst Higiene & Med Trop, Unidade Microbiol, Global Hlth & Trop Med, P-1349008 Lisbon, Portugal.
RP Theys, K (corresponding author), Katholieke Univ Leuven, Rega Inst Med Res Clin & Epidemiol Virol, Dept Microbiol & Immunol, B-3000 Louvain, Belgium.
EM lize.cuypers@kuleuven.be; pieter.libin@vub.ac.be;
   peter.simmonds@ndm.ox.ac.uk; ann.nowe@ai.vub.ac.be; jmunoz@cdc.gov;
   luiz.alcantara@ioc.fiocruz.br; annemie.vandamme@kuleuven.be;
   gsantiago@cdc.gov; kristof.theys@kuleuven.be
RI ; Cuypers, Lize/D-9460-2018; Theys, Kristof/D-9541-2018; Vandamme,
   Anne-Mieke/I-4127-2012
OI Alcantara, Luiz/0000-0002-6769-9931; Libin, Pieter/0000-0003-3906-758X;
   Simmonds, Peter/0000-0002-7964-4700; Nowe, Ann/0000-0001-6346-4564;
   Cuypers, Lize/0000-0002-9433-8752; Theys, Kristof/0000-0003-0242-7000;
   Vandamme, Anne-Mieke/0000-0002-6594-2766
FU FWO (Fonds Wetenschappelijk Onderzoek, Vlaanderen)FWO; VUB research
   council [VUB/OZR2714]; FWOFWO [PDO/11, V431117N]; European Union Horizon
   2020 research and innovation program [634650]; FWO Vlaanderen-Krediet
   aan Navorsers [KAN2017 1528217N]; Welcome TrustWellcome Trust
   [WT108418AIA]; Flemish Government, department EWI-FWO Krediet aan
   Navorsers [KAN2012 1.5.249.12]
FX Pieter Libin was supported by a PhD grant of the FWO (Fonds
   Wetenschappelijk Onderzoek, Vlaanderen) and a grant of the VUB research
   council (VUB/OZR2714). Kristof Theys was supported by a postdoctoral
   grant of the FWO (PDO/11). Lize Cuypers was supported by a travel grant
   for a long stay abroad from the FWO (V431117N). The VIROGENESIS project
   receives funding from the European Union Horizon 2020 research and
   innovation program under grant agreement No 634650. Part of this work
   was funded by the FWO Vlaanderen-Krediet aan Navorsers (Theys, KAN2017
   1528217N) and the Welcome Trust (Simmonds, WT108418AIA). The
   computational resources and services used in this work were provided by
   the Hercules Foundation and the Flemish Government, department EWI-FWO
   Krediet aan Navorsers (Theys, KAN2012 1.5.249.12.).
CR Afreen N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141628
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Carneiro AR, 2012, MEM I OSWALDO CRUZ, V107, P805, DOI 10.1590/S0074-02762012000600016
   de Melo FL, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000390
   Faria NR, 2018, SCIENCE, V361, P894, DOI 10.1126/science.aat7115
   Gyawali N, 2016, J VECTOR DIS, V53, P293
   Katzelnick LC, 2015, SCIENCE, V349, P1338, DOI 10.1126/science.aac5017
   Libin PJK, 2019, BIOINFORMATICS, V35, P1763, DOI 10.1093/bioinformatics/bty851
   Medlock JM, 2015, LANCET INFECT DIS, V15, P721, DOI 10.1016/S1473-3099(15)70091-5
   Messina JP, 2015, NAT REV MICROBIOL, V13, P230, DOI 10.1038/nrmicro3430
   Messina JP, 2014, TRENDS MICROBIOL, V22, P138, DOI 10.1016/j.tim.2013.12.011
   Murray Natasha Evelyn Anne, 2013, Clin Epidemiol, V5, P299, DOI 10.2147/CLEP.S34440
   Nunes MRT, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002769
   Pybus OG, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2878
   Ragonnet-Cronin M, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-317
   Revell LJ, 2008, SYST BIOL, V57, P591, DOI 10.1080/10635150802302427
   Rico-Hesse R, 2003, ADV VIRUS RES, V59, P315, DOI 10.1016/S0065-3527(03)59009-1
   Rico-Hesse R, 2010, CURR TOP MICROBIOL, V338, P45, DOI 10.1007/978-3-642-02215-9_4
   Rico-Hesse R, 2009, FUTURE VIROL, V4, P581, DOI 10.2217/FVL.09.51
   RICOHESSE R, 1990, VIROLOGY, V174, P479, DOI 10.1016/0042-6822(90)90102-W
   Santiago GA, 2012, J INFECT DIS, V206, P893, DOI 10.1093/infdis/jis426
   Shepard DS, 2016, LANCET INFECT DIS, V16, P935, DOI 10.1016/S1473-3099(16)00146-8
   Simmonds P, 2017, J GEN VIROL, V98, P2, DOI 10.1099/jgv.0.000672
   Trout A., 2010, Morbidity and Mortality Weekly Report, V59, P577
   Twiddy SS, 2003, MOL BIOL EVOL, V20, P122, DOI 10.1093/molbev/msg010
   Twiddy SS, 2002, VIROLOGY, V298, P63, DOI 10.1006/viro.2002.1447
NR 26
TC 3
Z9 3
U1 0
U2 1
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1999-4915
J9 VIRUSES-BASEL
JI Viruses-Basel
PD OCT
PY 2018
VL 10
IS 10
AR 569
DI 10.3390/v10100569
PG 7
WC Virology
SC Virology
GA GY7UL
UT WOS:000448821200057
PM 30340326
OA DOAJ Gold, Green Published
DA 2020-10-22
ER

PT J
AU do Rosario, MS
   Giovanetti, M
   de Jesus, PAP
   Farias, DS
   Faria, NR
   de Lima, CPS
   da Silva, SP
   Nunes, MR
   Alcantara, LC
   de Siqueira, IC
AF do Rosario, Mateus Santana
   Giovanetti, Marta
   Pereira de Jesus, Pedro Antonio
   Farias, Daniel Santana
   Faria, Nuno R.
   de Lima, Clayton Pereira S.
   da Silva, Sandro Patroca
   Nunes, Marcio Roberto
   Junior Alcantara, Luiz Carlos
   de Siqueira, Isadora Cristina
TI Opsoclonus-myoclonus-ataxia syndrome associated with chikungunya and
   dengue virus co-infection
SO INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
LA English
DT Article
DE Opsoclonus; Chikungunya; Dengue
ID NEUROLOGICAL MANIFESTATIONS; INFECTION; DIAGNOSIS
AB Opsoclonus-myoclonus-ataxia syndrome (OMAS) is a rare neurological disorder characterized by irregular multidirectional eye movements, myoclonus, cerebellar ataxia, sleep disturbances, and cognitive dysfunction. Although most commonly related to paraneoplastic syndrome, this condition has occasionally been described following infectious illnesses. This article reports the first case of OMAS in association with chikungunya and dengue virus co-infection. The genetic analysis identified chikungunya virus of East/Central/South African genotype and dengue serotype 4 virus of genotype II. This report represents an unusual clinical syndrome associated with viral co-infection and reinforces the need for clinical vigilance with regard to neurological syndromes in the context of emergent arboviruses. (c) 2018 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
C1 [do Rosario, Mateus Santana; Giovanetti, Marta; Junior Alcantara, Luiz Carlos; de Siqueira, Isadora Cristina] Fundacao Oswaldo Cruz, Minist Saude, Inst Goncalo Moniz, Salvador, BA, Brazil.
   [do Rosario, Mateus Santana; Pereira de Jesus, Pedro Antonio; Farias, Daniel Santana] Hosp Geral Roberto Santos, Secretaria Estadual Saude Bahia, Salvador, BA, Brazil.
   [Giovanetti, Marta] Univ Roma Tor Vergata, Rome, Italy.
   [Pereira de Jesus, Pedro Antonio] Univ Fed Bahia, Fac Med, Salvador, BA, Brazil.
   [Faria, Nuno R.] Univ Oxford, Dept Zool, Oxford, England.
   [de Lima, Clayton Pereira S.; da Silva, Sandro Patroca; Nunes, Marcio Roberto] Inst Evandro Chagas, Ctr Tecnol & Inovacao, Ananindeua, Para, Brazil.
RP de Siqueira, IC (corresponding author), Fundacao Oswaldo Cruz, Inst Goncalo Moniz, R Waldemar Falcao 121, BR-40296710 Salvador, BA, Brazil.
EM isadora.siqueira@bahia.fiocruz.br
RI Faria, Nuno R/I-2975-2012; Giovanetti, Marta/AAK-7408-2020; de Siqueira,
   Isadora Cristina/R-9953-2016
OI Faria, Nuno R/0000-0001-8839-2798; de Siqueira, Isadora
   Cristina/0000-0002-2520-4099; Alcantara, Luiz/0000-0002-6769-9931; do
   Rosario, Mateus/0000-0001-7404-6392; Jesus, Pedro
   Antonio/0000-0003-1211-2272
FU CNPq-National Council for Scientific and Technological
   DevelopmentNational Council for Scientific and Technological Development
   (CNPq) [302584/2015-3]; MCTI-Ministry of Science, Technology,
   Innovation/FINEP-Funding Authority for Studies and
   Projects/FNDCT-National Fund for the Development of Science and
   Technology [04160060-00/2016]
FX CNPq-National Council for Scientific and Technological Development
   (302584/2015-3) and MCTI-Ministry of Science, Technology,
   Innovation/FINEP-Funding Authority for Studies and
   Projects/FNDCT-National Fund for the Development of Science and
   Technology (04160060-00/2016)
CR Bintner M, 2015, NEUROLOGY, P2005
   Blaes F, 2008, J NEUROIMMUNOL, V201, P221, DOI 10.1016/j.jneuroim.2008.05.033
   Cao-Lormeau V. M., 2016, LANCET
   Chiam CW, 2013, DIAGN MICR INFEC DIS, V77, P133, DOI 10.1016/j.diagmicrobio.2013.06.018
   do Rosario MS, 2016, AM J TROP MED HYG, V95, P1157, DOI 10.4269/ajtmh.16-0306
   Furuya-Kanamori L, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1417-2
   Giovanetti M, 2016, INFECT GENET EVOL, V41, P142, DOI 10.1016/j.meegid.2016.03.030
   Gorman MP, 2010, CURR OPIN PEDIATR, V22, P745, DOI 10.1097/MOP.0b013e32833fde3f
   Johnson BW, 2005, J CLIN MICROBIOL, V43, P4977, DOI 10.1128/JCM.43.10.4977-4983.2005
   NIMMANNITYA S, 1969, AM J TROP MED HYG, V18, P954, DOI 10.4269/ajtmh.1969.18.954
   Solomon T, 2000, LANCET, V355, P1053, DOI 10.1016/S0140-6736(00)02036-5
   Tan AH, 2014, PARKINSONISM RELAT D, V20, P1309, DOI 10.1016/j.parkreldis.2014.09.002
   Nunes MRT, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0348-x
   Nunes MRT, 2012, EMERG INFECT DIS, V18, P1858, DOI 10.3201/eid1811.120217
   Verma R, 2014, J NEUROL SCI, V346, P26, DOI 10.1016/j.jns.2014.08.044
NR 15
TC 2
Z9 2
U1 0
U2 2
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1201-9712
EI 1878-3511
J9 INT J INFECT DIS
JI Int. J. Infect. Dis.
PD OCT
PY 2018
VL 75
BP 11
EP 14
DI 10.1016/j.ijid.2018.07.019
PG 4
WC Infectious Diseases
SC Infectious Diseases
GA GV6IS
UT WOS:000446213000003
PM 30076990
OA DOAJ Gold
DA 2020-10-22
ER

PT J
AU Giovanetti, M
   de Jesus, JG
   de Maia, ML
   Junior, JX
   Amarante, MFC
   Viana, P
   Barreto, FK
   de Cerqueira, EM
   Santos, NP
   Falcao, MB
   Costa, MCM
   Faical, AVB
   de Melo, ALA
   Amorim, LS
   de Siqueira, IC
   Macarenhas, DL
   de Filippis, AMB
   Faria, NR
   Acosta, AX
   Alcantara, LCJ
AF Giovanetti, M.
   Goes de Jesus, J.
   Lima de Maia, M.
   Junior, J. X.
   Castro Amarante, M. F.
   Viana, P.
   Khouri Barreto, F.
   de Cerqueira, E. M.
   Pedreira Santos, N.
   Barreto Falcao, M.
   Machado Costa, M. C.
   Barros Faical, A. V.
   Andrade de Melo, A. L.
   Santos Amorim, L.
   de Siqueira, I. C.
   Macarenhas, D. L.
   Bispo de Filippis, A. M.
   Faria, N. Rodrigues
   Xavier Acosta, A.
   Junior Alcantara, L. C.
TI Genetic evidence of Zika virus in mother's breast milk and body fluids
   of a newborn with severe congenital defects
SO CLINICAL MICROBIOLOGY AND INFECTION
LA English
DT Letter
C1 [Giovanetti, M.; Goes de Jesus, J.; Junior, J. X.; Castro Amarante, M. F.; Viana, P.; Khouri Barreto, F.; Santos Amorim, L.; Junior Alcantara, L. C.] Inst Goncalo Moniz Salvador, Lab Patol Expt, Salvador, BA, Brazil.
   [Giovanetti, M.; Bispo de Filippis, A. M.; Junior Alcantara, L. C.] Fiocruz MS, Lab Flavivirus, Inst Oswaldo Cruz, Rio De Janeiro, Brazil.
   [Lima de Maia, M.; de Cerqueira, E. M.] Univ Estadual Feira de Santana, Salvador, BA, Brazil.
   [Lima de Maia, M.; Pedreira Santos, N.; Barreto Falcao, M.; Machado Costa, M. C.; Andrade de Melo, A. L.; Macarenhas, D. L.] Secretaria Saude Feira Santana, Salvador, BA, Brazil.
   [Barreto Falcao, M.; Xavier Acosta, A.] Univ Fed Bahia, Salvador, BA, Brazil.
   [Faria, N. Rodrigues] Univ Oxford, Dept Zool, Oxford, England.
RP Alcantara, LCJ (corresponding author), Fiocruz MS, Fundac Oswaldo Cruz, Rio De Janeiro, Brazil.
EM lalcan@bahia.fiocruz.br
RI Giovanetti, Marta/AAK-7408-2020; Faria, Nuno R/I-2975-2012; de Siqueira,
   Isadora Cristina/R-9953-2016
OI Faria, Nuno R/0000-0001-8839-2798; de Siqueira, Isadora
   Cristina/0000-0002-2520-4099; Xavier, Joilson/0000-0003-3916-2018;
   Alcantara, Luiz/0000-0002-6769-9931
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior
   (CAPES)CAPES
FX Supported by Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico (CNPq) and the Coordenacao de Aperfeicoamento de Pessoal de
   Nivel Superior (CAPES). All authors report no conflicts of interest
   relevant to this article.
CR de Oliveira WK, 2017, LANCET, V390, P861, DOI 10.1016/S0140-6736(17)31368-5
   Dupont-Rouzeyrol M, 2016, LANCET LOND ENGL, V387, P1051
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Sotelo JR, 2017, EMERG INFECT DIS, V23, P854, DOI 10.3201/eid2305.161538
   Villar J, 2014, LANCET, V384, P857, DOI 10.1016/S0140-6736(14)60932-6
NR 5
TC 6
Z9 6
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1198-743X
EI 1469-0691
J9 CLIN MICROBIOL INFEC
JI Clin. Microbiol. Infect.
PD OCT
PY 2018
VL 24
IS 10
BP 1111
EP 1112
DI 10.1016/j.cmi.2018.06.008
PG 2
WC Infectious Diseases; Microbiology
SC Infectious Diseases; Microbiology
GA GU0EY
UT WOS:000444923000026
PM 29906587
OA Bronze
DA 2020-10-22
ER

PT J
AU Faria, NR
   Kraemer, MUG
   Hill, SC
   de Jesus, JG
   Aguiar, RS
   Iani, FCM
   Xavier, J
   Quick, J
   du Plessis, L
   Dellicour, S
   Theze, J
   Carvalho, RDO
   Baele, G
   Wu, CH
   Silveira, PP
   Arruda, MB
   Pereira, MA
   Pereira, GC
   Lourenco, J
   Obolski, U
   Abade, L
   Vasylyeva, TI
   Giovanetti, M
   Yi, D
   Weiss, DJ
   Wint, GRW
   Shearer, FM
   Funk, S
   Nikolay, B
   Fonseca, V
   Adelino, TER
   Oliveira, MAA
   Silva, MVF
   Sacchetto, L
   Figueiredo, PO
   Rezende, IM
   Mello, EM
   Said, RFC
   Santos, DA
   Ferraz, ML
   Brito, MG
   Santana, LF
   Menezes, MT
   Brindeiro, RM
   Tanuri, A
   dos Santos, FCP
   Cunha, MS
   Nogueira, JS
   Rocco, IM
   da Costa, AC
   Komninakis, SCV
   Azevedo, V
   Chieppe, AO
   Araujo, ESM
   Mendonca, MCL
   dos Santos, CC
   dos Santos, CD
   Mares-Guia, AM
   Nogueira, RMR
   Sequeira, PC
   Abreu, RG
   Garcia, MHO
   Abreu, AL
   Okumoto, O
   Kroon, EG
   de Albuquerque, CFC
   Lewandowski, K
   Pullan, ST
   Carroll, M
   de Oliveira, T
   Sabino, EC
   Souza, RP
   Suchard, MA
   Lemey, P
   Trindade, GS
   Drumond, BP
   Filippis, AMB
   Loman, NJ
   Cauchemez, S
   Alcantara, LCJ
   Pybus, OG
AF Faria, N. R.
   Kraemer, M. U. G.
   Hill, S. C.
   de Jesus, J. Goes
   Aguiar, R. S.
   Iani, F. C. M.
   Xavier, J.
   Quick, J.
   du Plessis, L.
   Dellicour, S.
   Theze, J.
   Carvalho, R. D. O.
   Baele, G.
   Wu, C. -H.
   Silveira, P. P.
   Arruda, M. B.
   Pereira, M. A.
   Pereira, G. C.
   Lourenco, J.
   Obolski, U.
   Abade, L.
   Vasylyeva, T. I.
   Giovanetti, M.
   Yi, D.
   Weiss, D. J.
   Wint, G. R. W.
   Shearer, F. M.
   Funk, S.
   Nikolay, B.
   Fonseca, V.
   Adelino, T. E. R.
   Oliveira, M. A. A.
   Silva, M. V. F.
   Sacchetto, L.
   Figueiredo, P. O.
   Rezende, I. M.
   Mello, E. M.
   Said, R. F. C.
   Santos, D. A.
   Ferraz, M. L.
   Brito, M. G.
   Santana, L. F.
   Menezes, M. T.
   Brindeiro, R. M.
   Tanuri, A.
   dos Santos, F. C. P.
   Cunha, M. S.
   Nogueira, J. S.
   Rocco, I. M.
   da Costa, A. C.
   Komninakis, S. C. V.
   Azevedo, V.
   Chieppe, A. O.
   Araujo, E. S. M.
   Mendonca, M. C. L.
   dos Santos, C. C.
   dos Santos, C. D.
   Mares-Guia, A. M.
   Nogueira, R. M. R.
   Sequeira, P. C.
   Abreu, R. G.
   Garcia, M. H. O.
   Abreu, A. L.
   Okumoto, O.
   Kroon, E. G.
   de Albuquerque, C. F. C.
   Lewandowski, K.
   Pullan, S. T.
   Carroll, M.
   de Oliveira, T.
   Sabino, E. C.
   Souza, R. P.
   Suchard, M. A.
   Lemey, P.
   Trindade, G. S.
   Drumond, B. P.
   Filippis, A. M. B.
   Loman, N. J.
   Cauchemez, S.
   Alcantara, L. C. J.
   Pybus, O. G.
TI Genomic and epidemiological monitoring of yellow fever virus
   transmission potential
SO SCIENCE
LA English
DT Article
ID SPREAD; BRAZIL; ANGOLA
AB The yellow fever virus (YFV) epidemic in Brazil is the largest in decades. The recent discovery of YFV in Brazilian Aedes species mosquitos highlights a need to monitor the risk of reestablishment of urban YFV transmission in the Americas. We use a suite of epidemiological, spatial, and genomic approaches to characterize YFV transmission. We show that the age and sex distribution of human cases is characteristic of sylvatic transmission. Analysis of YFV cases combined with genomes generated locally reveals an early phase of sylvatic YFV transmission and spatial expansion toward previously YFV-free areas, followed by a rise in viral spillover to humans in late 2016. Our results establish a framework for monitoring YFV transmission in real time that will contribute to a global strategy to eliminate future YFV epidemics.
C1 [Faria, N. R.; Kraemer, M. U. G.; Hill, S. C.; du Plessis, L.; Theze, J.; Lourenco, J.; Obolski, U.; Abade, L.; Vasylyeva, T. I.; Wint, G. R. W.; Pybus, O. G.] Univ Oxford, Dept Zool, Oxford, England.
   [Kraemer, M. U. G.] Boston Childrens Hosp, Computat Epidemiol Lab, Boston, MA USA.
   [Kraemer, M. U. G.] Harvard Med Sch, Dept Pediat, Boston, MA USA.
   [de Jesus, J. Goes; Xavier, J.; Giovanetti, M.; Araujo, E. S. M.; Mendonca, M. C. L.; dos Santos, C. C.; dos Santos, C. D.; Mares-Guia, A. M.; Nogueira, R. M. R.; Sequeira, P. C.; de Oliveira, T.; Filippis, A. M. B.; Alcantara, L. C. J.] Fiocruz MS, Inst Oswaldo Cruz, Lab Flavivirus, Rio De Janeiro, Brazil.
   [Aguiar, R. S.; Silveira, P. P.; Arruda, M. B.; Menezes, M. T.; Brindeiro, R. M.; Tanuri, A.] Univ Fed Rio de Janeiro, Inst Biol, Dept Genet, Mol Virol Lab, Rio De Janeiro, Brazil.
   [Iani, F. C. M.; Pereira, M. A.; Pereira, G. C.; Adelino, T. E. R.; Oliveira, M. A. A.; Silva, M. V. F.] FUNED, Inst Octavio Magalhaes, Lab Cent Saude Publ, Belo Horizonte, MG, Brazil.
   [Iani, F. C. M.; Carvalho, R. D. O.; Giovanetti, M.; Fonseca, V.; Sacchetto, L.; Figueiredo, P. O.; Rezende, I. M.; Mello, E. M.; Azevedo, V.; Kroon, E. G.; Trindade, G. S.; Drumond, B. P.; Alcantara, L. C. J.] Univ Fed Minas Gerais, Inst Ciencias Biol, Belo Horizonte, MG, Brazil.
   [Quick, J.; Loman, N. J.] Univ Birmingham, Inst Microbiol & Infect, Birmingham, W Midlands, England.
   [Dellicour, S.; Baele, G.; Lemey, P.] Katholieke Univ Leuven, Dept Microbiol & Immunol, Rega Inst, Leuven, Belgium.
   [Wu, C. -H.] Univ Oxford, Dept Stat, Oxford, England.
   [Abade, L.] Univ Oxford, Global Hlth Network, Oxford, England.
   [Yi, D.] Harvard Univ, Dept Stat, Cambridge, MA 02138 USA.
   [Weiss, D. J.; Shearer, F. M.] Univ Oxford, Nuffield Dept Med, Big Data Inst, Malaria Atlas Project, Oxford, England.
   [Funk, S.] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London, England.
   [Nikolay, B.; Cauchemez, S.] Inst Pasteur, Math Modelling Infect Dis, Paris, France.
   [Nikolay, B.; Cauchemez, S.] Inst Pasteur, Ctr Bioinformat, Paris, France.
   [Nikolay, B.; Cauchemez, S.] Inst Pasteur, CNRS, Genom Evolut Modelisat & Sante UMR2000, Paris, France.
   [Fonseca, V.; de Oliveira, T.] Univ KwaZulu Natal, KwaZulu Natal Res Innovat & Sequencing Platform K, Sch Lab Med & Med Sci, Durban, South Africa.
   [Said, R. F. C.; Santos, D. A.; Ferraz, M. L.; Brito, M. G.; Santana, L. F.] Secretaria Estado Saude Minas Gerais, Belo Horizonte, MG, Brazil.
   [dos Santos, F. C. P.; Cunha, M. S.; Nogueira, J. S.; Rocco, I. M.; Souza, R. P.] Adolfo Lutz Inst, Nucleo Doencas Transmissao Vetorial, Sao Paulo, Brazil.
   [da Costa, A. C.; Sabino, E. C.] Univ Sao Paulo, Inst Trop Med, Sao Paulo, Brazil.
   [da Costa, A. C.; Sabino, E. C.] Univ Sao Paulo, Fac Med, Sao Paulo, Brazil.
   [Komninakis, S. C. V.] Univ Fed Sao Paulo, Retrovirol Lab, Sao Paulo, Brazil.
   [Komninakis, S. C. V.] Sch Med ABC FMABC, Clin Immunol Lab, Santo Andre, SP, Brazil.
   [Chieppe, A. O.] Coordenacao Vigilancia Epidemiol Estado Rio de Ja, Rio De Janeiro, Brazil.
   [Abreu, R. G.; Garcia, M. H. O.] Minist Saude, Dept Vigilancia Doencas Transmissiveis, Secretaria Vigilancia Saude, Brasilia, DF, Brazil.
   [Abreu, A. L.; Okumoto, O.] Minist Saude, Secretaria Vigilancia Saude, Coordenacao Geral Labs Saude Publ, Brasilia, DF, Brazil.
   [de Albuquerque, C. F. C.] OMS, OPAS, Brasilia, DF, Brazil.
   [Lewandowski, K.; Pullan, S. T.] Publ Hlth England, Natl Infect Serv, Salisbury, Wilts, England.
   [Carroll, M.] Publ Hlth England, NIHR HPRU Emerging & Zoonot Infect, London, England.
   [de Oliveira, T.] Ctr AIDS Programme Res South Africa CAPRISA, Durban, South Africa.
   [Suchard, M. A.] Univ Calif Los Angeles, Dept Biostat, Fielding Sch Publ Hlth, Los Angeles, CA USA.
   [Suchard, M. A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Biomath & Human Genet, Los Angeles, CA 90095 USA.
RP Faria, NR; Pybus, OG (corresponding author), Univ Oxford, Dept Zool, Oxford, England.; Alcantara, LCJ (corresponding author), Fiocruz MS, Inst Oswaldo Cruz, Lab Flavivirus, Rio De Janeiro, Brazil.; Alcantara, LCJ (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Belo Horizonte, MG, Brazil.
EM nuno.faria@zoo.ox.ac.uk; luiz.alcantara@ioc.fiocruz.br;
   oliver.pybus@zoo.ox.ac.uk
RI Azevedo, Vasco A.C/F-4315-2011; Sacchetto, Livia/B-8841-2019;
   Komninakis, Shirley V/B-2915-2010; Fonseca, Vagner/R-5813-2019; Faria,
   Nuno R/I-2975-2012; Giovanetti, Marta/AAK-7408-2020; Funk,
   Stefan/B-7629-2015; Azevedo, Vasco A/B-1556-2019; da-Costa, Antonio
   Charlys/G-1548-2010; Pybus, Oliver G/B-2640-2012; Rezende, Izabela
   Mauricio/AAL-5766-2020; Sabino, Ester Cerdeira/F-7750-2010; Dellicour,
   Simon/AAE-9054-2020; Loman, Nicholas/Z-1573-2019; Kroon,
   Erna/V-5444-2019; Aguiar, Renato S/G-3542-2015; Baele, Guy/R-8157-2017;
   du Plessis, Louis/K-1667-2013
OI Azevedo, Vasco A.C/0000-0002-4775-2280; Sacchetto,
   Livia/0000-0001-9716-6899; Komninakis, Shirley V/0000-0001-7784-3418;
   Fonseca, Vagner/0000-0001-5521-6448; Faria, Nuno R/0000-0001-8839-2798;
   Funk, Stefan/0000-0002-2012-0080; Azevedo, Vasco A/0000-0002-4775-2280;
   da-Costa, Antonio Charlys/0000-0001-5516-5177; Pybus, Oliver
   G/0000-0002-8797-2667; Rezende, Izabela Mauricio/0000-0003-2616-6300;
   Sabino, Ester Cerdeira/0000-0003-2623-5126; Dellicour,
   Simon/0000-0001-9558-1052; Aguiar, Renato S/0000-0001-5180-3717; Pullan,
   Steven/0000-0002-8983-599X; Vasylyeva, Tetyana/0000-0002-9736-7022;
   Theze, Julien/0000-0001-8188-9494; Wu, Chieh-Hsi/0000-0001-9386-725X;
   Alcantara, Luiz/0000-0002-6769-9931; Baele, Guy/0000-0002-1915-7732;
   Xavier, Joilson/0000-0003-3916-2018; De Jesus,
   Jaqueline/0000-0002-5404-272X; Carvalho, Rodrigo/0000-0003-0216-7173;
   Hill, Sarah/0000-0002-2995-2596; du Plessis, Louis/0000-0003-0352-6289;
   Pereira de Souza, Renato/0000-0003-1315-7085; Iani,
   Felipe/0000-0002-3629-8529; Funk, Sebastian/0000-0002-2842-3406
FU CNPqNational Council for Scientific and Technological Development (CNPq)
   [400354/2016-0]; FAPESPFundacao de Amparo a Pesquisa do Estado de Sao
   Paulo (FAPESP) [2016/01735-2, 2017/00021-9]; Sir Henry Dale Fellowship
   [204311/Z/16/Z]; internal GCRF grant [005073]; John Fell Research Fund
   [005166]; ERCEuropean Research Council (ERC) [614725-PATHPHYLODYN];
   Oxford Martin School; Branco Weiss Fellowship; National Institute of
   Child Health and Human DevelopmentUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USANIH Eunice
   Kennedy Shriver National Institute of Child Health & Human Development
   (NICHD) [T32HD040128]; National Library of Medicine of the National
   Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Library of
   Medicine (NLM) [R01LM010812, R01LM011965]; Fonds Wetenschappelijk
   Onderzoek (FWO, Flanders, Belgium)FWO; Interne Fondsen KU
   Leuven/Internal Funds KU Leuven; EU's Horizon 2020 Programme through
   ZIKAlliance [734548]; Investissement d'Avenir programFrench National
   Research Agency (ANR); Laboratoire d'Excellence Integrative Biology of
   Emerging Infectious Diseases program [ANR-10-LABX-62-IBEID]; Models of
   Infectious Disease Agent Study of the National Institute of General
   Medical Sciences; AXA Research Fund; Association Robert Debre; European
   Research CouncilEuropean Research Council (ERC) [725422-ReservoirDOCS];
   Wellcome TrustWellcome Trust [206298/Z/17/Z]; Research Foundation,
   Flanders (Fonds voor Wetenschappelijk Onderzoek, Vlaanderen)FWO
   [G066215N, G0D5117N, G0B9317N]
FX This work was supported in part by CNPq 400354/2016-0 and FAPESP
   2016/01735-2. N.R.F. is supported by a Sir Henry Dale Fellowship
   (204311/Z/16/Z), internal GCRF grant 005073, and John Fell Research Fund
   grant 005166. This research received funding from the ERC (grant
   agreement 614725-PATHPHYLODYN) and from the Oxford Martin School.
   M.U.G.K. acknowledges funding from a Branco Weiss Fellowship,
   administered by ETH Zurich, a Training Grant from the National Institute
   of Child Health and Human Development (T32HD040128), and the National
   Library of Medicine of the National Institutes of Health (R01LM010812
   and R01LM011965). S.D. is funded by the Fonds Wetenschappelijk Onderzoek
   (FWO, Flanders, Belgium). G.B. acknowledges support from the Interne
   Fondsen KU Leuven/Internal Funds KU Leuven. A.C.d.C. is funded by FAPESP
   2017/00021-9. B.B.N. and S.C. are supported by the EU's Horizon 2020
   Programme through ZIKAlliance (grant 734548), the Investissement
   d'Avenir program, the Laboratoire d'Excellence Integrative Biology of
   Emerging Infectious Diseases program (grant ANR-10-LABX-62-IBEID), the
   Models of Infectious Disease Agent Study of the National Institute of
   General Medical Sciences, the AXA Research Fund, and the Association
   Robert Debre. P.L. and M.A.S. acknowledge funding from the European
   Research Council (grant agreement 725422-ReservoirDOCS) and from the
   Wellcome Trust Collaborative Award 206298/Z/17/Z. P.L. acknowledges
   support from the Research Foundation, Flanders (Fonds voor
   Wetenschappelijk Onderzoek, Vlaanderen, G066215N, G0D5117N, and
   G0B9317N).
CR Auguste AJ, 2015, EMERG INFECT DIS, V21, P99, DOI 10.3201/eid2101.140814
   Bonaldo MC, 2017, MEM I OSWALDO CRUZ, V112, P447, DOI 10.1590/0074-02760170134
   Brasil, 2017, B EPIDEMIOLOGICO, V48
   Camara FP, 2011, REV SOC BRAS MED TRO, V44, P297, DOI [10.1590/S0037-86822011005000024, 10.1590/s0037-86822011005000024]
   Cardoso JD, 2010, EMERG INFECT DIS, V16, P1918, DOI 10.3201/eid1612.100608
   CHANG GJJ, 1995, J VIROL, V69, P5773, DOI 10.1128/JVI.69.9.5773-5780.1995
   Consoli RAG., 1994, PRINCIPAIS MOSQUITOS
   Couto-Lima D, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05186-3
   do Nascimento Rafaela Almeida, 2013, Neotropical Biology and Conservation, V8, P79, DOI 10.4013/nbc.2013.82.03
   Dudas G, 2018, ELIFE, V7, DOI [10.7554/elife.37324, 10.7554/eLife.31257, 10.7554/eLife.37324]
   Dudas G, 2017, NATURE, V544, P309, DOI 10.1038/nature22040
   Estrada A, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1600946
   Faria NR, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15152-8
   Flacio E, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1577-3
   Franco O., 1969, HIST FEBRE AMARELA B
   Garske T, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001638
   Gill MS, 2016, SYST BIOL, V65, P1041, DOI 10.1093/sysbio/syw050
   Grobbelaar AA, 2016, EMERG INFECT DIS, V22, P1854, DOI 10.3201/eid2210.160818
   Jung L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129789
   Kraemer MUG, 2017, LANCET INFECT DIS, V17, P330, DOI [10.1016/s1473-3099(16)30513-8, 10.1016/S1473-3099(16)30513-8]
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Lemey P, 2010, MOL BIOL EVOL, V27, P1877, DOI 10.1093/molbev/msq067
   Lourenco-De-Oliveira R, 2004, T ROY SOC TROP MED H, V98, P43, DOI 10.1016/S0035-9203(03)00006-3
   Moreira-Soto A, 2018, CLIN MICROBIOL INFEC, V24, DOI 10.1016/j.cmi.2018.01.026
   Mutebi JP, 2001, J VIROL, V75, P6999, DOI 10.1128/JVI.75.15.6999-7008.2001
   NASIDI A, 1989, T ROY SOC TROP MED H, V83, P401, DOI 10.1016/0035-9203(89)90518-X
   Nunes MRT, 2012, J VIROL, V86, P13263, DOI 10.1128/JVI.00565-12
   PAHO, 2009, OUTBR YELL FEV PAR
   Pan American Health Organization/World Health Organization, 2018, EP UPD YELL FEV 16 F
   Paules CI, 2017, NEW ENGL J MED, V376, P1397, DOI 10.1056/NEJMp1702172
   Pybus OG, 2012, P NATL ACAD SCI USA, V109, P15066, DOI 10.1073/pnas.1206598109
   Quick J, 2017, NAT PROTOC, V12, P1261, DOI 10.1038/nprot.2017.066
   Ribeiro M, 2009, REV SOC BRAS MED TRO, V42, P523, DOI 10.1590/S0037-86822009000500009
   Rodrigues Faria Nuno, 2016, PLoS Curr, V8, DOI 10.1371/currents.outbreaks.c97507e3e48efb946401755d468c28b2
   Secretaria de Vigilancia em Saude Ministerio da Saude, 2015, B EPIDEMIOLOGICO, V46
   Segura M. N. O., 2007, ATLAS CULICIDEOS AMA, V167
   Shearer FM, 2018, LANCET GLOB HEALTH, V6, pE270, DOI 10.1016/S2214-109X(18)30024-X
   Shearer FM, 2017, LANCET INFECT DIS, V17, P1209, DOI 10.1016/S1473-3099(17)30419-X
   Stephens PR, 2017, ECOLOGY, V98, P1476, DOI 10.1002/ecy.1799
   Theiler M, 1937, J EXP MED, V65, P767, DOI 10.1084/jem.65.6.767
   Thiberville SD, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002004
   Tuboi SH, 2007, T ROY SOC TROP MED H, V101, P169, DOI 10.1016/j.trstmh.2006.04.001
   Vainio J., 1998, YELLOW FEVER
   Vasconcelos P F, 2001, Cad Saude Publica, V17 Suppl, P155, DOI 10.1590/S0102-311X2001000700025
   Vasconcelos PFC, 2004, EMERG INFECT DIS, V10, P1578, DOI 10.3201/eid1009.040197
   Vasconcelos PFC, 2001, J MED VIROL, V65, P598, DOI 10.1002/jmv.2078
   Vaughan TG, 2014, BIOINFORMATICS, V30, P2272, DOI 10.1093/bioinformatics/btu201
   von Lindern JJ, 2006, J GEN VIROL, V87, P895, DOI 10.1099/vir.0.81236-0
   Wang E, 1996, VIROLOGY, V225, P274, DOI 10.1006/viro.1996.0601
NR 49
TC 74
Z9 75
U1 1
U2 14
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA
SN 0036-8075
EI 1095-9203
J9 SCIENCE
JI Science
PD AUG 31
PY 2018
VL 361
IS 6405
BP 894
EP +
DI 10.1126/science.aat7115
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GS3UB
UT WOS:000443547000033
PM 30139911
OA Green Accepted, Bronze
DA 2020-10-22
ER

PT J
AU do Rosario, MS
   de Jesus, PAP
   Farias, DS
   Novaes, MAC
   Santos, CS
   Azar, SR
   Vasilakis, N
   de Moura, DL
   Lima, FWD
   Alcantara, LC
   de Siqueira, IC
AF do Rosario, Mateus Santana
   Pereira de Jesus, Pedro Antonio
   Farias, Daniel Santana
   Caires Novaes, Marco Antonio
   Santos, Cleiton Silva
   Azar, Sasha R.
   Vasilakis, Nikos
   de Moura, Daniel Lima
   Lima, Fernanda Washington de M.
   Junior Alcantara, Luiz Carlos
   de Siqueira, Isadora Cristina
TI Reversible sensory polyneuropathy during an arboviral outbreak in
   Salvador, Bahia, Brazil
SO JOURNAL OF THE NEUROLOGICAL SCIENCES
LA English
DT Letter
DE Reversible sensory polyneuropathy; Zika virus; Chikungunya virus
ID NEUROLOGICAL MANIFESTATIONS; CHIKUNGUNYA
C1 [do Rosario, Mateus Santana; Santos, Cleiton Silva; Junior Alcantara, Luiz Carlos; de Siqueira, Isadora Cristina] Fundacao Oswaldo Cruz, Inst Goncalo Moniz, Minist Saude, Salvador, BA, Brazil.
   [do Rosario, Mateus Santana] Hosp Santa Izabel, Salvador, BA, Brazil.
   [Pereira de Jesus, Pedro Antonio; Farias, Daniel Santana] Hosp Geral Roberto Santos, Secretaria Estadual Scude Bahia, Salvador, BA, Brazil.
   [Caires Novaes, Marco Antonio] Hosp Sao Rafael, Fundacao Monte Tabor, Salvador, BA, Brazil.
   [Azar, Sasha R.; Vasilakis, Nikos] Univ Texas Med Branch, Dept Pathol, Ctr Biodef & Emerging Infect Dis, Ctr Trop Dis,Inst Human Infect & Immun, Galveston, TX 77555 USA.
   [de Moura, Daniel Lima; Lima, Fernanda Washington de M.] Univ Fed Bahia, Lab Imunol Doencas Infecciosas, Fac Farm, Salvador, BA, Brazil.
RP de Siqueira, IC (corresponding author), Fundacao Oswaldo Cruz, Inst Goncalo Moniz, R Waldemar Falcao 121, BR-40296710 Salvador, BA, Brazil.
EM isadora.siqueira@bahia.fiocruz.br
RI de Siqueira, Isadora Cristina/R-9953-2016
OI de Siqueira, Isadora Cristina/0000-0002-2520-4099; do Rosario,
   Mateus/0000-0001-7404-6392; Alcantara, Luiz/0000-0002-6769-9931; Jesus,
   Pedro Antonio/0000-0003-1211-2272
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [R24AI120942, 1U01A1115577];
   MCTI/FINEP/FNDCT-Brazil grant [04160060-00/2016]
FX Zika work is supported in part by NIH grants R24AI120942 and
   1U01A1115577 (NV) and MCTI/FINEP/FNDCT-Brazil grant 04160060-00/2016
   (LCJA).
CR Acevedo N., 2017, FRONT MICROBIOL, V8, P1
   [Anonymous], 2016, PROC SER AD VIG FEBR
   CDC, ZIK MAC ELISA
   Chandak NH, 2009, NEUROL INDIA, V57, P177, DOI 10.4103/0028-3886.51289
   HUGHES RAC, 1978, LANCET, V2, P750, DOI 10.1016/s0140-6736(78)92644-2
   Medina MT, 2016, J NEUROL SCI, V369, P271, DOI 10.1016/j.jns.2016.08.044
   Mehta R., 2018, SPECTRUM NEUROLOGICA
   Nascimento OJM, 2017, NEUROLOGY, V88, P2330, DOI 10.1212/WNL.0000000000004026
   Oh Y, 2017, NAT NEUROSCI, V20, P1209, DOI 10.1038/nn.4612
   Pinheiro TJ, 2016, ARQ NEURO-PSIQUIAT, V74, P937, DOI [10.1590/0004-282X20160138, 10.1590/0004-282x20160138]
   Verma R, 2014, J NEUROL SCI, V346, P26, DOI 10.1016/j.jns.2014.08.044
   Wakerley BR, 2014, NAT REV NEUROL, V10, P537, DOI 10.1038/nrneurol.2014.138
NR 12
TC 1
Z9 1
U1 0
U2 1
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0022-510X
EI 1878-5883
J9 J NEUROL SCI
JI J. Neurol. Sci.
PD AUG 15
PY 2018
VL 391
BP 3
EP 4
DI 10.1016/j.jns.2018.05.009
PG 2
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA GO0YL
UT WOS:000439672500002
PM 30103966
DA 2020-10-22
ER

PT J
AU Cabral, J
   Faical, A
   Almeida, B
   Oliveira, JV
   Embirucu, E
   Ferreira, N
   Reis, L
   Salles, C
   Cabral, B
   Costa, B
   Francisco, MV
   Santos, C
   Alcantara, LC
   Acosta, A
   Siqueira, I
AF Cabral, J.
   Faical, A.
   Almeida, B.
   Oliveira, J. V.
   Embirucu, E.
   Ferreira, N.
   Reis, L.
   Salles, C.
   Cabral, B.
   Costa, B.
   Francisco, M. V.
   Santos, C.
   Alcantara, L. C.
   Acosta, A.
   Siqueira, I.
TI Neurodevelopmental delays arising from in utero exposure to Zika virus
   in Salvador, Brazil
SO INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
LA English
DT Meeting Abstract
C1 [Cabral, J.; Almeida, B.; Costa, B.; Francisco, M. V.; Alcantara, L. C.; Siqueira, I.] Inst Goncalo Moniz Fiocruz, Salvador, BA, Brazil.
   [Faical, A.] Univ Fed Bahia, Salvador, BA, Brazil.
   [Oliveira, J. V.; Santos, C.] Inst Goncalo Moniz Fiocruz, Salvdor, Brazil.
   [Embirucu, E.; Ferreira, N.; Reis, L.; Salles, C.; Cabral, B.; Acosta, A.] Univ Fed Bahia, Fac Med, Salvador, BA, Brazil.
RI de Siqueira, Isadora Cristina/R-9953-2016
OI de Siqueira, Isadora Cristina/0000-0002-2520-4099
NR 0
TC 1
Z9 2
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1201-9712
EI 1878-3511
J9 INT J INFECT DIS
JI Int. J. Infect. Dis.
PD AUG
PY 2018
VL 73
SU S
MA 22.002
BP 48
EP 49
DI 10.1016/j.ijid.2018.04.3533
PG 2
WC Infectious Diseases
SC Infectious Diseases
GA GO8MP
UT WOS:000440345100099
OA DOAJ Gold
DA 2020-10-22
ER

PT J
AU do Rosario, M
   Jesus, P
   Farias, D
   Novaes, MA
   Moura, D
   Lima, F
   Santos, C
   Giovanetti, M
   Alcantara, LC
   Siqueira, I
AF do Rosario, M.
   Jesus, P.
   Farias, D.
   Novaes, M. A.
   Moura, D.
   Lima, F.
   Santos, C.
   Giovanetti, M.
   Alcantara, L. C.
   Siqueira, I.
TI Neurological complications associated with arboviruses during Zika
   outbreak in Salvador, Bahia-Brazil
SO INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
LA English
DT Meeting Abstract
C1 [do Rosario, M.; Santos, C.; Giovanetti, M.; Alcantara, L. C.; Siqueira, I.] Inst Goncalo Moniz Fiocruz, Salvador, BA, Brazil.
   [Jesus, P.] Hosp Santa Izabel, Salvador, BA, Brazil.
   [Farias, D.] Hosp Geral Roberto Santos, Salvador, BA, Brazil.
   [Novaes, M. A.] Hosp Sao Rafael, Salvador, BA, Brazil.
   [Moura, D.; Lima, F.] Univ Fed Bahia, Fac Farm, Salvador, BA, Brazil.
RI de Siqueira, Isadora Cristina/R-9953-2016; Giovanetti,
   Marta/AAK-7408-2020
OI de Siqueira, Isadora Cristina/0000-0002-2520-4099; 
NR 0
TC 1
Z9 1
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1201-9712
EI 1878-3511
J9 INT J INFECT DIS
JI Int. J. Infect. Dis.
PD AUG
PY 2018
VL 73
SU S
MA 22.004
BP 49
EP 49
DI 10.1016/j.ijid.2018.04.3534
PG 1
WC Infectious Diseases
SC Infectious Diseases
GA GO8MP
UT WOS:000440345100100
OA DOAJ Gold
DA 2020-10-22
ER

PT J
AU Oliveira, JV
   Duarte, A
   Santos, C
   Pessoa, L
   Magalhaes, C
   Lima, J
   Carvalho, D
   Xavier, T
   Figueiredo, E
   Giovanetti, M
   Almeida, B
   Goes, J
   Lima, F
   Alcantara, LC
   Siqueira, I
AF Oliveira, J. V.
   Duarte, A.
   Santos, C.
   Pessoa, L.
   Magalhaes Filho, C.
   Lima, J.
   Carvalho, D.
   Xavier, T.
   Figueiredo, E.
   Giovanetti, M.
   Almeida, B.
   Goes, J.
   Lima, F.
   Alcantara, L. C.
   Siqueira, I.
TI Prevalence of Zika, dengue and Chikungunya virus infection in pregnant
   women and surveillance of congenital Zika infection in Salvador, Brazil
SO INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
LA English
DT Meeting Abstract
C1 [Oliveira, J. V.; Santos, C.; Pessoa, L.; Magalhaes Filho, C.; Lima, J.; Carvalho, D.; Giovanetti, M.; Almeida, B.; Goes, J.; Alcantara, L. C.; Siqueira, I.] Inst Goncalo Moniz Fiocruz, Salvdor, Brazil.
   [Duarte, A.; Lima, F.] Univ Fed Bahia, Fac Farm, Salvador, BA, Brazil.
   [Xavier, T.; Figueiredo, E.] Maternidade Referencia Prof Jose Maria Magalhaes, Salvador, BA, Brazil.
RI de Siqueira, Isadora Cristina/R-9953-2016; Giovanetti,
   Marta/AAK-7408-2020; amsalu, ribka/G-8780-2019
OI de Siqueira, Isadora Cristina/0000-0002-2520-4099; 
NR 0
TC 1
Z9 1
U1 0
U2 1
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1201-9712
EI 1878-3511
J9 INT J INFECT DIS
JI Int. J. Infect. Dis.
PD AUG
PY 2018
VL 73
SU S
MA UMP. 202
BP 182
EP 182
DI 10.1016/j.ijid.2018.04.3826
PG 1
WC Infectious Diseases
SC Infectious Diseases
GA GO8MP
UT WOS:000440345100392
OA DOAJ Gold
DA 2020-10-22
ER

PT J
AU Santos, LA
   Adhikarla, H
   Yan, XT
   Wang, Z
   Fouts, DE
   Vinetz, JM
   Alcantara, LCJ
   Hartskeerl, RA
   Goris, MGA
   Picardeau, M
   Reis, MG
   Townsend, JP
   Zhao, HY
   Ko, AI
   Wunder, EA
AF Santos, Luciane A.
   Adhikarla, Haritha
   Yan, Xiting
   Wang, Zheng
   Fouts, Derrick E.
   Vinetz, Joseph M.
   Alcantara, Luiz C. J.
   Hartskeerl, Rudy A.
   Goris, Marga G. A.
   Picardeau, Mathieu
   Reis, Mitermayer G.
   Townsend, Jeffrey P.
   Zhao, Hongyu
   Ko, Albert, I
   Wunder Jr, Elsio A.
TI Genomic Comparison Among Globa Isolates of L. interrogans Serovars
   Copenhageni and Icterohaemorrhagiae Identified Natural Genetic Variation
   Caused by an Indel
SO FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY
LA English
DT Article
DE Leptospira; leptospirosis; Copenhageni; Icterohaemorrhagiae;
   whole-genome sequencing; SNPs; Indels; phylogeny
ID SINGLE NUCLEOTIDE POLYMORPHISMS; LEPTOSPIRA-INTERROGANS;
   MYCOBACTERIUM-BOVIS; SEQUENCING DATA; EVOLUTION; VIRULENCE; BRAZIL;
   DIFFERENTIATION; RESOLUTION; DISCOVERY
AB Leptospirosis is a worldwide zoonosis, responsible for more than 1 million cases and 60,000 deaths every year. Among the 13 pathogenic species of the genus Leptospira, serovars belonging to L. interrogans serogroup Icterohaemorrhagiae are considered to be the most virulent strains, and responsible for majority of the reported severe cases. Serovars Copenhageni and Icterohaemorrhagiae are major representatives of this serogroup and despite their public health relevance, little is known regarding the genetic differences between these two serovars. In this study, we analyzed the genome sequences of 67 isolates belonging to L. interrogans serovars Copenhageni and Icterohaemorrhagiae to investigate the influence of spatial and temporal variations on DNA sequence diversity. Out of the 1072 SNPs identified, 276 were in non-coding regions and 796 in coding regions. Indel analyses identified 258 Indels, out of which 191 were found in coding regions and 67 in non-coding regions. Our phylogenetic analyses based on SNP dataset revealed that both serovars are closely related but showed distinct spatial clustering. However, likelihood ratio test of the indel data statistically confirmed the presence of a frameshift mutation within a homopolymeric tract of lic12008 gene (related to LPS biosynthesis) in all the L. interrogans serovar Icterohaemorrhagiae strains but not in the Copenhageni strains. Therefore, this internal indel identified can genetically distinguish L. interrogans serovar Copenhageni from serovar Icterohaemorrhagiae with high discriminatory power. To our knowledge, this is the first study to identify global sequence variations (SNPs and Indels) in L. interrogans serovars Copenhageni and Icterohaemorrhagiae.
C1 [Santos, Luciane A.; Adhikarla, Haritha; Ko, Albert, I; Wunder Jr, Elsio A.] Yale Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT 06510 USA.
   [Santos, Luciane A.; Alcantara, Luiz C. J.; Reis, Mitermayer G.; Ko, Albert, I; Wunder Jr, Elsio A.] Fundacao Oswaldo Cruz, Goncalo Moniz Inst, Salvador, BA, Brazil.
   [Yan, Xiting; Wang, Zheng; Townsend, Jeffrey P.; Zhao, Hongyu] Yale Sch Publ Hlth, Dept Biostat, New Haven, CT USA.
   [Fouts, Derrick E.] J Craig Venter Inst, Rockville, MD USA.
   [Vinetz, Joseph M.] Univ Calif San Diego, Sch Med, Dept Med, Div Infect Dis, La Jolla, CA 92093 USA.
   [Hartskeerl, Rudy A.; Goris, Marga G. A.] KIT Biomed Res, Royal Trop Inst, Amsterdam, Netherlands.
   [Picardeau, Mathieu] Inst Pasteur, Biol Spirochetes Unit, Paris, France.
RP Ko, AI; Wunder, EA (corresponding author), Yale Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT 06510 USA.; Ko, AI; Wunder, EA (corresponding author), Fundacao Oswaldo Cruz, Goncalo Moniz Inst, Salvador, BA, Brazil.
EM albert.ko@yale.edu; elsio.wunder@yale.edu
RI Townsend, Jeffrey/H-2747-2019; Ko, Albert Icksang/P-2343-2015; Wang,
   Zheng/A-2318-2011; Reis, Mitermayer/AAO-9742-2020; Wunder, Elsio
   Augusto/C-2733-2013
OI Townsend, Jeffrey/0000-0002-9890-3907; Ko, Albert
   Icksang/0000-0001-9023-2339; Wang, Zheng/0000-0002-8849-8549; Reis,
   Mitermayer/0000-0002-3051-9060; Wunder, Elsio
   Augusto/0000-0002-5239-8511; Alcantara, Luiz/0000-0002-6769-9931
FU National Institute of Allergy and Infectious Diseases, National
   Institutes of Health, Department of Health and Human ServicesUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Institute of Allergy & Infectious
   Diseases (NIAID) [HHSN272200900007C]; Programa Ciencias sem fronteiras
   Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) of
   Brazil; Brasil Sem Miseria Program of the Coordenacao de Aperfeicoamento
   de Pessoal de Nivel Superios (Capes) of Brazil;  [R01AI052473]; 
   [U01AI088752];  [R25TW009338];  [R01TW009504];  [R01AI121207]
FX Draft genome sequences used in this study are part of a project which
   was funded with federal funds from the National Institute of Allergy and
   Infectious Diseases, National Institutes of Health, Department of Health
   and Human Services under contract number HHSN272200900007C. This project
   has also been partially funded by the following grants: R01AI052473
   (AK), U01AI088752 (AK), R25TW009338 (AK), R01TW009504 (AK), and
   R01AI121207 (AK). LS was supported by Programa Ciencias sem fronteiras
   Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) of
   Brazil and Brasil Sem Miseria Program of the Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superios (Capes) of Brazil.
CR Ajawatanawong P, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-140
   BALDAUF SL, 1993, P NATL ACAD SCI USA, V90, P11558, DOI 10.1073/pnas.90.24.11558
   Barocchi MA, 2001, J CLIN MICROBIOL, V39, P191, DOI 10.1128/JCM.39.1.191-195.2001
   Bartling CM, 2009, BIOCHEMISTRY-US, V48, P8672, DOI 10.1021/bi901025v
   Bharti AR, 2003, LANCET INFECT DIS, V3, P757, DOI 10.1016/S1473-3099(03)00830-2
   Costa F, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003898
   de Faria MT, 2008, ACTA TROP, V108, P1, DOI 10.1016/j.actatropica.2008.07.005
   de Jong WW, 2003, MOL PHYLOGENET EVOL, V28, P328, DOI 10.1016/S1055-7903(03)00116-7
   de la Pena-Moctezuma A, 1999, FEMS MICROBIOL LETT, V177, P319, DOI 10.1111/j.1574-6968.1999.tb13749.x
   DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806
   Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214
   Eshghi A, 2015, INFECT IMMUN, V83, P4314, DOI 10.1128/IAI.00897-15
   Faine S., 1994, LEPTOSPIRA LEPTOSPIR, DOI [10.1016/j.vetmic.2009.03.012, DOI 10.1016/J.VETMIC.2009.03.012]
   Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960
   Fournier PE, 2014, GENOME MED, V6, DOI 10.1186/s13073-014-0114-2
   Galloway RL, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000824
   Garnier T, 2003, P NATL ACAD SCI USA, V100, P7877, DOI 10.1073/pnas.1130426100
   Gutacker MM, 2002, GENETICS, V162, P1533
   Harrison F, 2013, BIOESSAYS, V35, P108, DOI 10.1002/bies.201200154
   HILLIS DM, 1993, SYST BIOL, V42, P182, DOI 10.2307/2992540
   Ido Y, 1917, J EXP MED, V26, P341, DOI 10.1084/jem.26.3.341
   JOHNSON RC, 1967, J BACTERIOL, V94, P27, DOI 10.1128/JB.94.1.27-31.1967
   Jordan IK, 2002, THEOR POPUL BIOL, V61, P435, DOI 10.1006/tpbi.2002.1588
   Joshi D, 2012, J CLIN MICROBIOL, V50, P3853, DOI 10.1128/JCM.01499-12
   Kmety E, 1993, CLASSIFICATION SPECI
   Ko AI, 1999, LANCET, V354, P820, DOI 10.1016/S0140-6736(99)80012-9
   Ko AI, 2009, NAT REV MICROBIOL, V7, P736, DOI 10.1038/nrmicro2208
   Lehmann JS, 2014, PATHOGENS, V3, P280, DOI 10.3390/pathogens3020280
   Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698
   Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352
   Liu MM, 2015, HUM GENOMICS, V9, DOI 10.1186/s40246-015-0040-4
   Llanes A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159387
   Lunter G, 2011, GENOME RES, V21, P936, DOI 10.1101/gr.111120.110
   MADDISON WP, 1989, FOLIA PRIMATOL, V53, P190, DOI 10.1159/000156416
   Majed Z, 2005, J CLIN MICROBIOL, V43, P539, DOI 10.1128/JCM.43.2.539-545.2005
   McBride AJA, 2005, CURR OPIN INFECT DIS, V18, P376, DOI 10.1097/01.qco.0000178824.05715.2c
   Moran NA, 2009, SCIENCE, V323, P379, DOI 10.1126/science.1167140
   Moreno LZ, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.16
   Nalam K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012637
   Nascimento ALTO, 2004, J BACTERIOL, V186, P2164, DOI 10.1128/JB.186.7.2164-2172.2004
   Nielsen R, 2011, NAT REV GENET, V12, P443, DOI 10.1038/nrg2986
   Picardeau M, 2017, NAT REV MICROBIOL, V15, P297, DOI 10.1038/nrmicro.2017.5
   Price EP, 2013, MBIO, V4, DOI 10.1128/mBio.00388-13
   Puckett EE, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.1762
   Read TD, 2002, SCIENCE, V296, P2028, DOI 10.1126/science.1071837
   Reis RB, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000228
   Ren SX, 2003, NATURE, V422, P888, DOI 10.1038/nature01597
   Rogers JS, 1998, SYST BIOL, V47, P77, DOI 10.1080/106351598261049
   Romero EC, 2011, J CLIN MICROBIOL, V49, P3940, DOI 10.1128/JCM.01119-11
   Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73
   Silva EF, 2008, VACCINE, V26, P3892, DOI 10.1016/j.vaccine.2008.04.085
   Vinetz JM, 1996, ANN INTERN MED, V125, P794, DOI 10.7326/0003-4819-125-10-199611150-00002
   Williams LE, 2013, GENOME BIOL EVOL, V5, P599, DOI 10.1093/gbe/evt033
   Wunder EA, 2016, INFECT IMMUN, V84, P2105, DOI 10.1128/IAI.00094-16
   Zilber AL, 2014, J CLIN MICROBIOL, V52, P564, DOI 10.1128/JCM.02482-13
NR 55
TC 7
Z9 7
U1 1
U2 2
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 2235-2988
J9 FRONT CELL INFECT MI
JI Front. Cell. Infect. Microbiol.
PD JUN 19
PY 2018
VL 8
AR 193
DI 10.3389/fcimb.2018.00193
PG 11
WC Immunology; Microbiology
SC Immunology; Microbiology
GA GK0RJ
UT WOS:000435818900001
PM 29971217
OA DOAJ Gold, Green Published
DA 2020-10-22
ER

PT J
AU Cella, E
   Giovanetti, M
   Milano, T
   Fogolari, M
   Garilli, F
   Alexiev, I
   Bazzardi, R
   Salemi, M
   Alcantara, LCJ
   Angeletti, S
   Pascarella, S
   Ciccozzi, M
AF Cella, Eleonora
   Giovanetti, Marta
   Milano, Teresa
   Fogolari, Marta
   Garilli, Francesco
   Alexiev, Ivailo
   Bazzardi, Riccardo
   Salemi, Marco
   Alcantara, Luiz Carlos Junior
   Angeletti, Silvia
   Pascarella, Stefano
   Ciccozzi, Massimo
TI Mayaro virus infection, the next epidemic wave after Zika? Evolutionary
   and structural analysis
SO ASIAN PACIFIC JOURNAL OF TROPICAL MEDICINE
LA English
DT Article
DE Mayaro virus; Proteins; Evolutionary analysis
ID B-CELL EPITOPES; CHIKUNGUNYA VIRUS; PREDICTION; SEQUENCE; EMERGENCE;
   OUTBREAK; AMERICA; DISEASE; SURFACE; BRAZIL
AB Objective: To evaluate the evolution of the pathogen Mayaro virus, causing Mayaro fever (a mosquito-borne disease) and to perform selective pressure analysis and homology modelling. Methods: Nine different datasets were built, one for each protein (from protein C to non-structural protein 4) and the last one for the complete genome. Selective pressure and homology modelling analyses were applied. Results: Two main clades (A and B) were pointed in the maximum likelihood tree. The clade A included five Brazilian sequences sampled from 1955 to 2015. The Brazilian sequence sampled in 2014 significantly clustered with the Haitian sequence sampled in 2015. The clade B included the remaining 27 sequences sampled in the Central and Southern America from 1957 to 2013. Selective pressure analysis revealed several sites under episodic diversifying selection in envelope surface glycoprotein E1, non-structural protein 1 and nonstructural protein 3 with a posterior probability P <= 0.01. Homology modelling showed different sites modified by selective pressure and some protein-protein interaction sites at high interaction propensity. Conclusion: Maximum likelihood analysis confirmed the Mayaro virus previous circulation in Haiti and the successful spread to the Caribbean and USA. Selective pressure analysis revealed a strong presence of negatively selected sites, suggesting a probable purging of deleterious polymorphisms in functional genes. Homology model showed the position 31, under selective pressure, located in the edge of the ADP-ribose binding site predicting to possess a high potential of protein-protein interaction and suggesting the possible chance for a protective vaccine, thus preventing Mayaro virus urbanization as with Chikungunya virus.
C1 [Cella, Eleonora] Sapienza Univ, Publ Hlth & Infect Dis, Rome, Italy.
   [Cella, Eleonora; Fogolari, Marta; Angeletti, Silvia; Ciccozzi, Massimo] Univ Campus Biomed Rome, Unit Clin Lab Sci, Via Alvaro del Portillo 200, I-00125 Rome, Italy.
   [Giovanetti, Marta; Alcantara, Luiz Carlos Junior] Fundacao Oswaldo Cruz, Salvador, BA, Brazil.
   [Giovanetti, Marta] Univ Roma Tor Vergata, Rome, Italy.
   [Milano, Teresa; Pascarella, Stefano] Univ Roma La Sapienza, Dipartimento Sci Biochim A Rossi Fanelli, I-00185 Rome, Italy.
   [Garilli, Francesco] Univ Campus Biomed Rome, Dept Med, Rome, Italy.
   [Alexiev, Ivailo] Natl Ctr Infect & Parasit Dis, Natl Reference Lab HIV, Sofia, Bulgaria.
   [Bazzardi, Riccardo] Expt Zooprophylact Inst Sardinia, Dept Food Hyg, Sassari, Italy.
   [Salemi, Marco] Univ Florida, Emerging Pathogens Inst, Gainesville, FL USA.
RP Cella, E; Angeletti, S; Ciccozzi, M (corresponding author), Univ Campus Biomed Rome, Unit Clin Lab Sci, Via Alvaro del Portillo 200, I-00125 Rome, Italy.
EM Eleonora.cella@yahoo.it; s.angeletti@unicampus.it; ciccozzi@iss.it
RI Bazzardi, Riccardo/G-3191-2019; Fogolari, Marta/X-1945-2019; Giovanetti,
   Marta/AAK-7408-2020; Cella, Eleonora/ABA-8333-2020; BAZZARDI,
   RICCARDO/M-2103-2019; Cella, Eleonora/J-9961-2016
OI Bazzardi, Riccardo/0000-0001-5528-6892; Cella,
   Eleonora/0000-0002-7870-9744; BAZZARDI, RICCARDO/0000-0001-5528-6892;
   Cella, Eleonora/0000-0002-7870-9744; Alcantara,
   Luiz/0000-0002-6769-9931; Alexiev, Ivailo/0000-0002-3186-1124
CR Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389
   Ansari Hifzur Rahman, 2010, Immunome Res, V6, P6, DOI 10.1186/1745-7580-6-6
   Azevedo RSS, 2009, EMERG INFECT DIS, V15, P1830, DOI 10.3201/eid1511.090461
   Chen J, 2007, AMINO ACIDS, V33, P423, DOI 10.1007/s00726-006-0485-9
   Vieira CJDP, 2015, ACTA TROP, V147, P12, DOI 10.1016/j.actatropica.2015.03.020
   Mota MTD, 2015, FUTURE VIROL, V10, P1109, DOI 10.2217/fvl.15.76
   Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/0471140864.ps0209s50, 10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/cpps.20]
   Forshey BM, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000787
   Furuya-Kanamori L, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1417-2
   Giovanetti M, 2016, ASIAN PAC J TROP MED, V9, P445, DOI 10.1016/j.apjtm.2016.03.028
   Mourao MPG, 2012, VECTOR-BORNE ZOONOT, V12, P42, DOI 10.1089/vbz.2011.0669
   Gouandijka-Vasilache I, 2014, EMERG INFECT DIS, V20, P1254, DOI 10.3201/eid2007.131839
   Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010
   Hall T.A., 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008
   Hallengard D, 2014, J VIROL, V88, P2858, DOI 10.1128/JVI.03453-13
   Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198
   Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2
   Kringelum JV, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002829
   Larsen Jens Erik Pontoppidan, 2006, Immunome Res, V2, P2, DOI 10.1186/1745-7580-2-2
   Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148
   Lavergne A, 2006, VIRUS RES, V117, P283, DOI 10.1016/j.virusres.2005.11.006
   Liang SD, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-381
   Liang SD, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-302
   Lo Presti A, 2016, INFECT GENET EVOL, V41, P270, DOI 10.1016/j.meegid.2016.04.006
   Long KC, 2011, AM J TROP MED HYG, V85, P750, DOI 10.4269/ajtmh.2011.11-0359
   Mavian C, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07152-5
   McPherson RL, 2017, P NATL ACAD SCI USA, V114, P1666, DOI 10.1073/pnas.1621485114
   MEYER WJ, 1993, J VIROL, V67, P5117, DOI 10.1128/JVI.67.9.5117-5125.1993
   Mukhopadhyay S, 2006, STRUCTURE, V14, P63, DOI 10.1016/j.str.2005.07.025
   Murrell B, 2013, MOL BIOL EVOL, V30, P1196, DOI 10.1093/molbev/mst030
   Neumayr A, 2012, EMERG INFECT DIS, V18, P695, DOI 10.3201/eid1804.111717
   Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084
   PINHEIRO FP, 1981, AM J TROP MED HYG, V30, P674, DOI 10.4269/ajtmh.1981.30.674
   Pond SLK, 2005, MOL BIOL EVOL, V22, P1208, DOI 10.1093/molbev/msi105
   Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079
   Ponomarenko J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-514
   Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817
   Potocnakova L, 2016, J IMMUNOL RES, V2016, DOI 10.1155/2016/6760830
   Powers A, 2011, VIRUS TAXONOMY, P1103
   Rack JGM, 2016, ANNU REV BIOCHEM, V85, P431, DOI 10.1146/annurev-biochem-060815-014935
   ROBINSON DM, 1976, MIL MED, V141, P163
   Roussel A, 2006, STRUCTURE, V14, P75, DOI 10.1016/j.str.2005.09.014
   Rubinstein ND, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-287
   Saha S, 2006, PROTEINS, V65, P40, DOI 10.1002/prot.21078
   Schroedinger LLC, 2015, PYMOL MOL GRAPH SYST
   Sievers F, 2014, CURR PROTOC BIOINFOR, DOI [10.1002/0471250953.bi0313s48, DOI 10.1002/0471250953.BI0313S48]
   Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408
   Strimmer K, 1997, P NATL ACAD SCI USA, V94, P6815, DOI 10.1073/pnas.94.13.6815
   Sweredoski MJ, 2008, BIOINFORMATICS, V24, P1459, DOI 10.1093/bioinformatics/btn199
   Taubitz W, 2007, CLIN INFECT DIS, V45, pE1, DOI 10.1086/518701
   Tesh RB, 1999, CLIN INFECT DIS, V28, P67, DOI 10.1086/515070
   Tsetsarkin KA, 2011, P NATL ACAD SCI USA, V108, P7872, DOI 10.1073/pnas.1018344108
   Vasconcelos PFC, 2016, VECTOR-BORNE ZOONOT, V16, P295, DOI 10.1089/vbz.2016.1952
   Voss JE, 2010, NATURE, V468, P709, DOI 10.1038/nature09555
   Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033
   Wiederstein M, 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/gkm290
   Yao B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045152
NR 57
TC 1
Z9 1
U1 0
U2 2
PU WOLTERS KLUWER MEDKNOW PUBLICATIONS
PI MUMBAI
PA WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2
   VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA
SN 1995-7645
EI 2352-4146
J9 ASIAN PAC J TROP MED
JI Asian Pac. J. Trop. Med.
PD MAR
PY 2018
VL 11
IS 3
BP 194
EP 201
DI 10.4103/1995-7645.228433
PG 8
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA GB1VD
UT WOS:000428837700003
OA DOAJ Gold
DA 2020-10-22
ER

PT J
AU Tennant, W
   Lourenco, J
   Faria, NR
   Alcantara, LCJ
   Recker, M
AF Tennant, Warren
   Lourenco, Jose
   Faria, Nuno
   Junior Alcantara, Luiz
   Recker, Mario
TI INFLUENCE OF TEMPERATURE AND RAINFALL ON THE EPIDEMIOLOGY OF ARBOVIRAL
   DISEASES IN ENVIRONMENTALLY DISTINCTIVE REGIONS OF BRAZIL
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 67th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTHM)
CY OCT 28-NOV 01, 2018
CL New Orleans, LA
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Takeda Pharmaceut Int AG, Novartis Social Business, Celgene Corp, Techlab Inc, Indiana Univ, Sch Med, B EI Resources, Sanofi Pasteur, Welcome, PLOS, Elsevier
C1 [Tennant, Warren; Recker, Mario] Univ Exeter, Penryn, England.
   [Lourenco, Jose; Faria, Nuno] Univ Oxford, Oxford, England.
   [Junior Alcantara, Luiz] Fundacao Oswaldo Cruz, Salvador, BA, Brazil.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2018
VL 99
IS 4
SU S
MA 898
BP 282
EP 282
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA HP0WF
UT WOS:000461386603234
DA 2020-10-22
ER

PT J
AU Cuypers, L
   Libin, PJK
   Simmonds, P
   Nowe, A
   Munoz-Jordan, JL
   Alcantara, LCJ
   Vandamme, A
   Santiago, GA
   Theys, K
AF Cuypers, L.
   Libin, P. J. K.
   Simmonds, P.
   Nowe, A.
   Munoz-Jordan, J. L.
   Alcantara, L. C. J.
   Vandamme, A.
   Santiago, G. A.
   Theys, K.
TI Time to harmonize Dengue nomenclature and classification
SO TROPICAL MEDICINE & INTERNATIONAL HEALTH
LA English
DT Meeting Abstract
C1 [Cuypers, L.; Libin, P. J. K.; Vandamme, A.; Theys, K.] KU Leuven Univ Leuven, Rega Inst Med Res Clin & Epidemiol Virol, Dept Microbiol & Immunol, Leuven, Belgium.
   [Libin, P. J. K.; Nowe, A.] Vrije Univ Brussel, Dept Comp Sci, Artificial Intelligence Lab, Brussels, Belgium.
   [Simmonds, P.] Univ Oxford, Nuffield Dept Med, Oxford, England.
   [Munoz-Jordan, J. L.; Santiago, G. A.] Ctr Dis Control & Prevent, Div Vector Borne Dis, San Juan, PR USA.
   [Alcantara, L. C. J.] Fundacao Oswaldo Cruz, Lab Hematol Genet & Computat Biol, Salvador, BA, Brazil.
   [Vandamme, A.] Univ Nova Lisboa, Inst Higiene & Med Trop, Unidade Microbiolgia, Global Hlth & Trop Med, Lisbon, Portugal.
RI Vandamme, Anne-Mieke/I-4127-2012
OI Vandamme, Anne-Mieke/0000-0002-6594-2766
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1360-2276
EI 1365-3156
J9 TROP MED INT HEALTH
JI Trop. Med. Int. Health
PD OCT
PY 2017
VL 22
SU 1
SI SI
MA LBS2.2
BP 348
EP 349
PG 2
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FJ6VU
UT WOS:000412896900834
DA 2020-10-22
ER

PT J
AU Lourenco, J
   de Lima, MM
   Faria, NR
   Walker, A
   Kraemer, MUG
   Villabona-Arenas, CJ
   Lambert, B
   de Cerqueira, EM
   Pybus, OG
   Alcantara, LCJ
   Recker, M
AF Lourenco, Jose
   de Lima, Maricelia Maia
   Faria, Nuno Rodrigues
   Walker, Andrew
   Kraemer, Moritz U. G.
   Villabona-Arenas, Christian Julian
   Lambert, Ben
   de Cerqueira, Erenilde Marques
   Pybus, Oliver G.
   Alcantara, Luiz C. J.
   Recker, Mario
TI Epidemiological and ecological determinants of Zika virus transmission
   in an urban setting
SO ELIFE
LA English
DT Article
ID VECTOR-BORNE TRANSMISSION; AEDES-AEGYPTI; DENGUE; TEMPERATURE;
   INFECTION; MODEL; POPULATION; SURVEILLANCE; CULICIDAE; OUTBREAK
AB The Zika virus has emerged as a global public health concern. Its rapid geographic expansion is attributed to the success of Aedes mosquito vectors, but local epidemiological drivers are still poorly understood. Feira de Santana played a pivotal role in the Chikungunya epidemic in Brazil and was one of the first urban centres to report Zika infections. Using a climate-driven transmission model and notified Zika case data, we show that a low observation rate and high vectorial capacity translated into a significant attack rate during the 2015 outbreak, with a subsequent decline in 2016 and fade-out in 2017 due to herd-immunity. We find a potential Zika-related, low risk for microcephaly per pregnancy, but with significant public health impact given high attack rates. The balance between the loss of herd-immunity and viral re-importation will dictate future transmission potential of Zika in this urban setting.
C1 [Lourenco, Jose; Faria, Nuno Rodrigues; Walker, Andrew; Kraemer, Moritz U. G.; Lambert, Ben; Pybus, Oliver G.] Univ Oxford, Dept Zool, Oxford, England.
   [de Lima, Maricelia Maia; Alcantara, Luiz C. J.] Fiocruz MS, Lab Haematol Genet & Computat Biol, SalvadorBahia, Brazil.
   [Villabona-Arenas, Christian Julian] Univ Montreal, INSERM, UMI 233, Inst Rech Dev,U1175, Montpellier, France.
   [Villabona-Arenas, Christian Julian] Univ Montreal, LIRMM, Inst Biol Computat, Montpellier, France.
   [de Cerqueira, Erenilde Marques] Univ Estadual Feira de Santana, Dept Hlth, Ctr PostGrad Collect Hlth, Feira De SantanaBahia, Brazil.
   [Recker, Mario] Univ Exeter, Ctr Math & Environm, Penryn, England.
RP Lourenco, J (corresponding author), Univ Oxford, Dept Zool, Oxford, England.
EM jose.lourenco@zoo.ox.ac.uk
RI Faria, Nuno R/I-2975-2012; Pybus, Oliver G/B-2640-2012
OI Faria, Nuno R/0000-0001-8839-2798; Pybus, Oliver G/0000-0002-8797-2667;
   Villabona Arenas, Christian Julian/0000-0001-9928-3968; Alcantara,
   Luiz/0000-0002-6769-9931; Lourenco, Jose/0000-0002-9318-2581; Recker,
   Mario/0000-0001-9489-1315
FU European Research CouncilEuropean Research Council (ERC) [268904 -
   DIVERSITY, 614725-PATHPHYLODYN]; Wellcome TrustWellcome Trust
   [204311/Z/16/Z]; Royal SocietyRoyal Society of London [204311/Z/16/Z];
   International Development Emerging Pandemic Threats Program-2
   [AID-OAA-A-14-00102]; Labex EpiGenMed [ANR-10-LABX-12-01]; Engineering
   and Physical Sciences Research CouncilEngineering & Physical Sciences
   Research Council (EPSRC); Royal SocietyRoyal Society of London
FX Funder Grant reference number Author; European Research Council 268904 -
   DIVERSITY Jose Lourenco Andrew Walker; Wellcome Trust and Royal Society
   204311/Z/16/Z Nuno Rodrigues Faria; International Development Emerging
   Pandemic Threats Program-2 AID-OAA-A-14-00102 Moritz UG Kraemer; Labex
   EpiGenMed ANR-10-LABX-12-01 Christian Julian Villabona-Arenas;
   Engineering and Physical Sciences Research Council Ben Lambert; European
   Research Council 614725-PATHPHYLODYN Oliver G Pybus; Royal Society Mario
   Recker; The funders had no role in study design, data collection and
   interpretation, or the decision to submit the work for publication.
CR Alto BW, 2001, J MED ENTOMOL, V38, P646, DOI 10.1603/0022-2585-38.5.646
   Aman MJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004702
   Andraud M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049085
   Bewick S., 2016, ZIKA VIRUS ENDEMIC V
   Bicout DJ, 2004, VECTOR-BORNE ZOONOT, V4, P33, DOI 10.1089/153036604773082979
   Bogoch II, 2016, LANCET INFECT DIS, V16, P1237, DOI 10.1016/S1473-3099(16)30270-5
   Brady OJ, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-351
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brazil BDMEP, 1961, BANC DAD MET ENS PES
   Brazil SINAN, 2016, SIST INF AGR NOT
   Brazil ZG, 2016, NAT GUID ZIK VIR PAT
   Butler Declan, 2016, Nature, V530, P13, DOI 10.1038/nature.2016.19259
   Caminade C, 2017, P NATL ACAD SCI USA, V114, P119, DOI 10.1073/pnas.1614303114
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Carlson CJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004968
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Champagne C, 2016, ELIFE, V5, DOI [10.7554/eLife.19874.001, 10.7554/eLife.19874]
   Chowell G., 2016, PLOS CURRENTS, V8
   de Araujo TV, 2016, LANCET INFECT DIS
   de Oliveira WK, 2017, LANCET, V390, P861, DOI 10.1016/S0140-6736(17)31368-5
   De Santis M, 2006, REPROD TOXICOL, V21, P390, DOI 10.1016/j.reprotox.2005.01.014
   Dickerson CZ., 2007, DOCTOR OF PHILOS
   Dorigatti I, 2013, P NATL ACAD SCI USA, V110, P13422, DOI 10.1073/pnas.1303117110
   Dowall SD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004658
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   EUROCAT, 2003, EUR SURV CONG AN FIN
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213, DOI 10.1017/S0022172400025997
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Faria N. R., 2016, PLOS CURRENTS, V8
   Faria NR, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0356-2
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Feldstein LR, 2015, T ROY SOC TROP MED H, V109, P303, DOI 10.1093/trstmh/trv012
   Ferguson NM, 2016, SCIENCE, V353, P353, DOI 10.1126/science.aag0219
   FOCKS DA, 1995, AM J TROP MED HYG, V53, P489, DOI 10.4269/ajtmh.1995.53.489
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Funk S, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005173
   Gao DZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep28070
   Golden Gate Weather Services, 2017, NIN NIN YEARS INT BA
   Hii YL, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001908
   Cuong HQ, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001322
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Hugo LE, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002669
   Jaenisch T, 2016, B WORLD HEALTH ORGAN, P1
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Kraemer MUG, 2017, LANCET INFECT DIS, V17, P330, DOI [10.1016/s1473-3099(16)30513-8, 10.1016/S1473-3099(16)30513-8]
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Kucharski AJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004726
   Lambrechts L, 2011, P NATL ACAD SCI USA, V108, P7460, DOI 10.1073/pnas.1101377108
   Lampoudi S, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3074302
   Xuan LTT, 2014, GLOBAL HEALTH ACTION, V7, P52, DOI 10.3402/gha.v7.23119
   Lessler J, 2016, B WORLD HEALTH ORGAN, V94, P841, DOI 10.2471/BLT.16.174540
   Li MI, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001792
   Lounibos LP, 2008, J AM MOSQUITO CONTR, V24, P11, DOI 10.2987/5656.1
   Lourenco J, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003083
   Lourenco J, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003308
   Madeira NG, 2002, MEM I OSWALDO CRUZ, V97, P415, DOI 10.1590/S0074-02762002000300025
   Maxian  O., 2017, EPIDEMICS
   Messina JP, 2016, ELIFE, V5, DOI 10.7554/eLife.15272
   Moghadas SM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05013-9
   Mohammed A, 2011, ACTA TROP, V119, P38, DOI 10.1016/j.actatropica.2011.04.004
   Mordecai E, 2016, TEMPERATURE DETERMIN
   Mourya DT, 2004, AM J TROP MED HYG, V70, P346, DOI 10.4269/ajtmh.2004.70.346
   Naccache SN, 2016, EMERG INFECT DIS, V22, P1788, DOI 10.3201/eid2210.160663
   Naing ZW, 2016, AUST NZ J OBSTET GYN, V56, P9, DOI 10.1111/ajo.12408
   Nishiura H, 2016, INT J INFECT DIS, V45, P95, DOI 10.1016/j.ijid.2016.02.017
   Otero M, 2006, B MATH BIOL, V68, P1945, DOI 10.1007/s11538-006-9067-y
   Perkins TA, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.126, 10.1038/nmicrobiol.2016.126]
   Poletti P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018860
   Rossi MM, 2015, ANN BIOMETRICS BIOST, V2, P1
   Rubin EJ, 2016, NEW ENGL J MED, V374, P984, DOI 10.1056/NEJMe1601862
   Salje H, 2016, J INFECT DIS, V213, P604, DOI 10.1093/infdis/jiv470
   SCHOOLFIELD RM, 1981, J THEOR BIOL, V88, P719, DOI 10.1016/0022-5193(81)90246-0
   Silva MMO, 2016, EMERG INFECT DIS, V22, P336, DOI 10.3201/eid2202.150495
   de Araujo JSS, 2016, B WORLD HEALTH ORGAN, V94, P835, DOI 10.2471/BLT.16.170639
   Nunes MRT, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0348-x
   Tran A, 2013, INT J ENV RES PUB HE, V10, P1698, DOI 10.3390/ijerph10051698
   TRPIS M, 1986, AM J TROP MED HYG, V35, P1263, DOI 10.4269/ajtmh.1986.35.1263
   TRPIS M, 1995, J MED ENTOMOL, V32, P27, DOI 10.1093/jmedent/32.1.27
   Turmel JM, 2016, LANCET, V387, P2501, DOI 10.1016/S0140-6736(16)30775-9
   van Panhuis WG, 2015, P NATL ACAD SCI USA, V112, P13069, DOI 10.1073/pnas.1501375112
   Wearing HJ, 2006, P NATL ACAD SCI USA, V103, P11802, DOI 10.1073/pnas.0602960103
   WHO, 2016, MOSQ VECT CONTR EM R
   WHO, 2016, WHO BRAZ STAT
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
   World Health Organization (WHO), 2016, WHO DIR GEN SUMM OUT
   Yakob L, 2016, LANCET INFECT DIS, V16, P1100, DOI 10.1016/S1473-3099(16)30324-3
   Yang HM, 2009, EPIDEMIOL INFECT, V137, P1188, DOI 10.1017/S0950268809002040
   YASUNO M, 1970, B WORLD HEALTH ORGAN, V43, P319
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zhang Q, 2016, PROJECTED SPREAD ZIK
   ZIBRA, 2016, ZIK BRAZ REAL TIM AN
NR 91
TC 24
Z9 24
U1 0
U2 19
PU ELIFE SCIENCES PUBLICATIONS LTD
PI CAMBRIDGE
PA SHERATON HOUSE, CASTLE PARK, CAMBRIDGE, CB3 0AX, ENGLAND
SN 2050-084X
J9 ELIFE
JI eLife
PD SEP 9
PY 2017
VL 6
AR e29820
DI 10.7554/elife.29820
PG 25
WC Biology
SC Life Sciences & Biomedicine - Other Topics
GA FJ9HC
UT WOS:000413083000001
PM 28887877
OA DOAJ Gold, Green Published, Green Accepted
DA 2020-10-22
ER

PT J
AU Faria, NR
   Quick, J
   Claro, IM
   Theze, J
   de Jesus, JG
   Giovanetti, M
   Kraemer, MUG
   Hill, SC
   Black, A
   da Costa, AC
   Franco, LC
   Silva, SP
   Wu, CH
   Raghwani, J
   Cauchemez, S
   du Plessis, L
   Verotti, MP
   de Oliveira, WK
   Carmo, EH
   Coelho, GE
   Santelli, ACFS
   Vinhal, LC
   Henriques, CM
   Simpson, JT
   Loose, M
   Andersen, KG
   Grubaugh, ND
   Somasekar, S
   Chiu, CY
   Munoz-Medina, JE
   Gonzalez-Bonilla, CR
   Arias, CF
   Lewis-Ximenez, LL
   Baylis, SA
   Chieppe, AO
   Aguiar, SF
   Fernandes, CA
   Lemos, PS
   Nascimento, BLS
   Monteiro, HAO
   Siqueira, IC
   de Queiroz, MG
   de Souza, TR
   Bezerra, JF
   Lemos, MR
   Pereira, GF
   Loudal, D
   Moura, LC
   Dhalia, R
   Franca, RF
   Magalhaes, T
   Marques, ET
   Jaenisch, T
   Wallau, GL
   de Lima, MC
   Nascimento, V
   de Cerqueira, EM
   de Lima, MM
   Mascarenhas, DL
   Neto, JPM
   Levin, AS
   Tozetto-Mendoza, TR
   Fonseca, SN
   Mendes-Correa, MC
   Milagres, FP
   Segurado, A
   Holmes, EC
   Rambaut, A
   Bedford, T
   Nunes, MRT
   Sabino, EC
   Alcantara, LCJ
   Loman, NJ
   Pybus, OG
AF Faria, N. R.
   Quick, J.
   Claro, I. M.
   Theze, J.
   de Jesus, J. G.
   Giovanetti, M.
   Kraemer, M. U. G.
   Hill, S. C.
   Black, A.
   da Costa, A. C.
   Franco, L. C.
   Silva, S. P.
   Wu, C. -H.
   Raghwani, J.
   Cauchemez, S.
   du Plessis, L.
   Verotti, M. P.
   de Oliveira, W. K.
   Carmo, E. H.
   Coelho, G. E.
   Santelli, A. C. F. S.
   Vinhal, L. C.
   Henriques, C. M.
   Simpson, J. T.
   Loose, M.
   Andersen, K. G.
   Grubaugh, N. D.
   Somasekar, S.
   Chiu, C. Y.
   Munoz-Medina, J. E.
   Gonzalez-Bonilla, C. R.
   Arias, C. F.
   Lewis-Ximenez, L. L.
   Baylis, S. A.
   Chieppe, A. O.
   Aguiar, S. F.
   Fernandes, C. A.
   Lemos, P. S.
   Nascimento, B. L. S.
   Monteiro, H. A. O.
   Siqueira, I. C.
   de Queiroz, M. G.
   de Souza, T. R.
   Bezerra, J. F.
   Lemos, M. R.
   Pereira, G. F.
   Loudal, D.
   Moura, L. C.
   Dhalia, R.
   Franca, R. F.
   Magalhaes, T.
   Marques, E. T., Jr.
   Jaenisch, T.
   Wallau, G. L.
   de Lima, M. C.
   Nascimento, V.
   de Cerqueira, E. M.
   de Lima, M. M.
   Mascarenhas, D. L.
   Moura Neto, J. P.
   Levin, A. S.
   Tozetto-Mendoza, T. R.
   Fonseca, S. N.
   Mendes-Correa, M. C.
   Milagres, F. P.
   Segurado, A.
   Holmes, E. C.
   Rambaut, A.
   Bedford, T.
   Nunes, M. R. T.
   Sabino, E. C.
   Alcantara, L. C. J.
   Loman, N. J.
   Pybus, O. G.
TI Establishment and cryptic transmission of Zika virus in Brazil and the
   Americas
SO NATURE
LA English
DT Article
ID PHYLOGENETIC ANALYSIS; EVOLUTION; TIME; EMERGENCE; MODELS; DENGUE;
   BAHIA; RECOMBINATION; SEQUENCES; SELECTION
AB Transmission of Zika virus (ZIKV) in the Americas was first confirmed in May 2015 in northeast Brazil(1). Brazil has had the highest number of reported ZIKV cases worldwide (more than 200,000 by 24 December 20162) and the most cases associated with microcephaly and other birth defects (2,366 confirmed by 31 December 20162). Since the initial detection of ZIKV in Brazil, more than 45 countries in the Americas have reported local ZIKV transmission, with 24 of these reporting severe ZIKV-associated disease(3). However, the origin and epidemic history of ZIKV in Brazil and the Americas remain poorly understood, despite the value of this information for interpreting observed trends in reported microcephaly. Here we address this issue by generating 54 complete or partial ZIKV genomes, mostly from Brazil, and reporting data generated by a mobile genomics laboratory that travelled across northeast Brazil in 2016. One sequence represents the earliest confirmed ZIKV infection in Brazil. Analyses of viral genomes with ecological and epidemiological data yield an estimate that ZIKV was present in northeast Brazil by February 2014 and is likely to have disseminated from there, nationally and internationally, before the first detection of ZIKV in the Americas. Estimated dates for the international spread of ZIKV from Brazil indicate the duration of pre-detection cryptic transmission in recipient regions. The role of northeast Brazil in the establishment of ZIKV in the Americas is further supported by geographic analysis of ZIKV transmission potential and by estimates of the basic reproduction number of the virus.
C1 [Faria, N. R.; Theze, J.; Kraemer, M. U. G.; Hill, S. C.; Raghwani, J.; du Plessis, L.; Pybus, O. G.] Univ Oxford, Dept Zool, Oxford OX1 3SY, England.
   [Faria, N. R.; Franco, L. C.; Silva, S. P.; Lemos, P. S.; Nascimento, B. L. S.; Monteiro, H. A. O.; Nunes, M. R. T.] Minist Hlth, Evandro Chagas Inst, Ananindeua, Brazil.
   [Quick, J.; Loman, N. J.] Univ Birmingham, Inst Microbiol & Infect, Birmingham, W Midlands, England.
   [Claro, I. M.; da Costa, A. C.; Levin, A. S.; Tozetto-Mendoza, T. R.; Mendes-Correa, M. C.; Segurado, A.; Sabino, E. C.] Univ Sao Paulo, Sch Med, Dept Infect Dis, Sao Paulo, Brazil.
   [Claro, I. M.; da Costa, A. C.; Levin, A. S.; Tozetto-Mendoza, T. R.; Mendes-Correa, M. C.; Segurado, A.; Sabino, E. C.] Univ Sao Paulo, Inst Trop Med, Sao Paulo, Brazil.
   [de Jesus, J. G.; Giovanetti, M.; Siqueira, I. C.; Alcantara, L. C. J.] Fiocruz MS, Fundacao Oswaldo Cruz, Salvador, BA, Brazil.
   [Giovanetti, M.] Univ Roma Tor Vergata, Rome, Italy.
   [Kraemer, M. U. G.] Harvard Med Sch, Boston, MA USA.
   [Kraemer, M. U. G.] Boston Childrens Hosp, Boston, MA USA.
   [Black, A.; Bedford, T.] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, 1124 Columbia St, Seattle, WA 98104 USA.
   [Black, A.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA.
   [Wu, C. -H.] Univ Oxford, Dept Stat, Oxford OX1 3LB, England.
   [Cauchemez, S.] Inst Pasteur, Math Modelling Infect Dis, Paris, France.
   [Cauchemez, S.] Inst Pasteur, Ctr Bioinformat Biostat & Integrat Biol, Paris, France.
   [Cauchemez, S.] Ctr Natl Rech Sci, URA3012, Paris, France.
   [Verotti, M. P.] Minist Hlth, Coordena Lab Saude CGLAB DEVIT SVS, Brasilia, DF, Brazil.
   [de Oliveira, W. K.] Minist Hlth, Coordena Geral Vigilincia & Resposta Emergencias, Brasilia, DF, Brazil.
   [de Oliveira, W. K.] Fundacao Oswaldo Cruz FIOCRUZ, Ctr Data & Knowledge Integrat Hlth CIDACS, Salvador, BA, Brazil.
   [Carmo, E. H.; Henriques, C. M.] Minist Hlth, Dept Vigilincia Doencas Transmissiveis, Brasilia, DF, Brazil.
   [Coelho, G. E.; Santelli, A. C. F. S.; Vinhal, L. C.] Minist Hlth, Coordena Geral Programas Controle & Preven Malari, Brasilia, DF, Brazil.
   [Coelho, G. E.] PAHO, Buenos Aires, DF, Argentina.
   [Santelli, A. C. F. S.] Fundacao Oswaldo Cruz FIOCRUZ, Rio De Janeiro, Brazil.
   [Simpson, J. T.] Ontario Inst Canc Res, Toronto, ON, Canada.
   [Loose, M.] Univ Nottingham, Nottingham, England.
   [Andersen, K. G.; Grubaugh, N. D.] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA.
   [Somasekar, S.; Chiu, C. Y.] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA.
   [Somasekar, S.; Chiu, C. Y.] Univ Calif San Francisco, Dept Med Infect & Dis, San Francisco, CA 94143 USA.
   [Munoz-Medina, J. E.; Gonzalez-Bonilla, C. R.] Inst Mexicano Seguro Social, Div Labs Vigilancia & Invest Epidemiol, Mexico City, DF, Mexico.
   [Arias, C. F.] Univ Nacl Autonoma Mexico, Inst Biotecnol, Cuernavaca, Morelos, Mexico.
   [Lewis-Ximenez, L. L.] Inst Oswaldo Cruz FIOCRUZ, Rio De Janeiro, Brazil.
   [Baylis, S. A.] Paul Ehrlich Inst, Langen, Germany.
   [Chieppe, A. O.; Aguiar, S. F.; Fernandes, C. A.] Lab Cent Saude Publ Noel Nutels, Rio De Janeiro, Brazil.
   [de Queiroz, M. G.; de Souza, T. R.; Bezerra, J. F.] Labo Cent Saude Publ Estado Rio Grande Norte, Natal, RN, Brazil.
   [de Souza, T. R.] Univ Potiguar Rio Grande Norte, Natal, RN, Brazil.
   [Bezerra, J. F.] Fundacao Natalense Ensino & Cultura, Natal, RN, Brazil.
   [Lemos, M. R.; Pereira, G. F.; Loudal, D.; Moura, L. C.] Lab Cent Saude Publ Estado Paraiba, Joao Pessoa, Paraiba, Brazil.
   [Dhalia, R.; Franca, R. F.; Magalhaes, T.; Marques, E. T., Jr.; Wallau, G. L.] Fundacao Oswaldo Cruz FIOCRUZ, Recife, PE, Brazil.
   [Magalhaes, T.] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.
   Univ Pittsburgh, Grad Sch Publ Hlth, Ctr Vaccine Res, Pittsburgh, PA USA.
   [Jaenisch, T.] Univ Heidelberg Hosp, Dept Infect Dis, Sect Clin Trop Med, Heidelberg, Germany.
   [de Lima, M. C.; Nascimento, V.; de Cerqueira, E. M.] Lab Cent Saude Publ Estado Alagoas, Maceio, Brazil.
   [de Lima, M. M.] Univ Estadual Feira de Santana, Feira Santana, Bahia, Argentina.
   [Mascarenhas, D. L.] Secretaria Saude Feira Santana, Feira De Santana, Bahia, Brazil.
   [Moura Neto, J. P.] Univ Fed Amazonas, Manaus, Amazonas, Brazil.
   [Fonseca, S. N.] Hosp Sao Francisco, Ribeirao Preto, Brazil.
   [Milagres, F. P.] Univ Fed Tocantins, Palmas, Brazil.
   [Holmes, E. C.] Univ Sydney, Sydney, NSW, Australia.
   [Rambaut, A.] Univ Edinburgh, Inst Evolutionary Biol, Edinburgh EH9 3FL, Midlothian, Scotland.
   [Rambaut, A.] NIH, Fogarty Int Ctr, Bldg 10, Bethesda, MD 20892 USA.
   [Nunes, M. R. T.] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA.
   [Pybus, O. G.] Metabiota, San Francisco, CA 94104 USA.
RP Pybus, OG (corresponding author), Univ Oxford, Dept Zool, Oxford OX1 3SY, England.; Loman, NJ (corresponding author), Univ Birmingham, Inst Microbiol & Infect, Birmingham, W Midlands, England.; Sabino, EC (corresponding author), Univ Sao Paulo, Sch Med, Dept Infect Dis, Sao Paulo, Brazil.; Sabino, EC (corresponding author), Univ Sao Paulo, Inst Trop Med, Sao Paulo, Brazil.; Alcantara, LCJ (corresponding author), Fiocruz MS, Fundacao Oswaldo Cruz, Salvador, BA, Brazil.; Pybus, OG (corresponding author), Metabiota, San Francisco, CA 94104 USA.
EM sabinoec@usp.br; lalcan@bahia.fiocruz.br; n.j.loman@bham.ac.uk;
   oliver.pybus@zoo.ox.ac.uk
RI Esteban, Munoz Medina Jose/B-6186-2015; Faria, Nuno R/I-2975-2012;
   da-Costa, Antonio Charlys/G-1548-2010; Giovanetti, Marta/AAK-7408-2020;
   Bezerra, Joao Felipe/AAE-2500-2020; Levin, Anna S/C-8831-2012; Bezerrra,
   Joao/C-8867-2017; Rambaut, Andrew/B-2481-2009; Oliveira, Claudia
   DL/G-8618-2011; Arias, Carlos/O-4036-2019; Loman, Nicholas/Z-1573-2019;
   Pybus, Oliver G/B-2640-2012; Dhalia, Rafael/AAD-5432-2020; Wallau,
   Gabriel Luz/B-5911-2008; de Siqueira, Isadora Cristina/R-9953-2016;
   milagres, flavio/Q-2403-2019; Segurado, Aluisio C/K-2229-2012; Sabino,
   Ester Cerdeira/F-7750-2010; Magalhaes, Tereza/V-6632-2019; Marques,
   Ernesto T. A/L-4967-2013
OI Esteban, Munoz Medina Jose/0000-0002-1289-4457; Faria, Nuno
   R/0000-0001-8839-2798; da-Costa, Antonio Charlys/0000-0001-5516-5177;
   Levin, Anna S/0000-0003-2427-8368; Bezerrra, Joao/0000-0002-9978-628X;
   Rambaut, Andrew/0000-0003-4337-3707; Arias, Carlos/0000-0003-3130-4501;
   Pybus, Oliver G/0000-0002-8797-2667; Wallau, Gabriel
   Luz/0000-0002-1419-5713; de Siqueira, Isadora
   Cristina/0000-0002-2520-4099; Segurado, Aluisio C/0000-0002-6311-8036;
   Sabino, Ester Cerdeira/0000-0003-2623-5126; Marques, Ernesto T.
   A/0000-0003-3826-9358; Freitas de Oliveira Franca,
   Rafael/0000-0002-1846-6007; Grubaugh, Nathan/0000-0003-2031-1933; Vinhal
   Frutuoso, Livia Carla/0000-0001-7926-1075; Loose,
   Matthew/0000-0002-5264-0929; Alcantara, Luiz/0000-0002-6769-9931;
   Giovanetti, Marta/0000-0002-5849-7326; Holmes,
   Edward/0000-0001-9596-3552; Black, Allison/0000-0002-6618-4127; Wu,
   Chieh-Hsi/0000-0001-9386-725X; Loman, Nicholas/0000-0002-9843-8988;
   Theze, Julien/0000-0001-8188-9494; Raghwani, Jayna/0000-0001-8538-4995;
   Hill, Sarah/0000-0002-2995-2596
FU MRC/Wellcome Trust/Newton Fund Zika Rapid Response grant
   [MC_PC_15100/ZK/16-078]; USAID Emerging Pandemic Threats Program-2
   PREDICT-2United States Agency for International Development (USAID)
   [AID-OAA-A-14-00102]; MRC Bioinformatics Fellowship; Sir Henry Dale
   Fellowship [204311/Z/16/Z]; CNPqNational Council for Scientific and
   Technological Development (CNPq) [457480/2014-9, 302584/2015-3,
   439975/2016-6]; FAPESPFundacao de Amparo a Pesquisa do Estado de Sao
   Paulo (FAPESP) [2012/03417-7]; NIHUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USA [R35 GM119774,
   R01 HL105704]; NSFNational Science Foundation (NSF) [DGE-1256082];
   Abbott Laboratories, Inc.Abbott Laboratories; National Health and
   Medical Research CouncilNational Health and Medical Research Council of
   Australia [GNT1037231]; MRCMedical Research Council UK (MRC); CRUKCancer
   Research UK [ANR00310]; Wellcome TrustWellcome Trust; Royal SocietyRoyal
   Society of London [101237/Z/13/Z]; ERCEuropean Research Council (ERC)
   [614725-PATHPHYLODYN, 278433-PREDEMICS]; EUEuropean Union (EU)
   [643476-COMPARE, 734548-ZIKAlliance]; IDAMS; DENFREE; DengueTools;
   PPSUSFACEPE [APQ-0302-4.01/13]; FACEPE [APQ-0044.2.11/16,
   APQ-0055.2.11/16]; German Ministry of Health
FX We thank Fundacao Oswaldo Cruz in Bahia and Pernambuco states,
   University of Sao Paulo, Instituto Evandro Chagas, and the Brazilian
   Zika virus surveillance network for their essential contributions. We
   thank the following for giving us permission to use their unpublished
   genomes available on GenBank: R. Lanciotti, J. Lednicky, A. Enfissi, F.
   Baldanti, R. Shabman, B. Picket, R. Schinazi, M. Bonaldo, M. Gale, M.
   Capobianchi and C. Concetta, M. Leguia, J. Alberto Diaz, E.
   Sevilla-Reyes, A. Franz, M. GarciaBlanco and M. J. van Hemert. We thank
   P. Fernando da Costa Vasconcelos, S. Guerreiro Rodrigues, J. Cardoso, J.
   Vasconcelos, J. Vianez Jr, J. Gil Melgaco, J. Blumel, M. C. Brito
   Lobato, L. Nunes Fava, C. Ayres, L. Abade and F. Campos. L. C. J. A.
   thanks QIAGEN for reagents and equipment and M. R. T. N. thanks FERPEL
   for consumables. We thank Oxford Nanopore for technical support,
   particularly R. Dokos, Z. McDougall, S. Cowan, G. Sanghera, and O.
   Hartwell. This work was supported by an MRC/Wellcome Trust/Newton Fund
   Zika Rapid Response grant (MC_PC_15100/ZK/16-078) and by the USAID
   Emerging Pandemic Threats Program-2 PREDICT-2 (Cooperative Agreement
   AID-OAA-A-14-00102). N. J. L. is supported by an MRC Bioinformatics
   Fellowship. N. R. F. is funded by a Sir Henry Dale Fellowship (grant
   204311/Z/16/Z). CNPq contributed to trip expenses (grant 457480/2014-9).
   A.C.d.C. was supported by FAPESP # 2012/03417-7 and M. R. T. N. by CNPq
   grant no. 302584/2015-3. A. B. and T. B. were supported by NIH award R35
   GM119774. A. B. is supported by the NSF Graduate Research Fellowship
   Program (grant DGE-1256082). T. B. is a Pew Biomedical Scholar. C.Y.C.
   is partially supported by NIH grant R01 HL105704 and an award from
   Abbott Laboratories, Inc. E. C. H. is supported by a National Health and
   Medical Research Council Australia Fellowship (GNT1037231). C.- H. W. is
   supported by the MRC and CRUK (ANR00310) and by the Wellcome Trust and
   Royal Society (grant 101237/Z/13/Z). S. C. H. is supported by the
   Wellcome Trust. This research received funding from the ERC under grant
   agreements 614725-PATHPHYLODYN and 278433-PREDEMICS, and from EU Horizon
   2020 under agreements 643476-COMPARE and 734548-ZIKAlliance. T. J. and
   E. T. M. acknowledge funding from IDAMS, DENFREE, DengueTools, and
   PPSUSFACEPE (project APQ-0302-4.01/13). R. F. F. received funding from
   FACEPE (APQ-0044.2.11/16 and APQ-0055.2.11/16) and from CNPq
   (439975/2016-6). S. A. B. was supported by the Sicherheit von Blut und
   Geweben hinsichtlich der Abwesenheit von Zikaviren from the German
   Ministry of Health.
CR [Anonymous], 2014, R LANG ENV COMP
   Baele G, 2013, MOL BIOL EVOL, V30, P239, DOI 10.1093/molbev/mss243
   Bogoch II, 2016, LANCET INFECT DIS, V16, P1237, DOI 10.1016/S1473-3099(16)30270-5
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Bouckaert R, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003537
   Bruen TC, 2006, GENETICS, V172, P2665, DOI 10.1534/genetics.105.048975
   Caminade C, 2017, P NATL ACAD SCI USA, V114, P119, DOI 10.1073/pnas.1614303114
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cori A, 2013, AM J EPIDEMIOL, V178, P1505, DOI 10.1093/aje/kwt133
   Corman VM, 2016, B WORLD HEALTH ORGAN, V94, P880, DOI 10.2471/BLT.16.175950
   Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109
   De Maio N, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005421
   Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075
   Edwards CJ, 2011, CURR BIOL, V21, P1251, DOI 10.1016/j.cub.2011.05.058
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Ferguson NM, 2016, SCIENCE, V353, P353, DOI 10.1126/science.aag0219
   Ferreira MAR, 2008, CAN J STAT, V36, P355, DOI 10.1002/cjs.5550360302
   Gharbi M, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-166
   Giovanetti M, 2016, INFECT GENET EVOL, V41, P142, DOI 10.1016/j.meegid.2016.03.030
   Grubaugh N. D., 2017, NATURE
   Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010
   HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694
   Cuong HQ, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001322
   Holmes EC, 2003, J VIROL, V77, P11296, DOI 10.1128/JVI.77.20.11296-11298.2003
   Holmes EC, 2016, NATURE, V538, P193, DOI 10.1038/nature19790
   Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030
   Kindhauser MK, 2016, B WORLD HEALTH ORGAN, V94, P675, DOI 10.2471/BLT.16.171082
   Kozlov AM, 2015, BIOINFORMATICS, V31, P2577, DOI 10.1093/bioinformatics/btv184
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lemey P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000520
   Lessler J, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8160
   Lessler J, 2016, B WORLD HEALTH ORGAN, V94, P841, DOI 10.2471/BLT.16.174540
   Liu H, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.109
   Liu-Helmersson J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089783
   Martin DP, 2015, VIRUS EVOL, V1, DOI 10.1093/ve/vev003
   Metsky HC, 2017, NATURE
   Minin VN, 2008, PHILOS T R SOC B, V363, P3985, DOI 10.1098/rstb.2008.0176
   Ministerio da Saade, 2017, B EP SECR VIG SAUD
   Naccache SN, 2016, EMERG INFECT DIS, V22, P1788, DOI 10.3201/eid2210.160663
   O'Brien JD, 2009, MOL BIOL EVOL, V26, P801, DOI 10.1093/molbev/msp003
   Pacheco O., 2016, NEW ENGL J MED
   PAHO/WHO, 2016, PAHO WHO ZIK EP UPD
   Park DJ, 2015, CELL, V161, P1516, DOI 10.1016/j.cell.2015.06.007
   Paules CI, 2017, NEW ENGL J MED, V376, P1397, DOI 10.1056/NEJMp1702172
   Perkins TA, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.126, 10.1038/nmicrobiol.2016.126]
   Pettersson JHO, 2016, MBIO, V7, DOI [10.1128/mBio.01239-16, 10.1128/mbio.01239-16]
   Pond SLK, 2005, MOL BIOL EVOL, V22, P1208, DOI 10.1093/molbev/msi105
   Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079
   Quick J., 2017, NAT PROTOCOLS
   Quick J, 2016, NATURE, V530, P228, DOI 10.1038/nature16996
   Rambaut A, 2016, VIRUS EVOL, V2, DOI 10.1093/ve/vew007
   Rocklov J, 2016, EBIOMEDICINE, V9, P250, DOI 10.1016/j.ebiom.2016.06.009
   Schierup MH, 2000, GENETICS, V156, P879
   Shapiro B, 2006, MOL BIOL EVOL, V23, P7, DOI 10.1093/molbev/msj021
   Trosemeier J-H, 2016, GENOME ANNOUNC, V4
   Vasconcelos PFC, 2016, VECTOR-BORNE ZOONOT, V16, P295, DOI 10.1089/vbz.2016.1952
   Vogel G, 2016, SCIENCE, V354, P1088, DOI 10.1126/science.354.6316.1088
   Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1
   World Health Organization, 2017, SIT REP ZIK VIR MICR
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 62
TC 223
Z9 227
U1 9
U2 80
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0028-0836
EI 1476-4687
J9 NATURE
JI Nature
PD JUN 15
PY 2017
VL 546
IS 7658
BP 406
EP +
DI 10.1038/nature22401
PG 18
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EX5BK
UT WOS:000403250900035
PM 28538727
OA Green Accepted, Green Published
DA 2020-10-22
ER

PT J
AU Quick, J
   Grubaugh, ND
   Pullan, ST
   Claro, IM
   Smith, AD
   Gangavarapu, K
   Oliveira, G
   Robles-Sikisaka, R
   Rogers, TF
   Beutler, NA
   Burton, DR
   Lewis-Ximenez, LL
   de Jesus, JG
   Giovanetti, M
   Hill, SC
   Black, A
   Bedford, T
   Carroll, MW
   Nunes, M
   Alcantara, LC
   Sabino, EC
   Baylis, SA
   Faria, NR
   Loose, M
   Simpson, JT
   Pybus, OG
   Andersen, KG
   Loman, NJ
AF Quick, Joshua
   Grubaugh, Nathan D.
   Pullan, Steven T.
   Claro, Ingra M.
   Smith, Andrew D.
   Gangavarapu, Karthik
   Oliveira, Glenn
   Robles-Sikisaka, Refugio
   Rogers, Thomas F.
   Beutler, Nathan A.
   Burton, Dennis R.
   Lewis-Ximenez, Lia Laura
   de Jesus, Jaqueline Goes
   Giovanetti, Marta
   Hill, Sarah C.
   Black, Allison
   Bedford, Trevor
   Carroll, Miles W.
   Nunes, Marcio
   Alcantara, Luiz Carlos, Jr.
   Sabino, Ester C.
   Baylis, Sally A.
   Faria, Nuno R.
   Loose, Matthew
   Simpson, Jared T.
   Pybus, Oliver G.
   Andersen, Kristian G.
   Loman, Nicholas J.
TI Multiplex PCR method for MinION and Illumina sequencing of Zika and
   other virus genomes directly from clinical samples
SO NATURE PROTOCOLS
LA English
DT Article
ID SURESELECT TARGET ENRICHMENT; REAL-TIME; EBOLA; SURVEILLANCE;
   AMPLIFICATION; EVOLUTION; INSIGHTS; PASSAGES; ROBUST; LASSA
AB Genome sequencing has become a powerful tool for studying emerging infectious diseases; however, genome sequencing directly from clinical samples (i.e., without isolation and culture) remains challenging for viruses such as Zika, for which metagenomic sequencing methods may generate insufficient numbers of viral reads. Here we present a protocol for generating coding-sequence-complete genomes, comprising an online primer design tool, a novel multiplex PCR enrichment protocol, optimized library preparation methods for the portable MinION sequencer (Oxford Nanopore Technologies) and the Illumina range of instruments, and a bioinformatics pipeline for generating consensus sequences. The MinION protocol does not require an Internet connection for analysis, making it suitable for field applications with limited connectivity. Our method relies on multiplex PCR for targeted enrichment of viral genomes from samples containing as few as 50 genome copies per reaction. Viral consensus sequences can be achieved in 1-2 d by starting with clinical samples and following a simple laboratory workflow. This method has been successfully used by several groups studying Zika virus evolution and is facilitating an understanding of the spread of the virus in the Americas. The protocol can be used to sequence other viral genomes using the online Primal Scheme primer designer software. It is suitable for sequencing either RNA or DNA viruses in the field during outbreaks or as an inexpensive, convenient method for use in the lab.
C1 [Quick, Joshua; Smith, Andrew D.; Loman, Nicholas J.] Univ Birmingham, Sch Biosci, Inst Microbiol & Infect, Birmingham, W Midlands, England.
   [Grubaugh, Nathan D.; Gangavarapu, Karthik; Robles-Sikisaka, Refugio; Rogers, Thomas F.; Beutler, Nathan A.; Burton, Dennis R.; Andersen, Kristian G.] Scripps Res Inst, La Jolla, CA 92037 USA.
   [Pullan, Steven T.; Carroll, Miles W.; Andersen, Kristian G.] Publ Hlth England, Natl Infect Serv, Salisbury, Wilts, England.
   [Claro, Ingra M.; Sabino, Ester C.] Univ Sao Paulo, Dept Infect Dis, Sao Paulo, Brazil.
   [Claro, Ingra M.; Sabino, Ester C.] Univ Sao Paulo, Inst Trop Med, Sao Paulo, Brazil.
   [Oliveira, Glenn; Andersen, Kristian G.] Scripps Translat Sci Inst, La Jolla, CA USA.
   [Rogers, Thomas F.] Massachusetts Gen Hosp, Boston, MA 02114 USA.
   [Lewis-Ximenez, Lia Laura] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Rio De Janeiro, Brazil.
   [de Jesus, Jaqueline Goes; Giovanetti, Marta; Alcantara, Luiz Carlos, Jr.] Fiocruz MS, Fundacao Oswaldo Cruz, Salvador, BA, Brazil.
   [Giovanetti, Marta] Univ Rome, Tor Vergata, Italy.
   [Hill, Sarah C.; Faria, Nuno R.; Pybus, Oliver G.] Univ Oxford, Dept Zool, Oxford, England.
   [Black, Allison; Bedford, Trevor] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, 1124 Columbia St, Seattle, WA 98104 USA.
   [Black, Allison] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA.
   [Carroll, Miles W.] Univ Southampton, South Gen Hosp, Southampton, Hants, England.
   [Nunes, Marcio] Inst Evandro Chagas, Belem, Para, Brazil.
   [Baylis, Sally A.] Paul Ehrlich Inst, Langen, Germany.
   [Loose, Matthew] Univ Nottingham, Sch Life Sci, DeepSeq, Nottingham, England.
   [Simpson, Jared T.] OICR, Toronto, ON, Canada.
RP Loman, NJ (corresponding author), Univ Birmingham, Sch Biosci, Inst Microbiol & Infect, Birmingham, W Midlands, England.
EM n.j.loman@bham.ac.uk
RI Giovanetti, Marta/AAK-7408-2020; Pybus, Oliver G/B-2640-2012; Loman,
   Nicholas/Z-1573-2019; Faria, Nuno R/I-2975-2012; Sabino, Ester
   Cerdeira/F-7750-2010
OI Pybus, Oliver G/0000-0002-8797-2667; Faria, Nuno R/0000-0001-8839-2798;
   Sabino, Ester Cerdeira/0000-0003-2623-5126; Pullan,
   Steven/0000-0002-8983-599X; Beutler, Nathan/0000-0003-3240-9524;
   Giovanetti, Marta/0000-0002-5849-7326; Loman,
   Nicholas/0000-0002-9843-8988; Hill, Sarah/0000-0002-2995-2596; Loose,
   Matthew/0000-0002-5264-0929; Grubaugh, Nathan/0000-0003-2031-1933;
   Black, Allison/0000-0002-6618-4127; Alcantara, Luiz/0000-0002-6769-9931
FU Brazilian Ministry of Health and the Latin American Community Engagement
   Networks (LACENs); Medical Research Council/Wellcome Trust/Newton Fund
   Zika Rapid Response Initiative [ZK/16-078]; Medical Research Council
   Bioinformatics Fellowship as part of the Cloud Infrastructure for
   Microbial Bioinformatics (CLIMB) project; National Institutes of Health
   (NIH)United States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [5T32AI007244-33]; NIH National Center
   for Advancing Translational Studies Clinical and Translational Science
   Award [UL1TR001114]; National Institute of Allergy and Infectious
   Diseases (NIAID)United States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [HHSN272201400048C]; NIHUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USA [R35 GM119774, U54 GM111274]; National Science
   Foundation Graduate Research Fellowship ProgramNational Science
   Foundation (NSF) [DGE-1256082]; Sir Henry Dale Fellowship (Wellcome
   Trust/Royal Society) [204311/Z/16/Z]; grant ('Sicherheit von
   Blut(produkten) und Geweben hinsichtlich der Abwesenheit von Zikaviren')
   from the German Ministry of Health; USAID Emerging Pandemic Threats
   Program-2 PREDICT-2United States Agency for International Development
   (USAID) [AID-OAA-A-14-00102]
FX The authors thank the Brazilian Ministry of Health and the Latin
   American Community Engagement Networks (LACENs) of Natal, Joao Pessoa,
   Recife, Maceio and Salvador for their support. We thank T. Fredeking
   from Antibody Systems for providing the Zika virus samples from
   Colombia. We thank K. Brunker for testing the Primal Scheme software.
   The Zika in Brazil Real-time Analysis (ZiBRA) project
   (http://www.zibraproject.org) is supported by the Medical Research
   Council/Wellcome Trust/Newton Fund Zika Rapid Response Initiative (grant
   no, ZK/16-078), which also provides J.Q.'s salary. N.J.L. is supported
   by a Medical Research Council Bioinformatics Fellowship as part of the
   Cloud Infrastructure for Microbial Bioinformatics (CLIMB) project.
   Primal Scheme is hosted on the CLIMB platform, where pipeline
   development and MinION data analysis was performed<SUP>59</SUP>. N.D.G.
   is supported by National Institutes of Health (NIH) training grant
   5T32AI007244-33. K.G.A. is a PEW Biomedical Scholar, and his work is
   supported by NIH National Center for Advancing Translational Studies
   Clinical and Translational Science Award UL1TR001114 and National
   Institute of Allergy and Infectious Diseases (NIAID) contract
   HHSN272201400048C. A.B. and T.B. were supported by NIH awards R35
   GM119774 and U54 GM111274. T.B. is a Pew Biomedical Scholar. A.B. is
   supported by the National Science Foundation Graduate Research
   Fellowship Program under Grant no. DGE-1256082. N.R.F. was funded by a
   Sir Henry Dale Fellowship (Wellcome Trust/Royal Society grant
   204311/Z/16/Z). Work at the Paul-Ehrlich-Institut was supported by a
   grant ('Sicherheit von Blut(produkten) und Geweben hinsichtlich der
   Abwesenheit von Zikaviren') from the German Ministry of Health. This
   study was supported by USAID Emerging Pandemic Threats Program-2
   PREDICT-2 (cooperative agreement AID-OAA-A-14-00102). The contents of
   this article are the responsibility of the authors and do not
   necessarily reflect the views of USAID or the US government.
CR Andersen KG, 2015, CELL, V162, P738, DOI 10.1016/j.cell.2015.07.020
   Arias A, 2016, VIRUS EVOL, V2, DOI 10.1093/ve/vew016
   Atkinson B, 2016, MICROBIOL RESOUR ANN, V4, DOI 10.1128/genomeA.01116-16
   Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021
   Batty EM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066129
   Baylis SA, 2017, TRANSFUSION, V57, P748, DOI 10.1111/trf.14026
   Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170
   Brown JR, 2015, J CLIN VIROL, V70, pS12, DOI 10.1016/j.jcv.2015.07.037
   Brown JR, 2016, J CLIN MICROBIOL, V54, P2530, DOI 10.1128/JCM.01052-16
   Carrillo C, 2007, J VIROL, V81, P11341, DOI 10.1128/JVI.00930-07
   Carroll MW, 2015, NATURE, V524, P97, DOI 10.1038/nature14594
   Chan M, 2016, J APPL LAB MED, V1, P25, DOI 10.1373/jalm.2016.020131
   Connor TR, 2016, MICROB GENOMICS, V2, DOI 10.1099/mgen.0.000086
   Dudas G, 2017, NATURE, V544, P309, DOI 10.1038/nature22040
   Eckert SE, 2016, MICROB GENOMICS, V2, DOI 10.1099/mgen.0.000087
   Faria N. R., 2017, NATURE
   Faria NR, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0356-2
   Gardner Shea N., 2014, Advances in Bioinformatics, V2014, P101894, DOI 10.1155/2014/101894
   Gardy J, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0726-x
   Gire SK, 2014, SCIENCE, V345, P1369, DOI 10.1126/science.1259657
   Goodwin S, 2016, NAT REV GENET, V17, P333, DOI 10.1038/nrg.2016.49
   Greninger AL, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0220-9
   Grubaugh N. D., 2017, NATURE
   Guerbois M, 2016, J INFECT DIS, V214, P1349, DOI 10.1093/infdis/jiw302
   Hoenen T, 2016, EMERG INFECT DIS, V22, P331, DOI 10.3201/eid2202.151796
   Holmes EC, 2016, NATURE, V538, P193, DOI 10.1038/nature19790
   Houldcroft CJ, 2017, NAT REV MICROBIOL, V15, P183, DOI 10.1038/nrmicro.2016.182
   Hysom DA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034560
   Kilianski A, 2016, EMERG INFECT DIS, V22, P1448, DOI 10.3201/eid2208.160270
   Kilianski A, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0051-z
   Koster J, 2012, BIOINFORMATICS, V28, P2520, DOI 10.1093/bioinformatics/bts480
   KWOK S, 1990, NUCLEIC ACIDS RES, V18, P999, DOI 10.1093/nar/18.4.999
   KWOK S, 1994, PCR METH APPL, V3, pS39
   Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324
   Li K, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-261
   Loman NJ, 2012, NAT BIOTECHNOL, V30, P434, DOI 10.1038/nbt.2198
   Mamanova L, 2010, NAT METHODS, V7, P111, DOI 10.1038/nmeth.1419
   Marquez S, 2017, MICROBIOL RESOUR ANN, V5, DOI [10.1128/genomeA.01673-16, 10.1128/genomea.01673-16]
   Matranga CB, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0519-7
   Metsky HC, 2017, NATURE
   Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626
   Milne I, 2010, BIOINFORMATICS, V26, P401, DOI 10.1093/bioinformatics/btp666
   Misencik MJ, 2016, VECTOR-BORNE ZOONOT, V16, P181, DOI 10.1089/vbz.2015.1889
   Naccache SN, 2016, EMERG INFECT DIS, V22, P1788, DOI 10.3201/eid2210.160663
   Nakamura S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004219
   Palacios G, 2008, NEW ENGL J MED, V358, P991, DOI 10.1056/NEJMoa073785
   Quick J, 2016, NATURE, V530, P228, DOI 10.1038/nature16996
   Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754
   Rozen S, 2000, Methods Mol Biol, V132, P365
   Salzberg SL, 2007, EMERG INFECT DIS, V13, P713, DOI 10.3201/eid1305.070013
   Scotto-Lavino E, 2006, NAT PROTOC, V1, P2555, DOI 10.1038/nprot.2006.480
   Sipos B., 2016, BIORXIV
   Thomson E, 2016, J CLIN MICROBIOL, V54, P2470, DOI 10.1128/JCM.00330-16
   Trosemeier J-H, 2016, GENOME ANNOUNC, V4
   Wang J, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00766
   Wilson MR, 2014, NEW ENGL J MED, V370, P2408, DOI 10.1056/NEJMoa1401268
   Worobey M, 2016, NATURE, V539, P98, DOI 10.1038/nature19827
   Yu Q, 2011, BIOINFORMATICS, V27, P266, DOI 10.1093/bioinformatics/btq624
   Yuste E, 2000, J VIROL, V74, P9546, DOI 10.1128/JVI.74.20.9546-9552.2000
NR 59
TC 173
Z9 176
U1 7
U2 104
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1754-2189
EI 1750-2799
J9 NAT PROTOC
JI Nat. Protoc.
PD JUN
PY 2017
VL 12
IS 6
BP 1261
EP 1276
DI 10.1038/nprot.2017.066
PG 16
WC Biochemical Research Methods
SC Biochemistry & Molecular Biology
GA EV9RK
UT WOS:000402122900001
PM 28538739
OA Bronze, Green Published, Green Accepted
DA 2020-10-22
ER

PT J
AU Amaral, AG
   Oliveira, IB
   Carneiro, DC
   Alcantara, LC
   Monteiro-Cunha, JP
AF Amaral, Amanda G. M.
   Oliveira, Isabele B.
   Carneiro, Diego C.
   Alcantara, Luiz C. J.
   Monteiro-Cunha, Joana P.
TI An overview of the molecular and epidemiological features of HIV-1
   infection in two major cities of Bahia state, Brazil
SO MEMORIAS DO INSTITUTO OSWALDO CRUZ
LA English
DT Article
DE HIV subtype; drug resistance; Bahia; genotyping; mutations; epidemiology
ID PRIMARY ANTIRETROVIRAL RESISTANCE; VIRUS TYPE-1 HIV-1; NORTHEAST;
   PREVALENCE; SUBTYPE; MUTATIONS; DIVERSITY; THERAPY
AB BACKGROUND The high mutation rate of the human immunodeficiency virus (HIV) has created a public health challenge because the use of antiretroviral drugs can generate selective pressure that drives resistance in these viruses.
   OBJECTIVE The aim of this work was to characterise the molecular and epidemiological profile of HIV in Bahia, Brazil.
   METHODS DNA sequences from regions of HIV gag, pol, and env genes were obtained from previous studies performed in this area between 2002 and 2012. Their genotype and drug-resistance mutations were identified using bioinformatics tools. Clinical and epidemiological data were analysed.
   FINDINGS Among 263 individuals (46.4% male), 97.5% were asymptomatic and 49.1% were receiving treatment. Most of the individuals were 31 to 40 years old (36.9%) and infected through heterosexual contact (40.7%). The predominant genotype was B (68.1%) followed by BF recombinants (18.6%). Among the individuals infected with either F or BF genotypes, 68.4% were women and 76.8% were infected through heterosexual transmission. The prevalence of associated mutations conferring antiretroviral resistance was 14.2%, with 3.8% of all mutations conferring resistance to protease inhibitors, 9.43% to nucleoside reverse transcriptase inhibitors, and 8.5% to non-nucleoside reverse transcriptase inhibitors. Drug resistance was higher in individuals receiving treatment (26.1%) than in the drug-naive (4.3%) individuals.
   MAIN CONCLUSIONS This study will contribute to the understanding and monitoring of HIV epidemic in this Brazilian region.
C1 [Amaral, Amanda G. M.; Oliveira, Isabele B.; Carneiro, Diego C.; Monteiro-Cunha, Joana P.] Univ Fed Bahia, Dept Biofuncao, Nucleo Bioinformat, Salvador, BA, Brazil.
   [Alcantara, Luiz C. J.] Fundacao Oswaldo Cruz Fiocruz, Inst Goncalo Moniz, Salvador, BA, Brazil.
   [Monteiro-Cunha, Joana P.] Fundacao Bahiana Desenvolvimento Ciencias, Escola Bahiana Med & Saude Publ, Salvador, BA, Brazil.
RP Monteiro-Cunha, JP (corresponding author), Univ Fed Bahia, Dept Biofuncao, Nucleo Bioinformat, Salvador, BA, Brazil.; Monteiro-Cunha, JP (corresponding author), Fundacao Bahiana Desenvolvimento Ciencias, Escola Bahiana Med & Saude Publ, Salvador, BA, Brazil.
EM joana.monteiro@ufba.br
RI Carneiro, Diego C./X-9798-2019
OI Carneiro, Diego C./0000-0002-2258-8197; Alcantara,
   Luiz/0000-0002-6769-9931
FU UFBA; CNPqNational Council for Scientific and Technological Development
   (CNPq)
FX UFBA, CNPq.
CR Sucupira MCA, 2007, AIDS PATIENT CARE ST, V21, P116, DOI 10.1089/apc.2006.0079
   Araujo AF, 2010, AIDS RES HUM RETROV, V26, P1249, DOI 10.1089/aid.2010.0068
   Arruda E, 2011, AIDS RES HUM RETROV, V27, P153, DOI 10.1089/aid.2010.0028
   Brites C, 2016, BRAZ J INFECT DIS, V20, P323, DOI 10.1016/j.bjid.2016.03.010
   Chen RX, 2005, FRONT BIOSCI-LANDMRK, V10, P743, DOI 10.2741/1568
   Costa ZB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079189
   Couto-Fernandez JC, 2005, MEM I OSWALDO CRUZ, V100, P73, DOI 10.1590/S0074-02762005000100014
   Soares CMPD, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.19042
   Hall T.A., 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008
   Inocencio LA, 2009, J INT AIDS SOC, V12, DOI 10.1186/1758-2652-12-20
   IST, 2013, AIDS HEP VIR
   Monteiro JP, 2009, J MED VIROL, V81, P391, DOI 10.1002/jmv.21414
   Monteiro-Cunha JP, 2011, AIDS RES HUM RETROV, V27, P623, DOI [10.1089/aid.2010.0126, 10.1089/AID.2010.0126]
   MORGADO MG, 1994, AIDS RES HUM RETROV, V10, P569, DOI 10.1089/aid.1994.10.569
   Morgado MG, 1998, MEM I OSWALDO CRUZ, V93, P383, DOI 10.1590/S0074-02761998000300020
   MS-Ministerio da Saude/Secretaria de Vigilancia em Saude/Depar-tamento de DST, 2015, BOL EP HIV AIDS
   MS-Ministerio da Saude/Secretaria de Vigilancia em Saude/Depar-tamento de DST, 2014, BOL EP HIV AIDS
   Pedroso C, 2007, JAIDS-J ACQ IMM DEF, V45, P251, DOI 10.1097/QAI.0b013e318050d8b0
   Santos ED, 2009, REV BRAS GINECOL OBS, V31, P609, DOI 10.1590/S0100-72032009001200006
   Santos LA, 2011, J MED VIROL, V83, P2066, DOI 10.1002/jmv.22170
   SUVISA-Superintendencia de Vigilancia e Protecao da Saude/Sec-retaria da Saude do Estado da Bahia, 2015, 042015 SUVISA
   UNAIDS-Joint United Nations Program on HIV/AIDS, 2014, GLOB AIDS RESP PROGR
   Wirden M, 2011, J ANTIMICROB CHEMOTH, V66, P709, DOI 10.1093/jac/dkq544
NR 23
TC 4
Z9 4
U1 0
U2 0
PU FUNDACO OSWALDO CRUZ
PI RIO DE JANEIRO, RJ
PA AV BRASIL 4365, 21045-900 RIO DE JANEIRO, RJ, BRAZIL
SN 0074-0276
EI 1678-8060
J9 MEM I OSWALDO CRUZ
JI Mem. Inst. Oswaldo Cruz
PD JUN
PY 2017
VL 112
IS 6
BP 411
EP 418
DI 10.1590/0074-02760160458
PG 8
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA EX5HH
UT WOS:000403269600004
PM 28591401
OA DOAJ Gold, Green Published
DA 2020-10-22
ER

PT J
AU Amoussa, AER
   Wilkinson, E
   Giovanetti, M
   Rego, FFD
   Araujo, THA
   Goncalves, MD
   de Oliveira, T
   Alcantara, LC
AF Roukiyath Amoussa, Adjile Edjide
   Wilkinson, Eduan
   Giovanetti, Marta
   de Almeida Rego, Filipe Ferreira
   Araujo, Thessika Hialla A.
   Goncalves, Marilda de Souza
   de Oliveira, Tulio
   Junior Alcantara, Luiz Carlos
TI HTLV-1aA introduction into Brazil and its association with the
   trans-Atlantic slave trade
SO INFECTION GENETICS AND EVOLUTION
LA English
DT Article
DE HTLV; Brazil; Southern Africa; Trans-Atlantic slave trade
ID VIRUS TYPE-I; CELL LYMPHOTROPIC VIRUS; POST-COLUMBIAN INTRODUCTION;
   MOLECULAR EPIDEMIOLOGY; PHYLOGENETIC SUBTYPES; INFECTED INDIVIDUALS;
   AFRICAN ORIGIN; TYPE-1 HTLV-1; LEUKEMIA; STRAINS
AB Introduction: Human T-lymphotropic virus (HTLV) is an endemic virus in some parts of the world, with Africa being home to most of the viral genetic diversity. In Brazil, HTLV-1 is endemic amongst Japanese and African immigrant populations. Multiple introductions of the virus in Brazil from other epidemic foci were hypothesized. The long terminal repeat (LTR) region of HTLV-1 was used to infer the origin of the virus in Brazil, using phylo-genetic analysis.
   Methods: LTR sequences were obtained from the HTLV-1 database (http://htlv1db.bahia.fiocruz.br). Sequences were aligned and maximum-likelihood and Bayesian tree topologies were inferred. Brazilian specific clusters were identified and molecular-clock and coalescent models were used to estimate each cluster's time to the most recent common ancestor (tMRCA).
   Results: Three Brazilian clusters were identified with a posterior probability ranged from 0.61 to 0.99. Molecular clock analysis of these three clusters dated back their respective tMRCAs between the year 1499 and the year 1668. Additional analysis also identified a close association between Brazilian sequences and new sequences from South Africa.
   Conclusion: Our results support the hypothesis of a multiple introductions of HTLV-1 into Brazil, with the majority of introductions occurring in the post-Colombian period. Our results further suggest that HTLV-1 introduction into Brazil was facilitated by the trans-Atlantic slave trade from endemic areas of Africa. The close association between southern African and Brazilian sequences also suggested that greater numbers of the southern African Bantu population might also have been part of the slave trade than previously thought. (C) 2016 Published by Elsevier B.V.
C1 [Roukiyath Amoussa, Adjile Edjide; Giovanetti, Marta; de Almeida Rego, Filipe Ferreira; Araujo, Thessika Hialla A.; Goncalves, Marilda de Souza; Junior Alcantara, Luiz Carlos] Fundacao Oswaldo Cruz, Lab Hematol Genet & Computat Biol, Goncalo Moniz Res Ctr, Salvador, BA, Brazil.
   [Wilkinson, Eduan; de Oliveira, Tulio] Univ Kwazulu Natal, Africa Ctr Hlth & Populat Studies, Durban, South Africa.
   [Giovanetti, Marta] Univ Roma Tor Vergata, Rome, Italy.
   [de Almeida Rego, Filipe Ferreira] Univ Catolica Salvador, Salvador, BA, Brazil.
   [Araujo, Thessika Hialla A.] Bahia Fdn Dev Sci, Bahia Sch Med & Publ Hlth, Salvador, BA, Brazil.
RP Alcantara, LCJ (corresponding author), Fundacao Oswaldo Cruz, Salvador, BA, Brazil.
EM amoussaroukiyath@yahoo.fr; ewilkinson83@gmail.com;
   lalcan@bahia.fiocruz.br
RI Giovanetti, Marta/AAK-7408-2020
OI Giovanetti, Marta/0000-0002-5849-7326; Alcantara,
   Luiz/0000-0002-6769-9931
FU CNPq Conselho Nacional de Desenvolvimento Cientifico e Tecnologico -
   BrasilNational Council for Scientific and Technological Development
   (CNPq) [200328/2015-8]; Medical Research Council flagship grant of the
   Republic of South Africa [MRC-RFA-UFSP-01-2013/UKZNHIVEPI]
FX This work was supported by CNPq (200328/2015-8) Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico - Brasil. E.W. and T.d.O are
   funded by a Medical Research Council flagship grant of the Republic of
   South Africa (MRC-RFA-UFSP-01-2013/UKZNHIVEPI).
CR Alcantara LC, 2003, JAIDS-J ACQ IMM DEF, V33, P536, DOI 10.1097/00126334-200308010-00016
   Alcantara LCJ, 2006, AIDS, V20, P780, DOI 10.1097/01.aids.0000216383.14808.13
   Aleluia M. M., 2015, VIROL REP, V5, P63
   Araujo THA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042123
   ANDERSON CW, 1975, COMMUN STAT, V4, P437, DOI 10.1080/03610917508548402
   Mota ACA, 2007, AIDS RES HUM RETROV, V23, P503, DOI 10.1089/aid.2006.0203
   Bacelar J. A., 1994, GALEGOS PARAISO RACI
   Bandeira LM, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003691
   Berini CA, 2013, SEX TRANSM INFECT, V89, P333, DOI 10.1136/sextrans-2012-050594
   Bhatt NB, 2009, INT J STD AIDS, V20, P863, DOI 10.1258/ijsa.2008.008401
   Chen JL, 1995, AIDS RES HUM RETROV, V11, P1529, DOI 10.1089/aid.1995.11.1529
   CURTIN PD, 1969, SLAVE ATLANTIC TRADE
   Rego FFD, 2008, AIDS RES HUM RETROV, V24, P673, DOI 10.1089/aid.2007.0290
   Desrames A, 2014, J VIROL, V88, P9782, DOI 10.1128/JVI.01591-14
   Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214
   Gallo RC, 2011, BEST PRACT RES CL HA, V24, P559, DOI 10.1016/j.beha.2011.09.012
   Gastaldello R, 2008, AIDS RES HUM RETROV, V24, P1139, DOI 10.1089/aid.2007.0299
   GESSAIN A, 1985, LANCET, V2, P407
   GESSAIN A, 1991, P NATL ACAD SCI USA, V88, P7694, DOI 10.1073/pnas.88.17.7694
   Gessain A, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00388
   Goncalves DU, 2010, CLIN MICROBIOL REV, V23, P577, DOI 10.1128/CMR.00063-09
   Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754
   Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199
   KITAGAWA T, 1986, JAMA-J AM MED ASSOC, V256, P2342, DOI 10.1001/jama.1986.03380170058009
   LANAVE C, 1984, J MOL EVOL, V20, P86, DOI 10.1007/BF02101990
   Leira L. P., 2002, GALEGOS BAHIA TODOS, P5
   Li HC, 1999, NAT MED, V5, P1428
   Magalhaes T, 2008, J MED VIROL, V80, P2040, DOI 10.1002/jmv.21278
   Mahieux R, 1997, J VIROL, V71, P1317, DOI 10.1128/JVI.71.2.1317-1333.1997
   Martin DP, 2015, VIRUS EVOL, V1, DOI 10.1093/ve/vev003
   MIURA T, 1994, P NATL ACAD SCI USA, V91, P1124, DOI 10.1073/pnas.91.3.1124
   Padua E, 2011, AIDS RES HUM RETROV, V27, P317, DOI 10.1089/aid.2010.0195
   Paiva A, 2015, REV INST MED TROP SP, V57, P1, DOI 10.1590/S0036-46652015000100001
   Pineda M, 2015, RETROVIROLOGY, V12, DOI 10.1186/1742-4690-12-S1-P85
   POIESZ BJ, 1980, P NATL ACAD SCI-BIOL, V77, P7415, DOI 10.1073/pnas.77.12.7415
   Proietti FA, 2005, ONCOGENE, V24, P6058, DOI 10.1038/sj.onc.1208968
   Rego F. F. A., 2013, HIV HTLV 1 COI UNPUB
   RODRIGUEZ F, 1990, J THEOR BIOL, V142, P485, DOI 10.1016/S0022-5193(05)80104-3
   Salemi M, 1998, VIROLOGY, V246, P277, DOI 10.1006/viro.1998.9215
   Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033
   Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876
   Trevino A, 2014, AIDS RES HUM RETROV, V30, P856, DOI [10.1089/aid.2013.0128, 10.1089/AID.2013.0128]
   Vallejo A, 2003, AIDS RES HUM RETROV, V19, P609, DOI 10.1089/088922203322230978
   Van Dooren S, 2001, MOL BIOL EVOL, V18, P661, DOI 10.1093/oxfordjournals.molbev.a003846
   Van Dooren S, 1998, J GEN VIROL, V79, P2695, DOI 10.1099/0022-1317-79-11-2695
   van Tienen C, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001690
   VANDAMME AM, 1994, VIROLOGY, V202, P212, DOI 10.1006/viro.1994.1337
   Verger P., 1976, TRADE RELATIONS BIGH, p[12, 24]
   Vicente ACP, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001038
   Wolfe ND, 2005, P NATL ACAD SCI USA, V102, P7994, DOI 10.1073/pnas.0501734102
   Yamashita M, 1998, J MED VIROL, V55, P152, DOI 10.1002/(SICI)1096-9071(199806)55:2&lt;152::AID-JMV12&gt;3.0.CO;2-K
   YOSHIDA M, 1982, P NATL ACAD SCI-BIOL, V79, P2031, DOI 10.1073/pnas.79.6.2031
   Zehender G, 2008, JAIDS-J ACQ IMM DEF, V47, P269, DOI 10.1097/QAI.0b013e31816649a4
NR 53
TC 1
Z9 1
U1 0
U2 1
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1567-1348
EI 1567-7257
J9 INFECT GENET EVOL
JI Infect. Genet. Evol.
PD MAR
PY 2017
VL 48
BP 95
EP 101
DI 10.1016/j.meegid.2016.12.005
PG 7
WC Infectious Diseases
SC Infectious Diseases
GA EM6ZQ
UT WOS:000395461600015
PM 27940215
DA 2020-10-22
ER

PT J
AU Vandormael, A
   Rego, F
   Danaviah, S
   Alcantara, LCJ
   Boulware, D
   de Oliveira, T
AF Vandormael, Alain
   Rego, Filipe
   Danaviah, Siva
   Junior Alcantara, Luiz Carlos
   Boulware, David
   de Oliveira, Tulio
TI CD4+T-cell Count may not be a Useful Strategy to Monitor Antiretroviral
   Therapy Response in HTLV-1/HIV Co-infected Patients
SO CURRENT HIV RESEARCH
LA English
DT Article
DE HIV; HTLV-1; CD4+count; co-infection; ART; treatment failure; South
   Africa
ID LYMPHOTROPIC VIRUS TYPE-1; T-CELL LEUKEMIA;
   HUMAN-IMMUNODEFICIENCY-VIRUS; HTLV-I; IMMUNOLOGICAL CRITERIA; TREATMENT
   FAILURE; HIV TREATMENT; TRANSMISSION; REPLICATION; COINFECTION
AB Background: HTLV-1/HIV co-infection is known to elevate the CD4+ T-cell counts of treatment-naive persons. We investigated whether HTLV-1/HIV co-infected patients continued to have elevated CD4+ T-cell counts after developing virologic failure on antiretroviral therapy (ART).
   Methods: The data is taken from a drug resistance study located in the KwaZulu-Natal province of South Africa. All participants (N=383) presented for repeated CD4+ T-cell count and HIV viral load level testing between January 2006 and March 2014. We used a random-coefficient model to estimate the change in CD4+ T-cell count and HIV viral load level by HTLV-1/HIV co-infection status over time, adjusting for age, sex, and duration of virologic failure.
   Results: HTLV-1/HIV co-infected participants (n=8) had higher CD4+ T-cell counts, with a positive difference of 117.2 cells/mu L at the ART initiation date (p-value=0.001), 114.7 cells/mu L (p-value<0.001) 12 months after this date, and 112.3 cells/mu L (p-value=0.005) 24 months after this date, holding all else constant. In contrast, there was no difference in the HIV viral load level by HTLV-1/HIV co-infected status throughout the observation period.
   Conclusion: We show that HTLV-1/HIV co-infected participants continued to have elevated CD4+ T-cell counts after developing virologic failure on ART, despite no difference in their HIV viral load levels when compared with HIV mono-infected participants. Our results indicate that CD4+ T-cell count testing may not be a useful strategy to monitor ART response in the presence of HTLV-1/HIV co-infection.
C1 [Vandormael, Alain; Danaviah, Siva] Univ KwaZulu Natal, AHRI, Durban, South Africa.
   [Vandormael, Alain; de Oliveira, Tulio] Univ KwaZulu Natal, Nelson R Mandela Sch Med, Coll Hlth Sci, Durban, South Africa.
   [Rego, Filipe; Junior Alcantara, Luiz Carlos] Fundacao Oswaldo Cruz, Inst Goncalo Moniz, Salvador, BA, Brazil.
   [Boulware, David] Univ Minnesota, Ctr Infect Dis & Microbiol Translat Res, St Paul, MN 55108 USA.
   [de Oliveira, Tulio] Univ KwaZulu Natal, Ctr AIDS Programme Res South Africa CAPRISA, Durban, South Africa.
RP Vandormael, A (corresponding author), Univ KwaZulu Natal, AHRI, Durban, South Africa.
EM avandormael@africacentre.ac.za
OI Vandormael, Alain/0000-0002-5742-0511; Alcantara,
   Luiz/0000-0002-6769-9931; Boulware, David/0000-0002-4715-0060
FU Wellcome Trust, UKWellcome Trust [082384/Z/07/Z]; South African Medical
   Research Council (MRC) Flagship [MRC-RFA-UFSP-01-2013/UKZN HIVEPI];
   Brazil's Ciencia Sem Fronteiras project from CNPQ; United States Agency
   for International Development (USAID)United States Agency for
   International Development (USAID); President's Emergency Plan. Research
FX Data collected for this study was funded by the Wellcome Trust, UK
   (082384/Z/07/Z). The Hlabisa HIV Treatment and Care programme was made
   possible by the support of the United States Agency for International
   Development (USAID) and the President's Emergency Plan. Research was
   supported by a South African Medical Research Council (MRC) Flagship
   grant (MRC-RFA-UFSP-01-2013/UKZN HIVEPI) and by Brazil's Ciencia Sem
   Fronteiras project from CNPQ. The funders had no role in the design of
   the study, data analysis, interpretation of results, or writing of the
   manuscript.
CR Asquith B, 2007, P NATL ACAD SCI USA, V104, P8035, DOI 10.1073/pnas.0608832104
   Beilke MA, 2004, CLIN INFECT DIS, V39, P256, DOI 10.1086/422146
   BHIGJEE AI, 1993, S AFR MED J, V83, P665
   Carpentier A, 2015, VIRUSES-BASEL, V7, P3603, DOI 10.3390/v7072793
   Castelnuovo B, 2009, AIDS, V23, P1295, DOI 10.1097/QAD.0b013e32832cbd43
   Costa EAS, 2011, J VIROL METHODS, V173, P280, DOI 10.1016/j.jviromet.2011.02.018
   de Oliveira T, 2010, NATURE, V464, P673, DOI 10.1038/464673c
   GESSAIN A, 1985, LANCET, V2, P407
   Gudo ES, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-211
   Houlihan CF, 2011, INT J EPIDEMIOL, V40, P318, DOI 10.1093/ije/dyp402
   LaGrenade L, 1996, J ACQ IMMUN DEF SYND, V13, pS46, DOI 10.1097/00042560-199600001-00009
   Manasa J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072152
   MOCHIZUKI M, 1992, LANCET, V339, P1110, DOI 10.1016/0140-6736(92)90699-4
   Nadler JP, 1996, CLIN INFECT DIS, V23, P415, DOI 10.1093/clinids/23.2.415
   OSAME M, 1986, LANCET, V1, P1031
   Pomier C, 2013, J GEN VIROL, V94, P753, DOI 10.1099/vir.0.048348-0
   Rawizza HE, 2011, CLIN INFECT DIS, V53, P1283, DOI 10.1093/cid/cir729
   Regis C, 2009, BRAZ J INFECT DIS, V13, P311, DOI 10.1590/S1413-86702009000400014
   Reynolds SJ, 2009, AIDS, V23, P697, DOI 10.1097/QAD.0b013e3283262a78
   Schechter M, 1997, J ACQ IMMUN DEF SYND, V15, P308, DOI 10.1097/00042560-199708010-00010
   Silva MTT, 2012, AIDS, V26, P521, DOI 10.1097/QAD.0b013e32834c4a3e
   South African Department of Health, 2013, S AFR ANT TREATM GUI
   Takemura T, 2002, J VIROL, V76, P1642, DOI 10.1128/JVI.76.4.1642-1648.2002
   Vandormael AM, 2016, JAIDS-J ACQ IMM DEF, V71, P462, DOI 10.1097/QAI.0000000000000870
   WATTEL E, 1995, J VIROL, V69, P2863, DOI 10.1128/JVI.69.5.2863-2868.1995
   World Health Organization (WHO), 2013, CONS GUID US ANTR DR
   YOSHIDA M, 1982, P NATL ACAD SCI-BIOL, V79, P2031, DOI 10.1073/pnas.79.6.2031
NR 27
TC 4
Z9 4
U1 0
U2 5
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 1570-162X
EI 1873-4251
J9 CURR HIV RES
JI Curr. HIV Res.
PY 2017
VL 15
IS 3
BP 225
EP 231
DI 10.2174/1570162X15666170216114917
PG 7
WC Immunology; Infectious Diseases; Virology
SC Immunology; Infectious Diseases; Virology
GA FA3DA
UT WOS:000405320700008
PM 28215175
DA 2020-10-22
ER

PT J
AU Oliveira, JV
   Pessoa, L
   Magalhaes, C
   Lima, JG
   Carvalho, DA
   Xavier, TC
   Pellegrini, R
   Bessa, G
   Figueiredo, EM
   Calgano, JI
   Romero, F
   dos Santos, D
   Oliveira, A
   Silva, P
   Giovanetti, M
   Goes, J
   Lima, B
   Carneiro, MW
   Duarte, A
   Lima, FW
   Alcantara, LC
   de Siqueira, IC
AF Oliveira, Joao V.
   Pessoa, Lorena
   Magalhaes, Claudio
   Lima, Jessica G.
   Carvalho, Daniel A.
   Xavier, Tereza C.
   Pellegrini, Rosana
   Bessa, Gloryane
   Figueiredo, Eduardo M.
   Calgano, Juan I.
   Romero, Fernando
   dos Santos, Daiana
   Oliveira, Aline
   Silva, Paloma
   Giovanetti, Marta
   Goes, Jaqueline
   Lima, Breno
   Carneiro, Marcia W.
   Duarte, Alan
   Lima, Fernanda W.
   Alcantara, Luiz C.
   de Siqueira, Isadora C.
TI PREVALENCE OF PREVIOUS AND RECENT INFECTIONS BY ZIKA VIRUS, DENGUE VIRUS
   AND CHIKUNGUNYA VIRUS IN PREGNANT WOMEN AND SURVEILLANCE FOR CONGENITAL
   ZIKA INFECTIONS IN SALVADOR, BRAZIL
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 66th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 05-09, 2017
CL Baltimore, MD
SP Amer Soc Trop Med & Hyg
C1 [Oliveira, Joao V.; Pessoa, Lorena; Magalhaes, Claudio; Lima, Jessica G.; Carvalho, Daniel A.; dos Santos, Daiana; Oliveira, Aline; Silva, Paloma; Giovanetti, Marta; Goes, Jaqueline; Lima, Breno; Carneiro, Marcia W.; Alcantara, Luiz C.; de Siqueira, Isadora C.] Inst Goncalo Moniz Fiocruz, Salvador, BA, Brazil.
   [Xavier, Tereza C.; Pellegrini, Rosana; Bessa, Gloryane; Figueiredo, Eduardo M.; Calgano, Juan I.; Romero, Fernando] Secretaria Saude Estado Bahia, Salvador, BA, Brazil.
   [Duarte, Alan; Lima, Fernanda W.] Univ Fed Bahia, Fac Farm, Salvador, BA, Brazil.
RI de Siqueira, Isadora Cristina/R-9953-2016; amsalu, ribka/G-8780-2019;
   Giovanetti, Marta/AAK-7408-2020
OI de Siqueira, Isadora Cristina/0000-0002-2520-4099; 
NR 0
TC 0
Z9 0
U1 0
U2 2
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2017
VL 97
IS 5
SU S
MA 1426
BP 443
EP 443
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FT5TD
UT WOS:000423215204142
DA 2020-10-22
ER

PT J
AU Barreto, FK
   Khouri, R
   Rego, FFD
   Santos, LA
   de Castro-Amarante, MF
   Bialuk, I
   Pise-Masison, CA
   Galvao-Castro, B
   Gessain, A
   Jacobson, S
   Franchini, G
   Alcantara, LC
AF Barreto, Fernanda Khouri
   Khouri, Ricardo
   de Almeida Rego, Filipe Ferreira
   Santos, Luciane Amorim
   de Castro-Amarante, Maria Fernanda
   Bialuk, Izabela
   Pise-Masison, Cynthia A.
   Galvao-Castro, Bernardo
   Gessain, Antoine
   Jacobson, Steven
   Franchini, Genoveffa
   Alcantara, Luiz Carlos, Jr.
TI Analyses of HTLV-1 sequences suggest interaction between ORF-I mutations
   and HAM/TSP outcome
SO INFECTION GENETICS AND EVOLUTION
LA English
DT Article
DE HTLV-1; ORF-1; HAM/TSP
ID T-CELL LEUKEMIA; LYMPHOTROPIC-VIRUS TYPE-1; TROPICAL SPASTIC
   PARAPARESIS; NUCLEAR FACTOR; PROVIRAL LOAD; MESSENGER-RNA; PROTEIN;
   P12(I); PATHOGENESIS; PX
AB The region known as pX in the 3' end of the human T-cell lymphotropic virus type 1 (HTLV-1) genome contains four overlapping open reading frames (ORF) that encode regulatory proteins. HTLV-1 ORF-I produces the protein p12 and its cleavage product p8. The functions of these proteins have been linked to immune evasion and viral infectivity and persistence. It is known that the HTLV-1 infection does not necessarily imply the development of pathological processes and here we evaluated whether natural mutations in HTLV-1 ORF-I can influence the proviral load and clinical manifestation of HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/ TSP). For that, we performed molecular characterization, datamining and phylogenetic analysis with HTLV-1 ORF-I sequences from 156 patients with negative or positive diagnosis for HAM/TSP. Our analyses demonstrated that some mutations may be associated with the outcome of HAM/ TSP (C39R, L40F, P45L, S69G and R88K) or with proviral load (P34L and F61L). We further examined the presence of mutations in motifs of HBZ and observed that P45L mutation is located within the HBZ nuclear localization signal and was found more frequently between patients with HAM/TSP and high proviral load. These results indicate that some natural mutations are located in functional domains of ORF-I and suggests a potential association between these mutations and the proviral loads and development of HAM/TSP. Therefore it is necessary to conduct functional studies aimed at evaluating the impact of these mutations on the virus persistence and immune evasion. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Barreto, Fernanda Khouri; de Almeida Rego, Filipe Ferreira; Santos, Luciane Amorim; Galvao-Castro, Bernardo; Alcantara, Luiz Carlos, Jr.] Fiocruz MS, Ctr Pesquisa Goncalo Moniz, Lab Hematol Genet & Biol Computac, Salvador, Bahia, Brazil.
   [Khouri, Ricardo] Katholieke Univ Leuven, Rega Inst Med Res, Dept Microbiol & Immunol, Lab Clin & Epidemiol Virol, Leuven, Belgium.
   [de Castro-Amarante, Maria Fernanda; Pise-Masison, Cynthia A.; Franchini, Genoveffa] NCI, Anim Models & Retroviral Vaccines Sect, Bethesda, MD 20892 USA.
   [Bialuk, Izabela] Med Univ Bialystok, Dept Gen & Expt Pathol, Bialystok, Poland.
   [Galvao-Castro, Bernardo] Escola Bahiana Med & Saude Publ, Salvador, Bahia, Brazil.
   [Gessain, Antoine] Inst Pasteur, Unite Epidemiol & Physiopathol Virus Oncogenes, Dept Virol, Batiment Lwoff, Paris, France.
   [Jacobson, Steven] NINDS, Viral Immunol Sect, Neuroimmunol Branch, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA.
RP Alcantara, LC (corresponding author), Fiocruz MS, Ctr Pesquisa Goncalo Moniz, Lab Hematol Genet & Biol Computac, Salvador, Bahia, Brazil.
EM lalcan@bahia.fiocruz.br
RI Khouri, Ricardo/M-3184-2018; Bialuk, Izabela/U-8097-2018
OI Khouri, Ricardo/0000-0001-5664-4436; Bialuk,
   Izabela/0000-0002-4587-8613; Berneman, Zwi/0000-0002-9133-4588;
   Alcantara, Luiz/0000-0002-6769-9931
FU Intramural Program at the National Cancer Institute, National Institutes
   of Health, Bethesda, MD
FX This work was supported by the Intramural Program at the National Cancer
   Institute, National Institutes of Health, Bethesda, MD.
CR Albrecht B, 2002, MICROBIOL MOL BIOL R, V66, P396, DOI 10.1128/MMBR.66.3.396-406.2002
   Albrecht B, 2002, J VIROL, V76, P3493, DOI 10.1128/JVI.76.7.3493-3501.2002
   Banerjee P, 2007, J VIROL, V81, P9707, DOI 10.1128/JVI.00887-07
   BERNEMAN ZN, 1992, P NATL ACAD SCI USA, V89, P3005, DOI 10.1073/pnas.89.7.3005
   CIMINALE V, 1992, J VIROL, V66, P1737, DOI 10.1128/JVI.66.3.1737-1745.1992
   Deforche K, 2006, BIOINFORMATICS, V22, P2975, DOI 10.1093/bioinformatics/btl508
   Ding W, 2002, J VIROL, V76, P10374, DOI 10.1128/JVI.76.20.10374-10382.2002
   Edwards D, 2011, VIRUSES-BASEL, V3, P861, DOI 10.3390/v3060861
   Friedman N, 2013, ARXIV13016695CSSTAT
   Fukumoto R, 2009, BLOOD, V113, P3726, DOI 10.1182/blood-2008-04-146928
   Gaudray G, 2002, J VIROL, V76, P12813, DOI 10.1128/JVI.76.24.12813-12822.2002
   GESSAIN A, 1985, LANCET, V2, P407
   Gessain A, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00388
   Goncalves DU, 2003, AM J TROP MED HYG, V68, P562, DOI 10.4269/ajtmh.2003.68.562
   Johnson JM, 2001, INT J EXP PATHOL, V82, P135, DOI 10.1046/j.1365-2613.2001.00191.x
   Alcantara LCJ, 2009, NUCLEIC ACIDS RES, V37, pW634, DOI 10.1093/nar/gkp455
   KAPLAN JE, 1990, J ACQ IMMUN DEF SYND, V3, P1096
   Kim SJ, 2003, J BIOL CHEM, V278, P15550, DOI 10.1074/jbc.M210210200
   KIYOKAWA T, 1985, P NATL ACAD SCI USA, V82, P8359, DOI 10.1073/pnas.82.24.8359
   KIYOKAWA T, 1984, GANN, V75, P747
   KORALNIK IJ, 1992, P NATL ACAD SCI USA, V89, P8813, DOI 10.1073/pnas.89.18.8813
   Lairmore MD, 2012, CURR OPIN VIROL, V2, P474, DOI 10.1016/j.coviro.2012.06.007
   Lairmore MD, 2011, VIRUSES-BASEL, V3, P1131, DOI 10.3390/v3071131
   Maloney EM, 1998, J ACQ IMMUN DEF SYND, V17, P167, DOI 10.1097/00042560-199802010-00011
   Matsuoka M, 2010, MOL ASPECTS MED, V31, P359, DOI 10.1016/j.mam.2010.06.002
   Matsuoka M, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-71
   Matsuzaki T, 2001, J NEUROVIROL, V7, P228
   Nagai M, 1998, J NEUROVIROL, V4, P586, DOI 10.3109/13550289809114225
   Pineda-Pena AC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101738
   Pise-Masison CA, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004454
   POIESZ BJ, 1980, P NATL ACAD SCI-BIOL, V77, P7415, DOI 10.1073/pnas.77.12.7415
   Prosperi MCF, 2012, AIDS REV, V14, P145
   Trovato R, 1999, J VIROL, V73, P6460, DOI 10.1128/JVI.73.8.6460-6467.1999
   Van Prooyen N, 2010, P NATL ACAD SCI USA, V107, P20738, DOI 10.1073/pnas.1009635107
   WiaF E., 2011, DATA MINING PRACTICA
   Yamano Y, 2002, BLOOD, V99, P88, DOI 10.1182/blood.V99.1.88
   YOSHIDA M, 1982, P NATL ACAD SCI-BIOL, V79, P2031, DOI 10.1073/pnas.79.6.2031
NR 37
TC 7
Z9 7
U1 0
U2 4
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1567-1348
EI 1567-7257
J9 INFECT GENET EVOL
JI Infect. Genet. Evol.
PD NOV
PY 2016
VL 45
BP 420
EP 425
DI 10.1016/j.meegid.2016.08.020
PG 6
WC Infectious Diseases
SC Infectious Diseases
GA ED0ZY
UT WOS:000388574400055
PM 27553711
OA Green Accepted
DA 2020-10-22
ER

PT J
AU do Rosario, MS
   de Jesus, PAP
   Vasilakis, N
   Farias, DS
   Novaes, MAC
   Rodrigues, SG
   Martins, LC
   Vasconcelos, PFD
   Ko, AI
   Alcantara, LCJ
   de Siqueira, IC
AF do Rosario, Mateus Santana
   Pereira de Jesus, Pedro Antonio
   Vasilakis, Nikos
   Farias, Daniel Santana
   Caires Novaes, Marco Antonio
   Rodrigues, Sueli Guerreiro
   Martins, Livia Caricio
   da Costa Vasconcelos, Pedro Fernando
   Ko, Albert Icksang
   Junior Alcantara, Luiz Carlos
   de Siqueira, Isadora Cristina
TI Case Report: Guillain-Barre Syndrome after Zika Virus Infection in
   Brazil
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
ID DENGUE; OUTBREAK; BAHIA
AB Zika virus (ZIKV) is an emerging flavivirus, which has caused a widespread outbreak in the Americas. Shortly after its introduction in 2015, a cluster of cases with Guillain Barre syndrome was detected in Brazil. Herein, we describe two cases from the city of Salvador, who developed ascending paresis after an acute exanthematous illness. The patients were admitted to the intensive care unit with tetraparesis and cranial nerve palsy, which resolved after intravenous administration of human immunoglobulin. Serological evaluation detected IgM-specific ZIKV antibodies. In regions of Zika virus transmission, health-care workers must be aware of the potential severe neurological complications associated with ZIKV infection and be prepared to provide prompt diagnosis, treatment, and supportive care.
C1 [do Rosario, Mateus Santana; Pereira de Jesus, Pedro Antonio; Farias, Daniel Santana] Secretaria Estadual Saude Bahia, Hosp Geral Roberto Santos, Salvador, BA, Brazil.
   [Vasilakis, Nikos] Univ Texas Med Branch, Inst Human Infect & Immun, Ctr Biodefense & Emerging Infect Dis, Dept Pathol, Galveston, TX 77555 USA.
   [Vasilakis, Nikos] Univ Texas Med Branch, Ctr Trop Dis, Galveston, TX 77555 USA.
   [Caires Novaes, Marco Antonio] Fundacao Monte Tabor, Hosp Salo Rafael, Salvador, BA, Brazil.
   [Rodrigues, Sueli Guerreiro; Martins, Livia Caricio; da Costa Vasconcelos, Pedro Fernando] Inst Evandro Chagas SVS MS, Secao Arbovirol & Febres Hemorrag, Ananindeua, Brazil.
   [Ko, Albert Icksang] Yale Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT USA.
   [Junior Alcantara, Luiz Carlos; de Siqueira, Isadora Cristina] Minist Saude, Fundacao Oswaldo Cruz, Ctr Pesquisas Goncalo Moniz, Salvador, BA, Brazil.
   [do Rosario, Mateus Santana] Fundacao Oswaldo Cruz FIOCRUZ, Ctr Pesquisas, Salvador, BA, Brazil.
   [Vasilakis, Nikos] Univ Texas Med Branch, Dept Pathol, Ctr Biodef & Emerging Infect Dis, Galveston, TX 77555 USA.
   [Caires Novaes, Marco Antonio] Hosp Sao Rafael, Fundacao Monte Tabor, Salvador, BA, Brazil.
   [Martins, Livia Caricio; da Costa Vasconcelos, Pedro Fernando] Evandro Chagas Inst, Dept Arbovirol & Hemorrhag Fevers, Belem, Para, Brazil.
RP de Siqueira, IC (corresponding author), Fundacao Oswaldo Cruz, Ctr Pesquisas Gongalo Moniz, R Waldemar Falcao 121, BR-40296710 Salvador, BA, Brazil.
EM isadora.siqueira@bahia.fiocruz.br
RI de Siqueira, Isadora Cristina/R-9953-2016; Vasconcelos,
   Pedro/AAH-3142-2019; Ko, Albert Icksang/P-2343-2015
OI de Siqueira, Isadora Cristina/0000-0002-2520-4099; Ko, Albert
   Icksang/0000-0001-9023-2339; do Rosario, Mateus/0000-0001-7404-6392;
   Jesus, Pedro Antonio/0000-0003-1211-2272; Alcantara,
   Luiz/0000-0002-6769-9931
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [R24AI120942]
FX We are grateful to Marcia Weber for the laboratorial technical
   assistance, Fernanda Washington de M. Lima and Daniel Moura for
   assistance in the serological diagnosis, and the physicians and nurses
   involved in the patient's clinical treatment. We also thank Bruno B.
   Andrade for the critical review of the manuscript. This work was
   supported in part by the NIH grant R24AI120942 to Nikos Vasilakis.
CR Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Campos GS, 2015, JPN J INFECT DIS, V68, P45, DOI 10.7883/yoken.JJID.2014.063
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Chio A, 2003, NEUROLOGY, V60, P1146, DOI 10.1212/01.WNL.0000055091.96905.D0
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   DVIS/CIEVS, 2015, INF EP DOENC EX MAT
   Garg RK, 2015, NEUROL INDIA, V63, P497, DOI 10.4103/0028-3886.161990
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   HUGHES RAC, 1978, LANCET, V2, P750, DOI 10.1016/s0140-6736(78)92644-2
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Oehler E., 2014, Eurosurveillance, V19, P20720
   PAHO/WHO, 2016, EP UPD NEUR SYNDR CO
   Rodriguez-Morales AJ, 2015, J INFECT DEV COUNTR, V9, P684, DOI 10.3855/jidc.7230
   Roth A, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.41.20929
   Wakerley BR, 2014, NAT REV NEUROL, V10, P537, DOI 10.1038/nrneurol.2014.138
   Wielanek AC, 2007, NEUROLOGY, V69, P2105, DOI 10.1212/01.wnl.0000277267.07220.88
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 20
TC 52
Z9 52
U1 0
U2 4
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD NOV
PY 2016
VL 95
IS 5
BP 1157
EP 1160
DI 10.4269/ajtmh.16-0306
PG 4
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA ET3VC
UT WOS:000400206600035
PM 27645785
OA Green Published, Bronze
DA 2020-10-22
ER

PT J
AU Faria, NR
   Sabino, EC
   Nunes, MRT
   Alcantara, LC
   Loman, NJ
   Pybus, OG
AF Faria, Nuno Rodrigues
   Sabino, Ester C.
   Nunes, Marcio R. T.
   Junior Alcantara, Luiz Carlos
   Loman, Nicholas J.
   Pybus, Oliver G.
TI Mobile real-time surveillance of Zika virus in Brazil
SO GENOME MEDICINE
LA English
DT Article
C1 [Faria, Nuno Rodrigues; Pybus, Oliver G.] Univ Oxford, Dept Zool, S Parks Rd, Oxford OX1 3PS, England.
   [Sabino, Ester C.] Univ Sao Paulo, Dept Infect Dis, Sao Paulo, Brazil.
   [Sabino, Ester C.] Univ Sao Paulo, Inst Trop Med, Sao Paulo, Brazil.
   [Nunes, Marcio R. T.] Minist Hlth, Evandro Chagas Inst, Ctr Technol Innovat, BR-67030000 Ananindeua, PA, Brazil.
   [Nunes, Marcio R. T.] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA.
   [Junior Alcantara, Luiz Carlos] Oswaldo Cruz Fdn FIOCRUZ, BR-40296710 Salvador, BA, Brazil.
   [Loman, Nicholas J.] Univ Birmingham, Inst Microbiol & Infect, Birmingham B15 2TT, W Midlands, England.
RP Loman, NJ (corresponding author), Univ Birmingham, Inst Microbiol & Infect, Birmingham B15 2TT, W Midlands, England.
EM n.j.loman@bham.ac.uk
RI Pybus, Oliver G/B-2640-2012; Loman, Nicholas/Z-1573-2019; Sabino, Ester
   Cerdeira/F-7750-2010; Faria, Nuno R/I-2975-2012
OI Pybus, Oliver G/0000-0002-8797-2667; Sabino, Ester
   Cerdeira/0000-0003-2623-5126; Faria, Nuno R/0000-0001-8839-2798; Loman,
   Nicholas/0000-0002-9843-8988; Alcantara, Luiz/0000-0002-6769-9931
FU Medical Research Council/Wellcome Trust/Newton Fund Zika Rapid Response
   Initiative [ZK/16-078]; Medical Research Council Bioinformatics
   Fellowship, Cloud Infrastructure for Microbial Bioinformatics (CLIMB)
   project; Medical Research CouncilMedical Research Council UK (MRC)
   [MR/M501621/1, MC_PC_15100, MR/L015080/1] Funding Source: Researchfish
FX We are grateful to Wanderson Kleber de Oliveira (Coordinator of the
   Surveillance and Response Program to Public Health Emergencies (CGVR),
   Brazilian Ministry of Health), Giovanini Evelim Coelho and Livia Carla
   Vinhal Frutuoso (National Control of Dengue (PNCD), Brazilian Ministry
   of Health), Mariana Pastorello Verotti (Coordinator of the Central
   Laboratories of Public Health (CGLAB), Brazilian Ministry of Health),
   Eduardo Hage Carmo and Claudio Maerovich (Department of Infectious
   Disease Surveillance (DEVIT), Brazilian Ministry of Health). The ZiBRA
   project is supported by the Medical Research Council/Wellcome
   Trust/Newton Fund Zika Rapid Response Initiative (grant number
   ZK/16-078). NJL is supported by a Medical Research Council
   Bioinformatics Fellowship as part of the Cloud Infrastructure for
   Microbial Bioinformatics (CLIMB) project.
CR Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Perkins TA, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.126, 10.1038/nmicrobiol.2016.126]
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Quick J, 2016, NATURE, V530, P228, DOI 10.1038/nature16996
   Rubin EJ, 2016, NEW ENGL J MED, V374, P984, DOI 10.1056/NEJMe1601862
   Nunes MRT, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0348-x
   World Health Organization, 2016, WHO ZIK VIR SIT REP
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 10
TC 71
Z9 72
U1 1
U2 14
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1756-994X
J9 GENOME MED
JI Genome Med.
PD SEP 29
PY 2016
VL 8
AR 97
DI 10.1186/s13073-016-0356-2
PG 4
WC Genetics & Heredity
SC Genetics & Heredity
GA DX4UM
UT WOS:000384376600001
PM 27683027
OA DOAJ Gold, Green Published
DA 2020-10-22
ER

PT J
AU Giovanetti, M
   Faria, NR
   Nunes, MRT
   de Vasconcelos, JM
   Lourenco, J
   Rodrigues, SG
   Vianez, JL
   da Silva, SP
   Lemos, PS
   Tavares, FN
   Martin, DP
   do Rosario, MS
   Siqueira, IC
   Ciccozzi, M
   Pybus, OG
   de Oliveira, T
   Alcantara, LC
AF Giovanetti, Marta
   Faria, Nuno Rodrigues
   Teixeira Nunes, Marcio Roberto
   de Vasconcelos, Janaina Mota
   Lourenco, Jose
   Rodrigues, Sueli Guerreiro
   Vianez, Joao Lidio, Jr.
   da Silva, Sandro Patroca
   Lemos, Poliana Silva
   Tavares, Fernando Neto
   Martin, Darren Patrick
   do Rosario, Mateus Santana
   Siqueira, Isadora Cristina
   Ciccozzi, Massimo
   Pybus, Oliver G.
   de Oliveira, Tulio
   Alcantara Junior, Luiz Carlos
TI Zika virus complete genome from Salvador, Bahia, Brazil
SO INFECTION GENETICS AND EVOLUTION
LA English
DT Article
DE Zika virus; Full-length sequence; Phylogeny
AB In May 2015 the first autochthonous Zika virus infection was reported in Brazil. Rapid and urgent measures are needed to contain the ongoing outbreak. Here we report the full-length ZIKV coding sequence from Bahia. Genetic analysis of outbreak sequences will be essential for characterizing the diversity of circulating strains, identifying hotspots of virus transmission and guiding public health control. Rapid and urgent measures are needed to contain the ongoing outbreak. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Giovanetti, Marta; do Rosario, Mateus Santana; Siqueira, Isadora Cristina; Alcantara Junior, Luiz Carlos] Fundacao Oswaldo Cruz, Salvador, BA, Brazil.
   [Giovanetti, Marta] Univ Roma Tor Vergata, Rome, Italy.
   [Faria, Nuno Rodrigues; Lourenco, Jose; Pybus, Oliver G.] Univ Oxford, Dept Zool, Oxford OX1 2JD, England.
   [Teixeira Nunes, Marcio Roberto; de Vasconcelos, Janaina Mota; Rodrigues, Sueli Guerreiro; Vianez, Joao Lidio, Jr.; Lemos, Poliana Silva; Tavares, Fernando Neto] Inst Evandro Chagas, Ananindeua, Para, Brazil.
   [Martin, Darren Patrick] Univ Cape Town, Fac Hlth Sci, Div Computat Biol, ZA-7925 Cape Town, South Africa.
   [do Rosario, Mateus Santana] Hosp Santa Isabel, Salvador, BA, Brazil.
   [Ciccozzi, Massimo] Natl Inst Hlth, Rome, Italy.
   [de Oliveira, Tulio] Univ KwaZulu Natal, Africa Ctr, Durban, South Africa.
RP Giovanetti, M (corresponding author), Fundacao Oswaldo Cruz, Ctr Pesquisas Goncalo Moniz, Lab Hematol Genet & Biol Computac, BR-42296710 Salvador, BA, Brazil.
EM giovanetti.marta@gmail.com
RI de Siqueira, Isadora Cristina/R-9953-2016; Faria, Nuno R/I-2975-2012;
   Giovanetti, Marta/AAK-7408-2020; CICCOZZI, MASSIMO/C-6484-2016; Pybus,
   Oliver G/B-2640-2012; Vianez Junior, Joao Lidio/I-9547-2016
OI de Siqueira, Isadora Cristina/0000-0002-2520-4099; Faria, Nuno
   R/0000-0001-8839-2798; CICCOZZI, MASSIMO/0000-0003-3866-9239; Pybus,
   Oliver G/0000-0002-8797-2667; Giovanetti, Marta/0000-0002-5849-7326;
   Vianez Junior, Joao Lidio/0000-0001-6226-9441; Alcantara,
   Luiz/0000-0002-6769-9931; do Rosario, Mateus/0000-0001-7404-6392;
   Lourenco, Jose/0000-0002-9318-2581
CR Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9
   Faye O., 2014, PLOS NEGLECT TROP D, V9, P8
   Mourao MPG, 2012, VECTOR-BORNE ZOONOT, V12, P42, DOI 10.1089/vbz.2011.0669
   Grard G, 2014, PLOS NEGLECT TROP D, P8
   Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520
   Hall T.A., 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008
   Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Mlakar J, 2016, N ENGL J MED
   Oehler E, 2014, EUROSURVEILLANCE, V19, P4
   Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079
   Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304
   Rodrigues Faria N., 2016, PLOS CURR OUTBREAKS
   Ventura C. V., 2016, LANCET, V16
   Zamree I, 2005, Trop Biomed, V22, P217
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 18
TC 17
Z9 17
U1 0
U2 112
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1567-1348
EI 1567-7257
J9 INFECT GENET EVOL
JI Infect. Genet. Evol.
PD JUL
PY 2016
VL 41
BP 142
EP 145
DI 10.1016/j.meegid.2016.03.030
PG 4
WC Infectious Diseases
SC Infectious Diseases
GA DL5BU
UT WOS:000375652800020
PM 27071531
OA Green Published
DA 2020-10-22
ER

PT J
AU Pitanga, TN
   Oliveira, RR
   Zanette, DL
   Guarda, CC
   Santiago, RP
   Santana, SS
   Nascimento, VML
   Lima, JB
   Carvalho, GQ
   Maffili, VV
   Carvalho, MOS
   Alcantara, LCJ
   Borges, VM
   Goncalves, MS
AF Pitanga, Thassila N.
   Oliveira, Ricardo R.
   Zanette, Dalila L.
   Guarda, Caroline C.
   Santiago, Rayra P.
   Santana, Sanzio S.
   Nascimento, Valma M. L.
   Lima, Jonilson B.
   Carvalho, Graziele Q.
   Maffili, Vitor V.
   Carvalho, Magda O. S.
   Alcantara, Luiz C. J.
   Borges, Valeria M.
   Goncalves, Marilda S.
TI Sickle red cells as danger signals on proinflammatory gene expression,
   leukotriene B4 and interleukin-1 beta production in peripheral blood
   mononuclear cell
SO CYTOKINE
LA English
DT Article
DE Sickle cell anemia; Sickle red cell; IL-1 beta; Leukotriene B4; NLRP3
   inflammasome; Toll-like receptors
ID TOLL-LIKE RECEPTORS; NITRIC-OXIDE; NLRP3 INFLAMMASOME; NEUTROPHIL
   MIGRATION; ACTIVATION; DISEASE; HEMOLYSIS; ANEMIA; HYDROXYUREA; IL-18
AB This study tested the hypothesis that sickle red blood cell (SS-RBC) induce Toll-like receptors (TLR) and Nod-like receptor family, pyrin domain containing 3 (NLRP3)-inflammasome expression in peripheral blood mononuclear cells (PBMC). TLR and NLRP3 inflammasome could contribute to the maintenance of the inflammatory status in sickle cell anemia (SCA) patients, since SS-RBC act as danger signals activating these pathways. In this study, first, we evaluated TLR (2, 4, 5 and 9), NLRP3, Caspase-1, interleukin (IL)-1 beta and IL-18 expression in PBMC freshly isolated from SCA patients (SS-PBMC) in comparison with PBMC from healthy individuals (AA-PBMC). In the second moment, we investigated whether SS-RBC could interfere with the expression of these molecules in PBMC from healthy donor, in the absence or presence of hydroxyurea (HU) in vitro. TLRs and NLRP3 inflammasome expression were investigated by qPCR. IL 10, Leukotriene-B4 (LTB4) and nitrite production were measured in PBMC (from healthy donor) culture supernatants. TLR2, TLR4, TLR5, NLRP3 and IL-1 beta were highly expressed in SS-PBMC when compared to AA-PBMC. Additionally, SS-RBC induced TLR9, NLRP3, Caspase-1, IL1 beta and IL-18 expression and induced LTB4 and nitrite production in PBMC cultures. HU did not prevent TLR and NLRP3 inflammasome expression, but increased TLR2 and IL-18 expression and reduced nitrite production. In conclusion, our data suggest that TLR and inflammasome complexes may be key inducers of inflammation in SCA patients, probably through SS-RBC; also, HU does not prevent NLRP3 inflammasome- and TLR-dependent inflammation, indicating the need to develop new therapeutic strategies to SCA patients that act with different mechanisms of those observed for HU. (C) 2016 Elsevier Ltd. All rights reserved.
C1 [Pitanga, Thassila N.; Oliveira, Ricardo R.; Zanette, Dalila L.; Guarda, Caroline C.; Santiago, Rayra P.; Santana, Sanzio S.; Lima, Jonilson B.; Carvalho, Graziele Q.; Maffili, Vitor V.; Carvalho, Magda O. S.; Alcantara, Luiz C. J.; Borges, Valeria M.; Goncalves, Marilda S.] FIOCRUZ BA, Ctr Pesquisas Goncalo Moniz, Fundacao Oswaldo Cruz, BR-40296710 Salvador, BA, Brazil.
   [Pitanga, Thassila N.] Univ Fed Bahia UFBA, ICS, BR-40110902 Salvador, BA, Brazil.
   [Nascimento, Valma M. L.] Fundacao Hematol & Hemoterapia Bahia HEMOBA, BR-40286240 Salvador, BA, Brazil.
   [Carvalho, Magda O. S.] Univ Fed Bahia, HUPES, BR-40110060 Salvador, BA, Brazil.
   [Goncalves, Marilda S.] Univ Fed Bahia, Fac Farm, BR-40170115 Salvador, BA, Brazil.
RP Goncalves, MS (corresponding author), Ctr Pesquisas Goncalo Moniz, Lab Hematol Genet & Biol Computac, Rua Waldemar Falcao 121, BR-40296710 Salvador, BA, Brazil.
EM mari@bahia.fiocruz.br
RI Borges, Valeria/G-2009-2014; Oliveira, Ricardo/E-7707-2017; ZANETTE,
   DALILA/Q-3541-2016; Lima, Jonilson Berlink/E-1531-2015; Borges,
   Val/N-6647-2019; Pitanga, Thassila/E-8242-2017
OI Oliveira, Ricardo/0000-0001-9586-2313; Lima, Jonilson
   Berlink/0000-0002-1403-4768; Borges, Val/0000-0002-2775-5409; Pitanga,
   Thassila/0000-0001-6831-571X; zanette, dalila l./0000-0001-9397-4127;
   Alcantara, Luiz/0000-0002-6769-9931
FU Brazilian National Council of Research (CNPq)National Council for
   Scientific and Technological Development (CNPq) [311888/2013-5];
   Foundation of Research and Extension of Bahia (FAPESB) [3626/2013,
   1431040053063, 9073/2007]; PPSUS/FAPESB [020/2013 EFP00007295];
   Instituto Nacional de Ciencia e Tecnologia do Sangue (INCTs);
   MCD/CNPq/MS-SCTIE-DECITNational Council for Scientific and Technological
   Development (CNPq) [409800/2006-6]; CAPESCAPES; CNPqNational Council for
   Scientific and Technological Development (CNPq)
FX This work was supported by grants from the Brazilian National Council of
   Research (CNPq) (311888/2013-5) (M.S.G.); the Foundation of Research and
   Extension of Bahia (FAPESB) (3626/2013, 1431040053063, and 9073/2007)
   (M.S.G.); and PPSUS/FAPESB (020/2013 EFP00007295), (M.S.G.); the
   Instituto Nacional de Ciencia e Tecnologia do Sangue (INCTs)
   (Coordinated by S.T.O.S.), and MCD/CNPq/MS-SCTIE-DECIT (409800/2006-6),
   (M.S.G.). Sponsors of this study are public or nonprofit organizations
   that support science in general. They had no role in gathering
   analyzing, or interpreting the data. We are greatly grateful to SCA
   patients, all healthy individuals for trust us and for making possible
   the realization of this work. Finally, we would also like to thank
   Wendell Vilas Boas, Bruno Cerqueira, Lucio Barbosa, Kiyoshi Fukutani,
   Marcia Weber, Junia Raquel Ferreira, Viviane Junqueira Rocha and Cyntia
   Cajado for excellent discussions. TNP received a scholarship from CAPES.
   L.C.J.A., V.M.B. and MSG have productivity scholarship from CNPq.
CR Agostini L, 2004, IMMUNITY, V20, P319, DOI 10.1016/S1074-7613(04)00046-9
   Bahl N, 2011, J BIOL CHEM, V286, P37793, DOI 10.1074/jbc.M111.245472
   Bauer S, 2013, IMMUNOL LETT, V149, P85, DOI 10.1016/j.imlet.2012.11.003
   Bauernfeind F, 2011, J IMMUNOL, V187, P613, DOI 10.4049/jimmunol.1100613
   Bauernfeind FG, 2009, J IMMUNOL, V183, P787, DOI 10.4049/jimmunol.0901363
   Belcher JD, 2003, BLOOD, V101, P3953, DOI 10.1182/blood-2002-10-3313
   Belcher JD, 2014, BLOOD, V123, P377, DOI 10.1182/blood-2013-04-495887
   Bowie AG, 2005, MOL IMMUNOL, V42, P859, DOI 10.1016/j.molimm.2004.11.007
   Burkitt MJ, 2006, BLOOD, V107, P2219, DOI 10.1182/blood-2005-08-3429
   Cassel SL, 2010, EUR J IMMUNOL, V40, P607, DOI 10.1002/eji.200940207
   Cerqueira BAV, 2011, CYTOKINE, V56, P471, DOI 10.1016/j.cyto.2011.08.013
   Chen RC, 2015, BIOCHEM BIOPH RES CO, V458, P650, DOI 10.1016/j.bbrc.2015.01.159
   de Montalembert M, 2006, HAEMATOLOGICA, V91, P125
   Dinarello CA, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00289
   DING AH, 1988, J IMMUNOL, V141, P2407
   Dutra FF, 2014, P NATL ACAD SCI USA, V111, pE4110, DOI 10.1073/pnas.1405023111
   Eberhardt RT, 2003, AM J HEMATOL, V74, P104, DOI 10.1002/ajh.10387
   Elias Darcielle Bruna Dias, 2012, Rev. Bras. Hematol. Hemoter., V34, P265, DOI 10.5581/1516-8484.20120069
   Figueiredo RT, 2007, J BIOL CHEM, V282, P20221, DOI 10.1074/jbc.M610737200
   Ghonime MG, 2014, J IMMUNOL, V192, P3881, DOI 10.4049/jimmunol.1301974
   Gladwin MT, 2014, BLOOD, V123, P3689, DOI 10.1182/blood-2014-03-563874
   Gladwin MT, 2003, CIRCULATION, V107, P271, DOI 10.1161/01.CIR.0000044943.12533.A8
   Gladwin MT, 2002, BRIT J HAEMATOL, V116, P436, DOI 10.1046/j.1365-2141.2002.03274.x
   GLADWIN MT, 2005, AM SOC HEMATOL ED PR, P51
   Graca-Souza AV, 2002, BLOOD, V99, P4160, DOI 10.1182/blood.V99.11.4160
   Guarda G, 2011, J IMMUNOL, V186, P2529, DOI 10.4049/jimmunol.1002720
   Guma M, 2010, P NATL ACAD SCI USA, V107, P22122, DOI 10.1073/pnas.1016401107
   Gupta K, 2014, BLOOD, V124, P3837, DOI 10.1182/blood-2014-11-608984
   Husseinzadeh N, 2014, GYNECOL ONCOL, V135, P359, DOI 10.1016/j.ygyno.2014.08.013
   IBE BO, 1994, EUR J CLIN INVEST, V24, P57, DOI 10.1111/j.1365-2362.1994.tb02060.x
   Imai Y, 2008, CELL, V133, P235, DOI 10.1016/j.cell.2008.02.043
   Jialal I, 2014, ATHEROSCLEROSIS, V236, P182, DOI 10.1016/j.atherosclerosis.2014.06.022
   Kato GJ, 2007, BLOOD REV, V21, P37, DOI 10.1016/j.blre.2006.07.001
   Kauppila JH, 2013, BRIT J CANCER, V108, P638, DOI 10.1038/bjc.2012.589
   Ketelut-Carneiro N, 2015, J IMMUNOL, V194, P4507, DOI 10.4049/jimmunol.1402321
   Kim EH, 2015, J INFLAMM-LOND, V12, DOI 10.1186/s12950-015-0086-z
   Kitazawa M, 2011, J IMMUNOL, V187, P6539, DOI 10.4049/jimmunol.1100620
   Knight-Perry J, 2009, EXPERT REV HEMATOL, V2, P57, DOI 10.1586/17474086.2.1.57
   Lefebvre JS, 2011, ARTHRITIS RHEUM-US, V63, P1527, DOI 10.1002/art.30308
   Liew FY, 2005, NAT REV IMMUNOL, V5, P446, DOI 10.1038/nri1630
   Mariathasan S, 2007, NAT REV IMMUNOL, V7, P31, DOI 10.1038/nri1997
   Martinez-Godinez MA, 2015, ISR MED ASSOC J, V17, P5
   Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3
   Mitroulis I, 2010, EUR J INTERN MED, V21, P157, DOI 10.1016/j.ejim.2010.03.005
   Monteiro APT, 2011, J IMMUNOL, V186, P6562, DOI 10.4049/jimmunol.1002400
   Opene M, 2014, PULM CIRC, V4, P482, DOI 10.1086/677363
   Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45
   Pfirschke C, 2015, CANCER CELL, V27, P1, DOI 10.1016/j.ccell.2014.12.008
   Pimentel-Nunes P, 2011, PATHOL ONCOL RES, V17, P677, DOI 10.1007/s12253-011-9368-9
   Pitanga T. N., 2013, ADV BIOSCI BIOTECH, V4, P7
   Platt OS, 2008, NEW ENGL J MED, V358, P1362, DOI 10.1056/NEJMct0708272
   Platt OS, 2000, J CLIN INVEST, V106, P337, DOI 10.1172/JCI10726
   Potoka KP, 2015, AM J PHYSIOL-LUNG C, V308, pL314, DOI 10.1152/ajplung.00252.2014
   Raat NJH, 2013, ANTIOXID REDOX SIGN, V19, P2232, DOI 10.1089/ars.2013.5181
   Ramirez-Ramirez V., 2013, OXIDATIVE MED CELLUL, V2013, DOI DOI 10.1155/2013/709493
   REES DC, 1995, BRIT J HAEMATOL, V91, P834, DOI 10.1111/j.1365-2141.1995.tb05397.x
   Reiter CD, 2003, CURR OPIN HEMATOL, V10, P99, DOI 10.1097/00062752-200303000-00001
   Rojas-Mancilla E, 2015, INT J MOL SCI, V16, P1728, DOI 10.3390/ijms16011728
   Sanchez-Zauco N, 2014, ALLERGY ASTHMA PROC, V35, pE34, DOI 10.2500/aap.2014.35.3749
   Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040
   Setty BNY, 2002, J LAB CLIN MED, V139, P80, DOI 10.1067/mlc.2002.121200
   Setty BNY, 2002, BLOOD, V99, P1564, DOI 10.1182/blood.V99.5.1564
   Sheridan J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061326
   Steinberg MH, 2010, AM J HEMATOL, V85, P403, DOI 10.1002/ajh.21699
   Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3
   Tas F, 2015, BIOMED PHARMACOTHER, V70, P19, DOI 10.1016/j.biopha.2014.12.040
   Taylor JG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002095
   van Beers EJ, 2015, CIRC RES, V116, P298, DOI 10.1161/CIRCRESAHA.116.304577
   van Bergenhenegouwen J, 2013, J LEUKOCYTE BIOL, V94, P885, DOI 10.1189/jlb.0113003
   Vance RE, 2009, CELL HOST MICROBE, V6, P10, DOI 10.1016/j.chom.2009.06.007
   Vicari P, 2015, BLOOD CELL MOL DIS, V54, P244, DOI 10.1016/j.bcmd.2014.12.004
   Vilas-Boas W, 2010, ANN HEMATOL, V89, P877, DOI 10.1007/s00277-010-0954-9
   Wang R, 2012, J IMMUNOL, V189, P2217, DOI 10.4049/jimmunol.1101895
   Wang YC, 2014, ANN NEUROL, V75, P876, DOI 10.1002/ana.24159
   Weatherall DJ, 2000, LANCET, V355, P1169, DOI 10.1016/S0140-6736(00)02073-0
   Wood KC, 2004, AM J PHYSIOL-HEART C, V286, pH1608, DOI 10.1152/ajpheart.01056.2003
   Xu H, 2014, BLOOD, V124, P3978, DOI 10.1182/blood-2014-04-560813
   Yang K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095935
   Zennadi R, 2008, BLOOD, V112, P3474, DOI 10.1182/blood-2008-01-134346
   Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663
NR 80
TC 16
Z9 16
U1 2
U2 12
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 1043-4666
EI 1096-0023
J9 CYTOKINE
JI Cytokine
PD JUL
PY 2016
VL 83
BP 75
EP 84
DI 10.1016/j.cyto.2016.03.016
PG 10
WC Biochemistry & Molecular Biology; Cell Biology; Immunology
SC Biochemistry & Molecular Biology; Cell Biology; Immunology
GA DN7AS
UT WOS:000377228300011
PM 27045344
OA Green Published
DA 2020-10-22
ER

PT J
AU Costa, F
   Sarno, M
   Khouri, R
   Freitas, BD
   Siqueira, I
   Ribeiro, GS
   Ribeiro, HC
   Campos, GS
   Alcantara, LC
   Reis, MG
   Weaver, SC
   Vasilakis, N
   Ko, AI
   Almeida, AR
AF Costa, Federico
   Sarno, Manoel
   Khouri, Ricardo
   Freitas, Bruno de Paula
   Siqueira, Isadora
   Ribeiro, Guilherme S.
   Ribeiro, Hugo C.
   Campos, Gubio S.
   Alcantara, Luiz C.
   Reis, Mitermayer G.
   Weaver, Scott C.
   Vasilakis, Nikos
   Ko, Albert I.
   Almeida, Antonio Raimundo
TI Emergence of Congenital Zika Syndrome: Viewpoint From the Front Lines
SO ANNALS OF INTERNAL MEDICINE
LA English
DT Editorial Material
ID VIRUS; DENGUE
C1 [Khouri, Ricardo; Ribeiro, Guilherme S.; Alcantara, Luiz C.] Minist Saude, Ctr Pesquisas Goncalo Moniz, Fundacao Oswaldo Cruz, Rua Waldemar Falcao 121, BR-40296710 Salvador, BA, Brazil.
   [Ribeiro, Guilherme S.] Univ Fed Bahia, Inst Saude Colet, Rua Waldemar Falcao 121, BR-40296710 Salvador, BA, Brazil.
   Univ Fed Bahia, Fac Med Bahia, Salvador, BA, Brazil.
   [Freitas, Bruno de Paula; Ribeiro, Hugo C.] Secretaria Estadual Saude Bahia, Hosp Geral Roberto Santos, Ave Paulo 6,2240,Apt 1004, BR-41810001 Salvador, BA, Brazil.
   Univ Texas Med Branch, Dept Pathol, Inst Human Infect & Immun, Dept Microbiol & Immunol, Galveston, TX 77555 USA.
   Univ Texas Med Branch, Galveston, TX 77555 USA.
   [Ko, Albert I.] Yale Univ, Sch Publ Hlth, Dept Epidemiol Microbial Dis, 60 Coll St,POB 208034, New Haven, CT 06520 USA.
   [Costa, Federico] Inst Saude Colet, Rua Basilio da Gama S-N, BR-40110040 Salvador, BA, Brazil.
   [Sarno, Manoel] Univ Fed Bahia, Hosp Geral Roberto Santos, Secretaria Saude Estado Bahia & Maternidade Clime, Rua Limoeiro 137, BR-41055150 Salvador, BA, Brazil.
   [Siqueira, Isadora; Reis, Mitermayer G.] Funda, Ctr Pesquisas Goncalo Moniz, R Waldemar Falcao 121, BR-40296710 Salvador, BA, Brazil.
   [Campos, Gubio S.] Univ Fed Bahia, Inst Ciencias Saude, Salvador, BA, Brazil.
   [Weaver, Scott C.; Vasilakis, Nikos] Univ Texas, Inst Human Infect & Immun, 301 Univ Blvd, Galveston, TX 77555 USA.
   [Almeida, Antonio Raimundo] Univ Fed Bahia, Hosp Geral Roberto Santos, Secretaria Saude Estado Bahia, Ave Santa Luzia 149-302,Ed Bosque Italia, BR-40295050 Salvador, BA, Brazil.
RP Costa, F (corresponding author), Inst Saude Colet, Rua Basilio da Gama S-N, BR-40110040 Salvador, BA, Brazil.
EM fcosta2001@gmail.com
RI Khouri, Ricardo/M-3184-2018; Ko, Albert Icksang/P-2343-2015; Weaver,
   Scott C/D-6490-2011; Reis, Mitermayer/AAO-9742-2020; Costa,
   Federico/G-1838-2015; Ribeiro, Guilherme/B-6624-2008; de Siqueira,
   Isadora Cristina/R-9953-2016
OI Khouri, Ricardo/0000-0001-5664-4436; Ko, Albert
   Icksang/0000-0001-9023-2339; Weaver, Scott C/0000-0001-8016-8556; Reis,
   Mitermayer/0000-0002-3051-9060; Costa, Federico/0000-0001-6951-2336;
   Ribeiro, Guilherme/0000-0002-6798-2059; de Siqueira, Isadora
   Cristina/0000-0002-2520-4099; Alcantara, Luiz/0000-0002-6769-9931
FU FIC NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)
   [R01 TW009504] Funding Source: Medline; NIAID NIH HHSUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [R01 AI121207] Funding Source: Medline
CR Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Freitas BD, 2016, JAMA OPHTHALMOL, V134, P529, DOI 10.1001/jamaophthalmol.2016.0267
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Mlakar J, 2016, N ENGL J MED
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Victora CG, 2016, LANCET, V387, P621, DOI 10.1016/S0140-6736(16)00273-7
NR 9
TC 49
Z9 51
U1 0
U2 15
PU AMER COLL PHYSICIANS
PI PHILADELPHIA
PA INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA
SN 0003-4819
EI 1539-3704
J9 ANN INTERN MED
JI Ann. Intern. Med.
PD MAY 17
PY 2016
VL 164
IS 10
BP 689
EP +
DI 10.7326/M16-0332
PG 4
WC Medicine, General & Internal
SC General & Internal Medicine
GA DL8GF
UT WOS:000375878500019
PM 26914810
OA Green Published, Green Accepted
DA 2020-10-22
ER

PT J
AU Giovanetti, M
   Milano, T
   Alcantara, LC
   Carcangiu, L
   Cella, E
   Lai, A
   Lo Presti, A
   Pascarella, S
   Zehender, G
   Angeletti, S
   Ciccozzi, M
AF Giovanetti, Marta
   Milano, Teresa
   Alcantara, Luiz Carlos
   Carcangiu, Laura
   Cella, Eleonora
   Lai, Alessia
   Lo Presti, Alessandra
   Pascarella, Stefano
   Zehender, Gianguglielmo
   Angeletti, Silvia
   Ciccozzi, Massimo
TI Zika virus spreading in South America: evolutionary analysis of emerging
   neutralizing resistant Phe279Ser strains
SO ASIAN PACIFIC JOURNAL OF TROPICAL MEDICINE
LA English
DT Article
DE Zika virus; Phylogeny; Evolution
ID AMINO-ACID SITES; ENVELOPE PROTEIN; AEDES-AEGYPTI; SEQUENCE; PREDICTION;
   INFERENCE; ACCURACY; DYNAMICS; MODELS; POWER
AB Objective: To investigate the genetic diversity of Zika virus (ZIKV) and the relationships existing among these circulating viruses worldwide. To evaluate the genetic polymorphisms harboured from ZIKV that can have an influence on the virus circulation. Methods: Three different ZIKV dataset were built. The first dataset included 63 E gene sequences, the second one 22 NS3 sequences and the third dataset was composed of 108 NS5 gene sequences. Phylogenetic and selective pressure analysis was performed. The edited nucleic acid alignment from the Envelope dataset was used to generate a conceptual translation to the corresponding peptide sequences through UGene software. Results: The phylogeographic reconstruction was able to discriminate unambiguously that the Brazilian strains are belonged to the Asian lineage. The structural analysis reveals instead the presence of the Ser residue in the Brazilian sequences (however already observed in other previously reported ZIKV infections) that could suggest the presence of a neutralization-resistant population of viruses. Conclusions: Phylogenetic, evolutionary and selective pressure analysis contributed to improve the knowledge on the circulation of ZIKV.
C1 [Giovanetti, Marta; Carcangiu, Laura; Cella, Eleonora; Lo Presti, Alessandra; Ciccozzi, Massimo] Natl Inst Hlth, Dept Infect Parasit & Immunomediated Dis, Rome, Italy.
   [Giovanetti, Marta] Univ Roma Tor Vergata, Dept Biol, I-00173 Rome, Italy.
   [Giovanetti, Marta; Alcantara, Luiz Carlos] Oswaldo Cruz Fdn LHGB CPqGM FIOCRUZ, Goncalo Moniz Res Ctr, Lab Hematol Genet & Computat Biol, Salvador, BA, Brazil.
   [Milano, Teresa; Pascarella, Stefano] Univ Roma La Sapienza, Dipartimento Sci Biochim A Rossi Fanelli, I-00185 Rome, Italy.
   [Cella, Eleonora] Univ Roma La Sapienza, Dept Publ Hlth & Infect Dis, I-00185 Rome, Italy.
   [Lai, Alessia; Zehender, Gianguglielmo] Univ Milan, Lab Infect Dis & Trop Med, I-20122 Milan, Italy.
   [Angeletti, Silvia] Univ Hosp Campus Biomed Rome, Clin Pathol & Microbiol Lab, Rome, Italy.
   [Ciccozzi, Massimo] Univ Campus Biomed, Rome, Italy.
RP Ciccozzi, M (corresponding author), Natl Inst Hlth, Dept Infect Parasit & Immunomediated Dis, Epidemiol Unit, Reference Ctr Phylogeny Mol Epidemiol & Microbial, Rome, Italy.
EM ciccozzi@iss.it
RI CICCOZZI, MASSIMO/C-6484-2016; Cella, Eleonora/ABA-8333-2020;
   Giovanetti, Marta/AAK-7408-2020; Presti, Alessandra Lo/K-1451-2016;
   Cella, Eleonora/J-9961-2016
OI CICCOZZI, MASSIMO/0000-0003-3866-9239; Cella,
   Eleonora/0000-0002-7870-9744; Presti, Alessandra Lo/0000-0001-7611-5021;
   Cella, Eleonora/0000-0002-7870-9744; Alcantara,
   Luiz/0000-0002-6769-9931; Giovanetti, Marta/0000-0002-5849-7326
CR Anisimova M, 2002, MOL BIOL EVOL, V19, P950, DOI 10.1093/oxfordjournals.molbev.a004152
   Anisimova M, 2001, MOL BIOL EVOL, V18, P1585, DOI 10.1093/oxfordjournals.molbev.a003945
   [Anonymous], 2015, Wkly Epidemiol Rec, V90, P609
   Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399
   Beasley DWC, 2001, VIROLOGY, V279, P447, DOI 10.1006/viro.2000.0721
   Bisset J A, 2001, Rev Cubana Med Trop, V53, P37
   CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245
   Ciccozzi M, 2012, AIDS RES HUM RETROV, V28, P1280, DOI 10.1089/aid.2011.0138
   Ciccozzi M, 2011, AIDS RES HUM RETROV, V27, P921, DOI [10.1089/aid.2010.0323, 10.1089/AID.2010.0323]
   Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI 10.1093/molbev/msi103
   Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Gatherer D, 2016, J GEN VIROL, V97, P269, DOI 10.1099/jgv.0.000381
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Haddow AD, PLOS NEGL TROP DIS, V201
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Herrera F, 2006, MEM I OSWALDO CRUZ, V101, P625, DOI 10.1590/S0074-02762006000600008
   Kaplan W, 2001, Brief Bioinform, V2, P195, DOI 10.1093/bib/2.2.195
   KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572
   Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148
   Lee E, 1997, VIROLOGY, V232, P281, DOI 10.1006/viro.1997.8570
   Lemey P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000520
   Lo Presti A, 2012, INFECT GENET EVOL, V12, P392, DOI 10.1016/j.meegid.2011.12.015
   Marcondes CB, 2015, REV SOC BRAS MED TRO
   Modis Y, 2003, P NATL ACAD SCI USA, V100, P6986, DOI 10.1073/pnas.0832193100
   Modis Y, 2004, NATURE, V427, P313, DOI 10.1038/nature02165
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Nielsen R, 1998, GENETICS, V148, P929
   Okonechnikov K, 2012, BIOINFORMATICS, V28, P1166, DOI 10.1093/bioinformatics/bts091
   Pierson TC, 2013, CURR OPIN VIROL, V3, P3, DOI 10.1016/j.coviro.2012.12.001
   Pond SLK, 2005, MOL BIOL EVOL, V22, P1208, DOI 10.1093/molbev/msi105
   Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079
   Pybus OG, 2009, NAT REV GENET, V10, P540, DOI 10.1038/nrg2583
   REY FA, 1995, NATURE, V375, P291, DOI 10.1038/375291a0
   Rodriguez MM, 2001, J MED ENTOMOL, V38, P623, DOI 10.1603/0022-2585-38.5.623
   Salemi M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001390
   SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626
   Schroedinger L., 2015, PYMOL MOL GRAPHICS S
   Strimmer K, 1997, P NATL ACAD SCI USA, V94, P6815, DOI 10.1073/pnas.94.13.6815
   Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033
   Yang ZH, 2000, GENETICS, V155, P431
   Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097
NR 47
TC 13
Z9 13
U1 0
U2 41
PU WOLTERS KLUWER MEDKNOW PUBLICATIONS
PI MUMBAI
PA WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2
   VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA
SN 1995-7645
EI 2352-4146
J9 ASIAN PAC J TROP MED
JI Asian Pac. J. Trop. Med.
PD MAY
PY 2016
VL 9
IS 5
BP 445
EP 452
DI 10.1016/j.apjtm.2016.03.028
PG 8
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA DL0YS
UT WOS:000375359100006
PM 27261852
OA DOAJ Gold, Green Published
DA 2020-10-22
ER

PT J
AU Faria, NR
   Azevedo, RDD
   Kraemer, MUG
   Souza, R
   Cunha, MS
   Hill, SC
   Theze, J
   Bonsall, MB
   Bowden, TA
   Rissanen, I
   Rocco, IM
   Nogueira, JS
   Maeda, AY
   Vasami, FGD
   Macedo, FLD
   Suzuki, A
   Rodrigues, SG
   Cruz, ACR
   Nunes, BT
   Medeiros, DBD
   Rodrigues, DSG
   Queiroz, ALN
   da Silva, EVP
   Henriques, DF
   da Rosa, EST
   de Oliveira, CS
   Martins, LC
   Vasconcelos, HB
   Casseb, LMN
   Simith, DD
   Messina, JP
   Abade, L
   Loureno, J
   Alcantara, LCJ
   de Lima, MM
   Giovanetti, M
   Hay, SI
   de Oliveira, RS
   Lemos, PD
   de Oliveira, LF
   de Lima, CPS
   da Silva, SP
   de Vasconcelos, JM
   Franco, L
   Cardoso, JF
   Vianez, JLDG
   Mir, D
   Bello, G
   Delatorre, E
   Khan, K
   Creatore, M
   Coelho, GE
   de Oliveira, WK
   Tesh, R
   Pybus, OG
   Nunes, MRT
   Vasconcelos, PFC
AF Faria, Nuno Rodrigues
   da Silva Azevedo, Raimunda do Socorro
   Kraemer, Moritz U. G.
   Souza, Renato
   Cunha, Mariana Sequetin
   Hill, Sarah C.
   Theze, Julien
   Bonsall, Michael B.
   Bowden, Thomas A.
   Rissanen, Ilona
   Rocco, Iray Maria
   Nogueira, Juliana Silva
   Maeda, Adriana Yurika
   da Silva Vasami, Fernanda Giseli
   de Lima Macedo, Fernando Luiz
   Suzuki, Akemi
   Rodrigues, Sueli Guerreiro
   Ribeiro Cruz, Ana Cecilia
   Nunes, Bruno Tardeli
   de Almeida Medeiros, Daniele Barbosa
   Guerreiro Rodrigues, Daniela Sueli
   Nunes Queiroz, Alice Louize
   Pinto da Silva, Eliana Vieira
   Henriques, Daniele Freitas
   Travassos da Rosa, Elisabeth Salbe
   de Oliveira, Consuelo Silva
   Martins, Livia Caricio
   Vasconcelos, Helena Baldez
   Neves Casseb, Livia Medeiros
   Simith, Darlene de Brito
   Messina, Jane P.
   Abade, Leandro
   Loureno, Jose
   Junior Alcantara, Luiz Carlos
   de Lima, Maricelia Maia
   Giovanetti, Marta
   Hay, Simon I.
   de Oliveira, Rodrigo Santos
   Lemos, Poliana da Silva
   de Oliveira, Layanna Freitas
   Silva de Lima, Clayton Pereira
   da Silva, Sandro Patroca
   de Vasconcelos, Janaina Mota
   Franco, Luciano
   Cardoso, Jedson Ferreira
   da Silva Gonalves Vianez-Junior, Joao Lidio
   Mir, Daiana
   Bello, Gonzalo
   Delatorre, Edson
   Khan, Kamran
   Creatore, Marisa
   Coelho, Giovanini Evelim
   de Oliveira, Wanderson Kleber
   Tesh, Robert
   Pybus, Oliver G.
   Nunes, Marcio R. T.
   Vasconcelos, Pedro F. C.
TI Zika virus in the Americas: Early epidemiological and genetic findings
SO SCIENCE
LA English
DT Article
ID FRENCH-POLYNESIA; TRANSMISSION; INFECTION; BRAZIL; OUTBREAK; EVOLUTION;
   ISLAND; TRAVEL; CHILD
AB Brazil has experienced an unprecedented epidemic of Zika virus (ZIKV), with similar to 30,000 cases reported to date. ZIKV was first detected in Brazil in May 2015, and cases of microcephaly potentially associated with ZIKV infection were identified in November 2015. We performed next-generation sequencing to generate seven Brazilian ZIKV genomes sampled from four self-limited cases, one blood donor, one fatal adult case, and one newborn with microcephaly and congenital malformations. Results of phylogenetic and molecular clock analyses show a single introduction of ZIKV into the Americas, which we estimated to have occurred between May and December 2013, more than 12 months before the detection of ZIKV in Brazil. The estimated date of origin coincides with an increase in air passengers to Brazil from ZIKV-endemic areas, as well as with reported outbreaks in the Pacific Islands. ZIKV genomes from Brazil are phylogenetically interspersed with those from other South American and Caribbean countries. Mapping mutations onto existing structural models revealed the context of viral amino acid changes present in the outbreak lineage; however, no shared amino acid changes were found among the three currently available virus genomes from microcephaly cases. Municipality-level incidence data indicate that reports of suspected microcephaly in Brazil best correlate with ZIKV incidence around week 17 of pregnancy, although this correlation does not demonstrate causation. Our genetic description and analysis of ZIKV isolates in Brazil provide a baseline for future studies of the evolution and molecular epidemiology of this emerging virus in the Americas.
C1 [Faria, Nuno Rodrigues; de Oliveira, Rodrigo Santos; Lemos, Poliana da Silva; de Oliveira, Layanna Freitas; Silva de Lima, Clayton Pereira; da Silva, Sandro Patroca; de Vasconcelos, Janaina Mota; Franco, Luciano; Cardoso, Jedson Ferreira; da Silva Gonalves Vianez-Junior, Joao Lidio; Nunes, Marcio R. T.] Minist Hlth, Evandro Chagas Inst, Ctr Technol Innovat, BR-67030000 Ananindeua, PA, Brazil.
   [Faria, Nuno Rodrigues; Kraemer, Moritz U. G.; Hill, Sarah C.; Theze, Julien; Bonsall, Michael B.; Messina, Jane P.; Abade, Leandro; Loureno, Jose; Pybus, Oliver G.] Univ Oxford, Dept Zool, S Parks Rd, Oxford OX1 3PS, England.
   [da Silva Azevedo, Raimunda do Socorro; Rodrigues, Sueli Guerreiro; Ribeiro Cruz, Ana Cecilia; Nunes, Bruno Tardeli; de Almeida Medeiros, Daniele Barbosa; Guerreiro Rodrigues, Daniela Sueli; Nunes Queiroz, Alice Louize; Pinto da Silva, Eliana Vieira; Henriques, Daniele Freitas; Travassos da Rosa, Elisabeth Salbe; de Oliveira, Consuelo Silva; Martins, Livia Caricio; Vasconcelos, Helena Baldez; Neves Casseb, Livia Medeiros; Simith, Darlene de Brito; Vasconcelos, Pedro F. C.] Minist Hlth, Dept Arbovirol & Hemorrhag Fevers, Evandro Chagas Inst, Ananindeua, Para, Brazil.
   [Souza, Renato; Cunha, Mariana Sequetin; Rocco, Iray Maria; Nogueira, Juliana Silva; Maeda, Adriana Yurika; da Silva Vasami, Fernanda Giseli; de Lima Macedo, Fernando Luiz; Suzuki, Akemi] Univ Sao Paulo, Inst Adolfo Lutz, Sao Paulo, Brazil.
   [Bowden, Thomas A.; Rissanen, Ilona; Hay, Simon I.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England.
   [Messina, Jane P.; Pybus, Oliver G.] Metabiota, San Francisco, CA 94104 USA.
   [Junior Alcantara, Luiz Carlos; Giovanetti, Marta] Oswaldo Cruz Fdn FIOCRUZ, Salvador, BA, Brazil.
   [de Lima, Maricelia Maia] Univ Estadual Feira de Santana, Ctr Post Grad Collect Hlth, Dept Hlth, Feira De Santana, BA, Brazil.
   [Hay, Simon I.] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98121 USA.
   [Mir, Daiana; Bello, Gonzalo; Delatorre, Edson] Fiocruz MS, Lab AIDS & Imunol Mol, Inst Oswaldo Cruz, BR-21045900 Rio De Janeiro, Brazil.
   [Khan, Kamran] St Michaels Hosp, Li Ka Shing Knowledge Inst, 30 Bond St, Toronto, ON M5B 1W8, Canada.
   [Khan, Kamran] Univ Toronto, Dept Med, Div Infect Dis, Toronto, ON, Canada.
   [Creatore, Marisa] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada.
   [Coelho, Giovanini Evelim; de Oliveira, Wanderson Kleber] Brazilian Minist Hlth, Brasilia, DF, Brazil.
   [Tesh, Robert; Nunes, Marcio R. T.] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA.
RP Nunes, MRT (corresponding author), Minist Hlth, Evandro Chagas Inst, Ctr Technol Innovat, BR-67030000 Ananindeua, PA, Brazil.; Pybus, OG (corresponding author), Univ Oxford, Dept Zool, S Parks Rd, Oxford OX1 3PS, England.; Vasconcelos, PFC (corresponding author), Minist Hlth, Dept Arbovirol & Hemorrhag Fevers, Evandro Chagas Inst, Ananindeua, Para, Brazil.; Pybus, OG (corresponding author), Metabiota, San Francisco, CA 94104 USA.; Nunes, MRT (corresponding author), Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA.
EM oliver.pybus@zoo.ox.ac.uk; marcionunesbrasil@yahoo.com.br;
   pedrovasconcelos@iec.pa.gov.br
RI Bello, Gonzalo/E-6842-2013; Hay, Simon I/F-8967-2015; Azevedo,
   Raimunda/T-4656-2019; Cruz, Ana Cecilia Ribeiro/V-9276-2019; Bentancor,
   Gonzalo Jose Bello/N-7377-2019; Delatorre, Edson/J-8330-2015;
   Vasconcelos, Pedro/AAH-3142-2019; Giovanetti, Marta/AAK-7408-2020;
   Pybus, Oliver G/B-2640-2012; , daiana/J-5515-2019; Faria, Nuno
   R/I-2975-2012; Oliveira, Wanderson/AAF-5182-2019; Vianez Junior, Joao
   Lidio/I-9547-2016
OI Hay, Simon I/0000-0002-0611-7272; Azevedo, Raimunda/0000-0003-1932-9976;
   Bentancor, Gonzalo Jose Bello/0000-0002-2724-2793; Delatorre,
   Edson/0000-0002-5746-0820; Pybus, Oliver G/0000-0002-8797-2667; ,
   daiana/0000-0002-3172-4867; Faria, Nuno R/0000-0001-8839-2798; Oliveira,
   Wanderson/0000-0002-9662-1930; Vianez Junior, Joao
   Lidio/0000-0001-6226-9441; Hill, Sarah/0000-0002-2995-2596; Rissanen,
   Ilona/0000-0003-4937-1825; Lourenco, Jose/0000-0002-9318-2581; Pereira
   de Souza, Renato/0000-0003-1315-7085; Giovanetti,
   Marta/0000-0002-5849-7326; de Lima Macedo, Fernando
   Luiz/0000-0003-2097-0429; Theze, Julien/0000-0001-8188-9494; Alcantara,
   Luiz/0000-0002-6769-9931; Bowden, Thomas/0000-0002-8066-8785
FU European Research Council (ERC) under the European UnionEuropean
   Research Council (ERC) [614725-PATHPHYLODYN]; ERC under the European
   Union [268904-DIVERSITY]; Metabiota; American people through the United
   States Agency for International Development (USAID) Emerging Pandemic
   Threats Program-PREDICTUnited States Agency for International
   Development (USAID); Wellcome TrustWellcome Trust [095066, 102427,
   090532/Z/09/Z]; Bill and Melinda Gates FoundationBill & Melinda Gates
   Foundation [OPP1119467, OPP1093011, OPP1106023, OPP1132415]; Evandro
   Chagas Institute; Brazilian Ministry of Health; CNPq (Brazilian National
   Council for Scientific and Technological Development)National Council
   for Scientific and Technological Development (CNPq) [302032/2011-8,
   200024/2015-9]; National Institute of Science and Technology for Viral
   Hemorrhagic Fevers; U.S. NIHUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [R24 AT 120942]; UK
   Medical Research CouncilMedical Research Council UK (MRC)
   [MR/L009528/1]; CNPq-National Agency for Scientific and Technologic
   Development [573739/2008-0, 301641/2010-2, 457664/2013-4]; Medical
   Research CouncilMedical Research Council UK (MRC) [MR/L009528/1] Funding
   Source: Researchfish
FX We thank X. de Lamballerie and J. Lednicky for permission to include
   their unpublished ZIKV genomes in our analysis. We thank the Death
   Verification Service (SVO); Central Laboratories of Public Health
   (LACEN); and health departments of the Ceara State and Maranhao State,
   Brazil, for collaboration. O.G.P. is supported by the European Research
   Council (ERC) under the European Union's Seventh Framework Programme
   (FP7/2007-2013)/ERC grant 614725-PATHPHYLODYN. J.L. is supported by the
   ERC under the European Union's Seventh Framework Programme
   (FP7/2007-2013)/ERC grant 268904-DIVERSITY. O.G.P. received consulting
   fees from Metabiota between 2015 and 2016. This study is made possible
   in part by the generous support of the American people through the
   United States Agency for International Development (USAID) Emerging
   Pandemic Threats Program-PREDICT. The contents are the responsibility of
   the authors and do not necessarily reflect the views of USAID or the
   U.S. government. S.I.H. is funded by a Senior Research Fellowship from
   the Wellcome Trust (095066) and grants from the Bill and Melinda Gates
   Foundation (OPP1119467, OPP1093011, OPP1106023, and OPP1132415).
   M.R.T.N. is funded as an associated researcher in public health by the
   Evandro Chagas Institute, Brazilian Ministry of Health, and as a
   researcher in scientific productivity by CNPq (Brazilian National
   Council for Scientific and Technological Development) grants
   302032/2011-8 and 200024/2015-9 and is also supported in part by the
   National Institute of Science and Technology for Viral Hemorrhagic
   Fevers. R.T. is funded by grant R24 AT 120942 from the U.S. NIH. S.C.H.
   is supported by a Wellcome Trust grant (102427). T.A.B. and I.R. are
   supported by grants from the UK Medical Research Council (MR/L009528/1)
   and the Wellcome Trust (090532/Z/09/Z). P.F.C.V. is supported by
   CNPq-National Agency for Scientific and Technologic Development (grants
   573739/2008-0, 301641/2010-2, and 457664/2013-4). All samples were
   obtained from persons visiting local clinics or hospitalized by the
   Brazilian Ministry of Health personnel as part of dengue, chikungunya,
   and Zika fever surveillance activities. In these cases, patient consent
   was oral and not recorded. The study was authorized by the Coordination
   of the National Program for Dengue, Chikungunya, and Zika Control
   coordinated by Brazil's Ministry of Health. The data are available at
   DRYAD (DOI: 10.5061/dryad.6kn23). The ZIKV genomes reported in this
   study are deposited in GenBank under accession numbers KU321639,
   KU365777 to KU365780, KU729217, and KU729218.
CR Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dowd KA, 2011, VIROLOGY, V411, P306, DOI 10.1016/j.virol.2010.12.020
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   European Centre for Disease Prevention and Control, 2015, RAP RISK ASS MICR BR
   FAGBAMI A, 1988, AM J TROP MED HYG, V38, P205, DOI 10.4269/ajtmh.1988.38.205
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gerardin P, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002996
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Lemey P, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003932
   Lindenbach BD, 2003, ADV VIRUS RES, V59, P23, DOI 10.1016/S0065-3527(03)59002-9
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Meyer AG, 2015, VIRUS EVOL, V1, DOI 10.1093/ve/vev006
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Nunes MRT, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002769
   PAHO & WHO, 2015, EP AL NEUR SYNDR CON
   Park DJ, 2015, CELL, V161, P1516, DOI 10.1016/j.cell.2015.06.007
   Pybus OG, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2878
   Pybus OG, 2012, P NATL ACAD SCI USA, V109, P15066, DOI 10.1073/pnas.1206598109
   Pyke Alyssa T, 2014, PLoS Curr, V6, DOI 10.1371/currents.outbreaks.4635a54dbffba2156fb2fd76dc49f65e
   Roehrig JT, 2003, ADV VIRUS RES, V59, P141, DOI 10.1016/S0065-3527(03)59005-4
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Secretaria de Vigilancia em Saude, 2016, B EP MON CAS DENG FE, V47
   Silva MMO, 2016, EMERG INFECT DIS, V22, P336, DOI 10.3201/eid2202.150495
   Sorichetta A, 2015, SCI DATA, V2, DOI 10.1038/sdata.2015.45
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Nunes MRT, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0348-x
   Nunes MRT, 2012, EMERG INFECT DIS, V18, P1858, DOI 10.3201/eid1811.120217
   Tognarelli J, 2016, ARCH VIROL, V161, P665, DOI 10.1007/s00705-015-2695-5
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Victora CG, 2016, LANCET, V387, P621, DOI 10.1016/S0140-6736(16)00273-7
   Waehre T, 2014, EMERG INFECT DIS, V20, P1412, DOI 10.3201/eid2008.140302
   World Health Organization, 2016, ASS INF MICR CONT ZI
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 45
TC 547
Z9 558
U1 5
U2 248
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA
SN 0036-8075
EI 1095-9203
J9 SCIENCE
JI Science
PD APR 15
PY 2016
VL 352
IS 6283
BP 345
EP 349
DI 10.1126/science.aaf5036
PG 5
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DJ1UK
UT WOS:000373990100041
PM 27013429
OA Green Accepted, Bronze
DA 2020-10-22
ER

PT J
AU Rego, FFD
   de Oliveira, T
   Giovanetti, M
   Galvao-Castro, B
   Goncalves, MD
   Alcantara, LC
AF de Almeida Rego, Filipe Ferreira
   de Oliveira, Tulio
   Giovanetti, Marta
   Galvao-Castro, Bernardo
   Goncalves, Marilda de Souza
   Alcantara, Luiz Carlos
TI Deep Sequencing Analysis of Human T Cell Lymphotropic Virus Type 1 Long
   Terminal Repeat 5' Region from Patients with Tropical Spastic
   Paraparesis/Human T Cell Lymphotropic Virus Type 1-Associated Myelopathy
   and Asymptomatic Carriers
SO AIDS RESEARCH AND HUMAN RETROVIRUSES
LA English
DT Article
ID LTR POINT MUTATIONS; LEUKEMIA
AB The aim of this study was to analyze patients by deep sequencing the human T cell lymphotropic virus type 1 (HTLV-1) long terminal repeat (LTR) region in order to determine if minor and/or major mutations in this promoter region might be associated with tropical spastic paraparesis (TSP)/human T cell lymphotropic virus type 1-associated myelopathy (HAM) outcome or proviral load or HTLV-1 expression. This study is a cross-sectional analyze of 29 HTLV-1-infected patients with TSP/HAM or asymptomatic carriers. Proviral DNA from those subjects was submitted to a nested PCR for the HTLV-1 LTR5 region. The HTLV-1 LTR5 purified products were submitted to deep sequencing using the Ion Torrent sequencing technology (Life Technologies, Carlsbad, CA). We found that samples with low proviral load showed more detected minor mutations than the samples with high proviral load. Mutations in 136 positions were found over the 520-bp analyzed fragment of HTLV-1 LTR5 with at least 1% frequency. Eleven mutations were present in the previously determined major transcription factor binding sites (TFBS) and in more than one patient, indicating that there might be a differential HTLV-1 expression comparing individuals or in comparing different cells from the same individual. Three mutations were statistically significant using the Fisher nonparametric test between the groups but were not present in previously determined TFBS (G126C/T, G306C, and C479T). Those mutations that were not present in previously determined TFBS were statistically significant in this study and were most frequent in patients with low proviral load or in asymptomatic carriers. Although those mutations were not present in previously determined TFBS, one of those mutations (G306C/A) was present in an Sp-1 binding site determined by in silico analysis, and its presence abrogated the site for Sp-1 binding and created a new possible ATF binding site.
C1 [de Almeida Rego, Filipe Ferreira; Giovanetti, Marta; Goncalves, Marilda de Souza; Alcantara, Luiz Carlos] Oswaldo Cruz Fdn LHGB CPqGM FIOCRUZ, Goncalo Moniz Res Ctr, Lab Hematol Genet & Computat Biol, Salvador, BA, Brazil.
   [de Almeida Rego, Filipe Ferreira; de Oliveira, Tulio] Univ KwaZulu Natal, Africa Ctr Hlth & Populat Study, Kwa Zulu, South Africa.
   [de Almeida Rego, Filipe Ferreira] Univ Catolica Salvador, Salvador, BA, Brazil.
   [Galvao-Castro, Bernardo] HTLV Ctr, Bahia Sch Med & Publ Hlth, Salvador, BA, Brazil.
RP Alcantara, LC (corresponding author), LHGB CPqGM FIOCRUZ, Rua Waldemar Falcao 121, BR-40295001 Salvador, BA, Brazil.
EM lalcan@bahia.fiocruz.br
RI Giovanetti, Marta/AAK-7408-2020
OI Alcantara, Luiz/0000-0002-6769-9931
FU Brazil Ciencia Sem Fronteiras project from CNPQ; CAPESCAPES
FX The authors are grateful to Ms. Prevashine Padayache for technical
   assistance and Justen Manasa M.Sc. for DNA Sanger sequencing support.
   This project was supported by Brazil Ciencia Sem Fronteiras project from
   CNPQ. F.F.A.R. was supported by CAPES.
CR Asquith B, 2007, P NATL ACAD SCI USA, V104, P8035, DOI 10.1073/pnas.0608832104
   GESSAIN A, 1985, LANCET, V2, P407
   GESSAIN A, 1992, ANN INTERN MED, V117, P933, DOI 10.7326/0003-4819-117-11-933
   Gillet NA, 2011, BLOOD, V117, P3113, DOI 10.1182/blood-2010-10-312926
   Grant C, 2002, J CELL PHYSIOL, V190, P133, DOI 10.1002/JCP.10053
   Alcantara LCJ, 2009, NUCLEIC ACIDS RES, V37, pW634, DOI 10.1093/nar/gkp455
   Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199
   LaGrenade L, 1996, J ACQ IMMUN DEF SYND, V13, pS46, DOI 10.1097/00042560-199600001-00009
   Magri MC, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-184
   Mboudjeka I, 1997, JPN J CANCER RES, V88, P619, DOI 10.1111/j.1349-7006.1997.tb00427.x
   Mochizuki M, 1996, J ACQ IMMUN DEF SYND, V13, pS50, DOI 10.1097/00042560-199600001-00010
   Neto WK, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-535
   Olavarria VN, 2013, BRAZ J INFECT DIS, V16, P357
   OSAME M, 1986, LANCET, V1, P1031
   SHERMAN MP, 1992, J VIROL, V66, P2556, DOI 10.1128/JVI.66.4.2556-2563.1992
   Switzer WM, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-9
   Taniguchi Y, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-64
   YOSHIDA M, 1982, P NATL ACAD SCI-BIOL, V79, P2031, DOI 10.1073/pnas.79.6.2031
NR 18
TC 0
Z9 0
U1 0
U2 0
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 0889-2229
EI 1931-8405
J9 AIDS RES HUM RETROV
JI Aids Res. Hum. Retrovir.
PD MAR 1
PY 2016
VL 32
IS 3
BP 279
EP 283
DI 10.1089/aid.2015.0273
PG 5
WC Immunology; Infectious Diseases; Virology
SC Immunology; Infectious Diseases; Virology
GA DG1FY
UT WOS:000371812500010
PM 26472535
OA Green Published
DA 2020-10-22
ER

PT J
AU Angeletti, S
   Lo Presti, A
   Giovanetti, M
   Grifoni, A
   Amicosante, M
   Ciotti, M
   Alcantara, LCJ
   Cella, E
   Ciccozzi, M
AF Angeletti, Silvia
   Lo Presti, Alessandra
   Giovanetti, Marta
   Grifoni, Alba
   Amicosante, Massimo
   Ciotti, Marco
   Alcantara, Luiz-Carlos J.
   Cella, Eleonora
   Ciccozzi, Massimo
TI Phylogenesys and homology modeling in Zika virus epidemic: food for
   thought
SO PATHOGENS AND GLOBAL HEALTH
LA English
DT Article
DE Zika; Evolutionary analysis; Homology modeling; T-B cells epitope
   predictions
ID PREGNANT-WOMEN; PREDICTION; GENERATION; EVOLUTION; OUTBREAK
AB Zika virus (ZIKV) is an emerging Flavivirus that have recently caused an outbreak in Brazil and rapid spread in several countries. In this study, the consequences of ZIKV evolution on protein recognition by the host immune system have been analyzed. Evolutionary analysis was combined with homology modeling and T-B cells epitope predictions. Two separate clades, the African one with the Uganda sequence, as the most probable ancestor, and the second one containing all the most recent sequences from the equatorial belt were identified. Brazilian strains clustered all together and closely related to the French Polynesia isolates. A strong presence of a negatively selected site in the envelope gene (Env) protein was evidenced, suggesting a probable purging of deleterious polymorphisms in functionally important genes. Our results show relative conservancy of ZIKV sequences when envelope and other non-structural proteins (NS3 and NS5) are analyzed by homology modeling. However, some regions within the consensus sequence of NS5 protein and to a lesser extent in the envelope protein, show localized high mutation frequency corresponding to a considerable alteration in protein stability. In terms of viral immune escape, envelope protein is under a higher selective pressure than NS5 and NS3 proteins for HLA class I and II molecules. Moreover, envelope mutations that are not strictly related to T-cell immune responses are mostly located on the surface of the protein in putative B-cell epitopes, suggesting an important contribution of B cells in the immune response as well.
C1 [Angeletti, Silvia; Ciccozzi, Massimo] Univ Campus Biomed, Unit Clin Pathol & Microbiol, Rome, Italy.
   [Lo Presti, Alessandra; Cella, Eleonora; Ciccozzi, Massimo] Natl Inst Hlth, Dept Infect Parasit & Immune Mediated Dis, Epidemiol Unit, Reference Ctr Phylogeny Mol Epidemiol & Microbial, Rome, Italy.
   [Giovanetti, Marta; Alcantara, Luiz-Carlos J.] Oswaldo Cruz Fdn FIOCRUZ, Salvador, BA, Brazil.
   [Giovanetti, Marta] Univ Roma Tor Vergata, Dept Biol, Rome, Italy.
   [Grifoni, Alba; Amicosante, Massimo] ProxAgen Ltd, Sofia, Bulgaria.
   [Amicosante, Massimo] Univ Roma Tor Vergata, Dept Biomed & Prevent, Rome, Italy.
   [Ciotti, Marco] Polyclin Tor Vergata Fdn, Lab Mol Virol, Rome, Italy.
   [Cella, Eleonora] Sapienza Univ Rome, Dept Publ Hlth & Infect Dis, Rome, Italy.
RP Ciccozzi, M (corresponding author), Natl Inst Hlth, Dept Infect Parasit & Immune Mediated Dis, Epidemiol Unit, Reference Ctr Phylogeny Mol Epidemiol & Microbial, Rome, Italy.; Ciccozzi, M (corresponding author), Natl Inst Hlth, Viale Regina Elena 299, Rome, Italy.
EM ciccozzi@iss.it
RI Cella, Eleonora/ABA-8333-2020; Cella, Eleonora/J-9961-2016; Giovanetti,
   Marta/AAK-7408-2020; ciccozzi, massimo/C-6484-2016; Lo Presti,
   Alessandra/K-1451-2016
OI Cella, Eleonora/0000-0002-7870-9744; Cella,
   Eleonora/0000-0002-7870-9744; Alcantara, Luiz/0000-0002-6769-9931;
   ciccozzi, massimo/0000-0003-3866-9239; , Alba/0000-0002-2209-5966; Lo
   Presti, Alessandra/0000-0001-7611-5021
CR Ashfaq UA, 2016, VIRAL IMMUNOL
   Azarian T, 2015, SCI REP-UK, V5, DOI 10.1038/srep10170
   Bell BP, 2016, AM J PUBLIC HEALTH, V106, P589, DOI 10.2105/AJPH.2016.303124
   Bui HH, 2005, IMMUNOGENETICS, V57, P304, DOI 10.1007/s00251-005-0798-y
   Calvet GA, 2016, J CLIN VIROL, V74, P1, DOI 10.1016/j.jcv.2015.11.014
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Ciccozzi M, 2011, AIDS RES HUM RETROV, V27, P921, DOI [10.1089/aid.2010.0323, 10.1089/AID.2010.0323]
   Cox BD, 2016, ANTIVIR CHEM CHEMOTH
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Gatherer D, 2016, J GEN VIROL, V97, P269, DOI 10.1099/jgv.0.000381
   Higgs S, 2016, VECTOR-BORNE ZOONOT, V16, P75, DOI 10.1089/vbz.2016.29001.hig
   Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2
   Kelser EA, 2016, MICROBES INFECT, V18, P163, DOI 10.1016/j.micinf.2015.12.003
   Lo Presti A, 2012, INFECT GENET EVOL, V12, P392, DOI 10.1016/j.meegid.2011.12.015
   Nielsen M, 2003, PROTEIN SCI, V12, P1007, DOI 10.1110/ps.0239403
   Nielsen M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-238
   Nielsen R, 1998, GENETICS, V148, P929
   Patronov A, 2016, NEUTRACORP NEW TOOL
   Peters B, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-132
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   Pond SLK, 2005, MOL BIOL EVOL, V22, P1208, DOI 10.1093/molbev/msi105
   Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079
   Rodriguez-Morales AJ, 2015, J INFECT DEV COUNTR, V9, P684, DOI 10.3855/jidc.7230
   Salimi N, 2012, IMMUNOLOGY, V137, P117, DOI 10.1111/j.1365-2567.2012.03611.x
   Sturniolo T, 1999, NAT BIOTECHNOL, V17, P555
   Tetro JA, 2016, MICROBES INFECT, V18, P167, DOI 10.1016/j.micinf.2015.12.010
   Van Durme J, 2011, BIOINFORMATICS, V27, P1711, DOI 10.1093/bioinformatics/btr254
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Wahala WMPB, 2011, VIRUSES-BASEL, V3, P2374, DOI 10.3390/v3122374
   Weiskopf D, 2013, P NATL ACAD SCI USA, V110, pE2046, DOI 10.1073/pnas.1305227110
NR 30
TC 3
Z9 3
U1 0
U2 6
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 2047-7724
EI 2047-7732
J9 PATHOG GLOB HEALTH
JI Pathog. Glob. Health
PY 2016
VL 110
IS 7-8
BP 269
EP 274
DI 10.1080/20477724.2016.1235337
PG 6
WC Public, Environmental & Occupational Health; Parasitology; Tropical
   Medicine
SC Public, Environmental & Occupational Health; Parasitology; Tropical
   Medicine
GA EI2NN
UT WOS:000392324300003
PM 27670692
OA Green Published
DA 2020-10-22
ER

PT J
AU Vaz, SN
   Giovanetti, M
   Rego, FFD
   de Oliveira, T
   Danaviah, S
   Goncalves, MLF
   Alcantara, LC
   Brites, C
AF Vaz, Sara Nunes
   Giovanetti, Marta
   de Almeida Rego, Filipe Ferreira
   de Oliveira, Tulio
   Danaviah, Siva
   Freire Goncalves, Maria Luiza
   Junior Alcantara, Luiz Carlos
   Brites, Carlos
TI Molecular Characterization of the Human Immunodeficiency Virus Type 1 in
   Women and Their Vertically Infected Children
SO AIDS RESEARCH AND HUMAN RETROVIRUSES
LA English
DT Article
ID HIV-1; RESISTANCE; POLYMORPHISMS; TRANSMISSION; PREVALENCE
AB Approximately 35 million people worldwide are infected with human immunodeficiency virus (HIV) around 3.2 million of whom are children under 15 years. Mother-to-child-transmission (MTCT) of HIV-1 accounts for 90% of all infections in children. Despite great advances in the prevention of MTCT in Brazil, children are still becoming infected. Samples from 19 HIV-1-infected families were collected. DNA was extracted and fragments from gag, pol, and env were amplified and sequenced directly. Phylogenetic reconstruction was performed. Drug resistance analyses were performed in pol and env sequences. We found 82.1% of subtype B and 17.9% of BF recombinants. A prevalence of 43.9% drug resistance-associated mutations in pol sequences was identified. Of the drug-naive children 33.3% presented at least one mutation related to protease inhibitor/nucleoside reverse transcriptase inhibitor/nonnucleoside reverse transcriptase inhibitor (PI/NRTI/NNRTI) resistance. The prevalence of transmitted drug resistance mutations was 4.9%. On env we found a low prevalence of HR1 (4.9%) and HR2 (14.6%) mutations.
C1 [Vaz, Sara Nunes; Brites, Carlos] Univ Fed Bahia, Retrovirol Lab, Salvador, BA, Brazil.
   [Vaz, Sara Nunes; Giovanetti, Marta; de Almeida Rego, Filipe Ferreira; Junior Alcantara, Luiz Carlos] Fundacao Oswaldo Cruz, Goncalo Moniz Res Ctr, Lab Hematol Genet & Computat Biol, Salvador, BA, Brazil.
   [Giovanetti, Marta] Natl Inst Hlth, Dept Infect Parasit & Immunomediated Dis, Rome, Italy.
   [de Oliveira, Tulio; Danaviah, Siva] Univ KwaZulu Natal, Africa Ctr Hlth & Populat Studies, Durban, South Africa.
   [Freire Goncalves, Maria Luiza] Specialized Ctr Diag Care & Res, Salvador, BA, Brazil.
RP Brites, C (corresponding author), HUPES UFBA, Rua Augusto Viana Sn, BR-40110060 Salvador, BA, Brazil.
EM crbrites@gmail.com
RI Giovanetti, Marta/AAK-7408-2020
OI Giovanetti, Marta/0000-0002-5849-7326; Alcantara,
   Luiz/0000-0002-6769-9931
FU Wellcome TrustWellcome Trust [097410] Funding Source: Medline
CR Ahmad N, 2008, ADV PHARMACOL, V56, P453, DOI 10.1016/S1054-3589(07)56015-1
   Alencar CS, 2010, AIDS RES HUM RETROV, V26, P1267, DOI 10.1089/aid.2010.0057
   Araujo AF, 2010, AIDS RES HUM RETROV, V26, P1249, DOI 10.1089/aid.2010.0068
   Brazil Ministry of Health, 2014, B EP AIDS E DST, VIII, P1
   Reis MND, 2014, J MED VIROL, V86, P8, DOI 10.1002/jmv.23738
   da Silveira AA, 2012, AIDS RES HUM RETROV, V28, P304, DOI 10.1089/aid.2011.0128
   de Oliveira CM, 2008, ARCH VIROL, V153, P1799, DOI 10.1007/s00705-008-0178-7
   Gifford RJ, 2009, BIOINFORMATICS, V25, P1197, DOI 10.1093/bioinformatics/btp134
   Guimaraes PM, 2015, AIDS RES HUM RETROV, V31, P1
   Monteiro-Cunha JP, 2011, AIDS RES HUM RETROV, V27, P623, DOI [10.1089/aid.2010.0126, 10.1089/AID.2010.0126]
   MORGADO MG, 1994, AIDS RES HUM RETROV, V10, P569, DOI 10.1089/aid.1994.10.569
   Moutouh L, 1996, P NATL ACAD SCI USA, V93, P6106, DOI 10.1073/pnas.93.12.6106
   Salminen MO, 1997, J VIROL, V71, P2647, DOI 10.1128/JVI.71.4.2647-2655.1997
   Sanabani SS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062552
   Santos LA, 2011, J MED VIROL, V83, P2066, DOI 10.1002/jmv.22170
   Wensing Annemarie M, 2014, Top Antivir Med, V22, P642
   World Health Organization, AIDS EP 2013
NR 17
TC 5
Z9 5
U1 0
U2 3
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 0889-2229
EI 1931-8405
J9 AIDS RES HUM RETROV
JI Aids Res. Hum. Retrovir.
PD OCT 1
PY 2015
VL 31
IS 10
BP 1046
EP 1051
DI 10.1089/aid.2015.0166
PG 6
WC Immunology; Infectious Diseases; Virology
SC Immunology; Infectious Diseases; Virology
GA CR5PL
UT WOS:000361395500015
PM 26200738
OA Green Published
DA 2020-10-22
ER

PT J
AU Santos, LA
   Gray, RR
   Monteiro-Cunha, JP
   Strazza, E
   Kashima, S
   Santos, ED
   Araujo, THA
   Goncalves, MD
   Salemi, M
   Alcantara, LCJ
AF Santos, Luciane Amorim
   Gray, Rebecca R.
   Monteiro-Cunha, Joana Paixao
   Strazza, Evandra
   Kashima, Simone
   Santos, Edson de Souza
   Almeida Araujo, Thessika Hialla
   Goncalves, Marilda de Souza
   Salemi, Marco
   Junior Alcantara, Luiz Carlos
TI Short Communication: Phylodynamics Analysis of the Human
   Immunodeficiency Virus Type 1 Envelope Gene in Mother and Child Pairs
SO AIDS RESEARCH AND HUMAN RETROVIRUSES
LA English
DT Article
ID EVOLUTIONARY DYNAMICS; STATISTICAL TEST; ENV GENE; HIV-1; POPULATION;
   TRANSMISSION; LIKELIHOOD; SEQUENCES; ALGORITHM; DISEASE
AB Characterizing the impact of HIV transmission routes on viral genetic diversity can improve the understanding of the mechanisms of virus evolution and adaptation. HIV vertical transmission can occur in utero, during delivery, or while breastfeeding. The present study investigated the phylodynamics of the HIV-1 env gene in mother-to-child transmission by analyzing one chronically infected pair from Brazil and three acutely infected pairs from Zambia, with three to five time points. Sequences from 25 clones from each sample were obtained and aligned using Clustal X. ML trees were constructed in PhyML using the best evolutionary model. Bayesian analyses testing the relaxed and strict molecular clock were performed using BEAST and a Bayesian Skyline Plot (BSP) was construed. The genetic variability of previously described epitopes was investigated and compared between each individual time point and between mother and child sequences. The relaxed molecular clock was the best-fitted model for all datasets. The tree topologies did not show differentiation in the evolutionary dynamics of the virus circulating in the mother from the viral population in the child. In the BSP, the effective population size was more constant in time in the chronically infected patients while in the acute patients it was possible to detect bottlenecks. The genetic variability within viral epitopes recognized by the human immune system was considerably higher among the chronically infected pair in comparison with acutely infected pairs. These results contribute to a better understanding of HIV-1 evolutionary dynamics in mother-to-child transmission.
C1 [Santos, Luciane Amorim; Monteiro-Cunha, Joana Paixao; Santos, Edson de Souza; Almeida Araujo, Thessika Hialla; Goncalves, Marilda de Souza; Junior Alcantara, Luiz Carlos] Fundacao Oswaldo Cruz, Ctr Pesquisa Goncalo Moniz, Lab Hematol Genet & Biol Computac, Salvador, BA, Brazil.
   [Gray, Rebecca R.; Salemi, Marco] Univ Florida, Coll Med, Dept Pathol Immunol & Lab Med, Gainesville, FL USA.
   [Monteiro-Cunha, Joana Paixao] Univ Fed Bahia, BR-41170290 Salvador, BA, Brazil.
   [Strazza, Evandra; Kashima, Simone] Univ Sao Paulo, Hemoctr Ribeirao Preto, Sao Paulo, Brazil.
RP Alcantara, LCJ (corresponding author), LASP CPqGM FIOCRUZ, Rua Waldemar Falcao 121, BR-40296710 Salvador, BA, Brazil.
EM lalcan@bahia.fiocruz.br
RI Kashima, Simone/G-4876-2012
OI Kashima, Simone/0000-0002-1487-0141; Alcantara, Luiz/0000-0002-6769-9931
FU Brazilian Ministry of Heath Centro Nacional de Pesquisa (CNPq)
FX We thank the Brazilian Ministry of Heath Centro Nacional de Pesquisa
   (CNPq) for funding of the master student L.A.S.
CR Achaz G, 2004, MOL BIOL EVOL, V21, P1902, DOI 10.1093/molbev/msh196
   Bette Korber T, HIV MOL IMMUNOLOGY 2
   Brown AJL, 1997, P NATL ACAD SCI USA, V94, P1862, DOI 10.1073/pnas.94.5.1862
   Bruen TC, 2006, GENETICS, V172, P2665, DOI 10.1534/genetics.105.048975
   Derdeyn CA, 2004, SCIENCE, V303, P2019, DOI 10.1126/science.1093137
   Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214
   Grenfell BT, 2004, SCIENCE, V303, P327, DOI 10.1126/science.1090727
   Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520
   Hoffmann FG, 2008, AIDS, V22, P817, DOI 10.1097/QAD.0b013e3282f486af
   HUDSON RR, 1992, MOL BIOL EVOL, V9, P138
   Huson D, 2006, MOL BIOL EVOL, V9, P138
   Lemey P, 2006, AIDS REV, V8, P125
   Salemi M, 2008, MOL PHYLOGENET EVOL, V49, P618, DOI 10.1016/j.ympev.2008.08.017
   Seo TK, 2002, GENETICS, V160, P1283
   Shriner D, 2004, GENETICS, V166, P1155, DOI 10.1534/genetics.166.3.1155
   Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876
   Williamson S, 2003, MOL BIOL EVOL, V20, P1318, DOI 10.1093/molbev/msg144
   WOLINSKY SM, 1992, SCIENCE, V255, P1134, DOI 10.1126/science.1546316
   Zhang H, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-67
   Zhang H, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-73
NR 20
TC 1
Z9 1
U1 0
U2 5
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 0889-2229
EI 1931-8405
J9 AIDS RES HUM RETROV
JI Aids Res. Hum. Retrovir.
PD SEP 1
PY 2015
VL 31
IS 9
BP 913
EP 920
DI 10.1089/aid.2014.0352
PG 8
WC Immunology; Infectious Diseases; Virology
SC Immunology; Infectious Diseases; Virology
GA CQ1VJ
UT WOS:000360388000011
PM 26123053
OA Green Published
DA 2020-10-22
ER

PT J
AU Barreto, FK
   Khouri, R
   Rego, FFD
   de Castro-Amarante, MF
   Bialuk, I
   Pise-Masison, CA
   Galvao-Castro, B
   Gessain, A
   Jacobson, S
   Franchini, G
   Alcantara, LC
AF Barreto, Fernanda Khouri
   Khouri, Ricardo
   de Almeida Rego, Filipe Ferreira
   de Castro-Amarante, Maria Fernanda
   Bialuk, Izabela
   Pise-Masison, Cynthia A.
   Galvao-Castro, Bernardo
   Gessain, Antoine
   Jacobson, Steven
   Franchini, Genoveffa
   Alcantara, Luiz Carlos, Jr.
TI ORFI genetic polymorphisms in geographically distinct HTLV-1 infections
SO RETROVIROLOGY
LA English
DT Meeting Abstract
C1 [Barreto, Fernanda Khouri; Khouri, Ricardo; de Almeida Rego, Filipe Ferreira; Galvao-Castro, Bernardo; Alcantara, Luiz Carlos, Jr.] Fiocruz MS, Ctr Pesquisa Goncalo Moniz, Salvador, BA, Brazil.
   [Barreto, Fernanda Khouri; Galvao-Castro, Bernardo] Escola Bahiana Med & Saude Publ, Salvador, BA, Brazil.
   [de Castro-Amarante, Maria Fernanda; Pise-Masison, Cynthia A.; Franchini, Genoveffa] NCI, Anim Models & Retroviral Vaccines Sect, Bethesda, MD 20892 USA.
   [Bialuk, Izabela] Med Univ Bialystok, Dept Gen & Expt Pathol, Bialystok, Poland.
   [Gessain, Antoine] Inst Pasteur, Dept Virol, Unite Epidemiol & Physiopathol Virus Oncogenes, Paris, France.
   [Jacobson, Steven] NINDS, Viral Immunol Sect, Neuroimmunol Branch, Bethesda, MD 20892 USA.
EM fernanda.khouri@hotmail.com
RI Khouri, Ricardo/M-3184-2018; Bialuk, Izabela/U-8097-2018
OI Khouri, Ricardo/0000-0001-5664-4436; Bialuk, Izabela/0000-0002-4587-8613
NR 0
TC 0
Z9 0
U1 0
U2 1
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1742-4690
J9 RETROVIROLOGY
JI Retrovirology
PD AUG 28
PY 2015
VL 12
SU 1
MA P55
DI 10.1186/1742-4690-12-S1-P55
PG 1
WC Virology
SC Virology
GA DA0EC
UT WOS:000367468500096
OA DOAJ Gold, Green Accepted, Green Published
DA 2020-10-22
ER

PT J
AU Jesus, JG
   Junior, RMPS
   de Castro-Amarante, MF
   Haddad, SK
   Espreafico, EM
   Franchini, G
   Alcantara, LCJ
AF Jesus, Jaqueline G.
   Junior, Rui M. P. S.
   de Castro-Amarante, Maria F.
   Haddad, Simone K.
   Espreafico, Enilza M.
   Franchini, Genoveffa
   Alcantara, Luiz C. J.
TI Role of myosin Va on HTLV-1 p8I protein's traffic to cell surface
SO RETROVIROLOGY
LA English
DT Meeting Abstract
C1 [Jesus, Jaqueline G.; Alcantara, Luiz C. J.] Fundacao Oswaldo Cruz, Goncalo Moniz Res Ctr, BR-40296710 Candeal Salvador, BA, Brazil.
   [Junior, Rui M. P. S.; Espreafico, Enilza M.] Univ Sao Paulo, Fac Med Ribeirao Preto, BR-14049900 Monte Alegre Ribeirao Pr, Sao Paulov, Brazil.
   [de Castro-Amarante, Maria F.; Franchini, Genoveffa] NCI, Anim Models & Retroviral Vaccines Sect, NIH, Bethesda, MD 20892 USA.
   [Haddad, Simone K.] Univ Sao Paulo, Fac Pharmaceut Ribeirao Preto, BR-14040903 Sao Paulo, Brazil.
   [Haddad, Simone K.] Blood Ctr Ribeirao Preto, BR-14051140 Sao Paulo, Brazil.
EM jaquelinegoesdejesus@gmail.com
RI Espreafico, Enilza/O-3053-2016
OI Espreafico, Enilza/0000-0002-7552-4234
NR 0
TC 0
Z9 0
U1 0
U2 1
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1742-4690
J9 RETROVIROLOGY
JI Retrovirology
PD AUG 28
PY 2015
VL 12
SU 1
MA P1
DI 10.1186/1742-4690-12-S1-P1
PG 1
WC Virology
SC Virology
GA DA0EC
UT WOS:000367468500043
OA DOAJ Gold, Green Published
DA 2020-10-22
ER

PT J
AU Costa, GCD
   Nunes, MRT
   Jesus, JG
   Novaes, T
   Cardoso, JF
   Sousa, EC
   Santos, ED
   Galvao-Castro, B
   Zanette, DL
   Goncalves, MD
   Alcantara, LC
AF de Souza Costa, Giselle Calasans
   Nunes, Marcio Roberto T.
   Jesus, Jaqueline Goes
   Novaes, Thiago
   Cardoso, Jedson Ferreira
   Sousa Junior, Edivaldo Costa
   Santos, Edson de Souza
   Galvao-Castro, Bernardo
   Zanette, Dalila Luciola
   Goncalves, Marilda de Souza
   Junior Alcantara, Luiz Carlos
TI Amino- and Carboxyl-Terminal CCR5 Mutations in Brazilian HIV-1-Infected
   Women and Homology Model of p.L55Q CCR5 Mutant
SO AIDS RESEARCH AND HUMAN RETROVIRUSES
LA English
DT Article
ID IMMUNODEFICIENCY-VIRUS TYPE-1; CHEMOKINE-RECEPTOR GENE; HIV-1 ENTRY;
   TYROSINE SULFATION; N-TERMINUS; CORECEPTOR; INFECTION; PROTEIN;
   GLYCOPROTEIN; INDIVIDUALS
AB Genetic factors from an HIV-1 host can affect the rate of progression to AIDS and HIV infection. To investigate the frequency of mutations in the CCR5 gene, HIV-1 samples from infected women and uninfected individuals were selected for sequencing of the CCR5 gene regions encoding the N- and C-terminal protein domains. Physicochemical CCR5 modeling and potential protein domain analysis were performed in order to evaluate the impact of the mutations found in the properties and structure of CCR5. The p.L55Q mutation in the N-terminal protein domain was observed only in uninfected individuals, with an allelic frequency of 1.8%. Physicochemical analysis revealed that the p.L55Q mutation magnified the flexibility and accessibility profiles and the modeling of CCR5 structures showed resulting in a small deviation to the right, as well as a hydrophobic to hydrophilic property alteration. The p.L55Q mutation also resulted in a slight modification of the electrostatic load of this region. Additionally, three novel silent mutations were found at the C-terminal coding region among HIV-1-infected women. The results suggest that the p.L55Q mutation might alter CCR5 conformation. Further studies should be conducted to verify the role of this mutation in HIV-1 susceptibility.
C1 [de Souza Costa, Giselle Calasans; Jesus, Jaqueline Goes; Novaes, Thiago; Santos, Edson de Souza; Galvao-Castro, Bernardo; Zanette, Dalila Luciola; Goncalves, Marilda de Souza; Junior Alcantara, Luiz Carlos] Fundacao Oswaldo Cruz, Ctr Pesquisa Goncalo Moniz, BR-40296610 Salvador, BA, Brazil.
   [de Souza Costa, Giselle Calasans; Goncalves, Marilda de Souza] Univ Fed Bahia, Salvador, BA, Brazil.
   [Nunes, Marcio Roberto T.; Cardoso, Jedson Ferreira; Sousa Junior, Edivaldo Costa] Evandro Chagas Inst, Ctr Technol Innovat, Bioinformat Core, Belem, Para, Brazil.
RP Alcantara, LCJ (corresponding author), Fundacao Oswaldo Cruz, Ctr Pesquisa Goncalo Muniz, Lab Hematol Genet & Biol Computac, Rua Waldemar Falcao 121, BR-40296610 Salvador, BA, Brazil.
EM lalcan@bahia.fiocruz.br
RI ZANETTE, DALILA/Q-3541-2016; Nunes, Marcio Roberto/B-2238-2016
OI zanette, dalila l./0000-0001-9397-4127; Alcantara,
   Luiz/0000-0002-6769-9931; Nunes, Marcio Roberto/0000-0001-9739-5499
FU Brazilian Ministry of Health STD/AIDS Program; CNPqNational Council for
   Scientific and Technological Development (CNPq); FBDC; FIOCRUZ
FX This work was supported by grants from the Brazilian Ministry of Health
   STD/AIDS Program, CNPq, FBDC, and FIOCRUZ.
CR Acharya P, 2011, ACS CHEM BIOL, V6, P1069, DOI 10.1021/cb200068b
   AnsariLari MA, 1997, NAT GENET, V16, P221, DOI 10.1038/ng0797-221
   Ayres M, 2005, BIOESTAT VERSAO 5 0
   Blanpain C, 1999, J BIOL CHEM, V274, P34719, DOI 10.1074/jbc.274.49.34719
   Brelot A, 1997, J VIROL, V71, P4744, DOI 10.1128/JVI.71.6.4744-4751.1997
   Carrington M, 1997, AM J HUM GENET, V61, P1261, DOI 10.1086/301645
   Choe H, 2003, CELL, V114, P161, DOI 10.1016/S0092-8674(03)00508-7
   Combet C, 2000, TRENDS BIOCHEM SCI, V25, P147, DOI 10.1016/S0968-0004(99)01540-6
   Connor RI, 1997, J EXP MED, V185, P621, DOI 10.1084/jem.185.4.621
   Dragic T, 1996, NATURE, V381, P667, DOI 10.1038/381667a0
   Farzan M, 2000, J BIOL CHEM, V275, P33516, DOI 10.1074/jbc.M007228200
   Farzan M, 1999, CELL, V96, P667, DOI 10.1016/S0092-8674(00)80577-2
   Farzan M, 1998, J VIROL, V72, P1160, DOI 10.1128/JVI.72.2.1160-1164.1998
   Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985
   Gorry Paul R, 2011, Curr HIV/AIDS Rep, V8, P45, DOI 10.1007/s11904-010-0069-x
   Hall T.A., 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008
   Joshi A, 2011, J BIOL CHEM, V286, P36404, DOI 10.1074/jbc.M111.281659
   Kawashima Y, 2009, NATURE, V458, P641, DOI 10.1038/nature07746
   Kitamura A, 2002, DIABETIC MED, V19, P1000, DOI 10.1046/j.1464-5491.2002.00844.x
   LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944
   Licastro F, 2003, NEUROBIOL AGING, V24, P921, DOI 10.1016/S0197-4580(03)00013-7
   Liu R, 1996, CELL, V86, P367, DOI 10.1016/S0092-8674(00)80110-5
   Lu ZH, 1997, P NATL ACAD SCI USA, V94, P6426, DOI 10.1073/pnas.94.12.6426
   Mogensen TH, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-54
   Nazari R, 2008, CURR GENE THER, V8, P264, DOI 10.2174/156652308785160674
   Nicholas KB, 1997, EMBNEW NEWS, V4, P14
   O'Brien SJ, 2004, NAT GENET, V36, P565, DOI 10.1038/ng1369
   O'Brien SJ, 2000, IMMUNOL REV, V177, P99, DOI 10.1034/j.1600-065X.2000.17710.x
   OBrien TR, 1997, LANCET, V349, P1219, DOI 10.1016/S0140-6736(97)24017-1
   PARKER JMR, 1986, BIOCHEMISTRY-US, V25, P5425, DOI 10.1021/bi00367a013
   Rabut GEE, 1998, J VIROL, V72, P3464, DOI 10.1128/JVI.72.4.3464-3468.1998
   RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573
   Regoes RR, 2005, TRENDS MICROBIOL, V13, P269, DOI 10.1016/j.tim.2005.04.005
   Rogers TF, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-79
   Sabouri AH, 2004, J INFECT DIS, V190, P1279, DOI 10.1086/423942
   SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626
   Samson M, 1996, NATURE, V382, P722, DOI 10.1038/382722a0
   Schmitz JE, 1999, SCIENCE, V283, P857, DOI 10.1126/science.283.5403.857
   Slater-Handshy T, 2004, VIROLOGY, V319, P36, DOI 10.1016/j.virol.2003.10.008
   Teixeira Maria da Glória, 2002, Cad. Saúde Pública, V18, P1189, DOI 10.1590/S0102-311X2002000500011
   Walker BD, 2007, TOP HIV MED, V15, P134
   Yang CF, 2003, AIDS RES HUM RETROV, V19, P661, DOI 10.1089/088922203322280883
   Zhang M, 2004, GLYCOBIOLOGY, V14, P1229, DOI 10.1093/glycob/cwh106
NR 43
TC 0
Z9 0
U1 0
U2 4
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 0889-2229
EI 1931-8405
J9 AIDS RES HUM RETROV
JI Aids Res. Hum. Retrovir.
PD JUL
PY 2015
VL 31
IS 7
BP 685
EP 691
DI 10.1089/aid.2014.0140
PG 7
WC Immunology; Infectious Diseases; Virology
SC Immunology; Infectious Diseases; Virology
GA DD4IJ
UT WOS:000369885400005
PM 25825809
OA Green Published
DA 2020-10-22
ER

PT J
AU Pise-Masison, CA
   de Castro-Amarante, MF
   Enose-Akahata, Y
   Buchmann, RC
   Fenizia, C
   Parks, RW
   Edwards, D
   Fiocchi, M
   Alcantara, LC
   Bialuk, I
   Graham, J
   Walser, JC
   McKinnon, K
   Galvao-Castro, B
   Gessain, A
   Venzon, D
   Jacobson, S
   Franchini, G
AF Pise-Masison, Cynthia A.
   de Castro-Amarante, Maria Fernanda
   Enose-Akahata, Yoshimi
   Buchmann, R. Cody
   Fenizia, Claudio
   Parks, Robyn Washington
   Edwards, Dustin
   Fiocchi, Martina
   Alcantara, Luiz Carlos, Jr.
   Bialuk, Izabela
   Graham, Jhanelle
   Walser, Jean-Claude
   McKinnon, Katherine
   Galvao-Castro, Bernardo
   Gessain, Antoine
   Venzon, David
   Jacobson, Steven
   Franchini, Genoveffa
TI Co-dependence of HTLV-1 p12 and p8 Functions in Virus Persistence
SO PLOS PATHOGENS
LA English
DT Article
ID T-CELL LEUKEMIA/LYMPHOMA; PROVIRAL DNA LOAD; I HEAVY-CHAIN; TYPE-1
   P12(I); NUCLEAR FACTOR; PROTEIN; INFECTION; ACTIVATION; EXPRESSION; VIVO
AB HTLV-1 orf-I is linked to immune evasion, viral replication and persistence. Examining the orf-I sequence of 160 HTLV-1-infected individuals; we found polymorphism of orf-I that alters the relative amounts of p12 and its cleavage product p8. Three groups were identified on the basis of p12 and p8 expression: predominantly p12, predominantly p8 and balanced expression of p12 and p8. We found a significant association between balanced expression of p12 and p8 with high viral DNA loads, a correlate of disease development. To determine the individual roles of p12 and p8 in viral persistence, we constructed infectious molecular clones expressing p12 and p8 (D26), predominantly p12 (G29S) or predominantly p8 (N26). As we previously showed, cells expressing N26 had a higher level of virus transmission in vitro. However, when inoculated into Rhesus macaques, cells producing N26 virus caused only a partial seroconversion in 3 of 4 animals and only 1 of those animals was HTLV-1 DNA positive by PCR. None of the animals exposed to G29S virus seroconverted or had detectable viral DNA. In contrast, 3 of 4 animals exposed to D26 virus seroconverted and were HTLV-1 positive by PCR. In vitro studies in THP-1 cells suggested that expression of p8 was sufficient for productive infection of monocytes. Since orf-I plays a role in T-cell activation and recognition; we compared the CTL response elicited by CD4(+) T-cells infected with the different HTLV-1 clones. Although supernatant p19 levels and viral DNA loads for all four infected lines were similar, a significant difference in Tax-specific HLA. A2-restricted killing was observed. Cells infected with Orf-I-knockout virus (12KO), G29S or N26 were killed by CTLs, whereas cells infected with D26 virus were resistant to CTL killing. These results indicate that efficient viral persistence and spread require the combined functions of p12 and p8.
C1 [Pise-Masison, Cynthia A.; de Castro-Amarante, Maria Fernanda; Buchmann, R. Cody; Fenizia, Claudio; Parks, Robyn Washington; Edwards, Dustin; Fiocchi, Martina; Franchini, Genoveffa] NCI, Anim Models & Retroviral Vaccines Sect, Bethesda, MD 20892 USA.
   [Enose-Akahata, Yoshimi; Graham, Jhanelle; Jacobson, Steven] NINDS, Viral Immunol Sect, Neuroimmunol Branch, Bethesda, MD 20892 USA.
   [Alcantara, Luiz Carlos, Jr.; Galvao-Castro, Bernardo] Oswaldo Cruz Fdn Salvador, Salvador, BA, Brazil.
   [Bialuk, Izabela] Med Univ Bialystok, Dept Gen & Expt Pathol, Bialystok, Poland.
   [Walser, Jean-Claude] Univ Basel, Genet Divers Ctr, Basel, Switzerland.
   [McKinnon, Katherine] NCI, Vaccine Branch Flow Cytometry Core Lab, NIH, Bethesda, MD 20892 USA.
   [Gessain, Antoine] Inst Pasteur, Dept Virol, Unite Epidemiol & Physiopathol Virus Oncogenes, Paris, France.
   [Venzon, David] NCI, Biostat & Data Management Sect, Bethesda, MD 20892 USA.
RP Franchini, G (corresponding author), NCI, Anim Models & Retroviral Vaccines Sect, Bethesda, MD 20892 USA.
EM franchig@mail.nih.gov
RI Bialuk, Izabela/U-8097-2018
OI Bialuk, Izabela/0000-0002-4587-8613; fenizia,
   claudio/0000-0003-0735-8331; Alcantara, Luiz/0000-0002-6769-9931
FU Intramural Program at the National Cancer Institute, National Institutes
   of Health, Bethesda, MD
FX This work was supported by the Intramural Program at the National Cancer
   Institute, National Institutes of Health, Bethesda, MD. The funders had
   no role in study design, data collection and analysis, decision to
   publish, or preparation of the manuscript.
CR Albrecht B, 2002, J VIROL, V76, P3493, DOI 10.1128/JVI.76.7.3493-3501.2002
   Andresen V, 2011, BLOOD, V118, P1549, DOI 10.1182/blood-2010-06-293340
   Arnold J, 2006, BLOOD, V107, P3976, DOI 10.1182/blood-2005-11-4551
   ASTIERGIN T, 1995, J VIROL METHODS, V51, P19, DOI 10.1016/0166-0934(94)00097-Z
   Bai XT, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00400
   Banerjee P, 2007, J VIROL, V81, P9707, DOI 10.1128/JVI.00887-07
   Cook LB, 2013, VIROLOGY, V435, P131, DOI 10.1016/j.virol.2012.09.028
   Ding W, 2001, J VIROL, V75, P7672, DOI 10.1128/JVI.75.16.7672-7682.2001
   Edwards D, 2014, J VIROL, V88, P2319, DOI 10.1128/JVI.03444-13
   Enose-Akahata Y, 2008, BLOOD, V112, P2400, DOI 10.1182/blood-2008-02-138529
   Fenizia C, 2014, J VIROL, V88, P393, DOI 10.1128/JVI.01788-13
   FRANCHINI G, 1993, J VIROL, V67, P7701, DOI 10.1128/JVI.67.12.7701-7704.1993
   FRANCHINI G, 2007, FIELDS VIROLOGY, P2071
   Fukumoto R, 2007, J VIROL, V81, P9088, DOI 10.1128/JVI.02703-06
   Fukumoto R, 2009, BLOOD, V113, P3726, DOI 10.1182/blood-2008-04-146928
   Furukawa Y, 2004, AIDS RES HUM RETROV, V20, P1092, DOI 10.1089/aid.2004.20.1092
   GESSAIN A, 1985, LANCET, V2, P407
   Iwanaga M, 2010, BLOOD, V116, P1211, DOI 10.1182/blood-2009-12-257410
   Johnson JM, 2001, J VIROL, V75, P6086, DOI 10.1128/JVI.75.13.6086-6094.2001
   Johnson JM, 2001, INT J EXP PATHOL, V82, P135, DOI 10.1046/j.1365-2613.2001.00191.x
   Johnson JM, 2000, AIDS RES HUM RETROV, V16, P1777, DOI 10.1089/08892220050193308
   Jones KS, 2008, NAT MED, V14, P429, DOI 10.1038/nm1745
   Kannagi M, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00323
   Kim SJ, 2003, J BIOL CHEM, V278, P15550, DOI 10.1074/jbc.M210210200
   Kitazono T, 2011, CELL IMMUNOL, V272, P11, DOI 10.1016/j.cellimm.2011.10.002
   KORALNIK IJ, 1992, AIDS RES HUM RETROV, V8, P1845, DOI 10.1089/aid.1992.8.1845
   KORALNIK IJ, 1993, J VIROL, V67, P2360, DOI 10.1128/JVI.67.4.2360-2366.1993
   KOYANAGI Y, 1993, VIROLOGY, V196, P25, DOI 10.1006/viro.1993.1451
   Kubota R, 2000, J IMMUNOL, V164, P5192, DOI 10.4049/jimmunol.164.10.5192
   Matsuzaki T, 2001, J NEUROVIROL, V7, P228
   Mulloy JC, 1996, J VIROL, V70, P3599, DOI 10.1128/JVI.70.6.3599-3605.1996
   Nagai M, 2001, ANN NEUROL, V50, P807, DOI 10.1002/ana.10065
   Nicot C, 2001, BLOOD, V98, P823, DOI 10.1182/blood.V98.3.823
   Okayama A, 2004, INT J CANCER, V110, P621, DOI 10.1002/ijc.20144
   OSAME M, 1986, LANCET, V1, P1031
   Peaper DR, 2008, ANNU REV CELL DEV BI, V24, P343, DOI 10.1146/annurev.cellbio.24.110707.175347
   POIESZ BJ, 1980, P NATL ACAD SCI-BIOL, V77, P7415, DOI 10.1073/pnas.77.12.7415
   POIESZ BJ, 1980, P NATL ACAD SCI-BIOL, V77, P6815, DOI 10.1073/pnas.77.11.6815
   Rende Francesca, 2012, Leuk Res Treatment, V2012, P876153, DOI 10.1155/2012/876153
   Satou Y, 2010, J CLIN EXP HEMATOP, V50, P1, DOI 10.3960/jslrt.50.1
   Trovato R, 1999, J VIROL, V73, P6460, DOI 10.1128/JVI.73.8.6460-6467.1999
   Valeri VW, 2010, BLOOD, V116, P3809, DOI 10.1182/blood-2010-05-284141
   Van Prooyen N, 2010, P NATL ACAD SCI USA, V107, P20738, DOI 10.1073/pnas.1009635107
   Yamano Y, 2002, BLOOD, V99, P88, DOI 10.1182/blood.V99.1.88
   Yang JY, 2014, BIOMARK RES, V2, DOI 10.1186/2050-7771-2-1
NR 45
TC 23
Z9 23
U1 0
U2 2
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1553-7366
EI 1553-7374
J9 PLOS PATHOG
JI PLoS Pathog.
PD NOV
PY 2014
VL 10
IS 11
AR e1004454
DI 10.1371/journal.ppat.1004454
PG 13
WC Microbiology; Parasitology; Virology
SC Microbiology; Parasitology; Virology
GA AU3LX
UT WOS:000345515800010
PM 25375128
OA DOAJ Gold, Green Published
DA 2020-10-22
ER

PT J
AU Trevino, A
   Alcantara, LC
   Benito, R
   Caballero, E
   Aguilera, A
   Ramos, JM
   de Mendoza, C
   Rodriguez, C
   Garcia, J
   Rodriguez-Iglesias, M
   de Lejarazu, RO
   Roc, L
   Parra, P
   Eiros, J
   del Romero, J
   Soriano, V
AF Trevino, Ana
   Alcantara, Luiz Carlos, Jr.
   Benito, Rafael
   Caballero, Estrella
   Aguilera, Antonio
   Manuel Ramos, Jose
   de Mendoza, Carmen
   Rodriguez, Carmen
   Garcia, Juan
   Rodriguez-Iglesias, Manuel
   Ortiz de Lejarazu, Raul
   Roc, Lourdes
   Parra, Patricia
   Eiros, Jose
   del Romero, Jorge
   Soriano, Vincent
CA HTLV Spanish Study Grp
TI Molecular Epidemiology and Clinical Features of Human T Cell
   Lymphotropic Virus Type 1 Infection in Spain
SO AIDS RESEARCH AND HUMAN RETROVIRUSES
LA English
DT Article
ID HTLV-I; PREGNANT-WOMEN; CENTRAL-AFRICA; PREVALENCE; TRANSMISSION;
   SUBTYPES; AMERICA
AB Human T cell lymphotropic virus type 1 (HTLV-1) infection in Spain is rare and mainly affects immigrants from endemic regions and native Spaniards with a prior history of sexual intercourse with persons from endemic countries. Herein, we report the main clinical and virological features of cases reported in Spain. All individuals with HTLV-1 infection recorded at the national registry since 1989 were examined. Phylogenetic analysis was performed based on the long terminal repeat (LTR) region. A total of 229 HTLV-1 cases had been reported up to December 2012. The mean age was 41 years old and 61% were female. Their country of origin was Latin America in 59%, Africa in 15%, and Spain in 20%. Transmission had occurred following sexual contact in 41%, parenteral exposure in 12%, and vertically in 9%. HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) was diagnosed in 27 cases and adult T cell leukemia/lymphoma (ATLL) in 17 subjects. HTLV-1 subtype could be obtained for 45 patients; all but one belonged to the Cosmopolitan subtype a. One Nigerian pregnant woman harbored HTLV-1 subtype b. Within the Cosmopolitan subtype a, two individuals (from Bolivia and Peru, respectively) belonged to the Japanese subgroup B, another two (from Senegal and Mauritania) to the North African subgroup D, and 39 to the Transcontinental subgroup A. Of note, one divergent HTLV-1 strain from an Ethiopian branched off from all five known Cosmopolitan subtype 1a subgroups. Divergent HTLV-1 strains have been introduced and currently circulate in Spain. The relatively large proportion of symptomatic cases (19%) suggests that HTLV-1 infection is underdiagnosed in Spain.
C1 [Trevino, Ana; de Mendoza, Carmen; Parra, Patricia; Soriano, Vincent] Hosp Carlos III, Dept Infect Dis, Madrid 28029, Spain.
   [Alcantara, Luiz Carlos, Jr.] Oswaldo Cruz Fdn FIOCRUZ, Salvador, BA, Brazil.
   [Benito, Rafael] Hosp Clin Univ Lozano Blesa, Microbiol Serv, Zaragoza, Spain.
   [Caballero, Estrella] Hosp Valle De Hebron, Microbiol Serv, Barcelona, Spain.
   [Aguilera, Antonio] Hosp Conxo CHUS, Microbiol Serv, Santiago, Spain.
   [Manuel Ramos, Jose] Hosp Gen Elche, Infect Dis Unit, Elche, Spain.
   [Rodriguez, Carmen; del Romero, Jorge] Ctr Sanitario Sandoval, Madrid, Spain.
   [Garcia, Juan] Hosp Cristal Pinor, Microbiol Serv, Orense, Spain.
   [Rodriguez-Iglesias, Manuel] Hosp Univ Puerta Mar, Microbiol Serv, Cadiz, Spain.
   [Ortiz de Lejarazu, Raul; Eiros, Jose] Hosp Clin Univ, Microbiol Serv, Valladolid, Spain.
   [Roc, Lourdes] Hosp Miguel Servet, Microbiol Serv, Zaragoza, Spain.
RP Trevino, A (corresponding author), Hosp Carlos III, Dept Infect Dis, Sinesio Delgado 10, Madrid 28029, Spain.
EM ana.trevino.rc@gmail.com
RI de Mendoza, Carmen/O-5917-2017; Caballero, Estrella/I-4602-2015; Benito,
   Rafael/AAH-9885-2019; Ramos, Jose M./B-6420-2018; Soriano,
   Vicente/O-5730-2018; Aguilera, Antonio/L-6586-2018; Hernandez,
   Marta/I-3276-2016
OI de Mendoza, Carmen/0000-0001-5224-7492; Ramos, Jose
   M./0000-0002-6501-9867; Soriano, Vicente/0000-0002-4624-5199; Aguilera,
   Antonio/0000-0001-6940-241X; Hernandez, Marta/0000-0001-6914-9987;
   Rodriguez Iglesias, Manuel Antonio/0000-0002-7097-9651; Alcantara,
   Luiz/0000-0002-6769-9931
FU Fundacion Investigacion y Educacion en Sida (IES); RIS (Red de
   Investigacion en SIDA) [ISCIII-RETIC RD06/0006/0040, RD/12/0017/0031];
   European NEAT project [LSHP-CT-2006-037570]
FX This work was supported by grants from Fundacion Investigacion y
   Educacion en Sida (IES), RIS (Red de Investigacion en SIDA, ISCIII-RETIC
   RD06/0006/0040 and RD/12/0017/0031), and the European NEAT project
   (LSHP-CT-2006-037570).
CR BLATTNER WA, 1990, J ACQ IMMUN DEF SYND, V3, P1102
   Carneiro-Proietti ABF, 2006, REV PANAM SALUD PUBL, V19, P44, DOI 10.1590/S1020-49892006000100007
   Carvalho EM, 2004, PARASITE IMMUNOL, V26, P487, DOI 10.1111/j.0141-9838.2004.00726.x
   Etenna SLD, 2008, J CLIN MICROBIOL, V46, P3607, DOI 10.1128/JCM.01249-08
   Furukawa Y, 2000, J INFECT DIS, V182, P1343, DOI 10.1086/315897
   Gessain A, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00388
   Goubau P, 1996, J ACQ IMMUN DEF SYND, V13, P68
   HENEINE W, 1992, J CLIN MICROBIOL, V30, P1605, DOI 10.1128/JCM.30.6.1605-1607.1992
   Hlela C, 2009, AIDS REV, V11, P205
   Huelsenbeck JP, 1997, SCIENCE, V276, P227, DOI 10.1126/science.276.5310.227
   Jeanmougin F, 1998, TRENDS BIOCHEM SCI, V23, P403, DOI 10.1016/S0968-0004(98)01285-7
   Alcantara LCJ, 2009, NUCLEIC ACIDS RES, V37, pW634, DOI 10.1093/nar/gkp455
   Kashima S, 2006, AIDS RES HUM RETROV, V22, P953, DOI 10.1089/aid.2006.22.953
   Mahieux R, 1997, J VIROL, V71, P1317, DOI 10.1128/JVI.71.2.1317-1333.1997
   Manns A, 1999, LANCET, V353, P1951, DOI 10.1016/S0140-6736(98)09460-4
   MIURA T, 1994, P NATL ACAD SCI USA, V91, P1124, DOI 10.1073/pnas.91.3.1124
   Nicholas KB, 1997, EMBNEW NEWS, V4, P14
   Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357
   POIESZ BJ, 1980, P NATL ACAD SCI-BIOL, V77, P7415, DOI 10.1073/pnas.77.12.7415
   Proietti FA, 2005, ONCOGENE, V24, P6058, DOI 10.1038/sj.onc.1208968
   Salemi M., 1999, AIDS REV, V1, P131
   TAKE H, 1993, JPN J CANCER RES, V84, P1265, DOI 10.1111/j.1349-7006.1993.tb02832.x
   Taylor G, 1999, AIDS REV, V1, P195
   Toro C, 2003, TRANSPLANTATION, V75, P102, DOI 10.1097/00007890-200301150-00019
   Trevino A, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-71
   Trevino A, 2012, MED CLIN-BARCELONA, V138, P541, DOI 10.1016/j.medcli.2011.03.003
   Trevino A, 2011, J CLIN VIROL, V52, P119, DOI 10.1016/j.jcv.2011.06.010
   Trevino A, 2009, AIDS RES HUM RETROV, V25, P551, DOI 10.1089/aid.2008.0268
   Vallejo A, 2003, AIDS RES HUM RETROV, V19, P609, DOI 10.1089/088922203322230978
   Van Dooren S, 1998, J GEN VIROL, V79, P2695, DOI 10.1099/0022-1317-79-11-2695
   Verdonck K, 2007, LANCET INFECT DIS, V7, P266, DOI 10.1016/S1473-3099(07)70081-6
   Xia X, 2001, J HERED, V92, P371, DOI 10.1093/jhered/92.4.371
   Zehender G, 2008, JAIDS-J ACQ IMM DEF, V47, P269, DOI 10.1097/QAI.0b013e31816649a4
NR 33
TC 8
Z9 8
U1 0
U2 10
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 0889-2229
EI 1931-8405
J9 AIDS RES HUM RETROV
JI Aids Res. Hum. Retrovir.
PD SEP
PY 2014
VL 30
IS 9
BP 856
EP 862
DI 10.1089/aid.2013.0128
PG 7
WC Immunology; Infectious Diseases; Virology
SC Immunology; Infectious Diseases; Virology
GA AO7IO
UT WOS:000341526800007
PM 24924996
OA Green Published
DA 2020-10-22
ER

PT J
AU Araujo, THA
   Barreto, FK
   Alcantara, LCJ
   Miranda, ACAM
AF Almeida Araujo, Thessika Hialla
   Barreto, Fernanda Khouri
   Junior Alcantara, Luiz Carlos
   Andrade Mota Miranda, Aline Cristina
TI Inferences about the global scenario of human T-cell lymphotropic virus
   type 1 infection using data mining of viral sequences
SO MEMORIAS DO INSTITUTO OSWALDO CRUZ
LA English
DT Article
DE HTLV-1; data mining; HTLV-1 database
ID HTLV-I INFECTION; EPIDEMIOLOGY; RETROVIRUS; DISEASES
AB Human T-cell lymphotropic virus type 1 (HTLV-1) is mainly associated with two diseases: tropical spastic paraparesis/HTLV-1-associated myelopathy (TSP/HAM) and adult T-cell leukaemia/lymphoma. This retrovirus infects five-10 million individuals throughout the world. Previously, we developed a database that annotates sequence data from GenBank and the present study aimed to describe the clinical, molecular and epidemiological scenarios of HTLV-1 infection through the stored sequences in this database. A total of 2,545 registered complete and partial sequences of HTLV-1 were collected and 1,967 (77.3%) of those sequences represented unique isolates. Among these isolates, 93% contained geographic origin information and only 39% were related to any clinical status. A total of 1,091 sequences contained information about the geographic origin and viral subtype and 93% of these sequences were identified as subtype "a". Ethnicity data are very scarce. Regarding clinical status data, 29% of the sequences were generated from TSP/HAM and 67.8% from healthy carrier individuals. Although the data mining enabled some inferences about specific aspects of HTLV-1 infection to be made, due to the relative scarcity of data of available sequences, it was not possible to delineate a global scenario of HTLV-1 infection.
C1 [Almeida Araujo, Thessika Hialla; Barreto, Fernanda Khouri; Junior Alcantara, Luiz Carlos] Fiocruz MS, Ctr Pesquisa Goncalo Moniz, Salvador, BA, Brazil.
   [Andrade Mota Miranda, Aline Cristina] Univ Fed Bahia, Inst Ciencias Saude, Salvador, BA, Brazil.
RP Alcantara, LCJ (corresponding author), Fiocruz MS, Ctr Pesquisa Goncalo Moniz, Salvador, BA, Brazil.
EM alcan@bahia.fiocruz.br
OI Alcantara, Luiz/0000-0002-6769-9931
CR Araujo THA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042123
   Carneiro-Proietti ABF, 2006, REV PANAM SALUD PUBL, V19, P44, DOI 10.1590/S1020-49892006000100007
   GalvaoCastro B, 1997, TRANSFUSION, V37, P242, DOI 10.1046/j.1537-2995.1997.37297203532.x
   GESSAIN A, 1985, LANCET, V2, P407
   Gessain A, 1996, ADV VIRUS RES, V47, P377, DOI 10.1016/S0065-3527(08)60740-X
   Gessain A, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00388
   HANCHARD B, 1990, HUMAN RETROVIROLOGY : HTLV, P173
   La Grenade L, 1998, ARCH DERMATOL, V134, P439, DOI 10.1001/archderm.134.4.439
   MOCHIZUKI M, 1992, J INFECT DIS, V166, P943, DOI 10.1093/infdis/166.4.943
   MUELLER N, 1991, CANCER CAUSE CONTROL, V2, P37, DOI 10.1007/BF00052359
   Mueller N, 1996, J ACQ IMMUN DEF SYND, V13, pS2, DOI 10.1097/00042560-199600001-00002
   POIESZ BJ, 1980, P NATL ACAD SCI-BIOL, V77, P7415, DOI 10.1073/pnas.77.12.7415
   Proietti FA, 2005, ONCOGENE, V24, P6058, DOI 10.1038/sj.onc.1208968
   Sonoda S, 2011, CANCER SCI, V102, P295, DOI 10.1111/j.1349-7006.2010.01820.x
   YOSHIDA M, 1982, P NATL ACAD SCI-BIOL, V79, P2031, DOI 10.1073/pnas.79.6.2031
NR 15
TC 2
Z9 2
U1 0
U2 16
PU FUNDACO OSWALDO CRUZ
PI RIO DE JANEIRO, RJ
PA AV BRASIL 4365, 21045-900 RIO DE JANEIRO, RJ, BRAZIL
SN 0074-0276
EI 1678-8060
J9 MEM I OSWALDO CRUZ
JI Mem. Inst. Oswaldo Cruz
PD JUN
PY 2014
VL 109
IS 4
BP 448
EP 451
DI 10.1590/0074-0276130587
PG 4
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA AN3LE
UT WOS:000340488700008
PM 24863974
OA DOAJ Gold, Green Published
DA 2020-10-22
ER

PT J
AU Costa, GCD
   Jesus, JG
   Rego, FFD
   Santos, ES
   Galvao-Castro, B
   Goncalves, MD
   Alcantara, LC
AF de Souza Costa, Giselle Calasans
   Jesus, Jaqueline Goes
   de Almeida Rego, Filipe Ferreira
   Santos, Edson Souza
   Galvao-Castro, Bernardo
   Goncalves, Marilda de Souza
   Alcantara Junior, Luiz Carlos
TI Genetic characterisation of Langerin gene in human immunodeficiency
   virus-1-infected women from Bahia, Brazil
SO MEMORIAS DO INSTITUTO OSWALDO CRUZ
LA English
DT Article
DE HIV-1; Langerin; polymorphism
ID C-TYPE LECTIN; IMMUNE-RESPONSES; DENDRITIC CELLS; IDENTIFICATION; RISK
AB Studies on human genetic variations are a useful source of knowledge about human immunodeficiency virus (HIV)-1 infection. The Langerin protein, found at the surface of Langerhans cells, has an important protective role in HIV-1 infection. Differences in Langerin function due to host genetic factors could influence susceptibility to HIV-1 infection. To verify the frequency of mutations in the Langerin gene, 118 samples from HIV-1-infected women and 99 samples from HIV-1-uninfected individuals were selected for sequencing of the promoter and carbohydrate recognition domain (CRD)-encoding regions of the Langerin gene. Langerin promoter analysis revealed two single nucleotide polymorphisms (SNPs) and one mutation in both studied groups, which created new binding sites for certain transcription factors, such as NFAT5, HOXB9.01 and STAT6.01, according to MatInspector software analysis. Three SNPs were observed in the CRD-encoding region in HIV-1-infected and uninfected individuals: p.K313I, c.941C>T and c.983C>T. This study shows that mutations in the Langerin gene are present in the analysed populations at different genotypic and allelic frequencies. Further studies should be conducted to verify the role of these mutations in HIV-1 susceptibility.
C1 [de Souza Costa, Giselle Calasans; Jesus, Jaqueline Goes; de Almeida Rego, Filipe Ferreira; Galvao-Castro, Bernardo; Goncalves, Marilda de Souza; Alcantara Junior, Luiz Carlos] Fiocruz MS, Ctr Pesquisas Goncalo Moniz, Lab Hematol Genet & Biol Computac, Salvador, BA, Brazil.
   [de Souza Costa, Giselle Calasans; Jesus, Jaqueline Goes; Santos, Edson Souza; Galvao-Castro, Bernardo] Fundacao Bahiana Desenvolvimento Ciencias, Escola Bahiana Med & Saude Publ, Salvador, BA, Brazil.
   [Goncalves, Marilda de Souza] Univ Fed Bahia, Fac Farm, Salvador, BA, Brazil.
RP Alcantara, LC (corresponding author), Fiocruz MS, Ctr Pesquisas Goncalo Moniz, Lab Hematol Genet & Biol Computac, Salvador, BA, Brazil.
EM lalcan@bahia.fiocruz.br
OI Alcantara, Luiz/0000-0002-6769-9931
FU MS/STD/AIDS Program; CNPqNational Council for Scientific and
   Technological Development (CNPq); FBDC; FIOCRUZ
FX MS/STD/AIDS Program, CNPq, FBDC, FIOCRUZ
CR Ahmed Z, 2013, ADV EXP MED BIOL, V762, P201, DOI 10.1007/978-1-4614-4433-6_8
   ARGOS P, 1982, EUR J BIOCHEM, V128, P565
   Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770
   Ayres M, 2005, BIOESTAT V 5 0 SOCIE
   BURGLIN TR, 2005, ENCY MOL CELL BIOL M, P179
   Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473
   Combet C, 2000, TRENDS BIOCHEM SCI, V25, P147, DOI 10.1016/S0968-0004(99)01540-6
   de Witte L, 2008, TRENDS MOL MED, V14, P12, DOI 10.1016/j.molmed.2007.11.001
   de Witte L, 2007, NAT MED, V13, P367, DOI 10.1038/nm1541
   Feinberg H, 2010, J BIOL CHEM, V285, P13285, DOI 10.1074/jbc.M109.086058
   Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985
   Hall T.A., 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008
   Hirbod T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025551
   Hirbod T, 2009, JAIDS-J ACQ IMM DEF, V51, P239, DOI 10.1097/QAI.0b013e3181a74f89
   HOPP TP, 1983, MOL IMMUNOL, V20, P483, DOI 10.1016/0161-5890(83)90029-9
   JANIN J, 1979, NATURE, V277, P491, DOI 10.1038/277491a0
   Kogawa K, 2002, IMMUNOL LETT, V80, P195, DOI 10.1016/S0165-2478(01)00314-5
   KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0
   Lee GM, 2005, J BIOL CHEM, V280, P7088, DOI 10.1074/jbc.M410722200
   McGreal EP, 2004, MOL IMMUNOL, V41, P1109, DOI 10.1016/j.molimm.2004.06.013
   Mesman AW, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00059
   Nicholas KB, 1997, EMBNEW NEWS, V4, P14
   RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573
   Rinne A, 2009, J MOL CELL CARDIOL, V47, P400, DOI 10.1016/j.yjmcc.2009.06.010
   Sabouri AH, 2004, J INFECT DIS, V190, P1279, DOI 10.1086/423942
   Schwartz O, 2007, NAT MED, V13, P245, DOI 10.1038/nm0307-245
   Stambach NS, 2003, GLYCOBIOLOGY, V13, P401, DOI 10.1093/glycob/cwg045
   Tada Y, 2006, J INVEST DERMATOL, V126, P1549, DOI 10.1038/sj.jid.5700283
   Valladeau J, 2002, J IMMUNOL, V168, P782, DOI 10.4049/jimmunol.168.2.782
   van den Berg LM, 2013, ADV EXP MED BIOL, V762, P45, DOI 10.1007/978-1-4614-4433-6_2
   van der Vlist M, 2010, IMMUNOL CELL BIOL, V88, P410, DOI 10.1038/icb.2010.32
   Verdijk P, 2005, J INVEST DERMATOL, V124, P714, DOI 10.1111/j.0022-202X.2005.23645.x
   Vinkemeier U, 1998, SCIENCE, V279, P1048, DOI 10.1126/science.279.5353.1048
   Ward EM, 2006, J BIOL CHEM, V281, P15450, DOI 10.1074/jbc.M511502200
NR 34
TC 0
Z9 0
U1 0
U2 3
PU FUNDACO OSWALDO CRUZ
PI RIO DE JANEIRO, RJ
PA AV BRASIL 4365, 21045-900 RIO DE JANEIRO, RJ, BRAZIL
SN 0074-0276
EI 1678-8060
J9 MEM I OSWALDO CRUZ
JI Mem. Inst. Oswaldo Cruz
PD APR
PY 2014
VL 109
IS 2
BP 250
EP 255
DI 10.1590/0074-0276140337
PG 6
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA AJ7VQ
UT WOS:000337908500017
PM 24676666
OA DOAJ Gold, Green Published
DA 2020-10-22
ER

PT J
AU Mello, MAG
   da Conceicao, AF
   Sousa, SMB
   Alcantara, LC
   Marin, LJ
   Raiol, MRD
   Boa-Sorte, N
   Santos, LPS
   de Almeida, MDC
   Galvao, TC
   Bastos, RG
   Lazaro, N
   Galvao-Castro, B
   Gadelha, SR
AF Gomes Mello, Marco Antonio
   da Conceicao, Aline Ferreira
   Bispo Sousa, Sandra Mara
   Alcantara, Luiz Carlos
   Marin, Lauro Juliano
   da Silva Raiol, Monica Regina
   Boa-Sorte, Ney
   Souza Santos, Lucas Pereira
   Chagas de Almeida, Maria da Conceicao
   Galvao, Tamara Coutinho
   Bastos, Raquel Gois
   Lazaro, Noilson
   Galvao-Castro, Bernardo
   Gadelha, Sandra Rocha
TI HTLV-1 in pregnant women from the Southern Bahia, Brazil: a neglected
   condition despite the high prevalence
SO VIROLOGY JOURNAL
LA English
DT Article
DE HTLV; Bahia-Brazil; Vertical transmission; Pregnant; Prenatal care
ID LYMPHOTROPIC VIRUS TYPE-1; CELL LEUKEMIA-VIRUS; VERTICAL TRANSMISSION;
   GENERAL-POPULATION; INFECTION; ORIGIN; STATE; CITY
AB Background: As the most frequent pathway of vertical transmission of HTLV-1 is breast-feeding, and considering the higher prevalence in women, it is very important to perform screening examinations for anti-HTLV-1 antibodies as part of routine prenatal care. So far, no studies of HTLV-1 seroprevalence in pregnant women in the Southern region of Bahia, Brazil, have been described.
   Methods: Pregnant women were selected at the two regional reference centers for health care from Southern Bahia. A total of 2766 pregnant women attending the antenatal unit between November 2008 and May 2010 have been analyzed. An extra blood sample was drawn during their routine antenatal testing. A standardized questionnaire was applied and all positive plasma samples were tested by ELISA and were confirmed by Western Blot and PCR. Besides that, positive women were contacted and visited. The family members that were present during the visit were asked to be serologically screened to the virus. A prospective study was also carried out and newborns were followed up to two years for evaluation of vertical transmission.
   Results: HTLV prevalence was 1.05% (CI 95%: 0.70-1.50). There was no association of HTLV-1 infection with age, education, income and ethnic differences. The association with marital status was borderline (OR = 7.99; 95% CI 1.07-59.3; p = 0.042). In addition, 43 family members of the HTLV-1 seropositive women have been analyzed and specific reactivity was observed in 32.56%, including two children from previous pregnancy.
   Conclusion: It is very important to emphasize that the lack of HTLV-1 screening in pregnant women can promote HTLV transmission especially in endemic areas. HTLV screening in this vulnerable population and the promotion of bottle-feeding for children of seropositive mothers could be important cost-effective methods to limit the vertical transmission. Besides that, our data reinforce the need to establish strategies of active surveillance in household and family contacts as important epidemiological surveillance actions for the early detection of virus infection and the prevention of transmission by sexual or and parenteral contact.
C1 [Gomes Mello, Marco Antonio; Lazaro, Noilson; Galvao-Castro, Bernardo] LASP CPqGM FIOCRUZ, Salvador, BA, Brazil.
   [Gomes Mello, Marco Antonio] Fac Ilheus, Ilheus, BA, Brazil.
   [da Conceicao, Aline Ferreira; Marin, Lauro Juliano; da Silva Raiol, Monica Regina; Souza Santos, Lucas Pereira; Galvao, Tamara Coutinho; Bastos, Raquel Gois; Gadelha, Sandra Rocha] Univ Estadual Santa Cruz, Ilheus, BA, Brazil.
   [Bispo Sousa, Sandra Mara] Univ Estadual Sudoeste Bahia, Vitoria Da Conquista, BA, Brazil.
   [Alcantara, Luiz Carlos] LHGB CPqGM FIOCRUZ, Salvador, BA, Brazil.
   [Boa-Sorte, Ney; Lazaro, Noilson; Galvao-Castro, Bernardo] Escola Bahiana Med & Saude Publ, Salvador, BA, Brazil.
   [Chagas de Almeida, Maria da Conceicao] LEMB CPqGM FIOCRUZ, Salvador, BA, Brazil.
RP Gadelha, SR (corresponding author), Univ Estadual Santa Cruz, Rodovia Ilheus Itabuna Km 16 Salobrinho, Ilheus, BA, Brazil.
EM sandragadelha@hotmail.com
RI Boa-Sorte, Ney/AAG-8718-2020; Gadelha, Sandra/X-3373-2019; Boa-Sorte,
   Ney A/Q-9902-2018
OI Boa-Sorte, Ney/0000-0001-7068-3319; Gadelha, Sandra/0000-0002-3079-488X;
   CHAGAS DE ALMEIDA, MARIA DA CONCEICAO/0000-0002-4760-4157; Alcantara,
   Luiz/0000-0002-6769-9931
FU PROPP-UESC; FAPESB; CNPqNational Council for Scientific and
   Technological Development (CNPq)
FX This study was financially aided by the following institutions:
   PROPP-UESC, FAPESB and CNPq. The authors are thankful to
   LASP-FIOCRUZ-Bahia and Fundacao Bahiana para Desenvolvimento das
   Ciencias-Escola Bahiana de Medicina e Saude Publica for the technical
   and laboratorial support. The authors are also thankful to the staff of
   Maternidade Santa Helena, from llheus, and Hospital Manoel Novaes Santa
   Casa de Misericordia, from Itabuna for their operational support.
CR Alcantara LCJ, 2006, AIDS, V20, P780, DOI 10.1097/01.aids.0000216383.14808.13
   Biggar RJ, 2006, J INFECT DIS, V193, P277, DOI 10.1086/498910
   BITTENCOURT Achiléa L, 2002, Rev. Inst. Med. trop. S. Paulo, V44, P63, DOI 10.1590/S0036-46652002000200002
   Bittencourt Achiléa Lisboa, 2006, J. Pediatr. (Rio J.), V82, P411, DOI 10.1590/S0021-75572006000800004
   Bittencourt AL, 2001, J ACQ IMMUN DEF SYND, V26, P490, DOI 10.1097/00126334-200104150-00016
   Bittencourt AL, 2006, CADERNOS HEMOMINAS, P174
   Carneiro-Proietti AB, 2012, AIDS RES HUM RETROV, V28, P1265
   Carneiro-Proietti ABF, 2006, REV PANAM SALUD PUBL, V19, P44, DOI 10.1590/S1020-49892006000100007
   Catalan-Soares BC, 2001, REV BRAS EPIDEMIOL, V4, P81
   Catalan-Soares Bernadette, 2005, Cad. Saúde Pública, V21, P926, DOI 10.1590/S0102-311X2005000300027
   da Costa CA, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002272
   de Souza VG, 2012, REV SOC BRAS MED TRO, V45, P159, DOI 10.1590/S0037-86822012000200004
   Dourado I, 2003, JAIDS-J ACQ IMM DEF, V34, P527, DOI 10.1097/00126334-200312150-00013
   Dal Fabbrol MMFJ, 2008, REV SOC BRAS MED TRO, V41, P148, DOI 10.1590/S0037-86822008000200003
   GalvaoCastro B, 1997, TRANSFUSION, V37, P242, DOI 10.1046/j.1537-2995.1997.37297203532.x
   Gessain A, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00388
   Hino Shigeo, 1997, Leukemia (Basingstoke), V11, P57
   Hisada M, 2002, CLIN INFECT DIS, V34, P1551, DOI 10.1086/340537
   Hlela C, 2009, AIDS REV, V11, P205
   KAJIYAMA W, 1986, J INFECT DIS, V154, P851, DOI 10.1093/infdis/154.5.851
   Magalhaes T, 2008, J MED VIROL, V80, P2040, DOI 10.1002/jmv.21278
   OKOCHI K, 1984, VOX SANG, V46, P245, DOI 10.1111/j.1423-0410.1984.tb00083.x
   Olbrich Neto Jaime, 2004, Rev Soc Bras Med Trop, V37, P28
   Proietti FA, 2005, ONCOGENE, V24, P6058, DOI 10.1038/sj.onc.1208968
   Ribeiro MA, 2012, PEDIATR INFECT DIS J, V31, P1139, DOI 10.1097/INF.0b013e318263215e
   Ribeiro MA, 2010, REV PANAM SALUD PUBL, V27, P330, DOI 10.1590/S1020-49892010000500002
   Santos Jairo Vvo Dos, 1995, Revista do Instituto de Medicina Tropical de Sao Paulo, V37, P343
   Soares BCC, 2000, CADERNOS HEMOMINAS, P53
   van Tienen C, 2012, ARCH GYNECOL OBSTET, V286, P255, DOI 10.1007/s00404-011-2211-4
   Wiktor S Z, 1997, J Hum Virol, V1, P37
NR 30
TC 19
Z9 21
U1 0
U2 0
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1743-422X
J9 VIROL J
JI Virol. J.
PD FEB 13
PY 2014
VL 11
AR 28
DI 10.1186/1743-422X-11-28
PG 7
WC Virology
SC Virology
GA AF7BO
UT WOS:000334868600002
PM 24524416
OA DOAJ Gold, Green Published
DA 2020-10-22
ER

PT J
AU Edwards, D
   Fukumoto, R
   de Castro-Amarante, MF
   Alcantara, LC
   Galvao-Castro, B
   Parks, RW
   Pise-Masison, C
   Franchini, G
AF Edwards, Dustin
   Fukumoto, Risaku
   de Castro-Amarante, Maria Fernanda
   Alcantara Junior, Luiz Carlos
   Galvao-Castro, Bernardo
   Parks, Robyn Washington
   Pise-Masison, Cynthia
   Franchini, Genoveffa
TI Palmitoylation and p8-Mediated Human T-Cell Leukemia Virus Type 1
   Transmission
SO JOURNAL OF VIROLOGY
LA English
DT Article
ID P12(I) PROTEIN; NUCLEAR FACTOR; SIGNAL-TRANSDUCTION; ACTIVATION;
   EXPRESSION; MYELOPATHY; RECEPTOR; HTLV-1; FAMILY; LINES
AB The orf-I gene of human T-cell leukemia type 1 (HTLV-1) encodes p8 and p12 and has a conserved cysteine at position 39. p8 and p12 form disulfide-linked dimers, and only the monomeric forms of p8 and p12 are palmitoylated. Mutation of cysteine 39 to alanine (C39A) abrogated dimerization and palmitoylation of both proteins. However, the ability of p8 to localize to the cell surface and to increase cell adhesion and viral transmission was not affected by the C39A mutation.
C1 [Edwards, Dustin; Fukumoto, Risaku; de Castro-Amarante, Maria Fernanda; Alcantara Junior, Luiz Carlos; Parks, Robyn Washington; Pise-Masison, Cynthia; Franchini, Genoveffa] NCI, Anim Models & Retroviral Vaccines Sect, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.
   [Alcantara Junior, Luiz Carlos; Galvao-Castro, Bernardo] Fundacao Oswaldo Cruz, Goncalo Moniz Res Ctr, Salvador, BA, Brazil.
   [Galvao-Castro, Bernardo] Bahia Fdn Sci Dev, Bahia Sch Med & Publ Hlth, Salvador, BA, Brazil.
RP Franchini, G (corresponding author), NCI, Anim Models & Retroviral Vaccines Sect, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.
EM franchig@mail.nih.gov
OI Alcantara, Luiz/0000-0002-6769-9931
CR Albrecht B, 2002, J VIROL, V76, P3493, DOI 10.1128/JVI.76.7.3493-3501.2002
   BERNEMAN ZN, 1992, P NATL ACAD SCI USA, V89, P3005, DOI 10.1073/pnas.89.7.3005
   CIMINALE V, 1992, J VIROL, V66, P1737, DOI 10.1128/JVI.66.3.1737-1745.1992
   Ding W, 2002, J VIROL, V76, P10374, DOI 10.1128/JVI.76.20.10374-10382.2002
   Fukumoto R, 2007, J VIROL, V81, P9088, DOI 10.1128/JVI.02703-06
   Fukumoto R, 2009, BLOOD, V113, P3726, DOI 10.1182/blood-2008-04-146928
   GESSAIN A, 1985, LANCET, V2, P407
   Kim SJ, 2003, J BIOL CHEM, V278, P15550, DOI 10.1074/jbc.M210210200
   KORALNIK IJ, 1992, P NATL ACAD SCI USA, V89, P8813, DOI 10.1073/pnas.89.18.8813
   Linder ME, 2007, NAT REV MOL CELL BIO, V8, P74, DOI 10.1038/nrm2084
   Mulloy JC, 1996, J VIROL, V70, P3599, DOI 10.1128/JVI.70.6.3599-3605.1996
   NAKAMURA F, 1989, J GASTROEN HEPATOL, V4, P387, DOI 10.1111/j.1440-1746.1989.tb00850.x
   Nicot C, 2001, BLOOD, V98, P823, DOI 10.1182/blood.V98.3.823
   OSAME M, 1986, LANCET, V1, P1031
   Rouquette-Jazdanian AK, 2002, BIOCHEM J, V363, P645, DOI 10.1042/0264-6021:3630645
   SEIKI M, 1983, P NATL ACAD SCI-BIOL, V80, P3618, DOI 10.1073/pnas.80.12.3618
   Taylor JM, 2009, J VIROL, V83, P11467, DOI 10.1128/JVI.00952-09
   Van Prooyen N, 2010, P NATL ACAD SCI USA, V107, P20738, DOI 10.1073/pnas.1009635107
   Veit M, 2013, BIOCHEM SOC T, V41, P50, DOI 10.1042/BST20120210
   YOSHIDA M, 1982, P NATL ACAD SCI-BIOL, V79, P2031, DOI 10.1073/pnas.79.6.2031
NR 20
TC 6
Z9 6
U1 0
U2 2
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0022-538X
EI 1098-5514
J9 J VIROL
JI J. Virol.
PD FEB
PY 2014
VL 88
IS 4
BP 2319
EP 2322
DI 10.1128/JVI.03444-13
PG 4
WC Virology
SC Virology
GA AA5HA
UT WOS:000331125500041
PM 24284316
OA Bronze, Green Published
DA 2020-10-22
ER

PT J
AU Barreto, FK
   Rego, FFA
   Fonseca, LM
   Galvao-Castro, B
   Araujo, THA
   Mota-Miranda, ACA
   Monteiro-Cunha, JP
   Alcantara, LCJ
AF Barreto, Fernanda K.
   Rego, Felipe F. A.
   Fonseca, Loianna M.
   Galvao-Castro-Filho, Bernardo
   Araujo, Thessika H. A.
   Mota-Miranda, Aline Cristina A.
   Monteiro-Cunha, Joana P.
   Alcantara, Luiz Carlos J.
TI Molecular Characterization of the Human T Cell Lymphotropic Virus Type 2
   Long Terminal Repeat Region: A Discussion about Possible Influences at
   Viral Gene Expression
SO AIDS RESEARCH AND HUMAN RETROVIRUSES
LA English
DT Article
ID SUBTYPE
AB This study aimed to identify nucleotide signatures in the promoter region of human T cell lymphotropic virus type 2 (HTLV-2) isolated from infected individuals from Salvador, Brazil and in sequences from the GenBank database. DNA samples from HTLV-2-infected individuals were submitted to nested polymerase chain reaction (PCR) and sequencing, and molecular analyses were performed using bioinformatics tools. The phylogeny of HTLV-2 strains isolated from patients from Salvador reveals that all sequences were subtype c. One hundred and fifty-one sequences from GenBank were selected, among which 30 belong to subtype a, 88 to subtype b, 32 to subtype c, and one to subtype d. Subtype-specific signatures were identified as well as mutations resulting in loss or gain of motifs important to transcription regulation. The subtypes a and b have two E box motifs, while subtypes c and d have only one. These polymorphisms may impact viral fitness and infection outcome and should be more closely investigated.
C1 [Barreto, Fernanda K.; Rego, Felipe F. A.; Fonseca, Loianna M.; Araujo, Thessika H. A.; Alcantara, Luiz Carlos J.] Fundacao Oswaldo Cruz, Lab Hematol Genet & Biol Computac, Ctr Pesquisa Goncalo Moniz, Salvador, BA, Brazil.
   [Galvao-Castro-Filho, Bernardo; Mota-Miranda, Aline Cristina A.; Monteiro-Cunha, Joana P.] Escola Bahiana Med & Saude Publ, Salvador, BA, Brazil.
   [Mota-Miranda, Aline Cristina A.; Monteiro-Cunha, Joana P.] Univ Fed Bahia, Inst Ciencias Saude, Salvador, BA, Brazil.
RP Alcantara, LCJ (corresponding author), LHGB CPqGM FIOCRUZ, Rua Waldemar Falcao 121, BR-40295001 Salvador, BA, Brazil.
EM lalcan@bahia.fiocruz.br
OI Alcantara, Luiz/0000-0002-6769-9931
CR Alcantara LCJ, 2003, AIDS RES HUM RETROV, V19, P519, DOI 10.1089/088922203766774577
   [Anonymous], 1999, NUCL ACIDS S SER, V41, P95
   [Anonymous], 2013, GEN 6 1
   Araujo A, 2004, ANN NEUROL, V56, P10, DOI 10.1002/ana.20126
   Eiraku N, 1996, J VIROL, V70, P1481, DOI 10.1128/JVI.70.3.1481-1492.1996
   HALL WW, 1992, J VIROL, V66, P2456, DOI 10.1128/JVI.66.4.2456-2463.1992
   Jeanmougin F, 1998, TRENDS BIOCHEM SCI, V23, P403, DOI 10.1016/S0968-0004(98)01285-7
   KALYANARAMAN VS, 1982, SCIENCE, V218, P571, DOI 10.1126/science.6981847
   Merezak C, 2001, J VIROL, V75, P6977, DOI 10.1128/JVI.75.15.6977-6988.2001
   Roucoux DF, 2004, AIDS REV, V6, P144
   Swofford D. L., 2002, PAUP PHYLOGENETIC AN, DOI [10.1007/BF02198856, DOI 10.1007/BF02198856]
   Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/msr121, 10.1093/molbev/mst197]
   Vandamme AM, 1998, J VIROL, V72, P4327, DOI 10.1128/JVI.72.5.4327-4340.1998
   Vandamme AM, 2000, GENE, V261, P171, DOI 10.1016/S0378-1119(00)00473-X
NR 14
TC 1
Z9 1
U1 0
U2 4
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 0889-2229
EI 1931-8405
J9 AIDS RES HUM RETROV
JI Aids Res. Hum. Retrovir.
PD JAN 1
PY 2014
VL 30
IS 1
BP 92
EP 96
DI 10.1089/aid.2013.0181
PG 5
WC Immunology; Infectious Diseases; Virology
SC Immunology; Infectious Diseases; Virology
GA 284BO
UT WOS:000329291200015
PM 23808326
OA Green Published
DA 2020-10-22
ER

PT J
AU Mota-Miranda, ACA
   Barreto, FK
   Baptista, E
   Farre-Vale, L
   Monteiro-Cunha, JP
   Galvao-Castro, B
   Alcantara, LCJ
AF Mota-Miranda, Aline Cristina A.
   Barreto, Fernanda K.
   Baptista, Everton
   Farre-Vale, Lourdes
   Monteiro-Cunha, Joana P.
   Galvao-Castro, Bernardo
   Alcantara, Luiz Carlos J.
TI Molecular Study of HBZ and gp21 Human T Cell Leukemia Virus Type 1
   Proteins Isolated from Different Clinical Profile Infected Individuals
SO AIDS RESEARCH AND HUMAN RETROVIRUSES
LA English
DT Article
ID I-ASSOCIATED MYELOPATHY; HTLV-1; SEQUENCES
AB Human T cell leukemia virus type 1 (HTLV-1) is associated with a neurological syndrome named tropical spastic paraparesis/HTLV-associated myelopathy (TSP/HAM) and the disease progression involves viral factors. The gp21 glycoprotein is involved in envelope trafficking and membrane targeting while the bZIP protein is indispensable for cell growth and proliferation. This study aimed to assess the molecular diversity of gp21 and HBZ proteins in TSP/HAM and healthy carriers. DNA samples from HTLV-1-infected individuals were submitted to PCR and sequencing, and the molecular analyses were performed using bioinformatics tools. From eight gp21-analyzed sequences one amino acid change (Y477H) was associated with the switch of a helix to coil structure at secondary structure prediction. From 10 HBZ analyzed sequences, two amino acid changes were identified (S9P and T95I) at the activation domain. One mutation (R112C) located at the nuclear localization signal was present in 66.7% and 25% of healthy carriers (HC) and TSP/HAM groups, respectively. This is the first report of mutations in the HBZ region. These polymorphisms might be important for viral fitness.
C1 [Mota-Miranda, Aline Cristina A.; Barreto, Fernanda K.; Baptista, Everton; Farre-Vale, Lourdes; Monteiro-Cunha, Joana P.; Galvao-Castro, Bernardo; Alcantara, Luiz Carlos J.] Fundacao Oswaldo Cruz, Ctr Pesquisa Goncalo Moniz, Salvador, BA, Brazil.
   [Mota-Miranda, Aline Cristina A.; Monteiro-Cunha, Joana P.; Galvao-Castro, Bernardo] Escola Bahiana Med & Saude Publ, Salvador, BA, Brazil.
   [Mota-Miranda, Aline Cristina A.; Monteiro-Cunha, Joana P.] Univ Fed Bahia, Inst Ciencias Saude, BR-40110100 Salvador, BA, Brazil.
RP Mota-Miranda, ACA (corresponding author), Univ Fed Bahia, Inst Ciencias Saude, Rua Reitor Miguel Calmon S-N, BR-40110100 Salvador, BA, Brazil.
EM alinecmmiranda@yahoo.com.br
OI Farre, Lourdes/0000-0002-3168-1940; Alcantara, Luiz/0000-0002-6769-9931
CR Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770
   Dehee A, 2002, J VIROL METHODS, V102, P37, DOI 10.1016/S0166-0934(01)00445-1
   Hall T.A., 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008
   Iniguez AM, 2006, AIDS RES HUM RETROV, V22, P466, DOI 10.1089/aid.2006.22.466
   Maerz AL, 2000, J VIROL, V74, P6614, DOI 10.1128/JVI.74.14.6614-6621.2000
   Maloney EM, 1998, J ACQ IMMUN DEF SYND, V17, P167, DOI 10.1097/00042560-199802010-00011
   Matsuoka M, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-71
   Mota-Miranda AC, 2007, MEM I OSWALDO CRUZ, V102, P741, DOI 10.1590/S0074-02762007000600014
   Murata K, 2006, J VIROL, V80, P2495, DOI 10.1128/JVI.80.5.2495-2505.2006
   Nicholas KB, 1997, EMBNEW NEWS, V4, P14
   OSAME M, 1986, LANCET, V1, P1031
   POIESZ BJ, 1980, P NATL ACAD SCI-BIOL, V77, P7415, DOI 10.1073/pnas.77.12.7415
   Proietti FA, 2005, ONCOGENE, V24, P6058, DOI 10.1038/sj.onc.1208968
   Rosenberg AR, 1998, J VIROL, V72, P7609, DOI 10.1128/JVI.72.9.7609-7614.1998
   Satou Y, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001274
   Satou Y, 2010, J CLIN EXP HEMATOP, V50, P1, DOI 10.3960/jslrt.50.1
NR 16
TC 2
Z9 2
U1 0
U2 3
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 0889-2229
EI 1931-8405
J9 AIDS RES HUM RETROV
JI Aids Res. Hum. Retrovir.
PD OCT 1
PY 2013
VL 29
IS 10
BP 1370
EP 1372
DI 10.1089/aid.2013.0015
PG 3
WC Immunology; Infectious Diseases; Virology
SC Immunology; Infectious Diseases; Virology
GA 224UQ
UT WOS:000324915800013
PM 23800288
OA Green Published
DA 2020-10-22
ER

PT J
AU Libin, P
   Beheydt, G
   Deforche, K
   Imbrechts, S
   Ferreira, F
   Van Laethem, K
   Theys, K
   Carvalho, AP
   Cavaco-Silva, J
   Lapadula, G
   Torti, C
   Assel, M
   Wesner, S
   Snoeck, J
   Ruelle, J
   De Bel, A
   Lacor, P
   De Munter, P
   Van Wijngaerden, E
   Zazzi, M
   Kaiser, R
   Ayouba, A
   Peeters, M
   de Oliveira, T
   Alcantara, LCJ
   Grossman, Z
   Sloot, P
   Otelea, D
   Paraschiv, S
   Boucher, C
   Camacho, RJ
   Vandamme, AM
AF Libin, Pieter
   Beheydt, Gertjan
   Deforche, Koen
   Imbrechts, Stijn
   Ferreira, Fossie
   Van Laethem, Kristel
   Theys, Kristof
   Carvalho, Ana Patricia
   Cavaco-Silva, Joana
   Lapadula, Giuseppe
   Torti, Carlo
   Assel, Matthias
   Wesner, Stefan
   Snoeck, Joke
   Ruelle, Jean
   De Bel, Annelies
   Lacor, Patrick
   De Munter, Paul
   Van Wijngaerden, Eric
   Zazzi, Maurizio
   Kaiser, Rolf
   Ayouba, Ahidjo
   Peeters, Martine
   de Oliveira, Tulio
   Alcantara, Luiz C. J.
   Grossman, Zehava
   Sloot, Peter
   Otelea, Dan
   Paraschiv, Simona
   Boucher, Charles
   Camacho, Ricardo J.
   Vandamme, Anne-Mieke
TI RegaDB: community-driven data management and analysis for infectious
   diseases
SO BIOINFORMATICS
LA English
DT Article
ID DRUG-RESISTANCE; MICROBIAL SEQUENCES; THERAPY; AFRICA; SEARCH; HIV-1
AB RegaDB is a free and open source data management and analysis environment for infectious diseases. RegaDB allows clinicians to store, manage and analyse patient data, including viral genetic sequences. Moreover, RegaDB provides researchers with a mechanism to collect data in a uniform format and offers them a canvas to make newly developed bioinformatics tools available to clinicians and virologists through a user friendly interface.
C1 [Libin, Pieter; Beheydt, Gertjan; Imbrechts, Stijn; Ferreira, Fossie; Van Laethem, Kristel; Theys, Kristof; Snoeck, Joke; Van Wijngaerden, Eric; Vandamme, Anne-Mieke] Katholieke Univ Leuven, Dept Microbiol & Immunol, Rega Inst Med Res, B-3000 Louvain, Belgium.
   [Libin, Pieter; Deforche, Koen] Biomed IT Solut, Mybiodata, B-3110 Rotselaar, Belgium.
   [Ferreira, Fossie; Van Laethem, Kristel; De Munter, Paul; Van Wijngaerden, Eric] Univ Hosp Leuven, B-3000 Louvain, Belgium.
   [Carvalho, Ana Patricia; Camacho, Ricardo J.] Ctr Hosp Lisboa Ocidental, P-1349019 Lisbon, Portugal.
   [Cavaco-Silva, Joana; Camacho, Ricardo J.; Vandamme, Anne-Mieke] Univ Nova Lisboa, Ctr Malaria & Outras Doencas Tropicais, Inst Higiene Med & Trop, P-1349008 Lisbon, Portugal.
   [Lapadula, Giuseppe; Torti, Carlo] Univ Brescia, Dept Clin & Expt Sci, I-25121 Brescia, Italy.
   [Assel, Matthias; Wesner, Stefan] Univ Stuttgart, Ctr High Performance Comp, D-70049 Stuttgart, Germany.
   [Ruelle, Jean] Catholic Univ Louvain, B-1348 Louvain, Belgium.
   [De Bel, Annelies] Univ Ziekenhuis Brussel, B-1090 Brussels, Belgium.
   [Lacor, Patrick] Univ Ziekenhuis Brussel, B-1090 Brussels, Belgium.
   [Zazzi, Maurizio] Univ Siena, Dept Biotechnol, I-53100 Siena, Italy.
   [Kaiser, Rolf] Univ Cologne, Inst Virol, D-50923 Cologne, Germany.
   [Ayouba, Ahidjo; Peeters, Martine] Inst Rech Dev, F-34394 Montpellier, France.
   [de Oliveira, Tulio] Univ KwaZulu Natal, Africa Ctr Hlth & Populat Studies, Nelson R Mandela Sch Med, ZA-4041 Durban, South Africa.
   [Alcantara, Luiz C. J.] Fiocruz MS, Goncalo Moniz Res Ctr, BR-40296710 Salvador, BA, Brazil.
   [Grossman, Zehava] Tel Aviv Univ, Sackler Sch Med, IL-6997801 Tel Aviv, Israel.
   [Sloot, Peter] Univ Amsterdam, Dept Computat Sci, NL-1012 Amsterdam, Netherlands.
   [Otelea, Dan; Paraschiv, Simona] Inst Natl Boli Infect Prof Dr Matei Bals, Dept Mol Diagnost, Sect 2, Bucharest, Romania.
   [Boucher, Charles] Erasmus Univ, Dept Virol, Erasmus Med Ctr, NL-3015 Rotterdam, Netherlands.
RP Libin, P (corresponding author), Katholieke Univ Leuven, Dept Microbiol & Immunol, Rega Inst Med Res, B-3000 Louvain, Belgium.
EM pieter.libin@rega.kuleuven.be
RI Ayouba, Ahidjo/G-8775-2017; Lapadula, Giuseppe/J-5163-2012; Van Laethem,
   Kristel/R-6282-2016; Zazzi, Maurizio/K-3422-2018; Camacho, Ricardo
   J/I-7629-2012; Vandamme, Anne-Mieke/I-4127-2012; Sloot,
   Peter/B-3078-2014
OI Ayouba, Ahidjo/0000-0002-5081-1632; Van Laethem,
   Kristel/0000-0001-6036-2271; Zazzi, Maurizio/0000-0002-0344-6281;
   Camacho, Ricardo J/0000-0002-9129-3237; Vandamme,
   Anne-Mieke/0000-0002-6594-2766; Sloot, Peter/0000-0002-3848-5395;
   Alcantara, Luiz/0000-0002-6769-9931; Wesner, Stefan/0000-0002-7270-7959
FU Fonds voor Wetenschappelijk Onderzoek (FWO) FlandersFWO [G.0611.09,
   1.5.236.11N, G.A029.11]; KU LeuvenKU Leuven [OT/08/047, PDMK/10/204];
   Institute for the Promotion of Innovation through Sciences and
   Technology in Flanders (IWT)Institute for the Promotion of Innovation by
   Science and Technology in Flanders (IWT); Interuniversity Attraction
   Poles Programme, Belgian State, Belgian Science PolicyBelgian Federal
   Science Policy Office [IAP-VI P6/41]; Virolab project [EU IST STREP
   Project] [027446]; European CommunityEuropean Community (EC) [223131]
FX This work was supported by the Fonds voor Wetenschappelijk Onderzoek
   (FWO) Flanders [grants to K. T. and J.S., G.0611.09, 1.5.236.11N,
   G.A029.11]; the Research Fund of the KU Leuven [OT/08/047, PDMK/10/204
   to K. T.]; the Institute for the Promotion of Innovation through
   Sciences and Technology in Flanders (IWT) [PhD grant to G. B.]; the
   Interuniversity Attraction Poles Programme, Belgian State, Belgian
   Science Policy [IAP-VI P6/41]; the Virolab project [EU IST STREP Project
   027446]. The research leading to these results has received funding from
   the European Community's Seventh Framework Programme (FP7/2007-2013)
   under the project 'Collaborative HIV and Anti-HIV Drug Resistance
   Network (CHAIN)'-grant agreement no 223131.
CR Araujo THA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042123
   ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999
   Assel M, 2009, STUD HEALTH TECHNOL, V147, P51, DOI 10.3233/978-1-60750-027-8-51
   de Oliveira T, 2005, BIOINFORMATICS, V21, P3797, DOI 10.1093/bioinformatics/bti607
   De Oliveira T, 2003, BIOINFORMATICS, V19, P153, DOI 10.1093/bioinformatics/19.1.153
   de Oliveira T, 2010, NATURE, V464, P673, DOI 10.1038/464673c
   Drummond A, 2011, GENEIOUS V5 4
   Imbrechts S., 2009, REV ANTIVIRAL THER, V1, P104
   Alcantara LCJ, 2009, NUCLEIC ACIDS RES, V37, pW634, DOI 10.1093/nar/gkp455
   Libin P., 2007, REV ANTIVIRAL THER, V2, P82
   Liu TF, 2006, CLIN INFECT DIS, V42, P1608, DOI 10.1086/503914
   Manasa J, 2012, AIDS RES HUM RETROV, V28, P558, DOI [10.1089/aid.2011.0284, 10.1089/AID.2011.0284]
   Meynard JL, 2002, AIDS, V16, P727, DOI 10.1097/00002030-200203290-00008
   NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4
   Rossouw T., 2013, HIV TB DRUG RESISTAN
   Sloot PMA, 2009, PHILOS T R SOC A, V367, P2691, DOI 10.1098/rsta.2009.0043
   Sloot P.M.A., 2008, REV ANTIVIRAL THER, V3, P4
   Van Laethem K, 2002, ANTIVIR THER, V7, P123
NR 18
TC 19
Z9 19
U1 0
U2 10
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 1367-4803
J9 BIOINFORMATICS
JI Bioinformatics
PD JUN 1
PY 2013
VL 29
IS 11
BP 1477
EP 1480
DI 10.1093/bioinformatics/btt162
PG 4
WC Biochemical Research Methods; Biotechnology & Applied Microbiology;
   Computer Science, Interdisciplinary Applications; Mathematical &
   Computational Biology; Statistics & Probability
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Computer Science; Mathematical & Computational Biology; Mathematics
GA 150YU
UT WOS:000319428600022
PM 23645815
OA Bronze, Green Published
DA 2020-10-22
ER

PT J
AU Ferraro, GA
   Monteiro-Cunha, JP
   Fernandes, FMC
   Mota-Miranda, ACA
   Brites, C
   Alcantara, LCJ
   Galvao-Castro, B
   Morgado, MG
AF Ferraro, Geraldo A.
   Monteiro-Cunha, Joana P.
   Fernandes, Flora M. C.
   Mota-Miranda, Aline C. A.
   Brites, Carlos
   Alcantara, Luiz C. J.
   Galvao-Castro, Bernardo
   Morgado, Mariza G.
TI Molecular Characterization of Long Terminal Repeat Sequences from
   Brazilian Human Immunodeficiency Virus Type 1 Isolates
SO AIDS RESEARCH AND HUMAN RETROVIRUSES
LA English
DT Article
ID SUBTYPE-C; HIV-1
AB HIV-1 provirus activation is under control of the long terminal repeat (LTR)-5' viral promoter region, which presents remarkable genetic variation among HIV-1 subtypes. It is possible that molecular features of the LTR contribute to the unusual profile of the subtype C epidemic in the Brazilian Southern region. To characterize the LTR of Brazilian HIV isolates, we analyzed sequences from 21 infected individuals from Porto Alegre and Salvador cities. Sequences were compared with subtype B and C reference strains from different countries. Phylogenetic analysis showed that 17 (81%) samples were subtype B and four (19%) were subtype C. Common patterns of transcription factor binding sites (TFBS) in subtypes B and C sequences were confirmed and other potential TFBS specific for subtype C were found. Brazilian subtype C sequences contained an additional NF-kappa B biding site, as previously described for the majority of subtype C isolates. The high level of LTR polymorphisms identified in this study might be important for viral fitness.
C1 [Ferraro, Geraldo A.; Monteiro-Cunha, Joana P.; Fernandes, Flora M. C.; Mota-Miranda, Aline C. A.; Alcantara, Luiz C. J.; Galvao-Castro, Bernardo] Fundacao Oswaldo Cruz FIOCRUZ, Ctr Pesquisa Goncalo Moniz CPqGM, Lab Avancado Saude Publ, Salvador, BA, Brazil.
   [Ferraro, Geraldo A.; Monteiro-Cunha, Joana P.; Fernandes, Flora M. C.; Mota-Miranda, Aline C. A.; Alcantara, Luiz C. J.; Galvao-Castro, Bernardo] Fundacao Bahiana Desenvolvimento Ciencias, Escola Bahiana Med & Saude Publ, Salvador, BA, Brazil.
   [Monteiro-Cunha, Joana P.; Fernandes, Flora M. C.; Mota-Miranda, Aline C. A.; Brites, Carlos] Univ Fed Bahia, BR-40110100 Salvador, BA, Brazil.
   [Morgado, Mariza G.] Inst Oswaldo Cruz FIOCRUZ, Lab AIDS & Imunol Mol, Rio De Janeiro, RJ, Brazil.
RP Monteiro-Cunha, JP (corresponding author), Univ Fed Bahia, Inst Ciencias Saude, Dept Biofuncao, Av Reitor Miguel Calmon S-N Vale Canela, BR-40110100 Salvador, BA, Brazil.
EM joanapmonteiro@hotmail.com
OI Alcantara, Luiz/0000-0002-6769-9931
FU Fundacao de Amparo a Pesquisa do Estado da Bahia (FAPESB); Brazilian
   Ministry of Health STD/AIDS Program; CNPqNational Council for Scientific
   and Technological Development (CNPq); FIOCRUZ
FX The authors are grateful to Luciano Zulbaran Goldane for the selection
   of samples from Porto Alegre and David Watkins, visiting professor
   (CAPES-FIOCRUZ), for revising this manuscript. This work was supported
   by grants from the Fundacao de Amparo a Pesquisa do Estado da Bahia
   (FAPESB), the Brazilian Ministry of Health STD/AIDS Program, CNPq, and
   FIOCRUZ.
CR Berger EA, 1999, ANNU REV IMMUNOL, V17, P657, DOI 10.1146/annurev.immunol.17.1.657
   Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473
   de Arellano ER, 2007, VIRUS GENES, V34, P111, DOI 10.1007/s11262-006-0054-z
   De Sa DJ, 2006, AIDS RES HUM RETROV, V22, P1
   ElKharroubi A, 1996, MOL CELL BIOL, V16, P2958
   Jeanmougin F, 1998, TRENDS BIOCHEM SCI, V23, P403, DOI 10.1016/S0968-0004(98)01285-7
   Nicholas K. B., 1997, EMBNET NEWS, V4, P1
   PRESTON BD, 1988, SCIENCE, V242, P1168, DOI 10.1126/science.2460924
   Ranjbar S, 2006, PLOS PATHOG, V2, P1176, DOI 10.1371/journal.ppat.0020130
   Sanabani S, 2006, AIDS RES HUM RETROV, V22, P171, DOI 10.1089/aid.2006.22.171
   Silveira J, 2012, J CLIN VIROL, V54, P36, DOI 10.1016/j.jcv.2012.01.017
   Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092
   van Opijnen T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000271
   VARAS F, 1991, BIOTECHNIQUES, V11, P384
   Varas F, 1991, BIOTECHNIQUES, V11, P388
   Yedavalli VSRK, 2003, J BIOL CHEM, V278, P6404, DOI 10.1074/jbc.M209162200
NR 16
TC 1
Z9 1
U1 0
U2 4
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 0889-2229
EI 1931-8405
J9 AIDS RES HUM RETROV
JI Aids Res. Hum. Retrovir.
PD MAY
PY 2013
VL 29
IS 5
BP 837
EP 841
DI 10.1089/aid.2012.0326
PG 5
WC Immunology; Infectious Diseases; Virology
SC Immunology; Infectious Diseases; Virology
GA 132NA
UT WOS:000318074200014
PM 23153102
OA Green Published
DA 2020-10-22
ER

PT J
AU Mota-Miranda, ACA
   Barreto, FK
   Amarante, MFC
   Batista, E
   Monteiro-Cunha, JP
   Farre, L
   Galvao-Castro, B
   Alcantara, LCJ
AF Mota-Miranda, Aline C. A.
   Barreto, Fernanda K.
   Amarante, Maria F. C.
   Batista, Everton
   Monteiro-Cunha, Joana P.
   Farre, Lourdes
   Galvao-Castro, Bernardo
   Alcantara, Luiz C. J.
TI Molecular characterization of HTLV-1 gp46 glycoprotein from health
   carriers and HAM/TSP infected individuals
SO VIROLOGY JOURNAL
LA English
DT Article
DE HTLV-1; HAM/TSP; Gp46; Mutation
ID I-ASSOCIATED MYELOPATHY; TROPICAL SPASTIC PARAPARESIS; VIRUS TYPE-1
   HTLV-1; PROVIRAL LOAD; CELL; SELECTION; PROTEINS; SEQUENCES; RESPONSES;
   EPITOPES
AB Background: Human T-cell Leukemia Virus type 1 (HTLV-1) is the etiological agent of tropical spastic paraparesis/ HTLV-associated myelopathy (HAM/TSP) that can be identified in around 0.25%-3.8% of the infected population. Disease progression can be monitored by the proviral load and may depend on genetic factors, however, it is not well understood why some HTLV-1 infected people develop the disease while others do not. The present study attempts to assess the molecular diversity of gp46 glycoprotein in HAM/TSP patients and Health Carrier (HC) individuals.
   Methods: Blood samples were collected from 10 individuals, and DNA was extracted from PBMCs to measure the HTLV-1 proviral load. The gp46 coding sequences were amplified PCR, cloned and sequenced. The molecular characterization was performed using bioinformatics tools.
   Results: The median HTLV-1 proviral load of HC (n = 5) and HAM/TSP (n = 5) patients was similar (average 316,227 copies/106 PBMCs). The gp46 molecular characterization of 146 clones (70 HC and 76 HAM/TSP) revealed an overall diversity, within HC and HAM/TSP clones, of 0.4% and 0.6%, respectively. Five frequent mutations were detected among groups (HAM/TSP and HC clone sequences). A single amino acid (aa) substitution (S35L) was exclusive for the HC group, and three gp46 substitutions (F14S, N42H, G72S) were exclusive for the HAM/TSP group. The remaining frequent mutation (V247I) was present in both groups (p = 0.0014). The in silico protein analysis revealed that the mutated alleles F14S and N42H represent more hydrophilic and flexible protein domains that are likely to be less antigenic. The Receptor Binding Domain is quite variable in the HAM/TSP group. Two other domains (aa 53-75 and 175-209) that contain multiple linear T-cell epitopes showed genetic diversity in both HAM/TSP and HC groups. Further analysis revealed 27 and 13 T-cell epitopes for class I HLA alleles and class II HLA alleles, when analyzing the entire gp46.
   Conclusions: The most common gp46 mutations were not associated clinical status because they were found in only one individual, except for the V247I mutation, that was found at viral clones from HAM/TSP ad HC individuals. Because of this, we cannot associate any of the gp46 found mutations with the clinical profile.
C1 [Mota-Miranda, Aline C. A.; Barreto, Fernanda K.; Galvao-Castro, Bernardo; Alcantara, Luiz C. J.] Fiocruz MS, CPqGM, Fundacao Oswaldo Cruz, Ctr Pesquisa Goncalo Moniz, BR-40295001 Salvador, BA, Brazil.
   [Mota-Miranda, Aline C. A.; Monteiro-Cunha, Joana P.; Galvao-Castro, Bernardo] Escola Bahiana Med & Saude Publ, Salvador, BA, Brazil.
   [Mota-Miranda, Aline C. A.; Monteiro-Cunha, Joana P.] Univ Fed Bahia, Inst Ciencias Saude, Salvador, BA, Brazil.
   [Batista, Everton; Farre, Lourdes] Fundacao Oswaldo Cruz, Ctr Pesquisa Goncalo Moniz, Lab Patol Expt, Salvador, BA, Brazil.
   [Amarante, Maria F. C.] NCI, NIH, Bethesda, MD 20892 USA.
RP Alcantara, LCJ (corresponding author), Fiocruz MS, CPqGM, Fundacao Oswaldo Cruz, Ctr Pesquisa Goncalo Moniz, Rua Waldemar Falcao 121, BR-40295001 Salvador, BA, Brazil.
EM lalcan@bahia.fiocruz.br
OI Alcantara, Luiz/0000-0002-6769-9931; Farre, Lourdes/0000-0002-3168-1940
FU FAPESB; CNPqNational Council for Scientific and Technological
   Development (CNPq)
FX We would like to thank the FAPESB and CNPq financial support.
CR ARGOS P, 1982, EUR J BIOCHEM, V128, P565
   Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770
   Bangham CRM, 2003, J GEN VIROL, V84, P3177, DOI 10.1099/vir.0.19334-0
   de Oliveira T, 2004, GENETICS, V167, P1047, DOI 10.1534/genetics.103.018135
   Dehee A, 2002, J VIROL METHODS, V102, P37, DOI 10.1016/S0166-0934(01)00445-1
   GESSAIN A, 1985, LANCET, V2, P407
   Ghez D, 2006, J VIROL, V80, P6844, DOI 10.1128/JVI.02719-05
   Ghez D, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-99
   Hall T.A., 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008
   HOPP TP, 1983, MOL IMMUNOL, V20, P483, DOI 10.1016/0161-5890(83)90029-9
   Ilinskaya A, 2010, J VIROL, V84, P6995, DOI 10.1128/JVI.01853-09
   Iniguez AM, 2005, AIDS RES HUM RETROV, V21, P580, DOI 10.1089/aid.2005.21.580
   ISHIHARA S, 1994, J ACQ IMMUN DEF SYND, V7, P199
   Jeanmougin F, 1998, TRENDS BIOCHEM SCI, V23, P403, DOI 10.1016/S0968-0004(98)01285-7
   Jeffery KJM, 1999, P NATL ACAD SCI USA, V96, P3848, DOI 10.1073/pnas.96.7.3848
   Jeffery KJM, 2000, J IMMUNOL, V165, P7278, DOI 10.4049/jimmunol.165.12.7278
   Jones KS, 2005, J VIROL, V79, P12692, DOI 10.1128/JVI.79.20.12692-12702.2005
   KAPLAN JE, 1990, J ACQ IMMUN DEF SYND, V3, P1096
   KARPLUS PA, 1985, NATURWISSENSCHAFTEN, V72, P212, DOI 10.1007/BF01195768
   Kazanji M, 2006, J GEN VIROL, V87, P1331, DOI 10.1099/vir.0.81582-0
   Kozako T, 2011, J MED VIROL, V83, P501, DOI 10.1002/jmv.21985
   KUMAR S, 1994, COMPUT APPL BIOSCI, V10, P189
   Kuo CWS, 2011, J IMMUNOL, V187, P361, DOI 10.4049/jimmunol.1100070
   KURTZKE JF, 1955, NEUROLOGY, V5, P580, DOI 10.1212/WNL.5.8.580
   KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0
   LAL RB, 1994, J INFECT DIS, V169, P496, DOI 10.1093/infdis/169.3.496
   de Queiroz ATL, 2007, MEM I OSWALDO CRUZ, V102, P133, DOI 10.1590/S0074-02762007005000005
   Maloney EM, 1998, J ACQ IMMUN DEF SYND, V17, P167, DOI 10.1097/00042560-199802010-00011
   Manel N, 2003, CELL, V115, P449, DOI 10.1016/S0092-8674(03)00881-X
   Mota-Miranda AC, 2007, MEM I OSWALDO CRUZ, V102, P741, DOI 10.1590/S0074-02762007000600014
   Nagai M, 1998, J NEUROVIROL, V4, P586, DOI 10.3109/13550289809114225
   Nicholas KB, 1997, EMBNEW NEWS, V4, P14
   OSAME M, 1986, LANCET, V1, P1031
   PARKER JMR, 1986, BIOCHEMISTRY-US, V25, P5425, DOI 10.1021/bi00367a013
   POIESZ BJ, 1980, P NATL ACAD SCI-BIOL, V77, P7415, DOI 10.1073/pnas.77.12.7415
   Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079
   Proietti FA, 2005, ONCOGENE, V24, P6058, DOI 10.1038/sj.onc.1208968
   Rammensee HG, 1999, IMMUNOGENETICS, V50, P213, DOI 10.1007/s002510050595
   Grassi MFR, 2011, J MED VIROL, V83, P1269, DOI 10.1002/jmv.22087
   Rosenberg AR, 1998, J VIROL, V72, P7609, DOI 10.1128/JVI.72.9.7609-7614.1998
   Sagara Y, 1996, J VIROL, V70, P1564, DOI 10.1128/JVI.70.3.1564-1569.1996
   Seki M, 1990, Virus Genes, V3, P235, DOI 10.1007/BF00393183
   Shembade Noula, 2010, World J Biol Chem, V1, P13, DOI 10.4331/wjbc.v1.i1.13
   Yang ZH, 2000, GENETICS, V155, P431
NR 44
TC 6
Z9 6
U1 0
U2 8
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1743-422X
J9 VIROL J
JI Virol. J.
PD MAR 6
PY 2013
VL 10
AR 75
DI 10.1186/1743-422X-10-75
PG 10
WC Virology
SC Virology
GA 108NL
UT WOS:000316300400001
PM 23510700
OA DOAJ Gold, Green Published
DA 2020-10-22
ER

PT J
AU Araujo, THA
   Souza-Brito, LI
   Libin, P
   Deforche, K
   Edwards, D
   de Albuquerque, AE
   Vandamme, AM
   Galvao-Castro, B
   Alcantara, LC
AF Almeida Araujo, Thessika Hialla
   Souza-Brito, Leandro Inacio
   Libin, Pieter
   Deforche, Koen
   Edwards, Dustin
   de Albuquerque-Junior, Antonio Eduardo
   Vandamme, Anne-Mieke
   Galvao-Castro, Bernardo
   Junior Alcantara, Luiz Carlos
TI A Public HTLV-1 Molecular Epidemiology Database for Sequence Management
   and Data Mining
SO PLOS ONE
LA English
DT Article
ID VIRUS TYPE-I; T-CELL LEUKEMIA; BLOOD-DONORS; INFECTION
AB Background: It is estimated that 15 to 20 million people are infected with the human T-cell lymphotropic virus type 1 (HTLV-1). At present, there are more than 2,000 unique HTLV-1 isolate sequences published. A central database to aggregate sequence information from a range of epidemiological aspects including HTLV-1 infections, pathogenesis, origins, and evolutionary dynamics would be useful to scientists and physicians worldwide. Described here, we have developed a database that collects and annotates sequence data and can be accessed through a user- friendly search interface. The HTLV-1 Molecular Epidemiology Database website is available at http://htlv1db.bahia.fiocruz.br/.
   Methodology/Principal Findings: All data was obtained from publications available at GenBank or through contact with the authors. The database was developed using Apache Webserver 2.1.6 and SGBD MySQL. The webpage interfaces were developed in HTML and sever-side scripting written in PHP. The HTLV-1 Molecular Epidemiology Database is hosted on the Goncalo Moniz/FIOCRUZ Research Center server. There are currently 2,457 registered sequences with 2,024 (82.37%) of those sequences representing unique isolates. Of these sequences, 803 (39.67%) contain information about clinical status (TSP/HAM, 17.19%; ATL, 7.41%; asymptomatic, 12.89%; other diseases, 2.17%; and no information, 60.32%). Further, 7.26% of sequences contain information on patient gender while 5.23% of sequences provide the age of the patient.
   Conclusions/Significance: The HTLV-1 Molecular Epidemiology Database retrieves and stores annotated HTLV-1 proviral sequences from clinical, epidemiological, and geographical studies. The collected sequences and related information are now accessible on a publically available and user- friendly website. This open-access database will support clinical research and vaccine development related to viral genotype.
C1 [Almeida Araujo, Thessika Hialla; de Albuquerque-Junior, Antonio Eduardo; Galvao-Castro, Bernardo; Junior Alcantara, Luiz Carlos] Fundacao Oswaldo Cruz, Goncalo Moniz Res Center, Salvador, BA, Brazil.
   [Souza-Brito, Leandro Inacio; Galvao-Castro, Bernardo; Junior Alcantara, Luiz Carlos] Bahia Fdn Sci Dev, Bahia Sch Med & Publ Hlth, Salvador, BA, Brazil.
   [Libin, Pieter; Vandamme, Anne-Mieke] Katholieke Univ Leuven, Rega Inst Med Res, Louvain, Belgium.
   [Edwards, Dustin] NCI, Anim Models & Retroviral Vaccines Sect, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.
   [Libin, Pieter; Deforche, Koen] MyBioData, Rotselaar, Belgium.
   [Vandamme, Anne-Mieke] Univ Nova Lisboa, Ctr Malaria & Outras Doencas Trop, Inst Higiene & Med Trop, P-1200 Lisbon, Portugal.
RP Araujo, THA (corresponding author), Fundacao Oswaldo Cruz, Goncalo Moniz Res Center, Salvador, BA, Brazil.
EM lalcan@bahia.fiocruz.br
RI Vandamme, Anne-Mieke/I-4127-2012
OI Vandamme, Anne-Mieke/0000-0002-6594-2766; Alcantara,
   Luiz/0000-0002-6769-9931
FU Brazilian Ministry of Health [TC120/2010]
FX This work was supported by funds from Brazilian Ministry of Health
   (TC120/2010). The funders had no role in study design, data collection
   and analysis, decision to publish, or preparation of the manuscript.
CR Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389
   deThe G, 1996, J ACQ IMMUN DEF SYND, V13, pS191, DOI 10.1097/00042560-199600001-00029
   GalvaoCastro B, 1997, TRANSFUSION, V37, P242, DOI 10.1046/j.1537-2995.1997.37297203532.x
   Gessain A, 1996, J ACQ IMMUN DEF SYND, V13, pS228, DOI 10.1097/00042560-199600001-00034
   GESSAIN A, 1985, LANCET, V2, P407
   Goncalves DU, 2003, AM J TROP MED HYG, V68, P562, DOI 10.4269/ajtmh.2003.68.562
   HANCHARD B, 1990, HUMAN RETROVIROLOGY : HTLV, P173
   La Grenade L, 1998, ARCH DERMATOL, V134, P439, DOI 10.1001/archderm.134.4.439
   McCallum RM, 1997, MED CLIN N AM, V81, P261, DOI 10.1016/S0025-7125(05)70514-9
   MOCHIZUKI M, 1992, J INFECT DIS, V166, P943, DOI 10.1093/infdis/166.4.943
   MUELLER N, 1991, CANCER CAUSE CONTROL, V2, P37, DOI 10.1007/BF00052359
   Mueller N, 1996, J ACQ IMMUN DEF SYND, V13, pS2, DOI 10.1097/00042560-199600001-00002
   Nishioka K, 1996, J ACQUIRED DEFICIENC, V13, P57
   OSAME M, 1986, LANCET, V1, P1031
   Poiesz J, 1980, P NATL ACAD SCI USA, V77, P7415
   SEIKI M, 1983, P NATL ACAD SCI-BIOL, V80, P3618, DOI 10.1073/pnas.80.12.3618
   YAMAGUCHI K, 1994, LANCET, V343, P213, DOI 10.1016/S0140-6736(94)90994-6
   YOSHIDA M, 1982, P NATL ACAD SCI-BIOL, V79, P2031, DOI 10.1073/pnas.79.6.2031
NR 18
TC 11
Z9 11
U1 0
U2 4
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD SEP 10
PY 2012
VL 7
IS 9
AR e42123
DI 10.1371/journal.pone.0042123
PG 4
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 005KD
UT WOS:000308748400002
PM 22970114
OA DOAJ Gold, Green Published
DA 2020-10-22
ER

PT J
AU Lins, L
   de Carvalho, VJU
   Rego, FFD
   Azevedo, R
   Kashima, S
   Gallazi, VNO
   Xavier, MT
   Galvao-Castro, B
   Alcantara, LCJ
AF Lins, Liliane
   Uchoa de Carvalho, Victor Jose
   de Almeida Rego, Filipe Ferreira
   Azevedo, Rochele
   Kashima, Simone
   Olavarria Gallazi, Viviana Nilla
   Xavier, Marcia Tosta
   Galvao-Castro, Bernardo
   Junior Alcantara, Luiz Carlos
TI Oral health profile in patients infected with HTLV-1: Clinical findings,
   proviral load, and molecular analysis from HTLV-1 in saliva
SO JOURNAL OF MEDICAL VIROLOGY
LA English
DT Article
DE oral health; saliva; HTLV-1
ID VIRUS TYPE-I; SJOGRENS-SYNDROME; ANTIBODIES; GLANDS
AB Human T-lymphotropic virus type 1 (HTLV-1) is associated with adult T-cell leukemia (ATL) and HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP) and has also been implicated in several disorders, including periodontal disease. The proviral load is an important biological marker for understanding HTLV-1 pathogenesis and elucidating whether or not the virus is related to the clinical manifestation of the disease. This study describes the oral health profile of HTLV-1 carriers and HAM/TSP patients in order to investigate the association between the proviral load in saliva and the severity of the periodontal disease and to examine virus intra-host variations from peripheral blood mononuclear cells and saliva cells. It is a cross-sectional analytical study of 90 individuals carried out from November 2006 to May 2008. Of the patients, 60 were HTLV-1 positive and 30 were negative. Individuals from the HTLV-1 positive and negative groups had similar mean age and social-economic status. Data were analyzed using two available statistical software packages, STATA 8.0 and SPSS 11.0 to conduct frequency analysis. Differences of P?<?0.05 were considered statistically significant. HTLV-1 patients had poorer oral health status when compared to seronegative individuals. A weak positive correlation between blood and saliva proviral loads was observed. The mean values of proviral load in blood and saliva in patients with HAM/TSP was greater than those in HTLV-1 carriers. The HTLV-1 molecular analysis from PBMC and saliva specimens suggests that HTLV-1 in saliva is due to lymphocyte infiltration from peripheral blood. A direct relationship between the proviral load in saliva and oral manifestations was observed. J. Med. Virol. 84:1428-1436, 2012. (c) 2012 Wiley Periodicals, Inc.
C1 [Uchoa de Carvalho, Victor Jose; de Almeida Rego, Filipe Ferreira; Olavarria Gallazi, Viviana Nilla; Galvao-Castro, Bernardo; Junior Alcantara, Luiz Carlos] Fundacao Oswaldo Cruz, Goncalo Moniz Res Ctr, BR-40296610 Salvador, BA, Brazil.
   [Lins, Liliane; Uchoa de Carvalho, Victor Jose; de Almeida Rego, Filipe Ferreira; Olavarria Gallazi, Viviana Nilla; Xavier, Marcia Tosta; Galvao-Castro, Bernardo; Junior Alcantara, Luiz Carlos] Bahiana Sch Med & Publ Hlth, Salvador, BA, Brazil.
   [Lins, Liliane] Fed Univ Bahia UFBA, Sch Med, Salvador, BA, Brazil.
   [Azevedo, Rochele; Kashima, Simone] Univ Sao Paulo, Sch Med, Natl Inst Sci & Technol Stem Cells & Cell Theraph, Sao Paulo, Brazil.
RP Alcantara, LCJ (corresponding author), Fundacao Oswaldo Cruz, Goncalo Moniz Res Ctr, Rua Waldemar Falcao 121, BR-40296610 Salvador, BA, Brazil.
EM lalcan@bahia.fiocruz.br
RI Lins-Kusterer, Liliane/Q-5191-2019; Kashima, Simone/G-4876-2012
OI Lins-Kusterer, Liliane/0000-0003-3736-0002; Kashima,
   Simone/0000-0002-1487-0141; Alcantara, Luiz/0000-0002-6769-9931
FU FAPESB [303/03]; Brazilian Ministry of Health [306/04, 307/04]
FX Grant sponsor: FAPESB; Grant number: 303/03; Grant sponsor: Brazilian
   Ministry of Health; Grant numbers: 306/04. 307/04.
CR Alcantara LCJ, 2006, AIDS, V20, P780, DOI 10.1097/01.aids.0000216383.14808.13
   Belec L, 1996, AIDS RES HUM RETROV, V12, P157, DOI 10.1089/aid.1996.12.157
   Catalan-Soares BC, 2001, REV BRAS EPIDEMIOL, V4, P81
   Cruz Boris A., 2005, Rev. Bras. Reumatol., V45, P71, DOI 10.1590/S0482-50042005000200005
   Dehee A, 2002, J VIROL METHODS, V102, P37, DOI 10.1016/S0166-0934(01)00445-1
   Dourado I, 2003, JAIDS-J ACQ IMM DEF, V34, P527, DOI 10.1097/00126334-200312150-00013
   Ferraz-Chaoui AK, 2010, RHEUMATOL INT, V30, P775, DOI 10.1007/s00296-009-1066-5
   GalvaoCastro B, 1997, TRANSFUSION, V37, P242, DOI 10.1046/j.1537-2995.1997.37297203532.x
   Garlet GP, 2010, CLIN INFECT DIS, V50, pE11, DOI 10.1086/649871
   GESSAIN A, 1985, LANCET, V2, P407
   Giozza SP., 2006, THESIS U FEDERAL BAH
   Gushi Lívia Litsue, 2005, J. Appl. Oral Sci., V13, P305, DOI 10.1590/S1678-77572005000300019
   Haddad SK., 2004, THESIS U SAO PAULO S
   Jorge AOC., 1998, MICROBIOLOGIA BUCAL, P21
   Jovino-Silveira Renata Cimoes, 2005, Oral Health Prev Dent, V3, P151
   Korn Gustavo Polacow, 2002, Rev. Bras. Otorrinolaringol., V68, P624, DOI 10.1590/S0034-72992002000500004
   Krasse B., 1998, RISCO CARIE GUIA PRA, P113
   KUMAR S, 1994, COMPUT APPL BIOSCI, V10, P189
   La Grenade L, 1998, ARCH DERMATOL, V134, P439, DOI 10.1001/archderm.134.4.439
   Mariette X, 2000, CLIN EXP RHEUMATOL, V18, P341
   Mochizuki M, 1996, J ACQ IMMUN DEF SYND, V13, pS50, DOI 10.1097/00042560-199600001-00010
   Mota Augusto, 2006, Rev. Bras. Hematol. Hemoter., V28, P120, DOI 10.1590/S1516-84842006000200011
   Nakamura H, 2000, J LAB CLIN MED, V135, P139, DOI 10.1067/mlc.2000.103429
   Nicholas KB, 1997, EMBNEW NEWS, V4, P14
   OSAME M, 1986, LANCET, V1, P1031
   OSAME M, 1990, HUMAN RETROVIROLOGY : HTLV, P191
   Peres Marco Aurélio, 2003, Rev. bras. epidemiol., V6, P293, DOI 10.1590/S1415-790X2003000400004
   POIESZ BJ, 1980, P NATL ACAD SCI-BIOL, V77, P7415, DOI 10.1073/pnas.77.12.7415
   Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817
   Proietti FA, 2005, ONCOGENE, V24, P6058, DOI 10.1038/sj.onc.1208968
   Ragghianti Mariana Schützer, 2004, J. Appl. Oral Sci., V12, P273, DOI 10.1590/S1678-77572004000400004
   SWOFFORD DL, 1998, PAUP PHYLOGENETIC AN
   Tangy F, 1999, J INFECT DIS, V179, P497, DOI 10.1086/314588
   TERADA K, 1994, LANCET, V344, P1116, DOI 10.1016/S0140-6736(94)90630-0
   Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876
   Thylstrup A, 2001, CARIOLOGIA CLIN, P421
   World Health Organization (WHO), 1999, LAB MAN EX HUM SEM S, P68
   Yakova M, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-4
   YAMAMOTO T, 1995, J CLIN MICROBIOL, V33, P1510, DOI 10.1128/JCM.33.6.1510-1515.1995
NR 39
TC 7
Z9 7
U1 0
U2 4
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0146-6615
EI 1096-9071
J9 J MED VIROL
JI J. Med. Virol.
PD SEP
PY 2012
VL 84
IS 9
BP 1428
EP 1436
DI 10.1002/jmv.23327
PG 9
WC Virology
SC Virology
GA 977IA
UT WOS:000306648800014
PM 22825822
OA Green Published
DA 2020-10-22
ER

PT J
AU van Tienen, C
   de Silva, TI
   Alcantara, LCJ
   Onyango, CO
   Jarju, S
   Goncalves, N
   Vincent, T
   Aaby, P
   Whittle, H
   van der Loeff, MS
   Cotten, M
AF van Tienen, Carla
   de Silva, Thushan I.
   Junior Alcantara, Luiz Carlos
   Onyango, Clayton O.
   Jarju, Sheikh
   Goncalves, Nato
   Vincent, Tim
   Aaby, Peter
   Whittle, Hilton
   van der Loeff, Maarten Schim
   Cotten, Matthew
TI Molecular Epidemiology of Endemic Human T-Lymphotropic Virus Type 1 in a
   Rural Community in Guinea-Bissau
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID RETROVIRUS INFECTIONS; RISK-FACTORS; WEST-AFRICA; STLV-I; HTLV-1;
   TRANSMISSION; PREVALENCE; POPULATION; HIV-2; INDIVIDUALS
AB Background: Human T-Lymphotropic Virus Type 1 (HTLV-1) infection causes lethal adult T-cell leukemia (ATL) and severely debilitating HTLV-associated myelopathy/tropical spastic paraparesis (HAM/TSP) in up to 5% of infected adults. HTLV-1 is endemic in parts of Africa and the highest prevalence in West Africa (5%) has been reported in Caio, a rural area in the North-West of Guinea-Bissau. It is not known which HTLV-1 variants are present in this community. Sequence data can provide insights in the molecular epidemiology and help to understand the origin and spread of HTLV-1.
   Objective: To gain insight into the molecular diversity of HTLV-1 in West Africa.
   Methods: HTLV-1 infected individuals were identified in community surveys between 1990-2007. The complete Long Terminal Repeat (LTR) and p24 coding region of HTLV-1 was sequenced from infected subjects. Socio-demographic data were obtained from community census and from interviews performed by fieldworkers. Phylogenetic analyses were performed to characterize the relationship between the Caio HTLV-1 and HTLV-1 from other parts of the world.
   Results: LTR and p24 sequences were obtained from 72 individuals (36 LTR, 24 p24 only and 12 both). Consistent with the low evolutionary change of HTLV-1, many of the sequences from unrelated individuals showed 100% nucleotide identity. Most (45 of 46) of the LTR sequences clustered with the Cosmopolitan HTLV-1 subtype 1a, subgroup D (1aD). LTR and p24 sequences from two subjects were divergent and formed a significant cluster with HTLV-1 subtype 1g, and with the most divergent African Simian T-cell Lymphotropic Virus, Tan90.
   Conclusions: The Cosmopolitan HTLV-1 1aD predominates in this rural West African community. However, HTLV-1 subtype 1g is also present. This subtype has not been described before in West Africa and may be more widespread than previously thought. These data are in line with the hypothesis that multiple monkey-to-man zoonotic events are contributing to HTLV-1 diversity.
C1 [van Tienen, Carla; de Silva, Thushan I.; Onyango, Clayton O.; Jarju, Sheikh; Goncalves, Nato; Vincent, Tim; Whittle, Hilton; Cotten, Matthew] MRC, Fajara, Gambia.
   [van Tienen, Carla] Erasmus MC, Rotterdam, Netherlands.
   [de Silva, Thushan I.] UCL, UCL Ctr Med Mol Virol, Div Infect & Immun, London, England.
   [Junior Alcantara, Luiz Carlos] Fundacao Oswaldo Cruz, Publ Hlth Adv Lab, Goncalo Moniz Res Ctr, Salvador, BA, Brazil.
   [Junior Alcantara, Luiz Carlos] Bahia Sch Med & Publ Hlth Fdn Sci Dev, Salvador, BA, Brazil.
   [Onyango, Clayton O.] KEMRI Wellcome Trust Programme, Kilifi, Kenya.
   [Goncalves, Nato; Aaby, Peter] Indepth Network, Projecto Saude Bandim, Bissau, Guinea Bissau.
   [van der Loeff, Maarten Schim] Hlth Serv Amsterdam GGD, Amsterdam, Netherlands.
   [van der Loeff, Maarten Schim] Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands.
   [Cotten, Matthew] Wellcome Trust Sanger Inst, Cambridge, England.
RP van Tienen, C (corresponding author), MRC, Fajara, Gambia.
EM c.vantienen@erasmusmc.nl
RI de Silva, Thushan/AAT-4820-2020; van Tienen, Carla/A-1119-2012
OI de Silva, Thushan/0000-0002-6498-9212; Alcantara,
   Luiz/0000-0002-6769-9931; Cotten, Matthew/0000-0002-3361-3351; Aaby,
   Peter/0000-0001-8331-1389
FU Medical Research Council (UK/The Gambia)Medical Research Council UK
   (MRC); Medical Research CouncilMedical Research Council UK (MRC)
   [MC_U190081997] Funding Source: Researchfish
FX This research was funded by the Medical Research Council (UK/The
   Gambia). The funders had no role in study design, data collection and
   analysis, decision to publish, or preparation of the manuscript.
CR Alcantara LC, 2003, JAIDS-J ACQ IMM DEF, V33, P536, DOI 10.1097/00126334-200308010-00016
   Alcantara LCJ, 2006, AIDS, V20, P780, DOI 10.1097/01.aids.0000216383.14808.13
   Ariyoshi K, 2003, J INFECT DIS, V188, P1648, DOI 10.1086/379780
   Brucato N, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-314
   Buckner M, 2003, ENCYCLOPEDIA OF SEX AND GENDER, P617, DOI 10.1007/0-387-29907-6_62
   Calattini S, 2011, VIROLOGY, V410, P48, DOI 10.1016/j.virol.2010.10.025
   Cooper S, 2009, J NEUROL NEUROSUR PS, V80, P66, DOI 10.1136/jnnp.2008.152819
   Diop S, 2006, J CLIN MICROBIOL, V44, P1550, DOI 10.1128/JCM.44.4.1550-1554.2006
   Etenna SLD, 2008, J CLIN MICROBIOL, V46, P3607, DOI 10.1128/JCM.01249-08
   Fouchard N, 1998, LEUKEMIA, V12, P578, DOI 10.1038/sj.leu.2400956
   Hahn BH, 2000, SCIENCE, V287, P607, DOI 10.1126/science.287.5453.607
   Hall T.A., 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008
   Hlela C, 2009, AIDS REV, V11, P205
   Holmgren B, 1999, SCAND J INFECT DIS, V31, P459, DOI 10.1080/00365549950163978
   Iga M, 2002, J INFECT DIS, V185, P691, DOI 10.1086/339002
   Kakuda K, 2002, AM J TROP MED HYG, V66, P404, DOI 10.4269/ajtmh.2002.66.404
   Krook A, 1997, J ACQ IMMUN DEF SYND, V15, P381, DOI 10.1097/00042560-199708150-00009
   Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404
   MAHE A, 1994, ANN DERMATOL VENER, V121, P704
   Mahe A, 2004, BRIT J DERMATOL, V150, P958, DOI 10.1111/j.1365-2133.2004.05834.x
   Mauclere P, 2011, J INFECT DIS, V203, P1316, DOI 10.1093/infdis/jir031
   Melbye M, 1998, INT J CANCER, V76, P293, DOI 10.1002/(SICI)1097-0215(19980504)76:3&lt;293::AID-IJC1&gt;3.0.CO;2-Q
   Nicholas K. B., 1997, EMBNET NEWS, V4
   Padua E, 2011, AIDS RES HUM RETROV, V27, P317, DOI 10.1089/aid.2010.0195
   Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357
   Pepin J, 2006, AIDS, V20, P1303, DOI 10.1097/01.aids.0000232239.05545.33
   Pepin J, 2010, CLIN INFECT DIS, V51, P777, DOI 10.1086/656232
   POIESZ BJ, 1980, P NATL ACAD SCI-BIOL, V77, P7415, DOI 10.1073/pnas.77.12.7415
   Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817
   SAKSENA NK, 1993, VIROLOGY, V192, P312, DOI 10.1006/viro.1993.1035
   Salemi M, 1998, VIROLOGY, V246, P277, DOI 10.1006/viro.1998.9215
   Slattery JP, 1999, GENOME RES, V9, P525
   Swofford D. L., 2002, PAUP PHYLOGENETIC AN
   van der Loeff MFS, 2001, AIDS, V15, P2303, DOI 10.1097/00002030-200111230-00012
   Van Dooren S, 2005, J GEN VIROL, V86, P1953, DOI 10.1099/vir.0.80520-0
   Van Dooren S, 2004, MOL BIOL EVOL, V21, P603, DOI 10.1093/molbev/msh053
   Van Dooren S, 2001, MOL BIOL EVOL, V18, P661, DOI 10.1093/oxfordjournals.molbev.a003846
   Van Dooren S, 1998, J GEN VIROL, V79, P2695, DOI 10.1099/0022-1317-79-11-2695
   Van Dooren S, 2007, INFECT GENET EVOL, V7, P374, DOI 10.1016/j.meegid.2006.06.003
   van Tienen C, 2011, AIDS RES HUM RETROVI
   van Tienen C, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-50
   van Tienen C, 2010, JAIDS-J ACQ IMM DEF, V53, P640, DOI 10.1097/QAI.0b013e3181bf1a25
   Vandamme AM, 1998, TRENDS MICROBIOL, V6, P477, DOI 10.1016/S0966-842X(98)01406-1
   Verdonck K, 2007, LANCET INFECT DIS, V7, P266, DOI 10.1016/S1473-3099(07)70081-6
   Vicente ACP, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001038
   WATTEL E, 1995, J VIROL, V69, P2863, DOI 10.1128/JVI.69.5.2863-2868.1995
   WILKINS A, 1993, AIDS, V7, P1119, DOI 10.1097/00002030-199308000-00015
   Wolfe ND, 2005, P NATL ACAD SCI USA, V102, P7994, DOI 10.1073/pnas.0501734102
   Wolfe ND, 2004, LANCET, V363, P932, DOI 10.1016/S0140-6736(04)15787-5
   Xia X, 2001, J HERED, V92, P371, DOI 10.1093/jhered/92.4.371
   Zehender G, 2008, JAIDS-J ACQ IMM DEF, V47, P269, DOI 10.1097/QAI.0b013e31816649a4
NR 51
TC 15
Z9 15
U1 0
U2 2
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD JUN
PY 2012
VL 6
IS 6
AR e1690
DI 10.1371/journal.pntd.0001690
PG 8
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA 967YY
UT WOS:000305945300031
PM 22720106
OA DOAJ Gold, Green Published, Green Accepted
DA 2020-10-22
ER

PT J
AU Santos, LA
   Monteiro-Cunha, JP
   Araujo, AF
   Brites, C
   Galvao-Castro, B
   Alcantara, LCJ
AF Santos, Luciane Amorim
   Monteiro-Cunha, Joana Paixao
   Araujo, Adriano Fernando
   Brites, Carlos
   Galvao-Castro, Bernardo
   Junior Alcantara, Luiz Carlos
TI Detection of Distinct Human Immunodeficiency Virus Type 1 Circulating
   Recombinant Forms in Northeast Brazil
SO JOURNAL OF MEDICAL VIROLOGY
LA English
DT Article
DE HIV-1; CRF; resistance
ID DYNAMICS IN-VIVO; HIV TYPE-1; RESISTANCE MUTATIONS; DIVERSITY; SUBTYPE
AB The extraordinary genetic diversity and immune evasion of human immunodeficiency virus (HIV) pose significant challenges for vaccine development and antiretroviral therapy efficacy. The objective of this study was to characterize the molecular profile of HIV-1 epidemic in Salvador, Bahia, Brazil, determining the genetic subtypes and the presence of antiretroviral resistance mutations. HIV-1 pol DNA sequences from 57 individuals infected with HIV were obtained by PCR, followed by sequencing. The subtypes were determined by phylogenetic analyses and the intersubtype recombination was investigated by bootscanning. The pol subtypes were compared with gag and env subtypes. Antiretroviral susceptibility was evaluated through the Stanford HIV resistance Database. The subtypes frequencies were: 77.2% of subtype B, 1.8% of subtype F1, and 21.0% of BF recombinant forms. Two intergenic and three intragenic BF recombinant patterns were observed. Six (10.5%) viruses were related to CRF28/CRF29, two were related to CRF12 (3.5%), and one (1.8%) was CRF39. Fourteen (24.6%) strains carried one or more mutations associated with at least intermediate resistance: 24.6% had resistance to nucleoside reverse transcriptase inhibitors, 21.0% to non-nucleoside reverse transcriptase inhibitors, and 7% to protease inhibitors. The substitutions I54V (7.0%), M184V (14.0%), and K103N (10.5%) were the most frequent within each class of drugs. The results show a high diversity of BF genotypes and a lower prevalence of major reverse transcriptase and protease drug resistance mutations in Salvador, compared with other regions of Brazil. These findings may contribute to improve treatment strategies of patients infected with HIV-1 from this Brazilian region. J. Med. Virol. 83: 2066-2072, 2011. (C) 2011 Wiley Periodicals, Inc.
C1 [Santos, Luciane Amorim; Monteiro-Cunha, Joana Paixao; Araujo, Adriano Fernando; Galvao-Castro, Bernardo; Junior Alcantara, Luiz Carlos] Fundacao Oswaldo Cruz, Ctr Pesquisa Goncalo Moniz, Lab Avancado Saude Publ, BR-40296610 Salvador, BA, Brazil.
   [Brites, Carlos] Univ Fed Bahia, Salvador, BA, Brazil.
   [Galvao-Castro, Bernardo; Junior Alcantara, Luiz Carlos] Bahia Fdn Sci Dev, Bahia Sch Med & Publ Hlth, HTLV Ctr, Salvador, BA, Brazil.
   [Junior Alcantara, Luiz Carlos] NCI, NIH, Bethesda, MD 20892 USA.
RP Monteiro-Cunha, JP (corresponding author), Fundacao Oswaldo Cruz, Ctr Pesquisa Goncalo Moniz, Lab Avancado Saude Publ, Rua Waldemar Falca,121 Candeal, BR-40296610 Salvador, BA, Brazil.
EM jmonteiro@bahia.fiocruz.br
OI Alcantara, Luiz/0000-0002-6769-9931
FU FAPESB [303/03]; Brazilian Ministry of Health [306/04, 307/04];
   CNPqNational Council for Scientific and Technological Development (CNPq)
FX Grant sponsor: FAPESB; Grant number: 303/03; Grant sponsor: Brazilian
   Ministry of Health; Grant numbers: 306/04; 307/04; Grant sponsor: CNPq.
CR [Anonymous], 2010, B EPIDEMIOLOGICO AID
   Araujo AF, 2010, AIDS RES HUM RETROV, V26, P1249, DOI 10.1089/aid.2010.0068
   Brennan CA, 2007, AIDS RES HUM RETROV, V23, P1434, DOI 10.1089/aid.2007.0121
   COFFIN JM, 1995, SCIENCE, V267, P483, DOI 10.1126/science.7824947
   Couto-Fernandez JC, 2005, MEM I OSWALDO CRUZ, V100, P73, DOI 10.1590/S0074-02762005000100014
   de Oliveira T, 2005, BIOINFORMATICS, V21, P3797, DOI 10.1093/bioinformatics/bti607
   de Sa DJ, 2008, AIDS RES HUM RETROV, V24, P347, DOI 10.1089/aid.2007.0203
   Alcantara LCJ, 2009, NUCLEIC ACIDS RES, V37, pW634, DOI 10.1093/nar/gkp455
   McCutchan FE, 2000, AIDS, V14, pS31
   Toledo PV, 2010, BRAZ J INFECT DIS, V14, P360, DOI 10.1590/S1413-86702010000400009
   Monteiro JP, 2009, J MED VIROL, V81, P391, DOI 10.1002/jmv.21414
   Monteiro-Cunha JP, 2011, AIDS RES HUM RETROV, V27, P623, DOI [10.1089/aid.2010.0126, 10.1089/AID.2010.0126]
   Morgado MG, 2002, MEM I OSWALDO CRUZ, V97, P143, DOI 10.1590/S0074-02762002000200001
   NICHOLAS KB, 1997, EMB NEWS, V14, P30
   Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301
   Perelson AS, 1996, SCIENCE, V271, P1582, DOI 10.1126/science.271.5255.1582
   Rios M, 2005, AIDS RES HUM RETROV, V21, P835, DOI 10.1089/aid.2005.21.835
   SALMINEN MO, 1995, AIDS RES HUM RETROV, V11, P1423, DOI 10.1089/aid.1995.11.1423
   Sepkowitz KA, 2001, NEW ENGL J MED, V344, P1764, DOI 10.1056/NEJM200106073442306
   Soares MA, 2003, AIDS, V17, P11, DOI 10.1097/00002030-200301030-00004
   SWOFFORD DL, 1997, PAUP PHYLOGENETIC AN
   Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876
   *UNAIDS, AIDS EP UPD 2007
   LOS ALAMOS HIV DATAB
NR 24
TC 13
Z9 13
U1 0
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0146-6615
EI 1096-9071
J9 J MED VIROL
JI J. Med. Virol.
PD DEC
PY 2011
VL 83
IS 12
BP 2066
EP 2072
DI 10.1002/jmv.22170
PG 7
WC Virology
SC Virology
GA 838AM
UT WOS:000296257900002
PM 22012712
OA Green Published
DA 2020-10-22
ER

PT J
AU Monteiro-Cunha, JP
   Araujo, AF
   Santos, E
   Galvao-Castro, B
   Alcantara, LC
AF Monteiro-Cunha, Joana Paixao
   Araujo, Adriano Fernando
   Santos, Edson
   Galvao-Castro, Bernardo
   Junior Alcantara, Luiz Carlos
TI Lack of High-Level Resistance Mutations in HIV Type 1 BF Recombinant
   Strains Circulating in Northeast Brazil
SO AIDS RESEARCH AND HUMAN RETROVIRUSES
LA English
DT Article
ID HUMAN-IMMUNODEFICIENCY-VIRUS; ANTIRETROVIRAL DRUG-RESISTANCE;
   HETERODUPLEX MOBILITY ASSAY; SOUTHERN BRAZIL; BLOOD-DONORS; BAHIA STATE;
   IDENTIFICATION; DIVERSITY; SUBTYPES; EPIDEMIC
AB The genetic variability and the prevalence of drug resistance-associated mutations (DRAM) of HIV-1 isolates from 50 women and 8 children from Feira de Santana, Bahia, Brazil were investigated. DNA samples were obtained and pol sequences were generated by PCR and direct sequencing. Phylogenetic analysis showed that 39 (67.2%) samples were subtype B, four (6.9%) F, one (1.7%) C, and 14 (24.1%) BF recombinants. Four different BF recombination patterns were detected. Twelve (20.7%) samples shared the same breakpoint within the reverse transcriptase (RT) sequence. Fifty-five (94.8%) isolates showed several resistance-associated mutations in the RT and the protease (PR) genes. Ten (17.2%) isolates presented mutations associated with a high level of resistance: nine (15.5%) to nucleoside RT inhibitors (NRTI), four (6.9%) to nonnucleoside RT inhibitors (NNRTI), and three (5.2%) to PR inhibitors (PIs). Subtype B-infected patients had, on average, 0.5 high-level DRAM per sequence while no mutations were observed in BF recombinants, although the two groups were under ARV for a similar period of time. Our data indicate the predominance of the subtype B, followed by BF recombinants in this population, and the dissemination of a recombinant strain in Bahia, which could be related to adaptive advantages of these variants over the predominant subtype B.
C1 [Monteiro-Cunha, Joana Paixao; Araujo, Adriano Fernando; Galvao-Castro, Bernardo; Junior Alcantara, Luiz Carlos] Fiocruz MS, CPqGM, LASP, BR-40296710 Salvador, BA, Brazil.
   [Santos, Edson; Galvao-Castro, Bernardo; Junior Alcantara, Luiz Carlos] FBDC, EBMSP, Salvador, BA, Brazil.
   [Junior Alcantara, Luiz Carlos] NCI, Vaccine Branch, NIH, Bethesda, MD 20892 USA.
RP Monteiro-Cunha, JP (corresponding author), Fiocruz MS, CPqGM, LASP, Rua Waldemar Falcao 121, BR-40296710 Salvador, BA, Brazil.
EM jmonteiro@bahia.fiocruz.br
OI Alcantara, Luiz/0000-0002-6769-9931
FU Brazilian Ministry of Health; CNPqNational Council for Scientific and
   Technological Development (CNPq); FBDC; FIOCRUZ; Fundacao de Amparo a
   Pesquisa do Estado da Bahia (FAPESB)
FX This work was supported by grants from the Brazilian Ministry of Health
   STD/AIDS Program, CNPq, FBDC, and FIOCRUZ. J.P.M. acknowledges the
   Fundacao de Amparo a Pesquisa do Estado da Bahia (FAPESB) for a
   postdoctoral fellowship and support. We thank Mrs. Elisabeth Deliege
   Vasconcelos for editing and revising this manuscript. J.P.M. and A.F.A.
   contributed equally to this work.
CR Sucupira MCA, 2007, AIDS PATIENT CARE ST, V21, P116, DOI 10.1089/apc.2006.0079
   Arroyo MA, 2010, AIDS RES HUM RETROV, V26, P5, DOI 10.1089/aid.2009.0150
   Barreto CC, 2006, JAIDS-J ACQ IMM DEF, V41, P338
   Brennan CA, 2007, AIDS RES HUM RETROV, V23, P1434, DOI 10.1089/aid.2007.0121
   Brindeiro RM, 2003, AIDS, V17, P1063, DOI 10.1097/00002030-200305020-00016
   Brito A M, 2001, Rev Soc Bras Med Trop, V34, P207, DOI 10.1590/S0037-86822001000200010
   Casado G, 2005, JAIDS-J ACQ IMM DEF, V40, P532, DOI 10.1097/01.qai.0000186363.27587.c0
   CASEIRO MM, 2010, BRAZ J INFECT DIS, V12
   Couto-Fernandez JC, 1999, J ACQ IMMUN DEF SYND, V22, P288
   De Sa DJ, 2006, AIDS RES HUM RETROV, V22, P1
   de Sa DJ, 2008, AIDS RES HUM RETROV, V24, P347, DOI 10.1089/aid.2007.0203
   de Sa DJ, 2009, AIDS RES HUM RETROV, V25, P925, DOI 10.1089/aid.2009.0073
   DENNY T, 1992, JAMA-J AM MED ASSOC, V267, P1484, DOI 10.1001/jama.267.11.1484
   Dourado I, 2007, CAD SAUDE PUBLICA, V23, P25, DOI 10.1590/S0102-311X2007000100004
   Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340
   GalvaoCastro B, 1996, MEM I OSWALDO CRUZ, V91, P335, DOI 10.1590/S0074-02761996000300014
   Grangeiro A, 2010, REV SAUDE PUBL, V44, P430, DOI [10.1590/S0034-89102010005000013, 10.1590/s0034-89102010005000013]
   Guimaraes ML, 2008, AIDS, V22, P433, DOI 10.1097/QAD.0b013e3282f47ad0
   Guiniaraes ML, 2002, AIDS RES HUM RETROV, V18, P1261, DOI 10.1089/088922202320886307
   Hemelaar J, 2006, AIDS, V20, pW13, DOI 10.1097/01.aids.0000247564.73009.bc
   Johnson Victoria A, 2009, Top HIV Med, V17, P138
   Maia Teixeira Sylvia Lopes, 2006, J Med Virol, V78, P764, DOI 10.1002/jmv.20621
   Martinez AMB, 2006, AN ACAD BRAS CIENC, V78, P113, DOI 10.1590/S0001-37652006000100011
   Medeiros Roseane, 2002, Braz J Infect Dis, V6, P298, DOI 10.1590/S1413-86702002000600005
   Minin VN, 2007, GENETICS, V175, P1773, DOI 10.1534/genetics.106.066258
   Monteiro JP, 2007, AIDS RES HUM RETROV, V23, P135, DOI 10.1089/aid.2006.0064
   Monteiro JP, 2009, J MED VIROL, V81, P391, DOI 10.1002/jmv.21414
   Nicholas K. B., 1997, EMBNET NEWS, V4, P1
   Nijhuis M, 2001, CURR OPIN INFECT DIS, V14, P23, DOI 10.1097/00001432-200102000-00005
   Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357
   Pinto Mônica Edelenyi, 2006, Cad. Saúde Pública, V22, P473, DOI 10.1590/S0102-311X2006000300002
   Piyasirisilp S, 2000, J VIROL, V74, P11286, DOI 10.1128/JVI.74.23.11286-11295.2000
   Pond SLK, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000581
   Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817
   Quarleri JF, 2004, AIDS RES HUM RETROV, V20, P1100, DOI 10.1089/aid.2004.20.1100
   Salemi M, 2005, J MOL EVOL, V60, P598, DOI 10.1007/s00239-004-0206-5
   SALMINEN MO, 1995, AIDS RES HUM RETROV, V11, P1423, DOI 10.1089/aid.1995.11.1423
   Shearer WT, 1997, NEW ENGL J MED, V336, P1337, DOI 10.1056/NEJM199705083361901
   Soares EAJM, 2005, AIDS, V19, pS81, DOI 10.1097/01.aids.0000191497.00928.e4
   Swofford DL, 1999, PAUP 4 0 PHYLOGENETI
   Taylor BS, 2008, NEW ENGL J MED, V358, P1590, DOI 10.1056/NEJMra0706737
   Thomson MA, 2005, AIDS, V19, P1155, DOI 10.1097/01.aids.0000176215.95119.1d
   UNAIDS & WHO, 2009, UNAIDS REP GLOB AIDS
   WASI C, 1995, AIDS, V9, P843, DOI 10.1097/00002030-199508000-00003
   2009, AIDS EPIDEMIOLOGICAL
NR 45
TC 10
Z9 10
U1 0
U2 4
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 0889-2229
EI 1931-8405
J9 AIDS RES HUM RETROV
JI Aids Res. Hum. Retrovir.
PD JUN
PY 2011
VL 27
IS 6
BP 623
EP 631
DI 10.1089/aid.2010.0126
PG 9
WC Immunology; Infectious Diseases; Virology
SC Immunology; Infectious Diseases; Virology
GA 769LJ
UT WOS:000291014700006
PM 21087197
DA 2020-10-22
ER

PT J
AU Rego, FFD
   Mota-Miranda, A
   Santos, ED
   Galvao-Castro, B
   Alcantara, LC
AF de Almeida Rego, Filipe Ferreira
   Mota-Miranda, Aline
   Santos, Edson de Souza
   Galvao-Castro, Bernardo
   Alcantara, Luiz Carlos
TI Seroprevalence and Molecular Epidemiology of HTLV-1 Isolates from HIV-1
   Co-Infected Women in Feira de Santana, Bahia, Brazil
SO AIDS RESEARCH AND HUMAN RETROVIRUSES
LA English
DT Article
ID VIRUS TYPE-I; CELL LYMPHOTROPIC VIRUS; POST-COLUMBIAN INTRODUCTION;
   INTRAVENOUS-DRUG-USERS; LONG TERMINAL REPEAT; LEUKEMIA-VIRUS;
   PHYLOGENETIC SUBTYPES; AFRICAN ORIGIN; TYPE-1; STRAINS
AB HTLV-1/HIV-1 co-infection is associated with severe clinical manifestations, marked immunodeficiency, and opportunistic pathogenic infections, as well as risk behavior. Salvador, the capital of the State of Bahia, Brazil, has the highest HTLV-1 prevalence (1.74%) found in Brazil. Few studies exist which describe this co-infection found in Salvador and its surrounding areas, much less investigate how these viruses circulate or assess the relationship between them. To describe the epidemiological and molecular features of HTLV in HIV co-infected women. To investigate the prevalence of HTLV/HIV co-infection in surrounding areas, as well as the molecular epidemiology of HTLV, a cross sectional study was carried out involving 107 women infected with HIV-1 from the STD/HIV/AIDS Reference Center located in the neighboring City of Feira de Santana. Patient samples were submitted to ELISA, and HTLV infection was confirmed using Western Blot and Polymerase Chain Reaction (PCR). Phylogenetic analysis using Neighbor-Joining (NJ) and Maximum Likelihood (ML) was performed on HTLV LTR sequences in order to gain further insights about molecular epidemiology and the origins of this virus in Bahia. Four out of five reactive samples were confirmed to be infected with HTLV-1, and one with HTLV-2. The seroprevalence of HTLV among HIV-1 co-infected women was 4.7%. Phylogenetic analysis of the LTR region from four HTLV-1 sequences showed that all isolates were clustered into the main Latin American group within the Transcontinental subgroup of the Cosmopolitan subtype. The HTLV-2 sequence was classified as the HTLV-2c subtype. It was also observed that four HTLV/HIV-1 co-infected women exhibited risk behavior with two having parenteral exposure, while another two were sex workers. This article describes the characteristics of co-infected patients. This co-infection is known to be severe and further studies should be conducted to confirm the suggestion that HTLV-1 is spreading from Salvador to surrounding areas.
C1 [Alcantara, Luiz Carlos] NCI, NIH, Vaccine Branch, Bethesda, MD 20892 USA.
   [de Almeida Rego, Filipe Ferreira; Mota-Miranda, Aline; Santos, Edson de Souza; Galvao-Castro, Bernardo; Alcantara, Luiz Carlos] Bahia Fdn Sci Dev, Bahia Sch Med & Publ Hlth, HTLV Ctr, Salvador, BA, Brazil.
   [de Almeida Rego, Filipe Ferreira; Mota-Miranda, Aline; Galvao-Castro, Bernardo; Alcantara, Luiz Carlos] Fundacao Oswaldo Cruz, Goncalo Moniz Res Ctr, Adv Publ Hlth Lab, Salvador, BA, Brazil.
RP Alcantara, LC (corresponding author), NCI, NIH, Vaccine Branch, Bldg 41,Room C303,41 Lib Dr,MSC 5055, Bethesda, MD 20892 USA.
EM alcantaralc@mail.nih.gov
OI Alcantara, Luiz/0000-0002-6769-9931
FU FAPESB [303/03]; Brazilian Ministry of Health [306/04, 307/04]
FX Bioinformatics analysis was performed at the LASP/CPqGM/FIOCRUZ
   Bioinformatics Unit, supported by FAPESB (Grants 303/03) and the
   Brazilian Ministry of Health (306/04 and 307/04). The authors are
   grateful to Noilson Lazaro de Souza Goncalves and Elisabeth Deliege for
   their technical assistance.
CR Alcantara LCJ, 2006, AIDS, V20, P780, DOI 10.1097/01.aids.0000216383.14808.13
   Alcantara LCJ, 2003, AIDS RES HUM RETROV, V19, P519, DOI 10.1089/088922203766774577
   Mota ACA, 2007, AIDS RES HUM RETROV, V23, P503, DOI 10.1089/aid.2006.0203
   Beilke MA, 2007, CLIN INFECT DIS, V44, P1229, DOI 10.1086/513428
   BLATTNER WA, 1990, J ACQ IMMUN DEF SYND, V3, P1102
   BRITES C, 1997, J INFECT DIS, V1, P43
   CATALANSOARES B, 2004, VOX SANG, V87, P105
   Chen JL, 1995, AIDS RES HUM RETROV, V11, P1529, DOI 10.1089/aid.1995.11.1529
   Dan S, 1999, J VIROL, V73, P3258, DOI 10.1128/JVI.73.4.3258-3263.1999
   Rego FFD, 2008, AIDS RES HUM RETROV, V24, P673, DOI 10.1089/aid.2007.0290
   Dourado I, 2003, JAIDS-J ACQ IMM DEF, V34, P527, DOI 10.1097/00126334-200312150-00013
   Eiraku N, 1996, J VIROL, V70, P1481, DOI 10.1128/JVI.70.3.1481-1492.1996
   GalvaoCastro B, 1997, TRANSFUSION, V37, P242, DOI 10.1046/j.1537-2995.1997.37297203532.x
   GASMI M, 1994, AIDS RES HUM RETROV, V10, P1313, DOI 10.1089/aid.1994.10.1313
   GESSAIN A, 1991, P NATL ACAD SCI USA, V88, P7694, DOI 10.1073/pnas.88.17.7694
   KAJIYAMA W, 1986, AM J EPIDEMIOL, V123, P41, DOI 10.1093/oxfordjournals.aje.a114222
   Kashima S, 2006, AIDS RES HUM RETROV, V22, P953, DOI 10.1089/aid.2006.22.953
   KHABBAZ RF, 1992, NEW ENGL J MED, V326, P375, DOI 10.1056/NEJM199202063260604
   Laurentino RV, 2005, MEM I OSWALDO CRUZ, V100, P371, DOI 10.1590/S0074-02762005000400006
   Lemasson I, 2004, MOL CELL BIOL, V24, P6117, DOI 10.1128/MCB.24.14.6117-6126.2004
   Machuca A, 2001, VIRUS RES, V78, P93, DOI 10.1016/S0168-1702(01)00287-8
   Magalhaes T, 2008, J MED VIROL, V80, P2040, DOI 10.1002/jmv.21278
   MIURA T, 1994, P NATL ACAD SCI USA, V91, P1124, DOI 10.1073/pnas.91.3.1124
   Nicholas KB, 1997, EMBNEW NEWS, V4, P14
   Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357
   Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817
   Proietti FA, 2005, ONCOGENE, V24, P6058, DOI 10.1038/sj.onc.1208968
   Salemi M, 1998, VIROLOGY, V246, P277, DOI 10.1006/viro.1998.9215
   SWOFFORD DL, 1996, MOL SYSTEMATICS, V2, P407
   Tanimura A, 1998, J VIROL, V72, P3958, DOI 10.1128/JVI.72.5.3958-3964.1998
   TEDDER RS, 1984, LANCET, V2, P125
   Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876
   VALLEJO A, 1995, J VIROL METHODS, V51, P9, DOI 10.1016/0166-0934(94)00093-V
   Van Dooren S, 1998, J GEN VIROL, V79, P2695, DOI 10.1099/0022-1317-79-11-2695
   Vandamme AM, 1998, J VIROL, V72, P4327, DOI 10.1128/JVI.72.5.4327-4340.1998
   VANDAMME AM, 1994, VIROLOGY, V202, P212, DOI 10.1006/viro.1994.1337
   VERDIER M, 1994, AIDS AFRICA, V9, P173
   VIDAL AU, 1994, J GEN VIROL, V75, P3655, DOI 10.1099/0022-1317-75-12-3655
   VIGNOLI C, 1993, EUR J EPIDEMIOL, V9, P351, DOI 10.1007/BF00146277
   Wolfe ND, 2005, P NATL ACAD SCI USA, V102, P7994, DOI 10.1073/pnas.0501734102
   ZELLA D, 1990, LANCET, V336, P575, DOI 10.1016/0140-6736(90)92140-D
NR 41
TC 8
Z9 9
U1 0
U2 0
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 0889-2229
EI 1931-8405
J9 AIDS RES HUM RETROV
JI Aids Res. Hum. Retrovir.
PD DEC
PY 2010
VL 26
IS 12
BP 1333
EP 1339
DI 10.1089/aid.2009.0298
PG 7
WC Immunology; Infectious Diseases; Virology
SC Immunology; Infectious Diseases; Virology
GA 692YP
UT WOS:000285192100014
PM 20929351
OA Green Published
DA 2020-10-22
ER

PT J
AU Araujo, AF
   Brites, C
   Monteiro-Cunha, J
   Santos, LA
   Galvao-Castro, B
   Alcantara, LCJ
AF Araujo, Adriano Fernando
   Brites, Carlos
   Monteiro-Cunha, Joana
   Santos, Luciane Amorim
   Galvao-Castro, Bernardo
   Junior Alcantara, Luiz Carlos
TI Lower Prevalence of Human Immunodeficiency Virus Type 1 Brazilian
   Subtype B Found in Northeastern Brazil with Slower Progression to AIDS
SO AIDS RESEARCH AND HUMAN RETROVIRUSES
LA English
DT Article
ID V3 REGION; HIV-1
AB Besides being extremely useful in measuring the level of HIV-1 diversity and prevalence in populations, the molecular analysis of genomic sequences provides crucial surveillance support and aids in the development of new therapies and effective vaccines. The present study focused on gag and env DNA and amino acid sequences that were generated from samples taken from 61 infected patients in the City of Salvador, Bahia, located in northeastern Brazil. In order to determine selective pressure and predict coreceptor usage, Bioinformatics tools were employed in phylogeny reconstruction. Fifty-six (91.8%) viruses were classified as belonging to subtype B, three (4.9%) from F1, and two (3.3%) from BF1 recombinants. Based on the characterization of the V3 region, the subtype B strains were represented by eight (18.2%) Brazilian variants (B'-GWGR), 20 (46.5%) European/EUA B variants (GPGR), and 15 (34.9%) GXGX variants. The mean time elapsed since diagnosis was 13 years among subtype B' and 9 years in subtype B. The mean dN/dS ratios from the GWGR, GPGR, and GXGX groups, when compared to an HXB2 reference, were 0.72, 0.77, and 0.67, respectively. Seventy-six percent of the viruses studied were predicted to use the CCR5 coreceptor for cell entry (R5 viruses), while 24% were predicted to use the CXCR4 or were classified as dual tropic viruses. The prevalence of subtypes B' and recombinant B/F1 was shown to be lower than findings from previous studies performed both in Brazil (B') and in Bahia (B/F1). The association between subtype B' and a lengthy period of time since diagnosis can be correlated with a slower disease progression in infected patients, when compared with those infected with subtype B.
C1 [Junior Alcantara, Luiz Carlos] NCI, Anim Models & Retroviral Vaccines Sect, NIH, Bethesda, MD 20892 USA.
   [Araujo, Adriano Fernando; Monteiro-Cunha, Joana; Santos, Luciane Amorim; Galvao-Castro, Bernardo; Junior Alcantara, Luiz Carlos] Fundacao Oswaldo Cruz, Adv Publ Hlth Lab, Goncalo Moniz Res Ctr, Salvador, BA, Brazil.
   [Brites, Carlos] Univ Fed Bahia, Salvador, BA, Brazil.
   [Galvao-Castro, Bernardo; Junior Alcantara, Luiz Carlos] Fdn Dev Sci, Bahia Sch Med & Publ Hlth, Salvador, BA, Brazil.
RP Alcantara, LCJ (corresponding author), NCI, Anim Models & Retroviral Vaccines Sect, NIH, Bldg 41,Room C-303, Bethesda, MD 20892 USA.
EM alcantaralc@mail.nih.gov
RI Brites, Carlos/D-1353-2013
OI Brites, Carlos/0000-0002-4673-6991; Alcantara, Luiz/0000-0002-6769-9931
CR Bastos FI, 2008, INT J EPIDEMIOL, V37, P729, DOI 10.1093/ije/dyn127
   Brennan CA, 2007, AIDS RES HUM RETROV, V23, P1434, DOI 10.1089/aid.2007.0121
   de Brito A, 2006, CLIN INFECT DIS, V43, P1476, DOI 10.1086/508875
   Diaz RS, 2008, VIROLOGY, V381, P184, DOI 10.1016/j.virol.2008.08.014
   Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113
   Korber B, 2000, COMPUTATIONAL ANAL H, P55, DOI DOI 10.1007/B112102
   Mindell DP, 1996, P NATL ACAD SCI USA, V93, P3284, DOI 10.1073/pnas.93.8.3284
   Monteiro JP, 2009, J MED VIROL, V81, P391, DOI 10.1002/jmv.21414
   MORGADO MG, 1994, AIDS RES HUM RETROV, V10, P569, DOI 10.1089/aid.1994.10.569
   Morgado MG, 2002, MEM I OSWALDO CRUZ, V97, P143, DOI 10.1590/S0074-02762002000200001
   Nicholas K. B., 1997, EMBNET NEWS, V4, P1
   Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817
   POTTS KE, 1993, AIDS, V7, P1191, DOI 10.1097/00002030-199309000-00007
   SALMINEN M, 1995, AIDS RES HUM RETROV, V11, pS119
   Sing T, 2007, ANTIVIR THER, V12, P1097
   Swofford DL, 1999, PAUP 4 0 PHYLOGENETI
NR 16
TC 13
Z9 13
U1 0
U2 1
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 0889-2229
EI 1931-8405
J9 AIDS RES HUM RETROV
JI Aids Res. Hum. Retrovir.
PD NOV
PY 2010
VL 26
IS 11
BP 1249
EP 1254
DI 10.1089/aid.2010.0068
PG 6
WC Immunology; Infectious Diseases; Virology
SC Immunology; Infectious Diseases; Virology
GA 681KL
UT WOS:000284311900014
PM 20854208
DA 2020-10-22
ER

PT J
AU Costa, GCS
   Alcantara, LCJ
   Azevedo, R
   Muricy, G
   Kashima, SH
   Covas, DT
   Galvao-Castro, B
   Gadelha, SR
AF Costa, G. C. S.
   Alcantara, L. C. J.
   Azevedo, R.
   Muricy, G.
   Kashima, S. H.
   Covas, D. T.
   Galvao-Castro, B.
   Gadelha, S. R.
TI Frequency distribution of XbaIG > T and HaeIIIT > C GLUT1 polymorphisms
   among different Brazilian ethnic groups
SO MOLECULAR BIOLOGY REPORTS
LA English
DT Article
DE GLUT1; Polymorphisms; Brazilian populations
ID DEPENDENT DIABETES-MELLITUS; NEPHROPATHY; SUSCEPTIBILITY; GENE;
   POPULATIONS; INTERLEUKIN-6
AB GLUT is the major glucose transporter in mammalian cells. Single nucleotide polymorphisms (SNP) at GLUT1 promoter and regulatory regions have been associated to the risk of developing nephropathy in different type 1 and type 2 diabetic populations. It has been demonstrated that differences in allelic and genotypic frequencies of GLUT1 gene (SLC2A1) polymorphisms occur among different populations. Therefore, ethnic differences in distribution of GLUT1 gene polymorphisms may be an important factor in determining gene-disease association. In this study, we investigated the XbaIG > T and HaeIIIT > C polymorphisms in six different Brazilian populations: 102 individuals from Salvador population (Northern Brazil), 56 European descendants from Joinville (South Brazil), 85 Indians from Tiryi tribe (North Brazil) and 127 samples from Southern Brazil: 44 from European descendants, 42 from African descendants and 41 from Japanese descendants. Genotype frequencies from both sites did not differ significantly from those expected under the Hardy-Weinberg equilibrium. We verified that the allele frequencies of both polymorphisms were heterogeneous in these six Brazilian ethnic groups.
C1 [Gadelha, S. R.] Univ Estadual Santa Cruz, BR-45650000 Ilheus, BA, Brazil.
   [Costa, G. C. S.; Alcantara, L. C. J.; Muricy, G.; Galvao-Castro, B.; Gadelha, S. R.] Fundacao Oswaldo Cruz, Ctr Pesquisas Goncalo Moniz, Lab Avancado Saude Publ, Salvador, BA, Brazil.
   [Alcantara, L. C. J.; Muricy, G.; Galvao-Castro, B.; Gadelha, S. R.] Escola Bahiana Med & Saude Publ, Salvador, BA, Brazil.
   [Azevedo, R.; Kashima, S. H.; Covas, D. T.] Univ Sao Paulo, Fac Med Ribeirao Preto, Banco Sangue Reg Ribeirao Preto, Mol Biol Lab, Sao Paulo, Brazil.
RP Gadelha, SR (corresponding author), Univ Estadual Santa Cruz, Campus Prof Soane Nazare de Andrade,Km 16 Rodovia, BR-45650000 Ilheus, BA, Brazil.
EM srgmello@uesc.br
RI Covas, Dimas T/C-5431-2013; Gadelha, Sandra/X-3373-2019; Kashima,
   Simone/G-4876-2012
OI Covas, Dimas T/0000-0002-7364-2595; Kashima, Simone/0000-0002-1487-0141;
   Alcantara, Luiz/0000-0002-6769-9931; Gadelha, Sandra/0000-0002-3079-488X
FU Fundacao de Amparo a Pesquisa do Estado da Bahia (FAPESB)
FX This work was partially supported by the Fundacao de Amparo a Pesquisa
   do Estado da Bahia (FAPESB). We thank Mauricio Barreto, Gloria Teixeira,
   Ozenilda Carvalho and Ivo Brito for providing the samples from Salvador
   general population, Joinville and Tiryio, respectively.
CR ABESANDES K, 2002, THESIS USP RIBEIRAO
   Alves-Silva J, 2000, AM J HUM GENET, V67, P444, DOI 10.1086/303004
   AZEVEDO ES, 1982, HUM BIOL, V54, P329
   Brosius FC, 2005, PEDIATR NEPHROL, V20, P447, DOI 10.1007/s00467-004-1748-x
   Callegari-Jacques Sidia M., 1999, Ciencia e Cultura (Sao Paulo), V51, P166
   Cox ED, 2001, TRANSPLANTATION, V72, P720, DOI 10.1097/00007890-200108270-00027
   Dornelles CL, 1999, GENET MOL BIOL, V22, P151, DOI 10.1590/S1415-47571999000200003
   Gadelha SR, 2005, HUM BIOL, V77, P509, DOI 10.1353/hub.2005.0061
   Grimaldi R, 2002, HUM GENET, V111, P102, DOI 10.1007/s00439-002-0747-x
   Grzeszczak W, 2001, KIDNEY INT, V59, P631, DOI 10.1046/j.1523-1755.2001.059002631.x
   Gutierrez C, 1998, DIABETES RES CLIN PR, V41, P113, DOI 10.1016/S0168-8227(98)00050-3
   Hodgkinson AD, 2005, J DIABETES COMPLICAT, V19, P65, DOI 10.1016/j.jdiacomp.2004.07.002
   Liu Z, 1998, Zhonghua Yi Xue Za Zhi, V78, P662
   Liu ZH, 1999, KIDNEY INT, V55, P1843, DOI 10.1046/j.1523-1755.1999.00449.x
   Makni K, 2008, ANN HUM BIOL, V35, P490, DOI 10.1080/03014460802247142
   Meenagh A, 2002, HUM IMMUNOL, V63, P1055, DOI 10.1016/S0198-8859(02)00440-8
   Ng DPK, 2002, DIABETES, V51, P2264, DOI 10.2337/diabetes.51.7.2264
   PANASCI LC, 1997, ANAL BIOCHEM, V83, P677
   Pontiroli AE, 1996, ACTA DIABETOL, V33, P193
   RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573
   SALZANO FM, 1967, POPULACOES BRASILEIR, P32
   Shindo N, 2002, AIDS RES HUM RETROV, V18, P71, DOI 10.1089/088922202753394736
   TAO T, 1995, DIABETOLOGIA, V38, P942, DOI 10.1007/s001250050375
   Teixeira Maria da Glória, 2002, Cad. Saúde Pública, V18, P1189, DOI 10.1590/S0102-311X2002000500011
NR 24
TC 1
Z9 1
U1 0
U2 0
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0301-4851
EI 1573-4978
J9 MOL BIOL REP
JI Mol. Biol. Rep.
PD JAN
PY 2010
VL 37
IS 1
BP 75
EP 79
DI 10.1007/s11033-009-9528-0
PG 5
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 540GI
UT WOS:000273319000012
PM 19347605
OA Green Published
DA 2020-10-22
ER

PT J
AU Alcantara, LCJ
   Cassol, S
   Libin, P
   Deforche, K
   Pybus, O
   Van Ranst, M
   Galvao-Castro, B
   Vandamme, AM
   De Oliveira, T
AF Alcantara, L. C. J.
   Cassol, S.
   Libin, P.
   Deforche, K.
   Pybus, O.
   Van Ranst, M.
   Galvao-Castro, B.
   Vandamme, A. -M
   De Oliveira, T.
TI A Standardized Framework for Accurate, High-Throughput Genotyping of
   Recombinant and Non-Recombinant Viral Sequences
SO AIDS RESEARCH AND HUMAN RETROVIRUSES
LA English
DT Meeting Abstract
CT 14th International Conference on Human Retrovirology HTLV and Related
   Retroviruses
CY JUL 01-04, 2009
CL Salvador, BRAZIL
C1 [Alcantara, L. C. J.; Galvao-Castro, B.] Fundacao Oswaldo Cruz, Ctr Pesquisas Goncalo Moniz, Lab Avancado Saude Publ, Rio De Janeiro, Brazil.
   [Cassol, S.] Univ Pretoria, Dept Immunol, MRC, Unit Inflammat & Immun, ZA-0002 Pretoria, South Africa.
   [Cassol, S.] Natl Hlth Lab Serv, Tshwane Acad Div, Pretoria, South Africa.
   [Libin, P.; Van Ranst, M.; Vandamme, A. -M] Katholieke Univ Leuven, Lab Clin & Epidemiol Virol, Louvain, Belgium.
   [Deforche, K.] MyBioData Bvba, Rotselaar, Belgium.
   [Pybus, O.] Univ Oxford, Dept Zool, Oxford OX1 2JD, England.
   [De Oliveira, T.] Univ KwaZulu Natal, Africa Ctr Hlth & Populat Studies, Durban, South Africa.
RI Pybus, Oliver G/B-2640-2012; Vandamme, Anne-Mieke/I-4127-2012; Van
   Ranst, Marc/P-7522-2017
OI Pybus, Oliver G/0000-0002-8797-2667; Vandamme,
   Anne-Mieke/0000-0002-6594-2766; Van Ranst, Marc/0000-0002-1674-4157
NR 0
TC 0
Z9 0
U1 0
U2 1
PU MARY ANN LIEBERT INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 0889-2229
J9 AIDS RES HUM RETROV
JI Aids Res. Hum. Retrovir.
PD NOV
PY 2009
VL 25
IS 11
BP 1223
EP 1224
PG 2
WC Immunology; Infectious Diseases; Virology
SC Immunology; Infectious Diseases; Virology
GA 524ZF
UT WOS:000272182200082
DA 2020-10-22
ER

PT J
AU Rego, FFA
   Azevedo, R
   Mota-Miranda, AC
   Carvalho, VJU
   Kusterer, LEFL
   Kashima, S
   Galvao-Castro, B
   Alcantara, LCJ
AF Rego, F. F. A.
   Azevedo, R.
   Mota-Miranda, A. C.
   Carvalho, V. J. U.
   Kusterer, L. E. F. L.
   Kashima, S.
   Galvao-Castro, B.
   Alcantara, L. C. J.
TI Analysis of the HTLV-1 Intra-Host Variations in Peripheral Blood and
   Saliva of Infected Individuals
SO AIDS RESEARCH AND HUMAN RETROVIRUSES
LA English
DT Meeting Abstract
CT 14th International Conference on Human Retrovirology HTLV and Related
   Retroviruses
CY JUL 01-04, 2009
CL Salvador, BRAZIL
C1 [Rego, F. F. A.; Mota-Miranda, A. C.; Carvalho, V. J. U.; Kusterer, L. E. F. L.; Galvao-Castro, B.; Alcantara, L. C. J.] Bahia Fdn Dev Sci, Bahia Sch Med & Publ Hlth, Salvador, BA, Brazil.
   [Rego, F. F. A.; Mota-Miranda, A. C.; Galvao-Castro, B.; Alcantara, L. C. J.] Fundacao Oswaldo Cruz, Goncalo Moniz Res Ctr, Adv Publ Hlth Lab, Salvador, BA, Brazil.
   [Azevedo, R.; Kashima, S.] Univ Sao Paulo, Reg Blood Ctr Ribeirao Preto, BR-05508 Sao Paulo, Brazil.
RI Kashima, Simone/G-4876-2012
OI Kashima, Simone/0000-0002-1487-0141
NR 0
TC 0
Z9 0
U1 0
U2 1
PU MARY ANN LIEBERT INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 0889-2229
J9 AIDS RES HUM RETROV
JI Aids Res. Hum. Retrovir.
PD NOV
PY 2009
VL 25
IS 11
BP 1244
EP 1244
PG 1
WC Immunology; Infectious Diseases; Virology
SC Immunology; Infectious Diseases; Virology
GA 524ZF
UT WOS:000272182200129
DA 2020-10-22
ER

PT J
AU Frias, D
   Castro, BG
   Alcantara, LC
   Salemi, M
AF Frias, D.
   Castro, B. G.
   Alcantara, L. C.
   Salemi, M.
TI A Parallel Between Genetic Distances Based on Nucleotide Substitution
   Models in Primate T-Cell Lymphotropic Viruses and Distances Based on
   Codon Usage and tRNA Availability in the Host Cells
SO AIDS RESEARCH AND HUMAN RETROVIRUSES
LA English
DT Meeting Abstract
CT 14th International Conference on Human Retrovirology HTLV and Related
   Retroviruses
CY JUL 01-04, 2009
CL Salvador, BRAZIL
NR 0
TC 0
Z9 0
U1 0
U2 0
PU MARY ANN LIEBERT INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 0889-2229
J9 AIDS RES HUM RETROV
JI Aids Res. Hum. Retrovir.
PD NOV
PY 2009
VL 25
IS 11
BP 1249
EP 1250
PG 2
WC Immunology; Infectious Diseases; Virology
SC Immunology; Infectious Diseases; Virology
GA 524ZF
UT WOS:000272182200143
DA 2020-10-22
ER

PT J
AU Frias, D
   Rego, FFD
   Galvao-Castro, B
   Alcantara, LCJ
AF Frias, D.
   de Almeida Rego, F. F.
   Galvao-Castro, B.
   Alcantara, L. C. J.
TI Choosing the Most Frequent Codons in the Host Genes Could Not Be an
   Intelligent Choice for Virus Adaptation
SO AIDS RESEARCH AND HUMAN RETROVIRUSES
LA English
DT Meeting Abstract
CT 14th International Conference on Human Retrovirology HTLV and Related
   Retroviruses
CY JUL 01-04, 2009
CL Salvador, BRAZIL
C1 [Frias, D.] Univ Estado Bahia, Ilheus, BA, Brazil.
   [de Almeida Rego, F. F.; Galvao-Castro, B.; Alcantara, L. C. J.] Fundacao Oswaldo Cruz, Adv Publ Hlth Lab, Goncalo Moniz Res Ctr, Salvador, BA, Brazil.
   [de Almeida Rego, F. F.; Galvao-Castro, B.; Alcantara, L. C. J.] Bahia Fdn Dev Sci, Bahia Sch Med & Publ Hlth, Salvador, BA, Brazil.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU MARY ANN LIEBERT INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 0889-2229
J9 AIDS RES HUM RETROV
JI Aids Res. Hum. Retrovir.
PD NOV
PY 2009
VL 25
IS 11
BP 1271
EP 1271
PG 1
WC Immunology; Infectious Diseases; Virology
SC Immunology; Infectious Diseases; Virology
GA 524ZF
UT WOS:000272182200194
DA 2020-10-22
ER

PT J
AU Rego, FFA
   Mota-Miranda, AC
   Santos, ES
   Galvao-Castro, B
   Alcantara, LCJ
AF Rego, F. F. A.
   Mota-Miranda, A. C.
   Santos, E. S.
   Galvao-Castro, B.
   Alcantara, L. C. J.
TI Seroprevalence and Molecular Epidemiology Study of the HTLV-1 Isolates
   from HIV-1 Coinfected Women in Feira de Santana, Bahia, Brazil
SO AIDS RESEARCH AND HUMAN RETROVIRUSES
LA English
DT Meeting Abstract
CT 14th International Conference on Human Retrovirology HTLV and Related
   Retroviruses
CY JUL 01-04, 2009
CL Salvador, BRAZIL
C1 [Rego, F. F. A.; Mota-Miranda, A. C.; Santos, E. S.; Galvao-Castro, B.; Alcantara, L. C. J.] Bahia Fdn Dev Sci, Bahia Sch Med & Publ Hlth, Salvador, BA, Brazil.
   [Rego, F. F. A.; Mota-Miranda, A. C.; Galvao-Castro, B.; Alcantara, L. C. J.] Fundacao Oswaldo Cruz, Goncalo Moniz Res Ctr, Adv Publ Hlth Lab, Salvador, BA, Brazil.
NR 0
TC 2
Z9 2
U1 0
U2 1
PU MARY ANN LIEBERT INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 0889-2229
J9 AIDS RES HUM RETROV
JI Aids Res. Hum. Retrovir.
PD NOV
PY 2009
VL 25
IS 11
BP 1278
EP 1279
PG 2
WC Immunology; Infectious Diseases; Virology
SC Immunology; Infectious Diseases; Virology
GA 524ZF
UT WOS:000272182200212
DA 2020-10-22
ER

PT J
AU Mota-Miranda, AC
   Rego, FFA
   Galvao-Castro, B
   Alcantara, LCJ
AF Mota-Miranda, A. C.
   Rego, F. F. A.
   Galvao-Castro, B.
   Alcantara, L. C. J.
TI Molecular Features of HTLV Diferent Types: An Evolution Aproach
SO AIDS RESEARCH AND HUMAN RETROVIRUSES
LA English
DT Meeting Abstract
CT 14th International Conference on Human Retrovirology HTLV and Related
   Retroviruses
CY JUL 01-04, 2009
CL Salvador, BRAZIL
C1 [Mota-Miranda, A. C.; Rego, F. F. A.; Galvao-Castro, B.; Alcantara, L. C. J.] Bahia Fdn Dev Sci, Bahia Sch Med & Publ Hlth, Salvador, BA, Brazil.
   [Mota-Miranda, A. C.; Rego, F. F. A.; Galvao-Castro, B.; Alcantara, L. C. J.] Fundacao Oswaldo Cruz, Adv Publ Hlth Lab, Goncalo Moniz Res Ctr, Salvador, BA, Brazil.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU MARY ANN LIEBERT INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 0889-2229
J9 AIDS RES HUM RETROV
JI Aids Res. Hum. Retrovir.
PD NOV
PY 2009
VL 25
IS 11
BP 1289
EP 1290
PG 2
WC Immunology; Infectious Diseases; Virology
SC Immunology; Infectious Diseases; Virology
GA 524ZF
UT WOS:000272182200239
DA 2020-10-22
ER

PT J
AU Bialuk, I
   Gessain, A
   Castro, BG
   Franchini, G
   Walser, JC
   Graham, J
   Alcantara, LC
   Fukumoto, R
   Jacobson, S
   Andresen, V
AF Bialuk, I.
   Gessain, A.
   Castro, B. G.
   Franchini, G.
   Walser, J. C.
   Graham, J.
   Alcantara, L. C.
   Fukumoto, R.
   Jacobson, S.
   Andresen, V.
TI The 8 kDa Form Encoded by the HTLV-I ORF-I is Associated with Low
   Provirus Levels in a Subset of HTLV-I Infected Individuals
SO AIDS RESEARCH AND HUMAN RETROVIRUSES
LA English
DT Meeting Abstract
CT 14th International Conference on Human Retrovirology HTLV and Related
   Retroviruses
CY JUL 01-04, 2009
CL Salvador, BRAZIL
C1 NCI, NIH, Bethesda, MD 20892 USA.
   Med Univ Bialystok, Bialystok, Poland.
RI Andresen, Vibeke/I-9482-2018
OI Andresen, Vibeke/0000-0002-2368-2978
NR 0
TC 0
Z9 0
U1 0
U2 1
PU MARY ANN LIEBERT INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 0889-2229
J9 AIDS RES HUM RETROV
JI Aids Res. Hum. Retrovir.
PD NOV
PY 2009
VL 25
IS 11
BP 1297
EP 1297
PG 1
WC Immunology; Infectious Diseases; Virology
SC Immunology; Infectious Diseases; Virology
GA 524ZF
UT WOS:000272182200258
DA 2020-10-22
ER

PT J
AU Alcantara, LCJ
   Cassol, S
   Libin, P
   Deforche, K
   Pybus, OG
   Van Ranst, M
   Galvao-Castro, B
   Vandamme, AM
   de Oliveira, T
AF Junior Alcantara, Luiz Carlos
   Cassol, Sharon
   Libin, Pieter
   Deforche, Koen
   Pybus, Oliver G.
   Van Ranst, Marc
   Galvao-Castro, Bernardo
   Vandamme, Anne-Mieke
   de Oliveira, Tulio
TI A standardized framework for accurate, high-throughput genotyping of
   recombinant and non-recombinant viral sequences
SO NUCLEIC ACIDS RESEARCH
LA English
DT Article
ID SUBTYPE-C; VIRUS; HIV-1; SURVEILLANCE; ALGORITHM; VARIANT; SYSTEM;
   TYPE-1
AB Human immunodeficiency virus type-1 (HIV-1), hepatitis B and C and other rapidly evolving viruses are characterized by extremely high levels of genetic diversity. To facilitate diagnosis and the development of prevention and treatment strategies that efficiently target the diversity of these viruses, and other pathogens such as human T-lymphotropic virus type-1 (HTLV-1), human herpes virus type-8 (HHV8) and human papillomavirus (HPV), we developed a rapid high-throughput-genotyping system. The method involves the alignment of a query sequence with a carefully selected set of predefined reference strains, followed by phylogenetic analysis of multiple overlapping segments of the alignment using a sliding window. Each segment of the query sequence is assigned the genotype and sub-genotype of the reference strain with the highest bootstrap (>70%) and bootscanning (>90%) scores. Results from all windows are combined and displayed graphically using color-coded genotypes. The new Virus-Genotyping Tools provide accurate classification of recombinant and nonrecombinant viruses and are currently being assessed for their diagnostic utility. They have incorporated into several HIV drug resistance algorithms including the Stanford (http://hivdb.stanford.edu) and two European databases (http://www.umcutrecht.nl/subsite/spread-programme/ and http://www.hivrdb.org.uk/) and have been successfully used to genotype a large number of sequences in these and other databases. The tools are a PHP/JAVA web application and are freely accessible on a number of servers including: http://bioafrica.mrc.ac.za/rega-genotype/html/ http://lasp.cpqgm.fiocruz.br/virus-genotype/html/ http://jose.med.kuleuven.be/genotypetool/html/.
C1 [de Oliveira, Tulio] Univ Kwazulu Natal, Africa Ctr Hlth & Populat Studies, Durban, South Africa.
   [Junior Alcantara, Luiz Carlos; Galvao-Castro, Bernardo] Fundacao Oswaldo Cruz, Ctr Pesquisas Goncalo Moniz, Lab Avancado Saude Publ, Rio De Janeiro, Brazil.
   [Cassol, Sharon] Univ Pretoria, MRC, Dept Immunol, Unit Inflammat & Immun, ZA-0002 Pretoria, South Africa.
   [Cassol, Sharon] Natl Hlth Lab Serv, Tshwane Acad Div, Pretoria, South Africa.
   [Libin, Pieter; Van Ranst, Marc; Vandamme, Anne-Mieke] Katholieke Univ Leuven, Lab Clin & Epidemiol Virol, Bg, Belgium.
   [Deforche, Koen] MyBioData bvba, Rotselaar, Belgium.
   [Pybus, Oliver G.] Univ Oxford, Dept Zool, Oxford OX1 2JD, England.
RP de Oliveira, T (corresponding author), Univ Kwazulu Natal, Africa Ctr Hlth & Populat Studies, Durban, South Africa.
EM tuliodna@gmail.com
RI Vandamme, Anne-Mieke/I-4127-2012; Van Ranst, Marc/P-7522-2017; Pybus,
   Oliver G/B-2640-2012
OI Vandamme, Anne-Mieke/0000-0002-6594-2766; Van Ranst,
   Marc/0000-0002-1674-4157; Pybus, Oliver G/0000-0002-8797-2667;
   Alcantara, Luiz/0000-0002-6769-9931
FU Katholieke Universiteit LeuvenKU Leuven [OT/04/43]; Belgian Fonds voor
   Wetenschappelijk Onderzoek [G.0266.04]; Virolab project [027446];
   Wellcome TrustWellcome Trust [082384/Z/07/Z]; European UnionEuropean
   Union (EU) [SANTE 2007 147-790]; Africa Centre for Health and Population
   Studies
FX Katholieke Universiteit Leuven (grant OT/04/43); Belgian Fonds voor
   Wetenschappelijk Onderzoek (F.W.O. nr G.0266.04); Virolab project (EU
   IST STREP Project 027446). T. O. is funded by the Wellcome Trust
   (082384/Z/07/Z) and European Union (SANTE 2007 147-790) and the Africa
   Centre for Health and Population Studies; S. C. is funded by the
   European Union (SANTE 2007 147-790) and NRF, South Africa. The Royal
   Society (to O. G. P.). Funding for open access charge: European Union
   (SANTE 2007 147-790).
CR Akuta N, 2005, J ANTIMICROB CHEMOTH, V55, P139, DOI 10.1093/jac/dkh533
   Alcantara LCJ, 2006, AIDS, V20, P780, DOI 10.1097/01.aids.0000216383.14808.13
   Belshaw R, 2009, NUCLEIC ACIDS RES, V37, pD431, DOI 10.1093/nar/gkn729
   Bracho MA, 2006, J GEN VIROL, V87, P1697, DOI 10.1099/vir.0.81666-0
   Camacho RJ, 2007, CURR OPIN HIV AIDS, V2, P123, DOI 10.1097/COH.0b013e328029824a
   de Oliveira T, 2005, BIOINFORMATICS, V21, P3797, DOI 10.1093/bioinformatics/bti607
   GESSAIN A, 1993, J VIROL, V67, P1015, DOI 10.1128/JVI.67.2.1015-1023.1993
   Gifford R, 2006, AIDS, V20, P1521, DOI 10.1097/01.aids.0000237368.64488.ae
   Gifford RJ, 2007, J VIROL, V81, P13050, DOI 10.1128/JVI.00889-07
   Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520
   HAHN BH, 1984, INT J CANCER, V34, P613, DOI 10.1002/ijc.2910340505
   Hemelaar J, 2006, AIDS, V20, pW13, DOI 10.1097/01.aids.0000247564.73009.bc
   John-Stewart GC, 2005, J INFECT DIS, V192, P492, DOI 10.1086/431514
   Mahieux R, 1998, J VIROL, V72, P10316, DOI 10.1128/JVI.72.12.10316-10322.1998
   Martin DP, 2005, BIOINFORMATICS, V21, P260, DOI 10.1093/bioinformatics/bth490
   Pond SLK, 2006, BIOINFORMATICS, V22, P3096, DOI 10.1093/bioinformatics/btl474
   Pybus OG, 2001, SCIENCE, V292, P2323, DOI 10.1126/science.1058321
   Rambaut A, 2004, NAT REV GENET, V5, P52, DOI 10.1038/nrg1246
   Robertson DL, 2000, SCIENCE, V288, P55, DOI 10.1126/science.288.5463.55d
   Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180
   Salemi M, 1998, VIROLOGY, V246, P277, DOI 10.1006/viro.1998.9215
   Salemi M, 2008, AIDS RES HUM RETROV, V24, P771, DOI 10.1089/aid.2007.0181
   Schiffman M, 2007, LANCET, V370, P890, DOI 10.1016/S0140-6736(07)61416-0
   Simmonds P, 2005, HEPATOLOGY, V42, P962, DOI 10.1002/hep.20819
   Strimmer K, 1997, P NATL ACAD SCI USA, V94, P6815, DOI 10.1073/pnas.94.13.6815
   Verdonck K, 2007, LANCET INFECT DIS, V7, P266, DOI 10.1016/S1473-3099(07)70081-6
   Walter BL, 2009, AIDS, V23, P1047, DOI 10.1097/QAD.0b013e32832a1806
   Wilgenbusch JC, 2003, CURR PROTOC BIOINFOR
NR 28
TC 120
Z9 120
U1 0
U2 6
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0305-1048
EI 1362-4962
J9 NUCLEIC ACIDS RES
JI Nucleic Acids Res.
PD JUL 1
PY 2009
VL 37
SU S
BP W634
EP W642
DI 10.1093/nar/gkp455
PG 9
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 469IG
UT WOS:000267889100109
PM 19483099
OA DOAJ Gold, Green Published
DA 2020-10-22
ER

PT J
AU Monteiro, JP
   Alcantara, LC
   de Oliveira, T
   Oliveira, AM
   Melo, MAG
   Brites, C
   Galvao-Castro, B
AF Monteiro, Joana Paixao
   Junior Alcantara, Luiz Carlos
   de Oliveira, Tulio
   Oliveira, Antonio Marcos
   Gomes Melo, Marco Antonio
   Brites, Carlos
   Galvao-Castro, Bernardo
TI Genetic Variability of Human Immunodeficiency Virus-1 in Bahia State,
   Northeast, Brazil: High Diversity of HIV Genotypes
SO JOURNAL OF MEDICAL VIROLOGY
LA English
DT Article
DE HIV-1; epidemiology; phylogeny; Brazil; Bahia
ID HETERODUPLEX MOBILITY ASSAY; RIO-DE-JANEIRO; MOLECULAR EPIDEMIOLOGY;
   SAO-PAULO; DRUG-RESISTANCE; BF RECOMBINANT; TYPE-1 HIV-1; SUBTYPE-B;
   IDENTIFICATION; TRANSMISSION
AB The HIV-1 genetic variability in Bahia state, Brazil, was investigated. DNA samples from 229 and 213 HIV-1-infected individuals were analyzed using the heteroduplex mobility assay (HMA) in gag and env fragments, respectively. One hundred seventy-five samples were characterized in both genes. Thirty-two subtype F and BF recombinant viruses were sequenced and analyzed by phylogenetic methods. The combination of HMA and sequencing results showed that seven different HIV-1 genotypes comprised this sample: 147 (84%) B/B, 4 (2.3%) F/F, 3 (1.7%) B/F, 1 (0.6%) F/B, 1 (0.6%) F/D, 1 (0.6%) BF/F, and 18 (10.3%) BF/B. A significant divergence was observed between these two techniques results (84.4%). This is explained by the low accuracy of the HMA for detecting recombinant viruses. These recombinants were unrelated to CRF12, while two sequences were related to CRF28 and CRF29. Nineteen BF mosaics shared the same gag breakpoint. In conclusion, the use of HMA may be inappropriate in regions where different subtypes are co-circulating. Subtype B is the most common genotype, however, an increased prevalence (13.1%) of different BF variants and a potentially new CRF suggest that recombination is occurring frequently in Bahia. These viruses were associated with women infected heterosexually. Finally, this study identified the presence of an F/D recombinant HIV-1 in Brazil. J. Med. Virol. 81:391-399, 2009. (C) 2009 Wiley-Liss, Inc.
C1 [Galvao-Castro, Bernardo] Fundacao Oswaldo Cruz, FIOCRUZ, CPqGM, Lab Avancado Saude Publ, BR-40296610 Salvador, BA, Brazil.
   [Junior Alcantara, Luiz Carlos; Gomes Melo, Marco Antonio; Galvao-Castro, Bernardo] EBMSP, Escola Bahiana Med & Saude Publ, Salvador, BA, Brazil.
   [de Oliveira, Tulio] S African Natl Bioinformat Inst, Cape Town, South Africa.
   [Brites, Carlos] Univ Fed Bahia, Salvador, BA, Brazil.
RP Galvao-Castro, B (corresponding author), Fundacao Oswaldo Cruz, FIOCRUZ, CPqGM, Lab Avancado Saude Publ, Falcao 121, BR-40296610 Salvador, BA, Brazil.
EM bgalvao@bahia.fiocruz.br
RI Brites, Carlos/D-1353-2013
OI Brites, Carlos/0000-0002-4673-6991; Alcantara, Luiz/0000-0002-6769-9931
FU Fundacao de Amparo a Pesquisa do Estado da Bahia (FAPESB); Brazilian
   Ministry of Health STD/AIDS Program; CNPqNational Council for Scientific
   and Technological Development (CNPq)
FX Fundacao de Amparo a Pesquisa do Estado da Bahia (FAPESB); Grant
   sponsor: Brazilian Ministry of Health STD/AIDS Program; Grant sponsor:
   CNPq.
CR Barreto CC, 2006, JAIDS-J ACQ IMM DEF, V41, P338
   Buonaguro L, 2005, J VIROL METHODS, V124, P123, DOI 10.1016/j.jviromet.2004.11.014
   BURKE DS, 1996, AIDS BIOL DIAGNOSTIC, P119
   Cabral VP, 2006, MEM I OSWALDO CRUZ, V101, P881, DOI 10.1590/S0074-02762006000800010
   Carr JK, 2001, AIDS, V15, pF41, DOI 10.1097/00002030-200110190-00002
   Casado G, 2005, JAIDS-J ACQ IMM DEF, V40, P532, DOI 10.1097/01.qai.0000186363.27587.c0
   Couto-Fernandez JC, 2006, AIDS RES HUM RETROV, V22, P207, DOI 10.1089/aid.2006.22.207
   Couto-Fernandez JC, 2005, MEM I OSWALDO CRUZ, V100, P73, DOI 10.1590/S0074-02762005000100014
   Couto-Fernandez JC, 1999, J ACQ IMMUN DEF SYND, V22, P288
   De Sa DJ, 2005, AIDS RES HUM RETROV, V21, P145, DOI 10.1089/aid.2005.21.145
   De Sa DJ, 2006, AIDS RES HUM RETROV, V22, P1
   DELWART EL, 1993, SCIENCE, V262, P1257, DOI 10.1126/science.8235655
   Dourado I, 2007, CAD SAUDE PUBLICA, V23, P25, DOI 10.1590/S0102-311X2007000100004
   Eyer-Silva WA, 2007, AIDS RES HUM RETROV, V23, P303, DOI 10.1089/aid.2006.0199
   Guiniaraes ML, 2002, AIDS RES HUM RETROV, V18, P1261, DOI 10.1089/088922202320886307
   Heyndrickx L, 2000, J VIROL, V74, P363, DOI 10.1128/JVI.74.1.363-370.2000
   KUNANUSONT C, 1995, LANCET, V345, P1078, DOI 10.1016/S0140-6736(95)90818-8
   McCutchan FE, 2000, AIDS RES HUM RETROV, V16, P801, DOI 10.1089/088922200308792
   Monteiro JP, 2007, AIDS RES HUM RETROV, V23, P135, DOI 10.1089/aid.2006.0064
   Morgado MG, 2002, MEM I OSWALDO CRUZ, V97, P143, DOI 10.1590/S0074-02762002000200001
   Nicholas K. B., 1997, EMBNET NEWS, V4, P1
   Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357
   Pedroso C, 2007, JAIDS-J ACQ IMM DEF, V45, P251, DOI 10.1097/QAI.0b013e318050d8b0
   Pereira GAS, 2004, AM J TROP MED HYG, V71, P679, DOI 10.4269/ajtmh.2004.71.679
   Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817
   Quarleri JF, 2004, AIDS RES HUM RETROV, V20, P1100, DOI 10.1089/aid.2004.20.1100
   Rios M, 2005, AIDS RES HUM RETROV, V21, P835, DOI 10.1089/aid.2005.21.835
   SALMINEN MO, 1995, AIDS RES HUM RETROV, V11, P1423, DOI 10.1089/aid.1995.11.1423
   Sanabani S, 2006, INFECT GENET EVOL, V6, P368, DOI 10.1016/j.meegid.2006.01.003
   SWOFFORD D, 1999, PAUP 4 0 1999 PHYLOG
   Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092
   Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876
   Thomson MA, 2005, AIDS, V19, P1155, DOI 10.1097/01.aids.0000176215.95119.1d
   Thomson MM, 2002, J GEN VIROL, V83, P107, DOI 10.1099/0022-1317-83-1-107
   WENIGER BG, 1994, AIDS, V8, pS13
   Weniger BG, 2001, AIDS, V15, P545
   B EPIDEMIOLOGICO AID
NR 37
TC 16
Z9 16
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0146-6615
EI 1096-9071
J9 J MED VIROL
JI J. Med. Virol.
PD MAR
PY 2009
VL 81
IS 3
BP 391
EP 399
DI 10.1002/jmv.21414
PG 9
WC Virology
SC Virology
GA 399JC
UT WOS:000262795200001
PM 19152417
OA Green Published
DA 2020-10-22
ER

PT J
AU Costa, GCS
   Azevedo, R
   Gadelha, SR
   Kashima, SH
   Muricy, G
   Olavarria, VN
   Covas, DT
   Takayanagui, OM
   Galvao-Castro, B
   Alcantara, LC
AF Souza Costa, Giselle Calasans
   Azevedo, Rochele
   Gadelha, Sandra Rocha
   Kashima, Simone Haddad
   Muricy, Gabriel
   Olavarria, Viviana Nila
   Covas, Dimas Tadeu
   Takayanagui, Osvaldo Massaiti
   Galvao-Castro, Bernardo
   Junior alcantara, Luiz Carlos
TI Polymorphisms at GLUT1 Gene Are Not Associated With the Development of
   TSP/HAM in Brazilian HTLV-1 Infected Individuals and the Discovery of a
   New Polymorphism at GLUT1 Gene
SO JOURNAL OF MEDICAL VIROLOGY
LA English
DT Article
DE HTLV-1; GLUT1; polymorphisms
ID T-CELL LEUKEMIA; VIRUS TYPE-I; DIABETIC-NEPHROPATHY; ETHNIC-DIFFERENCES;
   PROVIRAL LOAD; SUSCEPTIBILITY; CYTOKINE; RISK; MYELOPATHY; EXPRESSION
AB The development of HTLV-1 associated clinical manifestations, such as TSP/HAM and ATLL, occur in 2-4% of the infected population and it is still unclear why this infection remains asymptomatic in most infected carriers. Recently, it has been demonstrated that HTLV uses the Glucose transporter type 1 (GLUT1) to infect T-CD4(+) lymphocytes and that single nucleotide polymorphisms (SNP) in the GLUT1 gene are associated with diabetic nephropathy in patients with diabetes mellitus in different populations. These polymorphisms could contribute to a higher GLUT1 protein expression on cellular membrane, facilitating the entry of HTLV and its transmission cell by cell. This could result in a higher provirus load and consequently in the development of TSP/HAM. To evaluate the role of GLUT1 gene polymorphisms in the development of TSP/HAM in HTLV-1 infected individuals, the g.22999G > T, g.15339T > C and c.-2841A > T sites were analyzed by PCR/RFLP or sequencing in 244 infected individuals and 102 normal controls. The proviral load of the HTLV-1 infected patients was also analyzed using Real Time Quantitative PCR. Genotypic and allelic frequencies of the three sites did not differ significantly between controls and HTLV-1 infected individuals. There was no difference in genotypic and allelic distributions among patients as to the presence or absence of HTLV-1 associated clinic manifestations. As regards the quantification of the provirus load, we observed a significant reduction in the asymptomatic individuals compared with the oligosymptomatic and TSP/HAM individuals. These results suggest that g.22999G > T, g.15339T > C, and c.-2841A > T SNP do not contribute to HTLV-1 infection nor to the genetic susceptibility of TSP/HAM in Brazilian HTLV-1 infected individuals. J. Med. Virol. 81:552557, 2009. (C) 2009 Wiley-Liss, Inc.
C1 [Souza Costa, Giselle Calasans; Gadelha, Sandra Rocha; Olavarria, Viviana Nila; Galvao-Castro, Bernardo; Junior alcantara, Luiz Carlos] Fundacao Oswaldo Cruz, Ctr Pesquisa Goncalo Moniz, Lab Avancado Saude Publ, BR-40296610 Salvador, BA, Brazil.
   [Azevedo, Rochele; Kashima, Simone Haddad; Covas, Dimas Tadeu] Hemoctr Ribeirao Preto, Sao Paulo, Brazil.
   [Muricy, Gabriel; Galvao-Castro, Bernardo; Junior alcantara, Luiz Carlos] Fundacao Bahiana Desenvolvimento Ciencias, Escola Bahiana Med & Saude Publ, Salvador, BA, Brazil.
   [Takayanagui, Osvaldo Massaiti] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Neurol Psiquiatria & Psicol Med, Sao Paulo, Brazil.
RP Alcantara, LC (corresponding author), Fundacao Oswaldo Cruz, Ctr Pesquisa Goncalo Moniz, Lab Avancado Saude Publ, Rua Waldemar Falcao 121, BR-40296610 Salvador, BA, Brazil.
EM lalcan@bahia.fiocruz.br
RI Takayanagui, Osvaldo M/C-8159-2013; Gadelha, Sandra/X-3373-2019; Covas,
   Dimas T/C-5431-2013; Kashima, Simone/G-4876-2012
OI Takayanagui, Osvaldo M/0000-0002-8190-0275; Covas, Dimas
   T/0000-0002-7364-2595; Kashima, Simone/0000-0002-1487-0141; Alcantara,
   Luiz/0000-0002-6769-9931; Gadelha, Sandra/0000-0002-3079-488X
FU Fundacao de Amparo a Pesquisa do Estado da Bahia
FX Grant sponsor: Fundacao de Amparo a Pesquisa do Estado da Bahia (FAPESB;
   partially supported).
CR AYRES M, 2005, BIOESTAT VERSA 4 0
   BANGHAM CR, 2003, SCIENCE, V299, P1713
   Coskun AK, 2005, J VIROL, V79, P4150, DOI 10.1128/JVI.79.7.4150-4158.2005
   Cox ED, 2001, TRANSPLANTATION, V72, P720, DOI 10.1097/00007890-200108270-00027
   D'Aiuto F, 2004, CYTOKINE, V28, P29, DOI 10.1016/j.cyto.2004.06.005
   Dehee A, 2002, J VIROL METHODS, V102, P37, DOI 10.1016/S0166-0934(01)00445-1
   Dourado I, 2003, JAIDS-J ACQ IMM DEF, V34, P527, DOI 10.1097/00126334-200312150-00013
   Fishman D, 1998, J CLIN INVEST, V102, P1369, DOI 10.1172/JCI2629
   Gadelha SR, 2008, J MED VIROL, V80, P2141, DOI 10.1002/jmv.21341
   Gadelha SR, 2005, HUM BIOL, V77, P509, DOI 10.1353/hub.2005.0061
   GESSAIN A, 1985, LANCET, V2, P407
   Grzeszczak W, 2001, KIDNEY INT, V59, P631, DOI 10.1046/j.1523-1755.2001.059002631.x
   Gutierrez C, 1998, DIABETES RES CLIN PR, V41, P113, DOI 10.1016/S0168-8227(98)00050-3
   Hayashi M, 2004, J ENDOCRINOL, V183, P145, DOI 10.1677/joe.1.05599
   Hodgkinson AD, 2005, J DIABETES COMPLICAT, V19, P65, DOI 10.1016/j.jdiacomp.2004.07.002
   Hoffmann SC, 2002, AM J TRANSPLANT, V2, P560, DOI 10.1034/j.1600-6143.2002.20611.x
   Kaplan JE, 1996, J ACQ IMMUN DEF SYND, V12, P193, DOI 10.1097/00042560-199606010-00014
   KITAJIMA I, 1989, ARTHRITIS RHEUM, V32, P1342, DOI 10.1002/anr.1780321030
   Kitamura A, 2002, DIABETIC MED, V19, P1000, DOI 10.1046/j.1464-5491.2002.00844.x
   LAGRENADE L, 1990, LANCET, V336, P1345
   Licastro F, 2003, NEUROBIOL AGING, V24, P921, DOI 10.1016/S0197-4580(03)00013-7
   Liu Z, 1998, Zhonghua Yi Xue Za Zhi, V78, P662
   Liu ZH, 1999, KIDNEY INT, V55, P1843, DOI 10.1046/j.1523-1755.1999.00449.x
   Manel N, 2005, J BIOL CHEM, V280, P29025, DOI 10.1074/jbc.M504549200
   MOCHIZUKI M, 1992, LANCET, V339, P1110, DOI 10.1016/0140-6736(92)90699-4
   MORGAN OS, 1989, LANCET, V2, P1184
   Nagai M, 1998, J NEUROVIROL, V4, P586, DOI 10.3109/13550289809114225
   Ng DPK, 2002, DIABETES, V51, P2264, DOI 10.2337/diabetes.51.7.2264
   Nishimura M, 2002, HUM IMMUNOL, V63, P696, DOI 10.1016/S0198-8859(02)00419-6
   OSAME M, 1986, LANCET, V1, P1031
   Plothow A, 2003, TRANSPLANT P, V35, P2908, DOI 10.1016/j.transproceed.2003.10.013
   POIESZ BJ, 1980, P NATL ACAD SCI-BIOL, V77, P7415, DOI 10.1073/pnas.77.12.7415
   RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573
   Rosenwasser LJ, 1997, AM J RESP CRIT CARE, V156, pS152, DOI 10.1164/ajrccm.156.4.12tac-14
   Sabouri AH, 2004, J INFECT DIS, V190, P1279, DOI 10.1086/423942
   Takenouchi N, 2003, J NEUROVIROL, V9, P29, DOI 10.1080/13550280390173418
   Tomita M, 2007, BIOCHEM J, V406, P317, DOI 10.1042/BJ20070286
   YOSHIDA M, 1982, P NATL ACAD SCI-BIOL, V79, P2031, DOI 10.1073/pnas.79.6.2031
NR 38
TC 2
Z9 2
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0146-6615
EI 1096-9071
J9 J MED VIROL
JI J. Med. Virol.
PD MAR
PY 2009
VL 81
IS 3
BP 552
EP 557
DI 10.1002/jmv.21421
PG 6
WC Virology
SC Virology
GA 399JC
UT WOS:000262795200023
PM 19152396
OA Green Published
DA 2020-10-22
ER

PT J
AU Gadelha, SR
   Alcantara, LCJ
   Costa, GC
   Acosta, AX
   Rios, D
   Kashima, S
   Covas, DT
   Galvao-Castro, B
AF Gadelha, Sandra Rocha
   Junior Alcantara, Luiz Carlos
   Costa, Gisele Calazans
   Acosta, Angelina Xavier
   Rios, Domingos
   Kashima, Simone
   Covas, Dimas Tadeu
   Galvao-Castro, Bernardo
TI Correlation Between Polymorphisms at Interleukin-6 But Not at
   Interleukin-10 Promoter and the Risk of Human T Lymphotropic Virus Type
   I-Associated Myelopathy/Tropical Spastic Paraparesis in Brazilian
   Individuals
SO JOURNAL OF MEDICAL VIROLOGY
LA English
DT Article
DE HTLV-1; interleukin-6; interleukin-10; polymorphisms; Brazilian
   populations
ID HTLV-I; CYTOKINE PRODUCTION; GENE PROMOTER; ETHNIC-DIFFERENCES; IL-6
   GENE; EXPRESSION; ALLELES; DISEASE; SUSCEPTIBILITY; TRANSCRIPTION
AB HTLV-1 is the etiologic agent of ATL and HAM/TSP. The majority of HTLV-1-infected individuals remain asymptomatic, indicating that the infection alone is not sufficient to cause the diseases. It has been reported that cytokine gene polymorphisms, including polymorphisms at IL-6 and IL-10 gene, might be important. We analyzed SNP in the promoter region of the IL-6: -174, -572, -597, and -634 positions, and IL-10: -592 position to evaluate the role of these polymorphisms in the HAM/TSP pathogenesis in 133 HTLV-1 infected individuals and in 100 healthy individuals from Salvador, Bahia, Brazil. The -634C allele frequencies were higher among HAM/TSP patients (21.2%) than among oligosymptomatic (6.5%; P=0.038) and asymptomatic (9.5%; P=0.025) subjects. Similarly, the -174G allele frequencies were higher in HAM/TSP patients than in oligosymptomatic patients (P=0.02). Moreover, the -634GC/-174GG genotype combination was identified at a higher frequency (38.5%) in the HAM/TSP patients than in subjects with other clinical status (8.7%; P=0.016 for oligosymptomatic and 15.5%, P=0.012 for asymptomatic patients). However, the multivariate logistic regression including the genotypes of the three studied loci showed that only -634 C IL-6 carriers remain as significant and independent TSP/HAM predictor (odds ratio [OR] = 5.31; 95% [CI] = 1.60-17.56; P=0.006). We suggest that -634 G C in IL-6 could contribute to HAM/TSP development and that identification of the collective influence of several cytokine is polymorphisms, their prevalence, and their interaction could help to better understand this disease. J. Med. Virol. 80:2141-2146, 2008. (C) 2008 Wiley-Liss, Inc.
C1 [Gadelha, Sandra Rocha; Junior Alcantara, Luiz Carlos; Costa, Gisele Calazans; Acosta, Angelina Xavier; Galvao-Castro, Bernardo] Fundacao Oswaldo Cruz, Ctr Pesquisas Goncalo Moniz, Lab Avancado Saude Publ, Salvador, BA, Brazil.
   [Gadelha, Sandra Rocha; Junior Alcantara, Luiz Carlos; Galvao-Castro, Bernardo] Fundacao Desenvolvimento Ciencias, Escola Bahiana Med Saude Publ, Salvador, BA, Brazil.
   [Acosta, Angelina Xavier] Univ Fed Bahia, UFBA, Fac Med, Dept Pediat, BR-41170290 Salvador, BA, Brazil.
   [Kashima, Simone; Covas, Dimas Tadeu] Hemoctr Ribeirao Preto, Sao Paulo, Brazil.
RP Galvao-Castro, B (corresponding author), Fiocruz MS, CPqGM, LASP, 121 Rua Waldemar Falcao, BR-40296710 Salvador, BA, Brazil.
EM bgalvao@cpqgm.fiocruz.br
RI Covas, Dimas T/C-5431-2013; Gadelha, Sandra/X-3373-2019; Kashima,
   Simone/G-4876-2012
OI Covas, Dimas T/0000-0002-7364-2595; Alcantara, Luiz/0000-0002-6769-9931;
   Kashima, Simone/0000-0002-1487-0141; Gadelha, Sandra/0000-0002-3079-488X
CR ABRAMSON JH, 2001, COMPUTER PROGRAM EPI
   Belluco C, 2003, CLIN CANCER RES, V9, P2173
   Cox ED, 2001, TRANSPLANTATION, V72, P720, DOI 10.1097/00007890-200108270-00027
   Dourado I, 2003, JAIDS-J ACQ IMM DEF, V34, P527, DOI 10.1097/00126334-200312150-00013
   Ershler WB, 2000, ANNU REV MED, V51, P245, DOI 10.1146/annurev.med.51.1.245
   Fishman D, 1998, J CLIN INVEST, V102, P1369, DOI 10.1172/JCI2629
   Font J, 2002, RHEUMATOLOGY, V41, P1025, DOI 10.1093/rheumatology/41.9.1025
   Furukawa Y, 2003, J INFECT DIS, V187, P1116, DOI 10.1086/368379
   Gabay C, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1917
   Gadelha SR, 2005, HUM BIOL, V77, P509, DOI 10.1353/hub.2005.0061
   GalvaoCastro B, 1997, TRANSFUSION, V37, P242, DOI 10.1046/j.1537-2995.1997.37297203532.x
   GESSAIN A, 1985, LANCET, V2, P407
   Hoffmann SC, 2002, AM J TRANSPLANT, V2, P560, DOI 10.1034/j.1600-6143.2002.20611.x
   Ishihara K, 2002, CYTOKINE GROWTH F R, V13, P357, DOI 10.1016/S1359-6101(02)00027-8
   Jahromi MM, 2000, J INTERF CYTOK RES, V20, P885, DOI 10.1089/10799900050163253
   Jeffery KJM, 1999, P NATL ACAD SCI USA, V96, P3848, DOI 10.1073/pnas.96.7.3848
   Jenny NS, 2002, ARTERIOSCL THROM VAS, V22, P2066, DOI 10.1161/01.ATV.0000040224.49362.60
   Kitamura A, 2002, DIABETIC MED, V19, P1000, DOI 10.1046/j.1464-5491.2002.00844.x
   Kodama D, 2004, J NEUROIMMUNOL, V156, P188, DOI 10.1016/j.jneuroim.2004.07.007
   Kubaszek A, 2003, DIABETES, V52, P558, DOI 10.2337/diabetes.52.2.558
   Li XH, 2000, AIDS RES HUM RETROV, V16, P1583, DOI 10.1089/08892220050192994
   Licastro F, 2003, NEUROBIOL AGING, V24, P921, DOI 10.1016/S0197-4580(03)00013-7
   Ma W, 2001, J BIOL CHEM, V276, P13664, DOI 10.1074/jbc.M011157200
   Meenagh A, 2002, HUM IMMUNOL, V63, P1055, DOI 10.1016/S0198-8859(02)00440-8
   Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683
   Mori N, 1996, BLOOD, V88, P1035
   MURPHY EL, 1989, INT J CANCER, V43, P250, DOI 10.1002/ijc.2910430214
   Nishimura M, 2002, HUM IMMUNOL, V63, P696, DOI 10.1016/S0198-8859(02)00419-6
   Nishimura M, 2000, HUM IMMUNOL, V61, P1262, DOI 10.1016/S0198-8859(00)00182-8
   Nobuhara Y, 2006, IMMUNOGENETICS, V57, P944, DOI 10.1007/s00251-005-0075-0
   Orland JR, 2003, NEUROLOGY, V61, P1588, DOI 10.1212/01.WNL.0000096011.92542.DA
   OSAME M, 1986, LANCET, V1, P1031
   Plothow A, 2003, TRANSPLANT P, V35, P2908, DOI 10.1016/j.transproceed.2003.10.013
   POIESZ BJ, 1980, P NATL ACAD SCI-BIOL, V77, P6815, DOI 10.1073/pnas.77.11.6815
   Rafatpanah H, 2004, HUM IMMUNOL, V65, P839, DOI 10.1016/j.humimm.2004.05.006
   RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573
   Rivera-Chavez FA, 2003, SHOCK, V20, P218, DOI 10.1097/00024382-200309000-00004
   Rosenwasser LJ, 1997, AM J RESP CRIT CARE, V156, pS152, DOI 10.1164/ajrccm.156.4.12tac-14
   Sabouri AH, 2004, J INFECT DIS, V190, P1279, DOI 10.1086/423942
   Saito M, 2005, J NEUROL SCI, V232, P29, DOI 10.1016/j.jns.2005.01.005
   Shin HD, 2000, P NATL ACAD SCI USA, V97, P14467, DOI 10.1073/pnas.97.26.14467
   Taylor A, 2006, IMMUNOLOGY, V117, P433, DOI 10.1111/j.1365-2567.2006.02321.x
   Terry CF, 2000, J BIOL CHEM, V275, P18138, DOI 10.1074/jbc.M000379200
   Warle MC, 2003, LIVER TRANSPLANT, V9, P170, DOI 10.1053/jlts.2002.50014
   Westendorp RGJ, 1997, LANCET, V349, P1912, DOI 10.1016/S0140-6736(05)63910-4
NR 45
TC 17
Z9 17
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0146-6615
EI 1096-9071
J9 J MED VIROL
JI J. Med. Virol.
PD DEC
PY 2008
VL 80
IS 12
BP 2141
EP 2146
DI 10.1002/jmv.21341
PG 6
WC Virology
SC Virology
GA 368FH
UT WOS:000260606500013
PM 19040291
OA Green Published
DA 2020-10-22
ER

PT J
AU Mota-Miranda, AC
   Araujo, SP
   Dias, JP
   Colin, DD
   Kashima, S
   Covas, DT
   Tavares-Neto, J
   Galvao-Castro, B
   Alcantara, LCJ
AF Mota-Miranda, Aline Cristina
   Araujo, Sergio Pereira
   Dias, Juarez Pereira
   Colin, Denise Duizit
   Kashima, Simone
   Covas, Dimas Tadeu
   Tavares-Neto, Jose
   Galvao-Castro, Bernardo
   Junior Alcantara, Luiz Carlos
TI HTLV-1 infection in blood donors from the western Brazilian Amazon
   region: Seroprevalence and molecular study of viral isolates
SO JOURNAL OF MEDICAL VIROLOGY
LA English
DT Article
DE LTR region; glycoproteins; phylogenetic analysis; protein sites
ID VIRUS TYPE-I; CELL LYMPHOTROPIC VIRUS; EPIDEMIOLOGY; AMERICA; ORIGIN;
   TYPE-1; GP46
AB To determine the seroprevalence of HTLV-1 in Brazil, and to review the virus molecular epidemiology in this Amazon population (Rio Branco-Acre), 219 blood donors were screened for HTLV-1. Only one case of infection (0.46% seroprevalence) was detected during July 2004 screening at the Acre Hospital Foundation (FUNDACRE). Neighbor-joining and Maximum Likelihood phylogenetic analyses of two (n = 2) complete LTR region sequences were performed with the PAUP* software. Since the HTLV-1 envelope surface (gp46) and transmembrane (gp21) glycoproteins are important for virus fitness, three envelope glycoproteins sequences (n = 3) were analyzed using the Prosite tool to determinate potential protein sites. Phylogenetic analysis demonstrated that the new isolate described in this study, and the unpublished LTR strain described in a previous report belong to the Transcontinental subgroup of the Cosmopolitan subtype, inside the Latin American cluster. A similar result was obtained when submitting, to the Automated Genotyping System, three LTR partial sequences from a previous study of the seroprevalence of HTLV-1 in the same Amazon population. In all analyzed env sequences, the potential protein site was found: two PKC phosphorylation sites at amino acid (aa) positions 310-312 and 342-344, one CK2 phosphorylation site at 194-197aa, three N-glycosylation sites at 222-225aa, 244-247aa and 272-275aa, and a single N-myristylation site at 327-338aa. In conclusion, potential protein sites described in HTLV-1 gp46 and gp21 confirm the presence of conserved sites in the HTLV-1 envelope proteins, likewise phylogenetic analysis suggests a possible recent introduction of the virus into North Brazil.
C1 [Mota-Miranda, Aline Cristina; Araujo, Sergio Pereira; Galvao-Castro, Bernardo; Junior Alcantara, Luiz Carlos] Fundacao Oswaldo Cruz, Adv Publ Hlth Lab, Goncalo Moniz Res Ctr, BR-40296610 Salvador, BA, Brazil.
   [Dias, Juarez Pereira; Tavares-Neto, Jose] Univ Fed Bahia, Salvador, BA, Brazil.
   [Colin, Denise Duizit] Fundaco Hosp Estadual Acre, Rio Branco, Acre, Brazil.
   [Kashima, Simone; Covas, Dimas Tadeu] Hemoctr Ribeirao Preto, Sao Paulo, Brazil.
   [Galvao-Castro, Bernardo; Junior Alcantara, Luiz Carlos] Fundacao Bahiana Desenvolvimento Ciencias, Escola Bahiana Med & Saude Publ, Salvador, BA, Brazil.
RP Alcantara, LCJ (corresponding author), Fundacao Oswaldo Cruz, Adv Publ Hlth Lab, Goncalo Moniz Res Ctr, Waldemar Falcao St 121, BR-40296610 Salvador, BA, Brazil.
EM lalcan@bahia.fiocruz.br
RI Covas, Dimas T/C-5431-2013; Kashima, Simone/G-4876-2012
OI Covas, Dimas T/0000-0002-7364-2595; Alcantara, Luiz/0000-0002-6769-9931;
   Kashima, Simone/0000-0002-1487-0141
FU Fundacao de Amparo a Pesquisa do Estado da Bahia (FAPESB); PN-DST/AIDS,
   Ministerio da Saude, Brazil
FX Fundacao de Amparo a Pesquisa do Estado da Bahia (FAPESB) (partial
   support); Grant sponsor: PN-DST/AIDS, Ministerio da Saude, Brazil
   (partial support).
CR Alcantara LC, 2003, JAIDS-J ACQ IMM DEF, V33, P536, DOI 10.1097/00126334-200308010-00016
   Alcantara LCJ, 2006, AIDS, V20, P780, DOI 10.1097/01.aids.0000216383.14808.13
   Bouamr F, 2003, BIOCHEMISTRY-US, V42, P6408, DOI 10.1021/bi020692z
   Carneiro-Proietti Anna Bárbara F., 2002, Rev. Soc. Bras. Med. Trop., V35, P499, DOI 10.1590/S0037-86822002000500013
   Colin Denise Duizit, 2003, Rev. Soc. Bras. Med. Trop., V36, P677, DOI 10.1590/S0037-86822003000600006
   Dourado I, 2003, JAIDS-J ACQ IMM DEF, V34, P527, DOI 10.1097/00126334-200312150-00013
   GalvaoCastro B, 1997, TRANSFUSION, V37, P242, DOI 10.1046/j.1537-2995.1997.37297203532.x
   GESSAIN A, 1985, LANCET, V2, P407
   ISHAK R, 1995, AIDS RES HUM RETROV, V11, P813, DOI 10.1089/aid.1995.11.813
   ISHAK R, 2003, CAD SAUDE PUBLICA, V19, P109
   Jeanmougin F, 1998, TRENDS BIOCHEM SCI, V23, P403, DOI 10.1016/S0968-0004(98)01285-7
   KUMAR S, 1994, COMPUT APPL BIOSCI, V10, P189
   MIURA T, 1994, P NATL ACAD SCI USA, V91, P1124, DOI 10.1073/pnas.91.3.1124
   Mota Augusto, 2006, Rev. Bras. Hematol. Hemoter., V28, P120, DOI 10.1590/S1516-84842006000200011
   Mota-Miranda AC, 2007, MEM I OSWALDO CRUZ, V102, P741, DOI 10.1590/S0074-02762007000600014
   NAGY K, 1983, INT J CANCER, V32, P321, DOI 10.1002/ijc.2910320310
   Nicholas KB, 1997, EMBNEW NEWS, V4, P14
   OSAME M, 1986, LANCET, V1, P1031
   Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357
   PALKER TJ, 1989, J IMMUNOL, V142, P971
   POIESZ BJ, 1980, P NATL ACAD SCI-BIOL, V77, P7415, DOI 10.1073/pnas.77.12.7415
   Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817
   Proietti FA, 2005, ONCOGENE, V24, P6058, DOI 10.1038/sj.onc.1208968
   QUEIROZ AT, 2007, MEM I OSWALDO CRUZ, V102, P133, DOI DOI 10.1590/S0074-02762007005000005
   Reitter JN, 1998, NAT MED, V4, P679, DOI 10.1038/nm0698-679
   SWOFFORD DL, 1998, PAUP PHYLOGENETIC AN
   Vallinoto ACR, 1998, MEM I OSWALDO CRUZ, V93, P407, DOI 10.1590/S0074-02761998000300026
   Van Dooren S, 1998, J GEN VIROL, V79, P2695, DOI 10.1099/0022-1317-79-11-2695
   Yamashita M, 1999, VIROLOGY, V261, P59
   Yang YC, 1997, J MED VIROL, V51, P25, DOI 10.1002/(SICI)1096-9071(199701)51:1&lt;25::AID-JMV4&gt;3.0.CO;2-U
   Zehender G, 2007, AIDS RES HUM RETROV, V23, P1146, DOI 10.1089/aid.2007.0039
NR 31
TC 5
Z9 6
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0146-6615
EI 1096-9071
J9 J MED VIROL
JI J. Med. Virol.
PD NOV
PY 2008
VL 80
IS 11
BP 1966
EP 1971
DI 10.1002/jmv.21300
PG 6
WC Virology
SC Virology
GA 354EX
UT WOS:000259622800015
PM 18814249
DA 2020-10-22
ER

PT J
AU Magalhaes, T
   Mota-Miranda, AC
   Alcantara, LCJ
   Olavarria, V
   Galvao-Castro, B
   Rios-Grassi, MF
AF Magalhaes, Themistocles
   Mota-Miranda, Aline Cristina
   Junior Alcantara, Luiz Carlos
   Olavarria, Viviana
   Galvao-Castro, Bernardo
   Rios-Grassi, Maria Fernanda
TI Phylogenetic and molecular analysis of HTLV-1 isolates from a medium
   sized town in northern of Brazil: Tracing a common origin of the virus
   from the most endemic city in the country
SO JOURNAL OF MEDICAL VIROLOGY
LA English
DT Article
DE HTLV-1; pregnant women; prevalence and molecular epidemiology
ID CELL LYMPHOTROPIC VIRUS; NORTHEASTERN BRAZIL; I INFECTION; EPIDEMIOLOGY;
   TYPE-1; TRANSMISSION; SALVADOR; AMERICA; COHORT; JAPAN
AB Salvador-Bahia has the highest prevalence of HTLV-1 infection in Brazil; about 2% of the population is infected. In this city, the prevalence of HTLV in pregnant women is 1%. There is no data of the HTLV-1 prevalence in others cities of the Bahia's Reconcavo, where the population has similar social and demography characteristics to those from Salvador. Our aim was to evaluate the seroprevalence of HTLV in pregnant women in Cruz das Almas-Bahia, a medium-sized city from the Bahia's Reconcavo. All individuals were tested for HTLV (ELISA) and the positive samples were confirmed by Western Blot. Phylogenetic analyses of the total LTR region were performed in all positive samples. We tested 408 samples (45.4% of the estimate pregnant women population) between June 1st and October 31, 2005. The prevalence of HTLV-1 infection was 0.98%. In addition, all isolated virus were grouped in the subtype HTLV-1a, in the Latin American group. Our results suggest that the introduction of HTLV-1 occurred after the slave trade into Salvador. In addition, HTLV-1 -infection should be screened during the pregnancy in women originating from HTLV-1 endemic areas.
C1 [Mota-Miranda, Aline Cristina; Junior Alcantara, Luiz Carlos; Olavarria, Viviana; Galvao-Castro, Bernardo; Rios-Grassi, Maria Fernanda] Oswaldo Cruz Fdn FIOCRUZ, Adv Lab Publ Hlth CPQGM, BR-40296710 Salvador, BA, Brazil.
RP Rios-Grassi, MF (corresponding author), Oswaldo Cruz Fdn FIOCRUZ, Adv Lab Publ Hlth CPQGM, Rua Waldemar Falcao 121, BR-40296710 Salvador, BA, Brazil.
EM grassi@bahia.fiocruz.br
RI Grassi, Fernanda/X-7360-2019
OI Grassi, Fernanda/0000-0002-7356-5569; Alcantara,
   Luiz/0000-0002-6769-9931
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); Funda do de Amparo a Pesquisa da Bahia (FAPESB)
FX Grant sponsor: Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico (CNPq); Grant sponsor: Funda do de Amparo a Pesquisa da
   Bahia (FAPESB).
CR Alcantara LCJ, 2006, AIDS, V20, P780, DOI 10.1097/01.aids.0000216383.14808.13
   Mota ACA, 2007, AIDS RES HUM RETROV, V23, P503, DOI 10.1089/aid.2006.0203
   Andrade TM, 1998, J ACQ IMMUN DEF SYND, V18, P186, DOI 10.1097/00042560-199806010-00011
   AZEVEDO ES, 1982, HUM BIOL, V54, P329
   Bittencourt AL, 2001, J ACQ IMMUN DEF SYND, V26, P490, DOI 10.1097/00126334-200104150-00016
   BRITTO AP, 1998, REV SOC BRAS MED TRO, V31, P85
   DOSSANTOS JI, 1995, REV INST MED TROP SP, V37, P343
   Dourado I, 2003, JAIDS-J ACQ IMM DEF, V34, P527, DOI 10.1097/00126334-200312150-00013
   GalvaoCastro B, 1997, TRANSFUSION, V37, P242, DOI 10.1046/j.1537-2995.1997.37297203532.x
   de Queiroz ATL, 2007, MEM I OSWALDO CRUZ, V102, P133, DOI 10.1590/S0074-02762007005000005
   MOREIRA ED, 1993, J ACQ IMMUN DEF SYND, V6, P959
   MUELLER N, 1991, CANCER CAUSE CONTROL, V2, P37, DOI 10.1007/BF00052359
   MURPHY EL, 1989, ANN INTERN MED, V111, P555, DOI 10.7326/0003-4819-111-7-555
   Proietti FA, 2005, ONCOGENE, V24, P6058, DOI 10.1038/sj.onc.1208968
   Shindo N, 2002, AIDS RES HUM RETROV, V18, P71, DOI 10.1089/088922202753394736
   STUVER SO, 1993, J INFECT DIS, V167, P57, DOI 10.1093/infdis/167.1.57
   Van Dooren S, 1998, J GEN VIROL, V79, P2695, DOI 10.1099/0022-1317-79-11-2695
   Yamashita M, 1999, VIROLOGY, V261, P59
NR 18
TC 17
Z9 17
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0146-6615
EI 1096-9071
J9 J MED VIROL
JI J. Med. Virol.
PD NOV
PY 2008
VL 80
IS 11
BP 2040
EP 2045
DI 10.1002/jmv.21278
PG 6
WC Virology
SC Virology
GA 354EX
UT WOS:000259622800025
PM 18814252
DA 2020-10-22
ER

PT J
AU Araujo, AF
   Santos, LA
   Abe-Sandes, K
   Galvao-Castro, B
   Alcantara, LC
AF Araujo, A. F.
   Santos, L. A.
   Abe-Sandes, K.
   Galvao-Castro, B.
   Alcantara, L. C.
TI Molecular Epidemiology of HIV-1 in Different Ethnic Group of Salvador,
   Brazil
SO AIDS RESEARCH AND HUMAN RETROVIRUSES
LA English
DT Meeting Abstract
CT AIDS Vaccine 2008 Conference
CY OCT 13-16, 2008
CL Cape Town, SOUTH AFRICA
SP NIAID, Div AIDS, NIH, Div AIDS
C1 [Araujo, A. F.; Santos, L. A.; Abe-Sandes, K.; Galvao-Castro, B.; Alcantara, L. C.] Fiocruz MS, CPqGM, Salvador, BA, Brazil.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU MARY ANN LIEBERT INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 0889-2229
J9 AIDS RES HUM RETROV
JI Aids Res. Hum. Retrovir.
PD OCT
PY 2008
VL 24
BP 159
EP 159
PG 1
WC Immunology; Infectious Diseases; Virology
SC Immunology; Infectious Diseases; Virology
GA 367CT
UT WOS:000260530800411
DA 2020-10-22
ER

PT J
AU Rego, FFD
   Alcantara, LCJ
   Moura, JP
   Miranda, ACAM
   Pereira, OD
   Goncalves, MD
   Galvao-Castro, B
AF de Almeida Rego, Filipe Ferreira
   Junior Alcantara, Luiz Carlos
   Moura Neto, Jose Pereira
   Andrade Mota Miranda, Aline Cristina
   Pereira, Osmario de Souza
   Goncalves, Marilda de Souza
   Galvao-Castro, Bernardo
TI HTLV type 1 molecular study in Brazilian villages with African
   characteristics giving support to the post-Columbian introduction
   hypothesis
SO AIDS RESEARCH AND HUMAN RETROVIRUSES
LA English
DT Article
ID VIRUS TYPE-I; CELL LYMPHOTROPIC VIRUS; PHYLOGENETIC SUBTYPES;
   SOUTH-AFRICAN; STRAINS; ORIGIN; PYGMY; LTR
AB We performed an HTLV epidemiological study of 986 individuals from 17 villages from the same state of Salvador, the city with the highest HTLV-1 prevalence in Brazil. The HTLV-1 prevalence was 3.85%, 1.56%, and 1.23% in three villages. Phylogenetic analysis of the LTR region demonstrated that all positive samples analyzed belonged to the Transcontinental subgroup of the HTLV-1 Cosmopolitan subtype. Three of the new HTLV-1 sequences formed a well-supported clade within one of the Latin American clusters that contain a South African sequence. This Latin American cluster that segregated from the same ancestor as the other clade contained a Central African sequence. This ancestral relationship could support our previous report that suggests that this subgroup was first introduced into South Africa as a result of the migration of the Bantu population from Central Africa to Southern Africa over the past 3000 years, and afterward to Brazil during the slave trade between the sixteenth and nineteenth centuries.
C1 [de Almeida Rego, Filipe Ferreira; Junior Alcantara, Luiz Carlos; Galvao-Castro, Bernardo] Bahia Fdn Dev Sci, Bahia Sch Med & Publ Hlth, Salvador, BA, Brazil.
   [de Almeida Rego, Filipe Ferreira; Junior Alcantara, Luiz Carlos; Andrade Mota Miranda, Aline Cristina; Galvao-Castro, Bernardo] Fundacao Oswaldo Cruz, Adv Publ Hlth Lab, Goncalo Moniz Res Ctr, Salvador, BA, Brazil.
   [Moura Neto, Jose Pereira; Pereira, Osmario de Souza; Goncalves, Marilda de Souza] Fundacao Oswaldo Cruz, Pathol & Mol Biol Lab, Goncalo Moniz Res Ctr, Salvador, BA, Brazil.
RP Alcantara, LCJ (corresponding author), LASP CPqGM FIOCRUZ, Rua Waldemar Falcao 121, BR-40295001 Salvador, BA, Brazil.
EM lalcan@cpqgm.fiocruz.br
RI de Moura, Josely Pinto/Q-6165-2017
OI Alcantara, Luiz/0000-0002-6769-9931
CR Alcantara LCJ, 2006, AIDS, V20, P780, DOI 10.1097/01.aids.0000216383.14808.13
   Mota ACA, 2007, AIDS RES HUM RETROV, V23, P503, DOI 10.1089/aid.2006.0203
   BLATTNER WA, 1990, J ACQ IMMUN DEF SYND, V3, P1102
   CATALANSOARES B, 2004, VOX SANG, V87, P105
   Chen JL, 1995, AIDS RES HUM RETROV, V11, P1529, DOI 10.1089/aid.1995.11.1529
   Dourado I, 2003, JAIDS-J ACQ IMM DEF, V34, P527, DOI 10.1097/00126334-200312150-00013
   GalvaoCastro B, 1997, TRANSFUSION, V37, P242, DOI 10.1046/j.1537-2995.1997.37297203532.x
   GESSAIN A, 1991, P NATL ACAD SCI USA, V88, P7694, DOI 10.1073/pnas.88.17.7694
   KAJIYAMA W, 1986, AM J EPIDEMIOL, V123, P41, DOI 10.1093/oxfordjournals.aje.a114222
   Kashima S, 2006, AIDS RES HUM RETROV, V22, P953, DOI 10.1089/aid.2006.22.953
   KUMAR S, 1994, COMPUT APPL BIOSCI, V10, P189
   MIURA T, 1994, P NATL ACAD SCI USA, V91, P1124, DOI 10.1073/pnas.91.3.1124
   NICHOLAS KB, 1997, GENEDOC ANAL VISUALI, P30
   Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817
   Proietti FA, 2005, ONCOGENE, V24, P6058, DOI 10.1038/sj.onc.1208968
   Salemi M, 1998, VIROLOGY, V246, P277, DOI 10.1006/viro.1998.9215
   SWOFFORD DL, 1996, MOL SYSTEMATICS, V2, P407
   VALLEJO A, 1995, J VIROL METHODS, V51, P9, DOI 10.1016/0166-0934(94)00093-V
   Van Dooren S, 1998, J GEN VIROL, V79, P2695, DOI 10.1099/0022-1317-79-11-2695
   VANDAMME AM, 1994, VIROLOGY, V202, P212, DOI 10.1006/viro.1994.1337
   VERDIER M, 1994, AIDS AFRICA, V9, P173
   Wolfe ND, 2005, P NATL ACAD SCI USA, V102, P7994, DOI 10.1073/pnas.0501734102
   Xia X., 2000, DATA ANAL MOL BIOL E
   Zehender G, 2007, AIDS RES HUM RETROV, V23, P1146, DOI 10.1089/aid.2007.0039
NR 24
TC 12
Z9 12
U1 0
U2 0
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 0889-2229
EI 1931-8405
J9 AIDS RES HUM RETROV
JI Aids Res. Hum. Retrovir.
PD MAY
PY 2008
VL 24
IS 5
BP 673
EP 677
DI 10.1089/aid.2007.0290
PG 5
WC Immunology; Infectious Diseases; Virology
SC Immunology; Infectious Diseases; Virology
GA 310HK
UT WOS:000256519300002
PM 18462080
OA Green Published
DA 2020-10-22
ER

PT J
AU Farre, L
   Bittencour, AL
   Silva-Santos, G
   Almeida, A
   Silva, AC
   Decanine, D
   Soares, GM
   Alcantara, LC
   Van Dooren, S
   Galvao-Castro, B
   Vandamme, AM
   Van Weyenbergh, J
AF Farre, L.
   Bittencour, A. L.
   Silva-Santos, G.
   Almeida, A.
   Silva, A. C.
   Decanine, D.
   Soares, G. M.
   Alcantara, L. C., Jr.
   Van Dooren, S.
   Galvao-Castro, B.
   Vandamme, A. M.
   Van Weyenbergh, J.
TI Fas-670 promoter polymorphism is associated to susceptibility, clinical
   presentation, and survival in adult T cell leukemia
SO JOURNAL OF LEUKOCYTE BIOLOGY
LA English
DT Article
DE TNFRSF6; ATL; STAT1; HTLV-1; apoptosis
ID FAS GENE; CD95; LEUKEMIA/LYMPHOMA; APOPTOSIS; RISK
AB Fas (TNFRSF6/Apo-1/CD95) is a type I transmembrane receptor, which mediates apoptosis. Fas gene mutations, aberrant transcripts, and abundant expression of Fas have been reported in adult T cell leukemia (ATL). To further elucidate the role of Fas in ATL pathogenesis, we investigated whether the -670 FAS promoter A/G polymorphism (STAT1-binding site) might contribute to susceptibility and clinical outcome in ATL. Thirty-one patients with ATL, 33 healthy, human T lymphotropic virus type 1-infected individuals, and 70 healthy, uninfected controls were genotyped for the FAS -670 polymorphism by PCR-restriction fragment-length polymorphism. The AA genotype was significantly over-represented in ATL patients in comparison with healthy controls (P = 0.006), as well as asymptomatics (P = 0.037), corresponding to an odds ratio (OR) of 3.79 [ 95% confidence intervals (CI; 1.28-11.41)] and 4.58 [95% CI (1.13-20.03)], respectively. The AA group also comprised significantly more aggressive (acute and lymphoma) clinical subtypes [P = 0.012; OR = 8.40; 95% CI (1.60-44.12)]. In addition, we observed a statistically significant association between GG genotype and survival (log rank test, P = 0.032). Finally, IFN-gamma-induced but not basal FAS mRNA levels were increased significantly (P = 0.049) in PBMCs from AA versus GG individuals, demonstrating the IFN-dependent functionality of the -670 polymorphism. In conclusion, our results demonstrate that a functional Fas promoter polymorphism is significantly associated to susceptibility, clinical manifestation, and survival in ATL.
C1 [Farre, L.; Silva-Santos, G.; Almeida, A.; Silva, A. C.; Decanine, D.; Soares, G. M.; Van Weyenbergh, J.] Lab Imunorregulacao Microbiol, Salvador, BA, Brazil.
   [Alcantara, L. C., Jr.; Galvao-Castro, B.] Lab Saude Publ, CPqGM, FIOCRUZ, Salvador, BA, Brazil.
   [Bittencour, A. L.] Hosp Univ Prof Edgard Santos, Salvador, BA, Brazil.
   [Van Weyenbergh, J.] Rega Inst, Clin & Epidemiol Virol, Louvain, Belgium.
RP Van Weyenbergh, J (corresponding author), Rua Waldemar 121, BR-40296710 Salvador, BA, Brazil.
EM johan@bahia.fiocruz.br
RI Van Weyenbergh, Johan/Q-3829-2019; Vandamme, Anne-Mieke/I-4127-2012; Van
   Weyenbergh, Johan/B-4187-2009
OI Van Weyenbergh, Johan/0000-0003-3234-8426; Vandamme,
   Anne-Mieke/0000-0002-6594-2766; Van Weyenbergh,
   Johan/0000-0003-3234-8426; Farre, Lourdes/0000-0002-3168-1940;
   Alcantara, Luiz/0000-0002-6769-9931
CR DEBATIN KM, 1993, BLOOD, V81, P2972
   Etoh K, 1997, CANCER RES, V57, P4862
   Huang QR, 1997, MOL IMMUNOL, V34, P577, DOI 10.1016/S0161-5890(97)00081-3
   Kanemitsu S, 2002, J RHEUMATOL, V29, P1183
   Muschen M, 2000, J MOL MED-JMM, V78, P312, DOI 10.1007/s001090000112
   Nolsoe RL, 2005, GENES IMMUN, V6, P699, DOI 10.1038/sj.gene.6364259
   Peter ME, 2007, CELL, V129, P447, DOI 10.1016/j.cell.2007.04.031
   SHIMOYAMA M, 1991, BRIT J HAEMATOL, V79, P428, DOI 10.1111/j.1365-2141.1991.tb08051.x
   Sibley K, 2003, CANCER RES, V63, P4327
   Sun T, 2005, J EXP MED, V202, P967, DOI 10.1084/jem.20050707
   TAKEMOTO S, 1994, BLOOD, V84, P3080
   Takeuchi S, 2005, BRIT J HAEMATOL, V131, P552, DOI 10.1111/j.1365-2141.2005.05798.x
   Tamiya S, 1998, BLOOD, V91, P3935
   Taylor GP, 2005, ONCOGENE, V24, P6047, DOI 10.1038/sj.onc.1208979
   Tsukasaki K, 2001, CANCER RES, V61, P3770
   Ueda M, 2005, GYNECOL ONCOL, V98, P129, DOI 10.1016/j.ygyno.2005.04.001
NR 16
TC 38
Z9 39
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0741-5400
EI 1938-3673
J9 J LEUKOCYTE BIOL
JI J. Leukoc. Biol.
PD JAN
PY 2008
VL 83
IS 1
BP 220
EP 222
DI 10.1189/jlb.0407198
PG 3
WC Cell Biology; Hematology; Immunology
SC Cell Biology; Hematology; Immunology
GA 243YV
UT WOS:000251834100026
PM 17962369
OA Bronze
DA 2020-10-22
ER

PT J
AU Locateli, D
   Stoco, PH
   de Queiroz, ATL
   Alcantara, LCJ
   Ferreira, LGE
   Zanetti, CR
   Rodrigues, R
   Grisard, EC
   Pinto, AR
AF Locateli, Dayse
   Stoco, Patricia H.
   de Queiroz, Artur T. L.
   Alcantara, Luiz C. J.
   Ferreira, Luiz G. E.
   Zanetti, Carlos R.
   Rodrigues, Rosangela
   Grisard, Edmundo C.
   Pinto, Aguinaldo R.
TI Molecular epidemiology of HIV-1 in Santa Catarina State confirms
   increases of subtype C in southern Brazil
SO JOURNAL OF MEDICAL VIROLOGY
LA English
DT Article
DE AIDS; HIV; subtypes; Brazil
ID IMMUNODEFICIENCY-VIRUS TYPE-1; RIO-DE-JANEIRO; IN-VIVO; SEQUENCES;
   POLYMORPHISM; INDIVIDUALS; DIVERSITY; ARGENTINA; AMERICA; REVEALS
AB Recent studies have demonstrated an increased prevalence of human immunodeficiency virus type 1 (HIV-1) subtype C in southern Brazil. Although Santa Catarina State (SC) is located in this area and presents one of the country's highest incidences of HIV/AIDS, knowledge on the molecular epidemiology of HIV-1 in such State is lacking. The aim of this study was to investigate the HIV-1 molecular diversity and epidemiological profileof HIV-1-infected patients from SC. DNA samples were PCR amplified and HIV-1 subtypes were determined using both env and gag genes by direct sequencing. Phylogenetic analyses revealed that 48% were subtype C and 23% were subtype B. Possible recombinant forms were observed for both B/C (23%) and B/F (6%) subtypes. Our results, for the first time, identifies HIV-1 subtype C as a major clade circulating in SC and contributes to the understanding of HIV epidemics in the country by confirming the epidemic spread of the HIV-1 subtype C in southern Brazil.
C1 Univ Fed Santa Catarina, Dept Microbiol & Parasitol, Lab Immunol Aplicada, BR-88040900 Florianopolis, SC, Brazil.
   Univ Fed Santa Catarina, Dept Microbiol & Parasitol, Lab Protozool & Bioinformat, Florianopolis, SC, Brazil.
   Ctr Pesquisas Goncalo Moniz, Lab Avancado Saude Publ, Salvador, BA, Brazil.
   Escola Bahiana Med & Saude Publ FBDC, Salvador, BA, Brazil.
   Hosp Reg Homero Miranda Gomes, Sao Jose Dos Campos, Brazil.
   Adolfo Lutz Inst, Retrovirus Lab, Sao Paulo, Brazil.
RP Pinto, AR (corresponding author), Univ Fed Santa Catarina, Dept Microbiol & Parasitol, Lab Immunol Aplicada, BR-88040900 Florianopolis, SC, Brazil.
EM pintoar@ccb.ufsc.br
RI Rodrigues, Rosangela/C-2447-2011; Grisard, Edmundo C/AAS-9429-2020;
   Grisard, Edmundo C/A-7338-2015; Queiroz, Artur/F-6083-2014; Pinto,
   Aguinaldo Roberto/R-6625-2016
OI Grisard, Edmundo C/0000-0001-8916-8296; Grisard, Edmundo
   C/0000-0001-8916-8296; Pinto, Aguinaldo Roberto/0000-0002-0991-8876; de
   Queiroz, Artur Trancoso Lopo/0000-0003-4908-9993; Alcantara,
   Luiz/0000-0002-6769-9931
CR Arien KK, 2005, AIDS, V19, P1555, DOI 10.1097/01.aids.0000185989.16477.91
   Ball SC, 2003, J VIROL, V77, P1021, DOI 10.1128/JVI.77.2.1021-1038.2003
   Bongertz V, 2000, J ACQ IMMUN DEF SYND, V23, P184
   Brindeiro RM, 2003, AIDS, V17, P1063, DOI 10.1097/00002030-200305020-00016
   Carrion G, 2004, AIDS RES HUM RETROV, V20, P1022, DOI 10.1089/aid.2004.20.1022
   Carrion G, 2003, AIDS RES HUM RETROV, V19, P329, DOI 10.1089/088922203764969537
   COFFIN JM, 1995, SCIENCE, V267, P483, DOI 10.1126/science.7824947
   CSILLAG C, 1994, LANCET, V344, P1354
   de Oliveira T, 2005, BIOINFORMATICS, V21, P3797, DOI 10.1093/bioinformatics/bti607
   De Sa DJ, 2005, AIDS RES HUM RETROV, V21, P145, DOI 10.1089/aid.2005.21.145
   DELWART EL, 1994, J VIROL, V68, P6672, DOI 10.1128/JVI.68.10.6672-6683.1994
   Guimaraes ML, 2002, MEM I OSWALDO CRUZ, V97, P523, DOI 10.1590/S0074-02762002000400013
   Guiniaraes ML, 2002, AIDS RES HUM RETROV, V18, P1261, DOI 10.1089/088922202320886307
   Heyndrickx L, 2000, J VIROL, V74, P363, DOI 10.1128/JVI.74.1.363-370.2000
   Hierholzer J, 2002, AIDS RES HUM RETROV, V18, P1339, DOI 10.1089/088922202320935410
   Jeanmougin F, 1998, TRENDS BIOCHEM SCI, V23, P403, DOI 10.1016/S0968-0004(98)01285-7
   LOUWAGIE J, 1994, AIDS RES HUM RETROV, V10, P561, DOI 10.1089/aid.1994.10.561
   McCutchan FE, 2006, J MED VIROL, V78, pS7, DOI 10.1002/jmv.20599
   Morgado MG, 2002, MEM I OSWALDO CRUZ, V97, P143, DOI 10.1590/S0074-02762002000200001
   *NAT PROGR STD AID, 2005, EPID B AIDS YEAR 2
   Nicholas KB, 1997, GENEDOC ANAL VISUALI
   Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357
   Pinto ME, 1998, J ACQ IMMUN DEF SYND, V19, P310, DOI 10.1097/00042560-199811010-00017
   Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817
   Ramos A, 1999, EMERG INFECT DIS, V5, P65, DOI 10.3201/eid0501.990108
   Renjifo B, 1998, AIDS RES HUM RETROV, V14, P635, DOI 10.1089/aid.1998.14.635
   Rodenburg CM, 2001, AIDS RES HUM RETROV, V17, P161, DOI 10.1089/08892220150217247
   Rodrigues R, 2006, VIRUS RES, V116, P201, DOI 10.1016/j.virusres.2005.10.004
   Rossini MAA, 2001, BRAZ J MED BIOL RES, V34, P45, DOI 10.1590/S0100-879X2001000100005
   Russell KL, 2000, AIDS, V14, P1785, DOI 10.1097/00002030-200008180-00014
   Sabino EC, 1996, AIDS, V10, P1579, DOI 10.1097/00002030-199611000-00018
   Salemi M, 2005, J MOL EVOL, V60, P598, DOI 10.1007/s00239-004-0206-5
   Sambrook J., 2001, MOL CLONING LAB MANU, V3
   Shankarappa R, 2001, J VIROL, V75, P10479, DOI 10.1128/JVI.75.21.10479-10487.2001
   Soares EAJM, 2005, AIDS, V19, pS81, DOI 10.1097/01.aids.0000191497.00928.e4
   Soares EAJM, 2003, JAIDS-J ACQ IMM DEF, V34, P520, DOI 10.1097/00126334-200312150-00012
   Soares MA, 2003, AIDS, V17, P11, DOI 10.1097/00002030-200301030-00004
   SotoRamirez LE, 1996, SCIENCE, V271, P1291, DOI 10.1126/science.271.5253.1291
   Swofford D.L., 1996, PHYLOGENETIC INFEREN
   Tanuri A, 1999, J ACQ IMMUN DEF SYND, V20, P60, DOI 10.1097/00042560-199901010-00009
   Thomson MM, 2004, AIDS RES HUM RETROV, V20, P1126, DOI 10.1089/aid.2004.20.1126
NR 41
TC 28
Z9 31
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0146-6615
EI 1096-9071
J9 J MED VIROL
JI J. Med. Virol.
PD OCT
PY 2007
VL 79
IS 10
BP 1455
EP 1463
DI 10.1002/jmv.20955
PG 9
WC Virology
SC Virology
GA 203JT
UT WOS:000248971600004
PM 17705166
OA Green Published
DA 2020-10-22
ER

PT J
AU Mota-Miranda, AC
   de-Oliveira, T
   Moreau, DR
   Bomfim, C
   Galvao-Castro, B
   Alcantara, LCJ
AF Mota-Miranda, Aline Cristina
   de-Oliveira, Tulio
   Moreau, Domingos Ramon
   Bomfim, Catarina
   Galvao-Castro, Bernardo
   Junior Alcantara, Luiz Carlos
TI Mapping the molecular characteristics of Brazilian human T-cell
   lymphotropic virus type 1 Env (gp46) and Pol amino acid sequences for
   vaccine design
SO MEMORIAS DO INSTITUTO OSWALDO CRUZ
LA English
DT Article
DE human T-cell lymphotropic virus type 1; Env; Pol; epitope
ID HUMAN MONOCLONAL-ANTIBODIES; TROPICAL SPASTIC PARAPARESIS;
   LEUKEMIA-VIRUS; NEUTRALIZING ANTIBODIES; ENVELOPE GLYCOPROTEINS;
   SYNTHETIC PEPTIDES; B-CELL; IDENTIFICATION; EPITOPES; PROTEIN
AB This study was carried out to evaluate the molecular pattern of all available Brazilian human T-cell lymphotropic virus type 1 Env (n = 15) and Pol ( n = 43) nucleotide sequences via epitope prediction, physicochemical analysis, and protein potential sites identification, giving support to the Brazilian AIDS vaccine program. In 12 previously described peptides of the Env sequences we found 12 epitopes, while in 4 peptides of the Pol sequences we found 4 epitopes. The total variation on the amino acid composition was 9 and 17% for human leukocyte antigen (HLA) class I and class II Env epitopes, respectively. After analyzing the Pol sequences, results revealed a total amino acid variation of 0.75% for HLA-I and HLA-II epitopes. In 5 of the 12 Env epitopes the physico-chemical analysis demonstrated that the mutations magnified the antigenicity profile. The potential protein domain analysis of Env sequences showed the loss of a CK-2 phosphorylation site caused by D197N mutation in one epitope, and a N-glycosylation site caused by S246Y and V247I mutations in another epitope. Besides, the analysis of selection pressure have found 8 positive selected sites (w = 9.59) using the codon-based substitution models and maximum-likelihood methods. These studies underscore the importance of this Env region for the virus fitness, for the host immune response and, therefore, for the development of vaccine candidates.
C1 Fiocruz MS, Ctr Pesquisas Goncalo Moniz, Lab Avancado Saude Publ, BR-40296610 Salvador, BA, Brazil.
   Fdn Bahiana Desenvolvimento Ciencias, Escola Bahiana Med & Saude Publ, Salvador, BA, Brazil.
   UWC, S African Natl Bioinformat Inst, MRC, Pathogen Bioinformat Unit, Cape Town, South Africa.
   Univ Oxford, Dept Zool, Oxford OX1 2JD, England.
   Fac Technol Ciencia, Salvador, BA, Brazil.
RP Alcantara, LCJ (corresponding author), Fiocruz MS, Ctr Pesquisas Goncalo Moniz, Lab Avancado Saude Publ, Rua Valdemar Falcao 121, BR-40296610 Salvador, BA, Brazil.
EM lalcan@cpqgm.fiocruz.br
OI Alcantara, Luiz/0000-0002-6769-9931
CR ARGOS P, 1982, EUR J BIOCHEM, V128, P565
   BABA E, 1993, J IMMUNOL, V151, P1013
   Blanchard S, 1999, J VIROL, V73, P9369, DOI 10.1128/JVI.73.11.9369-9376.1999
   Carneiro-Proietti Anna Bárbara F., 2002, Rev. Soc. Bras. Med. Trop., V35, P499, DOI 10.1590/S0037-86822002000500013
   De Groot AS, 2005, VACCINE, V23, P2136, DOI 10.1016/j.vaccine.2005.01.097
   de Oliveira T, 2004, GENETICS, V167, P1047, DOI 10.1534/genetics.103.018135
   DESGRANGES C, 1994, AIDS RES HUM RETROV, V10, P163, DOI 10.1089/aid.1994.10.163
   ELOVAARA I, 1993, J EXP MED, V177, P1567, DOI 10.1084/jem.177.6.1567
   Fonseca SG, 2006, AIDS, V20, P2263, DOI 10.1097/01.aids.0000253353.48331.5f
   GESSAIN A, 1985, LANCET, V2, P407
   Hadlock KG, 2002, AIDS RES HUM RETROV, V18, P57, DOI 10.1089/088922202753394727
   Hanabuchi S, 2001, J NATL CANCER I, V93, P1775, DOI 10.1093/jnci/93.23.1775
   HOPP TP, 1983, MOL IMMUNOL, V20, P483, DOI 10.1016/0161-5890(83)90029-9
   HORAL P, 1991, P NATL ACAD SCI USA, V88, P5754, DOI 10.1073/pnas.88.13.5754
   INOUE Y, 1992, INT J CANCER, V52, P877, DOI 10.1002/ijc.2910520608
   Jeanmougin F, 1998, TRENDS BIOCHEM SCI, V23, P403, DOI 10.1016/S0968-0004(98)01285-7
   KANNAGI M, 1991, INT IMMUNOL, V3, P761, DOI 10.1093/intimm/3.8.761
   KARPLUS PA, 1985, NATURWISSENSCHAFTEN, V72, P212, DOI 10.1007/BF01195768
   KAUMAYA PT, 1995, LEUKEMIA S1, V9, P133
   Kazanji M, 2006, J GEN VIROL, V87, P1331, DOI 10.1099/vir.0.81582-0
   KORBER B, 1997, COMPUTATIONAL ANAL H, P55
   KUROKI M, 1992, J IMMUNOL, V149, P940
   KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0
   MUELLER N, 1991, CANCER CAUSE CONTROL, V2, P37, DOI 10.1007/BF00052359
   NAGY K, 1983, INT J CANCER, V32, P321, DOI 10.1002/ijc.2910320310
   NICHOLAS KB, 1997, EMB NEWS, V14, P30
   OSAME M, 1986, LANCET, V1, P1031
   PALKER TJ, 1989, J IMMUNOL, V142, P971
   PARKER CE, 1992, VIROLOGY, V188, P628, DOI 10.1016/0042-6822(92)90517-S
   PARKER JMR, 1986, BIOCHEMISTRY-US, V25, P5425, DOI 10.1021/bi00367a013
   Pique C, 1996, J VIROL, V70, P4919, DOI 10.1128/JVI.70.8.4919-4926.1996
   POIESZ BJ, 1980, P NATL ACAD SCI-BIOL, V77, P7415, DOI 10.1073/pnas.77.12.7415
   QUEIROZ AT, 2007, MEM I OSWALDO CRUZ, V102, P133, DOI DOI 10.1590/S0074-02762007005000005
   Rammensee HG, 1999, IMMUNOGENETICS, V50, P213, DOI 10.1007/s002510050595
   Schonbach C, 1996, VIROLOGY, V226, P102, DOI 10.1006/viro.1996.0632
   SEIKI M, 1983, P NATL ACAD SCI-BIOL, V80, P3618, DOI 10.1073/pnas.80.12.3618
   Sundaram R, 2004, J BIOL CHEM, V279, P24141, DOI 10.1074/jbc.M313210200
   Tallet B, 2001, AIDS RES HUM RETROV, V17, P337, DOI 10.1089/08892220150503708
   TANAKA Y, 1991, J IMMUNOL, V147, P354
   Yang ZH, 2000, GENETICS, V155, P431
   Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555
NR 41
TC 3
Z9 3
U1 0
U2 2
PU FUNDACO OSWALDO CRUZ
PI RIO DE JANEIRO, RJ
PA AV BRASIL 4365, 21045-900 RIO DE JANEIRO, RJ, BRAZIL
SN 0074-0276
EI 1678-8060
J9 MEM I OSWALDO CRUZ
JI Mem. Inst. Oswaldo Cruz
PD SEP
PY 2007
VL 102
IS 6
BP 741
EP 749
DI 10.1590/S0074-02762007005000089
PG 9
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA 218HU
UT WOS:000250007400014
PM 17924005
OA DOAJ Gold, Green Published
DA 2020-10-22
ER

PT J
AU de Queiroz, ATL
   Mota-Miranda, ACA
   de Oliveira, T
   Moreau, DR
   Urpia, CD
   Carvalho, CM
   Galvao-Castro, B
   Alcantara, LCJ
AF Lopo de Queiroz, Artur Trancoso
   Andrade Mota-Miranda, Aline Cristina
   de Oliveira, Tulio
   Moreau, Domingos Ramon
   Urpia, Caroline de Carvalho
   Carvalho, Chandra Mara
   Galvao-Castro, Bernardo
   Junior Alcantara, Luiz Carlos
TI Re-mapping the molecular features of the human immunodeficiency virus
   type 1 and human T-cell lymphotropic virus type 1 Brazilian sequences
   using a bioinformatics unit established in Salvador, Bahia, Brazil, to
   give support to the viral epidemiology studies
SO MEMORIAS DO INSTITUTO OSWALDO CRUZ
LA English
DT Article
DE human immunodeficiency virus type 1; human T-cell lymphotropic virus
   type 1; bioinformatics; molecular epidemiology
ID HIV-1 SUBTYPE-B; RIO-DE-JANEIRO; JAPANESE IMMIGRANTS; DRUG-RESISTANCE;
   HIGH PREVALENCE; AMAZON REGION; HTLV-1; IDENTIFICATION; INDIVIDUALS;
   ORIGIN
AB The analysis of genetic data for human immunodeficiency virus type 1 (HIV-1) and human T-cell lymphotropic virus type 1 (HTLV-1) is essential to improve treatment and public health strategies as well as to select strains for vaccine programs. However, the analysis of large quantities of genetic data requires collaborative efforts in bioinformatics, computer biology, molecular biology, evolution, and medical science. The objective of this study was to review and improve the molecular epidemiology of HIM and HTLV-l viruses isolated in Brazil using bioinformatic tools available in the Laboratorio Avancado de Saude Publica (Lasp) bioinformatics unit. The analysis of HIV-1 isolates confirmed a heterogeneous distribution of the viral genotypes circulating in the country. The Brazilian HIV-1 epidemic is characterized by the presence of multiple subtypes (B, F1, C) and B/F1 recombinant virus while, on the other hand, most of the HTLV-1 sequences were classified as Transcontinental subgroup of the Cosmopolitan subtype. Despite the high variation among HIV-1 subtypes, protein glycosylation and phosphorylation domains were conserved in the pol, gag, and env genes of the Brazilian HIV-1 strains suggesting constraints in the HIM evolution process. As expected, the functional protein sites were highly conservative in the HTLV-1 env gene sequences. Furthermore, the presence of these functional sites in HIV-1 and HTLV-1 strains could help in the development of vaccines that pre-empt the viral escape process.
C1 Escola Bahiana Med & Saude Publ, Fdn Desenvolvimento Ciencias, Salvador, BA, Brazil.
   Fiocruz MS, Ctr Pesquisa Goncalo Moniz, Lab Avancado Saude Publ, BR-40295001 Salvador, BA, Brazil.
   Univ Oxford, Dept Zool, Oxford OX1 2JD, England.
RP Alcantara, LCJ (corresponding author), Escola Bahiana Med & Saude Publ, Fdn Desenvolvimento Ciencias, Salvador, BA, Brazil.
EM lalcan@cpqgm.fiocruz.br
RI Queiroz, Artur/F-6083-2014
OI de Queiroz, Artur Trancoso Lopo/0000-0003-4908-9993; Alcantara,
   Luiz/0000-0002-6769-9931
CR ADACHI Y, 1992, J BIOL CHEM, V267, P21977
   Addo MM, 2001, P NATL ACAD SCI USA, V98, P1781, DOI 10.1073/pnas.98.4.1781
   Alcantara LC, 2003, JAIDS-J ACQ IMM DEF, V33, P536, DOI 10.1097/00126334-200308010-00016
   Alcantara LCJ, 2006, AIDS, V20, P780, DOI 10.1097/01.aids.0000216383.14808.13
   Araujo LV, 2006, GENET MOL RES, V5, P203
   Barreto CC, 2006, JAIDS-J ACQ IMM DEF, V41, P338
   Bello G, 2006, AIDS, V20, P763, DOI 10.1097/01.aids.0000216377.84313.52
   Bongertz V, 2000, J ACQ IMMUN DEF SYND, V23, P184
   Bouamr F, 2003, BIOCHEMISTRY-US, V42, P6408, DOI 10.1021/bi020692z
   Caride E, 2000, VIROLOGY, V275, P107, DOI 10.1006/viro.2000.0487
   Couto-Fernandez JC, 2005, MEM I OSWALDO CRUZ, V100, P73, DOI 10.1590/S0074-02762005000100014
   de Oliveira T, 2004, GENETICS, V167, P1047, DOI 10.1534/genetics.103.018135
   De Sa DJ, 2006, AIDS RES HUM RETROV, V22, P1
   Gaschen B, 2001, BIOINFORMATICS, V17, P415, DOI 10.1093/bioinformatics/17.5.415
   Grassmann R, 2005, ONCOGENE, V24, P5976, DOI 10.1038/sj.onc.1208978
   Guiniaraes ML, 2002, AIDS RES HUM RETROV, V18, P1261, DOI 10.1089/088922202320886307
   HALL TA, 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.5598/IMAFUNGUS.2011.02.02.06
   Jeanmougin F, 1998, TRENDS BIOCHEM SCI, V23, P403, DOI 10.1016/S0968-0004(98)01285-7
   Laurentino RV, 2005, MEM I OSWALDO CRUZ, V100, P371, DOI 10.1590/S0074-02762005000400006
   Liu HF, 1996, J GEN VIROL, V77, P359, DOI 10.1099/0022-1317-77-2-359
   LOUWAGIE J, 1993, AIDS, V7, P769, DOI 10.1097/00002030-199306000-00003
   MORGADO MG, 1994, AIDS RES HUM RETROV, V10, P569, DOI 10.1089/aid.1994.10.569
   Morgado MG, 1998, J ACQ IMMUN DEF SYND, V18, P488, DOI 10.1097/00042560-199808150-00011
   Morgado MG, 2002, MEM I OSWALDO CRUZ, V97, P143, DOI 10.1590/S0074-02762002000200001
   NICHOLAS KB, 1997, EMB NEWS, V14, P30
   Ono A, 2000, J VIROL, V74, P2855, DOI 10.1128/JVI.74.6.2855-2866.2000
   Reitter JN, 1998, NAT MED, V4, P679, DOI 10.1038/nm0698-679
   SABINO EC, 1994, J VIROL, V68, P6340, DOI 10.1128/JVI.68.10.6340-6346.1994
   SCHULZ TF, 1991, VIROLOGY, V184, P483, DOI 10.1016/0042-6822(91)90418-B
   Shafer Robert W, 2000, AIDS Rev, V2, P211
   SOARES EA, 2005, AIDS S4, V18, pS81
   Soares MA, 2003, AIDS, V17, P11, DOI 10.1097/00002030-200301030-00004
   Sundaram R, 2004, J BIOL CHEM, V279, P24141, DOI 10.1074/jbc.M313210200
   SWOFFORD DL, 1998, PAUP PHYLOGENETIC AN
   Vallinoto ACR, 2004, JPN J INFECT DIS, V57, P156
   Yamashita M, 1999, VIROLOGY, V261, P59
   Zehender G, 2004, J MED VIROL, V74, P207, DOI 10.1002/jmv.20165
NR 37
TC 6
Z9 6
U1 0
U2 2
PU FUNDACO OSWALDO CRUZ
PI RIO DE JANEIRO, RJ
PA AV BRASIL 4365, 21045-900 RIO DE JANEIRO, RJ, BRAZIL
SN 0074-0276
EI 1678-8060
J9 MEM I OSWALDO CRUZ
JI Mem. Inst. Oswaldo Cruz
PD MAY 31
PY 2007
VL 102
IS 2
BP 133
EP 139
DI 10.1590/S0074-02762007005000005
PG 7
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA 172KD
UT WOS:000246802300002
PM 17426875
OA DOAJ Gold, Green Published
DA 2020-10-22
ER

PT J
AU Mota, ACA
   Van Dooren, S
   Fernandes, FMD
   Pereira, SA
   Queiroz, ATL
   Gallazzi, VO
   Vandamme, AM
   Galvao-Castro, B
   Alcantara, LCJ
AF Andrade Mota, Augusto Cesar
   Van Dooren, Sonia
   De Campos Fernandes, Flora Maria
   Pereira, Sergio Araujo
   Lopo Queiroz, Artur Trancoso
   Gallazzi, Viviana Olavarria
   Vandamme, Anne-Mieke
   Galvao-Castro, Bernardo
   Junior Alcantara, Luiz Carlos
TI The close relationship between South African and Latin American HTLV
   type 1 strains corroborated in a molecular epidemiological study of the
   HTLV type 1 isolates from a blood donor cohort
SO AIDS RESEARCH AND HUMAN RETROVIRUSES
LA English
DT Article
ID VIRUS TYPE-I; CELL LYMPHOTROPIC VIRUS; PHYLOGENETIC SUBTYPES;
   LEUKEMIA-LYMPHOMA; TRANSMISSION; RELATIVES; SEQUENCE; VARIANT; ORIGIN;
   BRAZIL
AB It has been difficult to explain why all HTLV-1 sequences in Salvador, a city in the northeast of Brazil, belong to the Transcontinental ( A) subgroup of the Cosmopolitan ( a) subtype, since according to historical data the vast majority of slaves brought to Brazil ( through Salvador) came from west Africa, where only the western African subgroup ( C) has been found. To shed more light on this subject we conducted a phylogenetic analysis of 23 isolates from blood donors of Salvador. DNA was extracted and submitted to a nested PCR for amplification of the entire LTR region. The PCR products were purified and sequenced on an automated sequencer. Neighbor-joining and maximum likelihood phylogenetic analyses were performed. None of the new sequences from Salvador clustered within the West-African subgroup C. Confirming previous results, all sequences belonged to the Transcontinental subgroup ( A) of the Cosmopolitan subtype, and clustered in two Latin American clusters. In addition we showed sequences from southern Africa clustering in both Latin American clusters. One of the new sequences is ancestral to the larger Latin American cluster beta due to a duplication of a 12-bp long fragment, a finding that has not been previously described. These findings support the hypothesis that HTLV-1 isolates circulating in Latin America have a closer relationship to South African compared to West-African HTLV-1 strains. The 12-bp- long duplications in one of the sequences has no obvious clinical or biological implications yet.
C1 LASP, CPqGM, FIOCRUZ,Goncalo Moniz Res Ctr, Oswaldo Cruz Fdn,Adv Publ Hlth Lab, BR-40295001 Salvador, BA, Brazil.
   Bahia Sch Med & Publ Hlth, Fdn Sci Dev, Salvador, BA, Brazil.
   Katholieke Univ Leuven, Rega Inst Med Res, Louvain, Belgium.
RP Alcantara, LCJ (corresponding author), LASP, CPqGM, FIOCRUZ,Goncalo Moniz Res Ctr, Oswaldo Cruz Fdn,Adv Publ Hlth Lab, Rua Waldemar Falcao 121, BR-40295001 Salvador, BA, Brazil.
EM lalcan@cpqgm.fiocruz.br
RI Vandamme, Anne-Mieke/I-4127-2012; Queiroz, Artur/F-6083-2014
OI Vandamme, Anne-Mieke/0000-0002-6594-2766; Alcantara,
   Luiz/0000-0002-6769-9931; de Queiroz, Artur Trancoso
   Lopo/0000-0003-4908-9993
CR Alcantara LC, 2003, JAIDS-J ACQ IMM DEF, V33, P536, DOI 10.1097/00126334-200308010-00016
   Alcantara LCJ, 2006, AIDS, V20, P780, DOI 10.1097/01.aids.0000216383.14808.13
   CURTIN PD, 1969, SLAVE ATLANTIC TRADE
   Dourado I, 2003, JAIDS-J ACQ IMM DEF, V34, P527, DOI 10.1097/00126334-200312150-00013
   GASMI M, 1994, AIDS RES HUM RETROV, V10, P1313, DOI 10.1089/aid.1994.10.1313
   GESSAIN A, 1993, J VIROL, V67, P1015, DOI 10.1128/JVI.67.2.1015-1023.1993
   GESSAIN A, 1992, J VIROL, V66, P2288, DOI 10.1128/JVI.66.4.2288-2295.1992
   HAHN BH, 1984, INT J CANCER, V34, P613, DOI 10.1002/ijc.2910340505
   Mahieux R, 1998, J VIROL, V72, P10316, DOI 10.1128/JVI.72.12.10316-10322.1998
   Mboudjeka I, 1997, JPN J CANCER RES, V88, P619, DOI 10.1111/j.1349-7006.1997.tb00427.x
   MIURA T, 1994, P NATL ACAD SCI USA, V91, P1124, DOI 10.1073/pnas.91.3.1124
   MOTA A, 2006, BRAZIL J HEMATOL HEM, V28, P120
   NICHOLS KB, 1997, EMBNEW NEWS, P30
   Proietti FA, 2005, ONCOGENE, V24, P6058, DOI 10.1038/sj.onc.1208968
   Salemi M, 1998, VIROLOGY, V246, P277, DOI 10.1006/viro.1998.9215
   Swofford David L., 1996, P407
   Van Dooren S, 2004, MOL BIOL EVOL, V21, P603, DOI 10.1093/molbev/msh053
   Van Dooren S, 1998, J GEN VIROL, V79, P2695, DOI 10.1099/0022-1317-79-11-2695
   Verger Pierre Fatumbi, 1968, FLUX REFLUX TRAITE N
   VIDAL AU, 1994, J GEN VIROL, V75, P3655, DOI 10.1099/0022-1317-75-12-3655
   WATTEL E, 1995, J VIROL, V69, P2863, DOI 10.1128/JVI.69.5.2863-2868.1995
   Wolfe ND, 2005, P NATL ACAD SCI USA, V102, P7994, DOI 10.1073/pnas.0501734102
   XIA X, 2000, DAMBE DATA ANAL MOL
   Yamashita M, 1999, VIROLOGY, V261, P59
NR 24
TC 12
Z9 13
U1 0
U2 0
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 0889-2229
EI 1931-8405
J9 AIDS RES HUM RETROV
JI Aids Res. Hum. Retrovir.
PD APR
PY 2007
VL 23
IS 4
BP 503
EP 507
DI 10.1089/aid.2006.0203
PG 5
WC Immunology; Infectious Diseases; Virology
SC Immunology; Infectious Diseases; Virology
GA 160AN
UT WOS:000245909300003
PM 17506606
DA 2020-10-22
ER

PT J
AU Rego, F
   Moura-Neto, J
   Goncalves, M
   Pereira, O
   Galvao-Castro, B
   Alcantara, L
AF Rego, Filipe
   Moura-neto, Jose
   Goncalves, Marilda
   Pereira, Osmario
   Galvao-Castro, Beardo
   Alcantara, Luiz
TI Seroprevalence and molecular epidemiology study of HTLV-1 isolates from
   three villages of the Sao Francisco Valley, Bahia, Brazil
SO AIDS RESEARCH AND HUMAN RETROVIRUSES
LA English
DT Meeting Abstract
CT 13th International Conference on Human Retrovirology - HTLV and Related
   Viruses
CY MAY 21-25, 2007
CL Hakone, JAPAN
C1 Fundacao Oswaldo Cruz, Goncalo Moniz Res Ctr, Adv Publ Hlth Lab, Salvador, BA, Brazil.
   Bahia Fdn Dev sci, Sch Med & Publ Hlth, HTLV Ctr, Salvador, BA, Brazil.
   Fundacao Oswaldo Cruz, Goncalo Res Ctr, Pathol & Mol Biol Lab, Salvador, BA, Brazil.
EM filipe_biomedicina@yahoo.com.br
NR 0
TC 0
Z9 0
U1 0
U2 0
PU MARY ANN LIEBERT INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 0889-2229
J9 AIDS RES HUM RETROV
JI Aids Res. Hum. Retrovir.
PD APR
PY 2007
VL 23
IS 4
BP 632
EP 632
PG 1
WC Immunology; Infectious Diseases; Virology
SC Immunology; Infectious Diseases; Virology
GA 160AN
UT WOS:000245909300161
DA 2020-10-22
ER

PT J
AU Mota-Miranda, AC
   Pereira, S
   Colin, D
   Galvao-Castro, B
   Alcantara, LC
AF Mota-Miranda, Aline Cristina
   Pereira, Sergio
   Colin, Denise
   Galvao-Castro, Bernardo
   Alcantara, Luiz Carlos
TI Molecular epidemiology of HTLV-1 in the north of Brazil
SO AIDS RESEARCH AND HUMAN RETROVIRUSES
LA English
DT Meeting Abstract
CT 13th International Conference on Human Retrovirology - HTLV and Related
   Viruses
CY MAY 21-25, 2007
CL Hakone, JAPAN
C1 Oswaldo Crus Fdn, Goncalo Moniz Res Ctr, Adv Publ Hlth Lab, Salvador, BA, Brazil.
   FUNDHACRE, Rio Branco, Brazil.
   Bahia Fdn Dev Sci, Sch Med & Publ Hlth, Salvador, BA, Brazil.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU MARY ANN LIEBERT INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 0889-2229
J9 AIDS RES HUM RETROV
JI Aids Res. Hum. Retrovir.
PD APR
PY 2007
VL 23
IS 4
BP 640
EP 640
PG 1
WC Immunology; Infectious Diseases; Virology
SC Immunology; Infectious Diseases; Virology
GA 160AN
UT WOS:000245909300184
DA 2020-10-22
ER

PT J
AU Mota-Miranda, AC
   de-Oliveira, T
   Bomfim, C
   Moreau, DR
   Galvao-Castro, B
   Alcantara, LC
AF Mota-Miranda, Aline Cristina
   de-Oliveira, Tulio
   Bomfim, Catarina
   Moreau, Domingos Ramon
   Galvao-Castro, Bernardo
   Alcantara, Luiz Carlos
TI Mapping the molecular characteristics of Brazilian HTLV-1 Env (gp46) and
   pol amino acid sequences for vaccine design
SO AIDS RESEARCH AND HUMAN RETROVIRUSES
LA English
DT Meeting Abstract
CT 13th International Conference on Human Retrovirology - HTLV and Related
   Viruses
CY MAY 21-25, 2007
CL Hakone, JAPAN
C1 Fundacao Oswaldo Cruz, Goncalo Moniz Res Ctr, Adv Publ Hlth Lab, Salvador, BA, Brazil.
   Univ Oxford, Oxford, England.
   Bahia Fdn Dev Sci, Sch Med & Publ Hlth, Salvador, BA, Brazil.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU MARY ANN LIEBERT INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 0889-2229
J9 AIDS RES HUM RETROV
JI Aids Res. Hum. Retrovir.
PD APR
PY 2007
VL 23
IS 4
BP 640
EP 640
PG 1
WC Immunology; Infectious Diseases; Virology
SC Immunology; Infectious Diseases; Virology
GA 160AN
UT WOS:000245909300182
DA 2020-10-22
ER

PT J
AU Alcantara, L
   Van Dooren, S
   Deforche, K
   Rambaut, A
   Cassol, S
   Galvao-Castro, B
   Vandamme, AM
   de Oliveira, T
AF Alcantara, Luiz
   Van Dooren, Sonia
   Deforche, Koen
   Rambaut, Andrew
   Cassol, Sharon
   Galvao-Castro, Bernardo
   Vandamme, Anne-Mieke
   de Oliveira, Tulio
TI The LASP HTLV-1 automated subtyping tool
   (http://lasp.cpqgm.fiocruz.br/virus-genotype/html/subtypinghtlv.html)
SO AIDS RESEARCH AND HUMAN RETROVIRUSES
LA English
DT Meeting Abstract
CT 13th International Conference on Human Retrovirology - HTLV and Related
   Viruses
CY MAY 21-25, 2007
CL Hakone, JAPAN
C1 Fiocruz MS, Goncalo Moniz Res Ctr, Adv Publ Hlth Lab, LASP,PqGM, Salvador, BA, Brazil.
   Fdn Sci Dev, Sch Med & Publ Hlth, Salvador, BA, Brazil.
   Katholieke Univ Leuven VIB, Rega Inst Med Res, B-3000 Louvain, Belgium.
   Univ Oxford, Dept Zool, Evolut Grp, Oxford, England.
   Univ Pretoria, Dept Med Virol, HIV Immunopathogenesis & Therapeut Res Program 1, ZA-0002 Pretoria, South Africa.
RI Rambaut, Andrew/B-2481-2009; Vandamme, Anne-Mieke/I-4127-2012
OI Rambaut, Andrew/0000-0003-4337-3707; Vandamme,
   Anne-Mieke/0000-0002-6594-2766
NR 0
TC 0
Z9 0
U1 0
U2 0
PU MARY ANN LIEBERT INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 0889-2229
J9 AIDS RES HUM RETROV
JI Aids Res. Hum. Retrovir.
PD APR
PY 2007
VL 23
IS 4
BP 650
EP 650
PG 1
WC Immunology; Infectious Diseases; Virology
SC Immunology; Infectious Diseases; Virology
GA 160AN
UT WOS:000245909300214
DA 2020-10-22
ER

PT J
AU de Queiroz, ATL
   Santos, LA
   Moreau, DR
   de Oliveira, T
   Watkins, DI
   Galvao-Castro, B
   Alcantara, LC
AF Lopo de Queiroz, Artur Trancoso
   Santos, Luciane Amorim
   Moreau, Domingos Ramon
   de Oliveira, Tulio
   Watkins, David I.
   Galvao-Castro, Bernardo
   Alcantara, Luiz Carlos Junior
TI Identification and characterization of previously described epitopes in
   HIV-1 subtypes B, C, F and BF in Brazil
SO BRAZILIAN JOURNAL OF INFECTIOUS DISEASES
LA English
DT Article
DE hIV-1; env; vaccine; epitope
ID IMMUNODEFICIENCY VIRUS; PREDICTION; PROTEINS; MACAQUES; DATABASE; AIDS
AB Genetic analysis of HIV-1 is essential to improve treatment strategies and select epitopes for vaccine programs. The objective of this study was to determine whether known CD4(+) and CD8(+) epitopes were present in Brazilian HIV-1 strains. We used previously described CD8(+) and CD4(+) epitopes from the Los Alamos laboratory to search for these epitopes in the Brazilian sequences using the HIVbase program and we compared the frequency results with the analyses using physical-chemical profile tools from Network Protein Sequence Analysis (NPSA), and the SYFPEITHI program. Furthermore, this analysis was carried out with the Prosite tool using the GeneDoc program and ds/dn analyses using the Synonymous Nonsynonymous Analysis Program (SNAP). The HIVbase epitope mapping demonstrated that 30 CD8+ and 6 CD41 epitopes were present in the Brazilian sequences at a high frequency. Only two of these epitopes were heavily glycosylated. Interestingly, ds/dn analyses showed evidence of purifying selective pressure. These types of analyses could be useful for the assessment of possible vaccine efficiency in populations.
C1 [Lopo de Queiroz, Artur Trancoso; Santos, Luciane Amorim; Moreau, Domingos Ramon; Galvao-Castro, Bernardo; Alcantara, Luiz Carlos Junior] Fundacao Oswaldo Cruz, Goncalo Moniz Res Ctr, Adv Publ Hlth Lab, BR-40296610 Salvador, BA, Brazil.
   [Lopo de Queiroz, Artur Trancoso; Santos, Luciane Amorim; Galvao-Castro, Bernardo; Alcantara, Luiz Carlos Junior] Fdn Dev Sci, Bahia Sch Med & Publ Hlth, Salvador, BA, Brazil.
   [de Oliveira, Tulio] Univ Oxford, Dept Zool, Oxford OX1 3PS, England.
   [Watkins, David I.] Univ Wisconsin, Sch Med, Dept Pathol, Madison, WI 53706 USA.
RP Alcantara, LC (corresponding author), Fundacao Oswaldo Cruz, Goncalo Moniz Res Ctr, Adv Publ Hlth Lab, Rua Waldemar Falcao 121, BR-40296610 Salvador, BA, Brazil.
EM lalcan@cpqgm.fiocruz.br
RI Queiroz, Artur/F-6083-2014
OI Alcantara, Luiz/0000-0002-6769-9931; de Queiroz, Artur Trancoso
   Lopo/0000-0003-4908-9993
CR ARGOS P, 1982, EUR J BIOCHEM, V128, P565
   BARRESINOUSSI F, 1983, SCIENCE, V220, P868, DOI 10.1126/science.6189183
   BETTE TM, 2004, HIV IMMUNOLOGY HIV S
   Burton DR, 2005, P NATL ACAD SCI USA, V102, P14943, DOI 10.1073/pnas.0505126102
   Carrington M, 1999, SCIENCE, V283, P1748, DOI 10.1126/science.283.5408.1748
   Falquet L, 2002, NUCLEIC ACIDS RES, V30, P235, DOI 10.1093/nar/30.1.235
   Goulder PJR, 2004, NAT REV IMMUNOL, V4, P630, DOI 10.1038/nri1417
   HOPP TP, 1983, MOL IMMUNOL, V20, P483, DOI 10.1016/0161-5890(83)90029-9
   Jeanmougin F, 1998, TRENDS BIOCHEM SCI, V23, P403, DOI 10.1016/S0968-0004(98)01285-7
   Jin X, 1999, J EXP MED, V189, P991, DOI 10.1084/jem.189.6.991
   KARPLUS PA, 1985, NATURWISSENSCHAFTEN, V72, P212, DOI 10.1007/BF01195768
   Korber B, 2000, COMPUTATIONAL ANAL H, P55, DOI DOI 10.1007/B112102
   KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0
   Lamers S, 2004, BIOINFORMATICS, V20, P436, DOI 10.1093/bioinformatics/btg445
   Matano T, 1998, J VIROL, V72, P164, DOI 10.1128/JVI.72.1.164-169.1998
   NEI M, 1986, MOL BIOL EVOL, V3, P418
   Nicholas KB, 1997, EMBNEW NEWS, V4, P14
   PARKER JMR, 1986, BIOCHEMISTRY-US, V25, P5425, DOI 10.1021/bi00367a013
   Rammensee HG, 1999, IMMUNOGENETICS, V50, P213, DOI 10.1007/s002510050595
   Reitter JN, 1998, NAT MED, V4, P679, DOI 10.1038/nm0698-679
NR 20
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER BRAZIL
PI RIO DE JANEIRO
PA R SETE SETEMBRO, 111-16, RIO DE JANEIRO, RJ 20050-006, BRAZIL
SN 1413-8670
EI 1678-4391
J9 BRAZ J INFECT DIS
JI Braz. J. Infect. Dis.
PD FEB
PY 2007
VL 11
IS 1
BP 27
EP 30
PG 4
WC Infectious Diseases
SC Infectious Diseases
GA 274JM
UT WOS:000253997600008
PM 17625722
OA DOAJ Gold, Green Published
DA 2020-10-22
ER

PT J
AU Monteiro, JP
   Ferraro, GA
   Oliveira, T
   Goldani, LZ
   Kashima, S
   Alcantara, LCJ
   Morgado, MG
   Bou-Habib, DC
   Galvao-Castro, B
AF Monteiro, Joana P.
   Ferraro, Geraldo A.
   Oliveira, Tulio
   Goldani, Luciano Z.
   Kashima, Simone
   Alcantara, Luiz C. J.
   Morgado, Mariza G.
   Bou-Habib, Dumith Chequer
   Galvao-Castro, Bernardo
TI Genetic and biologic characterization of HIV type 1 subtype C isolates
   from South Brazil
SO AIDS RESEARCH AND HUMAN RETROVIRUSES
LA English
DT Article
ID IMMUNODEFICIENCY-VIRUS TYPE-1; FULL-LENGTH SEQUENCE; DISEASE
   PROGRESSION; V3 LOOP; ENVELOPE; IDENTIFICATION; VACCINE; GP120
AB The molecular and biological properties of HIV-1 subtype C strains from South Brazil were investigated. We sequenced gag and env fragments of viruses from 22 HIV-1-infected individuals from Porto Alegre City, which has the highest frequency of subtype C in the country. The sequences were then compared with other subtype B, C, and F strains isolated in Brazil and other countries using phylogenetic methods. Amino acid signatures were identified and correlated with phenotypic characteristics. We identified six strains with subtype C (27.3%), eight subtype B (36.4%), one subtype F (4.5%), six C/B recombinants (27.3%), and one B/F recombinant (4.5%). The Brazilian subtype C sequences formed a unique phylogenetic group and presented 6 and 18 specific amino acid signatures in gag and env, respectively. Three distinct patterns of C/B recombinants presented characteristic Brazilian amino acid substitutions. Subtype C viruses were predominantly R5 and non-syncytium-inducing, while C/B recombinants were R5/X4 and syncytium-inducing viruses. These findings suggest that subtype C viruses circulating in Brazil are the result of a unique introduction into the country. Recombination events between subtypes B and C have been occurring frequently for more than 10 years in South Brazil. Biological characterization confirms the hypothesis that subtype C is distinct from the others in the evolution of coreceptor utilization.
C1 LASP CP GM FIOCRUZ, BR-40296710 Salvador, BA, Brazil.
   FBDC, EBMSP, Salvador, BA, Brazil.
   Univ Oxford, Dept Zool, Oxford, England.
   UFRS, Hosp Clin Porto Alegre, Unidade Med Interna, Porto Alegre, RS, Brazil.
   Univ Sao Paulo, Hemoctr Ribeirao Preto, Sao Paulo, Brazil.
   Fiocruz MS, Inst Oswaldo Cruz, Dept Imunol, Lab AIDS & Imunol Mol, Rio De Janeiro, RJ, Brazil.
   Fiocruz MS, Inst Oswaldo Cruz, Dept Imunol, Lab Imunol Clin, Rio De Janeiro, RJ, Brazil.
RP Galvao-Castro, B (corresponding author), LASP CP GM FIOCRUZ, Rua Waldemar Falcao 121, BR-40296710 Salvador, BA, Brazil.
EM bgalvao@cpqgm.fiocruz.br
RI Kashima, Simone/G-4876-2012
OI Kashima, Simone/0000-0002-1487-0141; Alcantara, Luiz/0000-0002-6769-9931
CR Aulicino PC, 2005, AIDS RES HUM RETROV, V21, P894, DOI 10.1089/aid.2005.21.894
   Blackard JT, 1999, VIROLOGY, V254, P220, DOI 10.1006/viro.1998.9504
   Bongertz V, 2000, J ACQ IMMUN DEF SYND, V23, P184
   Brindeiro R, 1999, ANTIMICROB AGENTS CH, V43, P1674, DOI 10.1128/AAC.43.7.1674
   Brindeiro RM, 2003, AIDS, V17, P1063, DOI 10.1097/00002030-200305020-00016
   Carr JK, 1996, J VIROL, V70, P5935, DOI 10.1128/JVI.70.9.5935-5943.1996
   Carrillo A, 1996, J VIROL, V70, P1301, DOI 10.1128/JVI.70.2.1301-1309.1996
   Carrion G, 2004, AIDS RES HUM RETROV, V20, P1022, DOI 10.1089/aid.2004.20.1022
   Cecilia D, 2000, VIROLOGY, V271, P253, DOI 10.1006/viro.2000.0297
   Chackerian B, 1997, J VIROL, V71, P7719, DOI 10.1128/JVI.71.10.7719-7727.1997
   Connor RI, 1997, J EXP MED, V185, P621, DOI 10.1084/jem.185.4.621
   Cornelissen M, 1996, J VIROL, V70, P8209, DOI 10.1128/JVI.70.11.8209-8212.1996
   de Oliveira T, 2005, BIOINFORMATICS, V21, P3797, DOI 10.1093/bioinformatics/bti607
   DELWART EL, 1993, SCIENCE, V262, P1257, DOI 10.1126/science.8235655
   DEWOLF F, 1994, AIDS RES HUM RETROV, V10, P1387, DOI 10.1089/aid.1994.10.1387
   DOE B, 1994, EUR J IMMUNOL, V24, P2369, DOI 10.1002/eji.1830241017
   Esparza J, 2000, LANCET, V355, P2061, DOI 10.1016/S0140-6736(00)02360-6
   Ferraro GA, 2001, AIDS RES HUM RETROV, V17, P1241, DOI 10.1089/088922201750461294
   Gordon M, 2003, J VIROL, V77, P2587, DOI 10.1128/JVI.77.4.2587-2599.2003
   Guiniaraes ML, 2002, AIDS RES HUM RETROV, V18, P1261, DOI 10.1089/088922202320886307
   HALL TA, 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.5598/IMAFUNGUS.2011.02.02.06
   Heyndrickx L, 2000, J VIROL, V74, P363, DOI 10.1128/JVI.74.1.363-370.2000
   Hu QX, 2000, J VIROL, V74, P11858, DOI 10.1128/JVI.74.24.11858-11872.2000
   KORBER BTM, 1994, J VIROL, V68, P6730, DOI 10.1128/JVI.68.10.6730-6744.1994
   Kumar S, 2001, BIOINFORMATICS, V17, P1244, DOI 10.1093/bioinformatics/17.12.1244
   Montano MA, 1997, J VIROL, V71, P8657, DOI 10.1128/JVI.71.11.8657-8665.1997
   Morgado MG, 2002, MEM I OSWALDO CRUZ, V97, P143, DOI 10.1590/S0074-02762002000200001
   Ndung'u T, 2001, J VIROL, V75, P4964, DOI 10.1128/JVI.75.11.4964-4972.2001
   Nicholas KB, 1997, GENEDOC ANAL VISUALI
   OSMANOV S, 1994, AIDS RES HUM RETROV, V10, P1327, DOI 10.1089/aid.1994.10.1327
   Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357
   Reitter JN, 1998, NAT MED, V4, P679, DOI 10.1038/nm0698-679
   Rodrigues R, 2006, VIRUS RES, V116, P201, DOI 10.1016/j.virusres.2005.10.004
   RUBSAMENWAIGMANN H, 1994, AIDS RES HUM RETROV, V10, P1401, DOI 10.1089/aid.1994.10.1401
   Salemi M, 2005, J MOL EVOL, V60, P598, DOI 10.1007/s00239-004-0206-5
   SALMINEN MO, 1995, AIDS RES HUM RETROV, V11, P1423, DOI 10.1089/aid.1995.11.1423
   Salminen MO, 1996, AIDS RES HUM RETROV, V12, P1329, DOI 10.1089/aid.1996.12.1329
   Shankarappa R, 2001, J VIROL, V75, P10479, DOI 10.1128/JVI.75.21.10479-10487.2001
   Soares MA, 2003, AIDS, V17, P11, DOI 10.1097/00002030-200301030-00004
   Swofford DL, 1999, PAUP 4 0 PHYLOGENETI
   Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876
   Yamaguchi-Kabata Y, 2000, J VIROL, V74, P4335, DOI 10.1128/JVI.74.9.4335-4350.2000
NR 42
TC 7
Z9 8
U1 0
U2 0
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 0889-2229
EI 1931-8405
J9 AIDS RES HUM RETROV
JI Aids Res. Hum. Retrovir.
PD JAN
PY 2007
VL 23
IS 1
BP 135
EP 143
DI 10.1089/aid.2006.0064
PG 9
WC Immunology; Infectious Diseases; Virology
SC Immunology; Infectious Diseases; Virology
GA 133EM
UT WOS:000243995300018
PM 17263643
OA Green Published
DA 2020-10-22
ER

PT J
AU Kashima, S
   Alcantara, LC
   Takayanagui, OM
   Cunha, MAV
   Castro, BG
   Pombo-De-Oliveira, MS
   Zago, MA
   Covas, DT
AF Kashima, Simone
   Alcantara, Luiz Carlos
   Takayanagui, Osvaldo Massaiti
   Valtas Cunha, Marco Aurelio
   Castro, Bernardo Galvao
   Pombo-De-Oliveira, Maria Socorro
   Zago, Marco Antonio
   Covas, Dimas Tadeu
TI Distribution of human T cell lymphotropic virus type 1 (HTLV-1) subtypes
   in Brazil: Genetic characterization of LTR and tax region
SO AIDS RESEARCH AND HUMAN RETROVIRUSES
LA English
DT Article
ID TROPICAL SPASTIC PARAPARESIS; PHYLOGENETIC SUBTYPES; LEUKEMIA-LYMPHOMA;
   I INFECTION; EPIDEMIOLOGY; SEQUENCE; AMERICA; STRAINS; PYGMY;
   CLASSIFICATION
AB We report the molecular and epidemiological characterization of 128 human T cell lymphotropic virus type 1 (HTLV-1) isolates from Brazilian patients with different clinical manifestations of the infection. Thirty-two percent of the patients were asymptomatic, 44% had HTLV-1-associated myelopathy/ tropical spastic paraparesis (HAM/TSP), and 23% had adult T cell leukemia/lymphoma (ATLL). Phylogenetic analysis performed using part of the LTR region of the viral genome revealed that all Brazilian isolates belonged to the Cosmopolitan subtype, with the following distribution within the Transcontinental subgroup: 81.6% within the Latin American cluster and 15.8% outside the Latin American cluster. Two isolates belonged to the Japanese subgroup. Molecular analysis of the tax region showed a high nucleotide similarity (similar to 99%) with 41 prototype sequences, including the ATK-1 isolate. The mean number of nucleotide substitutions ranged from 1 to 8. Five specific nucleotide substitutions, C7401T, T7914C, C7920T, C7982T, and G8231A, were highly conserved among the Brazilian isolates (79.6%), with a frequency ranging from 81.6% to 100% in the sample group and from 18.4% to 24.1% in the prototypes used, suggesting the existence of a molecular signature. These changes were not correlated with a specific clinical status of the patients and could be a molecular characteristic of the HTLV-1 strains that circulate in Brazil.
C1 Reg Blood Ctr Ribeirao Preto, Mol Biol Lab, BR-14051140 Ribeirao Preto, Brazil.
   Fundacao Oswaldo Cruz, Goncalo Moniz Res Ctr, Adv Publ Hlth Lab, Salvador, BA, Brazil.
   Univ Sao Paulo, Dept Neurol, Sao Paulo, Brazil.
   Reg Blood Ctr Ribeirao Preto, Bioinformat Lab, BR-14051140 Ribeirao Preto, Brazil.
   Inst Nacl Canc, Rio De Janeiro, Brazil.
   Univ Sao Paulo, Fac Med Ribeirao Preto, Sao Paulo, Brazil.
RP Kashima, S (corresponding author), Reg Blood Ctr Ribeirao Preto, Mol Biol Lab, Rue Tenente Catao Roxo,2501, BR-14051140 Ribeirao Preto, Brazil.
EM skashima@hemocentro.fmrp.usp.br
RI Covas, Dimas T/C-5431-2013; Kashima, Simone/G-4876-2012;
   Pombo-de-Oliveira, Maria S./I-8884-2014; Takayanagui, Osvaldo
   M/C-8159-2013; ZAGO, MARCO A/E-9442-2017
OI Covas, Dimas T/0000-0002-7364-2595; Kashima, Simone/0000-0002-1487-0141;
   Pombo-de-Oliveira, Maria S./0000-0002-1507-004X; Takayanagui, Osvaldo
   M/0000-0002-8190-0275; Alcantara, Luiz/0000-0002-6769-9931
CR Alcantara LCJ, 2003, AIDS RES HUM RETROV, V19, P519, DOI 10.1089/088922203766774577
   ARANGO C, 1988, ANN NEUROL, V23, pS161, DOI 10.1002/ana.410230736
   CARTIER L, 1989, J NEUROL NEUROSUR PS, V52, P304, DOI 10.1136/jnnp.52.3.304
   Chen JL, 1995, AIDS RES HUM RETROV, V11, P1529, DOI 10.1089/aid.1995.11.1529
   Dourado I, 2003, JAIDS-J ACQ IMM DEF, V34, P527, DOI 10.1097/00126334-200312150-00013
   Furukawa Y, 2000, J INFECT DIS, V182, P1343, DOI 10.1086/315897
   GalvaoCastro B, 1997, TRANSFUSION, V37, P242, DOI 10.1046/j.1537-2995.1997.37297203532.x
   GASMI M, 1994, AIDS RES HUM RETROV, V10, P1313, DOI 10.1089/aid.1994.10.1313
   GESSAIN A, 1993, J VIROL, V67, P1015, DOI 10.1128/JVI.67.2.1015-1023.1993
   GESSAIN A, 1985, LANCET, V2, P407
   GUDERIAN R, 1994, T ROY SOC TROP MED H, V88, P399, DOI 10.1016/0035-9203(94)90398-0
   HAHN BH, 1984, INT J CANCER, V34, P613, DOI 10.1002/ijc.2910340505
   KORBER B, 1992, AIDS RES HUM RETROV, V8, P1549, DOI 10.1089/aid.1992.8.1549
   Mboudjeka I, 1997, JPN J CANCER RES, V88, P619, DOI 10.1111/j.1349-7006.1997.tb00427.x
   MIURA T, 1994, P NATL ACAD SCI USA, V91, P1124, DOI 10.1073/pnas.91.3.1124
   MOREIRA ED, 1993, J ACQ IMMUN DEF SYND, V6, P959
   MUELLER N, 1991, CANCER CAUSE CONTROL, V2, P37, DOI 10.1007/BF00052359
   OSAME M, 1986, LANCET, V1, P1031
   Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357
   POIESZ BJ, 1980, P NATL ACAD SCI-BIOL, V77, P7415, DOI 10.1073/pnas.77.12.7415
   Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817
   Salemi M, 1998, VIROLOGY, V246, P277, DOI 10.1006/viro.1998.9215
   SHIMOYAMA M, 1991, BRIT J HAEMATOL, V79, P428, DOI 10.1111/j.1365-2141.1991.tb08051.x
   UCHIYAMA T, 1977, BLOOD, V50, P481, DOI 10.1182/blood.V50.3.481.481
   Van Dooren S, 1998, J GEN VIROL, V79, P2695, DOI 10.1099/0022-1317-79-11-2695
   VIDAL AU, 1994, J GEN VIROL, V75, P3655, DOI 10.1099/0022-1317-75-12-3655
   Wolfe ND, 2005, P NATL ACAD SCI USA, V102, P7994, DOI 10.1073/pnas.0501734102
   YAMASHITA M, 1995, VIRUS GENES, V10, P85, DOI 10.1007/BF01724300
   Yamashita M, 1999, VIROLOGY, V261, P59
NR 29
TC 19
Z9 19
U1 0
U2 2
PU MARY ANN LIEBERT INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 0889-2229
J9 AIDS RES HUM RETROV
JI Aids Res. Hum. Retrovir.
PD OCT
PY 2006
VL 22
IS 10
BP 953
EP 959
DI 10.1089/aid.2006.22.953
PG 7
WC Immunology; Infectious Diseases; Virology
SC Immunology; Infectious Diseases; Virology
GA 101FV
UT WOS:000241726000005
PM 17067264
OA Green Published
DA 2020-10-22
ER

PT J
AU Alcantara, LCJ
   de Oliveira, T
   Gordon, M
   Pybus, O
   Mascarenhas, RE
   Seixas, MO
   Goncalves, M
   Hlela, C
   Cassol, S
   Galvao-Castro, B
AF Alcantara, LCJ
   de Oliveira, T
   Gordon, M
   Pybus, O
   Mascarenhas, RE
   Seixas, MO
   Goncalves, M
   Hlela, C
   Cassol, S
   Galvao-Castro, B
TI Tracing the origin of Brazilian HTLV-1 as determined by analysis of host
   and viral genes
SO AIDS
LA English
DT Editorial Material
ID VIRUS TYPE-I; SEQUENCE; STRAINS
AB We compared the genetic diversity of the Brazilian human T-cell lymphotropic virus type 1 isolates with those found in KwaZulu-Natal (KZN), South Africa, and with the genetic background of the hosts. The seroprevalence rate in KZN was 1.7%. All sequences belonged to the A subgroup. The presence of South African sequences in two different clusters from Brazil, and the finding of the beta(A)-globin haplotype in infected hosts are consistent with the transmission of this virus from southern Africa to Brazil.
C1 Oswaldo Cruz Fdn, Goncalo Moniz Res Ctr, Publ Hlth Adv Lab, Salvador, BA, Brazil.
   Bahia Sch Med & Publ Hlth Fdn Sci Dev, Salvador, BA, Brazil.
   Univ KwaZulu Natal, Nelson Mandela Med Sch, Africa Ctr Hlth & Populat Studies, Mol Virol & Bioinformat Unit, Durban, South Africa.
   Univ Oxford, Dept Zool, Oxford, England.
   Oswaldo Cruz Fdn, Goncalo Moniz Res Ctr, Mol Biol & Pathol Lab, Salvador, BA, Brazil.
   Univ Pretoria, Dept Virol, Immunopathogenesis Unit HIV1, ZA-0002 Pretoria, South Africa.
RP Alcantara, LCJ (corresponding author), Oswaldo Cruz Fdn, Goncalo Moniz Res Ctr, Publ Hlth Adv Lab, Salvador, BA, Brazil.
RI Hlela, Carol/AAC-2832-2020; Pybus, Oliver G/B-2640-2012
OI Hlela, Carol/0000-0002-8028-3252; Pybus, Oliver G/0000-0002-8797-2667;
   Alcantara, Luiz/0000-0002-6769-9931
CR ALCANTARA LCJ, 2003, J ACQ IMMUN DEF SYND, V3, P536
   Bhigjee AI, 1999, AIDS RES HUM RETROV, V15, P1229, DOI 10.1089/088922299310322
   CURTIN PD, 1969, SLAVE ATLANTIC TRADE
   GESSAIN A, 1993, J VIROL, V67, P1015, DOI 10.1128/JVI.67.2.1015-1023.1993
   SHILLINGTON K, 1995, HIST AFRICA
   VALLEJO A, 1995, J VIROL METHODS, V51, P9, DOI 10.1016/0166-0934(94)00093-V
   Van Dooren S, 2004, MOL BIOL EVOL, V21, P603, DOI 10.1093/molbev/msh053
   Vandamme AM, 1998, TRENDS MICROBIOL, V6, P477, DOI 10.1016/S0966-842X(98)01406-1
NR 8
TC 23
Z9 23
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0269-9370
J9 AIDS
JI Aids
PD MAR 21
PY 2006
VL 20
IS 5
BP 780
EP 782
DI 10.1097/01.aids.0000216383.14808.13
PG 3
WC Immunology; Infectious Diseases; Virology
SC Immunology; Infectious Diseases; Virology
GA 027MZ
UT WOS:000236421000022
PM 16514313
OA Green Published
DA 2020-10-22
ER

PT J
AU Carneiro-Proietti, ABF
   Catalan-Soares, BC
   Castro-Costa, CM
   Murphy, EL
   Sabino, EC
   Hisada, M
   Galvao-Castro, B
   Alcantara, LCJ
   Remondegui, C
   Verdonck, K
   Proietti, FA
AF Carneiro-Proietti, ABF
   Catalan-Soares, BC
   Castro-Costa, CM
   Murphy, EL
   Sabino, EC
   Hisada, M
   Galvao-Castro, B
   Alcantara, LCJ
   Remondegui, C
   Verdonck, K
   Proietti, FA
TI HTLV in the Americas: challenges and perspectives
SO REVISTA PANAMERICANA DE SALUD PUBLICA-PAN AMERICAN JOURNAL OF PUBLIC
   HEALTH
LA English
DT Article
DE Human T-lymphotropic virus 1; human T-lymphotropic virus 2;
   Retroviridae; RNA tumor viruses; blood donors; preventive medicine;
   Americas
ID CELL LYMPHOTROPIC VIRUS; INTRAVENOUS-DRUG-USERS; TROPICAL SPASTIC
   PARAPARESIS; LEUKEMIA-VIRUS; BLOOD-DONORS; II INFECTION; MOLECULAR
   EPIDEMIOLOGY; VERTICAL TRANSMISSION; NATURAL-HISTORY; AFRICAN ORIGIN
AB The first description of the human T-lymphotropic virus type 1 (HTLV-1) was made in 1980, followed closely by the discovery of HTLV-2, in 1982. Since then, the main characteristics of these viruses, commonly referred to as HTLV-1/2, have been thoroughly studied. Central and South America and the Caribbean are areas of high prevalence of HTLV-1 and HTVL-2 and have clusters of infected people. The major modes of transmission have been through sexual contact, blood, and mother to child via breast-feeding. HTLV-1 is associated with adult T-cell leukemia/lymphoma (ATL), HTLV-associated myelopathy/tropical spastic paraparesis (HAM/TSP), and HTLV-associated uveitis as well as infectious dermatitis of children. More clarification is needed in the possible role of HTLV in rheumatologic, psychiatric, and infectious diseases. Since cures for ATL and HAM/TSP are lacking and no vaccine is available to prevent HTLV-1 and HTLV-2 transmission, these illnesses impose enormous social and financial costs on infected individuals, their families, and health care systems. For this reason, public health interventions aimed at counseling and educating high-risk individuals and populations are of vital importance. In the Americas this is especially important in the areas of high prevalence.
C1 Fdn Hemominas, Belo Horizonte, MG, Brazil.
   Univ Fed Ceara, Fortaleza, Ceara, Brazil.
   Univ Calif San Francisco, San Francisco, CA 94143 USA.
   Fdn Pro Sangue, Hemoctr Sao Paulo, Sao Paulo, Brazil.
   NCI, NIH, Div Canc Epidemiol & Genet, Viral Epidemiol Branch, Bethesda, MD 20892 USA.
   Fundacao Oswaldo Cruz, Ctr Pewquisas Goncalo Moniz, Lab Avancado Saude Publ, Salvador, BA, Brazil.
   Fdn Bahiana Desenvolvimento Ciencias, Escola Bahiana Med & Saude Publ, Salvador, BA, Brazil.
   Hosp San Roque, Serv Infectol & Med Trop, San Salvador De Jujuy, Argentina.
   Univ Peruana Cayetano Heredia, Inst Trop Med Alexander Von Humboldt, Lima, Peru.
   Univ Fed Minas Gerais, Dept Med Prevent & Social, Belo Horizonte, MG, Brazil.
RP Carneiro-Proietti, ABF (corresponding author), Rua Grao Para,882, BR-30150341 Belo Horizonte, MG, Brazil.
EM presid@hemominas.mg.gov.br
RI Sabino, Ester Cerdeira/F-7750-2010; Verdonck, Kristien/AAN-8937-2020
OI Sabino, Ester Cerdeira/0000-0003-2623-5126; Alcantara,
   Luiz/0000-0002-6769-9931
CR Adedayo OA, 2004, AM J HEMATOL, V77, P336, DOI 10.1002/ajh.20208
   Alcantara LC, 2003, JAIDS-J ACQ IMM DEF, V33, P536, DOI 10.1097/00126334-200308010-00016
   Alcantara LCJ, 2003, AIDS RES HUM RETROV, V19, P519, DOI 10.1089/088922203766774577
   ALCANTARA LCJ, 2006, IN PRESS AIDS
   Araujo A, 2004, ANN NEUROL, V56, P10, DOI 10.1002/ana.20126
   Bartholomew C, 1989, Bull Pan Am Health Organ, V23, P76
   *BRAS MIN SAUD, 2003, GUIA MAN CLIN PAC HT
   Buggage Ronald R, 2003, Curr Opin Ophthalmol, V14, P420, DOI 10.1097/00055735-200312000-00016
   Calattini S, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-30
   Carneiro-Proietti ABF, 2002, J BIOMED SCI, V9, P587, DOI 10.1007/BF02254986
   Costa CMD, 2002, ACTA NEUROL BELG, V102, P21
   DAISLEY H, 1991, TROP MED PARASITOL, V42, P404
   De Castro Costa C M, 1994, Arq Neuropsiquiatr, V52, P585
   Dourado I, 2003, JAIDS-J ACQ IMM DEF, V34, P527, DOI 10.1097/00126334-200312150-00013
   Edlich RF, 2000, J EMERG MED, V18, P109, DOI 10.1016/S0736-4679(99)00173-0
   FEIGAL E, 1991, J INFECT DIS, V164, P36, DOI 10.1093/infdis/164.1.36
   FEIGENBAUM F, 1994, TRANSFUSION, V34, P158, DOI 10.1046/j.1537-2995.1994.34294143946.x
   Fujiyoshi T, 1999, AIDS RES HUM RETROV, V15, P1235, DOI 10.1089/088922299310124
   GILL PS, 1995, NEW ENGL J MED, V332, P1744, DOI 10.1056/NEJM199506293322603
   Gongora-Biachi RA, 1997, ARCH MED RES, V28, P555
   Gotuzzo E, 2000, INFECT DIS CLIN N AM, V14, P211, DOI 10.1016/S0891-5520(05)70225-7
   Goubau P, 1996, J ACQ IMMUN DEF SYND, V13, pS242, DOI 10.1097/00042560-199600001-00036
   GRANT W, 1992, DIAGN MICR INFEC DIS, V15, P121, DOI 10.1016/0732-8893(92)90034-Q
   Hisada M, 2005, HEPATOLOGY, V42, P1446, DOI 10.1002/hep.20938
   Hisada M, 2004, J INFECT DIS, V190, P1605, DOI 10.1086/424598
   Hisada M, 2002, CLIN INFECT DIS, V34, P1551, DOI 10.1086/340537
   HJELLE B, 1994, AM J TROP MED HYG, V51, P11, DOI 10.4269/ajtmh.1994.51.11
   HORAI S, 1993, MOL BIOL EVOL, V10, P23
   KALYANARAMAN VS, 1982, SCIENCE, V218, P571, DOI 10.1126/science.6981847
   KAPLAN JE, 1989, AM J TROP MED HYG, V40, P659, DOI 10.4269/ajtmh.1989.40.659
   KHABBAZ RF, 1990, AIDS RES HUM RETROV, V6, P959, DOI 10.1089/aid.1990.6.959
   KHABBAZ RF, 1992, NEW ENGL J MED, V326, P375, DOI 10.1056/NEJM199202063260604
   KIRA J, 1991, J NEUROL SCI, V106, P41, DOI 10.1016/0022-510X(91)90192-A
   LAGRENADE L, 1990, LANCET, V336, P1345
   LEE HH, 1990, J INFECT DIS, V162, P347, DOI 10.1093/infdis/162.2.347
   Liu H, 2001, VIROLOGY, V279, P90, DOI 10.1006/viro.2000.0632
   Manns A, 1999, LANCET, V353, P1951, DOI 10.1016/S0140-6736(98)09460-4
   Mansuy JM, 1999, AM J TROP MED HYG, V61, P598, DOI 10.4269/ajtmh.1999.61.598
   MASSARI V, 1994, TRANSFUSION, V34, P198, DOI 10.1046/j.1537-2995.1994.34394196615.x
   MURPHY EL, 1991, AM J EPIDEMIOL, V133, P1114, DOI 10.1093/oxfordjournals.aje.a115824
   Murphy EL, 1999, J INFECT DIS, V180, P1777, DOI 10.1086/315139
   Nakagawa M, 1996, J NEUROVIROL, V2, P345, DOI 10.3109/13550289609146899
   Okamura J, 2005, BLOOD, V105, P4143, DOI 10.1182/blood-2004-11-4193
   Orland Jennie R, 2004, Retrovirology, V1, P4, DOI 10.1186/1742-4690-1-4
   Peters AA, 2000, AIDS RES HUM RETROV, V16, P883, DOI 10.1089/08892220050042828
   POIESZ BJ, 1980, P NATL ACAD SCI-BIOL, V77, P7415, DOI 10.1073/pnas.77.12.7415
   Proietti FA, 2005, ONCOGENE, V24, P6058, DOI 10.1038/sj.onc.1208968
   Rabkin CS, 1996, J ACQ IMMUN DEF SYND, V12, P519, DOI 10.1097/00042560-199608150-00013
   RODRIGUEZ EM, 1993, J ACQ IMMUN DEF SYND, V6, P313
   Roucoux DF, 2004, AIDS REV, V6, P144
   Rouet F, 2001, J CLIN MICROBIOL, V39, P1247, DOI 10.1128/JCM.39.4.1247-1253.2001
   Sabino EC, 1999, J CLIN MICROBIOL, V37, P1324, DOI 10.1128/JCM.37.5.1324-1328.1999
   Salles Nanci A., 2003, Rev Panam Salud Publica, V13, P111, DOI 10.1590/S1020-49892003000200011
   Seed CR, 2003, TRANSFUSION, V43, P226, DOI 10.1046/j.1537-2995.2003.00304.x
   Segurado A, 1997, J ACQ IMMUN DEF SYND, V16, P308, DOI 10.1097/00042560-199712010-00014
   SHIMOYAMA M, 1991, BRIT J HAEMATOL, V79, P428, DOI 10.1111/j.1365-2141.1991.tb08051.x
   Shindo N, 2002, AIDS RES HUM RETROV, V18, P71, DOI 10.1089/088922202753394736
   Silva Cabrera E, 1997, Rev Cubana Med Trop, V49, P24
   SWITZER WM, 1995, J VIROL, V69, P621, DOI 10.1128/JVI.69.2.621-632.1995
   Taylor GP, 2005, ONCOGENE, V24, P6047, DOI 10.1038/sj.onc.1208979
   Thomas MC, 1998, INT J CLIN PRACT, V52, P520
   Vallinoto ACR, 2004, JPN J INFECT DIS, V57, P156
   Vallinoto ACR, 2002, HUM BIOL, V74, P633, DOI 10.1353/hub.2002.0059
   Van Dooren S, 2004, MOL BIOL EVOL, V21, P603, DOI 10.1093/molbev/msh053
   Van Dooren S, 1998, J GEN VIROL, V79, P2695, DOI 10.1099/0022-1317-79-11-2695
   Vandamme AM, 1998, J VIROL, V72, P4327, DOI 10.1128/JVI.72.5.4327-4340.1998
   VITEK CR, 1995, J INFECT DIS, V171, P1022, DOI 10.1093/infdis/171.4.1022
   Wolfe ND, 2005, P NATL ACAD SCI USA, V102, P7994, DOI 10.1073/pnas.0501734102
   Yamasaki K, 1997, J NEUROL SCI, V147, P135, DOI 10.1016/S0022-510X(96)05319-1
   YOSHIDA M, 1984, P NATL ACAD SCI-BIOL, V81, P2534, DOI 10.1073/pnas.81.8.2534
NR 70
TC 50
Z9 57
U1 1
U2 5
PU PAN AMER HEALTH ORGANIZATION
PI WASHINGTON
PA 525 23RD ST NW, WASHINGTON, DC 20037 USA
SN 1020-4989
J9 REV PANAM SALUD PUBL
JI Rev. Panam. Salud Publica
PD JAN
PY 2006
VL 19
IS 1
BP 44
EP 53
DI 10.1590/S1020-49892006000100007
PG 10
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA 014DL
UT WOS:000235458900008
PM 16536938
OA Bronze, Green Published
DA 2020-10-22
ER

PT J
AU Gadelha, SR
   Alcantara, LC
   Costa, GCS
   Rios, DL
   Galvao-Castro, B
AF Gadelha, SR
   Alcantara, LC
   Costa, GCS
   Rios, DL
   Galvao-Castro, B
TI Ethnic differences in the distribution of interleukin-6 polymorphisms
   among three Brazilian ethnic groups
SO HUMAN BIOLOGY
LA English
DT Article
DE interleukin-6; IL-6 gene; polymorphisms; Brazilian populations
ID VIRUS TYPE-I; IL-6 GENE; LYMPHOTROPIC VIRUS; PROMOTER REGION; CYTOKINE;
   ASSOCIATION; SUSCEPTIBILITY; POPULATIONS; HAPLOTYPES; SALVADOR
AB Polymorphisms in the interleukin-6 promoter region have been associated with diseases. In this study we investigated the -634G/C and -174G/C IL-6 promoter polymorphisms in three Brazilian ethnic groups. We verified that the allele frequencies of the two polymorphisms and haplotype frequencies varied significantly between the populations.
C1 Fundacao Oswaldo Cruz, Lab Avancado Saude Publ, Ctr Pesquisas Goncalo Moniz, Salvador, BA, Brazil.
   Escola Bahiana Med & Saude Publ, Fdn Bahiana Desenvolvimento Ciencias, Salvador, BA, Brazil.
RP Gadelha, SR (corresponding author), Fundacao Oswaldo Cruz, Lab Avancado Saude Publ, Ctr Pesquisas Goncalo Moniz, Rua Waldemar Falcao 121, Salvador, BA, Brazil.
RI Gadelha, Sandra/X-3373-2019
OI Gadelha, Sandra/0000-0002-3079-488X; Alcantara, Luiz/0000-0002-6769-9931
CR ABRAMSON JH, 2001, COMPUTER PROGRAM EPI
   Alcantara LC, 2003, JAIDS-J ACQ IMM DEF, V33, P536, DOI 10.1097/00126334-200308010-00016
   Alves-Silva J, 2000, AM J HUM GENET, V67, P444, DOI 10.1086/303004
   Callegari-Jacques Sidia M., 1999, Ciencia e Cultura (Sao Paulo), V51, P166
   Cox ED, 2001, TRANSPLANTATION, V72, P720, DOI 10.1097/00007890-200108270-00027
   Dornelles CL, 1999, GENET MOL BIOL, V22, P151, DOI 10.1590/S1415-47571999000200003
   Dourado I, 2003, JAIDS-J ACQ IMM DEF, V34, P527, DOI 10.1097/00126334-200312150-00013
   Ershler WB, 2000, ANNU REV MED, V51, P245, DOI 10.1146/annurev.med.51.1.245
   Fishman D, 1998, J CLIN INVEST, V102, P1369, DOI 10.1172/JCI2629
   GADELHA SR, 2004, NAT M VIR 15 SAO PAU, V9, P203
   GalvaoCastro B, 1997, TRANSFUSION, V37, P242, DOI 10.1046/j.1537-2995.1997.37297203532.x
   Grimaldi R, 2002, HUM GENET, V111, P102, DOI 10.1007/s00439-002-0747-x
   Hayakawa T, 2002, DIABETOLOGIA, V45, P453
   Hoffmann SC, 2002, AM J TRANSPLANT, V2, P560, DOI 10.1034/j.1600-6143.2002.20611.x
   Jahromi MM, 2000, J INTERF CYTOK RES, V20, P885, DOI 10.1089/10799900050163253
   Jenny NS, 2002, ARTERIOSCL THROM VAS, V22, P2066, DOI 10.1161/01.ATV.0000040224.49362.60
   Kitamura A, 2002, DIABETIC MED, V19, P1000, DOI 10.1046/j.1464-5491.2002.00844.x
   Kubaszek A, 2003, DIABETES, V52, P558, DOI 10.2337/diabetes.52.2.558
   Licastro F, 2003, NEUROBIOL AGING, V24, P921, DOI 10.1016/S0197-4580(03)00013-7
   Meenagh A, 2002, HUM IMMUNOL, V63, P1055, DOI 10.1016/S0198-8859(02)00440-8
   Nishimura M, 2002, HUM IMMUNOL, V63, P696, DOI 10.1016/S0198-8859(02)00419-6
   Ota N, 2001, J HUM GENET, V46, P267, DOI 10.1007/s100380170077
   Ribeiro DM, 2003, AM J PHYS ANTHROPOL, V121, P58, DOI 10.1002/ajpa.10193
   Schneider S., 2000, ARLEQUIN VERSION 200
   Shindo N, 2002, AIDS RES HUM RETROV, V18, P71, DOI 10.1089/088922202753394736
   Tokunaga K, 2001, HUM IMMUNOL, V62, P1001, DOI 10.1016/S0198-8859(01)00301-9
   Villuendas G, 2002, J CLIN ENDOCR METAB, V87, P1134, DOI 10.1210/jc.87.3.1134
   Yamada Y, 2003, MOL GENET METAB, V80, P344, DOI 10.1016/S1096-7192(03)00125-2
   Zhai RH, 2001, PHARMACOGENETICS, V11, P699, DOI 10.1097/00008571-200111000-00008
NR 29
TC 12
Z9 12
U1 0
U2 1
PU WAYNE STATE UNIV PRESS
PI DETROIT
PA 4809 WOODWARD AVE, DETROIT, MI 48201-1309 USA
SN 0018-7143
EI 1534-6617
J9 HUM BIOL
JI Hum. Biol.
PD AUG
PY 2005
VL 77
IS 4
BP 509
EP 514
DI 10.1353/hub.2005.0061
PG 6
WC Anthropology; Biology; Genetics & Heredity
SC Anthropology; Life Sciences & Biomedicine - Other Topics; Genetics &
   Heredity
GA 998AA
UT WOS:000234289000008
PM 16485780
OA Green Published
DA 2020-10-22
ER

PT J
AU Catalan-Soares, B
   Barbosa-Stancioli, EF
   Alcantara, LCJ
   Carneiro-Proietti, ABD
   Martins, ML
   Namen-Lopes, MS
   Galvao-Castro, B
   Ferreira, CES
   Costa, MCR
   Pinheiro, SR
   Proietti, FA
AF Catalan-Soares, B
   Barbosa-Stancioli, EF
   Alcantara, LCJ
   Carneiro-Proietti, ABD
   Martins, ML
   Namen-Lopes, MS
   Galvao-Castro, B
   Ferreira, CES
   Costa, MCR
   Pinheiro, SR
   Proietti, FA
CA GIPH Interdisciplinary HTLV I II R
TI HTLV-2 horizontal and vertical transmission in a family from a Brazilian
   urban area: Seroepidemiological, clinical and molecular study
SO AIDS RESEARCH AND HUMAN RETROVIRUSES
LA English
DT Article
ID VIRUS TYPE-II; DRUG-USERS; INFECTION; INDIANS; TYPE-2
AB Human T cell lymphotropic virus type 2 (HTLV-2) has been shown to be endemic in Brazilian Indians and among intravenous drug users in urban areas, but transmission of this infection seems to be infrequent in the general population living in urban areas in Brazil. Six persons in three generations of a Brazilian family were evaluated to assess HTLV-2 transmission and its molecular features in the positive cases. The index was detected during screening (HTLV EIA) of donated blood in Fundacao Hemominas, Belo Horizonte, Brazil. Confirmatory serological test and viral typing were performed by Western blotting and polymerase chain reaction. The family consisted of husband, wife (index case), three daughters, and the mother of the index case. The husband and one daughter were found positive, thus pointing to horizontal and vertical transmission. The husband was a truck driver, who reported casual sex during frequent traveling. The positive daughter was breast-fed for 3 months, as opposed to the remaining two ( seronegative), who breast-fed for 1 month. The index case's mother was negative. To identify HTLV-2 subtype(s), phylogenetic analysis of the noncoding long terminal repeat region and part of the env and tax coding regions was performed. These new isolates from Belo Horizonte are related to subtype IIa but present a molecular variant with extended tax, previously reported in subtype IIc. Analyzing both LTR and env regions, the family's sequences clustered with isolates of Brazilian intravenous drug users and transfusion transmitted virus.
C1 Univ Fed Minas Gerais, Dept Prevent & Social Med, Fdn Ctr Hematol & Hemoterapia Minas Gerais, Lab Biol Microorganismos Intercelulares,Dept Micr, Belo Horizonte, MG, Brazil.
   Fundacao Oswaldo Cruz, Lab Avancado Saude Publ, Ctr Pesquisas Goncalo Moniz, Salvador, BA, Brazil.
   Hemoctr Ribeirao Preto, Sao Paulo, Brazil.
RP Catalan-Soares, B (corresponding author), Minas Gerais State Blood Ctr, Fdn Hemominas, Alameda Ezequiel Dias,321, BR-30130110 Belo Horizonte, MG, Brazil.
EM bcorreacatalansoares@yahoo.com.br
RI Barbosa-Stancioli, Edel F/J-7230-2012
OI Barbosa-Stancioli, Edel F/0000-0001-6584-4333; Alcantara,
   Luiz/0000-0002-6769-9931
CR Alcantara LCJ, 2003, AIDS RES HUM RETROV, V19, P519, DOI 10.1089/088922203766774577
   Biggar RJ, 1996, VIROLOGY, V216, P165, DOI 10.1006/viro.1996.0043
   Biglione MM, 2003, CLIN INFECT DIS, V37, P456, DOI 10.1086/376620
   Eiraku N, 1996, J VIROL, V70, P1481, DOI 10.1128/JVI.70.3.1481-1492.1996
   Kaplan JE, 1996, J ACQ IMMUN DEF SYND, V12, P193, DOI 10.1097/00042560-199606010-00014
   LAIRMORE MD, 1990, P NATL ACAD SCI USA, V87, P8840, DOI 10.1073/pnas.87.22.8840
   LEE H, 1989, SCIENCE, V244, P471, DOI 10.1126/science.2655084
   Lewis MJ, 2000, VIROLOGY, V271, P142, DOI 10.1006/viro.2000.0284
   Modahl LE, 1997, J ACQ IMMUN DEF SYND, V16, P169, DOI 10.1097/00042560-199711010-00005
   Murphy EL, 1997, NEUROLOGY, V48, P315, DOI 10.1212/WNL.48.2.315
   Nicholas KB, 1997, GENEDOC ANAL VISUALI
   Shindo N, 2002, AIDS RES HUM RETROV, V18, P71, DOI 10.1089/088922202753394736
   Silva EA, 2002, J MED VIROL, V66, P253, DOI 10.1002/jmv.2138
   Soares BC, 2003, REV SAUDE PUBL, V37, P470, DOI [10.1590/S0034-89102003000400012, 10.1590/s0034-89102003000400012]
   SWITZER WM, 1995, J VIROL, V69, P621, DOI 10.1128/JVI.69.2.621-632.1995
   Swofford David L., 1996, P407
   Vandamme AM, 2000, GENE, V261, P171, DOI 10.1016/S0378-1119(00)00473-X
   XIA X, 2000, DAMBE DATA ANAL MOL
NR 18
TC 5
Z9 6
U1 0
U2 1
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 0889-2229
EI 1931-8405
J9 AIDS RES HUM RETROV
JI Aids Res. Hum. Retrovir.
PD JUN
PY 2005
VL 21
IS 6
BP 521
EP 526
DI 10.1089/aid.2005.21.521
PG 6
WC Immunology; Infectious Diseases; Virology
SC Immunology; Infectious Diseases; Virology
GA 946CU
UT WOS:000230550500001
PM 15989456
DA 2020-10-22
ER

PT J
AU Porto, AF
   Santos, SB
   Alcantara, L
   Guerreiro, JB
   Passos, J
   Gonzalez, T
   Neva, F
   Gonzalez, D
   Ho, JL
   Carvalho, EM
AF Porto, AF
   Santos, SB
   Alcantara, L
   Guerreiro, JB
   Passos, J
   Gonzalez, T
   Neva, F
   Gonzalez, D
   Ho, JL
   Carvalho, EM
TI HTLV-1 modifies the clinical and immunological response to
   schistosomiasis
SO CLINICAL AND EXPERIMENTAL IMMUNOLOGY
LA English
DT Article
DE HTLV-1; schistosomiasis; liver fibrosis
ID VIRUS TYPE-I; STRONGYLOIDES-STERCORALIS HYPERINFECTION; T-CELL LEUKEMIA;
   GRANULOMA-FORMATION; MANSONI INFECTION; INTERFERON-GAMMA; TYPE-1
   INFECTION; IMMUNE-RESPONSE; IGE RESPONSES; EXPRESSION
AB The immunological response in HTLV-1 infected individuals is characterized by a prominent Type-1 cytokine response with high production of IFN-gamma and TNF-alpha. In contrast, helminthic infections and in particular chronic schistosomiasis are associated with a predominant production of IL-4, IL-5, IL-10 and IL-13. Liver fibrosis is the main pathological finding in schistosomiasis that occurs after many years of infection. This pathology is T cell dependent but the immune response mechanisms are not completely understood. The North-east region of Brazil is endemic for both HTLV-1 and schistosomiasis. In the present study the immune response, clinical severity, and therapeutic response to praziquantel of patients with schistosomiasis coinfected with HTLV-1 were compared with patients infected only with S. mansoni. Patients with HTLV-1 and S. mansoni had lower levels of IL-5 (P < 0.05) and higher levels of IFN-gamma (P < 0.05) in cultures stimulated with S. mansoni antigen and decreased S. mansoni antigen specific IgE levels when compared with patients with schistosomiasis without HTLV-1 coinfection. Liver fibrosis was mild in all HTLV-1 coinfected patients and efficacy of praziquantel was lower in patients dually infected than in patients infected only with S. mansoni.
C1 Hosp Univ Prof Edgard Santos, Serv Imunol, Lab Imunol, BR-40110160 Salvador, BA, Brazil.
   Univ Fed Bahia, Fac Farm, Parasitol Lab, Salvador, BA, Brazil.
   Clin Ultrassonog Delfin, Salvador, BA, Brazil.
   NIH, Parasit Dis Lab, Bethesda, MD 20892 USA.
   Cornell Univ, Weill Med, New York, NY USA.
RP Carvalho, EM (corresponding author), Hosp Univ Prof Edgard Santos, Serv Imunol, Lab Imunol, 5 Andar,Rua Joao das Botas S-N Canela, BR-40110160 Salvador, BA, Brazil.
EM edgar@ufba.br
OI Alcantara, Luiz/0000-0002-6769-9931
CR ABDELWAHAB MF, 1992, AM J TROP MED HYG, V46, P403, DOI 10.4269/ajtmh.1992.46.403
   Araujo MI, 1996, EUR J IMMUNOL, V26, P1399, DOI 10.1002/eji.1830260633
   Caldas IR, 2000, AM J TROP MED HYG, V62, P57, DOI 10.4269/ajtmh.2000.62.57
   Carvalho EM, 2001, J ACQ IMMUN DEF SYND, V27, P1, DOI 10.1097/00126334-200105010-00001
   Chiaramonte MG, 1999, J CLIN INVEST, V104, P777, DOI 10.1172/JCI7325
   Chiaramonte MG, 1999, J IMMUNOL, V162, P920
   CORREAOLIVEIRA R, 1989, T ROY SOC TROP MED H, V83, P798, DOI 10.1016/0035-9203(89)90334-9
   De Jesus AR, 2000, AM J TROP MED HYG, V63, P1
   de Jesus AR, 2000, INFECT IMMUN, V68, P2797, DOI 10.1128/IAI.68.5.2797-2803.2000
   DEJESUS AMR, 1993, EUR J IMMUNOL, V23, P152, DOI 10.1002/eji.1830230125
   DESSEIN AJ, 1988, J IMMUNOL, V140, P2727
   DUNNE DW, 1992, MEM I OSWALDO CRUZ, V87, P99, DOI 10.1590/S0074-02761992000800014
   Edlich RF, 2000, J EMERG MED, V18, P109, DOI 10.1016/S0736-4679(99)00173-0
   Finkelman FD, 1997, ANNU REV IMMUNOL, V15, P505, DOI 10.1146/annurev.immunol.15.1.505
   Furuya T, 1999, J NEUROIMMUNOL, V95, P185, DOI 10.1016/S0165-5728(98)00263-X
   GalvaoCastro B, 1997, TRANSFUSION, V37, P242, DOI 10.1046/j.1537-2995.1997.37297203532.x
   Goon PKC, 2003, J VIROL, V77, P9716, DOI 10.1128/JVI.77.17.9716-9722.2003
   Gotuzzo E, 1999, AM J TROP MED HYG, V60, P146, DOI 10.4269/ajtmh.1999.60.146
   Hayashi J, 1997, AM J TROP MED HYG, V56, P71, DOI 10.4269/ajtmh.1997.56.71
   Jankovic D, 1999, J IMMUNOL, V163, P337
   Karanja DMS, 1997, AM J TROP MED HYG, V56, P515, DOI 10.4269/ajtmh.1997.56.515
   KATZ N, 1968, Revista do Instituto de Medicina Tropical de Sao Paulo, V10, P295
   KRAMER A, 1989, LANCET, V2, P923
   Leptak CL, 1997, J IMMUNOL, V158, P301
   Neva FA, 1998, J INFECT DIS, V178, P1856, DOI 10.1086/314507
   NEWTON RC, 1992, AM J MED, V92, P202, DOI 10.1016/0002-9343(92)90113-P
   Pagliuca A, 1999, BRIT J HAEMATOL, V105, P1, DOI 10.1111/j.1365-2141.1999.01401.x
   PATEY O, 1992, AIDS, V6, P575, DOI 10.1097/00002030-199206000-00009
   PHELPS KR, 1991, AM J MED SCI, V302, P224, DOI 10.1097/00000441-199110000-00006
   Plumelle Y, 1996, REV MED INTERNE, V17, P125, DOI 10.1016/0248-8663(96)82961-4
   Porto AF, 2001, PARASITE IMMUNOL, V23, P503, DOI 10.1046/j.1365-3024.2001.00407.x
   Porto AF, 2001, AM J TROP MED HYG, V65, P610, DOI 10.4269/ajtmh.2001.65.610
   Rezende SA, 1997, INFECT IMMUN, V65, P3457, DOI 10.1128/IAI.65.8.3457-3461.1997
   ROBINSON RD, 1994, J INFECT DIS, V169, P692, DOI 10.1093/infdis/169.3.692
   Satoh M, 2002, CLIN EXP IMMUNOL, V127, P354, DOI 10.1046/j.1365-2249.2002.01733.x
   Shikiya K, 1994, Kansenshogaku Zasshi, V68, P13
   SLEIGH AC, 1981, T ROY SOC TROP MED H, V75, P234, DOI 10.1016/0035-9203(81)90323-0
   UMEHARA F, 1994, J NEUROPATH EXP NEUR, V53, P72, DOI 10.1097/00005072-199401000-00009
   WYNN TA, 1994, J EXP MED, V179, P1551, DOI 10.1084/jem.179.5.1551
NR 39
TC 19
Z9 19
U1 0
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0009-9104
EI 1365-2249
J9 CLIN EXP IMMUNOL
JI Clin. Exp. Immunol.
PD AUG
PY 2004
VL 137
IS 2
BP 424
EP 429
DI 10.1111/j.1365-2249.2004.02508.x
PG 6
WC Immunology
SC Immunology
GA 838KJ
UT WOS:000222711900026
PM 15270862
OA Green Published, Bronze
DA 2020-10-22
ER

PT J
AU Van Dooren, S
   Pybus, OG
   Salemi, M
   Liu, HF
   Goubau, P
   Remondegui, C
   Talarmin, A
   Gotuzzo, E
   Alcantara, LCJ
   Galvao-Castro, B
   Vandamme, AM
AF Van Dooren, S
   Pybus, OG
   Salemi, M
   Liu, HF
   Goubau, P
   Remondegui, C
   Talarmin, A
   Gotuzzo, E
   Alcantara, LCJ
   Galvao-Castro, B
   Vandamme, AM
TI The low evolutionary rate of human T-cell lymphotropic virus type-1
   confirmed by analysis of vertical transmission chains
SO MOLECULAR BIOLOGY AND EVOLUTION
LA English
DT Article
DE HTLV-1; vertical transmission; evolutionary rate; molecular clock
ID I HTLV-I; AFRICAN ORIGIN; PHYLOGENETIC ANALYSIS; MOLECULAR PHYLOGENY;
   INFECTION; TRANSFUSION; SEQUENCES; SUBTYPES; AMERICA
AB The evolutionary rate of the human T-cell lymphotropic virus type-1 (HTLV-1) is considered to be very low, in strong contrast to the related human retrovirus HIV. However, current estimates of the HTLV-1 rate rely on the anthropological calibration of phylogenies using assumed dates of human migration events. To obtain an independent rate estimate, we analyzed two variable regions of the HTLV-1 genome (LTR and env) from eight infected families. Remarkable genetic stability was observed, as only two mutations in LTR (756 bp) and three mutations in env (522 bp) occurred within the 16 vertical transmission chains, including one ambiguous position in each region. The evolutionary rate in HTLV-1 was then calculated using a maximum-likelihood approach that used the highest and lowest possible times of HTLV-1 shared ancestry, given the known transmission histories. The rates for the LTR and env regions were 9.58 x 10(-8)-1.25 x 10(-5) and 7.84 x 10(-7)-2.33 x 10(-5) nucleotide substitutions per site per year, respectively. A more precise estimate was obtained for the combined LTR-env data set, which was 7.06 x 10(-7)-1.38 x 10(-5) substitutions per site per year. We also note an interesting correlation between the occurrence of mutations in HTLV-1 and the age of the individual infected.
C1 Katholieke Univ Leuven, Rega Inst Med Res, Louvain, Belgium.
   Univ Oxford, Dept Zool, Oxford OX1 3PS, England.
   Mackay Mem Hosp, Dept Med Res, Taipei, Taiwan.
   Catholic Univ Louvain, Virol Unit, B-1200 Brussels, Belgium.
   Hosp San Roque, San Salvador de Jujuy, Argentina.
   Inst Pasteur, Lab Retrovirol, Cayenne, French Guiana.
   Univ Peruana Cayetano Heredia, Inst Med Trop Alexander Von Humboldt, Lima, Peru.
   Fundacao Oswaldo Cruz, Bahia Sch Med & Publ Hlth, Goncalo Moniz Res Ctr, Salvador, BA, Brazil.
RP Van Dooren, S (corresponding author), Katholieke Univ Leuven, Rega Inst Med Res, Louvain, Belgium.
EM Sonia.VanDooren@uz.kuleuven.ac.be
RI Pybus, Oliver G/B-2640-2012; Vandamme, Anne-Mieke/I-4127-2012; Liu,
   Hsin-Fu/AAR-5960-2020; Van Dooren, Sonia/E-3113-2019
OI Pybus, Oliver G/0000-0002-8797-2667; Vandamme,
   Anne-Mieke/0000-0002-6594-2766; Liu, Hsin-Fu/0000-0003-0082-2269;
   Alcantara, Luiz/0000-0002-6769-9931
CR Alcantara LC, 2003, JAIDS-J ACQ IMM DEF, V33, P536, DOI 10.1097/00126334-200308010-00016
   Ando Y, 2003, J INFECTION, V46, P177, DOI 10.1053/jinf.2002.1107
   Bittencourt A L, 1998, Rev Inst Med Trop Sao Paulo, V40, P245, DOI 10.1590/S0036-46651998000400008
   Gessain A, 2000, NAT MED, V6, P232, DOI 10.1038/73020
   GESSAIN A, 1992, J VIROL, V66, P2288, DOI 10.1128/JVI.66.4.2288-2295.1992
   HJELLE B, 1990, VOX SANG, V59, P119, DOI 10.1111/j.1423-0410.1990.tb05023.x
   Holmes EC, 2003, J VIROL, V77, P3893, DOI 10.1128/JVI.77.7.3893-3897.2003
   Jeanmougin F, 1998, TRENDS BIOCHEM SCI, V23, P403, DOI 10.1016/S0968-0004(98)01285-7
   Jenkins GM, 2002, J MOL EVOL, V54, P156, DOI 10.1007/s00239-001-0064-3
   Kaplan JE, 1996, J ACQ IMMUN DEF SYND, V12, P193, DOI 10.1097/00042560-199606010-00014
   LEE H, 1989, SCIENCE, V244, P471, DOI 10.1126/science.2655084
   Li HC, 1999, NAT MED, V5, P1428
   LI WH, 1988, MOL BIOL EVOL, V5, P313
   LIU HF, 1994, AIDS RES HUM RETROV, V10, P1135, DOI 10.1089/aid.1994.10.1135
   Maddison W. P., 1992, MACCLADE ANAL PHYLOG
   MANNS A, 1992, INT J CANCER, V51, P886, DOI 10.1002/ijc.2910510609
   Miura T, 1997, J MOL EVOL, V44, pS76, DOI 10.1007/PL00000053
   MIURA T, 1994, P NATL ACAD SCI USA, V91, P1124, DOI 10.1073/pnas.91.3.1124
   MURPHY EL, 1989, ANN INTERN MED, V111, P555, DOI 10.7326/0003-4819-111-7-555
   NERURKAR VR, 1993, VIROLOGY, V196, P506, DOI 10.1006/viro.1993.1506
   Ohkura S, 1999, J GEN VIROL, V80, P1995, DOI 10.1099/0022-1317-80-8-1995
   Plancoulaine S, 1998, INT J CANCER, V76, P331, DOI 10.1002/(SICI)1097-0215(19980504)76:3&lt;331::AID-IJC8&gt;3.0.CO;2-W
   Ramirez E, 2002, VIRUS RES, V84, P135, DOI 10.1016/S0168-1702(02)00005-9
   Salemi M, 1998, J MOL EVOL, V46, P602, DOI 10.1007/PL00006340
   Salemi M, 1999, GENE, V234, P11, DOI 10.1016/S0378-1119(99)00169-9
   Salemi M, 2000, MOL BIOL EVOL, V17, P374, DOI 10.1093/oxfordjournals.molbev.a026317
   SULLIVAN MT, 1991, ARCH INTERN MED, V151, P2043, DOI 10.1001/archinte.151.10.2043
   SWOFFORD DL, 1998, PAUP PHYLOGENETIC AN
   TAKE H, 1993, JPN J CANCER RES, V84, P1265, DOI 10.1111/j.1349-7006.1993.tb02832.x
   Thorne JL, 1998, MOL BIOL EVOL, V15, P1647, DOI 10.1093/oxfordjournals.molbev.a025892
   Van Dooren S, 2001, MOL BIOL EVOL, V18, P661, DOI 10.1093/oxfordjournals.molbev.a003846
   Van Dooren S, 1998, J GEN VIROL, V79, P2695, DOI 10.1099/0022-1317-79-11-2695
   Vandamme AM, 2000, NAT MED, V6, P232, DOI 10.1038/73023
   VANDAMME AM, 1994, VIROLOGY, V202, P212, DOI 10.1006/viro.1994.1337
   Wattel E, 1996, J ACQ IMMUN DEF SYND, V13, pS92, DOI 10.1097/00042560-199600001-00016
   WATTEL E, 1995, J VIROL, V69, P2863, DOI 10.1128/JVI.69.5.2863-2868.1995
   Wiktor S Z, 1997, J Hum Virol, V1, P37
   Yamashita M, 1996, J ACQ IMMUN DEF SYND, V13, pS124, DOI 10.1097/00042560-199600001-00021
   Yamashita M, 1998, J MED VIROL, V55, P152, DOI 10.1002/(SICI)1096-9071(199806)55:2&lt;152::AID-JMV12&gt;3.0.CO;2-K
   YANAGIHARA R, 1995, CELL MOL BIOL, V41, pS145
   Yang YC, 1997, J MED VIROL, V51, P25, DOI 10.1002/(SICI)1096-9071(199701)51:1&lt;25::AID-JMV4&gt;3.0.CO;2-U
   Zuckerkandl E., 1962, HORIZONS BIOCH, P189, DOI DOI 10.1038/NCHEMBIO.2477
NR 42
TC 42
Z9 42
U1 0
U2 5
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0737-4038
EI 1537-1719
J9 MOL BIOL EVOL
JI Mol. Biol. Evol.
PD MAR
PY 2004
VL 21
IS 3
BP 603
EP 611
DI 10.1093/molbev/msh053
PG 9
WC Biochemistry & Molecular Biology; Evolutionary Biology; Genetics &
   Heredity
SC Biochemistry & Molecular Biology; Evolutionary Biology; Genetics &
   Heredity
GA 804BG
UT WOS:000220273600018
PM 14739252
OA Green Published, Bronze
DA 2020-10-22
ER

PT J
AU Dourado, I
   Alcantara, LCJ
   Barreto, ML
   Teixeira, MD
   Galvao-Castro, B
AF Dourado, Ines
   Alcantara, Luiz C. J.
   Barreto, Mauricio L.
   Teixeira, Maria da Gloria
   Galvao-Castro, Bernardo
TI HTLV-I in the General Population of Salvador, Brazil A City With African
   Ethnic and Sociodemographic Characteristics
SO JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
LA English
DT Article
AB The city of Salvador has the highest prevalence of HTLV-I among blood donors in Brazil. To study the prevalence of HTLV-I among the general population of Salvador, 30 "sentinel surveillance areas" were selected for the investigation of various infectious diseases, and 1385 individuals within these areas were surveyed according to a simple random sample procedure. ELISA was used to screen plasma samples for antibodies to HTLV-I, and the positive samples were tested by a confirmatory assay (Western blotting). The overall prevalence of HTLV-I was 1.76% (23/1385). Infection rates were 1.2% for males and 2.0% for females. Specific prevalence demonstrated an increasing linear trend with age. No one younger than 13 years of age was infected. Multivariate analysis estimated adjusted odds ratios for the association of HTLV-I with age of 9.7 (3.3; 30.4) for females and 12.3 (1.47; 103.1) for males. Less education and income might be associated with HTLV-I infection in females. Phylogenetic analysis of the long terminal repeat fragments showed that most of the samples belonged to the Latin American cluster of the Transcontinental subgroup (Cosmopolitan subtype). For the entire city of Salvador, it is estimated that similar to 40,000 individuals are infected with HTLV-I. Our results suggest multiple post-Colombian introductions of African HTLV-Ia strains in Salvador.
C1 [Dourado, Ines; Barreto, Mauricio L.; Teixeira, Maria da Gloria] Univ Fed Bahia, Inst Saude Coletiva, BR-40110170 Salvador, BA, Brazil.
   [Alcantara, Luiz C. J.; Galvao-Castro, Bernardo] Fundacao Oswaldo Cruz, Ctr Pesquisa Goncalo Moniz, Salvador, BA, Brazil.
   [Alcantara, Luiz C. J.; Galvao-Castro, Bernardo] Escola Bahiana Med & Saude Publ, Salvador, BA, Brazil.
   [Alcantara, Luiz C. J.; Galvao-Castro, Bernardo] Fundacao Desenvolvimento Ciencias, Salvador, BA, Brazil.
RP Dourado, I (corresponding author), Univ Fed Bahia, Inst Saude Coletiva, Rua Padre Feijo 29-4 Andar, BR-40110170 Salvador, BA, Brazil.
EM maines@ufba.br
RI Dourado, Ines/Q-6535-2016; Teixeira, Maria Gloria/G-4808-2012; Barreto,
   Mauricio L/B-1752-2008
OI Dourado, Ines/0000-0003-1675-2146; Teixeira, Maria
   Gloria/0000-0003-3318-3408; Barreto, Mauricio L/0000-0002-0215-4930;
   Alcantara, Luiz/0000-0002-6769-9931
FU Fundacao de Amparo a Pesquisa da Bahia (FAPESB); Brazilian National
   Research Council (CNPq)National Council for Scientific and Technological
   Development (CNPq)
FX Partially supported by the Fundacao de Amparo a Pesquisa da Bahia
   (FAPESB) and the Brazilian National Research Council (CNPq).
CR ALCANTARA LC, 2003, JAIDS IN PRESS
   Andrade TM, 1998, J ACQ IMMUN DEF SYND, V18, P186, DOI 10.1097/00042560-199806010-00011
   Araujo AQC, 1998, J ACQ IMMUN DEF SYND, V19, P536, DOI 10.1097/00042560-199812150-00014
   AZEVEDO ES, 1982, HUM BIOL, V54, P329
   Barbosa HS, 1999, J ACQ IMMUN DEF SYND, V21, P65, DOI 10.1097/00126334-199905010-00009
   Bittencourt AL, 2001, J ACQ IMMUN DEF SYND, V26, P490, DOI 10.1097/00126334-200104150-00016
   CLARK J, 1985, INT J CANCER, V36, P37, DOI 10.1002/ijc.2910360107
   Cochran W.G., 1977, SAMPLING TECHNIQUES
   De Oliveira MSP, 1999, INT J CANCER, V83, P291, DOI 10.1002/(SICI)1097-0215(19991029)83:3&lt;291::AID-IJC1&gt;3.0.CO;2-P
   Edlich RF, 2000, J EMERG MED, V18, P109, DOI 10.1016/S0736-4679(99)00173-0
   *FUND IBGE, 1996, CENS DEM
   GALVAOCASTRO B, 1997, TRANSFUSION, V37, P42
   GASMI M, 1994, AIDS RES HUM RETROV, V10, P1313, DOI 10.1089/aid.1994.10.1313
   GESSAIN A, 1993, J VIROL, V67, P1015, DOI 10.1128/JVI.67.2.1015-1023.1993
   Gomes I, 1999, J NEUROL SCI, V165, P84, DOI 10.1016/S0022-510X(99)00083-0
   HAHN BH, 1984, INT J CANCER, V34, P613, DOI 10.1002/ijc.2910340505
   Hino Shigeo, 1997, Leukemia (Basingstoke), V11, P57
   KAJIYAMA W, 1986, J INFECT DIS, V154, P851, DOI 10.1093/infdis/154.5.851
   KALYANARAMAN VS, 1982, SCIENCE, V218, P571, DOI 10.1126/science.6981847
   Kaplan JE, 1996, J ACQ IMMUN DEF SYND, V12, P193, DOI 10.1097/00042560-199606010-00014
   KILLINGER C. L, 2000, CIENCIA SAUDE COLE S, V5, P83
   Kleinbaum D, 1982, EPIDEMIOLOGIC RES PR
   Levine P H, 1987, Infect Dis Clin North Am, V1, P501
   Mahieux R, 1997, J VIROL, V71, P1317, DOI 10.1128/JVI.71.2.1317-1333.1997
   Mboudjeka I, 1997, JPN J CANCER RES, V88, P619, DOI 10.1111/j.1349-7006.1997.tb00427.x
   MIURA T, 1994, P NATL ACAD SCI USA, V91, P1124, DOI 10.1073/pnas.91.3.1124
   MOROFUJIHIRATA M, 1993, AM J EPIDEMIOL, V137, P43, DOI 10.1093/oxfordjournals.aje.a116600
   MUELLER N, 1991, CANCER CAUSE CONTROL, V2, P37, DOI 10.1007/BF00052359
   MURPHY EL, 1991, AM J EPIDEMIOL, V133, P1114, DOI 10.1093/oxfordjournals.aje.a115824
   PATE EJ, 1991, NEW ENGL J MED, V325, P284, DOI 10.1056/NEJM199107253250413
   Plancoulaine S, 1998, INT J CANCER, V76, P331, DOI 10.1002/(SICI)1097-0215(19980504)76:3&lt;331::AID-IJC8&gt;3.0.CO;2-W
   POIESZ BJ, 1980, P NATL ACAD SCI-BIOL, V77, P7415, DOI 10.1073/pnas.77.12.7415
   Prado Md, 2001, Rev Soc Bras Med Trop, V34, P99
   Rouet F, 2002, VOX SANG, V82, P61, DOI 10.1046/j.0042-9007.2001.00143.x
   Salemi M, 1998, VIROLOGY, V246, P277, DOI 10.1006/viro.1998.9215
   TAJIMA K, 1982, GANN, V73, P893
   Teixeira Maria da Glória, 2002, Cad. Saúde Pública, V18, P1189, DOI 10.1590/S0102-311X2002000500011
   UEDA K, 1989, LANCET, V2, P979
   Van Dooren S, 1998, J GEN VIROL, V79, P2695, DOI 10.1099/0022-1317-79-11-2695
   Venancio SI, 2002, REV SAUDE PUBL, V36, P313, DOI 10.1590/S0034-89102002000300009
   VIDAL AU, 1994, J GEN VIROL, V75, P3655, DOI 10.1099/0022-1317-75-12-3655
   Yamashita M, 1999, VIROLOGY, V261, P59
NR 42
TC 129
Z9 140
U1 0
U2 2
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 1525-4135
J9 JAIDS-J ACQ IMM DEF
JI JAIDS
PD DEC 15
PY 2003
VL 34
IS 5
BP 527
EP 531
DI 10.1097/00126334-200312150-00013
PG 5
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA V93OL
UT WOS:000206324300013
PM 14657765
DA 2020-10-22
ER

PT J
AU Alcantara, LC
   Van Dooren, S
   Goncalves, MS
   Kashima, S
   Costa, MCR
   Santos, FLN
   Bittencourt, AL
   Dourado, I
   Andrade, A
   Covas, DT
   Vandamme, AM
   Galvao-Castro, B
AF Alcantara, LC
   Van Dooren, S
   Goncalves, MS
   Kashima, S
   Costa, MCR
   Santos, FLN
   Bittencourt, AL
   Dourado, I
   Andrade, A
   Covas, DT
   Vandamme, AM
   Galvao-Castro, B
TI Globin haplotypes of human T-cell lymphotropic virus type I-infected
   individuals in Salvador, Bahia, Brazil, suggest a post-Columbian African
   origin of this virus
SO JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
LA English
DT Article
DE HTLV-1; LTR; beta-globin haplotypes; Bantu; Salvador-Brazil; Southern
   Africa
ID POLYMERASE CHAIN-REACTION; BETA-S-CHROMOSOMES; HTLV-I; MOLECULAR
   EPIDEMIOLOGY; PHYLOGENETIC SUBTYPES; JAPANESE IMMIGRANTS; STRAINS;
   SEQUENCE; AMERICA; GENE
AB The city of Salvador, Bahia, Brazil, has sociodemographic characteristics similar to some African cities. Up to now, it has had the highest prevalence of human T-cell lymphotropic virus type I (HTLV-I) infection (1.74%) in the country. To investigate which strains of HTLV-I are circulating in Salvador, we studied isolates from 82 patients infected with HTLV-I: 19 from the general population, 21 from pregnant women, 16 from intravenous drug users, and 26 from patients and their family attending a neurologic clinic. Phylogenetic analysis from part of the LTR fragments showed that most of these isolates belonged to the Transcontinental subgroup of the Cosmopolitan subtype (HTLV-Ia). Only one sample from a pregnant woman was closely related to the Japanese subgroup, suggesting recent introduction of a Japanese HTLV-I lineage into Salvador. beta(A)-Globin haplotypes were examined in 34 infected individuals and found to be atypical, confirming the racial heterogeneity of this population. A total of 20 chromosomes were characterized as Central African Republic (CAR) haplotype (29.4%), 31 (45.6%) were characterized as Benin (BEN) haplotype, and 17 (25%) were characterized as Senegal (SEN) haplotype. Five patients' genotypes (14.7%) were CAR/CAR; 10 (29,4%), BEN/BEN; 9 (26.5%), CAR/BEN; 2 (5.9%), BEN/SEN; and 7 (20.6%), SEN/SEN. One patient's genotype (2.9%) was CAR/SEN. The beta(A)-globin haplotype distribution in Salvador is unusual compared with other Brazilian states. Our data support the hypothesis of multiple post-Columbian introductions of African HTLV-Ia strains-in Salvador, Bahia, Brazil.
C1 Oswaldo Cruz Fdn, Adv Publ Hlth Lab, Goncalo Moniz Res Ctr, BR-40295001 Salvador, BA, Brazil.
   Fdn Sci Dev, Bahia Sch Med & Publ Hlth, Salvador, BA, Brazil.
   Katholieke Univ Leuven, Rega Inst, Louvain, Belgium.
   Brazil Blood Ctr Ribeirao Preto, Ribeirao Preto, SP, Brazil.
   Univ Fed Bahia, Salvador, BA, Brazil.
RP Galvao-Castro, B (corresponding author), Oswaldo Cruz Fdn, Adv Publ Hlth Lab, Goncalo Moniz Res Ctr, Rua Waldemar Falcao 121,Brotas, BR-40295001 Salvador, BA, Brazil.
RI Dourado, Ines/Q-6535-2016; Goncalves, Marilda/B-5904-2014; Van Dooren,
   Sonia/E-3113-2019; SANTOS, Fred/S-2954-2019; Vandamme,
   Anne-Mieke/I-4127-2012; Kashima, Simone/G-4876-2012; Santos,
   Fred/G-6077-2012; Covas, Dimas T/C-5431-2013
OI Dourado, Ines/0000-0003-1675-2146; SANTOS, Fred/0000-0002-3944-0818;
   Vandamme, Anne-Mieke/0000-0002-6594-2766; Kashima,
   Simone/0000-0002-1487-0141; Covas, Dimas T/0000-0002-7364-2595;
   Alcantara, Luiz/0000-0002-6769-9931
CR Andrade TM, 1998, J ACQ IMMUN DEF SYND, V18, P186, DOI 10.1097/00042560-199806010-00011
   ANTONARAKIS SE, 1984, P NATL ACAD SCI-BIOL, V81, P853, DOI 10.1073/pnas.81.3.853
   AZEVEDO ES, 1981, HUM HERED, V31, P353, DOI 10.1159/000153237
   Bittencourt AL, 2001, J ACQ IMMUN DEF SYND, V26, P490, DOI 10.1097/00126334-200104150-00016
   CURTIN PD, 1969, SLAVE ATLANTIC TRADE
   DOURADO I, 2001, AIDS RES HUM RETR S9, V17, pO17
   GalvaoCastro B, 1997, TRANSFUSION, V37, P242, DOI 10.1046/j.1537-2995.1997.37297203532.x
   GASMI M, 1994, AIDS RES HUM RETROV, V10, P1313, DOI 10.1089/aid.1994.10.1313
   GESSAIN A, 1993, J VIROL, V67, P1015, DOI 10.1128/JVI.67.2.1015-1023.1993
   GESSAIN A, 1994, AIDS RES HUM RETROV, V10, P103, DOI 10.1089/aid.1994.10.103
   GONCALVES MS, 1994, HUM HERED, V44, P322, DOI 10.1159/000154238
   GONCALVES MS, 2003, IN PRESS BRAZ J MED
   HAHN BH, 1984, INT J CANCER, V34, P613, DOI 10.1002/ijc.2910340505
   HATTORI Y, 1986, HEMOGLOBIN, V10, P623, DOI 10.3109/03630268609036566
   KITAGAWA T, 1986, JAMA-J AM MED ASSOC, V256, P2342, DOI 10.1001/jama.1986.03380170058009
   LANCLOS KD, 1991, BLOOD, V77, P2488
   LAPOUMEROULIE C, 1992, HUM GENET, V89, P333
   Mahieux R, 1997, J VIROL, V71, P1317, DOI 10.1128/JVI.71.2.1317-1333.1997
   Mboudjeka I, 1997, JPN J CANCER RES, V88, P619, DOI 10.1111/j.1349-7006.1997.tb00427.x
   MIURA T, 1994, P NATL ACAD SCI USA, V91, P1124, DOI 10.1073/pnas.91.3.1124
   MIURA T, 1997, J MOL EVOL, V44, P76
   MUELLER N, 1991, CANCER CAUSE CONTROL, V2, P37, DOI 10.1007/BF00052359
   NAGEL R L, 1984, Einstein Quarterly Journal of Biology and Medicine, V2, P53
   NAGEL RL, 1990, SEMIN HEMATOL, V27, P342
   NICHOLAS KB, 1997, GENEDOC ANAL VISUALI, P30
   PINSKY J, 1988, ESCRAVIDAO BRASIL, P24
   RODRIGUES N, 1977, OS AFRICANOS BRASIL, P13
   Salemi M, 1998, VIROLOGY, V246, P277, DOI 10.1006/viro.1998.9215
   SUTTON M, 1989, AM J HEMATOL, V32, P66, DOI 10.1002/ajh.2830320113
   Swofford David L., 1996, P407
   VALLEJO A, 1995, J VIROL METHODS, V51, P9, DOI 10.1016/0166-0934(94)00093-V
   Van Dooren S, 1998, J GEN VIROL, V79, P2695, DOI 10.1099/0022-1317-79-11-2695
   Vandamme AM, 1998, TRENDS MICROBIOL, V6, P477, DOI 10.1016/S0966-842X(98)01406-1
   Verger P., 1976, TRADE RELATIONS BIGH, p[12, 24]
   Verger Pierre Fatumbi, 1968, FLUX REFLUX TRAITE N
   VIANA L, 1988, NEGRO BAHIA, P224
   VIDAL AU, 1994, J GEN VIROL, V75, P3655, DOI 10.1099/0022-1317-75-12-3655
   XIA X, 2000, DAMBE DATA ANAL MOL
   Yamashita M, 1999, VIROLOGY, V261, P59
   ZAGO MA, 1992, AM J PHYS ANTHROPOL, V88, P295, DOI 10.1002/ajpa.1330880304
NR 40
TC 19
Z9 21
U1 0
U2 1
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 1525-4135
J9 JAIDS-J ACQ IMM DEF
JI JAIDS
PD AUG 1
PY 2003
VL 33
IS 4
BP 536
EP 542
DI 10.1097/00126334-200308010-00016
PG 7
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA 703LA
UT WOS:000184279800016
PM 12869844
OA Green Published
DA 2020-10-22
ER

PT J
AU Alcantara, LCJ
   Shindo, N
   Van Dooren, S
   Salemi, M
   Costa, MCR
   Kashima, S
   Covas, DT
   Vandamme, AM
   Galvao-Castro, B
AF Alcantara, LCJ
   Shindo, N
   Van Dooren, S
   Salemi, M
   Costa, MCR
   Kashima, S
   Covas, DT
   Vandamme, AM
   Galvao-Castro, B
TI Brazilian HTLV type 2a strains from intravenous drug users (IDUs) appear
   to have originated from two sources: Brazilian Amerindians and
   European/North American IDUs
SO AIDS RESEARCH AND HUMAN RETROVIRUSES
LA English
DT Article
ID VIRUS TYPE-II; COMPLETE NUCLEOTIDE-SEQUENCE; IDENTIFICATION; PHYLOGENY;
   INFECTION; SALVADOR; SUBTYPE; ISOLATE; INDIANS; KAYAPO
AB In Brazil, HTLV-2 has been detected in blood donors, in intravenous drug users (IDUs) from urban areas, and in Amerindians living in the Amazon basin. Of the three main HTLV-2 subtypes (2a, 2b, and 2d) only subtype 2a has been detected in Brazil. However, a molecular variant of subtype 2a (also called HTLV-2c) characterized by an extended Tax protein has been isolated from Brazilian blood donors, IDUs, and Indians. Here, we analyzed HTLV-2 isolates from 10 IDUs and a Chilean woman living in Salvador, Bahia, Brazil. Sequencing of env, pX, and long terminal repeat (LTR) genes demonstrated that 10 of the isolates are related to the Brazilian subtype 2a molecular variant described previously. We show that most HTLV-2a Brazilian strains comprise a phylogenetic group harboring a considerable degree of diversity within the env region but not within the LTR region. Interestingly, we demonstrated for the first time in Brazil the presence of a subtype 2a in IDUs that is closely related to the prototype Mo but distinct from the Brazilian 2a molecular variant.
C1 Oswaldo Cruz Fdn, Goncalo Moniz Res Ctr, Adv Publ Hlth Lab, BR-40295001 Salvador, BA, Brazil.
   Fdn Dev Sci, Bahia Sch Med & Publ Hlth, BR-40050420 Salvador, BA, Brazil.
   Univ Washington, Dept Microbiol, Seattle, WA 98195 USA.
   Katholieke Univ Leuven, Rega Inst Med Res, B-5000 Namur, Belgium.
   Blood Ctr Ribeirao Preto, BR-14051140 Sao Paulo, Brazil.
RP Galvao-Castro, B (corresponding author), Oswaldo Cruz Fdn, Goncalo Moniz Res Ctr, Adv Publ Hlth Lab, Rua Waldemat Falcao 121, BR-40295001 Salvador, BA, Brazil.
RI Kashima, Simone/G-4876-2012; Van Dooren, Sonia/E-3113-2019; Covas, Dimas
   T/C-5431-2013; Vandamme, Anne-Mieke/I-4127-2012
OI Kashima, Simone/0000-0002-1487-0141; Covas, Dimas T/0000-0002-7364-2595;
   Vandamme, Anne-Mieke/0000-0002-6594-2766; Alcantara,
   Luiz/0000-0002-6769-9931
CR Andrade TM, 1998, J ACQ IMMUN DEF SYND, V18, P186, DOI 10.1097/00042560-199806010-00011
   Biggar RJ, 1996, VIROLOGY, V216, P165, DOI 10.1006/viro.1996.0043
   Eiraku N, 1996, J VIROL, V70, P1481, DOI 10.1128/JVI.70.3.1481-1492.1996
   Felsenstein J, 1989, PHYLIP PHYLOGENY INF
   Gomes I, 1999, J NEUROL SCI, V165, P84, DOI 10.1016/S0022-510X(99)00083-0
   ISHAK R, 1995, AIDS RES HUM RETROV, V11, P813, DOI 10.1089/aid.1995.11.813
   LEE H, 1993, VIROLOGY, V196, P57, DOI 10.1006/viro.1993.1454
   Lewis MJ, 2000, VIROLOGY, V271, P142, DOI 10.1006/viro.2000.0284
   Miura T, 1997, J MOL EVOL, V44, pS76, DOI 10.1007/PL00000053
   Nicholas KB, 1997, GENEDOC ANAL VISUALI
   SHIMOTOHNO K, 1985, P NATL ACAD SCI USA, V82, P3101, DOI 10.1073/pnas.82.10.3101
   Shindo N, 2002, AIDS RES HUM RETROV, V18, P71, DOI 10.1089/088922202753394736
   Switzer WM, 1996, AIDS RES HUM RETROV, V12, P635, DOI 10.1089/aid.1996.12.635
   SWITZER WM, 1995, J VIROL, V69, P621, DOI 10.1128/JVI.69.2.621-632.1995
   XIA X, 2000, DAMBE DATA ANAL MOL
NR 15
TC 24
Z9 27
U1 0
U2 2
PU MARY ANN LIEBERT INC PUBL
PI LARCHMONT
PA 2 MADISON AVENUE, LARCHMONT, NY 10538 USA
SN 0889-2229
J9 AIDS RES HUM RETROV
JI Aids Res. Hum. Retrovir.
PD JUN
PY 2003
VL 19
IS 6
BP 519
EP 523
DI 10.1089/088922203766774577
PG 5
WC Immunology; Infectious Diseases; Virology
SC Immunology; Infectious Diseases; Virology
GA 699KF
UT WOS:000184055500011
PM 12892061
OA Green Published
DA 2020-10-22
ER

PT J
AU Shindo, N
   Alcantara, LCJ
   Van Dooren, S
   Salemi, M
   Costa, MCR
   Kashima, S
   Covas, DT
   Teva, A
   Pellegrini, M
   Brito, I
   Vandamme, AM
   Galvao-Castro, B
AF Shindo, N
   Alcantara, LCJ
   Van Dooren, S
   Salemi, M
   Costa, MCR
   Kashima, S
   Covas, DT
   Teva, A
   Pellegrini, M
   Brito, I
   Vandamme, AM
   Galvao-Castro, B
TI Human retroviruses (HIV and HTLV) in Brazilian Indians:
   Seroepidemiological study and molecular epidemiology of HTLV type 2
   isolates
SO AIDS RESEARCH AND HUMAN RETROVIRUSES
LA English
DT Article
ID VIRUS TYPE-II; T-CELL LEUKEMIA; COMPLETE NUCLEOTIDE-SEQUENCE; GUAYMI
   INDIANS; KAYAPO INDIANS; LYMPHOMA VIRUS; DRUG-ABUSERS; PAN-PANISCUS;
   INFECTION; IDENTIFICATION
AB To investigate serological, epidemiological, and molecular aspects of HTLV-1, HTLV-2, and HIV-1 infections in Amerindian populations in Brazil, we tested 683 and 321 sera from Tiriyo and Waiampi Indians, respectively. Both HIV-1 and HTLV-2 infections were detected at low prevalence among the Tiriyos whereas only HTLV-1 was present among the Waiampis, also at low prevalence. Analysis of the nucleotide sequence of the 631 bp of the env gene obtained from the three HTLV-2 isolates detected among the Tiriyos demonstrated by restriction fragment length polymorphism that these viruses belong to subtype IIa. Phylogenetic analysis of this same fragment showed that these sequences cluster closer to HTLV-2 isolates from intravenous drug users living in urban areas of southern Brazil than to the same gene sequence studied in another Brazilian tribe, the Kayapos. Our results confirm the distribution of Brazilian HTLV-2 sequences in a unique cluster I and cluster IIa and suggest that there is a considerable degree of diversity within this cluster. We also report for the first time HIV-1 infection among Brazilian Amerindians.
C1 Fundacao Oswaldo Cruz, Goncalo Moniz Res Ctr, Adv Publ Hlth Lab, BR-40295001 Salvador, BA, Brazil.
   Fdn Dev Sci, Bahi Sch Med & Publ Hlth, BR-40290000 Salvador, BA, Brazil.
   Univ Fed Rio de Janeiro, BR-27941590 Rio De Janeiro, Brazil.
   Katholieke Univ Leuven, Rega Inst, B-3000 Louvain, Belgium.
   Blood Ctr Ribeirao Preto, BR-14051140 Sao Paulo, Brazil.
   Fundacao Oswaldo Cruz, IOS, BR-21045400 Rio De Janeiro, Brazil.
   Brazilian Minist Hlth, CN DST AIDS, BR-70750543 Brasilia, DF, Brazil.
RP Shindo, N (corresponding author), Univ Washington, Dept Microbiol, Box 35870,1959 Pacific Ave, Seattle, WA 98195 USA.
EM nshindo@u.washington.edu
RI Kashima, Simone/G-4876-2012; Vandamme, Anne-Mieke/I-4127-2012; Van
   Dooren, Sonia/E-3113-2019; Covas, Dimas T/C-5431-2013
OI Kashima, Simone/0000-0002-1487-0141; Vandamme,
   Anne-Mieke/0000-0002-6594-2766; Covas, Dimas T/0000-0002-7364-2595;
   Alcantara, Luiz/0000-0002-6769-9931
CR ANDRADASERPA MJ, 1988, IMMUNOL LETT, V18, P15, DOI 10.1016/0165-2478(88)90063-6
   Biggar RJ, 1996, VIROLOGY, V216, P165, DOI 10.1006/viro.1996.0043
   BIGLIONE M, 1993, J ACQ IMMUN DEF SYND, V6, P631
   BLACK FL, 1994, AIDS RES HUM RETROV, V10, P1165, DOI 10.1089/aid.1994.10.1165
   *BRAZ MIN HLTH NAT, 1997, REL VIAG TERR IND TU
   DELWART EL, 1993, SCIENCE, V262, P1257, DOI 10.1126/science.8235655
   Digilio L, 1997, J VIROL, V71, P3684, DOI 10.1128/JVI.71.5.3684-3692.1997
   DUBE DK, 1993, J VIROL, V67, P1175, DOI 10.1128/JVI.67.3.1175-1184.1993
   DUENASBARAJAS E, 1992, AIDS RES HUM RETROV, V8, P1851, DOI 10.1089/aid.1992.8.1851
   Eiraku N, 1996, J VIROL, V70, P1481, DOI 10.1128/JVI.70.3.1481-1492.1996
   FEIGAL E, 1991, J INFECT DIS, V164, P36, DOI 10.1093/infdis/164.1.36
   Felsenstein J, 1989, PHYLIP PHYLOGENY INF
   FERRER JF, 1993, VIROLOGY, V197, P576, DOI 10.1006/viro.1993.1631
   FUJIYAMA C, 1993, J INFECT DIS, V168, P1075, DOI 10.1093/infdis/168.4.1075
   Fujiyoshi T, 1999, AIDS RES HUM RETROV, V15, P1235, DOI 10.1089/088922299310124
   FUKUSHIMA Y, 1995, AIDS RES HUM RETROV, V11, P637, DOI 10.1089/aid.1995.11.637
   GESSAIN A, 1985, LANCET, V2, P407
   GLVAOCASTRO B, 1986, LANCET, V1, P976
   Hall BG, 1996, MOL BIOL EVOL, V13, P1
   HALL WW, 1994, SEMIN VIROL, V5, P165, DOI 10.1006/smvy.1994.1017
   HALL WW, 1992, J VIROL, V66, P2456, DOI 10.1128/JVI.66.4.2456-2463.1992
   HENEINE W, 1991, NEW ENGL J MED, V324, P565, DOI 10.1056/NEJM199102213240815
   HINUMA Y, 1993, LEUKEMIA RES, V17, P379, DOI 10.1016/0145-2126(93)90027-I
   IJICHI S, 1993, JPN J CANCER RES, V84, P1215, DOI 10.1111/j.1349-7006.1993.tb02824.x
   ISHAK R, 1995, AIDS RES HUM RETROV, V11, P813, DOI 10.1089/aid.1995.11.813
   LAIRMORE MD, 1990, P NATL ACAD SCI USA, V87, P8840, DOI 10.1073/pnas.87.22.8840
   LEE H, 1989, SCIENCE, V244, P471, DOI 10.1126/science.2655084
   LEE H, 1993, VIROLOGY, V196, P57, DOI 10.1006/viro.1993.1454
   LEVINE PH, 1993, AIDS RES HUM RETROV, V9, P123, DOI 10.1089/aid.1993.9.123
   Lewis MJ, 2000, VIROLOGY, V271, P142, DOI 10.1006/viro.2000.0284
   MALONEY EM, 1992, J INFECT DIS, V166, P100, DOI 10.1093/infdis/166.1.100
   MIURA T, 1997, J MOL EVOL, V44, P76
   MUELLER N, 1991, CANCER CAUSE CONTROL, V2, P37, DOI 10.1007/BF00052359
   Murphy EL, 1996, J ACQ IMMUN DEF SYND, V13, pS215, DOI 10.1097/00042560-199600001-00032
   NAKAUCHI CM, 1990, MEM I OSWALDO CRUZ, V85, P29, DOI 10.1590/S0074-02761990000100004
   OSAME M, 1986, LANCET, V1, P1031
   PARDI D, 1993, J VIROL, V67, P7663, DOI 10.1128/JVI.67.12.7663-7667.1993
   SALZANO FM, 1977, AM J PHYS ANTHROPOL, V47, P337, DOI 10.1002/ajpa.1330470214
   SHIMOTOHNO K, 1985, P NATL ACAD SCI USA, V82, P3101, DOI 10.1073/pnas.82.10.3101
   Switzer WM, 1996, AIDS RES HUM RETROV, V12, P635, DOI 10.1089/aid.1996.12.635
   SWITZER WM, 1995, J VIROL, V69, P621, DOI 10.1128/JVI.69.2.621-632.1995
   TAKAHASHI H, 1993, AIDS RES HUM RETROV, V9, P721, DOI 10.1089/aid.1993.9.721
   Talarmin A, 1999, J GEN VIROL, V80, P3083, DOI 10.1099/0022-1317-80-12-3083
   TEDDER RS, 1984, LANCET, V2, P125
   Van Brussel M, 1998, VIROLOGY, V243, P366, DOI 10.1006/viro.1998.9075
   Vandamme AM, 1998, J VIROL, V72, P4327, DOI 10.1128/JVI.72.5.4327-4340.1998
NR 46
TC 37
Z9 45
U1 0
U2 4
PU MARY ANN LIEBERT INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 0889-2229
J9 AIDS RES HUM RETROV
JI Aids Res. Hum. Retrovir.
PD JAN 1
PY 2002
VL 18
IS 1
BP 71
EP 77
DI 10.1089/088922202753394736
PG 7
WC Immunology; Infectious Diseases; Virology
SC Immunology; Infectious Diseases; Virology
GA 513FN
UT WOS:000173367400008
PM 11804558
OA Green Published
DA 2020-10-22
ER

PT J
AU Porto, AF
   Neva, FA
   Bittencourt, H
   Lisboa, W
   Thompson, R
   Alcantara, L
   Carvalho, EM
AF Porto, AF
   Neva, FA
   Bittencourt, H
   Lisboa, W
   Thompson, R
   Alcantara, L
   Carvalho, EM
TI HTLV-1 decreases Th2 type of immune response in patients with
   strongyloidiasis
SO PARASITE IMMUNOLOGY
LA English
DT Article
DE HTLV-1; strongyloidiasis; IgE; S. stercoralis
ID T-CELL LEUKEMIA; INHIBITS CYTOKINE PRODUCTION; LYMPHOTROPIC VIRUS
   TYPE-1; STERCORALIS HYPERINFECTION; LYMPHOCYTES-T; INFECTION; MICE;
   ANTIBODY; CLONES; IL-10
AB Eosinophils, immunoglobilin (Ig)E and cytokines have important roles in defence mechanisms against helminths. In this study, the influence of HTLV-1 infection, characterized by a Th1 type of immune response, was evaluated on the cytokine pattern and parasitic specific IgE response in patients with strongyloidiasis. Patients were divided into four groups: strongyloidiasis without HTLV-1 infection, strongyloidiasis with HTLV-1, HTLV-1 without strongyloidiasis and controls without either helminth infection or HTLV-1. The cytokine profile was determined in supernatants of mononuclear cells stimulated with Strongyloides stercoralis crude antigen and the parasite specific IgE was measured by ELISA. Patients coinfected with HTLV-1 had higher levels of interfron (IFN)-gamma and interleukin (IL)-10 (P < 0.05) and lower levels of IL-5 and IgE (P < 0.05) than patients with strongyloidiasis without HTLV-1. There was an inverse relationship between IFN-gamma and IL-5 (P = 0.01; r(s) = - 0.37) and between IFN-gamma and parasite specific IgE (P = 0.01; r(s) = - 0.39), and a direct relationship between IFN-gamma and IL-10 (P = 0.04;, r(s) = 0.35). These data show that coinfection with HTLV-1 decreases IL-5 and IgE responses in patients with strongyloidiasis consistent with a relative switch from Th2 to Th1 response. Immunological responses such as these are important in the control of this helminthic infection.
C1 Univ Fed Bahia, Hosp Univ Prof Edgard Santos, Serv Imunol, Lab Imunol, BR-40110160 Salvador, BA, Brazil.
   NIAID, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA.
   Inst Gastroenterol & Hepatol, Salvador, BA, Brazil.
   Serv Transfusao Sangue, Salvador, BA, Brazil.
   Fundacao Oswaldo Cruz, Lab Avancado Saude Publ, Salvador, BA, Brazil.
RP Carvalho, EM (corresponding author), Univ Fed Bahia, Hosp Univ Prof Edgard Santos, Serv Imunol, Lab Imunol, 5 Andar,Rua Joao das Botas S-N Canela, BR-40110160 Salvador, BA, Brazil.
EM edgar@ufba.br
OI Alcantara, Luiz/0000-0002-6769-9931
FU NIAID NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [AI-30639] Funding Source: Medline
CR AHMAD A, 1991, J IMMUNOL, V146, P3563
   Arima N, 1997, LEUKEMIA LYMPHOMA, V26, P479, DOI 10.3109/10428199709050884
   Atkins NS, 1998, J ACQ IMMUN DEF SYND, V18, P188, DOI 10.1097/00042560-199806010-00013
   Bancroft AJ, 1997, EUR J IMMUNOL, V27, P866, DOI 10.1002/eji.1830270410
   Barner M, 1998, CURR BIOL, V8, P669, DOI 10.1016/S0960-9822(98)70256-8
   CAPRON M, 1978, J IMMUNOL, V121, P2518
   CARVALHO EM, 1983, T ROY SOC TROP MED H, V77, P346, DOI 10.1016/0035-9203(83)90162-1
   COFFMAN RL, 1989, SCIENCE, V245, P308, DOI 10.1126/science.2787531
   Finkelman FD, 1997, ANNU REV IMMUNOL, V15, P505, DOI 10.1146/annurev.immunol.15.1.505
   FINKELMAN FD, 1991, IMMUNOL TODAY, V12, P62
   FIORENTINO DF, 1989, J EXP MED, V170, P2081, DOI 10.1084/jem.170.6.2081
   FIORENTINO DF, 1991, J IMMUNOL, V147, P3815
   Goldhill J, 1997, AM J PHYSIOL-GASTR L, V272, pG1135
   Gotuzzo E, 1999, AM J TROP MED HYG, V60, P146, DOI 10.4269/ajtmh.1999.60.146
   Hayashi J, 1997, AM J TROP MED HYG, V56, P71, DOI 10.4269/ajtmh.1997.56.71
   Hogarth PJ, 1999, PARASITE IMMUNOL, V21, P81, DOI 10.1046/j.1365-3024.1999.00204.x
   HOLLSBERG P, 1992, J IMMUNOL, V148, P3256
   KING CL, 1993, J CLIN INVEST, V92, P1667, DOI 10.1172/JCI116752
   KLIMPEL GR, 1990, CELL IMMUNOL, V128, P603, DOI 10.1016/0008-8749(90)90052-S
   KORENAGA M, 1994, INT J PARASITOL, V24, P951, DOI 10.1016/0020-7519(94)90159-7
   MADDEN KB, 1991, J IMMUNOL, V147, P1387
   MCRURY J, 1986, CLIN EXP IMMUNOL, V65, P631
   MOORE KW, 1993, ANNU REV IMMUNOL, V11, P165, DOI 10.1146/annurev.immunol.11.1.165
   NAKADA K, 1984, LANCET, V1, P633
   Neva FA, 1998, J INFECT DIS, V178, P1856, DOI 10.1086/314507
   NEWTON RC, 1992, AM J MED, V92, P202, DOI 10.1016/0002-9343(92)90113-P
   PATEY O, 1992, AIDS, V6, P575, DOI 10.1097/00002030-199206000-00009
   PHELPS KR, 1991, AM J MED SCI, V302, P224, DOI 10.1097/00000441-199110000-00006
   Plumelle Y, 1997, AM J CLIN PATHOL, V107, P81
   POPOVIC M, 1984, SCIENCE, V226, P459, DOI 10.1126/science.6093248
   ROBINSON RD, 1994, J INFECT DIS, V169, P692, DOI 10.1093/infdis/169.3.692
   ROMAGNANI S, 1991, INT J CLIN LAB RES, V21, P152
   Rossi Claudio L., 1993, Revista do Instituto de Medicina Tropical de Sao Paulo, V35, P361, DOI 10.1590/S0036-46651993000400010
   Rotman HL, 1997, PARASITE IMMUNOL, V19, P29, DOI 10.1046/j.1365-3024.1997.d01-142.x
   RUSSO DM, 1992, J IMMUNOL, V148, P202
   SATO Y, 1994, T ROY SOC TROP MED H, V88, P59, DOI 10.1016/0035-9203(94)90499-5
   SHER A, 1991, J IMMUNOL, V147, P2713
   TAGA K, 1992, J IMMUNOL, V148, P1143
   URBAN JF, 1995, J IMMUNOL, V154, P4675
   YSSEL H, 1992, J IMMUNOL, V149, P2378
NR 40
TC 79
Z9 84
U1 0
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0141-9838
EI 1365-3024
J9 PARASITE IMMUNOL
JI Parasite Immunol.
PD SEP
PY 2001
VL 23
IS 9
BP 503
EP 507
DI 10.1046/j.1365-3024.2001.00407.x
PG 5
WC Immunology; Parasitology
SC Immunology; Parasitology
GA 473CL
UT WOS:000171022000005
PM 11589779
OA Green Published
DA 2020-10-22
ER

PT J
AU Bittencourt, AL
   Dourado, I
   Bastos, P
   Santos, M
   Valadao, E
   Alcantara, LCJ
   Galvao-Castro, B
AF Bittencourt, AL
   Dourado, I
   Bastos, P
   Santos, M
   Valadao, E
   Alcantara, LCJ
   Galvao-Castro, B
TI Human T-cell lymphotropic virus type 1 infection among pregnant women in
   northeastern Brazil
SO JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
LA English
DT Article
DE clinical epidemiologic findings of HTLV-1; HTLV-1-associated infective
   dermatitis; HTLV-1 transmission; obstetric aspects of HTLV-1 infection
ID CHILD TRANSMISSION; HTLV-I; LEUKEMIA/LYMPHOMA
AB An evaluation of human T-cell lymphotropic virus type 1 (HTLV-1) infection among 6754 pregnant women in Salvador. Bahia. Brazil using enzyme-linked immunosorbent assay, Western blot analysis, and polymerase chain reaction assay found a rate of infection of 0.84% (57 of 6754 women). Epidemiologic and obstetric data on the HTLV-1-positive pregnant women were analyzed and compared with data on a control group of HTLV-1-negative pregnant women. The mean age of the HTLV-1-positive women was 26.2 years. All were seronegative for HIV and syphilis. and only 2 reported a past history of sexually transmitted infection and more than 10 sexual partners. Of the HTLV-1-positive women, 88.5% were breast-fed. 4% were bottle fed, and 7.5% did not know. Six women had received blood transfusions, and only I reported intravenous drug use. Fifty-two HTLV-1-positive women could be followed: 45 had full-term deliveries. 5 had premature deliveries, and 2 had abortions. Our results indicate that (1) the frequency of HTLV-1 infection among pregnant women is relatively high in Salvador, Bahia. Brazil: (2) maternal infection was probably acquired more frequently through breast-feeding, but the sexual route was certainly the second most important means of transmission: (3) HTLV-1-positive women had a history of eczema-like infections in childhood more frequently than the control group: (4) HTLV-1 infection did not interfere in the course of pregnancy; and (5) no associated congenital infections were observed in the HTLV-1-positive women.
C1 Univ Fed Bahia, Sch Med, Dept Pathol, BR-41170290 Salvador, BA, Brazil.
   Univ Fed Bahia, Sch Med, Inst Saude Colet, BR-41170290 Salvador, BA, Brazil.
   Inst Perinatol Bahia, Salvador, BA, Brazil.
   State Publ Hlth Lab Bahia LACEN, Salvador, BA, Brazil.
   Oswaldo Cruz Fdn, Goncalo Moniz Res Ctr LASP, Salvador, BA, Brazil.
RP Bittencourt, AL (corresponding author), Hosp Univ Prof Edgard Santos, Serv Anat Patol, Rua Joao da Botas S-N, BR-40110060 Salvador, BA, Brazil.
RI Dourado, Ines/Q-6535-2016
OI Dourado, Ines/0000-0003-1675-2146; Alcantara, Luiz/0000-0002-6769-9931
CR ARAUJO CA, 1994, EUR J EPIDEMIOL, V10, P165
   Barbosa HS, 1999, J ACQ IMMUN DEF SYND, V21, P65, DOI 10.1097/00126334-199905010-00009
   BATTAGLI.FC, 1967, J PEDIATR-US, V71, P159, DOI 10.1016/S0022-3476(67)80066-0
   BENIRSCHKE K, 1995, PATHOLOGY HUMAN PLAC
   Dourado I, 1999, MEM I OSWALDO CRUZ, V94, P13, DOI 10.1590/S0074-02761999000100006
   FLEISS JL, 1981, SAT METHODS RATES PR
   GalvaoCastro B, 1997, TRANSFUSION, V37, P242, DOI 10.1046/j.1537-2995.1997.37297203532.x
   Hino S, 1996, J ACQ IMMUN DEF SYND, V13, pS199, DOI 10.1097/00042560-199600001-00030
   La Grenade L, 1996, J ACQ IMMUN DEF SYND, V13, pS42
   MANNING FA, 1991, PRINCIPLES PRACTICE, P331
   Marsh BJ, 1996, CLIN INFECT DIS, V23, P138, DOI 10.1093/clinids/23.1.138
   PANNUTI CS, 1985, REV I MED TROP, V27, P105, DOI 10.1590/S0036-46651985000200010
   SANTOS JI, 1995, REV INST MED TROP SP, V37, P149
   SUGIYAMA H, 1986, J MED VIROL, V20, P253, DOI 10.1002/jmv.1890200307
   Tortevoye P, 2000, INT J CANCER, V87, P534, DOI 10.1002/1097-0215(20000815)87:4&lt;534::AID-IJC12&gt;3.0.CO;2-M
   UEDA K, 1993, INT J CANCER, V53, P597, DOI 10.1002/ijc.2910530412
   VALLEJO A, 1995, J VIROL METHODS, V51, P9, DOI 10.1016/0166-0934(94)00093-V
NR 17
TC 45
Z9 52
U1 0
U2 3
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 1525-4135
J9 J ACQ IMMUN DEF SYND
JI J. Acquir. Immune Defic. Syndr.
PD APR 15
PY 2001
VL 26
IS 5
BP 490
EP 494
PG 5
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA 433QP
UT WOS:000168771500014
PM 11391171
OA Green Published
DA 2020-10-22
ER

EF